U.S. patent application number 14/151271 was filed with the patent office on 2014-08-07 for plants with increased yield.
This patent application is currently assigned to BASF Plant Science GmbH. The applicant listed for this patent is BASF Plant Science GmbH. Invention is credited to Oliver Blasing, Piotr Puzio, Gerhard Ritte, Hardy Schon, Oliver Thimm.
Application Number | 20140223605 14/151271 |
Document ID | / |
Family ID | 40032633 |
Filed Date | 2014-08-07 |
United States Patent
Application |
20140223605 |
Kind Code |
A1 |
Puzio; Piotr ; et
al. |
August 7, 2014 |
Plants with Increased Yield
Abstract
This invention relates generally to a plant cell with enhanced
nitrogen use efficiency and/or increased biomass production as
compared to a corresponding non-transformed wild type plant cell by
increasing or generating one or more activities of polypeptides
associated with enhanced nitrogen use efficiency in plants.
Inventors: |
Puzio; Piotr; (Mariakerke
(Gent), BE) ; Blasing; Oliver; (Potsdam, DE) ;
Thimm; Oliver; (Neustadt, DE) ; Ritte; Gerhard;
(Potsdam, DE) ; Schon; Hardy; (Berlin,
DE) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
BASF Plant Science GmbH |
Ludwigshafen |
|
DE |
|
|
Assignee: |
BASF Plant Science GmbH
Ludwigshafen
DE
|
Family ID: |
40032633 |
Appl. No.: |
14/151271 |
Filed: |
January 9, 2014 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
12678387 |
Mar 16, 2010 |
8664475 |
|
|
PCT/EP08/62362 |
Sep 17, 2008 |
|
|
|
14151271 |
|
|
|
|
Current U.S.
Class: |
800/290 ;
435/320.1; 435/411; 435/412; 435/414; 435/415; 435/416; 435/417;
435/419; 435/468; 435/69.1; 536/23.2; 536/23.6; 800/278; 800/298;
800/306; 800/312; 800/314; 800/317; 800/317.1; 800/317.2;
800/317.3; 800/317.4; 800/320; 800/320.1; 800/320.2; 800/320.3;
800/322 |
Current CPC
Class: |
C07K 14/415 20130101;
Y02A 40/146 20180101; C12N 15/8273 20130101; C12N 15/8261
20130101 |
Class at
Publication: |
800/290 ;
800/278; 435/468; 800/298; 435/419; 800/320.1; 800/320.3; 800/320;
800/320.2; 800/312; 800/314; 800/306; 800/317.1; 800/322; 800/317;
800/317.2; 800/317.3; 800/317.4; 435/411; 435/412; 435/414;
435/415; 435/416; 435/417; 435/320.1; 435/69.1; 536/23.6;
536/23.2 |
International
Class: |
C12N 15/82 20060101
C12N015/82 |
Foreign Application Data
Date |
Code |
Application Number |
Sep 18, 2007 |
EP |
07117448.6 |
Jul 25, 2008 |
EP |
08161134.5 |
Claims
1. A method for producing a transgenic plant, plant cell or plant
part with increased yield, enhanced nitrogen use efficiency (NUE)
and/or increased biomass production as compared to a corresponding
non-transformed wild type plant, plant cell or plant part,
comprising increasing or generating in a plant, plant cell or plant
part one or more activities selected from the group consisting of
3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease.
2. A method for producing a transgenic plant, plant cell or plant
part with increased yield, enhanced nitrogen use efficiency (NUE)
and/or increased biomass production as compared to a corresponding
non-transformed wild type plant, plant cell or plant part,
comprising increasing or generating in a plant, plant cell or plant
part the expression and/or activity of a polypeptide encoded by a
nucleic acid molecule selected from the group consisting of: (a) a
nucleic acid molecule encoding the polypeptide shown in column 5 or
7 of table II; (b) a nucleic acid molecule shown in column 5 or 7
of table I; (c) a nucleic acid molecule having at least 30%
sequence identity to any one of the nucleic acid molecules shown in
column 5 or 7 of table I and conferring increased yield, enhanced
NUE and/or increased biomass production when expressed in a plant,
plant cell or plant part as compared to a corresponding
non-transformed wild type plant, plant cell or plant part; (d) a
nucleic acid molecule encoding a polypeptide having at least 30%
sequence identity to any one of the polypeptides shown in column 5
or 7 of table II and conferring increased yield, enhanced NUE
and/or increased biomass production when expressed in a plant,
plant cell or plant part as compared to a corresponding
non-transformed wild type plant, plant cell or plant part; (e) a
nucleic acid molecule which hybridizes with the nucleic acid
molecule of (a) or (b) under stringent hybridization conditions and
confers increased yield, enhanced NUE and/or increased biomass
production when expressed in a plant, plant cell or plant part as
compared to a corresponding non-transformed wild type plant, plant
cell or plant part; and (f) a nucleic acid molecule encoding a
polypeptide comprising one or more polypeptide motifs as shown in
column 7 of table IV and conferring increased yield, enhanced NUE
and/or increased biomass production when expressed in a plant,
plant cell or plant part as compared to a corresponding
non-transformed wild type plant, plant cell or plant part, and
optionally selecting for a plant, plant cell or plant part with
increased yield, enhanced nitrogen use efficiency (NUE) and/or
increased biomass production as compared to a corresponding
non-transformed wild type plant, plant cell or plant part.
3. The method of claim 2, wherein the expression and/or activity of
said polypeptide is increased or generated by transforming said
nucleic acid molecule into said plant, plant cell or plant
part.
4. The method of claim 2, wherein said transgenic plant, plant cell
or plant part has increased yield, enhanced nitrogen use efficiency
(NUE) and/or increased biomass production as compared to a
corresponding non-transformed wild type plant, plant cell or plant
part under standard growth conditions.
5. A transgenic plant, plant cell or plant part obtained by the
method of claim 2, wherein said transgenic plant, plant cell or
plant part has increased yield, enhanced nitrogen use efficiency
(NUE) and/or increased biomass production as compared to a
corresponding non-transformed wild type plant, plant cell or plant
part.
6. The transgenic plant, plant cell or plant part of claim 5,
wherein said plant is, or said plant cell or plant part is from, a
monocotyledonous plant or a dicotyledonous plant.
7. The transgenic plant, plant cell or plant part of claim 5,
wherein said plant is, or said plant cell or plant part is from, a
plant selected from the group consisting of maize, wheat, rye, oat,
triticale, rice, barley, soybean, peanut, cotton, oil seed rape,
canola, winter oil seed rape, cotton, corn, manihot, pepper,
sunflower, flax, borage, safflower, linseed, primrose, rapeseed,
turnip rape, tagetes, solanaceous plants, potato, tobacco,
eggplant, tomato, Vicia species, pea, alfalfa, coffee, cacao, tea,
Salix species, oil palm, coconut, perennial grass, forage crops and
Arabidopsis thaliana.
8. Seeds or progeny of the transgenic plant of claim 5, wherein
said seeds or progeny comprise a recombinant nucleic acid molecule
encoding said polypeptide.
9. Harvestable parts of the transgenic plant of claim 5, wherein
said harvestable parts comprise a recombinant nucleic acid molecule
encoding said polypeptide.
10. An isolated recombinant nucleic acid molecule selected from the
group consisting of: (a) a nucleic acid molecule encoding the
polypeptide shown in column 5 or 7 of table II B; (b) a nucleic
acid molecule shown in column 5 or 7 of table I B; (c) a nucleic
acid molecule having at least 30% sequence identity to any one of
the nucleic acid molecules shown in column 5 or 7 of table I and
conferring increased yield, enhanced NUE and/or increased biomass
production when expressed in a plant, plant cell or plant part as
compared to a corresponding non-transformed wild type plant, plant
cell or plant part; (d) a nucleic acid molecule encoding a
polypeptide having at least 30% sequence identity to any one of the
polypeptides shown in column 5 or 7 of table II and conferring
increased yield, enhanced NUE and/or increased biomass production
when expressed in a plant, plant cell or plant part as compared to
a corresponding non-transformed wild type plant, plant cell or
plant part; (e) a nucleic acid molecule which hybridizes with the
nucleic acid molecule of (a) or (b) under stringent hybridization
conditions and confers increased yield, enhanced NUE and/or
increased biomass production when expressed in a plant, plant cell
or plant part as compared to a corresponding non-transformed wild
type plant, plant cell or plant part; and (f) a nucleic acid
molecule encoding a polypeptide comprising one or more polypeptide
motifs as shown in column 7 of table IV and conferring increased
yield, enhanced NUE and/or increased biomass production when
expressed in a plant, plant cell or plant part as compared to a
corresponding non-transformed wild type plant, plant cell or plant
part.
11. An expression construct comprising the isolated recombinant
nucleic acid molecule of claim 10.
12. A vector comprising: (a) the isolated recombinant nucleic acid
molecule of claim 10; or (b) an expression construct comprising the
isolated recombinant nucleic acid molecule of (a).
13. A non-human host cell comprising: (a) the isolated recombinant
nucleic acid molecule of claim 10; (b) an expression construct
comprising the isolated recombinant nucleic acid molecule of (a);
or (c) a vector comprising the isolated recombinant nucleic acid
molecule of (a) or the expression construct of (b).
14. A process for producing a polypeptide comprising producing a
polypeptide in the non-human host cell of claim 13.
15. A transgenic plant, plant cell or plant part comprising: (a)
the isolated recombinant nucleic acid molecule of claim 10; (b) an
expression construct comprising the isolated recombinant nucleic
acid molecule of (a); or (c) a vector comprising the isolated
recombinant nucleic acid molecule of (a) or the expression
construct of (b).
16. The transgenic plant, plant cell or plant part of claim 15,
wherein said transgenic plant, plant cell or plant part shows
improved nutrient use efficiency, improved abiotic stress
tolerance, or both improved nutrient use efficiency and improved
abiotic stress tolerance.
17. The transgenic plant, plant cell or plant part of claim 15,
wherein said transgenic plant, plant cell or plant part shows
enhanced NUE.
18. The transgenic plant, plant cell or plant part of claim 15,
wherein said transgenic plant, plant cell or plant part shows
increased low temperature tolerance and/or increased tolerance to
drought conditions.
19. The transgenic plant, plant cell or plant part of claim 15,
wherein said transgenic plant, plant cell or plant part has
increased yield in the absence of stress as well as nutrient
deficiency.
20. A method for producing a transgenic plant, plant cell or plant
part with increased yield, enhanced nitrogen use efficiency (NUE)
and/or increased biomass production as compared to a corresponding
non-transformed wild type plant, plant cell or plant part,
comprising: (a) transforming a plant, plant cell or plant part an
expression vector comprising the isolated recombinant nucleic acid
molecule of claim 10; (b) generating from the plant cell or plant
part a transgenic plant; and (c) selecting for a transgenic plant
having increased yield, enhanced nitrogen use efficiency (NUE)
and/or increased biomass production as compared to a corresponding
non-transformed wild type plant.
Description
RELATED APPLICATIONS
[0001] This application is a divisional application of U.S. patent
application Ser. No. 12/678,387, filed on Mar. 16, 2010, which is a
national stage application (under 35 U.S.C. .sctn.371) of
PCT/EP2008/062362, filed Sep. 17, 2008, which claims benefit of
European application 07117448.6, filed Sep. 18, 2007 and European
application 08161134.5, filed Jul. 25, 2008. The entire contents of
each of these applications are hereby incorporated by reference
herein in their entirety.
SUBMISSION OF SEQUENCE LISTING
[0002] The Sequence Listing associated with this application is
filed in electronic format via EFS-Web and hereby incorporated by
reference into the specification in its entirety. The name of the
text file containing the Sequence Listing is
Sequence_Listing.sub.--13987.sub.--00234. The size of the text file
is 68,247 KB, and the text file was created on Jan. 8, 2014.
[0003] The present invention pertains to the field of molecular
biology, plant genetics, plant physiology and developmental
biology. More specifically, the present invention disclosed herein
provides plant cells comprising nucleic acids enhancing or
improving one or more traits of a transgenic plant, plants
comprising such cells, progeny, seed and pollen derived from such
plants, and methods of making and methods of using such plant
cell(s) or plant(s), progeny, seed(s) or pollen. Particularly, said
improved trait(s) are manifested in an increased yield, preferably
by improving one or more yield-related trait(s).
[0004] Under field conditions, plant performance, for example in
terms of growth, development, biomass accumulation and seed
generation, depends on a plant's tolerance and acclimation ability
to numerous environmental conditions, changes and stresses. Since
the beginning of agriculture and horticulture, there was a need for
improving plant traits in crop cultivation. Besides increasing
yield by applying technical advances in crop planting, breeding
strategies foster crop properties to withstand biotic and abiotic
stresses, to increase nutrient use efficiency and to alter other
crop specific yield parameters. The intrinsic growth and
development characteristics of plants are improved, tolerance to
biotic and abiotic stresses are introduced to maintain yield under
environmental stress conditions and to extend acreage under
different climatic situations. Crops with better nutrient use
efficiency are developed to reduce fertilizer input and also to
extend acreage into regions with nutrient poor soil.
[0005] Plants are sessile organisms and consequently need to cope
with various environmental stresses. Biotic stresses such as plant
pests and pathogens on the one hand, and abiotic environmental
stresses on the other hand are major limiting factors of plant
growth and productivity (Boyer, Plant Productivity and Environment,
Science 218, 443-448 (1982); Bohnert et al., Adaptations to
Environmental Stresses, Plant Cell 7 (7), 1099-1111 (1995)),
thereby limiting plant cultivation and geographical distribution.
Plants exposed to the different stresses typically have low yields
of plant material, seeds, fruit and other products. Crop losses and
crop yield losses of e.g. major crops such as rice, maize (corn),
oil seed rape (including winter oil seed rape and canola), cotton,
soybean and wheat caused by these stresses represent a significant
economic and political factor and contribute to food shortages,
particularly in many underdeveloped countries.
[0006] Conventional means for crop and horticultural improvements
today utilize selective breeding techniques to identify plants with
desirable characteristics. Such conventional techniques, however,
have several drawbacks. Very often plants contain heterogeneous
genetic components that may not always result in the desirable
trait being passed on from parent plants, particularly not without
other negative impacts. Thus, particularly complex traits such as
yield and stress phenomena make genetic optimization by traditional
breeding approaches difficult, costly and time-consuming. On the
contrary, advances in molecular biology have allowed modifying the
germplam of plants in a specific way. The modification of a single
gene, for example, resulted in several cases in a significant
increase in e.g. stress tolerance (Wang et al., 2003) and other
yield-related traits. As different plants have to resist different
kinds and strengths of stress in different cultivation areas there
is still a need to identify genes which show various combinations
of stress resistance to produce optimal yield. There is still a
need to identify genes which have the overall capacity to improve
yield of plants.
[0007] The present invention provides transgenic plant nuclei
and/or transgenic plant cells comprising one or more nucleic
acid(s) which enhances or improves one or more trait(s) of a
transgenic plant, plants comprising such cells, progeny, seed and
pollen derived from such plants, and methods of making and methods
of using such plant cell(s) or plant(s), progeny, seed(s) or
pollen. Particularly, said improved trait(s) are manifested in an
increased yield.
[0008] In one embodiment, the present invention provides a method
for producing such transgenic plant cell(s) or plant(s) with
increased yield by increasing or generating one or more activities
selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease.
[0009] In a further embodiment, the activity is increased by
increasing the amount and/or activity of one or more protein(s)
having an activity selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydrolyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease; and wherein such one
or more protein(s) each comprises a polypeptide as depicted in
table II, column 5 or 7.
[0010] Said increased yield in accordance with the present
invention can typically be achieved by enhancing or improving, in
comparison to a non-transformed starting or wild-type plant, one or
more yield-related traits of a plant. Such yield-related traits of
a plant the improvement of which results in increased yield
comprise, without limitation, the increase of the intrinsic yield
capacity of a plant, improved nutrient use efficiency, and/or
increased stress tolerance.
[0011] According to the present invention, yield-related traits
concerning an increase of the intrinsic yield capacity of a plant
may be manifested by improving the specific (intrinsic) seed yield
(e.g. in terms of increased seed/grain size, increased ear number,
increased seed number per ear, improvement of seed filling,
improvement of seed composition, embryo and/or endosperm
improvements, or the like); modification and improvement of
inherent growth and development mechanisms of a plant (such as
plant height, plant growth rate, pod number, pod position on the
plant, number of internodes, incidence of pod shatter, efficiency
of nodulation and nitrogen fixation, efficiency of carbon
assimilation, improvement of seedling vigour/early vigour, enhanced
efficiency of germination (under stressed or non-stressed
conditions), improvement in plant architecture, cell cycle
modifications, photosynthesis modifications, various signaling
pathway modifications, modification of transcriptional regulation,
modification of translational regulation, modification of enzyme
activities, and the like); and/or the like.
[0012] According to the present invention, yield-related traits
concerning an improvement or increase in nutrient use efficiency of
a plant may be manifested by improving a plant's general efficiency
of nutrient assimilation (e.g. in terms of improvement of general
nutrient uptake and/or transport, improving a plant's general
transport mechanisms, assimilation pathway improvements, and the
like), and/or by improving specific nutrient use efficiency of
nutrients including, but not limited to, phosphorus, potassium, and
nitrogen.
[0013] According to the present invention, yield-related traits
concerning an improvement or increase of stress tolerance of a
plant may be manifested by improving or increasing a plant's
tolerance against stress, particularly abiotic stress. In the
present application, abiotic stress refers generally to abiotic
environmental conditions a plant is typically confronted with,
including conditions which are typically referred to as "abiotic
stress" conditions including, but not limited to, drought
(tolerance to drought may be achieved as a result of improved water
use efficiency), heat, low temperatures and cold conditions (such
as freezing and chilling conditions), salinity, osmotic stress,
shade, high plant density, mechanical stress, oxidative stress, and
the like.
[0014] According to the present invention, the improvement of
yield-related traits relating to an increase of the intrinsic yield
capacity of a plant and/or to a plant's tolerance to abiotic
stress(es) is a particularly preferred embodiment for enhancing or
improving yield of said plant.
[0015] The term "yield" as used herein generally refers to a
measurable produce from a plant, particularly a crop.
[0016] Yield and yield increase (in comparison to a non-transformed
starting or wild-type plant) can be measured in a number of ways,
and it is understood that a skilled person will be able to apply
the correct meaning in view of the particular embodiments, the
particular crop concerned and the specific purpose or application
concerned.
[0017] In the preferred embodiments of the present invention
described herein, an increase in yield refers to increased biomass
yield, increased seed yield, and/or increased yield regarding one
or more specific content(s) of a whole plant or parts thereof or
plant seed(s).
[0018] In preferred embodiments, "yield" refers to biomass yield
comprising dry weight biomass yield and/or fresh weight biomass
yield, each with regard to the aerial and/or underground parts of a
plant, depending on the specific circumstances (test conditions,
specific crop of interest, application of interest, and the like).
In each case, biomass yield may be calculated as fresh weight, dry
weight or a moisture adjusted basis, and on the other hand on a per
plant basis or in relation to a specific area (e.g. biomass yield
per acre/square meter/or the like).
[0019] In other preferred embodiments, "yield" refers to seed yield
which can be measured by one or more of the following parameters:
number of seed or number of filled seed (per plant or per area
(acre/square meter or the like)); seed filling rate (ratio between
number of filled seeds and total number of seeds); number of
flowers per plant; seed biomass or total seed weight (per plant or
per area (acre/square meter or the like); thousand kernel weight
(TKW; extrapolated from the number of filled seeds counted and
their total weight; an increase in TKW may be caused by an
increased seed size, an increased seed weight, an increased embryo
size, and/or an increased endosperm); or other parameters allowing
to measure seed yield. Seed yield may be determined on a dry weight
or on a fresh weight basis, or typically on a moisture adjusted
basis, e.g. at 15.5 percent moisture.
[0020] In further preferred embodiments, yield refers to the
specific content and/or composition of a harvestable product,
including, without limitation, an enhanced and/or improved sugar
content or sugar composition, an enhanced or improved starch
content and/or starch composition, an enhanced and/or improved oil
content and/or oil composition (such as enhanced seed oil content),
an enhanced or improved protein content and/or protein composition
(such as enhanced seed protein content), an enhanced and/or
improved vitamin content and/or vitamin composition, or the
like.
[0021] In a preferred meaning according to the present application,
"yield" as described herein may also refer to the harvestable yield
of a plant, which largely depends on the specific plant/crop of
interest as well as its intended application (such as food
production, feed production, processed food production, biofuel,
biogas or alcohol production, or the like) of interest in each
particular case. Thus, yield may also be calculated as harvest
index (expressed as a ratio of the weight of the respective
harvestable parts divided by the total biomass), harvestable parts
weight per area (acre, square meter, or the like); and the
like.
[0022] Preferably, the preferred enhanced or improved yield
characteristics of a plant described herein according to the
present invention can be achieved in the absence or presence of
stress conditions.
[0023] The meaning of "yield" is, thus, mainly dependent on the
crop of interest and the intended application, and it is
understood, that the skilled person will understand in each
particular case what is meant from the circumstances of the
description.
[0024] In a preferred embodiment of the present invention, plant
yield is increased by increasing one or more of yield-related
traits selected from one or more improvements concerning the
nutrient use efficiency of a photosynthetic active organism,
especially a plant. An improvement or increase in nutrient use
efficiency of a plant may be manifested by improving a plant's
general efficiency of nutrient assimilation (e.g. in terms of
improvement of general nutrient uptake and/or transport, improving
a plant's general transport mechanisms, assimilation pathway
improvements, and the like), and/or by improving specific nutrient
use efficiency of nutrients including, but not limited to,
phosphorus, potassium, and nitrogen.
[0025] The term "nutrient deficiency" refers to conditions where
the respective photosynthetic organism, especially a plant, lacks
of nutrient, like phosphorus, potassium or nitrogen; especially the
term "nitrogen deficiency" refers to conditions where the
respective photosynthetic organism, especially a plant, lacks of or
nitrogen.
[0026] In a preferred embodiment the present invention relates to
the manipulation of the nitrogen use efficiency in photosynthetic
active organisms, preferably in plants. In particular, the present
invention relates to a process for the enhanced nitrogen uptake
and/or nitrogen utilization, in photosynthetic active organisms,
especially in plants. Also the present invention relates to a
process for enhanced biomass production, especially under nitrogen
limited conditions, in photosynthetic active organisms, especially
in plants.
[0027] In particular, this invention relates to plant cells and/or
plants tailored to grow under conditions of nitrogen deficiency,
and/or to plant cells and/or plants showing increased yield when
grown under non-nitrogen-deficiency conditions.
[0028] The invention also deals with methods of producing and
screening for and breeding such plant cells and/or plants.
[0029] Plant nutrition is essential to the growth and development
of plants and therefore also for quantity and quality of plant
products. Because of the strong influence of the efficiency of
nutrition uptake as well as nutrition utilization on plant yield
and product quality, a huge amount of fertilizer is poured onto
soils to optimize plant growth and quality.
[0030] Plant growth is primarily limited by three
nutrients--phosphorous, potassium and nitrogen. Therefore nitrogen
(N) is one of the major nutritional elements required for plant
growth, which is usually the rate-limiting element in plant growth.
Nitrogen is part of numerous important compounds found in living
cells, like amino acids, proteins (e.g. enzymes), nucleic acids,
and chlorophyll. 1.5% to 2% of plant dry matter is nitrogen and
approximately 16% of total plant protein. Thus, the availability of
nitrogen has a major impact on amino acid synthesis as well as
amino acid composition, accumulation of amino acids, on protein
synthesis and accumulation thereof, and based thereupon it is a
major limiting factor for plant growth and yield (Frink C.R., Proc.
Natl. Acad. Sci. USA 96, 1175 (1999)).
[0031] Plants can utilize a wide range of nitrogen species
including volatile ammonia (NH.sub.3), nitrogen oxides (NO.sub.x),
mineral nitrogen, like nitrate (NO.sub.3.sup.-) and ammonium salts
(NH.sub.4.sup.+), urea and urea derivates, and organic nitrogen
(amino acids, peptides, and the like). Some plants are able to
utilize atmospheric nitrogen by symbiotic bacteria or certain
fungi. However, in most agricultural soils, nitrate
(NO.sub.3.sup.-) is the most important source of nitrogen (Crawford
N.M., Glass A.D.M., Trends in Plant Science, 3 389 (1998); Hirsch
R. E., Sussman M. R., TIBTech 17, 356 (1999)). Nevertheless also
ammonium NH.sub.4.sup.+ plays an important, probably underestimated
role, because most plants preferentially take up NH.sub.4.sup.+
when both forms are present--even if NH.sub.4.sup.+ is present at
lower concentrations than NO.sub.3.sup.- (von Wiren N. et al.,
Curr. Opin. Plant Biol. 3, 254 (2000)).
[0032] Because of the high nitrogen requirements for crop plants,
nitrogen fertilization is a major worldwide agricultural
investment, with 80 million metric tons of nitrogen fertilizers (as
nitrate and/or ammonium) applied annually (Frink C.R., Proc. Natl.
Acad. Sci. USA 96, 1175 (1999)). There are also negative
environmental consequences for the extensive use of nitrogen
containing fertilizers in crop production since the crops retain
only about two-thirds of the applied nitrogen. Therefore high
inputs of fertilizer are followed by large outputs by leaching,
gaseous losses and crop removal. The unabsorbed nitrogen can
subsequently leach into the soil and contaminate water supplies
(Frink C.R., Proc. Natl. Acad. Sci. USA 96, 1175 (1999)). Because
of the high leaching losses of nitrogen from agricultural
ecosystems to surface water and groundwater, nitrogen is also
recognized as a pollutant. Nitrogen leaching, namely as nitrate
from agricultural lands, affects drinking water quality and causes
eutrophication of lakes and coastal areas. Abundant use of nitrogen
containing fertilizers can further lead to final deterioration of
soil quality, to environmental pollution and health hazards.
[0033] Because of the high costs of nitrogen fertilizer in relation
to the revenues for agricultural products, and additionally its
deleterious effect on the environment, it is desirable to develop
strategies to reduce nitrogen input and/or to optimize nitrogen
uptake and/or utilization of a given nitrogen availability while
simultaneously maintaining optimal yield, productivity and quality
of photosynthetic active organisms, preferably cultivated plants,
e.g. crops. Also it is desirable to obtain "existing" yield of
crops with lower fertilizer input and/or higher yield on soils of
similar or even poorer quality.
[0034] For efficient nitrogen uptake and utilization, complex
processes associated with absorption, translocation, assimilation,
and redistribution of nitrogen are required to operate effectively.
Differences in nitrogen absorption between genotypes have been
demonstrated for several species by different researchers (Chang S.
C., Robison D. J., Sci. World J., Suppl. 2, 407 (2001)).
Considerable evidence of genotypic differences in nitrogen uptake
has also been reported for maize and canola (Weisler et al., Sci.
World J., Suppl. 2, 61 (2001); Gallais A., Hirel B., J. Exper. Bot.
55, 295 (2004)).
[0035] Plants absorb nitrate via transporters localized to the root
epidermal and cortical cell plasma membrane over a wide nitrate
concentration range using several different transport mechanisms,
including constitutive and nitrate-inducible high-affinity
transport systems, as well as nitrate-inducible low-affinity
transporters (Stitt M., Curr. Opin. Plant Biol. 2, 178 (1999)). In
addition nitrate uptake in plants is highly regulated and
coordinated with other transport and metabolic pathways (Crawford
N.M. Plant Cell 7, 859 (1995)), and a number of nitrate uptake and
assimilation-related genes have been identified and characterized
(Forde B.G., Ann. Rev. Plant Biol 53, 203 (2002)). Once in the root
cell cytoplasm, nitrate may be stored in the vacuole for later use,
transported into the xylem and translocated to the shoot for
assimilation and/or storage, released back into the rhizosphere, or
reduced to nitrite and then to ammonia via nitrate reductase (NR)
and nitrite reductases (NiR). The reduction of nitrate to nitrite
and then to ammonia enables the assimilation of nitrogen into amino
acids via the GOGAT pathway (Stitt M., Curr. Opin. Plant Biol. 2,
178 (1999)). In order to be incorporated into amino acids, nucleic
acids, and other compounds, NO.sub.3.sup.- must be reduced to
NH.sub.4.sup.+. NR (nitrate reductase) is the first enzyme in the
process of NO.sub.3.sup.- reduction to NH.sub.4.sup.+. It is a
substrate-inducible enzyme and is thought to be the most limiting
step in nitrogen assimilation.
[0036] The in-situ rate of NO.sub.3.sup.- reduction is controlled
primarily by the rate of NO.sub.3.sup.- uptake, rather than by
alterations in nitrate reductase activity (NRA) or limitations in
reducing power. Thus, NO.sub.3.sup.- uptake appears to be of
primary importance in nitrogen assimilation in NO.sub.3.sup.--fed
plants. Genetic variation in NRA is well documented in several
species. NRA is affected by factors such as environmental
conditions and plant developmental stages, as well as plant part,
such as roots and tops. Furthermore, in vivo and in vitro assays
usually give different results. Variable results were found by
several researchers in their efforts to relate NRA to grain yield
and N-related traits such as total reduced plant nitrogen, grain
nitrogen content, grain nitrogen concentration, and nitrogen
harvest index.
[0037] Beneath NO.sub.3.sup.- plants can take up nitrogen also in
the form of ammonium. Although the average NH.sub.4.sup.+
concentrations in soil are often 10 to 1000 times lower than those
of NO.sub.3.sup.- (Marschner H.L., "Mineral Nutrition in Higher
Plants", London, Academic Press, 1995), the difference in soil
concentrations does not necessarily reflect the uptake ratio of
each nitrogen source. Plants take up NH.sub.4.sup.+ preferentially
when both forms--NO.sub.3.sup.- as well as NH.sub.4.sup.+--are
available, possibly because its assimilation requires less energy
since NO.sub.3.sup.- has to be reduced prior to assimilation (Bloom
et al., Plant Phys. 1294-1301 (1992)).
[0038] Ammonium uptake systems have been characterized in different
organisms, including yeast and plants. The yeast Saccharomyces
cerevisiae contains three MEP genes for ammonium transporters,
which are all controlled by nitrogen, being repressed in the
presence of an nitrogen source that is readily metabolized, such as
NH.sub.4.sup.+ (Marini et al., Mol. Cell. Biol. 17, 4282 (1997)).
Plant genes encoding ammonium transport systems have been cloned by
complementation of a yeast mutant, homology searches in databases
and heterogonous hybridizations (von Wiren N. et al., Curr. Opin.
Plant Biol., 3, 254 (2000)). Experimental evidence of the
physiological function of NH.sub.4.sup.+ transporters mainly rely
on correlations between ammonium transporter expression and influx
of labeled ammonium. The situation is complicated by the fact, that
in Arabidopsis but also in other plants ammonium transporters are
present in gene families, the members of which have different
expression patterns and physiological characteristics. Although DE
43 37 597 claims sequences for plant ammonium transporters and
their use for manipulation of the nitrogen metabolism and plant
growth under certain conditions, any evidence for positive effects
on nitrogen assimilation or plant growth under certain conditions
through ectopic expression of the plant ammonium transporters are
missing.
[0039] Usually the first step in the assimilation of inorganic
nitrogen into organic form involves the reaction of glutamate with
ammonium to form glutamine being catalyzed by glutamine synthase.
Glutamine thus formed may transfer in turn its amino function of
the amido group to asparate to form asparagine being catalyzed by
asparagine synthase. The steady flow of nitrogen from ammonia to
asparagine depends upon the recycling of glutamate,
alpha-ketogluterate and aspartate, being catalyzed by
glutamine-2-oxoglutarate aminotransferase and aspartate
aminotransferase. Glutamine and asparagine represent the major long
distance "nitrogen transport compounds" in plants. These are
abundant in phloem sap but they have somewhat different roles in
plant nitrogen metabolism since glutamine is more metabolic active
based on the fact that it can directly transfer its amino function
of the amido group to a number of substrates, whereas asparagine is
more efficient in "nitrogen transport and storage".
[0040] In order to describe the efficiency of the complete pathway
of nitrogen, starting with the uptake from the soil, assimilation
of nitrogen, transport and accumulation of N-containing compounds
within the photosynthetic organism, influencing biomass and yield,
different approaches are known. And in the light of the importance
of optimal nitrogen use different strategies have been followed for
plant optimizations.
[0041] In some cases enzymes of the nitrogen assimilation pathway,
like of glutamine synthetase, asparagine synthetase and
asparaginase, were overexpressed. Although initially unsuccessful
like the over-expression of a cytosolic glutamine synthetase gene
in Lotus (Vincent R. et al., Planta 201, 424 (1997)), recent
documents show at least some success. WO 95/09911 describes the
over-expression of glutamine-synthetase, asparagine-synthetase and
asparaginase in transgenic plant for application in enhanced
nitrogen-fixation and improved yield. Chichkova et al. reported in
J. Exp. Bot., 52, 2079 (2001) that transgenic tobacco plants that
overexpress alfalfa NADH-glutamate-synthase have higher carbon and
nitrogen content, but not a specific enrichment in nitrogen in
comparison to carbon. In another case, the over-expression of a
nitrogen assimilation gene, in this case the Escherichia coli
glutamate-dehydrogenase, did not lead to a relative increase in
nitrogen content, but rather to a significant increase in fresh
weight and dry weight. In another case, over-expression of the ASN1
gene enhances the nitrogen status in seeds of Arabidopsis (Lam H.
et al., Plant Physiol. 321, 926 (2003)). In seeds of those
overexpressing lines the authors observed the elevation of soluble
seed protein contents, elevation of total protein contents from
acid-hydrolyzed seeds and a higher tolerance of young seedlings
when grown under nitrogen-limiting conditions.
[0042] A different interesting approach was followed by Yanagisawa
et al., PNAS 101, 7833 (2004). The authors used hereby the
transcription factor Dof1. The over-expression of this regulatory
factor induced the up-regulation of genes encoding enzymes for
carbon skeleton production, a marked increase of amino acid
contents, and a reduction of the glucose level in transgenic
Arabidopsis. Elementary analysis revealed that the nitrogen content
increased in transgenic plants (approximate to 30%), indicating a
promotion of net nitrogen assimilation. Most significantly, the
Dof1 transgenic plants exhibit improved growth under low-nitrogen
conditions. Although looking promising, this approach likely has
the drawback, that it relies on a plant transcription factor and
the complex corresponding signaling cascade which both might be the
subject of different internal regulatory and feedback mechanism
modifying or even diminishing the desired effect at least under
certain conditions.
[0043] Therefore, there is still a need for photosynthetic active
organisms, especially plants, that are capable to use nitrogen more
efficiently so that less nitrogen is required for the same yield or
higher yields may be obtained with current levels of nitrogen use.
In addition, there is still a need for photosynthetic active
organism, especially plants, that show an increase in biomass
and/or yield.
[0044] Accordingly, it is also an object of this invention to
develop an inexpensive process for an enhanced nitrogen up-take
and/or transport and/or assimilation and/or utilisation in a
photosynthetic active organism, which are reflected alone or
altogether in an increased nitrogen use efficiency (NUE) and/or a
process for an increased biomass production and/or yield under
conditions of limited nitrogen supply.
[0045] It was found that this object is achieved by providing a
process according to the present invention described herein.
[0046] It is further an object of this invention to provide plant
cells and/or plants, which show an enhanced NUE, and/or exhibit
under conditions of limited nitrogen supply an increased biomass
production and/or yield, as compared to a corresponding
non-transformed wild type plant cell and/or plant.
[0047] It was found that this object is achieved by providing plant
cells and/or plants according to the present invention described
herein.
[0048] In one embodiment of the present invention, these traits are
achieved by a process for the enhanced nitrogen utilization
(=nitrogen use efficiency (NUE)) in a photosynthetic active
organism, preferably a plant, as compared to a corresponding
non-transformed wild type photosynthetic active organism.
[0049] In an embodiment thereof, the term "enhanced NUE" means that
the photosynthetic active organism, preferably a plant, exhibits a
generally enhanced yield (as defined hereinabove) under normal
conditions or under low nutrient conditions, especially an enhanced
biomass yield per unit of nitrogen available from the surrounding
medium, soil or environment, including nitrogen fertilizer, on
which the photosynthetic active organism, preferably a plant, is
grown, as compared to a corresponding non-transformed wild type
photosynthetic active organism.
[0050] In an embodiment thereof, the term "enhanced NUE" means that
the photosynthetic active organism, preferably a plant, exhibits an
enhanced dry biomass yield per unit of nitrogen available from the
surrounding medium, soil or environment, including nitrogen
fertilizer, on which the photosynthetic active organism, preferably
a plant, is grown, as compared to a corresponding non-transformed
wild type photosynthetic active organism.
[0051] In an embodiment thereof, the term "enhanced NUE" means that
the photosynthetic active organism, preferably a plant, exhibits an
enhanced aerial dry biomass yield per unit of nitrogen available
from the surrounding medium, soil or environment, including
nitrogen fertilizer, on which the photosynthetic active organism,
preferably a plant, is grown, as compared to a corresponding
non-transformed wild type photosynthetic active organism.
[0052] In an embodiment thereof, the term "enhanced NUE" means that
the photosynthetic active organism, preferably a plant, exhibits an
enhanced underground dry biomass yield per unit of nitrogen
available from the surrounding medium, soil or environment,
including nitrogen fertilizer, on which the photosynthetic active
organism, preferably a plant, is grown, as compared to a
corresponding non-transformed wild type photosynthetic active
organism.
[0053] In another embodiment thereof, the term "enhanced NUE" means
that the photosynthetic active organism, preferably a plant,
exhibits an enhanced fresh weight biomass yield per unit of
nitrogen available from the surrounding medium, soil or
environment, including nitrogen fertilizer, on which the
photosynthetic active organism, preferably a plant, is grown, as
compared to a corresponding non-transformed wild type
photosynthetic active organism.
[0054] In an embodiment thereof, the term "enhanced NUE" means that
the photosynthetic active organism, preferably a plant, exhibits an
enhanced aerial fresh weight biomass yield per unit of nitrogen
available from the surrounding medium, soil or environment,
including nitrogen fertilizer, on which the photosynthetic active
organism, preferably a plant, is grown, as compared to a
corresponding non-transformed wild type photosynthetic active
organism.
[0055] In an embodiment thereof, the term "enhanced NUE" means that
the photosynthetic active organism, preferably a plant, exhibits an
enhanced underground fresh weight biomass yield per unit of
nitrogen available from the surrounding medium, soil or
environment, including nitrogen fertilizer, on which the
photosynthetic active organism, preferably a plant, is grown, as
compared to a corresponding non-transformed wild type
photosynthetic active organism.
[0056] In another embodiment thereof, the term "enhanced NUE" means
that the photosynthetic active organism, preferably a plant,
exhibits an enhanced yield of harvestable parts of a plant per unit
of nitrogen available from the surrounding medium, soil or
environment, including nitrogen fertilizer, on which the
photosynthetic active organism, preferably a plant, is grown, as
compared to a corresponding non-transformed wild type
photosynthetic active organism.
[0057] In an embodiment thereof, the term "enhanced NUE" means that
the photosynthetic active organism, preferably a plant, exhibits an
enhanced yield of dry harvestable parts of a plant per unit of
nitrogen available from the surrounding medium, soil or
environment, including nitrogen fertilizer, on which the
photosynthetic active organism, preferably a plant, is grown, as
compared to a corresponding non-transformed wild type
photosynthetic active organism.
[0058] In an embodiment thereof, the term "enhanced NUE" means that
the photosynthetic active organism, preferably a plant, exhibits an
enhanced yield of dry aerial harvestable parts of a plant per unit
of nitrogen available from the surrounding medium, soil or
environment, including nitrogen fertilizer, on which the
photosynthetic active organism, preferably a plant, is grown, as
compared to a corresponding non-transformed wild type
photosynthetic active organism.
[0059] In an embodiment thereof, the term "enhanced NUE" means that
the photosynthetic active organism, preferably a plant, exhibits an
enhanced yield of underground dry harvestable parts of a plant per
unit of nitrogen available from the surrounding medium, soil or
environment, including nitrogen fertilizer, on which the
photosynthetic active organism, preferably a plant, is grown, as
compared to a corresponding non-transformed wild type
photosynthetic active organism.
[0060] In another embodiment thereof, the term "enhanced NUE" means
that the photosynthetic active organism, preferably a plant,
exhibits an enhanced yield of fresh weight harvestable parts of a
plant per unit of nitrogen available from the surrounding medium,
soil or environment, including nitrogen fertilizer, on which the
photosynthetic active organism, preferably a plant, is grown, as
compared to a corresponding non-transformed wild type
photosynthetic active organism.
[0061] In an embodiment thereof, the term "enhanced NUE" means that
the photosynthetic active organism, preferably a plant, exhibits an
enhanced yield of aerial fresh weight harvestable parts of a plant
per unit of nitrogen available from the surrounding medium, soil or
environment, including nitrogen fertilizer, on which the
photosynthetic active organism, preferably a plant, is grown, as
compared to a corresponding non-transformed wild type
photosynthetic active organism.
[0062] In an embodiment thereof, the term "enhanced NUE" means that
the photosynthetic active organism, preferably a plant, exhibits an
enhanced yield of underground fresh weight harvestable parts of a
plant per unit of nitrogen available from the surrounding medium,
soil or environment, including nitrogen fertilizer, on which the
photosynthetic active organism, preferably a plant, is grown, as
compared to a corresponding non-transformed wild type
photosynthetic active organism.
[0063] In a further embodiment, the term "enhanced NUE" means that
the photosynthetic active organism, preferably a plant, exhibits an
enhanced yield of the crop fruit per unit of nitrogen available
from the surrounding medium, soil or environment, including
nitrogen fertilizer, on which the photosynthetic active organism,
preferably a plant, is grown, as compared to a corresponding
non-transformed wild type photosynthetic active organism.
[0064] In an embodiment thereof, the term "enhanced NUE" means that
the photosynthetic active organism, preferably a plant, exhibits an
enhanced yield of the fresh crop fruit per unit of nitrogen
available from the surrounding medium, soil or environment,
including nitrogen fertilizer, on which the photosynthetic active
organism, preferably a plant, is grown, as compared to a
corresponding non-transformed wild type photosynthetic active
organism.
[0065] In an embodiment thereof, the term "enhanced NUE" means that
the photosynthetic active organism, preferably a plant, exhibits an
enhanced yield of the dry crop fruit per unit of nitrogen available
from the surrounding medium, soil or environment, including
nitrogen fertilizer, on which the photosynthetic active organism,
preferably a plant, is grown, as compared to a corresponding
non-transformed wild type photosynthetic active organism.
[0066] In an embodiment thereof, the term "enhanced NUE" means that
the photosynthetic active organism, preferably a plant, exhibits an
enhanced grain dry weight per unit of nitrogen supplied, as
compared to a corresponding non-transformed wild type
photosynthetic active organism, in analogy to Reynolds, M.P.,
Ortiz-Monasterioi J.J., and McNab A. (eds.), 2001, "Application of
Physiology in Whaet Breeding, Mexico, D.F.:CIMMYT, which is
incorporated by reference.
[0067] In a further embodiment, the term "enhanced NUE" means that
the photosynthetic active organism, preferably a plant, exhibits an
enhanced yield of seeds per unit of nitrogen available from the
surrounding medium, soil or environment, including nitrogen
fertilizer, on which the photosynthetic active organism, preferably
a plant, is grown, as compared to a corresponding non-transformed
wild type photosynthetic active organism.
[0068] In an embodiment thereof, the term "enhanced NUE" means that
the photosynthetic active organism, preferably a plant, exhibits an
enhanced yield of fresh weight seeds per unit of nitrogen available
from the surrounding medium, soil or environment, including
nitrogen fertilizer, on which the photosynthetic active organism,
preferably a plant, is grown, as compared to a corresponding
non-transformed wild type photosynthetic active organism.
[0069] In an embodiment thereof, the term "enhanced NUE" means that
the photosynthetic active organism, preferably a plant, exhibits an
enhanced yield of dry seeds per unit of nitrogen available from the
surrounding medium, soil or environment, including nitrogen
fertilizer, on which the photosynthetic active organism, preferably
a plant, is grown, as compared to a corresponding non-transformed
wild type photosynthetic active organism.
[0070] In another embodiment of the present invention, these traits
are achieved by a process for an increased biomass production
and/or yield under conditions of limited nitrogen supply, in a
photosynthetic active organism, preferably plant, as compared to a
corresponding non-transformed wild type photosynthetic active
organism.
[0071] In an embodiment thereof, the term "increased biomass
production" means that the photosynthetic active organism,
especially a plant, exhibit an increased growth rate under
conditions of limited nitrogen supply, compared to the
corresponding wild-type photosynthetic active organism. An
increased growth rate may be reflected inter alia by an increased
biomass production of the whole plant, or by an increased biomass
production of the aerial parts of a plant, or by an increased
biomass production of the underground parts of a plant, or by an
increased biomass production of parts of a plant, like stems,
leaves, blossoms, fruits, seeds.
[0072] In an embodiment thereof, increased biomass production
includes higher fruit yields, higher seed yields, higher fresh
matter production, and/or higher dry matter production.
[0073] In another embodiment thereof, the term "increased biomass
production" means that the photosynthetic active organism,
preferably plant, exhibits a prolonged growth under conditions of
limited nitrogen supply, as compared to the corresponding
non-transformed wild type photosynthetic active organism. A
prolonged growth comprises survival and/or continued growth of the
photosynthetic active organism, preferably plant, at the moment
when the non-transformed wild type photosynthetic active organism
shows visual symptoms of deficiency and/or death.
[0074] In one embodiment of the invention the enhanced NUE is
determinated and quantified according to the following method:
[0075] Transformed plants are grown in pots in a growth chamber
(Svalof Weibull, Svalov, Sweden). In case the plants are
Arabidopsis thaliana seeds thereof are sown in pots containing a
1:1 (v:v) mixture of nutrient depleted soil ("Einheitserde Typ 0",
30% clay, Tantau, Wansdorf Germany) and sand. Germination is
induced by a four day period at 4.degree. C., in the dark.
Subsequently the plants are grown under standard growth conditions.
In case the plants are Arabidopsis thaliana, the standard growth
conditions are: photoperiod of 16 h light and 8 h dark, 20.degree.
C., 60% relative humidity, and a photon flux density of 200
.mu.E/m.sup.2s. Plants are grown and cultured. In case the plants
are Arabidopsis thaliana they are watered every second day with a
N-depleted nutrient solution. The N-depleted nutrient solution e.g.
contains beneath water
TABLE-US-00001 mineral nutrient final concentration KCl 3.00 mM
MgSO.sub.4 .times. 7 H.sub.2O 0.5 mM CaCl.sub.2 .times. 6 H.sub.2O
1.5 mM K.sub.2SO.sub.4 1.5 mM NaH.sub.2PO.sub.4 1.5 mM Fe-EDTA 40
.mu.M H.sub.3BO.sub.3 25 .mu.M MnSO.sub.4 .times. H.sub.2O 1 .mu.M
ZnSO.sub.4 .times. 7 H.sub.2O 0.5 .mu.M Cu.sub.2SO.sub.4 .times. 5
H.sub.2O 0.3 .mu.M Na.sub.2MoO.sub.4 .times. 2 H.sub.2O 0.05
.mu.M
but no other N-containing salt.
[0076] After 9 to 10 days the plants are individualized. After a
total time of 29 to 31 days the plants are harvested and rated by
the fresh weight of the aerial parts of the plants, preferably the
rosettes.
[0077] In another embodiment of the present invention, plant yield
is increased by increasing one or more of yield-related traits
selected from one or more stress tolerance(s). During its
life-cycle, a plant is generally confronted with a diversity of
environmental conditions. Any such conditions which may, under
certain circumstances, have an impact on plant yield, are herein
referred to as "stress" condition. Environmental stresses may
generally be divided into biotic and abiotic (environmental)
stresses. For the sake of completeness, it is mentioned that
unfavorable nutrient conditions are sometimes also referred to as
"environmental stress". As will be appreciated by the skilled
artisan, the present invention does also contemplate solutions for
this kind of environmental stress. This topic is described and
dealt with in detail in the paragraphs hereinabove referring to
increased nutrient use efficiency.
[0078] In a particularly preferred embodiment of the present
invention, yield-related traits which can be improved by the
present invention are stress tolerance(s).
[0079] In a preferred embodiment of the present invention, plant
yield is increased by increasing one or more of yield-related
traits selected from one or more abiotic stress tolerance(s).
[0080] Generally, the term "increased tolerance to stress" can be
defined as survival of plants, and/or higher yield production,
under stress conditions as compared to a non-transformed wild type
or starting plant.
[0081] For the purposes of the description of the present
invention, the terms "enhanced tolerance to abiotic stress",
"enhanced resistance to abiotic environmental stress", "enhanced
tolerance to environmental stress", "improved adaptation to
environmental stress" and other variations and expressions similar
in its meaning are used interchangeably and refer, without
limitation, to an improvement in tolerance to one or more abiotic
environmental stress(es) as described herein and as compared to a
corresponding (non-transformed) wild type (or starting) plant.
[0082] In a preferred embodiment of the present invention, plant
yield is increased by increasing one or more of yield-related
traits selected from one or more abiotic stress tolerance(s). In a
particularly preferred embodiment of the present invention, said
yield-related trait is increased water use efficiency of a plant
and/or increased tolerance to drought conditions.
[0083] Drought, heat, cold and salt stress have a common theme
important for plant growth and that is water availability. Plants
are typically exposed during their life cycle to conditions of
reduced environmental water content. Most plants have evolved
strategies to protect themselves against these conditions of low
water or desiccation. However, if the severity and duration of the
drought conditions are too great, the effects on plant development,
growth and yield of most crop plants are profound. Continuous
exposure to drought causes major alterations in the plant
metabolism. These great changes in metabolism ultimately lead to
cell death and consequently yield losses.
[0084] Developing stress-tolerant plants is a strategy that has the
potential to solve or mediate at least some of these problems
(McKersie and Leshem, 1994. Stress and Stress Coping in Cultivated
Plants, Kluwer Academic Publishers). However, traditional plant
breeding strategies to develop new lines of plants that exhibit
resistance (tolerance) to these types of stress are relatively slow
and require specific resistant lines for crossing with the desired
line. Limited germplasm resources for stress tolerance and
incompatibility in crosses between distantly related plant species
represent significant problems encountered in conventional
breeding. Additionally, the cellular processes leading to drought,
cold and salt tolerance and/or resistance are complex in nature and
involve multiple mechanisms of cellular adaptation and numerous
metabolic pathways (McKersie and Leshem, 1994. Stress and Stress
Coping in Cultivated Plants, Kluwer Academic Publishers). This
multi-component nature of stress tolerance and/or resistance has
not only made breeding for tolerance and/or resistance largely
unsuccessful.
[0085] Plants are exposed during their life cycle also to heat,
cold and salt stress. The protection strategies are similar to
those of drought resistance. Since high salt content in some soils
results in less available water for cell intake, its effect is
similar to those observed under drought conditions. Likewise, under
freezing temperatures, plant cells loose water as a result of ice
formation that starts in the apoplast and withdraws water from the
symplast (McKersie and Leshem, 1994. Stress and Stress Coping in
Cultivated Plants, Kluwer Academic Publishers). Physiologically
these stresses are also interconnected and may induce similar
cellular damage. For example drought and salt stress are manifested
primarily as osmotic stress, leading to the disruption of
homeostasis and ion distribution in the cell (Serrano et al., 1999;
Zhu, 2001a; Wang et al., 2003). Oxidative stress, which frequently
accompanies high temperature, salinity or drought stress, may cause
denaturation of functional or structural proteins (Smirnoff, 1998).
As a consequence these abiotic stresses often activate similar
signaling pathways (Shinozaki and Ymaguchi-Shinozaki, 2000; Knight
and Knight, 2001; Zhu 2001b, 2002) and cellular responses, e.g. the
production of certain stress proteins, anti-oxidants and compatible
solutes (Vierling and Kimpel, 1992; Zhu et al., 1997; Cushman and
Bohnert, 2000).
[0086] At the moment many genetical and biotechnological approaches
are known in order to obtain plants growing under conditions of low
water availability.
[0087] These approaches are generally based on the introduction and
expression of genes in plant cell coding for different enzymes as
disclosed for example in WO 2004/011888, WO 2006.032708, US
20050097640, US 20060037108, US 20050108791, Serrano et al.
(Scientia Horticulturae 78, 261-269 (1999)) and many others.
[0088] For example the over-expression of antioxidant enzymes or
ROS-scavenging enzymes is one possibility to engineer tolerance,
e.g. transgenic alfalfa plants expressing Mn-superoxide dismutase
tend to have reduced injury after water-deficit stress (McKersie et
al., Plant Physiol. 111, 1177-1181 (1996)). These same transgenic
plants have increased biomass production in field trials (McKersie
et al., Plant Physiology 119, 839-847 (1999); McKersie et al.,
Plant Physiol. 111, 1177-1181 (1996)). Transgenic plants that
overproduce osmolytes such as mannitol, fructans, proline or
glycine-betaine also show increased resistance to some forms of
abiotic stress and it is proposed that the synthesized osmolytes
act as ROS scavengers (Tarczynski. et al. Science 259, 508-510
(1993); Sheveleva, et al., Plant Physiol. 115, 1211-1219
(1997)).
[0089] Generally the transformed and stress resistant plants cited
exhibit slower growth and reduced biomass, due to an imbalance in
development and physiology of the plant, thus having significant
fitness cost (Kasuga et al., 1999, Danby and Gehring et al., 2005).
Despite maintaining basic metabolic function this leads to severe
biomass and yield loss. Sometimes the root/shoot dry weight ratio
increases as plant water stress develops. The increase is mostly
due to a relative reduction in shoot dry weight. The ratio of seed
yield to above-ground dry weight is relatively stable under many
environmental conditions and so a robust correlation between plant
size and grain yield can often be obtained. These processes are
intrinsically linked because the majority of grain biomass is
dependent on current stored photosynthetic productivity by the
leaves and stem of the plant. Therefore selecting for plant size,
even at early stages of development, has been used as an indicator
for future potential.
[0090] In some cases (US 20060037108) an increased biomass, mainly
a greater shoot biomass was observed after a drought treatment by
withholding water for 6 to 8 days.
[0091] There is still a need to identify genes expressed in stress
tolerant plants that have the capacity to confer stress resistance
to its host plant and to other plant species, especially to confer
increased tolerance and/or resistance to environmental stress,
preferably under conditions of water deficiency and confers
increased biomass production.
[0092] It is an object of this invention to identify new methods to
confer stress tolerance and/or resistance in plants or plant
cells.
[0093] In preferred embodiments of the present invention, thus,
abiotic environmental stress refers to drought and low water
content, wherein drought stress means any environmental stress
which leads to a lack of water in plants or reduction of water
supply to plants, including desiccation.
[0094] In a further embodiment of the invention the term "increased
tolerance to abiotic stress" relates to an increased tolerance to
water stress, which is produced as a secondary stress by low
temperature and/or salt, and/or as a primary stress during drought
or heat.
[0095] In accordance with the present invention, in one embodiment,
increased tolerance to drought conditions can be determinated and
quantified according to the following method:
[0096] Transformed plants are grown individually in pots in a
growth chamber (York Industriekalte GmbH, Mannheim, Germany).
Germination is induced. In case the plants are Arabidopsis thaliana
sown seeds are kept at 4.degree. C., in the dark, for 3 days in
order to induce germination. Subsequently conditions are changed
for 3 days to 20.degree. C./6.degree. C. day/night temperature with
a 16/8 h day-night cycle at 150 .mu.E. Subsequently the plants are
grown under standard growth conditions. In case the plants are
Arabidopsis thaliana, the standard growth conditions are:
photoperiod of 16 h light and 8 h dark, 20.degree. C., 60% relative
humidity, and a photon flux density of 200 .mu.E. Plants are grown
and cultured until they develop leaves. In case the plants are
Arabidopsis thaliana they are watered daily until they were
approximately 3 weeks old. Starting at that time drought was
imposed by withholding water. After the non-transformed wild type
plants show visual symptoms of injury, the evaluation starts and
plants are scored for symptoms of drought symptoms and biomass
production comparison to wild type and neighboring plants for 5-6
days in succession.
[0097] Visual symptoms of injury stating for one or any combination
of two, three or more of the following features: [0098] a) wilting
[0099] b) leaf browning [0100] c) loss of turgor, which results in
drooping of leaves or needles stems, and flowers, [0101] d)
drooping and/or shedding of leaves or needles, [0102] e) the leaves
are green but leaf angled slightly toward the ground compared with
controls, [0103] f) leaf blades begun to fold (curl) inward, [0104]
g) premature senescence of leaves or needles, [0105] h) loss of
chlorophyll in leaves or needles and/or yellowing.
[0106] In another preferred embodiment of the present invention,
plant yield is increased by increasing one or more of yield-related
traits selected from one or more abiotic stress tolerance(s). In a
particularly preferred embodiment of the present invention, said
yield-related trait is increased tolerance to heat conditions.
[0107] In a preferred embodiment of the present invention, plant
yield is increased by increasing one or more of yield-related
traits selected from one or more abiotic stress tolerance(s). In a
particularly preferred embodiment of the present invention, said
yield-related trait is increased low temperature tolerance,
comprising freezing tolerance and/or chilling tolerance.
[0108] Environmental temperatures change within minutes to hours in
the diurnal cycle, in hours to days as a result of changing
weather, and over weeks to months as a result of seasonal changes.
Low temperatures impinge on a plethora of biological processes.
They retard or inhibit almost all metabolic and cellular processes,
with the typical Q10 for protein-dependent catalysis lying between
2 and 3. They impact on membrane-based processes, because low
temperatures alter the physical properties of lipids and reduce
membrane fluidity. At temperatures below zero, there is the
additional danger of ice formation. This typically takes place in
the apoplast of a cell, leading to withdrawal of water and
dehydration of the symplast. The response of plants to low
temperature is an important determinant of their ecological range.
The problem of coping with low temperatures is exacerbated by the
need to prolong the growing season beyond the short summer found at
high latitudes or altitudes.
[0109] Most plants have evolved adaptive strategies to protect
themselves against low temperatures. Generally, adaptation to low
temperature may be divided into chilling tolerance, and freezing
tolerance.
[0110] Chilling tolerance is naturally found in species from
temperate or boreal zones and allows survival and an enhanced
growth at low but non-freezing temperatures. Species from tropical
or subtropical zones are chilling sensitive and often show wilting,
chlorosis or necrosis, slowed growth and even death at temperatures
around 10.degree. C. during one or more stages of development.
Freezing tolerance allows survival at near zero to particularly
subzero temperatures. It is believed to be promoted by a process
termed cold-acclimation which occurs at low but non-freezing
temperatures and provides increased freezing tolerance at subzero
temperatures. In addition, most species from temperate regions have
life cycles that are adapted to seasonal changes of the
temperature. For those plants, low temperatures may also play an
important role in plant development through the process of
stratification and vernalisation. It becomes obvious that a
clearcut distinction between or definition of chilling tolerance
and freezing tolerance is difficult and that the processes may be
overlapping or interconnected.
[0111] The molecular basis of freezing tolerance has been
intensively researched in Arabidopsis. Physiological changes during
cold acclimation include changes in lipid composition to increase
membrane fluidity, expression of proteins that modify the physical
characteristics of membranes, accumulation of compatible solutes
like sucrose, raffinose and proline (Cook et al., Proc. Natl. Acad.
Sci. USA 101, 15243-15248 (2004)), detoxification of active oxygen
species and altered leaf development to increase the levels of
proteins involved in photosynthetic electron transport and carbon
fixation. Some of these changes are specific for low temperature,
and others also occur in response to dehydration, mechanical
stress.
[0112] Less is known about the molecular basis of chilling
tolerance at different stages of plant development. Exposure of
chilling-sensitive species to low temperatures has a negative
impact on seed germination rates as well as early seedling growth
and interferes with photosynthesis of the growing plant which may
result in photoinhibition. In particular, the process of seed
germination strongly depends on environmental temperature and the
properties of the seeds determine the level of activity and
performance during germination and seedling emergence when being
exposed to low temperature. Chilling often delays leaf development
and interferes with plastid biogenesis, leading to delayed
greening, chlorosis and thickening or deformation of new leaves.
Chilling temperatures inhibit respiration, phloem transport, and
restrict the utilization of photoassimilate for growth. As one
result, sugars and other metabolites accumulate and cause osmotic
imbalance.
[0113] Chilling tolerance is a major breeding trait because most
major crops, particularly corn (maize), bean, rice, soy bean,
cotton, tomato, banana, cucumber and potato, are
chilling-sensitive.
[0114] Breeding of crops with improved adaption to abiotic
environmental stresses, and particularly low temperature (i.e.
chilling tolerance and/or freezing tolerance), will result in a
better trait for stress tolerance and is expected to increase
quality and yield of the respective crop. However, the genetic and
molecular basis of chilling responses is poorly understood.
Although genetic diversity has been identified, for example from
landraces and related species that grow at light altitudes, and is
being introduced into breeding lines, the genes responsible for the
qualitative trait loci have not yet been identified. Additionally,
it becomes evident that stress tolerance in plants like low
temperature, drought, heat and salt stress tolerance have a common
theme important for plant growth, namely the availability of water.
Plants are typically exposed during their life cycle to conditions
of reduced environmental water content.
[0115] The protection strategies are similar to those of chilling
tolerance. For example components of low temperature, drought, heat
and salt stress are manifested as osmotic stress, leading to the
disruption of homeostasis and ion distribution in the cell (Serrano
et al., J Exp Bot 50, 1023-1036 (1999); Zhu J.K. Trends Plant Sci
6, 66-71 (2001a); Wang et al., 2003). Under freezing temperatures,
plant cells loose water as a result of ice formation that starts in
the apoplast and withdraws water from the symplast (McKersie and
Leshem, 1994. Stress and Stress Coping in Cultivated Plants, Kluwer
Academic Publishers). Oxidative stress, which frequently
accompanies low/high temperature, salinity or drought stress, may
cause denaturation of functional or structural proteins (Smirnoff,
Curr. Opin. Biotech. 9, 214-219 (1998)). As a consequence these
abiotic stresses often activate similar signaling pathways
(Shinozaki and Ymaguchi-Shinozaki, 2000; Knight and Knight, 2001;
Zhu J.K. Curr.Opin Plant Biol. 4, 401-406 (2001b), Zhu, Annu. Rev.
Plant Biol. 53, 247-73 (2002)) and cellular responses, e.g. the
production of certain stress proteins, anti-oxidants and compatible
solutes (Vierling and Kimpel, 1992; Zhu et al., 1997; Cushman and
Bohnert, 2000). For example, heat stress shares transcriptional
responses that are similar to response pathways induced by other
abiotic stresses (e.g. Swindell et al., BMC Genomics, 8,125
(2007)).
[0116] Developing stress-tolerant and/or resistant plants,
particularly low temperature tolerant and/or resistant plants, is a
strategy that has the potential to solve or mediate at least some
of the existing problems (McKersie and Leshem, 1994. Stress and
Stress Coping in Cultivated Plants, Kluwer Academic Publishers).
However, traditional plant breeding strategies to develop new lines
of plants that exhibit tolerance to these types of stress are
relatively slow and require specific resistant lines for crossing
with the desired line. Limited germplasm resources for stress
tolerance and incompatibility in crosses between distantly related
plant species represent significant problems encountered in
conventional breeding.
[0117] Additionally, the cellular processes leading to drought, low
temperature and salt tolerance are complex in nature and involve
multiple mechanisms of cellular adaptation and numerous metabolic
pathways (McKersie and Leshem, 1994. Stress and Stress Coping in
Cultivated Plants, Kluwer Academic Publishers). This
multi-component nature of stress tolerance has not only made
breeding for tolerance largely unsuccessful, but has also limited
the ability to genetically engineer stress tolerance plants using
biotechnological methods.
[0118] The results of current research indicate that tolerance to
low temperature is a complex quantitative trait. The lack of a
mechanistic understanding makes it difficult to design a transgenic
approach to improve stress tolerance.
[0119] At the time the invention was made, a couple of genetical
and biotechnological approaches are known in order to obtain plants
growing under conditions of low temperature. These approaches are
generally based on the introduction and expression of genes in
plant cells coding for different enzymes, as disclosed for example
in WO 2007/044988, WO 2007/078280, WO 1992/013082, WO 2007/052376,
WO 2006/137574.
[0120] The over-expression of antioxidant enzymes or ROS-scavenging
enzymes is one possibility to engineer tolerance, e.g. transgenic
alfalfa plants expressing Mn-superoxide dismutase tend to have
reduced injury after water-deficit stress (McKersie et al., Plant
Physiol. 111, 1177-1181 (1996)). These same transgenic plants show
increased yield in field trials (McKersie et al., 1999. Plant
Physiology, 119, 839-847 (1999); McKersie et al., Plant Physiol.
111, 1177-1181 (1996)). Transgenic plants that overproduce
osmolytes such as mannitol, fructans, proline or glycine-betaine
also show increased tolerance to some forms of abiotic stress and
it is proposed that the synthesized osmolytes act as ROS scavengers
(Tarczynski et al., Science 259, 508-510 (1993); Sheveleva, et al.,
Plant Physiol. 115, 1211-1219 (1997)).
[0121] Nevertheless, the transformed and stress resistant plants
cited above generally exhibit slower growth and reduced biomass,
due to an imbalance in development and physiology of the plant,
thus having significant fitness cost (Kasuga et al., Nature Biotech
17, 287-291 (1999)). Despite maintaining basic metabolic function
this leads to severe biomass and yield loss. Sometimes the
root/shoot dry weight ratio increase as plant water stress
develops. The increase is mostly due to a relative reduction in
shoot dry weight. The ratio of seed yield to above-ground dry
weight is relatively stable under many environmental conditions and
so a robust correlation between plant size and grain yield can
often be obtained. These processes are intrinsically linked because
the majority of grain biomass is dependent on current stored
photosynthetic productivity by the leaves and stem of the plant.
Therefore selecting for plant size, even at early stages of
development, has been used as an indicator for future yield
potential.
[0122] Accordingly, for the purposes of the description of the
present invention, improved or enhanced "chilling tolerance" or
variations thereof refers to improved adaptation to low but
non-freezing temperatures around 10.degree. C., preferably
temperatures between 1 to 18.degree. C., more preferably
4-14.degree. C., and most preferred 8 to 12.degree. C.; hereinafter
called "chilling temperature.
[0123] For the purposes of the description of the present
invention, improved or enhanced "freezing tolerance" or variations
thereof refers to improved adaptation to temperatures near or below
zero, namely preferably temperatures below 4.degree. C., more
preferably below 3 or 2.degree. C., and particularly preferred at
or below 0 (zero).degree. C. or below -4.degree. C., or even
extremely low temperatures down to -10.degree. C. or lower;
hereinafter called "freezing temperature.
[0124] More generally, "improved adaptation" to environmental
stress like e.g. freezing and/or chilling temperatures refers to an
improved plant performance, while plant performance refers to more
yield, particularly with regard to one or more of the yield related
traits as defined in more detail above.
[0125] Accordingly, for the purposes of the description of the
present invention, the term "low temperature" with respect to low
temperature stress on a plant, and preferably a crop plant, refers
to any of the low temperature conditions as described herein,
preferably chilling and/or freezing temperatures as defined above,
as the context requires. It is understood that a skilled artisan
will be able to recognize from the particular context in the
present description which temperature or temperature range is meant
by "low temperature".
[0126] In the present invention, enhanced tolerance to low
temperature may, for example and preferably, be determined
according to the following method:
[0127] Transformed plants are grown in pots in a growth chamber
(e.g. York, Mannheim, Germany). In case the plants are Arabidopsis
thaliana seeds thereof are sown in pots containing a 3.5:1 (v:v)
mixture of nutrient rich soil (GS90, Tantau, Wansdorf, Germany) and
sand. Plants are grown under standard growth conditions. In case
the plants are Arabidopsis thaliana, the standard growth conditions
are: photoperiod of 16 h light and 8 h dark, 20.degree. C., 60%
relative humidity, and a photon flux density of 200
.mu.mol/m.sup.2s. Plants are grown and cultured. In case the plants
are Arabidopsis thaliana they are watered every second day. After 9
to 10 days the plants are individualized. Cold (e.g. chilling at
11-12.degree. C.) is applied 14 days after sowing until the end of
the experiment. After a total growth period of 29 to 31 days the
plants are harvested and rated by the fresh weight of the aerial
parts of the plants, in the case of Arabidopsis preferably the
rosettes.
[0128] In another preferred embodiment of the present invention,
plant yield is increased by increasing one or more of yield-related
traits selected from one or more abiotic stress tolerance(s). In a
particularly preferred embodiment of the present invention, said
yield-related trait may also be increased salinity tolerance (salt
tolerance), tolerance to osmotic stress, increased shade tolerance,
increased tolerance to a high plant density, increased tolerance to
mechanical stresses, and/or increased tolerance to oxidative
stress.
[0129] In another preferred embodiment of the present invention,
plant yield is increased by increasing yield in the absence of
stress as well as the absence of nutrient deficiencies (=intrinsic
yield).
[0130] Accordingly, in preferred embodiments, the present invention
provides a method for producing a transgenic plant cell nucleus; a
transgenic plant cell; plant(s) comprising one or more of such
transgenic nuclei or plant cell(s); progeny, seed, and/or pollen
derived from such plant cell and/or transgenic plant(s); each
showing increased yield as compared to a corresponding
non-transformed wild type plant cell or plant, by increasing or
generating one or more activities selected from the group
consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto
sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, 61267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease. Furthermore, the
present invention provides a transgenic plant cell nucleus; a
transgenic plant cell; plant(s) comprising one or more of such
transgenic nuclei or plant cell(s); progeny, seed, and/or pollen
derived from such plant cell and/or transgenic plant(s); each
showing increased yield as compared to a corresponding
non-transformed wild type plant cell or plant, by increasing or
generating one or more activities selected from the group
consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto
sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-ketoreductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease.
[0131] In the preferred embodiments of the present invention, yield
is increased by improving one or more of the yield-related traits
as defined herein.
[0132] Accordingly, in an embodiment, the present invention
provides a method for producing a transgenic plant cell nucleus; a
transgenic plant cell; plant(s) comprising one or more of such
transgenic nuclei or plant cell(s); progeny, seed, and/or pollen
derived from such plant cell and/or transgenic plant(s); each
showing an increased nutrient use efficiency as compared to a
corresponding non-transformed wild type plant cell or plant,
especially a transgenic plant cell and/or plant with increased NUE
and/or increased biomass production as compared to a corresponding
non-transformed wild type plant cell or plant, by increasing or
generating one or more activities selected from the group
consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto
sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease. Furthermore, in
particularly preferred embodiments, the present invention provides
a transgenic plant cell nucleus; a transgenic plant cell; plant(s)
comprising one or more of such transgenic nuclei or plant cell(s);
progeny, seed, and/or pollen derived from such plant cell and/or
transgenic plant(s); each showing increased nutrient use efficiency
as compared to a corresponding non-transformed wild type plant cell
or plant, especially a transgenic plant cell and/or plant with
increased NUE and/or increased biomass production as compared to a
corresponding non-transformed wild type plant cell or plant, by
increasing or generating one or more activities selected from the
group consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase,
3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydrolyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease.
[0133] In other particularly preferred embodiments, the present
invention provides a method for producing a transgenic plant cell
nucleus; a transgenic plant cell; plant(s) comprising one or more
of such transgenic nuclei or plant cell(s); progeny, seed, and/or
pollen derived from such plant cell and/or transgenic plant(s);
each showing an increased nutrient use efficiency, especially a
transgenic plant cell and/or plant with increased NUE and/or
increased biomass production, and an increased stress resistance,
particularly abiotic stress resistance, especially an increased low
temperature tolerance, in particular an increased tolerance to
chilling, and/or an increased water use efficiency, in particular
tolerance to drought conditions, as compared to a corresponding
non-transformed wild type plant cell or plant, by increasing or
generating one or more activities selected from the group
consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto
sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-ketoreductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease. Furthermore, in such
other particularly preferred embodiments, the present invention
provides a transgenic plant cell nucleus; a transgenic plant cell;
plant(s) comprising one or more of such transgenic nuclei or plant
cell(s); progeny, seed, and/or pollen derived from such plant cell
and/or transgenic plant(s); each showing an increased nutrient use
efficiency, especially a transgenic plant cell and/or plant with
increased NUE and/or increased biomass production, and increased
stress resistance, particularly abiotic stress resistance,
especially an increased low temperature tolerance, in particular an
increased tolerance to chilling, and/or an increased water use
efficiency, in particular tolerance to drought conditions, as
compared to a corresponding non-transformed wild type plant cell or
plant, by increasing or generating one or more activities selected
from the group consisting of 2-dehydro-3-deoxy-phosphoheptonate
aldolase, 3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease.
[0134] Thus, in the most preferred embodiments of the present
invention, a method is provided for producing a transgenic plant
cell nucleus; a transgenic plant cell; plant(s) comprising one or
more of such transgenic nuclei or plant cell(s); progeny, seed,
and/or pollen derived from such plant cell and/or transgenic
plant(s); each showing an increased nitrogen use efficiency (NUE)
and an increased low temperature tolerance, particularly chilling
tolerance, as compared to a corresponding non-transformed wild type
plant cell or plant, by increasing or generating one or more
activities selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease. Furthermore, in such
most preferred embodiments, the present invention provides a
transgenic plant cell nucleus; a transgenic plant cell; plant(s)
comprising one or more of such transgenic nuclei or plant cell(s);
progeny, seed, and/or pollen derived from such plant cell and/or
transgenic plant(s); each showing increased nitrogen use efficiency
(NUE) and an increased low temperature tolerance, particularly
chilling tolerance, as compared to a corresponding non-transformed
wild type plant cell or plant, by increasing or generating one or
more activities selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydrolyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease.
[0135] Thus, in the most preferred embodiments of the present
invention, a method is provided for producing a transgenic plant
cell nucleus; a transgenic plant cell; plant(s) comprising one or
more of such transgenic nuclei or plant cell(s); progeny, seed,
and/or pollen derived from such plant cell and/or transgenic
plant(s); each showing an increased nitrogen use efficiency (NUE)
and an increased water use efficiency, particularly tolerance to
drought conditions, as compared to a corresponding non-transformed
wild type plant cell or plant, by increasing or generating one or
more activities selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease. Furthermore, in such
most preferred embodiments, the present invention provides a
transgenic plant cell nucleus; a transgenic plant cell; plant(s)
comprising one or more of such transgenic nuclei or plant cell(s);
progeny, seed, and/or pollen derived from such plant cell and/or
transgenic plant(s); each showing increased nitrogen use efficiency
(NUE) and an increased water use efficiency (WUE) particularly
tolerance to drought conditions, as compared to a corresponding
non-transformed wild type plant cell or plant, by increasing or
generating one or more activities selected from the group
consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto
sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydrolyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease.
[0136] Thus, in the most preferred embodiments of the present
invention, a method is provided for producing a transgenic plant
cell nucleus; a transgenic plant cell; plant(s) comprising one or
more of such transgenic nuclei or plant cell(s); progeny, seed,
and/or pollen derived from such plant cell and/or transgenic
plant(s); each showing an increased nitrogen use efficiency (NUE),
an increased low temperature tolerance, particularly chilling
tolerance, and an increased water use efficiency, particularly
tolerance to drought conditions, as compared to a corresponding
non-transformed wild type plant cell or plant, by increasing or
generating one or more activities selected from the group
consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto
sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease. Furthermore, in such
most preferred embodiments, the present invention provides a
transgenic plant cell nucleus; a transgenic plant cell; plant(s)
comprising one or more of such transgenic nuclei or plant cell(s);
progeny, seed, and/or pollen derived from such plant cell and/or
transgenic plant(s); each showing increased nitrogen use efficiency
(NUE), an increased low temperature tolerance, particularly
chilling tolerance and an increased water use efficiency (WUE)
particularly tolerance to drought conditions, as compared to a
corresponding non-transformed wild type plant cell or plant, by
increasing or generating one or more activities selected from the
group consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase,
3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydrolyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease.
[0137] Accordingly, in an embodiment, the present invention
provides a method for producing a transgenic plant cell nucleus; a
transgenic plant cell; plant(s) comprising one or more of such
transgenic nuclei or plant cell(s); progeny, seed, and/or pollen
derived from such plant cell and/or transgenic plant(s); each
showing an increased nutrient use efficiency as compared to a
corresponding non-transformed wild type plant cell or plant,
especially a transgenic plant cell and/or plant with increased NUE
and/or increased biomass production as compared to a corresponding
non-transformed wild type plant cell or plant, and increased yield
in the absence of stress as well as the absence of nutrient
deficiencies, by increasing or generating one or more activities
selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
61258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease. Furthermore, in
particularly preferred embodiments, the present invention provides
a transgenic plant cell nucleus; a transgenic plant cell; plant(s)
comprising one or more of such transgenic nuclei or plant cell(s);
progeny, seed, and/or pollen derived from such plant cell and/or
transgenic plant(s); each showing increased nutrient use efficiency
as compared to a corresponding non-transformed wild type plant cell
or plant, especially a transgenic plant cell and/or plant with
increased NUE and/or increased biomass production as compared to a
corresponding non-transformed wild type plant cell or plant, and
increased yield in the absence of stress as well as the absence of
nutrient deficiencies, by increasing or generating one or more
activities selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease.
[0138] In other particularly preferred embodiments, the present
invention provides a method for producing a transgenic plant cell
nucleus; a transgenic plant cell; plant(s) comprising one or more
of such transgenic nuclei or plant cell(s); progeny, seed, and/or
pollen derived from such plant cell and/or transgenic plant(s);
each showing an increased nutrient use efficiency, especially a
transgenic plant cell and/or plant with increased NUE and/or
increased biomass production, and an increased stress resistance,
particularly abiotic stress resistance, especially an increased low
temperature tolerance, in particular an increased tolerance to
chilling, and/or an increased water use efficiency, in particular
tolerance to drought conditions, and increased yield in the absence
of stress as well as the absence of nutrient deficiencies, as
compared to a corresponding non-transformed wild type plant cell or
plant, by increasing or generating one or more activities selected
from the group consisting of 2-dehydro-3-deoxy-phosphoheptonate
aldolase, 3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-ketoreductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease. Furthermore, in such
other particularly preferred embodiments, the present invention
provides a transgenic plant cell nucleus; a transgenic plant cell;
plant(s) comprising one or more of such transgenic nuclei or plant
cell(s); progeny, seed, and/or pollen derived from such plant cell
and/or transgenic plant(s); each showing an increased nutrient use
efficiency, especially a transgenic plant cell and/or plant with
increased NUE and/or increased biomass production, and an increased
stress resistance, particularly abiotic stress resistance,
especially an increased low temperature tolerance, in particular an
increased tolerance to chilling, and/or an increased water use
efficiency, in particular tolerance to drought conditions, and
increased yield in the absence of stress as well as the absence of
nutrient deficiencies, as compared to a corresponding
non-transformed wild type plant cell or plant, by increasing or
generating one or more activities selected from the group
consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto
sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease.
[0139] Thus, in the most preferred embodiments of the present
invention, a method is provided for producing a transgenic plant
cell nucleus; a transgenic plant cell; plant(s) comprising one or
more of such transgenic nuclei or plant cell(s); progeny, seed,
and/or pollen derived from such plant cell and/or transgenic
plant(s); each showing an increased nitrogen use efficiency (NUE)
and increased yield, in the absence of stress as well as the
absence of nutrient deficiencies, and an increased low temperature
tolerance, particularly chilling tolerance, as compared to a
corresponding non-transformed wild type plant cell or plant, by
increasing or generating one or more activities selected from the
group consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase,
3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease. Furthermore, in such
most preferred embodiments, the present invention provides a
transgenic plant cell nucleus; a transgenic plant cell; plant(s)
comprising one or more of such transgenic nuclei or plant cell(s);
progeny, seed, and/or pollen derived from such plant cell and/or
transgenic plant(s); each showing increased nitrogen use efficiency
(NUE) and increased yield, in the absence of stress as well as the
absence of nutrient deficiencies, and an increased low temperature
tolerance, particularly chilling tolerance, as compared to a
corresponding non-transformed wild type plant cell or plant, by
increasing or generating one or more activities selected from the
group consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase,
3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydrolyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease.
Thus, in the most preferred embodiments of the present invention, a
method is provided for producing a transgenic plant cell nucleus; a
transgenic plant cell; plant(s) comprising one or more of such
transgenic nuclei or plant cell(s); progeny, seed, and/or pollen
derived from such plant cell and/or transgenic plant(s); each
showing an increased nitrogen use efficiency (NUE) and increased
yield, in the absence of stress as well as the absence of nutrient
deficiencies, and an increased water use efficiency, particularly
tolerance to drought conditions, as compared to a corresponding
non-transformed wild type plant cell or plant, by increasing or
generating one or more activities selected from the group
consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto
sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-ketoreductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease. Furthermore, in such
most preferred embodiments, the present invention provides a
transgenic plant cell nucleus; a transgenic plant cell; plant(s)
comprising one or more of such transgenic nuclei or plant cell(s);
progeny, seed, and/or pollen derived from such plant cell and/or
transgenic plant(s); each showing increased nitrogen use efficiency
(NUE) and increased yield, in the absence of stress as well as the
absence of nutrient deficiencies, and an increased water use
efficiency (WUE) particularly tolerance to drought conditions, as
compared to a corresponding non-transformed wild type plant cell or
plant, by increasing or generating one or more activities selected
from the group consisting of 2-dehydro-3-deoxy-phosphoheptonate
aldolase, 3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease. Thus, in the most
preferred embodiments of the present invention, a method is
provided for producing a transgenic plant cell nucleus; a
transgenic plant cell; plant(s) comprising one or more of such
transgenic nuclei or plant cell(s); progeny, seed, and/or pollen
derived from such plant cell and/or transgenic plant(s); each
showing an increased nitrogen use efficiency (NUE), an increased
yield, in the absence of stress as well as the absence of nutrient
deficiencies, an increased low temperature tolerance, particularly
chilling tolerance, and an increased water use efficiency,
particularly tolerance to drought conditions, as compared to a
corresponding non-transformed wild type plant cell or plant, by
increasing or generating one or more activities selected from the
group consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase,
3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein,
ydr355c-protein, YFR007W-protein, ygr122c-a-protein,
ygr266w-protein, ygr290w-protein, YHL005C-protein, yhl021c-protein,
yhr127w-protein, YJL010C-protein, yjl064w-protein, yjl067w-protein,
yjl213w-protein, ykl100c-protein, YKL111C-protein, ykl131w-protein,
ykr016w-protein, ykr021w-protein, yll014w-protein, yll023c-protein,
yll037w-protein, yll049w-protein, ylr042c-protein, YLR053c-protein,
ylr065c-protein, ylr125w-protein, ylr404w-protein, ylr463c-protein,
yml089c-protein, YML101C-protein, yml128c-protein, YMR082C-protein,
YMR126c membrane protein, YMR144W-protein, YMR160W-protein,
YMR209C-protein, YMR233W-protein, YNL320W-protein, YOR097c-protein,
YOR203W-protein, YPL068C-protein, Zinc finger protein, and zinc
metalloprotease. Furthermore, in such most preferred embodiments,
the present invention provides a transgenic plant cell nucleus; a
transgenic plant cell; plant(s) comprising one or more of such
transgenic nuclei or plant cell(s); progeny, seed, and/or pollen
derived from such plant cell and/or transgenic plant(s); each
showing increased nitrogen use efficiency (NUE), an increased yield
in the absence of stress as well as the absence of nutrient
deficiencies, an increased low temperature tolerance, particularly
chilling tolerance and an increased water use efficiency (WUE)
particularly tolerance to drought conditions, as compared to a
corresponding non-transformed wild type plant cell or plant, by
increasing or generating one or more activities selected from the
group consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase,
3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydrolyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease.
[0141] Among these particularly preferred embodiments of the
present invention, the preferred increased nutrient use efficiency
achieved in accordance with the methods of the present invention,
and shown by the transgenic plant cell nucleus; a transgenic plant
cell; plant(s) comprising one or more of such transgenic nuclei or
plant cell(s); progeny, seed, and/or pollen derived from such plant
cell and/or transgenic plant(s), which are provided by the present
invention, is increased nitrogen use efficiency (NUE).
[0142] In the preferred embodiments of the present invention
described above, it is even more preferred the increase or
generation of one or more activities selected from the group
consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto
sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-ketoreductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease is effected by one or
more nucleic acid sequences as shown in table I, column 5 or 7, by
one or more proteins each comprising a polypeptide encoded by one
or more nucleic acid sequences as shown in table I, column 5 or 7,
and/or by one or more protein(s) each comprising a polypeptide as
depicted in table II, column 5 or 7.
[0143] For the purpose of the description of the present invention
the proteins having an activity selected from the group consisting
of 2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, polypeptides encoded
by one or more nucleic acid sequences encoded by one or more
nucleic acid sequences as shown in table I, column 5 or 7, and/or
the polypeptides as depicted in table II, application no. 1, column
5 or 7 are named as "NUE related protein" NUERP.
[0144] Thus, in preferred embodiments, the present invention
provides a method for producing a transgenic plant cell nucleus; a
transgenic plant cell; plant(s) comprising one or more of such
transgenic nuclei or plant cell(s); progeny, seed, and/or pollen
derived from such plant cell and/or transgenic plant(s); each
showing increased yield as compared to a corresponding
non-transformed wild type plant cell or plant, by increasing or
generating one or more activities selected from the group
consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto
sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydrolyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7. Furthermore, the present
invention provides a transgenic plant cell nucleus; a transgenic
plant cell; plant(s) comprising one or more of such transgenic
nuclei or plant cell(s); progeny, seed, and/or pollen derived from
such plant cell and/or transgenic plant(s); each showing increased
yield as compared to a corresponding non-transformed wild type
plant cell or plant, by increasing or generating one or more
activities selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-ketoreductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7.
[0145] In these preferred embodiments of the present invention,
yield is increased by improving one or more of the yield-related
traits as defined herein.
[0146] Thus, in particularly preferred embodiments, the present
invention provides a method for producing a transgenic plant cell
nucleus; a transgenic plant cell; plant(s) comprising one or more
of such transgenic nuclei or plant cell(s); progeny, seed, and/or
pollen derived from such plant cell and/or transgenic plant(s);
each showing an increased nutrient use efficiency as compared to a
corresponding non-transformed wild type plant cell or plant, by
increasing or generating one or more activities selected from the
group consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase,
3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7. Furthermore, in
particularly preferred embodiments, the present invention provides
a transgenic plant cell nucleus; a transgenic plant cell; plant(s)
comprising one or more of such transgenic nuclei or plant cell(s);
progeny, seed, and/or pollen derived from such plant cell and/or
transgenic plant(s); each showing increased nutrient use efficiency
as compared to a corresponding non-transformed wild type plant cell
or plant, by increasing or generating one or more activities
selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7.
[0147] In other preferred embodiments, the present invention
provides a method for producing a transgenic plant cell nucleus; a
transgenic plant cell; plant(s) comprising one or more of such
transgenic nuclei or plant cell(s); progeny, seed, and/or pollen
derived from such plant cell and/or transgenic plant(s); each
showing an increased NUE and/or increased biomass production, and
an increased stress resistance, particularly abiotic stress
resistance, especially an increased low temperature tolerance, in
particular an increased tolerance to chilling, and/or an increased
water use efficiency, in particular tolerance to drought
conditions, as compared to a corresponding non-transformed wild
type plant cell or plant, by increasing or generating one or more
activities selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7. Furthermore, in such other
particularly preferred embodiments, the present invention provides
a transgenic plant cell nucleus; a transgenic plant cell; plant(s)
comprising one or more of such transgenic nuclei or plant cell(s);
progeny, seed, and/or pollen derived from such plant cell and/or
transgenic plant(s); each showing an increased NUE and/or increased
biomass production, and an increased stress resistance,
particularly abiotic stress resistance, especially an increased low
temperature tolerance, in particular an increased tolerance to
chilling, and/or an increased water use efficiency, in particular
tolerance to drought conditions, as compared to a corresponding
non-transformed wild type plant cell or plant, by increasing or
generating one or more activities selected from the group
consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto
sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7.
[0148] In other preferred embodiments, the present invention
provides a method for producing a transgenic plant cell nucleus; a
transgenic plant cell; plant(s) comprising one or more of such
transgenic nuclei or plant cell(s); progeny, seed, and/or pollen
derived from such plant cell and/or transgenic plant(s); each
showing an increased nitrogen use efficiency and an increased low
temperature resistance, particularly chilling tolerance, as
compared to a corresponding non-transformed wild type plant cell or
plant, by increasing or generating one or more activities selected
from the group consisting of 2-dehydro-3-deoxy-phosphoheptonate
aldolase, 3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydrolyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7. Furthermore, in such even
more preferred embodiments, the present invention provides a
transgenic plant cell nucleus; a transgenic plant cell; plant(s)
comprising one or more of such transgenic nuclei or plant cell(s);
progeny, seed, and/or pollen derived from such plant cell and/or
transgenic plant(s); each showing increased nitrogen use efficiency
and an increased low temperature tolerance, particularly chilling
tolerance, as compared to a corresponding non-transformed wild type
plant cell or plant, by increasing or generating one or more
activities selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, 62646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydrolyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7.
[0149] In other preferred embodiments, the present invention
provides a method for producing a transgenic plant cell nucleus; a
transgenic plant cell; plant(s) comprising one or more of such
transgenic nuclei or plant cell(s); progeny, seed, and/or pollen
derived from such plant cell and/or transgenic plant(s); each
showing an increased nitrogen use efficiency and an increased water
use efficiency, particularly tolerance to drought conditions, as
compared to a corresponding non-transformed wild type plant cell or
plant, by increasing or generating one or more activities selected
from the group consisting of 2-dehydro-3-deoxy-phosphoheptonate
aldolase, 3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, 62646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydrolyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7. Furthermore, in such even
more preferred embodiments, the present invention provides a
transgenic plant cell nucleus; a transgenic plant cell; plant(s)
comprising one or more of such transgenic nuclei or plant cell(s);
progeny, seed, and/or pollen derived from such plant cell and/or
transgenic plant(s); each showing increased nitrogen use efficiency
and an increased water use efficiency, particularly tolerance to
drought conditions, as compared to a corresponding non-transformed
wild type plant cell or plant, by increasing or generating one or
more activities selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydrolyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7.
[0150] In other preferred embodiments, the present invention
provides a method for producing a transgenic plant cell nucleus; a
transgenic plant cell; plant(s) comprising one or more of such
transgenic nuclei or plant cell(s); progeny, seed, and/or pollen
derived from such plant cell and/or transgenic plant(s); each
showing an increased nitrogen use efficiency and an increased low
temperature resistance, particularly chilling tolerance, and an
increased water use efficiency, particularly tolerance to drought
conditions, as compared to a corresponding non-transformed wild
type plant cell or plant, by increasing or generating one or more
activities selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7. Furthermore, in such even
more preferred embodiments, the present invention provides a
transgenic plant cell nucleus; a transgenic plant cell; plant(s)
comprising one or more of such transgenic nuclei or plant cell(s);
progeny, seed, and/or pollen derived from such plant cell and/or
transgenic plant(s); each showing increased nitrogen use efficiency
and an increased low temperature tolerance, particularly chilling
tolerance, and an increased water use efficiency, particularly
tolerance to drought conditions, as compared to a corresponding
non-transformed wild type plant cell or plant, by increasing or
generating one or more activities selected from the group
consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto
sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7.
[0151] In other preferred embodiments, the present invention
provides a method for producing a transgenic plant cell nucleus; a
transgenic plant cell; plant(s) comprising one or more of such
transgenic nuclei or plant cell(s); progeny, seed, and/or pollen
derived from such plant cell and/or transgenic plant(s); each
showing an increased nutrient efficiency, especially an increased
nitrogen use efficiency and/or increased biomass production, and
increased yield in the absence of stress as well as the absence of
nutrient deficiencies, as compared to the corresponding
non-transformed wild type plant cell or plant, by increasing or
generating one or more activities selected from the group
consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto
sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydrolyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7. Furthermore, in such even
more preferred embodiments, the present invention provides a
transgenic plant cell nucleus; a transgenic plant cell; plant(s)
comprising one or more of such transgenic nuclei or plant cell(s);
progeny, seed, and/or pollen derived from such plant cell and/or
transgenic plant(s); each showing increased nutrient efficiency,
especially increased nitrogen use efficiency and/or increased
biomass production, and an increased in the absence of stress as
well as the absence of nutrient deficiencies, as compared to a
corresponding non-transformed wild type plant cell or plant, by
increasing or generating one or more activities selected from the
group consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase,
3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydrolyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7.
[0152] In other preferred embodiments, the present invention
provides a method for producing a transgenic plant cell nucleus; a
transgenic plant cell; plant(s) comprising one or more of such
transgenic nuclei or plant cell(s); progeny, seed, and/or pollen
derived from such plant cell and/or transgenic plant(s); each
showing an increased nutrient efficiency, especially an increased
nitrogen use efficiency and/or increased biomass production, and
increased yield in the absence of stress as well as the absence of
nutrient deficiencies, as compared to the corresponding
non-transformed wild type plant cell or plant, by increasing or
generating one or more activities selected from the group
consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto
sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydrolyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7. Furthermore, in such even
more preferred embodiments, the present invention provides a
transgenic plant cell nucleus; a transgenic plant cell; plant(s)
comprising one or more of such transgenic nuclei or plant cell(s);
progeny, seed, and/or pollen derived from such plant cell and/or
transgenic plant(s); each showing increased nutrient efficiency,
especially increased nitrogen use efficiency and/or increased
biomass production, and an increased yield in the absence of stress
as well as the absence of nutrient deficiencies, as compared to a
corresponding non-transformed wild type plant cell or plant, by
increasing or generating one or more activities selected from the
group consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase,
3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydrolyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7.
[0153] In other preferred embodiments, the present invention
provides a method for producing a transgenic plant cell nucleus; a
transgenic plant cell; plant(s) comprising one or more of such
transgenic nuclei or plant cell(s); progeny, seed, and/or pollen
derived from such plant cell and/or transgenic plant(s); each
showing an increased nutrient efficiency, especially an increased
nitrogen use efficiency and/or increased biomass production, and an
increased stress resistance, particularly abiotic stress
resistance, especially an increased low temperature tolerance, in
particular an increased tolerance to chilling, and/or an increased
water use efficiency, in particular tolerance to drought
conditions, and increased yield in the absence of stress as well as
the absence of nutrient deficiencies, as compared to the
corresponding non-transformed wild type plant cell or plant, by
increasing or generating one or more activities selected from the
group consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase,
3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7. Furthermore, in such even
more preferred embodiments, the present invention provides a
transgenic plant cell nucleus; a transgenic plant cell; plant(s)
comprising one or more of such transgenic nuclei or plant cell(s);
progeny, seed, and/or pollen derived from such plant cell and/or
transgenic plant(s); each showing increased nutrient efficiency,
especially increased nitrogen use efficiency and/or increased
biomass production, and an increased stress resistance, particular
abiotic stress resistance, especially low temperature tolerance, in
particular tolerance to chilling, and/or an increased water use
efficiency, in particular tolerance to drought conditions, and an
increased yield in the absence of stress as well as the absence of
nutrient deficiencies, as compared to a corresponding
non-transformed wild type plant cell or plant, by increasing or
generating one or more activities selected from the group
consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto
sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7.
[0154] In other preferred embodiments, the present invention
provides a method for producing a transgenic plant cell nucleus; a
transgenic plant cell; plant(s) comprising one or more of such
transgenic nuclei or plant cell(s); progeny, seed, and/or pollen
derived from such plant cell and/or transgenic plant(s); each
showing an increased nitrogen use efficiency and increased yield in
the absence of stress as well as the absence of nutrient
deficiencies, and an increased low temperature tolerance,
particularly chilling tolerance, as compared to the corresponding
non-transformed wild type plant cell or plant, by increasing or
generating one or more activities selected from the group
consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto
sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydrolyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7. Furthermore, in such even
more preferred embodiments, the present invention provides a
transgenic plant cell nucleus; a transgenic plant cell; plant(s)
comprising one or more of such transgenic nuclei or plant cell(s);
progeny, seed, and/or pollen derived from such plant cell and/or
transgenic plant(s); each showing increased nitrogen use efficiency
and an increased yield in the absence of stress as well as the
absence of nutrient deficiencies, and an increased low temperature
tolerance, particularly chilling tolerance, as compared to a
corresponding non-transformed wild type plant cell or plant, by
increasing or generating one or more activities selected from the
group consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase,
3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydrolyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7.
[0155] In other preferred embodiments, the present invention
provides a method for producing a transgenic plant cell nucleus; a
transgenic plant cell; plant(s) comprising one or more of such
transgenic nuclei or plant cell(s); progeny, seed, and/or pollen
derived from such plant cell and/or transgenic plant(s); each
showing an increased nitrogen use efficiency and increased yield in
the absence of stress as well as the absence of nutrient
deficiencies, and an increased water use efficiency, particularly
tolerance to drought conditions, as compared to the corresponding
non-transformed wild type plant cell or plant, by increasing or
generating one or more activities selected from the group
consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto
sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydrolyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7. Furthermore, in such even
more preferred embodiments, the present invention provides a
transgenic plant cell nucleus; a transgenic plant cell; plant(s)
comprising one or more of such transgenic nuclei or plant cell(s);
progeny, seed, and/or pollen derived from such plant cell and/or
transgenic plant(s); each showing increased nitrogen use efficiency
and an increased yield in the absence of stress as well as the
absence of nutrient deficiencies, and an increased water use
efficiency, particularly tolerance to drought conditions, as
compared to a corresponding non-transformed wild type plant cell or
plant, by increasing or generating one or more activities selected
from the group consisting of 2-dehydro-3-deoxy-phosphoheptonate
aldolase, 3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7.
[0156] In other preferred embodiments, the present invention
provides a method for producing a transgenic plant cell nucleus; a
transgenic plant cell; plant(s) comprising one or more of such
transgenic nuclei or plant cell(s); progeny, seed, and/or pollen
derived from such plant cell and/or transgenic plant(s); each
showing an increased nitrogen use efficiency, increased yield in
the absence of stress as well as the absence of nutrient
deficiencies, an increased low temperature tolerance, particularly
chilling tolerance, and an increased water use efficiency,
particularly tolerance to drought conditions, as compared to the
corresponding non-transformed wild type plant cell or plant, by
increasing or generating one or more activities selected from the
group consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase,
3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7. Furthermore, in such even
more preferred embodiments, the present invention provides a
transgenic plant cell nucleus; a transgenic plant cell; plant(s)
comprising one or more of such transgenic nuclei or plant cell(s);
progeny, seed, and/or pollen derived from such plant cell and/or
transgenic plant(s); each showing increased nitrogen use
efficiency, an increased yield in the absence of stress as well as
the absence of nutrient deficiencies, an increased low temperature
tolerance, particularly chilling tolerance, and an increased water
use efficiency, particularly tolerance to drought conditions, as
compared to a corresponding non-transformed wild type plant cell or
plant, by increasing or generating one or more activities selected
from the group consisting of 2-dehydro-3-deoxy-phosphoheptonate
aldolase, 3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease, which is effected by
one or more nucleic acid sequences as shown in table I, column 5 or
7, by one or more proteins each comprising a polypeptide encoded by
one or more nucleic acid sequences as shown in table I, column 5 or
7, and/or by one or more protein(s) each comprising a polypeptide
as depicted in table II, column 5 or 7.
[0157] In a preferred embodiment of the invention a photosynthetic
active organism, especially a plant, shows an enhanced NUE.
[0158] In another preferred embodiment a photosynthetic active
organism, especially a plant, shows increased biomass production
and/or yield under conditions of limited nitrogen supply.
[0159] In another embodiment this invention fulfills the need to
identify new, unique genes capable of effecting an increased yield
in a plant upon expression or over-expression of endogenous and/or
exogenous genes.
[0160] In preferred embodiments thereof, this invention fulfills
the need to identify new, unique genes capable of effecting an
increased yield in a plant upon expression or over-expression of
one or more endogenous genes.
[0161] In preferred embodiments thereof, this invention fulfills
the need to identify new, unique genes capable of effecting an
increased yield in a plant upon expression or over-expression of
one or more exogenous genes.
[0162] In another embodiment this invention fulfills the need to
identify new, unique genes capable of effecting an increased
nutrient efficiency, especially an increased NUE, and an increased
stress resistance, particularly abiotic stress resistance,
especially an increased low temperature tolerance, in particular an
increased tolerance to chilling, and/or an increased water use
efficiency, in particular tolerance to drought conditions, in a
plant upon expression or over-expression of endogenous and/or
exogenous genes.
[0163] In preferred embodiments thereof, this invention fulfills
the need to identify new, unique genes capable of effecting an
increased nutrient efficiency, especially an increased NUE, and an
increased stress resistance, particularly abiotic stress
resistance, especially an increased low temperature tolerance, in
particular an increased tolerance to chilling, and/or an increased
water use efficiency, in particular tolerance to drought
conditions, in a plant upon expression or over-expression of one or
more endogenous genes.
[0164] In preferred embodiments thereof, this invention fulfills
the need to identify new, unique genes capable of effecting an
increased nutrient efficiency, especially an increased NUE, and an
increased stress resistance, particularly abiotic stress
resistance, especially an increased low temperature tolerance, in
particular an increased tolerance to chilling, and/or an increased
water use efficiency, in particular tolerance to drought
conditions, in a plant upon expression or over-expression of one or
more exogenous genes.
[0165] In another embodiment this invention fulfills the need to
identify new, unique genes capable of effecting an increased NUE,
and an increased low temperature tolerance, in particular an
increased tolerance to chilling, in a plant upon expression or
over-expression of endogenous and/or exogenous genes.
[0166] In preferred embodiments thereof, this invention fulfills
the need to identify new, unique genes capable of effecting an
increased NUE, and an increased low temperature tolerance, in
particular an increased tolerance to chilling, in a plant upon
expression or over-expression of one or more endogenous genes.
[0167] In preferred embodiments thereof, this invention fulfills
the need to identify new, unique genes capable of effecting an
increased NUE, and an increased low temperature tolerance, in
particular an increased tolerance to chilling, in a plant upon
expression or over-expression of one or more exogenous genes.
[0168] In another embodiment this invention fulfills the need to
identify new, unique genes capable of effecting an increased NUE,
and an increased water use efficiency, in particular tolerance to
drought conditions, in a plant upon expression or over-expression
of endogenous and/or exogenous genes.
[0169] In preferred embodiments thereof, this invention fulfills
the need to identify new, unique genes capable of effecting an
increased NUE, and an increased water use efficiency, in particular
tolerance to drought conditions, in a plant upon expression or
over-expression of one or more endogenous genes.
[0170] In preferred embodiments thereof, this invention fulfills
the need to identify new, unique genes capable of effecting an
increased NUE, and an increased water use efficiency, in particular
tolerance to drought conditions, in a plant upon expression or
over-expression of one or more exogenous genes.
[0171] In another embodiment this invention fulfills the need to
identify new, unique genes capable of effecting an increased NUE,
an increased low temperature tolerance, in particular an increased
tolerance to chilling, and an increased water use efficiency, in
particular tolerance to drought conditions, in a plant upon
expression or over-expression of endogenous and/or exogenous
genes.
[0172] In preferred embodiments thereof, this invention fulfills
the need to identify new, unique genes capable of effecting an
increased NUE, an increased low temperature tolerance, in
particular an increased tolerance to chilling, and an increased
water use efficiency, in particular tolerance to drought
conditions, in a plant upon expression or over-expression of one or
more endogenous genes.
[0173] In preferred embodiments thereof, this invention fulfills
the need to identify new, unique genes capable of effecting an
increased NUE, an increased low temperature tolerance, in
particular an increased tolerance to chilling, and an increased
water use efficiency, in particular tolerance to drought
conditions, in a plant upon expression or over-expression of one or
more exogenous genes.
[0174] In another embodiment this invention fulfills the need to
identify new, unique genes capable of effecting an increased
nutrient efficiency, especially an increased NUE, and an increased
yield in the absence of stress as well as the absence of nutrient
deficiencies, in a plant upon expression or over-expression of
endogenous and/or exogenous genes.
[0175] In preferred embodiments thereof, this invention fulfills
the need to identify new, unique genes capable of effecting an
increased nutrient efficiency, especially an increased NUE, and an
increased yield in the absence of stress as well as the absence of
nutrient deficiencies, in a plant upon expression or
over-expression of one or more endogenous genes.
[0176] In preferred embodiments thereof, this invention fulfills
the need to identify new, unique genes capable of effecting an
increased nutrient efficiency, especially an increased NUE, and an
increased yield in the absence of stress as well as the absence of
nutrient deficiencies, in a plant upon expression or
over-expression of one or more exogenous genes.
[0177] In another embodiment this invention fulfills the need to
identify new, unique genes capable of effecting an increased
nutrient efficiency, especially an increased NUE, an increased
stress resistance, particularly abiotic stress resistance,
especially an increased low temperature tolerance, in particular an
increased tolerance to chilling, and/or an increased water use
efficiency, in particular tolerance to drought conditions, and an
increased yield in the absence of stress as well as the absence of
nutrient deficiencies, in a plant upon expression or
over-expression of endogenous and/or exogenous genes.
[0178] In preferred embodiments thereof, this invention fulfills
the need to identify new, unique genes capable of effecting an
increased nutrient efficiency, especially an increased NUE, and an
increased stress resistance, particularly abiotic stress
resistance, especially an increased low temperature tolerance, in
particular an increased tolerance to chilling, and/or an increased
water use efficiency, in particular tolerance to drought
conditions, and an increased yield in the absence of stress as well
as the absence of nutrient deficiencies, in a plant upon expression
or over-expression of one or more endogenous genes.
[0179] In preferred embodiments thereof, this invention fulfills
the need to identify new, unique genes capable of effecting an
increased nutrient efficiency, especially an increased NUE, and an
increased stress resistance, particularly abiotic stress
resistance, especially an increased low temperature tolerance, in
particular an increased tolerance to chilling, and/or an increased
water use efficiency, in particular tolerance to drought
conditions, and an increased yield in the absence of stress as well
as the absence of nutrient deficiencies, in a plant upon expression
or over-expression of one or more exogenous genes.
[0180] In another embodiment this invention fulfills the need to
identify new, unique genes capable of effecting an increased NUE,
an increased low temperature tolerance, in particular an increased
tolerance to chilling, and an increased yield in the absence of
stress as well as the absence of nutrient deficiencies, in a plant
upon expression or over-expression of endogenous and/or exogenous
genes.
[0181] In preferred embodiments thereof, this invention fulfills
the need to identify new, unique genes capable of effecting an NUE,
an increased low temperature tolerance, in particular an increased
tolerance to chilling, and an increased yield in the absence of
stress as well as the absence of nutrient deficiencies, in a plant
upon expression or over-expression of one or more endogenous
genes.
[0182] In preferred embodiments thereof, this invention fulfills
the need to identify new, unique genes capable of effecting an
increased NUE, an increased low temperature tolerance, and an
increased yield in the absence of stress as well as the absence of
nutrient deficiencies, in a plant upon expression or
over-expression of one or more exogenous genes.
[0183] In another embodiment this invention fulfills the need to
identify new, unique genes capable of effecting an increased NUE,
an increased water use efficiency, in particular tolerance to
drought conditions, and an increased yield in the absence of stress
as well as the absence of nutrient deficiencies, in a plant upon
expression or over-expression of endogenous and/or exogenous
genes.
[0184] In preferred embodiments thereof, this invention fulfills
the need to identify new, unique genes capable of effecting an
increased NUE, an increased water use efficiency, in particular
tolerance to drought conditions, and an increased yield in the
absence of stress as well as the absence of nutrient deficiencies,
in a plant upon expression or over-expression of one or more
endogenous genes.
[0185] In preferred embodiments thereof, this invention fulfills
the need to identify new, unique genes capable of effecting an
increased NUE, an increased water use efficiency, in particular
tolerance to drought conditions, and an increased yield in the
absence of stress as well as the absence of nutrient deficiencies,
in a plant upon expression or over-expression of one or more
exogenous genes.
[0186] In another embodiment this invention fulfills the need to
identify new, unique genes capable of effecting an increased NUE,
an increased low temperature tolerance, in particular an increased
tolerance to chilling, an increased water use efficiency, in
particular tolerance to drought conditions, and an increased yield
in the absence of stress as well as the absence of nutrient
deficiencies, in a plant upon expression or over-expression of
endogenous and/or exogenous genes.
[0187] In preferred embodiments thereof, this invention fulfills
the need to identify new, unique genes capable of effecting an
increased NUE, an increased low temperature tolerance, in
particular an increased tolerance to chilling, an increased water
use efficiency, in particular tolerance to drought conditions, and
an increased yield in the absence of stress as well as the absence
of nutrient deficiencies, in a plant upon expression or
over-expression of one or more endogenous genes.
[0188] In preferred embodiments thereof, this invention fulfills
the need to identify new, unique genes capable of effecting an
increased NUE, an increased low temperature tolerance, in
particular an increased tolerance to chilling, an increased water
use efficiency, in particular tolerance to drought conditions, and
an increased yield in the absence of stress as well as the absence
of nutrient deficiencies, in a plant upon expression or
over-expression of one or more exogenous genes.
[0189] In another embodiment this invention fulfills the need to
identify new, unique genes capable of conferring enhanced nutrient
efficiency, especially enhanced NUE, to photosynthetic active
organism, preferably plants, upon expression or over-expression of
one or more endogenous and/or exogenous genes.
[0190] In another embodiment thereof this invention fulfills the
need to identify new, unique genes capable of conferring enhanced
nutrient efficiency, especially enhanced NUE, to photosynthetic
active organism, preferably plants, upon expression or
over-expression of one or more endogenous genes.
[0191] In another embodiment thereof this invention fulfills the
need to identify new, unique genes capable of conferring enhanced
nutrient efficiency, especially enhanced NUE, to photosynthetic
active organism, preferably plants, upon expression or
over-expression of one or more exogenous genes.
[0192] In another embodiment this invention fulfills the need to
identify new, unique genes capable of conferring an increase of
biomass production to photosynthetic active organism, preferably
plants, upon expression or over-expression of one or more
endogenous and/or exogenous genes.
[0193] In another embodiment thereof this invention fulfills the
need to identify new, unique genes capable of conferring an
increase of biomass production to photosynthetic active organism,
preferably plants, upon expression or over-expression of one or
more endogenous genes.
[0194] In another embodiment thereof this invention fulfills the
need to identify new, unique genes capable of conferring an
increase of biomass production to photosynthetic active organism,
preferably plants, upon expression or over-expression of one or
more exogenous genes.
[0195] In another embodiment this invention fulfills the need to
identify new, unique genes capable of conferring an enhanced NUE in
combination with an increase of biomass production to
photosynthetic active organism, preferably plants, upon expression
or over-expression of one or more endogenous and/or exogenous
genes.
[0196] In another embodiment thereof this invention fulfills the
need to identify new, unique genes capable of conferring an
enhanced NUE in combination with an increase of biomass production
to photosynthetic active organism, preferably plants, upon
expression or over-expression of one or more endogenous genes.
[0197] In another embodiment this invention fulfills the need to
identify new, unique genes capable of conferring an enhanced NUE in
combination with an increase of biomass production to
photosynthetic active organism, preferably plants, upon expression
or over-expression of one or more exogenous genes.
[0198] Thus, in the most preferred embodiments of the present
invention, this invention fulfills the need to identify new, unique
genes capable of effecting an increased nitrogen use efficiency
(NUE), optionally an increased low temperature tolerance,
particularly chilling tolerance, optionally an increased water use
efficiency, in particular tolerance to drought conditions, and
optionally an increased yield in the absence of stress as well as
the absence of nutrient deficiencies. In each of the above
described preferred embodiments, it is preferred that said genes of
the invention have the capacity of increasing or generating one or
more activities selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydrolyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease. In these preferred
embodiments of the present invention, it is even more preferred
that the increase or generation of one or more activities selected
from the group consisting of 2-dehydro-3-deoxy-phosphoheptonate
aldolase, 3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease is effected by one or
more nucleic acid sequences as shown in table I, column 5 or 7, by
one or more proteins encoded by one or more nucleic acid sequences
as shown in table I, column 5 or 7, and/or by one or more
protein(s) as depicted in table II, column 5 or 7. The need to
identify such new, unique genes is particularly fulfilled by
providing the NUERP encoding genes disclosed herein.
[0199] Accordingly, the present invention relates to a method for
producing a transgenic photosynthetic active organism or a part
thereof, preferably a plant cell, a plant or a part thereof,
resulting in increased yield, preferably with enhanced NUE and/or
increased biomass production, as compared to a corresponding
non-transformed wild type photosynthetic active organism or a part
thereof, preferably a plant cell, a plant or a part thereof, which
comprises [0200] (a) increasing or generating one or more
activities selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease. in a photosynthetic
active organism or a part thereof, preferably a plant cell, a plant
or a part thereof, and [0201] (b) growing the photosynthetic active
organism or a part thereof, preferably a plant cell, a plant or a
part thereof under conditions which permit the development of a
photosynthetic active organism or a part thereof, preferably a
plant cell, a plant or a part thereof, showing increased yield,
preferably enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type
photosynthetic active organism or a part thereof, preferably a
plant cell, a plant or a part thereof.
[0202] In an further embodiment, the present invention relates to a
method for producing a transgenic plant cell nucleus, a transgenic
plant cell, a transgenic plant or a part thereof, resulting in
increased yield as compared to a corresponding non-transformed wild
type plant cell, a transgenic plant or a part thereof, which
comprises
[0203] (a) increasing or generating, in said plant cell nucleus,
plant cell, plant or part thereof, one or more activities selected
from the group consisting of 2-dehydro-3-deoxy-phosphoheptonate
aldolase, 3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease; [0204] (b) growing a
plant cell, a plant or a part thereof under conditions, preferably
in presence or absence of nutrient deficiency and/or abiotic
stress, which permits the development of a plant cell, a plant or a
part thereof, showing increased yield as compared to a
corresponding non-transformed wild type plant cell, a transgenic
plant or a part thereto, and [0205] (c) selecting the plant cell, a
plant or a part thereof, showing increased yield, preferably
improved nutrient use efficiency and/or abiotic stress resistance,
as compared to a corresponding non-transformed wild type plant
cell, a transgenic plant or a part thereof which shows visual
symptoms of deficiency and/or death under said conditions.
[0206] In an embodiment the present invention relates to a method
for producing a transgenic photosynthetic active organism or a part
thereof, preferably a plant cell, a plant or a part thereof with
enhanced NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type photosynthetic active
organism or a part thereof, preferably a plant cell, a plant or a
part thereof, which comprises [0207] (a) increasing or generating
one or more activities selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease. in a photosynthetic
active organism or a part thereof, preferably a plant cell, a plant
or a part thereof, [0208] (b) growing the photosynthetic active
organism or a part thereof, preferably a plant cell, a plant or a
part thereof together with non-transformed wildtype photosynthetic
active organism or a part thereof, preferably a plant, under
conditions of limited nitrogen supply, and [0209] (c) selecting the
photosynthetic active organism or a part thereof, preferably a
plant cell, a plant or a part thereof, with enhanced NUE and/or
increased biomass production, as compared to a corresponding
non-transformed wild type photosynthetic active organism or a part
thereof, preferably a plant cell, a plant or a part thereof, after
the non-transformed wild type photosynthetic active organism or a
part thereof, preferably a plant cell, a plant or a part thereof,
show visual symptoms of deficiency and/or death.
[0210] In one embodiment the present invention relates to a method
for producing a transgenic photosynthetic active organism or a part
thereof, preferably plant cell nucleus, a plant cell, a plant or a
part thereof, resulting in increased yield, especially enhanced NUE
and/or increased biomass production, as compared to a corresponding
non-transformed wild type photosynthetic active organism or a part
thereof, preferably a plant cell, a plant or a part thereof, which
comprises [0211] (a) increasing or generating the activity of a
protein as shown in table II, application no. 1, column 3,
preferably encoded by the nucleic acid sequences as shown in table
I, application no. 1, column 5, in photosynthetic active organism
or a part thereof, preferably a plant cell nucleus, a plant cell, a
plant or a part thereof, and [0212] (b) growing the photosynthetic
active organism or a part thereof, preferably a plant cell, a plant
or a part thereof under conditions which permit the development of
a plant showing increased yield, especially enhanced NUE and/or
increased biomass production, as compared to a corresponding
non-transformed wild type photosynthetic active organism or a part
thereof, preferably a plant.
[0213] Accordingly, the present invention relates to a method for
producing a transgenic plant cell, a plant or a part thereof,
resulting in increased yield, especially enhanced NUE and/or
increased biomass production, as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof,
which comprises [0214] (a) increasing or generating one or more
activities selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease in an organelle,
especially the plastid, of a plant cell, and [0215] (b) growing the
plant cell under conditions which permit the development of a plant
showing increased yield, especially enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant.
[0216] In another embodiment the present invention relates to a
method for producing a transgenic plant cell, a plant or a part
thereof, resulting in increased yield, especially enhanced NUE
and/or increased biomass production, as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof,
which comprises [0217] (a) increasing or generating one or more
activities selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease in the cytosol of a
plant cell, and [0218] (b) growing the plant cell under conditions
which permit the development of a plant showing increased yield,
especially enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant.
[0219] In one embodiment the present invention relates to a method
for producing a transgenic plant cell, a plant or a part thereof,
resulting in increased yield, especially enhanced NUE and/or
increased biomass production, as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof,
which comprises [0220] (a) increasing or generating the activity of
a protein as shown in table II, application no. 1, column 3,
preferably encoded by the nucleic acid sequences as shown in table
I, application no. 1, column 5 or 7, in an organelle, especially in
the plastid, of a plant cell, and [0221] (b) growing the plant cell
under conditions which permit the development of a plant showing
increased yield, especially enhanced NUE and/or increased biomass
production, as compared to a corresponding non-transformed wild
type plant.
[0222] In one embodiment the present invention relates to a method
for producing a transgenic plant cell, a plant or a part thereof,
resulting in increased yield, especially enhanced NUE and/or
increased biomass production, as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof,
which comprises [0223] (a) increasing or generating the activity of
a protein as shown in table II, application no. 1, column 3,
preferably encoded by the nucleic acid sequences as shown in table
I, application no. 1, column 5 or 7, in the cytosol of a plant
cell, and [0224] (b) growing the plant cell under conditions which
permit the development of a plant showing increased yield,
especially enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant.
[0225] In another embodiment the present invention is related to a
method for producing a transgenic plant cell, a plant or a part
thereof, resulting in increased yield, especially enhanced NUE
and/or increased biomass production, as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof,
which comprises [0226] (a) increasing or generating one or more
activities selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, 60165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease. in an organelle of a
plant cell; or [0227] (b) increasing or generating the activity of
a protein as shown in table II, application no. 1, column 3 encoded
by the nucleic acid sequences as shown in table I, application no.
1, column 5 or 7, which are joined to a nucleic acid sequence
encoding a transit peptide in a plant cell; or [0228] (c)
increasing or generating the activity of a protein as shown in
table II, application no. 1, column 3 encoded by the nucleic acid
sequences as shown in table I, application no. 1, column 5 or 7,
which are joined to a nucleic acid sequence encoding an organelle
localization sequence, especially a chloroplast localization
sequence, in a plant cell, and [0229] (d) growing the plant cell
under conditions which permit the development of a plant showing
increased yield, especially enhanced NUE and/or increased biomass
production, as compared to a corresponding non-transformed wild
type plant.
[0230] In another embodiment, the present invention relates to a
method for producing a transgenic plant cell, a plant or a part
thereof, resulting in increased yield, especially enhanced nutrient
efficiency, in particular enhanced NUE and/or increased biomass
production, and optionally resulting in increased stress tolerance,
especially abiotic stress tolerance, preferably low temperature
tolerance and/or increased water use efficiency, as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof, which comprises [0231] (a) increasing or generating
the activity of a protein as shown in table II, application no. 1,
column 3 encoded by the nucleic acid sequences as shown in table I,
application no. 1, column 5 or 7, in an organelle of a plant
through the transformation of the organelle, or [0232] (b)
increasing or generating the activity of a protein as shown in
table II, application no. 1, column 3 encoded by the nucleic acid
sequences as shown in table I, application no. 1, column 5 or 7 in
the plastid of a plant, or in one or more parts thereof through the
transformation of the plastids; and [0233] (c) growing the plant
cell under conditions which permit the development of a plant
showing increased yield, especially enhanced nutrient efficiency,
in particular enhanced NUE and/or increased biomass production, and
optionally resulting in increased stress tolerance, especially
abiotic stress tolerance, preferably low temperature tolerance
and/or increased water use efficiency, as compared to a
corresponding non-transformed wild type plant.
[0234] In principle the nucleic acid sequence encoding a transit
peptide can be isolated from every organism such as microorganisms
such as algae or plants containing plastids preferably
chloroplasts. A "transit peptide" is an amino acid sequence, whose
encoding nucleic acid sequence is translated together with the
corresponding structural gene. That means the transit peptide is an
integral part of the translated protein and forms an amino terminal
extension of the protein. Both are translated as so called
"preprotein". In general the transit peptide is cleaved off from
the preprotein during or just after import of the protein into the
correct cell organelle such as a plastid to yield the mature
protein. The transit peptide ensures correct localization of the
mature protein by facilitating the transport of proteins through
intracellular membranes.
[0235] Preferred nucleic acid sequences encoding a transit peptide
are derived from a nucleic acid sequence encoding a protein finally
resided in the plastid and stemming from an organism selected from
the group consisting of the genera Acetabularia, Arabidopsis,
Brassica, Capsicum, Chlamydomonas, Cururbita, Dunaliella, Euglena,
Flayeria, Glycine, Helianthus, Hordeum, Lemna, Lolium, Lycopersion,
Malus, Medicago, Mesembryanthemum, Nicotiana, Oenotherea, Oryza,
Petunia, Phaseolus, Physcomitrella, Pinus, Pisum, Raphanus, Silene,
Sinapis, Solanum, Spinacea, Stevia, Synechococcus, Triticum and
Zea.
[0236] Advantageously such transit peptides, which are beneficially
used in the inventive process, are derived from the nucleic acid
sequence encoding a protein selected from the group consisting of
ribulose bisphosphate carboxylase/oxygenase,
5-enolpyruvyl-shikimate-3-phosphate synthase, acetolactate
synthase, chloroplast ribosomal protein CS17, Cs protein,
ferredoxin, plastocyanin, ribulose bisphosphate carboxylase
activase, tryptophan synthase, acyl carrier protein, plastid
chaperonin-60, cytochrome c.sub.552, 22-kDA heat shock protein,
33-kDa Oxygen-evolving enhancer protein 1, ATP synthase .gamma.
subunit, ATP synthase .delta. subunit, chlorophyll-a/b-binding
proteinII-1, Oxygen-evolving enhancer protein 2, Oxygen-evolving
enhancer protein 3, photosystem I: P21, photosystem I: P28,
photosystem I: P30, photosystem I: P35, photosystem I: P37,
glycerol-3-phosphate acyltransferases, chlorophyll a/b binding
protein, CAB2 protein, hydroxymethyl-bilane synthase,
pyruvate-orthophosphate dikinase, CAB3 protein, plastid ferritin,
ferritin, early light-inducible protein, glutamate-1-semialdehyde
aminotransferase, protochlorophyllide reductase,
starch-granule-bound amylase synthase, light-harvesting chlorophyll
a/b-binding protein of photosystem II, major pollen allergen LoI p
5a, plastid ClpB ATP-dependent protease, superoxide dismutase,
ferredoxin NADP oxidoreductase, 28-kDa ribonucleoprotein, 31-kDa
ribonucleoprotein, 33-kDa ribonucleoprotein, acetolactate synthase,
ATP synthase CF.sub.0 subunit 1, ATP synthase CF.sub.0 subunit 2,
ATP synthase CF.sub.0 subunit 3, ATP synthase CF.sub.0 subunit 4,
cytochrome f, ADP-glucose pyrophosphorylase, glutamine synthase,
glutamine synthase 2, carbonic anhydrase, GapA protein,
heat-shock-protein hsp21, phosphate translocator, plastid CIpA
ATP-dependent protease, plastid ribosomal protein CL24, plastid
ribosomal protein CL9, plastid ribosomal protein PsCL18, plastid
ribosomal protein PsCL25, DAHP synthase, starch phosphorylase, root
acyl carrier protein II, betaine-aldehyde dehydrogenase, GapB
protein, glutamine synthetase 2, phosphoribulokinase, nitrite
reductase, ribosomal protein L12, ribosomal protein L13, ribosomal
protein L21, ribosomal protein L35, ribosomal protein L40, triose
phosphate-3-phosphoglyerate-phosphate translocator,
ferredoxin-dependent glutamate synthase, glyceraldehyde-3-phosphate
dehydrogenase, NADP-dependent malic enzyme and NADP-malate
dehydrogenase.
[0237] More preferred the nucleic acid sequence encoding a transit
peptide is derived from a nucleic acid sequence encoding a protein
finally resided in the plastid and stemming from an organism
selected from the group consisting of the species Acetabularia
mediterranea, Arabidopsis thaliana, Brassica campestris, Brassica
napus, Capsicum annuum, Chlamydomonas reinhardtii, Cururbita
moschata, Dunaliella salina, Dunaliella tertiolecta, Euglena
gracilis, Flayeria trinervia, Glycine max, Helianthus annuus,
Hordeum vulgare, Lemna gibba, Lolium perenne, Lycopersion
esculentum, Malus domestica, Medicago falcata, Medicago sativa,
Mesembryanthemum crystallinum, Nicotiana plumbaginifolia, Nicotiana
sylvestris, Nicotiana tabacum, Oenotherea hookeri, Oryza sativa,
Petunia hybrida, Phaseolus vulgaris, Physcomitrella patens, Pinus
tunbergii, Pisum sativum, Raphanus sativus, Silene pratensis,
Sinapis alba, Solanum tuberosum, Spinacea oleracea, Stevia
rebaudiana, Synechococcus, Synechocystis, Triticum aestivum and Zea
mays.
[0238] Even more preferred nucleic acid sequences are encoding
transit peptides as disclosed by von Heijne et al. (Plant Molecular
Biology Reporter, 9 (2), 104, (1991)), which are hereby
incorparated by reference. Table V shows some examples of the
transit peptide sequences disclosed by von Heijne et al. According
to the disclosure of the invention especially in the examples the
skilled worker is able to link other nucleic acid sequences
disclosed by von Heijne et al. to the nucleic acid sequences shown
in table I, application no. 1, columns 5 and 7. Most preferred
nucleic acid sequences encoding transit peptides are derived from
the genus Spinacia such as chlorplast 30S ribosomal protein PSrp-1,
root acyl carrier protein II, acyl carrier protein, ATP synthase:
.gamma. subunit, ATP synthase: .delta. subunit, cytochrom f,
ferredoxin I, ferredoxin NADP oxidoreductase (=FNR), nitrite
reductase, phosphoribulokinase, plastocyanin or carbonic anhydrase.
The skilled worker will recognize that various other nucleic acid
sequences encoding transit peptides can easely isolated from
plastid-localized proteins, which are expressed from nuclear genes
as precursors and are then targeted to plastids. Such transit
peptides encoding sequences can be used for the construction of
other expression constructs. The transit peptides advantageously
used in the inventive process and which are part of the inventive
nucleic acid sequences and proteins are typically 20 to 120 amino
acids, preferably 25 to 110, 30 to 100 or 35 to 90 amino acids,
more preferably 40 to 85 amino acids and most preferably 45 to 80
amino acids in length and functions post-translationally to direct
the protein to the plastid preferably to the chloroplast. The
nucleic acid sequences encoding such transit peptides are localized
upstream of nucleic acid sequence encoding the mature protein. For
the correct molecular joining of the transit peptide encoding
nucleic acid and the nucleic acid encoding the protein to be
targeted it is sometimes necessary to introduce additional base
pairs at the joining position, which forms restriction enzyme
recognition sequences useful for the molecular joining of the
different nucleic acid molecules. This procedure might lead to very
few additional amino acids at the N-terminal of the mature imported
protein, which usually and preferably do not interfer with the
protein function. In any case, the additional base pairs at the
joining position which forms restriction enzyme recognition
sequences have to be choosen with care, in order to avoid the
formation of stop codons or codons which encode amino acids with a
strong influence on protein folding, like e.g. proline. It is
preferred that such additional codons encode small structural
flexible amino acids such as glycine or alanine.
[0239] As mentioned above the nucleic acid sequences coding for the
proteins as shown in table II, application no. 1, column 3 and its
homologs as disclosed in table I, application no. 1, columns 5 and
7 can be joined to a nucleic acid sequence encoding a transit
peptide. This nucleic acid sequence encoding a transit peptide
ensures transport of the protein to the respective organelle,
especially the plastid. The nucleic acid sequence of the gene to be
expressed and the nucleic acid sequence encoding the transit
peptide are operably linked. Therefore the transit peptide is fused
in frame to the nucleic acid sequence coding for proteins as shown
in table II, application no. 1, column 3 and its homologs as
disclosed in table I, application no. 1, columns 5 and 7.
[0240] The term "organelle" according to the invention shall mean
for example "mitochondria" or preferably "plastid" (throughout the
specification the "plural" shall comprise the "singular" and vice
versa). The term "plastid" according to the invention is intended
to include various forms of plastids including proplastids,
chloroplasts, chromoplasts, gerontoplasts, leucoplasts,
amyloplasts, elaioplasts and etioplasts, preferably chloroplasts.
They all have as a common ancestor the aforementioned
proplasts.
[0241] Other transit peptides are disclosed by Schmidt et al. (J.
Biol. Chem. 268 (36), 27447 (1993)), Della-Cioppa et al. (Plant.
Physiol. 84, 965 (1987)), de Castro Silva Filho et al. (Plant Mol.
Biol. 30, 769 (1996)), Zhao et al. (J. Biol. Chem. 270 (11), 6081
(1995)), Romer et al. (Biochem. Biophys. Res. Commun. 196 (3), 1414
(1993)), Keegstra et al. (Annu. Rev. Plant Physiol. Plant Mol.
Biol. 40, 471 (1989)), Lubben et al. (Photosynthesis Res. 17, 173
(1988)) and Lawrence et al. (J. Biol. Chem. 272 (33), 20357
(1997)). A general review about targeting is disclosed by Kermode
Allison R. in Critical Reviews in Plant Science 15 (4), 285 (1996)
under the title "Mechanisms of Intracellular Protein Transport and
Targeting in Plant Cells."
[0242] Favored transit peptide sequences, which are used in the
inventive process and which form part of the inventive nucleic acid
sequences are generally enriched in hydroxylated amino acid
residues (serine and threonine), with these two residues generally
constituting 20 to 35% of the total. They often have an
amino-terminal region empty of Gly, Pro, and charged residues.
Furthermore they have a number of small hydrophobic amino acids
such as valine and alanine and generally acidic amino acids are
lacking. In addition they generally have a middle region rich in
Ser, Thr, Lys and Arg. Overall they have very often a net positive
charge.
[0243] Alternatively, nucleic acid sequences coding for the transit
peptides may be chemically synthesized either in part or wholly
according to structure of transit peptide sequences disclosed in
the prior art. Said natural or chemically synthesized sequences can
be directly linked to the sequences encoding the mature protein or
via a linker nucleic acid sequence, which may be typically less
than 500 base pairs, preferably less than 450, 400, 350, 300, 250
or 200 base pairs, more preferably less than 150, 100, 90, 80, 70,
60, 50, 40 or 30 base pairs and most preferably less than 25, 20,
15, 12, 9, 6 or 3 base pairs in length and are in frame to the
coding sequence. Furthermore favorable nucleic acid sequences
encoding transit peptides may comprise sequences derived from more
than one biological and/or chemical source and may include a
nucleic acid sequence derived from the amino-terminal region of the
mature protein, which in its native state is linked to the transit
peptide. In a preferred embodiment of the invention said
amino-terminal region of the mature protein is typically less than
150 amino acids, preferably less than 140, 130, 120, 110, 100 or 90
amino acids, more preferably less than 80, 70, 60, 50, 40, 35, 30,
25 or 20 amino acids and most preferably less than 19, 18, 17, 16,
15, 14, 13, 12, 11 or 10 amino acids in length. But even shorter or
longer stretches are also possible. In addition target sequences,
which facilitate the transport of proteins to other cell
compartments such as the vacuole, endoplasmic reticulum, golgi
complex, glyoxysomes, peroxisomes or mitochondria may be also part
of the inventive nucleic acid sequence. The proteins translated
from said inventive nucleic acid sequences are a kind of fusion
proteins that means the nucleic acid sequences encoding the transit
peptide for example the ones shown in table V, preferably the last
one of the table are joint to the nucleic acid sequences shown in
table I, application no. 1, columns 5 and 7. The person skilled in
the art is able to join said sequences in a functional manner.
Advantageously the transit peptide part is cleaved off from the
protein part shown in table II, application no. 1, columns 5 and 7
during the transport preferably into the plastids. All products of
the cleavage of the preferred transit peptide shown in the last
line of table V have preferably the N-terminal amino acid sequences
QIA CSS or QIA EFQLTT in front of the start methionine of the
protein mentioned in table II, application no. 1, columns 5 and 7.
Other short amino acid sequences of an range of 1 to 20 amino acids
preferable 2 to 15 amino acids, more preferable 3 to 10 amino acids
most preferably 4 to 8 amino acids are also possible in front of
the start methionine of the protein motioned in table II,
application no. 1, columns 5 and 7. In case of the amino acid
sequence QIA CSS the three amino acids in front of the start
methionine are stemming from the LIC (=ligatation independent
cloning) cassette. Said short amino acid sequence is preferred in
the case of the expression of E. coli genes. In case of the amino
acid sequence QIA EFQLTT the six amino acids in front of the start
methionine are stemming from the LIC cassette. Said short amino
acid sequence is preferred in the case of the expression of S.
cerevisiae genes. The skilled worker knows that other short
sequences are also useful in the expression of the genes mentioned
in table I, application no. 1, columns 5 and 7. Furthermore the
skilled worker is aware of the fact that there is not a need for
such short sequences in the expression of the genes.
TABLE-US-00002 TABLE V Examples of transit peptides disclosed by
von Heijne et al. SEQ Trans ID Pep Organism Transit Peptide NO:
Reference 1 Acetabularia MASIMMNKSVVLSKECAKPLATPK 17 Mol. Gen.
mediterranea VTLNKRGFATTIATKNREMMVWQP Genet. 218, FNNKMFETFSFLPP
445 (1989) 2 Arabidopsis MAASLQSTATFLQSAKIATAPSRG 18 EMBO J. 8,
thaliana SSHLRSTQAVGKSFGLETSSARLT 3187 (1989)
CSFQSDFKDFTGKCSDAVKIAGFA LATSALVVSGASAEGAPK 3 Arabidopsis
MAQVSRICNGVQNPSLICNLSKSS 19 Mol. Gen. thaliana
QRKSPLSVSLKTQQHPRAYPISSS Genet. 210, WGLKKSGMTLIGSELRPLKVMSSV 437
(1987) STAEKASEIVLQPIREISGLIKLP 4 Arabidopsis
MAAATTTTTTSSSISFSTKPSPSS 20 Plant Phys- thaliana
SKSPLPISRFSLPFSLNPNKSSSS iol. 85, 1110 SRRRGIKSSSPSSISAVLNTTTNV
(1987) TTTPSPTKPTKPETFISRFAPDQP RKGA 5 Arabidopsis
MITSSLTCSLQALKLSSPFAHGST 21 J. Biol. thaliana
PLSSLSKPNSFPNHRMPALVPV Chem. 265, 2763 (1990) 6 Arabidopsis
MASLLGTSSSAIWASPSLSSPSSKP 22 EMBO J. 9, thaliana
SSSPICFRPGKLFGSKLNAGIQI 1337 (1990) RPKKNRSRYHVSVMNVATEINSTE
QVVGKFDSKKSARPVYPFAAI 7 Arabidopsis MASTALSSAIVGTSFIRRSPAPISL 23
Plant Phys- thaliana RSLPSANTQSLFGLKSGTARGG iol. 93, 572 RVVAM
(1990) 8 Arabidopsis MAASTMALSSPAFAGKAVNLSPAA 24 Nucl. Acids
thaliana SEVLGSGRVTNRKTV Res. 14, 4051 (1986) 9 Arabidopsis
MAAITSATVTIPSFTGLKLAVSSK 25 Gene 65, 59 thaliana
PKTLSTISRSSSATRAPPKLALKS (1988) SLKDFGVIAVATAASIVLAGNAMA
MEVLLGSDDGSLAFVPSEFT 10 Arabidopsis MAAAVSTVGAINRAPLSLNGSGSG 26
Nucl. Acids thaliana AVSAPASTFLGKKVVTVSRFAQSN Res. 17,
KKSNGSFKVLAVKEDKQTDGDRWR 2871 (1989) GLAYDTSDDQIDI 11 Arabidopsis
MKSSMLSSTAWTSPAQATMVAPF 27 Plant Mol. thaliana
TGLKSSASFPVTRKANNDITSITS Biol. 11, 745 NGGRVSC (1988) 12
Arabidopsis MAASGTSATFRASVSSAPSSSSQL 28 Proc. Natl. thaliana
THLKSPFKAVKYTPLPSSRSKSSS Acad. Sci. FSVSCTIAKDPPVLMAAGSDPALW USA,
86, QRPDSFGRFGKFGGKYVPE 4604 (1989) 13 Brassica
MSTTFCSSVCMQATSLAATTRISF 29 Nucl. Acids campestris
QKPALVSTTNLSFNLRRSIPTRFS Res. 15, ISCAAKPETVEKVSKIVKKQLSLK 7197
(1987) DDQKVVAE 14 Brassica MATTFSASVSMQATSLATTTRISF 30 Eur. J.
Bio- napus QKPVLVSNHGRTNLSFNLSRTRLSI chem. 174, SC 287 (1988) 15
Chlamydo- MQALSSRVNIAAKPQRAQRLWRA 31 Plant Mol. monas
EEVKAAPKKEVGPKRGSLVK Biol. 12, 463 reinhardtii (1989) 16 Cucurbita
MAELIQDKESAQSAATAAAASSGY 32 FEBS Lett. moschata ERRNEPAHSRK- 238,
424 FLEVRSEEELLSCIKK (1988) 17 Spinacea MSTINGCLTSISPSRTQLKNTSTL 33
J. Biol. oleracea RPTFIANSRVNPSSSVPPSLIRNQ Chem. 265,
PVFAAPAPIITPTL (10) 5414 (1990) 18 Spinacea
MTTAVTAAVSFPSTKTTSLSARCS 34 Curr. Genet. oleracea
SVISPDKISYKKVPLYYRNVSATG 13, 517 KMGPIRAQIASDVEAPPPAPAK- (1988)
VEKMS 19 Spinacea MTTAVTAAVSFPSTKTTSLSARSS 35 oleracea
SVISPDKISYKKVPLYYRNVSATG KMGPIRA
[0244] Alternatively to the targeting of the sequences shown in
table II, application no. 1, columns 5 and 7, preferably of
sequences in general encoded in the nucleus with the aid of the
targeting sequences mentioned for example in table V alone or in
combination with other targeting sequences preferably into the
plastids, the nucleic acids of the invention can directly be
introduced into the plastidal genome. Therefore in a preferred
embodiment the nucleic acid sequences shown in table I, application
no. 1, columns 5 and 7 are directly introduced and expressed in
plastids.
[0245] The term "introduced" in the context of this specification
shall mean the insertion of a nucleic acid sequence into the
organism by means of a "transfection", "transduction" or preferably
by "transformation".
[0246] A plastid, such as a chloroplast, has been "transformed" by
an exogenous (preferably foreign) nucleic acid sequence if nucleic
acid sequence has been introduced into the plastid that means that
this sequence has crossed the membrane or the membranes of the
plastid. The foreign DNA may be integrated (covalently linked) into
plastid DNA making up the genome of the plastid, or it may remain
unintegrated (e.g., by including a chloroplast origin of
replication). "Stably" integrated DNA sequences are those, which
are inherited through plastid replication, thereby transferring new
plastids, with the features of the integrated DNA sequence to the
progeny.
[0247] For expression a person skilled in the art is familiar with
different methods to introduce the nucleic acid sequences into
different organelles such as the preferred plastids. Such methods
are for example disclosed by Maiga P. (Annu. Rev. Plant Biol. 55,
289 (2004)), Evans T. (WO 2004/040973), McBride K.E. et al. (U.S.
Pat. No. 5,455,818), Daniell H. et al. (U.S. Pat. No. 5,932,479 and
U.S. Pat. No. 5,693,507) and Straub J. M. et al. (U.S. Pat. No.
6,781,033). A preferred method is the transformation of
microspore-derived hypocotyl or cotyledonary tissue (which are
green and thus contain numerous plastids) leaf tissue and
afterwards the regeneration of shoots from said transformed plant
material on selective medium. As methods for the transformation
bombarding of the plant material or the use of independently
replicating shuttle vectors are well known by the skilled worker.
But also a PEG-mediated transformation of the plastids or
Agrobacterium transformation with binary vectors is possible.
Useful markers for the transformation of plastids are positive
selection markers for example the chloramphenicol-, streptomycin-,
kanamycin-, neomycin-, amikamycin-, spectinomycin-, triazine-
and/or lincomycin-resistance genes. As additional markers named in
the literature often as secondary markers, genes coding for the
resistance against herbicides such as phosphinothricin
(=glufosinate, BASTA.TM., Liberty.TM., encoded by the bar gene),
glyphosate (=N(phosphonomethyl)glycine, Roundup.TM., encoded by the
5-enolpyruvylshikimate-3-phosphate synthase gene=epsps),
sulfonylureas (like Staple.TM., encoded by the acetolactate
synthase (ALS) gene), imidazolinones [=IMI, like imazethapyr,
imazamox, Clearfield.TM., encoded by the acetohydroxyacid synthase
(AHAS) gene, also known as acetolactate synthase (ALS) gene] or
bromoxynil (=Buctril.TM., encoded by the oxy gene) or genes coding
for antibiotics such as hygromycin or G418 are useful for further
selection. Such secondary markers are useful in the case when most
genome copies are transformed. In addition negative selection
markers such as the bacterial cytosine deaminase (encoded by the
codA gene) are also useful for the transformation of plastids.
[0248] To increase the possibility of identification of
transformants it is also desirable to use reporter genes other then
the aforementioned resistance genes or in addition to said genes.
Reporter genes are for example .beta.-galactosidase-,
.beta.-glucuronidase-(GUS), alkaline phosphatase- and/or
green-fluorescent protein-genes (GFP).
[0249] For the inventive process it is of great advantage that by
transforming the plastids the intraspecies specific transgene flow
is blocked, because a lot of species such as corn, cotton and rice
have a strict maternal inheritance of plastids. By placing the
genes specified in table I, application no. 1, columns 5 and 7 or
active fragments thereof in the plastids of plants, these genes
will not be present in the pollen of said plants.
[0250] A further preferred embodiment of the invention relates to
the use of so called "chloroplast localization sequences", in which
a first RNA sequence or molecule is capable of transporting or
"chaperoning" a second RNA sequence, such as a RNA sequence
transcribed from the sequences depicted in table I, application no.
1, columns 5 and 7 or a sequence encoding a protein, as depicted in
table II, application no. 1, columns 5 and 7, from an external
environment inside a cell or outside a plastid into a chloroplast.
In one embodiment the chloroplast localization signal is
substantially similar or complementary to a complete or intact
viroid sequence. The chloroplast localization signal may be encoded
by a DNA sequence, which is transcribed into the chloroplast
localization RNA. The term "viroid" refers to a naturally occurring
single stranded RNA molecule (Flores, C. R. Acad Sci III. 324 (10),
943 (2001)). Viroids usually contain about 200-500 nucleotides and
generally exist as circular molecules. Examples of viroids that
contain chloroplast localization signals include but are not
limited to ASBVd, PLMVd, CChMVd and ELVd. The viroid sequence or a
functional part of it can be fused to the sequences depicted in
table I, application no. 1, columns 5 and 7 or a sequence encoding
a protein, as depicted in table II, application no. 1, columns 5
and 7 in such a manner that the viroid sequence transports a
sequence transcribed from a sequence as depicted in table I,
application no. 1, columns 5 and 7 or a sequence encoding a protein
as depicted in table II, application no. 1, columns 5 and 7 into
the chloroplasts. A preferred embodiment uses a modified ASBVd
(Navarro et al., Virology. 268 (1), 218 (2000)).
[0251] In a further specific embodiment the protein to be expressed
in the plastids such as the proteins depicted in table II,
application no. 1, columns 5 and 7 are encoded by different nucleic
acids. Such a method is disclosed in WO 2004/040973, which shall be
incorporated by reference. WO 2004/040973 teaches a method, which
relates to the translocation of an RNA corresponding to a gene or
gene fragment into the chloroplast by means of a chloroplast
localization sequence. The genes, which should be expressed in the
plant or plants cells, are split into nucleic acid fragments, which
are introduced into different compartments in the plant e.g. the
nucleus, the plastids and/or mitochondria. Additionally plant cells
are described in which the chloroplast contains a ribozyme fused at
one end to an RNA encoding a fragment of a protein used in the
inventive process such that the ribozyme can trans-splice the
translocated fusion RNA to the RNA encoding the gene fragment to
form and as the case may be reunite the nucleic acid fragments to
an intact mRNA encoding a functional protein for example as
disclosed in table II, columns 5 and 7.
[0252] In a preferred embodiment of the invention the nucleic acid
sequences as shown in table I, application no. 1, columns 5 and 7
used in the inventive process are transformed into plastids, which
are metabolically active. Those plastids should preferably maintain
at a high copy number in the plant or plant tissue of interest,
most preferably the chloroplasts found in green plant tissues, such
as leaves or cotyledons or in seeds.
[0253] For a good expression in the plastids the nucleic acid
sequences as shown in table I, application no. 1, columns 5 and 7
are introduced into an expression cassette using a preferably a
promoter and terminator, which are active in plastids preferably a
chloroplast promoter. Examples of such promoters include the psbA
promoter from the gene from spinach or pea, the rbcL promoter, and
the atpB promoter from corn.
[0254] For the purposes of the description of the present
invention, the terms "cytoplasmic" shall indicate, that the nucleic
acid of the invention is expressed without the addition of an
non-natural transit peptide encoding sequence. A non-natural
transit peptide encoding sequence is a sequence which is not a
natural part of a nucleic acid of the invention, e.g. of the
nucleic acids depicted in table I column 5 or 7, but is rather
added by molecular manipulation steps as for example described in
the example under "plastid targeted expression". Therfore the terms
"cytoplasmic" shall not exclude a targeted localisation to any cell
compartment for the products of the inventive nucleic acid
sequences by their naturally occurring sequence properties within
the background of the transgenic organism. The subcellular location
of the mature polypetide derived from the enclosed sequences can be
predicted by a skilled person for the organism (plant) by using
software tools like TargetP (Emanuelsson et al., (2000), Predicting
subcellular localization of proteins based on their N-terminal
amino acid sequence., J. Mol. Biol. 300, 1005-1016.), ChloroP
(Emanuelsson et al. (1999), ChloroP, a neural network-based method
for predicting chloroplast transit peptides and their cleavage
sites., Protein Science, 8: 978-984.) or other predictive software
tools (Emanuelsson et al. (2007), Locating proteins in the cell
using TargetP, SignalP, and related tools., Nature Protocols 2,
953-971).
[0255] Comprises/comprising and grammatical variations thereof when
used in this specification are to be taken to specify the presence
of stated features, integers, steps or components or groups
thereof, but not to preclude the presence or addition of one or
more other features, integers, steps, components or groups
thereof.
[0256] In accordance with the invention, the term "plant cell" or
the term "organism" as understood herein relates always to a plant
cell or an organelle thereof, preferably a plastid, more preferably
chloroplast.
[0257] As used herein, "plant" is meant to include not only a whole
plant but also a part thereof i.e., one or more cells, and tissues,
including for example, leaves, stems, shoots, roots, flowers,
fruits and seeds.
[0258] Surprisingly it was found, that the transgenic expression of
a protein as shown in table II, application no. 1, column 3,
especially from the Saccaromyces cerevisiae and/or the transgenic
expression of a protein as shown in table II, application no. 1,
column 3, especially from the E. coli, in a plant, such as
Arabidopsis thaliana for example, conferred a yield increase,
especially an enhanced NUE and/or increased biomass production, to
the transgenic plant cell, plant or a part thereof as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof. In addition the yield increase may be generated by an
increased tolerance to stress, especially abiotic stress,
particularly low temperature stress and/or enhanced water use
efficiency and/or enhanced intrinsic yield in the absence of
nutrient deficiencies as well as stress conditions.
[0259] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 38, or a nucleic acid which
differs from nucleic acid SEQ ID NO. 38 by exchanging the stop
codon taa by tga, or the activity of a polypeptide encoded by a
nucleic acid molecule comprising the nucleic acid SEQ ID NO. 38 (or
a nucleic acid which differs from nucleic acid SEQ ID NO. 38 by
exchanging the stop codon taa by tga) or a polypeptide SEQ ID NO.
39, respectively, is increased or generated, e.g. if the activity
of such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 38 or polypeptide SEQ ID NO. 39, respectively,
is increased or generated, or if the activity "b0017-protein" is
increased or generated in an plant cell, plant or part thereof,
especially with cytoplasmic localization, an increase of yield as
compared to a corresponding non-transformed wild type plant cell,
plant or a part thereof is conferred, especially an enhanced
nutrient use efficiency and/or an increased stress tolerance and/or
an increased yield, in the absence of a nutrient deficiency as well
as stress conditions, in particular an enhancement of NUE and/or an
increase of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0260] Particularly, an increase from 1.1-fold to 1.19-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0261] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 42, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 42 or a polypeptide SEQ ID NO. 43,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 42 or polypeptide SEQ ID NO. 43, respectively,
is increased or generated, or if the activity "transport protein"
is increased or generated in an plant cell, plant or part thereof,
especially with cytoplasmic localization, an increase of yield as
compared to a corresponding non-transformed wild type plant cell,
plant or a part thereof is conferred, especially an enhanced
nutrient use efficiency and/or an increased stress tolerance and/or
an increased yield, in the absence of a nutrient deficiency as well
as stress conditions, in particular an enhancement of NUE and/or an
increase of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0262] Particularly, an increase from 1.1-fold to 1.15-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0263] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 123, or a nucleic acid which
differs from nucleic acid SEQ ID NO. 123 by exchanging the stop
codon taa by tga, or the activity of a polypeptide encoded by a
nucleic acid molecule comprising the nucleic acid SEQ ID NO. 123
(or a nucleic acid which differs from nucleic acid SEQ ID NO. 123
by exchanging the stop codon taa by tga) or a polypeptide SEQ ID
NO. 124, respectively, is increased or generated, e.g. if the
activity of such a nucleic acid molecule or a polypeptide
comprising the nucleic acid or polypeptide or the consensus
sequence or the polypeptide motif, as depicted in table I, II or
IV, application no. 1, column 7 in the respective same line as the
nucleic acid molecule SEQ ID NO. 123 or polypeptide SEQ ID NO. 124,
respectively, is increased or generated, or if the activity
"hydroxymyristol acyl carrier protein dehydratase" is increased or
generated in an plant cell, plant or part thereof, especially with
plastidic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0264] Particularly, an increase from 1.1-fold to 1.41-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.33-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0265] Accordingly, in one embodiment, in case the Escherichia coli
K12 nucleic acid molecule SEQ ID NO. 380, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 380 or a polypeptide SEQ ID NO. 381,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 380 or polypeptide SEQ ID NO. 381,
respectively, is increased or generated, or if the activity
"gamma-glutamyl kinase" is increased or generated in an plant cell,
plant or part thereof, especially with plastidic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0266] Particularly, an increase from 1.1-fold to 1.16-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0267] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 679, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 679 or a polypeptide SEQ ID NO. 680,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 679 or polypeptide SEQ ID NO. 680,
respectively, is increased or generated, or if the activity
"alpha-glucosidase" is increased or generated in an plant cell,
plant or part thereof, especially with plastidic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0268] Particularly, an increase from 1.1-fold to 1.10-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0269] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 812, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 812 or a polypeptide SEQ ID NO. 813,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 812 or polypeptide SEQ ID NO. 813,
respectively, is increased or generated, or if the activity
"adenylate kinase" is increased or generated in an plant cell,
plant or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0270] Particularly, an increase from 1.1-fold to 1.24-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.09-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0271] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 1055, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 1055 or a polypeptide SEQ ID NO. 1056,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 1055 or polypeptide SEQ ID NO. 1056,
respectively, is increased or generated, or if the activity
"2-dehydro-3-deoxy-phosphoheptonate aldolase" is increased or
generated in an plant cell, plant or part thereof, especially with
plastidic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0272] Particularly, an increase from 1.1-fold to 1.15-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.23-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0273] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 1563, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 1563 or a polypeptide SEQ ID NO. 1564,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 1563 or polypeptide SEQ ID NO. 1564,
respectively, is increased or generated, or if the activity
"molybdopterin biosynthesis protein" is increased or generated in
an plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0274] Particularly, an increase from 1.1-fold to 1.20-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0275] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 1705, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 1705 or a polypeptide SEQ ID NO. 1706,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 1705 or polypeptide SEQ ID NO. 1706,
respectively, is increased or generated, or if the activity
"hydroxylamine reductase" is increased or generated in an plant
cell, plant or part thereof, especially with plastidic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0276] Particularly, an increase from 1.1-fold to 1.17-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0277] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 1844, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 1844 or a polypeptide SEQ ID NO. 1845,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 1844 or polypeptide SEQ ID NO. 1845,
respectively, is increased or generated, or if the activity
"proline dehydrogenase" is increased or generated in an plant cell,
plant or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0278] Particularly, an increase from 1.1-fold to 1.19-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0279] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 1950, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 1950 or a polypeptide SEQ ID NO. 1951,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 1950 or polypeptide SEQ ID NO. 1951,
respectively, is increased or generated, or if the activity
"PhoH-like protein" is increased or generated in an plant cell,
plant or part thereof, especially with plastidic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0280] Particularly, an increase from 1.1-fold to 1.10-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.17-fold plus at least 100% thereof under low temperature
conditions; as compared to a corresponding non-transformed wild
type plant cell, a plant or a part thereof.
[0281] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 1975, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 1975 or a polypeptide SEQ ID NO. 1976,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 1975 or polypeptide SEQ ID NO. 1976,
respectively, is increased or generated, or if the activity
"isomerase" is increased or generated in an plant cell, plant or
part thereof, especially with cytoplasmic localization, an increase
of yield as compared to a corresponding non-transformed wild type
plant cell, plant or a part thereof is conferred, especially an
enhanced nutrient use efficiency and/or an increased stress
tolerance and/or an increased yield, in the absence of a nutrient
deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0282] Particularly, an increase from 1.1-fold to 1.23-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.18-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0283] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 2127, or a nucleic acid which
differs from nucleic acid SEQ ID NO. 2127 by exchanging the stop
codon taa by tga, or the activity of a polypeptide encoded by a
nucleic acid molecule comprising the nucleic acid SEQ ID NO. 2127
(or a nucleic acid which differs from nucleic acid SEQ ID NO. 2127
by exchanging the stop codon taa by tga) or a polypeptide SEQ ID
NO. 2128, respectively, is increased or generated, e.g. if the
activity of such a nucleic acid molecule or a polypeptide
comprising the nucleic acid or polypeptide or the consensus
sequence or the polypeptide motif, as depicted in table I, II or
IV, application no. 1, column 7 in the respective same line as the
nucleic acid molecule SEQ ID NO. 2127 or polypeptide SEQ ID NO.
2128, respectively, is increased or generated, or if the activity
"b1933-protein" is increased or generated in an plant cell, plant
or part thereof, especially with plastidic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0284] Particularly, an increase from 1.1-fold to 1.55-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.12-fold plus at least 100% thereof under low temperature
conditions; as compared to a corresponding non-transformed wild
type plant cell, a plant or a part thereof.
[0285] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 2135, or a nucleic acid which
differs from nucleic acid SEQ ID NO. 2135 by exchanging the stop
codon taa by tga, or the activity of a polypeptide encoded by a
nucleic acid molecule comprising the nucleic acid SEQ ID NO. 2135
(or a nucleic acid which differs from nucleic acid SEQ ID NO. 2135
by exchanging the stop codon taa by tga) or a polypeptide SEQ ID
NO. 2136, respectively, is increased or generated, e.g. if the
activity of such a nucleic acid molecule or a polypeptide
comprising the nucleic acid or polypeptide or the consensus
sequence or the polypeptide motif, as depicted in table I, II or
IV, application no. 1, column 7 in the respective same line as the
nucleic acid molecule SEQ ID NO. 2135 or polypeptide SEQ ID NO.
2136, respectively, is increased or generated, or if the activity
"glycosyltransferase" is increased or generated in an plant cell,
plant or part thereof, especially with plastidic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0286] Particularly, an increase from 1.1-fold to 1.24-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.14-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0287] Accordingly, in one embodiment, in case the Escherichia coli
K12 nucleic acid molecule SEQ ID NO. 2171, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 2171 or a polypeptide SEQ ID NO. 2172,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 2171 or polypeptide SEQ ID NO. 2172,
respectively, is increased or generated, or if the activity
"b2165-protein" is increased or generated in an plant cell, plant
or part thereof, especially with plastidic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0288] Particularly, an increase from 1.1-fold to 1.24-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.24-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0289] Accordingly, in one embodiment, in case the Escherichia coli
K12 nucleic acid molecule SEQ ID NO. 2297, or a nucleic acid which
differs from nucleic acid SEQ ID NO. 2297 by exchanging the stop
codon taa by tga, or the activity of a polypeptide encoded by a
nucleic acid molecule comprising the nucleic acid SEQ ID NO. 2297
(or a nucleic acid which differs from nucleic acid SEQ ID NO. 2297
by exchanging the stop codon taa by tga) or a polypeptide SEQ ID
NO. 2298, respectively, is increased or generated, e.g. if the
activity of such a nucleic acid molecule or a polypeptide
comprising the nucleic acid or polypeptide or the consensus
sequence or the polypeptide motif, as depicted in table I, II or
IV, application no. 1, column 7 in the respective same line as the
nucleic acid molecule SEQ ID NO. 2297 or polypeptide SEQ ID NO.
2298, respectively, is increased or generated, or if the activity
"short chain fatty acid transporter" is increased or generated in
an plant cell, plant or part thereof, especially with plastidic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0290] Particularly, an increase from 1.1-fold to 1.36-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0291] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 2426, or a nucleic acid which
differs from nucleic acid SEQ ID NO. 2426 by exchanging the stop
codon taa by tga, or the activity of a polypeptide encoded by a
nucleic acid molecule comprising the nucleic acid SEQ ID NO. 2426
(or a nucleic acid which differs from nucleic acid SEQ ID NO. 2426
by exchanging the stop codon taa by tga) or a polypeptide SEQ ID
NO. 2427, respectively, is increased or generated, e.g. if the
activity of such a nucleic acid molecule or a polypeptide
comprising the nucleic acid or polypeptide or the consensus
sequence or the polypeptide motif, as depicted in table I, II or
IV, application no. 1, column 7 in the respective same line as the
nucleic acid molecule SEQ ID NO. 2426 or polypeptide SEQ ID NO.
2427, respectively, is increased or generated, or if the activity
"b2238-protein" is increased or generated in an plant cell, plant
or part thereof, especially with plastidic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance, especially an increased tolerance to low
temperatures, and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0292] Particularly, an increase from 1.1-fold to 1.26-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.19-fold plus at least 100% thereof under low temperature
conditions; also particularly, an increase from 1.05-fold to
1.18-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0293] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 2426, or a nucleic acid which
differs from nucleic acid SEQ ID NO. 2426 by exchanging the stop
codon taa by tga, or the activity of a polypeptide encoded by a
nucleic acid molecule comprising the nucleic acid SEQ ID NO. 2426
(or a nucleic acid which differs from nucleic acid SEQ ID NO. 2426
by exchanging the stop codon taa by tga) or a polypeptide SEQ ID
NO. 2427, respectively, is increased or generated, e.g. if the
activity of such a nucleic acid molecule or a polypeptide
comprising the nucleic acid or polypeptide or the consensus
sequence or the polypeptide motif, as depicted in table I, II or
IV, application no. 1, column 7 in the respective same line as the
nucleic acid molecule SEQ ID NO. 2426 or polypeptide SEQ ID NO.
2427, respectively, is increased or generated, or if the activity
"b2238-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance, especially an increased tolerance to drought
conditions, and/or an increased yield, in the absence of a nutrient
deficiency as well as stress conditions.
[0294] Particularly, an increase from 1.05-fold to 1.11-fold plus
at least 100% thereof under drought conditions is conferred; also
particularly, as compared to a corresponding non-transformed wild
type plant cell, a plant or a part thereof.
[0295] Accordingly, in one embodiment, in case the Escherichia coli
K12 nucleic acid molecule SEQ ID NO. 2452, or a nucleic acid which
differs from nucleic acid SEQ ID NO. 2452 by exchanging the stop
codon taa by tga, or the activity of a polypeptide encoded by a
nucleic acid molecule comprising the nucleic acid SEQ ID NO. 2452
(or a nucleic acid which differs from nucleic acid SEQ ID NO. 2452
by exchanging the stop codon taa by tga) or a polypeptide SEQ ID
NO. 2453, respectively, is increased or generated, e.g. if the
activity of such a nucleic acid molecule or a polypeptide
comprising the nucleic acid or polypeptide or the consensus
sequence or the polypeptide motif, as depicted in table I, II or
IV, application no. 1, column 7 in the respective same line as the
nucleic acid molecule SEQ ID NO. 2452 or polypeptide SEQ ID NO.
2453, respectively, is increased or generated, or if the activity
"lysine/arginine/ornithine transporter subunit" is increased or
generated in an plant cell, plant or part thereof, especially with
plastidic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0296] Particularly, an increase from 1.1-fold to 1.18-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.25-fold plus at least 100% thereof under low temperature
conditions; also particularly, an increase from 1.05-fold to
1.20-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0297] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 2551, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 2551 or a polypeptide SEQ ID NO. 2552,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 2551 or polypeptide SEQ ID NO. 2552,
respectively, is increased or generated, or if the activity
"b2431-protein" is increased or generated in an plant cell, plant
or part thereof, especially with plastidic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0298] Particularly, an increase from 1.1-fold to 1.47-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.34-fold plus at least 100% thereof under low temperature
conditions; also particularly, an increase from 1.05-fold to
1.17-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0299] Accordingly, in one embodiment, in case the Escherichia coli
K12 nucleic acid molecule SEQ ID NO. 2600, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 2600 or a polypeptide SEQ ID NO. 2601,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 2600 or polypeptide SEQ ID NO. 2601,
respectively, is increased or generated, or if the activity
"chorismate mutase T/prephenate dehydrogenase (bifunctional)" is
increased or generated in an plant cell, plant or part thereof,
especially with plastidic localization, an increase of yield as
compared to a corresponding non-transformed wild type plant cell,
plant or a part thereof is conferred, especially an enhanced
nutrient use efficiency and/or an increased stress tolerance and/or
an increased yield, in the absence of a nutrient deficiency as well
as stress conditions, in particular an enhancement of NUE and/or an
increase of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0300] Particularly, an increase from 1.1-fold to 1.12-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.16-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0301] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 2668, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 2668 or a polypeptide SEQ ID NO. 2669,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 2668 or polypeptide SEQ ID NO. 2669,
respectively, is increased or generated, or if the activity
"b2766-protein" is increased or generated in an plant cell, plant
or part thereof, especially with plastidic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0302] Particularly, an increase from 1.1-fold to 1.10-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.26-fold plus at least 100% thereof under low temperature
conditions; also particularly, an increase from 1.05-fold to
1.20-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0303] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 2772, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 2772 or a polypeptide SEQ ID NO. 2773,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 2772 or polypeptide SEQ ID NO. 2773,
respectively, is increased or generated, or if the activity
"glycine decarboxylase" is increased or generated in an plant cell,
plant or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0304] Particularly, an increase from 1.1-fold to 1.65-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0305] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 3117, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 3117 or a polypeptide SEQ ID NO. 3118,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 3117 or polypeptide SEQ ID NO. 3118,
respectively, is increased or generated, or if the activity
"threonine ammonia-lyase" is increased or generated in an plant
cell, plant or part thereof, especially with plastidic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0306] Particularly, an increase from 1.1-fold to 1.42-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.16-fold plus at least 100% thereof under low temperature
conditions; as compared to a corresponding non-transformed wild
type plant cell, a plant or a part thereof.
[0307] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 3390, or a nucleic acid which
differs from nucleic acid SEQ ID NO. 3390 by exchanging the stop
codon taa by tga, or the activity of a polypeptide encoded by a
nucleic acid molecule comprising the nucleic acid SEQ ID NO. 3390
(or a nucleic acid which differs from nucleic acid SEQ ID NO. 3390
by exchanging the stop codon taa by tga) or a polypeptide SEQ ID
NO. 3391, respectively, is increased or generated, e.g. if the
activity of such a nucleic acid molecule or a polypeptide
comprising the nucleic acid or polypeptide or the consensus
sequence or the polypeptide motif, as depicted in table I, II or
IV, application no. 1, column 7 in the respective same line as the
nucleic acid molecule SEQ ID NO. 3390 or polypeptide SEQ ID NO.
3391, respectively, is increased or generated, or if the activity
"b3120-protein" is increased or generated in an plant cell, plant
or part thereof, especially with plastidic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0308] Particularly, an increase from 1.1-fold to 1.28-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.15-fold plus at least 100% thereof under low temperature
conditions; also particularly, an increase from 1.05-fold to
1.39-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0309] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 3396, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 3396 or a polypeptide SEQ ID NO. 3397,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 3396 or polypeptide SEQ ID NO. 3397,
respectively, is increased or generated, or if the activity "outer
membrane usher protein" is increased or generated in an plant cell,
plant or part thereof, especially with plastidic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0310] Particularly, an increase from 1.1-fold to 1.19-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0311] Accordingly, in one embodiment, in case the Escherichia coli
K12 nucleic acid molecule SEQ ID NO. 3470, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 3470 or a polypeptide SEQ ID NO. 3471,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 3470 or polypeptide SEQ ID NO. 3471,
respectively, is increased or generated, or if the activity
"glycerol-3-phosphate transporter subunit" is increased or
generated in an plant cell, plant or part thereof, especially with
plastidic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0312] Particularly, an increase from 1.1-fold to 1.21-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.10-fold plus at least 100% thereof under low temperature
conditions; also particularly, an increase from 1.05-fold to
1.23-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0313] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 3563, or a nucleic acid which
differs from nucleic acid SEQ ID NO. 3563 by exchanging the stop
codon taa by tga, or the activity of a polypeptide encoded by a
nucleic acid molecule comprising the nucleic acid SEQ ID NO. 3563
(or a nucleic acid which differs from nucleic acid SEQ ID NO. 3563
by exchanging the stop codon taa by tga) or a polypeptide SEQ ID
NO. 3564, respectively, is increased or generated, e.g. if the
activity of such a nucleic acid molecule or a polypeptide
comprising the nucleic acid or polypeptide or the consensus
sequence or the polypeptide motif, as depicted in table I, II or
IV, application no. 1, column 7 in the respective same line as the
nucleic acid molecule SEQ ID NO. 3563 or polypeptide SEQ ID NO.
3564, respectively, is increased or generated, or if the activity
"hydro-lyase" is increased or generated in an plant cell, plant or
part thereof, especially with cytoplasmic localization, an increase
of yield as compared to a corresponding non-transformed wild type
plant cell, plant or a part thereof is conferred, especially an
enhanced nutrient use efficiency and/or an increased stress
tolerance and/or an increased yield, in the absence of a nutrient
deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0314] Particularly, an increase from 1.1-fold to 1.25-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0315] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 3770, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 3770 or a polypeptide SEQ ID NO. 3771,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 3770 or polypeptide SEQ ID NO. 3771,
respectively, is increased or generated, or if the activity
"lysophospholipase" is increased or generated in an plant cell,
plant or part thereof, especially with plastidic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0316] Particularly, an increase from 1.1-fold to 1.42-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0317] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 3868, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 3868 or a polypeptide SEQ ID NO. 3869,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 3868 or polypeptide SEQ ID NO. 3869,
respectively, is increased or generated, or if the activity
"yal019w-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0318] Particularly, an increase from 1.1-fold to 1.42-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.14-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0319] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 3895, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 3895 or a polypeptide SEQ ID NO. 3896,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 3895 or polypeptide SEQ ID NO. 3896,
respectively, is increased or generated, or if the activity
"carnitine acetyltransferase" is increased or generated in an plant
cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0320] Particularly, an increase from 1.1-fold to 1.38-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.43-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0321] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 3953, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 3953 or a polypeptide SEQ ID NO. 3954,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 3953 or polypeptide SEQ ID NO. 3954,
respectively, is increased or generated, or if the activity
"Transcriptional activator" is increased or generated in an plant
cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0322] Particularly, an increase from 1.1-fold to 1.15-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0323] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 4111, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 4111 or a polypeptide SEQ ID NO. 4112,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 4111 or polypeptide SEQ ID NO. 4112,
respectively, is increased or generated, or if the activity
"splicing factor" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0324] Particularly, an increase from 1.1-fold to 1.10-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0325] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 4149, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 4149 or a polypeptide SEQ ID NO. 4150,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 4149 or polypeptide SEQ ID NO. 4150,
respectively, is increased or generated, or if the activity
"autophagy-specific phosphatidylinositol 3-kinase complex protein
subunit" is increased or generated in an plant cell, plant or part
thereof, especially with cytoplasmic localization, an increase of
yield as compared to a corresponding non-transformed wild type
plant cell, plant or a part thereof is conferred, especially an
enhanced nutrient use efficiency and/or an increased stress
tolerance and/or an increased yield, in the absence of a nutrient
deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0326] Particularly, an increase from 1.1-fold to 1.19-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0327] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 4162, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 4162 or a polypeptide SEQ ID NO. 4163,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 4162 or polypeptide SEQ ID NO. 4163,
respectively, is increased or generated, or if the activity
"microsomal beta-keto-reductase" is increased or generated in an
plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0328] Particularly, an increase from 1.1-fold to 1.23-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.07-fold plus at least 100% thereof under low temperature
conditions; as compared to a corresponding non-transformed wild
type plant cell, a plant or a part thereof.
[0329] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 4235, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 4235 or a polypeptide SEQ ID NO. 4236,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 4235 or polypeptide SEQ ID NO. 4236,
respectively, is increased or generated, or if the activity
"UDP-N-acetyl-glucosamine-1-P transferase" is increased or
generated in an plant cell, plant or part thereof, especially with
cytoplasmic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0330] Particularly, an increase from 1.1-fold to 1.16-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0331] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 4235, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 4235 or a polypeptide SEQ ID NO. 4236,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 4235 or polypeptide SEQ ID NO. 4236,
respectively, is increased or generated, or if the activity
"UDP-N-acetyl-glucosamine-1-P transferase" is increased or
generated in an plant cell, plant or part thereof, especially with
plastidic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions.
[0332] Particularly, an increase from 1.05-fold to 1.26-fold plus
at least 100% thereof under low temperature conditions; also
particularly, an increase from 1.05-fold to 1.29-fold plus at least
100% thereof of yield in the absence of nutrient deficiency as well
as stress conditions; as compared to a corresponding
non-transformed wild type plant cell, a plant or a part
thereof.
[0333] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 4280, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 4280 or a polypeptide SEQ ID NO. 4281,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 4280 or polypeptide SEQ ID NO. 4281,
respectively, is increased or generated, or if the activity
"ybr262c-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0334] Particularly, an increase from 1.1-fold to 1.31-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0335] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 4288, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 4288 or a polypeptide SEQ ID NO. 4289,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 4288 or polypeptide SEQ ID NO. 4289,
respectively, is increased or generated, or if the activity
"protein necessary for structural stability of L-A double-stranded
RNA-containing particles" is increased or generated in an plant
cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0336] Particularly, an increase from 1.1-fold to 1.31-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.24-fold plus at least 100% thereof under low temperature
conditions; as compared to a corresponding non-transformed wild
type plant cell, a plant or a part thereof. Accordingly, in one
embodiment, in case the Saccharomyces cerevisiae nucleic acid
molecule SEQ ID NO. 4315, or the activity of a polypeptide encoded
by a nucleic acid molecule comprising the nucleic acid SEQ ID NO.
4315 or a polypeptide SEQ ID NO. 4316, respectively, is increased
or generated, e.g. if the activity of such a nucleic acid molecule
or a polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 4315 or polypeptide
SEQ ID NO. 4316, respectively, is increased or generated, or if the
activity "YDR070C-protein" is increased or generated in an plant
cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0337] Particularly, an increase from 1.1-fold to 1.20-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.47-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0338] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 4325, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 4325 or a polypeptide SEQ ID NO. 4326,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 4325 or polypeptide SEQ ID NO. 4326,
respectively, is increased or generated, or if the activity
"chaperone" is increased or generated in an plant cell, plant or
part thereof, especially with cytoplasmic localization, an increase
of yield as compared to a corresponding non-transformed wild type
plant cell, plant or a part thereof is conferred, especially an
enhanced nutrient use efficiency and/or an increased stress
tolerance and/or an increased yield, in the absence of a nutrient
deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0339] Particularly, an increase from 1.1-fold to 1.29-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.09-fold plus at least 100% thereof under low temperature
conditions; as compared to a corresponding non-transformed wild
type plant cell, a plant or a part thereof.
[0340] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 4335, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 4335 or a polypeptide SEQ ID NO. 4336,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 4335 or polypeptide SEQ ID NO. 4336,
respectively, is increased or generated, or if the activity
"helix-loop-helix transcription activator that binds
inositol/choline-responsive elements" is increased or generated in
an plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0341] Particularly, an increase from 1.1-fold to 1.19-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0342] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 4346, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 4346 or a polypeptide SEQ ID NO. 4347,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 4346 or polypeptide SEQ ID NO. 4347,
respectively, is increased or generated, or if the activity "golgi
membrane exchange factor subunit" is increased or generated in an
plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0343] Particularly, an increase from 1.1-fold to 1.22-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.14-fold plus at least 100% thereof under low temperature
conditions; as compared to a corresponding non-transformed wild
type plant cell, a plant or a part thereof.
[0344] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 4361, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 4361 or a polypeptide SEQ ID NO. 4362,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 4361 or polypeptide SEQ ID NO. 4362,
respectively, is increased or generated, or if the activity
"dihydrosphingosine phosphate lyase" is increased or generated in
an plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0345] Particularly, an increase from 1.1-fold to 1.13-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0346] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 4361, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 4361 or a polypeptide SEQ ID NO. 4362,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 4361 or polypeptide SEQ ID NO. 4362,
respectively, is increased or generated, or if the activity
"dihydrosphingosine phosphate lyase" is increased or generated in
an plant cell, plant or part thereof, especially with plastidic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions.
[0347] Particularly, an increase from 1.05-fold to 1.35-fold plus
at least 100% thereof under drought conditions is conferred as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof.
[0348] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 4402, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 4402 or a polypeptide SEQ ID NO. 4403,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 4402 or polypeptide SEQ ID NO. 4403,
respectively, is increased or generated, or if the activity
"ubiquitin regulatory protein" is increased or generated in an
plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0349] Particularly, an increase from 1.1-fold to 1.38-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.24-fold plus at least 100% thereof under low temperature
conditions; also particularly, an increase from 1.05-fold to
1.14-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0350] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 4431, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 4431 or a polypeptide SEQ ID NO. 4432,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 4431 or polypeptide SEQ ID NO. 4432,
respectively, is increased or generated, or if the activity
"ydr355c-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0351] Particularly, an increase from 1.1-fold to 1.34-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0352] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 4435, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 4435 or a polypeptide SEQ ID NO. 4436,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 4435 or polypeptide SEQ ID NO. 4436,
respectively, is increased or generated, or if the activity
"lysine-specific metalloprotease" is increased or generated in an
plant cell, plant or part thereof, especially with plastidic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0353] Particularly, an increase from 1.1-fold to 1.16-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.10-fold plus at least 100% thereof under low temperature
conditions; also particularly, an increase from 1.05-fold to
1.61-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0354] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 4485, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 4485 or a polypeptide SEQ ID NO. 4486,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 4485 or polypeptide SEQ ID NO. 4486,
respectively, is increased or generated, or if the activity
"subunit of the transport protein particle (TRAPP) complex of the
cis-Golgi" is increased or generated in an plant cell, plant or
part thereof, especially with cytoplasmic localization, an increase
of yield as compared to a corresponding non-transformed wild type
plant cell, plant or a part thereof is conferred, especially an
enhanced nutrient use efficiency and/or an increased stress
tolerance and/or an increased yield, in the absence of a nutrient
deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production. Particularly, an increase from 1.1-fold to 1.20-fold
plus at least 100% thereof under conditions of nitrogen deficiency
is conferred as compared to a corresponding non-transformed wild
type plant cell, a plant or a part thereof.
[0355] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 4506, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 4506 or a polypeptide SEQ ID NO. 4507,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 4506 or polypeptide SEQ ID NO. 4507,
respectively, is increased or generated, or if the activity
"myo-inositol transporter" is increased or generated in an plant
cell, plant or part thereof, especially with plastidic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0356] Particularly, an increase from 1.1-fold to 1.16-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.23-fold plus at least 100% thereof under low temperature
conditions; also particularly, an increase from 1.05-fold to
1.10-fold plus at least 100% thereof under drought conditions; also
particularly, an increase from 1.05-fold to 1.14-fold plus at least
100% thereof of yield in the absence of nutrient deficiency as well
as stress conditions; as compared to a corresponding
non-transformed wild type plant cell, a plant or a part
thereof.
[0357] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 4790, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 4790 or a polypeptide SEQ ID NO. 4791,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 4790 or polypeptide SEQ ID NO. 4791,
respectively, is increased or generated, or if the activity "SM
complex B protein for mRNA splicing" is increased or generated in
an plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0358] Particularly, an increase from 1.1-fold to 1.23-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.13-fold plus at least 100% thereof under low temperature
conditions; also particularly, an increase from 1.05-fold to
1.10-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0359] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 4806, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 4806 or a polypeptide SEQ ID NO. 4807,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 4806 or polypeptide SEQ ID NO. 4807,
respectively, is increased or generated, or if the activity
"YFR007W-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0360] Particularly, an increase from 1.1-fold to 1.36-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0361] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 4836, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 4836 or a polypeptide SEQ ID NO. 4837,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 4836 or polypeptide SEQ ID NO. 4837,
respectively, is increased or generated, or if the activity
"oxidoreductase" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0362] Particularly, an increase from 1.1-fold to 1.22-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.32-fold plus at least 100% thereof under low temperature
conditions; as compared to a corresponding non-transformed wild
type plant cell, a plant or a part thereof.
[0363] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 5311, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 5311 or a polypeptide SEQ ID NO. 5312,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 5311 or polypeptide SEQ ID NO. 5312,
respectively, is increased or generated, or if the activity
"transcription elongation factor" is increased or generated in an
plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0364] Particularly, an increase from 1.1-fold to 1.26-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0365] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 5346, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 5346 or a polypeptide SEQ ID NO. 5347,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 5346 or polypeptide SEQ ID NO. 5347,
respectively, is increased or generated, or if the activity
"cytosolic catalase" is increased or generated in an plant cell,
plant or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0366] Particularly, an increase from 1.1-fold to 1.13-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0367] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 5533, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 5533 or a polypeptide SEQ ID NO. 5534,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 5533 or polypeptide SEQ ID NO. 5534,
respectively, is increased or generated, or if the activity
"ygr122c-a-protein" is increased or generated in an plant cell,
plant or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0368] Particularly, an increase from 1.1-fold to 1.30-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0369] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 5551, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 5551 or a polypeptide SEQ ID NO. 5552,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 5551 or polypeptide SEQ ID NO. 5552,
respectively, is increased or generated, or if the activity
"v-SNARE binding protein" is increased or generated in an plant
cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0370] Particularly, an increase from 1.1-fold to 1.21-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0371] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 5559, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 5559 or a polypeptide SEQ ID NO. 5560,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 5559 or polypeptide SEQ ID NO. 5560,
respectively, is increased or generated, or if the activity
"protein involved in sphingolipid biosynthesis" is increased or
generated in an plant cell, plant or part thereof, especially with
Cytoplasmic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0372] Particularly, an increase from 1.1-fold to 1.19-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0373] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 5602, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 5602 or a polypeptide SEQ ID NO. 5603,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 5602 or polypeptide SEQ ID NO. 5603,
respectively, is increased or generated, or if the activity
"mitochondrial ribosomal protein of the small subunit" is increased
or generated in an plant cell, plant or part thereof, especially
with cytoplasmic localization, an increase of yield as compared to
a corresponding non-transformed wild type plant cell, plant or a
part thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0374] Particularly, an increase from 1.1-fold to 1.23-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0375] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 5608, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 5608 or a polypeptide SEQ ID NO. 5609,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 5608 or polypeptide SEQ ID NO. 5609,
respectively, is increased or generated, or if the activity
"phosphatidylserine decarboxylase" is increased or generated in an
plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0376] Particularly, an increase from 1.1-fold to 1.12-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0377] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 5614, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 5614 or a polypeptide SEQ ID NO. 5615,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 5614 or polypeptide SEQ ID NO. 5615,
respectively, is increased or generated, or if the activity
"cholinephosphate cytidylyltransferase" is increased or generated
in an plant cell, plant or part thereof, especially with
cytoplasmic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0378] Particularly, an increase from 1.1-fold to 1.55-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0379] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 5666, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 5666 or a polypeptide SEQ ID NO. 5667,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 5666 or polypeptide SEQ ID NO. 5667,
respectively, is increased or generated, or if the activity
"ygr266w-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0380] Particularly, an increase from 1.1-fold to 1.34-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0381] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 5701, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 5701 or a polypeptide SEQ ID NO. 5702,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 5701 or polypeptide SEQ ID NO. 5702,
respectively, is increased or generated, or if the activity "cell
wall endo-beta-1,3-glucanase" is increased or generated in an plant
cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0382] Particularly, an increase from 1.1-fold to 1.21-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0383] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 5750, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 5750 or a polypeptide SEQ ID NO. 5751,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 5750 or polypeptide SEQ ID NO. 5751,
respectively, is increased or generated, or if the activity
"ygr290w-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0384] Particularly, an increase from 1.1-fold to 1.19-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0385] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 5754, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 5754 or a polypeptide SEQ ID NO. 5755,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 5754 or polypeptide SEQ ID NO. 5755,
respectively, is increased or generated, or if the activity
"yhl021c-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0386] Particularly, an increase from 1.1-fold to 1.19-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.12-fold plus at least 100% thereof under low temperature
conditions; as compared to a corresponding non-transformed wild
type plant cell, a plant or a part thereof. Accordingly, in one
embodiment, in case the Saccharomyces cerevisiae nucleic acid
molecule SEQ ID NO. 5778, or the activity of a polypeptide encoded
by a nucleic acid molecule comprising the nucleic acid SEQ ID NO.
5778 or a polypeptide SEQ ID NO. 5779, respectively, is increased
or generated, e.g. if the activity of such a nucleic acid molecule
or a polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 5778 or polypeptide
SEQ ID NO. 5779, respectively, is increased or generated, or if the
activity "v-SNARE protein involved in Golgi transport" is increased
or generated in an plant cell, plant or part thereof, especially
with cytoplasmic localization, an increase of yield as compared to
a corresponding non-transformed wild type plant cell, plant or a
part thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0387] Particularly, an increase from 1.1-fold to 1.21-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0388] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 5812, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 5812 or a polypeptide SEQ ID NO. 5813,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 5812 or polypeptide SEQ ID NO. 5813,
respectively, is increased or generated, or if the activity
"mitochondrial seryl-tRNA synthetase" is increased or generated in
an plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0389] Particularly, an increase from 1.1-fold to 1.21-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0390] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 5967, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 5967 or a polypeptide SEQ ID NO. 5968,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 5967 or polypeptide SEQ ID NO. 5968,
respectively, is increased or generated, or if the activity
"yhr127w-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0391] Particularly, an increase from 1.1-fold to 1.36-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0392] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 5973, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 5973 or a polypeptide SEQ ID NO. 5974,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 5973 or polypeptide SEQ ID NO. 5974,
respectively, is increased or generated, or if the activity
"aromatic amino acid aminotransferase II" is increased or generated
in an plant cell, plant or part thereof, especially with
cytoplasmic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0393] Particularly, an increase from 1.1-fold to 1.39-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0394] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 5973, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 5973 or a polypeptide SEQ ID NO. 5974,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 5973 or polypeptide SEQ ID NO. 5974,
respectively, is increased or generated, or if the activity
"aromatic amino acid aminotransferase II" is increased or generated
in an plant cell, plant or part thereof, especially with plastidic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0395] Particularly, an increase from 1.05-fold to 1.13-fold plus
at least 100% thereof under low temperature conditions is conferred
as compared to a corresponding non-transformed wild type plant
cell, a plant or a part thereof.
[0396] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 6027, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 6027 or a polypeptide SEQ ID NO. 6028,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 6027 or polypeptide SEQ ID NO. 6028,
respectively, is increased or generated, or if the activity
"glucoamylase" is increased or generated in an plant cell, plant or
part thereof, especially with cytoplasmic localization, an increase
of yield as compared to a corresponding non-transformed wild type
plant cell, plant or a part thereof is conferred, especially an
enhanced nutrient use efficiency and/or an increased stress
tolerance and/or an increased yield, in the absence of a nutrient
deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0397] Particularly, an increase from 1.1-fold to 3.09-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0398] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 6027, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 6027 or a polypeptide SEQ ID NO. 6028,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 6027 or polypeptide SEQ ID NO. 6028,
respectively, is increased or generated, or if the activity
"glucoamylase" is increased or generated in an plant cell, plant or
part thereof, especially with plastidic localization, an increase
of yield as compared to a corresponding non-transformed wild type
plant cell, plant or a part thereof is conferred, especially an
enhanced nutrient use efficiency and/or an increased stress
tolerance and/or an increased yield, in the absence of a nutrient
deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0399] Particularly, an increase from 1.05-fold to 1.20-fold plus
at least 100% thereof under low temperature conditions is conferred
as compared to a corresponding non-transformed wild type plant
cell, a plant or a part thereof.
[0400] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 6107, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 6107 or a polypeptide SEQ ID NO. 6108,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 6107 or polypeptide SEQ ID NO. 6108,
respectively, is increased or generated, or if the activity
"histidine kinase osmosensor that regulates an osmosensing MAP
kinase cascade" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0401] Particularly, an increase from 1.1-fold to 1.21-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0402] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 6150, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 6150 or a polypeptide SEQ ID NO. 6151,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 6150 or polypeptide SEQ ID NO. 6151,
respectively, is increased or generated, or if the activity
"saccharopine dehydrogenase" is increased or generated in an plant
cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0403] Particularly, an increase from 1.1-fold to 2.42-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0404] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 6198, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 6198 or a polypeptide SEQ ID NO. 6199,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 6198 or polypeptide SEQ ID NO. 6199,
respectively, is increased or generated, or if the activity
"spindle checkpoint complex subunit" is increased or generated in
an plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0405] Particularly, an increase from 1.1-fold to 1.42-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0406] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 6208, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 6208 or a polypeptide SEQ ID NO. 6209,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 6208 or polypeptide SEQ ID NO. 6209,
respectively, is increased or generated, or if the activity
"nuclear pore complex subunit" is increased or generated in an
plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0407] Particularly, an increase from 1.1-fold to 1.41-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0408] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 6242, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 6242 or a polypeptide SEQ ID NO. 6243,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 6242 or polypeptide SEQ ID NO. 6243,
respectively, is increased or generated, or if the activity
"yjl064w-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0409] Particularly, an increase from 1.1-fold to 1.30-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0410] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 6246, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 6246 or a polypeptide SEQ ID NO. 6247,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 6246 or polypeptide SEQ ID NO. 6247,
respectively, is increased or generated, or if the activity
"yjl067w-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0411] Particularly, an increase from 1.1-fold to 1.29-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0412] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 6250, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 6250 or a polypeptide SEQ ID NO. 6251,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 6250 or polypeptide SEQ ID NO. 6251,
respectively, is increased or generated, or if the activity
"potassium:hydrogen antiporter" is increased or generated in an
plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0413] Particularly, an increase from 1.1-fold to 1.23-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0414] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 6297, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 6297 or a polypeptide SEQ ID NO. 6298,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 6297 or polypeptide SEQ ID NO. 6298,
respectively, is increased or generated, or if the activity
"GPI-anchored cell wall protein" is increased or generated in an
plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0415] Particularly, an increase from 1.1-fold to 1.19-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0416] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 6326, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 6326 or a polypeptide SEQ ID NO. 6327,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 6326 or polypeptide SEQ ID NO. 6327,
respectively, is increased or generated, or if the activity
"yjl213w-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0417] Particularly, an increase from 1.1-fold to 1.62-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.12-fold plus at least 100% thereof under low temperature
conditions; as compared to a corresponding non-transformed wild
type plant cell, a plant or a part thereof. Accordingly, in one
embodiment, in case the Saccharomyces cerevisiae nucleic acid
molecule SEQ ID NO. 6488, or the activity of a polypeptide encoded
by a nucleic acid molecule comprising the nucleic acid SEQ ID NO.
6488 or a polypeptide SEQ ID NO. 6489, respectively, is increased
or generated, e.g. if the activity of such a nucleic acid molecule
or a polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 6488 or polypeptide
SEQ ID NO. 6489, respectively, is increased or generated, or if the
activity "peptidyl-prolyl cis-trans isomerase" is increased or
generated in an plant cell, plant or part thereof, especially with
cytoplasmic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0418] Particularly, an increase from 1.1-fold to 1.50-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0419] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 6550, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 6550 or a polypeptide SEQ ID NO. 6551,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 6550 or polypeptide SEQ ID NO. 6551,
respectively, is increased or generated, or if the activity
"clathrin associated protein complex small subunit" is increased or
generated in an plant cell, plant or part thereof, especially with
cytoplasmic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0420] Particularly, an increase from 1.1-fold to 1.28-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.36-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0421] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 6700, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 6700 or a polypeptide SEQ ID NO. 6701,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 6700 or polypeptide SEQ ID NO. 6701,
respectively, is increased or generated, or if the activity "zinc
metalloprotease" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0422] Particularly, an increase from 1.1-fold to 1.81-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.22-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0423] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 6816, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 6816 or a polypeptide SEQ ID NO. 6817,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 6816 or polypeptide SEQ ID NO. 6817,
respectively, is increased or generated, or if the activity "F1F0
ATP synthase beta subunit" is increased or generated in an plant
cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0424] Particularly, an increase from 1.1-fold to 1.52-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.37-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0425] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 7366, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 7366 or a polypeptide SEQ ID NO. 7367,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 7366 or polypeptide SEQ ID NO. 7367,
respectively, is increased or generated, or if the activity
"alpha-mannosidase" is increased or generated in an plant cell,
plant or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0426] Particularly, an increase from 1.1-fold to 1.52-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0427] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 7475, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 7475 or a polypeptide SEQ ID NO. 7476,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 7475 or polypeptide SEQ ID NO. 7476,
respectively, is increased or generated, or if the activity
"ribosomal protein of the small subunit" is increased or generated
in an plant cell, plant or part thereof, especially with
cytoplasmic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0428] Particularly, an increase from 1.1-fold to 1.41-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0429] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 7602, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 7602 or a polypeptide SEQ ID NO. 7603,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 7602 or polypeptide SEQ ID NO. 7603,
respectively, is increased or generated, or if the activity
"mitochondrial intermembrane space protein" is increased or
generated in an plant cell, plant or part thereof, especially with
cytoplasmic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0430] Particularly, an increase from 1.1-fold to 1.20-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.10-fold plus at least 100% thereof under low temperature
conditions; as compared to a corresponding non-transformed wild
type plant cell, a plant or a part thereof.
[0431] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 7651, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 7651 or a polypeptide SEQ ID NO. 7652,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 7651 or polypeptide SEQ ID NO. 7652,
respectively, is increased or generated, or if the activity
"phosphopantothenoylcysteine decarboxylase" is increased or
generated in an plant cell, plant or part thereof, especially with
cytoplasmic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0432] Particularly, an increase from 1.1-fold to 1.23-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0433] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 7661, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 7661 or a polypeptide SEQ ID NO. 7662,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 7661 or polypeptide SEQ ID NO. 7662,
respectively, is increased or generated, or if the activity
"ykl100c-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0434] Particularly, an increase from 1.1-fold to 1.25-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0435] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 7675, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 7675 or a polypeptide SEQ ID NO. 7676,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 7675 or polypeptide SEQ ID NO. 7676,
respectively, is increased or generated, or if the activity
"ykl131w-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0436] Particularly, an increase from 1.1-fold to 1.22-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0437] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 7679, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 7679 or a polypeptide SEQ ID NO. 7680,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 7679 or polypeptide SEQ ID NO. 7680,
respectively, is increased or generated, or if the activity
"mitochondrial ribosomal protein of the large subunit" is increased
or generated in an plant cell, plant or part thereof, especially
with cytoplasmic localization, an increase of yield as compared to
a corresponding non-transformed wild type plant cell, plant or a
part thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0438] Particularly, an increase from 1.1-fold to 1.24-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0439] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 7710, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 7710 or a polypeptide SEQ ID NO. 7711,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 7710 or polypeptide SEQ ID NO. 7711,
respectively, is increased or generated, or if the activity "G
protein coupled pheromone receptor receptor" is increased or
generated in an plant cell, plant or part thereof, especially with
cytoplasmic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0440] Particularly, an increase from 1.1-fold to 2.69-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.57-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0441] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 7735, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 7735 or a polypeptide SEQ ID NO. 7736,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 7735 or polypeptide SEQ ID NO. 7736,
respectively, is increased or generated, or if the activity "golgi
membrane protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0442] Particularly, an increase from 1.1-fold to 1.58-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.22-fold plus at least 100% thereof under low temperature
conditions; as compared to a corresponding non-transformed wild
type plant cell, a plant or a part thereof. Accordingly, in one
embodiment, in case the Saccharomyces cerevisiae nucleic acid
molecule SEQ ID NO. 7778, or the activity of a polypeptide encoded
by a nucleic acid molecule comprising the nucleic acid SEQ ID NO.
7778 or a polypeptide SEQ ID NO. 7779, respectively, is increased
or generated, e.g. if the activity of such a nucleic acid molecule
or a polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 7778 or polypeptide
SEQ ID NO. 7779, respectively, is increased or generated, or if the
activity "regulatory subunit of Glc7p type 1 protein
serine-threonine phosphatase" is increased or generated in an plant
cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0443] Particularly, an increase from 1.1-fold to 1.77-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0444] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 7829, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 7829 or a polypeptide SEQ ID NO. 7830,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 7829 or polypeptide SEQ ID NO. 7830,
respectively, is increased or generated, or if the activity
"dihydroorotate dehydrogenase" is increased or generated in an
plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0445] Particularly, an increase from 1.1-fold to 2.09-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0446] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 8017, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 8017 or a polypeptide SEQ ID NO. 8018,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 8017 or polypeptide SEQ ID NO. 8018,
respectively, is increased or generated, or if the activity
"ykr016w-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0447] Particularly, an increase from 1.1-fold to 2.00-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0448] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 8045, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 8045 or a polypeptide SEQ ID NO. 8046,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 8045 or polypeptide SEQ ID NO. 8046,
respectively, is increased or generated, or if the activity
"ykr021w-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0449] Particularly, an increase from 1.1-fold to 2.14-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0450] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 8073, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 8073 or a polypeptide SEQ ID NO. 8074,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 8073 or polypeptide SEQ ID NO. 8074,
respectively, is increased or generated, or if the activity
"non-essential small GTPase of the Rho/Rac subfamily of Ras-like
proteins" is increased or generated in an plant cell, plant or part
thereof, especially with cytoplasmic localization, an increase of
yield as compared to a corresponding non-transformed wild type
plant cell, plant or a part thereof is conferred, especially an
enhanced nutrient use efficiency and/or an increased stress
tolerance and/or an increased yield, in the absence of a nutrient
deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0451] Particularly, an increase from 1.1-fold to 1.57-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.09-fold plus at least 100% thereof under low temperature
conditions; as compared to a corresponding non-transformed wild
type plant cell, a plant or a part thereof.
[0452] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 8263, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 8263 or a polypeptide SEQ ID NO. 8264,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 8263 or polypeptide SEQ ID NO. 8264,
respectively, is increased or generated, or if the activity
"integral membrane protein localized to late Golgi vesicles" is
increased or generated in an plant cell, plant or part thereof,
especially with plastidic localization, an increase of yield as
compared to a corresponding non-transformed wild type plant cell,
plant or a part thereof is conferred, especially an enhanced
nutrient use efficiency and/or an increased stress tolerance and/or
an increased yield, in the absence of a nutrient deficiency as well
as stress conditions, in particular an enhancement of NUE and/or an
increase of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0453] Particularly, an increase from 1.1-fold to 1.29-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.20-fold plus at least 100% thereof under low temperature
conditions; as compared to a corresponding non-transformed wild
type plant cell, a plant or a part thereof.
[0454] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 8287, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 8287 or a polypeptide SEQ ID NO. 8288,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 8287 or polypeptide SEQ ID NO. 8288,
respectively, is increased or generated, or if the activity
"peptide transporter" is increased or generated in an plant cell,
plant or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0455] Particularly, an increase from 1.1-fold to 3.98-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0456] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 8468, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 8468 or a polypeptide SEQ ID NO. 8469,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 8468 or polypeptide SEQ ID NO. 8469,
respectively, is increased or generated, or if the activity
"transcription factor" is increased or generated in an plant cell,
plant or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0457] Particularly, an increase from 1.1-fold to 1.15-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.50-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0458] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 8484, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 8484 or a polypeptide SEQ ID NO. 8485,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 8484 or polypeptide SEQ ID NO. 8485,
respectively, is increased or generated, or if the activity
"transmembrane protein with a role in cell wall polymer
composition" is increased or generated in an plant cell, plant or
part thereof, especially with cytoplasmic localization, an increase
of yield as compared to a corresponding non-transformed wild type
plant cell, plant or a part thereof is conferred, especially an
enhanced nutrient use efficiency and/or an increased stress
tolerance and/or an increased yield, in the absence of a nutrient
deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0459] Particularly, an increase from 1.1-fold to 4.43-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.12-fold plus at least 100% thereof under low temperature
conditions; also particularly, an increase from 1.05-fold to
1.30-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0460] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 8492, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 8492 or a polypeptide SEQ ID NO. 8493,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 8492 or polypeptide SEQ ID NO. 8493,
respectively, is increased or generated, or if the activity
"yll014w-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0461] Particularly, an increase from 1.1-fold to 1.61-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0462] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 8514, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 8514 or a polypeptide SEQ ID NO. 8515,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 8514 or polypeptide SEQ ID NO. 8515,
respectively, is increased or generated, or if the activity
"non-essential Ras guanine nucleotide exchange factor" is increased
or generated in an plant cell, plant or part thereof, especially
with cytoplasmic localization, an increase of yield as compared to
a corresponding non-transformed wild type plant cell, plant or a
part thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0463] Particularly, an increase from 1.1-fold to 1.24-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0464] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 8539, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 8539 or a polypeptide SEQ ID NO. 8540,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 8539 or polypeptide SEQ ID NO. 8540,
respectively, is increased or generated, or if the activity
"yll023c-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0465] Particularly, an increase from 1.1-fold to 1.17-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0466] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 8571, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 8571 or a polypeptide SEQ ID NO. 8572,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 8571 or polypeptide SEQ ID NO. 8572,
respectively, is increased or generated, or if the activity
"yll037w-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0467] Particularly, an increase from 1.1-fold to 1.32-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0468] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 8575, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 8575 or a polypeptide SEQ ID NO. 8576,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 8575 or polypeptide SEQ ID NO. 8576,
respectively, is increased or generated, or if the activity
"yll049w-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0469] Particularly, an increase from 1.1-fold to 1.75-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0470] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 8579, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 8579 or a polypeptide SEQ ID NO. 8580,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 8579 or polypeptide SEQ ID NO. 8580,
respectively, is increased or generated, or if the activity
"cysteine transporter" is increased or generated in an plant cell,
plant or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0471] Particularly, an increase from 1.1-fold to 5.25-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0472] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 8661, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 8661 or a polypeptide SEQ ID NO. 8662,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 8661 or polypeptide SEQ ID NO. 8662,
respectively, is increased or generated, or if the activity "metal
ion transporter" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0473] Particularly, an increase from 1.1-fold to 4.38-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0474] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 8991, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 8991 or a polypeptide SEQ ID NO. 8992,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 8991 or polypeptide SEQ ID NO. 8992,
respectively, is increased or generated, or if the activity
"ylr042c-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0475] Particularly, an increase from 1.1-fold to 1.40-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0476] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 8995, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 8995 or a polypeptide SEQ ID NO. 8996,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 8995 or polypeptide SEQ ID NO. 8996,
respectively, is increased or generated, or if the activity
"YLR053c-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0477] Particularly, an increase from 1.1-fold to 1.55-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.17-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0478] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 8999, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 8999 or a polypeptide SEQ ID NO. 9000,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 8999 or polypeptide SEQ ID NO. 9000,
respectively, is increased or generated, or if the activity
"cytosolic serine hydroxymethyltransferase" is increased or
generated in an plant cell, plant or part thereof, especially with
cytoplasmic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0479] Particularly, an increase from 1.1-fold to 1.19-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0480] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 9551, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 9551 or a polypeptide SEQ ID NO. 9552,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 9551 or polypeptide SEQ ID NO. 9552,
respectively, is increased or generated, or if the activity
"subunit of cytoplasmic phenylalanyl-tRNA synthetase" is increased
or generated in an plant cell, plant or part thereof, especially
with cytoplasmic localization, an increase of yield as compared to
a corresponding non-transformed wild type plant cell, plant or a
part thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0481] Particularly, an increase from 1.1-fold to 3.72-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0482] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 9637, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 9637 or a polypeptide SEQ ID NO. 9638,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 9637 or polypeptide SEQ ID NO. 9638,
respectively, is increased or generated, or if the activity
"ylr065c-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0483] Particularly, an increase from 1.1-fold to 1.88-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.24-fold plus at least 100% thereof under drought conditions; as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof.
[0484] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 9672, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 9672 or a polypeptide SEQ ID NO. 9673,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 9672 or polypeptide SEQ ID NO. 9673,
respectively, is increased or generated, or if the activity
"xylitol dehydrogenase" is increased or generated in an plant cell,
plant or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0485] Particularly, an increase from 1.1-fold to 2.66-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0486] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 10182, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 10182 or a polypeptide SEQ ID NO. 10183,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 10182 or polypeptide SEQ ID NO. 10183,
respectively, is increased or generated, or if the activity "3-keto
sterol reductase" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0487] Particularly, an increase from 1.1-fold to 1.57-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0488] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 10214, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 10214 or a polypeptide SEQ ID NO. 10215,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 10214 or polypeptide SEQ ID NO. 10215,
respectively, is increased or generated, or if the activity "alkyl
hydroperoxide reductase" is increased or generated in an plant
cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0489] Particularly, an increase from 1.1-fold to 1.55-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0490] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 10447, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 10447 or a polypeptide SEQ ID NO. 10448,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 10447 or polypeptide SEQ ID NO. 10448,
respectively, is increased or generated, or if the activity
"ylr25w-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0491] Particularly, an increase from 1.1-fold to 1.28-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0492] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 10451, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 10451 or a polypeptide SEQ ID NO. 10452,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 10451 or polypeptide SEQ ID NO. 10452,
respectively, is increased or generated, or if the activity
"anaphase promoting complex (APC) subunit" is increased or
generated in an plant cell, plant or part thereof, especially with
cytoplasmic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0493] Particularly, an increase from 1.1-fold to 1.22-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0494] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 10463, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 10463 or a polypeptide SEQ ID NO. 10464,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 10463 or polypeptide SEQ ID NO. 10464,
respectively, is increased or generated, or if the activity
"protein component of the large ribosomal subunit" is increased or
generated in an plant cell, plant or part thereof, especially with
cytoplasmic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0495] Particularly, an increase from 1.1-fold to 1.14-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0496] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 10533, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 10533 or a polypeptide SEQ ID NO. 10534,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 10533 or polypeptide SEQ ID NO. 10534,
respectively, is increased or generated, or if the activity
"mitochondrial protein" is increased or generated in an plant cell,
plant or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0497] Particularly, an increase from 1.1-fold to 1.38-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0498] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 10533, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 10533 or a polypeptide SEQ ID NO. 10534,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 10533 or polypeptide SEQ ID NO. 10534,
respectively, is increased or generated, or if the activity
"mitochondrial protein" is increased or generated in an plant cell,
plant or part thereof, especially with plastidic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0499] Particularly, an increase from 1.05-fold to 1.22-fold plus
at least 100% thereof under low temperature conditions is conferred
as compared to a corresponding non-transformed wild type plant
cell, a plant or a part thereof.
[0500] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 10541, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 10541 or a polypeptide SEQ ID NO. 10542,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 10541 or polypeptide SEQ ID NO. 10542,
respectively, is increased or generated, or if the activity "ARV1
protein" is increased or generated in an plant cell, plant or part
thereof, especially with cytoplasmic localization, an increase of
yield as compared to a corresponding non-transformed wild type
plant cell, plant or a part thereof is conferred, especially an
enhanced nutrient use efficiency and/or an increased stress
tolerance and/or an increased yield, in the absence of a nutrient
deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0501] Particularly, an increase from 1.1-fold to 1.61-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0502] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 10562, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 10562 or a polypeptide SEQ ID NO. 10563,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 10562 or polypeptide SEQ ID NO. 10563,
respectively, is increased or generated, or if the activity
"GTP-binding protein" is increased or generated in an plant cell,
plant or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0503] Particularly, an increase from 1.1-fold to 2.75-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0504] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 10990, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 10990 or a polypeptide SEQ ID NO. 10991,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 10990 or polypeptide SEQ ID NO. 10991,
respectively, is increased or generated, or if the activity
"protein involved in shmoo formation and bipolar bud site
selection" is increased or generated in an plant cell, plant or
part thereof, especially with cytoplasmic localization, an increase
of yield as compared to a corresponding non-transformed wild type
plant cell, plant or a part thereof is conferred, especially an
enhanced nutrient use efficiency and/or an increased stress
tolerance and/or an increased yield, in the absence of a nutrient
deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0505] Particularly, an increase from 1.1-fold to 1.25-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0506] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 10998, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 10998 or a polypeptide SEQ ID NO. 10999,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 10998 or polypeptide SEQ ID NO. 10999,
respectively, is increased or generated, or if the activity
"non-essential kinetochore protein" is increased or generated in an
plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0507] Particularly, an increase from 1.1-fold to 1.54-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0508] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 11004, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 11004 or a polypeptide SEQ ID NO. 11005,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 11004 or polypeptide SEQ ID NO. 11005,
respectively, is increased or generated, or if the activity
"Meiotic recombination protein" is increased or generated in an
plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0509] Particularly, an increase from 1.1-fold to 1.27-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0510] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 11012, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 11012 or a polypeptide SEQ ID NO. 11013,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 11012 or polypeptide SEQ ID NO. 11013,
respectively, is increased or generated, or if the activity "signal
transducing MEK kinase" is increased or generated in an plant cell,
plant or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0511] Particularly, an increase from 1.1-fold to 3.40-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0512] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 11054, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 11054 or a polypeptide SEQ ID NO. 11055,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 11054 or polypeptide SEQ ID NO. 11055,
respectively, is increased or generated, or if the activity
"cytochrome c oxidase subunit VIII" is increased or generated in an
plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0513] Particularly, an increase from 1.1-fold to 1.56-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0514] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 11066, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 11066 or a polypeptide SEQ ID NO. 11067,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 11066 or polypeptide SEQ ID NO. 11067,
respectively, is increased or generated, or if the activity
"ylr404w-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0515] Particularly, an increase from 1.1-fold to 1.33-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0516] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 11074, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 11074 or a polypeptide SEQ ID NO. 11075,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 11074 or polypeptide SEQ ID NO. 11075,
respectively, is increased or generated, or if the activity
"ylr463c-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0517] Particularly, an increase from 1.1-fold to 1.33-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0518] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 11080, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 11080 or a polypeptide SEQ ID NO. 11081,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 11080 or polypeptide SEQ ID NO. 11081,
respectively, is increased or generated, or if the activity
"adenine phosphoribosyltransferase" is increased or generated in an
plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0519] Particularly, an increase from 1.1-fold to 1.27-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0520] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 11552, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 11552 or a polypeptide SEQ ID NO. 11553,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 11552 or polypeptide SEQ ID NO. 11553,
respectively, is increased or generated, or if the activity "Mcm1p
binding transcriptional repressor" is increased or generated in an
plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0521] Particularly, an increase from 1.1-fold to 1.42-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0522] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 11569, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 11569 or a polypeptide SEQ ID NO. 11570,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 11569 or polypeptide SEQ ID NO. 11570,
respectively, is increased or generated, or if the activity "origin
recognition complex subunit" is increased or generated in an plant
cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0523] Particularly, an increase from 1.1-fold to 1.14-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0524] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 11596, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 11596 or a polypeptide SEQ ID NO. 11597,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 11596 or polypeptide SEQ ID NO. 11597,
respectively, is increased or generated, or if the activity
"yml089c-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0525] Particularly, an increase from 1.1-fold to 1.17-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0526] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 11600, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 11600 or a polypeptide SEQ ID NO. 11601,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 11600 or polypeptide SEQ ID NO. 11601,
respectively, is increased or generated, or if the activity
"yml128c-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0527] Particularly, an increase from 1.1-fold to 1.12-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0528] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 11612, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 11612 or a polypeptide SEQ ID NO. 11613,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 11612 or polypeptide SEQ ID NO. 11613,
respectively, is increased or generated, or if the activity "hexose
transporter" is increased or generated in an plant cell, plant or
part thereof, especially with cytoplasmic localization, an increase
of yield as compared to a corresponding non-transformed wild type
plant cell, plant or a part thereof is conferred, especially an
enhanced nutrient use efficiency and/or an increased stress
tolerance and/or an increased yield, in the absence of a nutrient
deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0529] Particularly, an increase from 1.1-fold to 1.52-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0530] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 12246, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 12246 or a polypeptide SEQ ID NO. 12247,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 12246 or polypeptide SEQ ID NO. 12247,
respectively, is increased or generated, or if the activity "Zinc
finger protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0531] Particularly, an increase from 1.1-fold to 1.41-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0532] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 12263, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 12263 or a polypeptide SEQ ID NO. 12264,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 12263 or polypeptide SEQ ID NO. 12264,
respectively, is increased or generated, or if the activity
"protein required for maturation of ribosomal RNAs" is increased or
generated in an plant cell, plant or part thereof, especially with
cytoplasmic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0533] Particularly, an increase from 1.1-fold to 3.71-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0534] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 12316, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 12316 or a polypeptide SEQ ID NO. 12317,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 12316 or polypeptide SEQ ID NO. 12317,
respectively, is increased or generated, or if the activity "Factor
arrest protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0535] Particularly, an increase from 1.1-fold to 1.28-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0536] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 12327, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 12327 or a polypeptide SEQ ID NO. 12328,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 12327 or polypeptide SEQ ID NO. 12328,
respectively, is increased or generated, or if the activity
"YMR082C-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0537] Particularly, an increase from 1.1-fold to 1.26-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0538] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 12331, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 12331 or a polypeptide SEQ ID NO. 12332,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 12331 or polypeptide SEQ ID NO. 12332,
respectively, is increased or generated, or if the activity
"Nuclear cap-binding protein complex subunit" is increased or
generated in an plant cell, plant or part thereof, especially with
cytoplasmic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0539] Particularly, an increase from 1.1-fold to 1.24-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0540] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 12378, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 12378 or a polypeptide SEQ ID NO. 12379,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 12378 or polypeptide SEQ ID NO. 12379,
respectively, is increased or generated, or if the activity
"YMR126c membrane protein" is increased or generated in an plant
cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0541] Particularly, an increase from 1.1-fold to 1.19-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0542] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 12394, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 12394 or a polypeptide SEQ ID NO. 12395,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 12394 or polypeptide SEQ ID NO. 12395,
respectively, is increased or generated, or if the activity
"YMR144W-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0543] Particularly, an increase from 1.1-fold to 1.36-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0544] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 12406, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 12406 or a polypeptide SEQ ID NO. 12407,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 12406 or polypeptide SEQ ID NO. 12407,
respectively, is increased or generated, or if the activity
"YMR160W-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0545] Particularly, an increase from 1.1-fold to 1.29-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0546] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 12414, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 12414 or a polypeptide SEQ ID NO. 12415,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 12414 or polypeptide SEQ ID NO. 12415,
respectively, is increased or generated, or if the activity
"Stationary phase protein" is increased or generated in an plant
cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0547] Particularly, an increase from 1.1-fold to 1.51-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0548] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 12420, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 12420 or a polypeptide SEQ ID NO. 12421,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 12420 or polypeptide SEQ ID NO. 12421,
respectively, is increased or generated, or if the activity
"YMR209C-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0549] Particularly, an increase from 1.1-fold to 1.18-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0550] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 12440, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 12440 or a polypeptide SEQ ID NO. 12441,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 12440 or polypeptide SEQ ID NO. 12441,
respectively, is increased or generated, or if the activity
"YMR233W-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0551] Particularly, an increase from 1.1-fold to 1.61-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0552] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 12470, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 12470 or a polypeptide SEQ ID NO. 12471,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 12470 or polypeptide SEQ ID NO. 12471,
respectively, is increased or generated, or if the activity
"phosphoglucomutase/phosphomannomutase" is increased or generated
in an plant cell, plant or part thereof, especially with
cytoplasmic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0553] Particularly, an increase from 1.1-fold to 1.20-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0554] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 12749, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 12749 or a polypeptide SEQ ID NO. 12750,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 12749 or polypeptide SEQ ID NO. 12750,
respectively, is increased or generated, or if the activity
"Regulatory CAT8 protein" is increased or generated in an plant
cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0555] Particularly, an increase from 1.1-fold to 1.31-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0556] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 12773, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 12773 or a polypeptide SEQ ID NO. 12774,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 12773 or polypeptide SEQ ID NO. 12774,
respectively, is increased or generated, or if the activity
"translational elongation factor EF-3 (HEF3)" is increased or
generated in an plant cell, plant or part thereof, especially with
cytoplasmic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0557] Particularly, an increase from 1.1-fold to 1.21-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.11-fold plus at least 100% thereof under low temperature
conditions; as compared to a corresponding non-transformed wild
type plant cell, a plant or a part thereof.
[0558] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 12829, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 12829 or a polypeptide SEQ ID NO. 12830,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 12829 or polypeptide SEQ ID NO. 12830,
respectively, is increased or generated, or if the activity
"YNL320W-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0559] Particularly, an increase from 1.1-fold to 1.46-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0560] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 12883, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 12883 or a polypeptide SEQ ID NO. 12884,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 12883 or polypeptide SEQ ID NO. 12884,
respectively, is increased or generated, or if the activity "Chitin
synthase 3 complex protein" is increased or generated in an plant
cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0561] Particularly, an increase from 1.1-fold to 1.15-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0562] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 12889, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 12889 or a polypeptide SEQ ID NO. 12890,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 12889 or polypeptide SEQ ID NO. 12890,
respectively, is increased or generated, or if the activity
"Alkyl/aryl-sulfatase" is increased or generated in an plant cell,
plant or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0563] Particularly, an increase from 1.1-fold to 1.21-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0564] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 13014, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 13014 or a polypeptide SEQ ID NO. 13015,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 13014 or polypeptide SEQ ID NO. 13015,
respectively, is increased or generated, or if the activity
"antiviral adaptor protein" is increased or generated in an plant
cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0565] Particularly, an increase from 1.1-fold to 1.10-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0566] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 13018, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 13018 or a polypeptide SEQ ID NO. 13019,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 13018 or polypeptide SEQ ID NO. 13019,
respectively, is increased or generated, or if the activity
"repressor of G1 transcription" is increased or generated in an
plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0567] Particularly, an increase from 1.1-fold to 1.48-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0568] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 13024, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 13024 or a polypeptide SEQ ID NO. 13025,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 13024 or polypeptide SEQ ID NO. 13025,
respectively, is increased or generated, or if the activity
"YOR097c-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0569] Particularly, an increase from 1.1-fold to 1.19-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0570] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 13030, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 13030 or a polypeptide SEQ ID NO. 13031,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 13030 or polypeptide SEQ ID NO. 13031,
respectively, is increased or generated, or if the activity
"Phosphoribosylaminoimidazole carboxylase" is increased or
generated in an plant cell, plant or part thereof, especially with
cytoplasmic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0571] Particularly, an increase from 1.1-fold to 1.46-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0572] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 14085, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 14085 or a polypeptide SEQ ID NO. 14086,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 14085 or polypeptide SEQ ID NO. 14086,
respectively, is increased or generated, or if the activity
"component of the RAM signaling network" is increased or generated
in an plant cell, plant or part thereof, especially with
cytoplasmic localization, an increase of yield as compared to a
corresponding non-transformed wild type plant cell, plant or a part
thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0573] Particularly, an increase from 1.1-fold to 1.26-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0574] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 14093, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 14093 or a polypeptide SEQ ID NO. 14094,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 14093 or polypeptide SEQ ID NO. 14094,
respectively, is increased or generated, or if the activity
"protein kinase" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0575] Particularly, an increase from 1.1-fold to 1.33-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0576] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 14113, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 14113 or a polypeptide SEQ ID NO. 14114,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 14113 or polypeptide SEQ ID NO. 14114,
respectively, is increased or generated, or if the activity "signal
recognition particle subunit (SRP54)" is increased or generated in
an plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0577] Particularly, an increase from 1.1-fold to 1.61-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.26-fold plus at least 100% thereof under low temperature
conditions; as compared to a corresponding non-transformed wild
type plant cell, a plant or a part thereof. Accordingly, in one
embodiment, in case the Saccharomyces cerevisiae nucleic acid
molecule SEQ ID NO. 14246, or the activity of a polypeptide encoded
by a nucleic acid molecule comprising the nucleic acid SEQ ID NO.
14246 or a polypeptide SEQ ID NO. 14247, respectively, is increased
or generated, e.g. if the activity of such a nucleic acid molecule
or a polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 14246 or polypeptide
SEQ ID NO. 14247, respectively, is increased or generated, or if
the activity "regulatory subunit of the 26S proteasome" is
increased or generated in an plant cell, plant or part thereof,
especially with cytoplasmic localization, an increase of yield as
compared to a corresponding non-transformed wild type plant cell,
plant or a part thereof is conferred, especially an enhanced
nutrient use efficiency and/or an increased stress tolerance and/or
an increased yield, in the absence of a nutrient deficiency as well
as stress conditions, in particular an enhancement of NUE and/or an
increase of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0578] Particularly, an increase from 1.1-fold to 1.25-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0579] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 14311, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 14311 or a polypeptide SEQ ID NO. 14312,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 14311 or polypeptide SEQ ID NO. 14312,
respectively, is increased or generated, or if the activity "RNA
polymerase III subunit" is increased or generated in an plant cell,
plant or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0580] Particularly, an increase from 1.1-fold to 1.22-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0581] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 14914, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 14914 or a polypeptide SEQ ID NO. 14915,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 14914 or polypeptide SEQ ID NO. 14915,
respectively, is increased or generated, or if the activity
"lysophospholipase" is increased or generated in an plant cell,
plant or part thereof, especially with plastidic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0582] Particularly, an increase from 1.1-fold to 1.42-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0583] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 15382, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 15382 or a polypeptide SEQ ID NO. 15383,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 15382 or polypeptide SEQ ID NO. 15383,
respectively, is increased or generated, or if the activity
"saccharopine dehydrogenase" is increased or generated in an plant
cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0584] Particularly, an increase from 1.1-fold to 2.42-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0585] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 15460, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 15460 or a polypeptide SEQ ID NO. 15461,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 15460 or polypeptide SEQ ID NO. 15461,
respectively, is increased or generated, or if the activity
"alpha-mannosidase" is increased or generated in an plant cell,
plant or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0586] Particularly, an increase from 1.1-fold to 1.52-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0587] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 15571, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 15571 or a polypeptide SEQ ID NO. 15572,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 15571 or polypeptide SEQ ID NO. 15572,
respectively, is increased or generated, or if the activity
"ykl100c-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0588] Particularly, an increase from 1.1-fold to 1.25-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0589] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 15593, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 15593 or a polypeptide SEQ ID NO. 15594,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 15593 or polypeptide SEQ ID NO. 15594,
respectively, is increased or generated, or if the activity
"regulatory subunit of Glc7p type 1 protein serine-threonine
phosphatase" is increased or generated in an plant cell, plant or
part thereof, especially with cytoplasmic localization, an increase
of yield as compared to a corresponding non-transformed wild type
plant cell, plant or a part thereof is conferred, especially an
enhanced nutrient use efficiency and/or an increased stress
tolerance and/or an increased yield, in the absence of a nutrient
deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0590] Particularly, an increase from 1.1-fold to 1.77-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0591] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 15646, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 15646 or a polypeptide SEQ ID NO. 15647,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 15646 or polypeptide SEQ ID NO. 15647,
respectively, is increased or generated, or if the activity
"non-essential Ras guanine nucleotide exchange factor" is increased
or generated in an plant cell, plant or part thereof, especially
with cytoplasmic localization, an increase of yield as compared to
a corresponding non-transformed wild type plant cell, plant or a
part thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0592] Particularly, an increase from 1.1-fold to 1.24-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0593] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 15673, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 15673 or a polypeptide SEQ ID NO. 15674,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 15673 or polypeptide SEQ ID NO. 15674,
respectively, is increased or generated, or if the activity "metal
ion transporter" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0594] Particularly, an increase from 1.1-fold to 4.38-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0595] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 16005, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 16005 or a polypeptide SEQ ID NO. 16006,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 16005 or polypeptide SEQ ID NO. 16006,
respectively, is increased or generated, or if the activity
"subunit of cytoplasmic phenylalanyl-tRNA synthetase" is increased
or generated in an plant cell, plant or part thereof, especially
with cytoplasmic localization, an increase of yield as compared to
a corresponding non-transformed wild type plant cell, plant or a
part thereof is conferred, especially an enhanced nutrient use
efficiency and/or an increased stress tolerance and/or an increased
yield, in the absence of a nutrient deficiency as well as stress
conditions, in particular an enhancement of NUE and/or an increase
of biomass production as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof is
conferred, or in particular an enhancement of NUE, or in particular
an increase of biomass production, or an enhancement of NUE and an
increase of biomass production.
[0596] Particularly, an increase from 1.1-fold to 3.72-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0597] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 16114, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 16114 or a polypeptide SEQ ID NO. 16115,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 16114 or polypeptide SEQ ID NO. 16115,
respectively, is increased or generated, or if the activity
"YMR082C-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0598] Particularly, an increase from 1.1-fold to 1.26-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0599] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 14402, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 14402 or a polypeptide SEQ ID NO. 14403,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 14402 or polypeptide SEQ ID NO. 14403,
respectively, is increased or generated, or if the activity
"B1258-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0600] Particularly, an increase from 1.1-fold to 1.36-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0601] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 16093, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 16093 or a polypeptide SEQ ID NO. 16094,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 16093 or polypeptide SEQ ID NO. 16094,
respectively, is increased or generated, or if the activity
"YML101C-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0602] Particularly, an increase from 1.1-fold to 1.35-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0603] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 16106, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 16106 or a polypeptide SEQ ID NO. 16107,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 16106 or polypeptide SEQ ID NO. 16107,
respectively, is increased or generated, or if the activity
"nuclear fusion protein precursor" is increased or generated in an
plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0604] Particularly, an increase from 1.1-fold to 1.28-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0605] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 16120, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 16120 or a polypeptide SEQ ID NO. 16121,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 16120 or polypeptide SEQ ID NO. 16121,
respectively, is increased or generated, or if the activity
"inheritance of peroxisomes protein" is increased or generated in
an plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0606] Particularly, an increase from 1.1-fold to 1.21-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0607] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 16275, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 16275 or a polypeptide SEQ ID NO. 16276,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 16275 or polypeptide SEQ ID NO. 16276,
respectively, is increased or generated, or if the activity
"exoribonuclease" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0608] Particularly, an increase from 1.1-fold to 1.16-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0609] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 16305, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 16305 or a polypeptide SEQ ID NO. 16306,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 16305 or polypeptide SEQ ID NO. 16306,
respectively, is increased or generated, or if the activity "iron
sulfur cluster assembly protein" is increased or generated in an
plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0610] Particularly, an increase from 1.1-fold to 1.24-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0611] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 16573, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 16573 or a polypeptide SEQ ID NO. 16574,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 16573 or polypeptide SEQ ID NO. 16574,
respectively, is increased or generated, or if the activity
"YPL068C-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0612] Particularly, an increase from 1.1-fold to 1.11-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0613] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 14396, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 14396 or a polypeptide SEQ ID NO. 14397,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 14396 or polypeptide SEQ ID NO. 14397,
respectively, is increased or generated, or if the activity
"B0165-protein" is increased or generated in an plant cell, plant
or part thereof, especially with plastidic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0614] Particularly, an increase from 1.1-fold to 1.14-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.08-fold plus at least 100% thereof under low temperature
conditions; also particularly, an increase from 1.05-fold to
1.79-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0615] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 16299, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 16299 or a polypeptide SEQ ID NO. 16300,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 16299 or polypeptide SEQ ID NO. 16300,
respectively, is increased or generated, or if the activity
"YOR203W-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0616] Particularly, an increase from 1.1-fold to 1.21-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0617] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 16133, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 16133 or a polypeptide SEQ ID NO. 16134,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 16133 or polypeptide SEQ ID NO. 16134,
respectively, is increased or generated, or if the activity
"ribonucleoprotein" is increased or generated in an plant cell,
plant or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0618] Particularly, an increase from 1.1-fold to 1.15-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0619] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 15056, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 15056 or a polypeptide SEQ ID NO. 15057,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 15056 or polypeptide SEQ ID NO. 15057,
respectively, is increased or generated, or if the activity
"transcription factor" is increased or generated in an plant cell,
plant or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0620] Particularly, an increase from 1.1-fold to 1.11-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0621] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 15587, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 15587 or a polypeptide SEQ ID NO. 15588,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 15587 or polypeptide SEQ ID NO. 15588,
respectively, is increased or generated, or if the activity
"YKL111C-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0622] Particularly, an increase from 1.1-fold to 1.11-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0623] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 16582, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 16582 or a polypeptide SEQ ID NO. 16583,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 16582 or polypeptide SEQ ID NO. 16583,
respectively, is increased or generated, or if the activity "iron
sulfur cluster assembly protein" is increased or generated in an
plant cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0624] Particularly, an increase from 1.1-fold to 1.13-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0625] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 14839, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 14839 or a polypeptide SEQ ID NO. 14840,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 14839 or polypeptide SEQ ID NO. 14840,
respectively, is increased or generated, or if the activity
"transport protein" is increased or generated in an plant cell,
plant or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0626] Particularly, an increase from 1.1-fold to 1.16-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0627] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 15014, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 15014 or a polypeptide SEQ ID NO. 15015,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 15014 or polypeptide SEQ ID NO. 15015,
respectively, is increased or generated, or if the activity
"protein translocase protein" is increased or generated in an plant
cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0628] Particularly, an increase from 1.1-fold to 1.42-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0629] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 15432, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 15432 or a polypeptide SEQ ID NO. 15433,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 15432 or polypeptide SEQ ID NO. 15433,
respectively, is increased or generated, or if the activity
"YJL010C-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0630] Particularly, an increase from 1.1-fold to 1.11-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.47-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0631] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 14497, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 14497 or a polypeptide SEQ ID NO. 14498,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 14497 or polypeptide SEQ ID NO. 14498,
respectively, is increased or generated, or if the activity
"B1267-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0632] Particularly, an increase from 1.1-fold to 1.23-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0633] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 14718, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 14718 or a polypeptide SEQ ID NO. 14719,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 14718 or polypeptide SEQ ID NO. 14719,
respectively, is increased or generated, or if the activity
"membrane protein" is increased or generated in an plant cell,
plant or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0634] Particularly, an increase from 1.1-fold to 1.33-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.06-fold plus at least 100% thereof under low temperature
conditions; also particularly, an increase from 1.05-fold to
1.20-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0635] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 14791, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 14791 or a polypeptide SEQ ID NO. 14792,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 14791 or polypeptide SEQ ID NO. 14792,
respectively, is increased or generated, or if the activity
"B1381-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0636] Particularly, an increase from 1.1-fold to 1.11-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0637] Accordingly, in one embodiment, in case the Escherichia coli
nucleic acid molecule SEQ ID NO. 14879, or the activity of a
polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 14879 or a polypeptide SEQ ID NO. 14880,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 14879 or polypeptide SEQ ID NO. 14880,
respectively, is increased or generated, or if the activity
"B2646-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0638] Particularly, an increase from 1.1-fold to 1.31-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.11-fold plus at least 100% thereof under low temperature
conditions; also particularly, an increase from 1.05-fold to
1.23-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0639] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 15064, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 15064 or a polypeptide SEQ ID NO. 15065,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 15064 or polypeptide SEQ ID NO. 15065,
respectively, is increased or generated, or if the activity "60S
ribosomal protein" is increased or generated in an plant cell,
plant or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0640] Particularly, an increase from 1.1-fold to 1.12-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0641] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 15257, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 15257 or a polypeptide SEQ ID NO. 15258,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 15257 or polypeptide SEQ ID NO. 15258,
respectively, is increased or generated, or if the activity "Rho
GDP-dissociation inhibitor" is increased or generated in an plant
cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0642] Particularly, an increase from 1.1-fold to 1.33-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0643] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 15378, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 15378 or a polypeptide SEQ ID NO. 15379,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 15378 or polypeptide SEQ ID NO. 15379,
respectively, is increased or generated, or if the activity
"YHL005C-protein" is increased or generated in an plant cell, plant
or part thereof, especially with cytoplasmic localization, an
increase of yield as compared to a corresponding non-transformed
wild type plant cell, plant or a part thereof is conferred,
especially an enhanced nutrient use efficiency and/or an increased
stress tolerance and/or an increased yield, in the absence of a
nutrient deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0644] Particularly, an increase from 1.1-fold to 1.25-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0645] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 16629, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 16629 or a polypeptide SEQ ID NO. 16630,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 16629 or polypeptide SEQ ID NO. 16630,
respectively, is increased or generated, or if the activity
"transmembrane protein with a role in cell wall polymer
composition" is increased or generated in an plant cell, plant or
part thereof, especially with cytoplasmic localization, an increase
of yield as compared to a corresponding non-transformed wild type
plant cell, plant or a part thereof is conferred, especially an
enhanced nutrient use efficiency and/or an increased stress
tolerance and/or an increased yield, in the absence of a nutrient
deficiency as well as stress conditions, in particular an
enhancement of NUE and/or an increase of biomass production as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof is conferred, or in particular an
enhancement of NUE, or in particular an increase of biomass
production, or an enhancement of NUE and an increase of biomass
production.
[0646] Particularly, an increase from 1.1-fold to 4.43-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred; also particularly, an increase from 1.05-fold to
1.12-fold plus at least 100% thereof under low temperature
conditions; also particularly, an increase from 1.05-fold to
1.30-fold plus at least 100% thereof of yield in the absence of
nutrient deficiency as well as stress conditions; as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof.
[0647] Accordingly, in one embodiment, in case the Saccharomyces
cerevisiae nucleic acid molecule SEQ ID NO. 16647, or the activity
of a polypeptide encoded by a nucleic acid molecule comprising the
nucleic acid SEQ ID NO. 16647 or a polypeptide SEQ ID NO. 16648,
respectively, is increased or generated, e.g. if the activity of
such a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 16647 or polypeptide SEQ ID NO. 16648,
respectively, is increased or generated, or if the activity
"Stationary phase protein" is increased or generated in an plant
cell, plant or part thereof, especially with cytoplasmic
localization, an increase of yield as compared to a corresponding
non-transformed wild type plant cell, plant or a part thereof is
conferred, especially an enhanced nutrient use efficiency and/or an
increased stress tolerance and/or an increased yield, in the
absence of a nutrient deficiency as well as stress conditions, in
particular an enhancement of NUE and/or an increase of biomass
production as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof is conferred, or in
particular an enhancement of NUE, or in particular an increase of
biomass production, or an enhancement of NUE and an increase of
biomass production.
[0648] Particularly, an increase from 1.1-fold to 1.51-fold plus at
least 100% thereof under conditions of nitrogen deficiency is
conferred as compared to a corresponding non-transformed wild type
plant cell, a plant or a part thereof.
[0649] The ratios indicated above particularly refer to an
increased yield actually measured as increase of biomass,
especially as fresh weight biomass of aerial parts.
[0650] For the purposes of the invention, as a rule the plural is
intended to encompass the singular and vice versa.
[0651] Unless otherwise specified, the terms "polynucleotides",
"nucleic acid" and "nucleic acid molecule" are interchangeably in
the present context. Unless otherwise specified, the terms
"peptide", "polypeptide" and "protein" are interchangeably in the
present context. The term "sequence" may relate to polynucleotides,
nucleic acids, nucleic acid molecules, peptides, polypeptides and
proteins, depending on the context in which the term "sequence" is
used. The terms "gene(s)", "polynucleotide", "nucleic acid
sequence", "nucleotide sequence", or "nucleic acid molecule(s)" as
used herein refers to a polymeric form of nucleotides of any
length, either ribonucleotides or deoxyribonucleotides. The terms
refer only to the primary structure of the molecule.
[0652] Thus, the terms "gene(s)", "polynucleotide", "nucleic acid
sequence", "nucleotide sequence", or "nucleic acid molecule(s)" as
used herein include double- and single-stranded DNA and/or RNA.
They also include known types of modifications, for example,
methylation, "caps", substitutions of one or more of the naturally
occurring nucleotides with an analog. Preferably, the DNA or RNA
sequence comprises a coding sequence encoding the herein defined
polypeptide.
[0653] A "coding sequence" is a nucleotide sequence, which is
transcribed into an RNA, e.g. a regulatory RNA, such as a miRNA, a
ta-siRNA, cosuppression molecule, an RNAi, a ribozyme, etc. or into
a mRNA which is translated into a polypeptide when placed under the
control of appropriate regulatory sequences. The boundaries of the
coding sequence are determined by a translation start codon at the
5'-terminus and a translation stop codon at the 3'-terminus. The
tripletts taa, tga and tag represent the (usual) stop codons which
are interchangeable. A coding sequence can include, but is not
limited to mRNA, cDNA, recombinant nucleotide sequences or genomic
DNA, while introns may be present as well under certain
circumstances.
[0654] As used in the present context a nucleic acid molecule may
also encompass the untranslated sequence located at the 3' and at
the 5' end of the coding gene region, for example at least 500,
preferably 200, especially preferably 100, nucleotides of the
sequence upstream of the 5' end of the coding region and at least
100, preferably 50, especially preferably 20, nucleotides of the
sequence downstream of the 3' end of the coding gene region. In the
event for example the antisense, RNAi, snRNA, dsRNA, siRNA, miRNA,
ta-siRNA, cosuppression molecule, ribozyme etc. technology is used
coding regions as well as the 5'- and/or 3'-regions can
advantageously be used. However, it is often advantageous only to
choose the coding region for cloning and expression purposes.
[0655] "Polypeptide" refers to a polymer of amino acid (amino acid
sequence) and does not refer to a specific length of the molecule.
Thus, peptides and oligopeptides are included within the definition
of polypeptide. This term does also refer to or include
posttranslational modifications of the polypeptide, for example,
glycosylations, acetylations, phosphorylations and the like.
Included within the definition are, for example, polypeptides
containing one or more analogs of an amino acid (including, for
example, unnatural amino acids, etc.), polypeptides with
substituted linkages, as well as other modifications known in the
art, both naturally occurring and non-naturally occurring.
[0656] The term "table I" used in this specification is to be taken
to specify the content of table I A and table I B. The term "table
II" used in this specification is to be taken to specify the
content of table II A and table II B. The term "table I A" used in
this specification is to be taken to specify the content of table I
A. The term "table I B" used in this specification is to be taken
to specify the content of table I B. The term "table II A" used in
this specification is to be taken to specify the content of table
II A. The term "table II B" used in this specification is to be
taken to specify the content of table II B. In one preferred
embodiment, the term "table I" means table I B. In one preferred
embodiment, the term "table II" means table II B.
[0657] The terms "comprise" or "comprising" and grammatical
variations thereof when used in this specification are to be taken
to specify the presence of stated features, integers, steps or
components or groups thereof, but not to preclude the presence or
addition of one or more other features, integers, steps, components
or groups thereof.
[0658] In accordance with the invention, a protein or polypeptide
has the "activity of an protein as shown in table II, column 3" if
its de novo activity, or its increased expression directly or
indirectly leads to and confers an increased yield, especially an
enhanced NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof and the protein has the above mentioned activities of a
protein as shown in table II, column 3. Throughout the
specification the activity or preferably the biological activity of
such a protein or polypeptide or an nucleic acid molecule or
sequence encoding such protein or polypeptide is identical or
similar if it still has the biological or enzymatic activity of a
protein as shown in table II, column 3, or which has at least 10%
of the original enzymatic activity, preferably 20%, 30%, 40%, 50%,
particularly preferably 60%, 70%, 80% most particularly preferably
90%, 95%, 98%, 99% in comparison to a protein as shown in table II,
column 3 of E. coli or Saccharomyces cerevisiae. In another
embodiment the biological or enzymatic activity of a protein as
shown in table II, column 3, has at least 101% of the original
enzymatic activity, preferably 110%, 120%, %, 150%, particularly
preferably 150%, 200%, 300% in comparison to a protein as shown in
table II, column 3 of E. coli or Saccharomyces cerevisiae.
[0659] The terms "increased", "raised", "extended", "enhanced",
"improved" or "amplified" relate to a corresponding change of a
property in a plant, an organism, a part of an organism such as a
tissue, seed, root, leave, flower etc. or in a cell and are
interchangeable. Preferably, the overall activity in the volume is
increased or enhanced in cases if the increase or enhancement is
related to the increase or enhancement of an activity of a gene
product, independent whether the amount of gene product or the
specific activity of the gene product or both is increased or
enhanced or whether the amount, stability or translation efficacy
of the nucleic acid sequence or gene encoding for the gene product
is increased or enhanced.
[0660] The terms "increase" relate to a corresponding change of a
property an organism or in a part of a plant, an organism, such as
a tissue, seed, root, leave, flower etc. or in a cell. Preferably,
the overall activity in the volume is increased in cases the
increase relates to the increase of an activity of a gene product,
independent whether the amount of gene product or the specific
activity of the gene product or both is increased or generated or
whether the amount, stability or translation efficacy of the
nucleic acid sequence or gene encoding for the gene product is
increased.
[0661] Under "change of a property" it is understood that the
activity, expression level or amount of a gene product or the
metabolite content is changed in a specific volume relative to a
corresponding volume of a control, reference or wild type,
including the de novo creation of the activity or expression.
[0662] The terms "increase" include the change of said property in
only parts of the subject of the present invention, for example,
the modification can be found in compartment of a cell, like a
organelle, or in a part of a plant, like tissue, seed, root, leave,
flower etc. but is not detectable if the overall subject, i.e.
complete cell or plant, is tested.
[0663] Accordingly, the term "increase" means that the specific
activity of an enzyme as well as the amount of a compound or
metabolite, e.g. of a polypeptide, a nucleic acid molecule of the
invention or an encoding mRNA or DNA, can be increased in a
volume.
[0664] The terms "wild type", "control" or "reference" are
exchangeable and can be a cell or a part of organisms such as an
organelle like a chloroplast or a tissue, or an organism, in
particular a plant, which was not modified or treated according to
the herein described process according to the invention.
Accordingly, the cell or a part of organisms such as an organelle
like a chloroplast or a tissue, or an organism, in particular a
plant used as wild type, control or reference corresponds to the
cell, organism, plant or part thereof as much as possible and is in
any other property but in the result of the process of the
invention as identical to the subject matter of the invention as
possible. Thus, the wild type, control or reference is treated
identically or as identical as possible, saying that only
conditions or properties might be different which do not influence
the quality of the tested property.
[0665] Preferably, any comparison is carried out under analogous
conditions. The term "analogous conditions" means that all
conditions such as, for example, culture or growing conditions,
soil, nutrient, water content of the soil, temperature, humidity or
surrounding air or soil, assay conditions (such as buffer
composition, temperature, substrates, pathogen strain,
concentrations and the like) are kept identical between the
experiments to be compared.
[0666] The "reference", "control", or "wild type" is preferably a
subject, e.g. an organelle, a cell, a tissue, an organism, in
particular a plant, which was not modified or treated according to
the herein described process of the invention and is in any other
property as similar to the subject matter of the invention as
possible. The reference, control or wild type is in its genome,
transcriptome, proteome or metabolome as similar as possible to the
subject of the present invention. Preferably, the term "reference-"
"control-" or "wild type-"-organelle, -cell, -tissue or -organism,
in particular plant, relates to an organelle, cell, tissue or
organism, in particular plant, which is nearly genetically
identical to the organelle, cell, tissue or organism, in particular
plant, of the present invention or a part thereof preferably 95%,
more preferred are 98%, even more preferred are 99.00%, in
particular 99,10%, 99,30%, 99.50%, 99,70%, 99,90%, 99,99%, 99,999%
or more. Most preferable the "reference", "control", or "wild type"
is a subject, e.g. an organelle, a cell, a tissue, an organism, in
particular a plant, which is genetically identical to the organism,
in particular plant, cell, a tissue or organelle used according to
the process of the invention except that the responsible or
activity conferring nucleic acid molecules or the gene product
encoded by them are amended, manipulated, exchanged or introduced
according to the inventive process.
[0667] In case, a control, reference or wild type differing from
the subject of the present invention only by not being subject of
the process of the invention can not be provided, a control,
reference or wild type can be an organism in which the cause for
the modulation of an activity conferring the enhanced NUE and/or
increased biomass production for example as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof or expression of the nucleic acid molecule of the invention
as described herein has been switched back or off, e.g. by knocking
out the expression of responsible gene product, e.g. by antisense
inhibition, by inactivation of an activator or agonist, by
activation of an inhibitor or antagonist, by inhibition through
adding inhibitory antibodies, by adding active compounds as e.g.
hormones, by introducing negative dominant mutants, etc. A gene
production can for example be knocked out by introducing
inactivating point mutations, which lead to an enzymatic activity
inhibition or a destabilization or an inhibition of the ability to
bind to cofactors etc.
[0668] Accordingly, preferred reference subject is the starting
subject of the present process of the invention. Preferably, the
reference and the subject matter of the invention are compared
after standardization and normalization, e.g. to the amount of
total RNA, DNA, or protein or activity or expression of reference
genes, like housekeeping genes, such as ubiquitin, actin or
ribosomal proteins.
[0669] The increase or modulation according to this invention can
be constitutive, e.g. due to a stable permanent transgenic
expression or to a stable mutation in the corresponding endogenous
gene encoding the nucleic acid molecule of the invention or to a
modulation of the expression or of the behavior of a gene
conferring the expression of the polypeptide of the invention, or
transient, e.g. due to an transient transformation or temporary
addition of a modulator such as a agonist or antagonist or
inducible, e.g. after transformation with a inducible construct
carrying the nucleic acid molecule of the invention under control
of a inducible promoter and adding the inducer, e.g. tetracycline
or as described herein below.
[0670] The increase in activity of the polypeptide amounts in a
cell, a tissue, an organelle, an organ or an organism, preferably a
plant, or a part thereof preferably to at least 5%, preferably to
at least 20% or at to least 50%, especially preferably to at least
70%, 80%, 90% or more, very especially preferably are to at least
100%, 150% or 200%, most preferably are to at least 250% or more in
comparison to the control, reference or wild type.
[0671] In one embodiment the term increase means the increase in
amount in relation to the weight of the organism or part thereof
(w/w).
[0672] In one embodiment the increase in activity of the
polypeptide amounts in an organelle such as a plastid.
[0673] In another embodiment the increase in activity of the
polypeptide amounts in the cytosol.
[0674] The specific activity of a polypeptide encoded by a nucleic
acid molecule of the present invention or of the polypeptide of the
present invention can be tested as described in the examples. In
particular, the expression of a protein in question in a cell, e.g.
a plant cell in comparison to a control is an easy test and can be
performed as described in the state of the art.
[0675] The term "increase" includes, that a compound or an
activity, especially an activity, is introduced into a cell, the
cytosol or a subcellular compartment or organelle de novo or that
the compound or the activity, especially an activity, has not been
detected before, in other words it is "generated".
[0676] Accordingly, in the following, the term "increasing" also
comprises the term "generating" or "stimulating". The increased
activity manifests itself in an increased yield, especially an
enhanced NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof.
[0677] The sequence of B0017 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
b0017-protein.
[0678] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "b0017-protein" from Escherichia
coli or its functional equivalent or its homolog, e.g. the increase
of [0679] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said B0017 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said B0017; or
[0680] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown n column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said B0017 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said B0017, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[0681] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "b0017-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0682] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "b0017-protein", is
increased cytoplasmic.
[0683] The sequence of B0045 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
transport protein.
[0684] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "transport protein" from Escherichia
coli or its functional equivalent or its homolog, e.g. the increase
of [0685] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said B0045 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said B0045; or
[0686] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said B0045 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said B0045, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[0687] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "transport protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0688] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "transport protein", is
increased cytoplasmic.
[0689] The sequence of B0180 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
hydroxymyristol acyl carrier protein dehydratase.
[0690] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "hydroxymyristol acyl carrier
protein dehydratase" from Escherichia coli or its functional
equivalent or its homolog, e.g. the increase of [0691] (a) a gene
product of a gene comprising the nucleic acid molecule as shown in
column 5 of table I, application no. 1, and being depicted in the
same respective line as said B0180 or a functional equivalent or a
homologue thereof as shown in column 7 of table I, application no.
1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said B0180; or [0692] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said B0180 or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said B0180, as mentioned herein, for an
increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[0693] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "hydroxymyristol acyl
carrier protein dehydratase", preferably it is the molecule of
section (a) or (b) of this paragraph.
[0694] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "hydroxymyristol acyl
carrier protein dehydratase", is increased plastidic.
[0695] The sequence of B0242 from Escherichia coli K12, e.g. as
shown in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
gamma-glutamyl kinase.
[0696] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "gamma-glutamyl kinase" from
Escherichia coli K12 or its functional equivalent or its homolog,
e.g. the increase of [0697] (a) a gene product of a gene comprising
the nucleic acid molecule as shown in column 5 of table I,
application no. 1, and being depicted in the same respective line
as said B0242 or a functional equivalent or a homologue thereof as
shown in column 7 of table I, application no. 1, preferably a
homologue or functional equivalent as shown in column 7 of table I
B, application no. 1, and being depicted in the same respective
line as said B0242; or [0698] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said B0242 or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said B0242, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[0699] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "gamma-glutamyl kinase",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0700] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "gamma-glutamyl kinase",
is increased plastidic.
[0701] The sequence of B0403 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
alpha-glucosidase.
[0702] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "alpha-glucosidase" from Escherichia
coli or its functional equivalent or its homolog, e.g. the increase
of [0703] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said B0403 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said B0403; or
[0704] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said B0403 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said B0403, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[0705] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "alpha-glucosidase",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0706] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "alpha-glucosidase", is
increased plastidic.
[0707] The sequence of B0474 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
adenylate kinase.
[0708] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "adenylate kinase" from Escherichia
coli or its functional equivalent or its homolog, e.g. the increase
of [0709] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said B0474 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said B0474; or
[0710] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said B0474 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said B0474, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[0711] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "adenylate kinase",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0712] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "adenylate kinase", is
increased cytoplasmic.
[0713] The sequence of B0754 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
2-dehydro-3-deoxy-phosphoheptonate aldolase.
[0714] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "2-dehydro-3-deoxy-phosphoheptonate
aldolase" from Escherichia coli or its functional equivalent or its
homolog, e.g. the increase of [0715] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said B0754 or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said B0754; or [0716] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said B0754 or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said B0754, as mentioned herein, for an
increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[0717] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a
"2-dehydro-3-deoxy-phosphoheptonate aldolase", preferably it is the
molecule of section (a) or (b) of this paragraph.
[0718] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a
"2-dehydro-3-deoxy-phosphoheptonate aldolase", is increased
plastidic.
[0719] The sequence of B0784 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
molybdopterin biosynthesis protein.
[0720] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "molybdopterin biosynthesis protein"
from Escherichia coli or its functional equivalent or its homolog,
e.g. the increase of [0721] (a) a gene product of a gene comprising
the nucleic acid molecule as shown in column 5 of table I,
application no. 1, and being depicted in the same respective line
as said B0784 or a functional equivalent or a homologue thereof as
shown in column 7 of table I, application no. 1, preferably a
homologue or functional equivalent as shown in column 7 of table I
B, application no. 1, and being depicted in the same respective
line as said B0784; or [0722] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said B0784 or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said B0784, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[0723] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "molybdopterin
biosynthesis protein", preferably it is the molecule of section (a)
or (b) of this paragraph.
[0724] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "molybdopterin
biosynthesis protein", is increased cytoplasmic.
[0725] The sequence of B0873 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
hydroxylamine reductase.
[0726] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "hydroxylamine reductase" from
Escherichia coli or its functional equivalent or its homolog, e.g.
the increase of [0727] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said B0873
or a functional equivalent or a homologue thereof as shown in
column 7 of table I, application no. 1, preferably a homologue or
functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said B0873; or [0728] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said B0873 or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said B0873, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[0729] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "hydroxylamine
reductase", preferably it is the molecule of section (a) or (b) of
this paragraph.
[0730] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "hydroxylamine
reductase", is increased plastidic.
[0731] The sequence of B1014 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
proline dehydrogenase.
[0732] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "proline dehydrogenase" from
Escherichia coli or its functional equivalent or its homolog, e.g.
the increase of [0733] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said B1014
or a functional equivalent or a homologue thereof as shown in
column 7 of table I, application no. 1, preferably a homologue or
functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said B1014; or [0734] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said B1014 or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said B1014, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[0735] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "proline dehydrogenase",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0736] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "proline dehydrogenase",
is increased cytoplasmic.
[0737] The sequence of B1020 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
PhoH-like protein.
[0738] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "PhoH-like protein" from Escherichia
coli or its functional equivalent or its homolog, e.g. the increase
of [0739] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said B1020 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said B1020; or
[0740] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said B1020 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said B1020, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[0741] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "PhoH-like protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0742] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "PhoH-like protein", is
increased plastidic.
[0743] The sequence of B1180 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
isomerase.
[0744] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "isomerase" from Escherichia coli or
its functional equivalent or its homolog, e.g. the increase of
[0745] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said B1180 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said B1180; or
[0746] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said B1180 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said B1180, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[0747] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "isomerase", preferably
it is the molecule of section (a) or (b) of this paragraph.
[0748] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "isomerase", is
increased cytoplasmic.
[0749] The sequence of B1933 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
b1933-protein.
[0750] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "b1933-protein" from Escherichia
coli or its functional equivalent or its homolog, e.g. the increase
of [0751] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said B1933 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said B1933; or
[0752] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said B1933 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said B1933, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[0753] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "b1933-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0754] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "b1933-protein", is
increased plastidic.
[0755] The sequence of B2032 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
glycosyltransferase.
[0756] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "glycosyltransferase" from
Escherichia coli or its functional equivalent or its homolog, e.g.
the increase of [0757] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said B2032
or a functional equivalent or a homologue thereof as shown in
column 7 of table I, application no. 1, preferably a homologue or
functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said B2032; or [0758] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said B2032 or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said B2032, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[0759] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "glycosyltransferase",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0760] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "glycosyltransferase",
is increased plastidic.
[0761] The sequence of B2165 from Escherichia coli K12, e.g. as
shown in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
b2165-protein.
[0762] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "b2165-protein" from Escherichia
coli K12 or its functional equivalent or its homolog, e.g. the
increase of [0763] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said B2165
or a functional equivalent or a homologue thereof as shown in
column 7 of table I, application no. 1, preferably a homologue or
functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said B2165; or [0764] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said B2165 or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said B2165, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[0765] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "b2165-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0766] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "b2165-protein", is
increased plastidic.
[0767] The sequence of B2223 from Escherichia coli K12, e.g. as
shown in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as short
chain fatty acid transporter.
[0768] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "short chain fatty acid transporter"
from Escherichia coli K12 or its functional equivalent or its
homolog, e.g. the increase of [0769] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said B2223 or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said B2223; or [0770] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said B2223 or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said B2223, as mentioned herein, for an
increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[0771] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "short chain fatty acid
transporter", preferably it is the molecule of section (a) or (b)
of this paragraph.
[0772] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "short chain fatty acid
transporter", is increased plastidic.
[0773] The sequence of B2238 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
b2238-protein.
[0774] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "b2238-protein" from Escherichia
coli or its functional equivalent or its homolog, e.g. the increase
of [0775] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said B2238 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said B2238; or
[0776] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said B2238 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said B2238, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[0777] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "b2238-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0778] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "b2238-protein", is
increased plastidic.
[0779] In another embodiment, said molecule, which activity is to
be increased in the process of the invention and which is the gene
product with an activity as described as a "b2238-protein", is
increased cytoplasmic.
[0780] The sequence of B2310 from Escherichia coli K12, e.g. as
shown in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
lysine/arginine/ornithine transporter subunit.
[0781] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "lysine/arginine/ornithine
transporter subunit" from Escherichia coli K12 or its functional
equivalent or its homolog, e.g. the increase of [0782] (a) a gene
product of a gene comprising the nucleic acid molecule as shown in
column 5 of table I, application no. 1, and being depicted in the
same respective line as said B2310 or a functional equivalent or a
homologue thereof as shown in column 7 of table I, application no.
1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said B2310; or [0783] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said B2310 or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said B2310, as mentioned herein, for an
increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[0784] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a
"lysine/arginine/ornithine transporter subunit", preferably it is
the molecule of section (a) or (b) of this paragraph.
[0785] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a
"lysine/arginine/ornithine transporter subunit", is increased
plastidic.
[0786] The sequence of B2431 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
b2431-protein.
[0787] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "b2431-protein" from Escherichia
coli or its functional equivalent or its homolog, e.g. the increase
of [0788] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said B2431 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said B2431; or
[0789] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said B2431 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said B2431, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[0790] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "b2431-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0791] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "b2431-protein", is
increased plastidic.
[0792] The sequence of B2600 from Escherichia coli K12, e.g. as
shown in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
chorismate mutase T/prephenate dehydrogenase (bifunctional).
[0793] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "chorismate mutase T/prephenate
dehydrogenase (bifunctional)" from Escherichia coli K12 or its
functional equivalent or its homolog, e.g. the increase of [0794]
(a) a gene product of a gene comprising the nucleic acid molecule
as shown in column 5 of table I, application no. 1, and being
depicted in the same respective line as said B2600 or a functional
equivalent or a homologue thereof as shown in column 7 of table I,
application no. 1, preferably a homologue or functional equivalent
as shown in column 7 of table I B, application no. 1, and being
depicted in the same respective line as said B2600; or [0795] (b) a
polypeptide comprising a polypeptide, a consensus sequence or a
polypeptide motif as shown in column 5 of table II or in column 7
of table IV, application no. 1, respectively, and being depicted in
the same respective line as said B2600 or a functional equivalent
or a homologue thereof as depicted in column 7 of table II,
application no. 1, preferably a homologue or functional equivalent
as depicted in column 7 of table II B, application no. 1, and being
depicted in the same respective line as said B2600, as mentioned
herein, for an increased yield, especially an enhanced NUE and/or
increased biomass production, as compared to a corresponding
non-transformed wild type plant cell, plant or part thereof in
plant cell, plant or part thereof, as mentioned, especially for an
enhanced NUE, or increased biomass production, or an enhanced NUE
and increased biomass production.
[0796] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "chorismate mutase
T/prephenate dehydrogenase (bifunctional)", preferably it is the
molecule of section (a) or (b) of this paragraph.
[0797] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "chorismate mutase
T/prephenate dehydrogenase (bifunctional)", is increased
plastidic.
[0798] The sequence of B2766 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
b2766-protein.
[0799] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "b2766-protein" from Escherichia
coli or its functional equivalent or its homolog, e.g. the increase
of [0800] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said B2766 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said B2766; or
[0801] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said B2766 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said B2766, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[0802] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "b2766-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0803] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "b2766-protein", is
increased plastidic.
[0804] The sequence of B2903 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
glycine decarboxylase.
[0805] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "glycine decarboxylase" from
Escherichia coli or its functional equivalent or its homolog, e.g.
the increase of [0806] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said B2903
or a functional equivalent or a homologue thereof as shown in
column 7 of table I, application no. 1, preferably a homologue or
functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said B2903; or [0807] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said B2903 or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said B2903, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[0808] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "glycine decarboxylase",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0809] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "glycine decarboxylase",
is increased cytoplasmic.
[0810] The sequence of B3117 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
threonine ammonia-lyase.
[0811] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "threonine ammonia-lyase" from
Escherichia coli or its functional equivalent or its homolog, e.g.
the increase of [0812] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said B3117
or a functional equivalent or a homologue thereof as shown in
column 7 of table I, application no. 1, preferably a homologue or
functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said B3117; or [0813] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said B3117 or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said B3117, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[0814] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "threonine
ammonia-lyase", preferably it is the molecule of section (a) or (b)
of this paragraph.
[0815] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "threonine
ammonia-lyase", is increased plastidic.
[0816] The sequence of B3120 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
b3120-protein.
[0817] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "b3120-protein" from Escherichia
coli or its functional equivalent or its homolog, e.g. the increase
of [0818] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said B3120 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said B3120; or
[0819] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said B3120 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said B3120, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[0820] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "b3120-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0821] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "b3120-protein", is
increased plastidic.
[0822] The sequence of B3216 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as outer
membrane usher protein.
[0823] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "outer membrane usher protein" from
Escherichia coli or its functional equivalent or its homolog, e.g.
the increase of [0824] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said B3216
or a functional equivalent or a homologue thereof as shown in
column 7 of table I, application no. 1, preferably a homologue or
functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said B3216; or [0825] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said B3216 or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said B3216, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[0826] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "outer membrane usher
protein", preferably it is the molecule of section (a) or (b) of
this paragraph.
[0827] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "outer membrane usher
protein", is increased plastidic.
[0828] The sequence of B3451 from Escherichia coli K12, e.g. as
shown in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
glycerol-3-phosphate transporter subunit.
[0829] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "glycerol-3-phosphate transporter
subunit" from Escherichia coli K12 or its functional equivalent or
its homolog, e.g. the increase of [0830] (a) a gene product of a
gene comprising the nucleic acid molecule as shown in column 5 of
table I, application no. 1, and being depicted in the same
respective line as said B3451 or a functional equivalent or a
homologue thereof as shown in column 7 of table I, application no.
1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said B3451; or [0831] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said B3451 or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said B3451, as mentioned herein, for an
increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[0832] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "glycerol-3-phosphate
transporter subunit", preferably it is the molecule of section (a)
or (b) of this paragraph.
[0833] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "glycerol-3-phosphate
transporter subunit", is increased plastidic.
[0834] The sequence of B3791 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
hydro-lyase.
[0835] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "hydro-lyase" from Escherichia coli
or its functional equivalent or its homolog, e.g. the increase of
[0836] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said B3791 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said B3791; or
[0837] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said B3791 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said B3791, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[0838] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "hydrolyase", preferably
it is the molecule of section (a) or (b) of this paragraph.
[0839] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "hydrolyase", is
increased cytoplasmic.
[0840] The sequence of B3825 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
lysophospholipase.
[0841] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "lysophospholipase" from Escherichia
coli or its functional equivalent or its homolog, e.g. the increase
of [0842] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said B3825 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said B3825; or
[0843] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said B3825 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said B3825, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[0844] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "lysophospholipase",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0845] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "lysophospholipase", is
increased plastidic.
[0846] The sequence of Yal019w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
yal019w-protein.
[0847] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "yal019w-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [0848] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Yal019w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Yal019w; or [0849] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Yal019w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Yal019w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[0850] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "yal019w-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0851] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "yal019w-protein", is
increased cytoplasmic.
[0852] The sequence of Yar035w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
carnitine acetyltransferase.
[0853] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "carnitine acetyltransferase" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [0854] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Yar035w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Yar035w; or [0855] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yar035w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yar035w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[0856] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "carnitine
acetyltransferase", preferably it is the molecule of section (a) or
(b) of this paragraph.
[0857] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "carnitine
acetyltransferase", is increased cytoplasmic.
[0858] The sequence of Ybl021c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
Transcriptional activator.
[0859] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "Transcriptional activator" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [0860] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ybl021c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ybl021c; or [0861] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table I or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ybl021c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ybl021c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[0862] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "Transcriptional
activator", preferably it is the molecule of section (a) or (b) of
this paragraph.
[0863] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "Transcriptional
activator", is increased cytoplasmic.
[0864] The sequence of Ybr055c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
splicing factor.
[0865] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "splicing factor" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [0866] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ybr055c or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ybr055c; or [0867] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ybr055c or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ybr055c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[0868] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "splicing factor",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0869] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "splicing factor", is
increased cytoplasmic.
[0870] The sequence of YBR128C from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
autophagy-specific phosphatidylinositol 3-kinase complex protein
subunit.
[0871] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "autophagy-specific
phosphatidylinositol 3-kinase complex protein subunit" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [0872] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said YBR128C or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said YBR128C; or [0873] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said YBR128C or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said YBR128C, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[0874] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "autophagy-specific
phosphatidylinositol 3-kinase complex protein subunit", preferably
it is the molecule of section (a) or (b) of this paragraph.
[0875] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "autophagy-specific
phosphatidylinositol 3-kinase complex protein subunit", is
increased cytoplasmic.
[0876] The sequence of Ybr159w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
microsomal beta-ketoreductase.
[0877] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "microsomal beta-keto-reductase"
from Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [0878] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ybr159w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ybr159w; or [0879] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ybr159w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ybr159w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[0880] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "microsomal
beta-keto-reductase", preferably it is the molecule of section (a)
or (b) of this paragraph.
[0881] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "microsomal
beta-keto-reductase", is increased cytoplasmic.
[0882] The sequence of Ybr243c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
UDP-N-acetyl-glucosamine-1-P transferase.
[0883] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "UDP-N-acetyl-glucosamine-1-P
transferase" from Saccharomyces cerevisiae or its functional
equivalent or its homolog, e.g. the increase of [0884] (a) a gene
product of a gene comprising the nucleic acid molecule as shown in
column 5 of table I, application no. 1, and being depicted in the
same respective line as said Ybr243c or a functional equivalent or
a homologue thereof as shown in column 7 of table I, application
no. 1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Ybr243c; or [0885] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ybr243c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ybr243c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[0886] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a
"UDP-N-acetyl-glucosamine-1-P transferase", preferably it is the
molecule of section (a) or (b) of this paragraph.
[0887] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a
"UDP-N-acetyl-glucosamine-1-P transferase", is increased
cytoplasmic.
[0888] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a
"UDP-N-acetyl-glucosamine-1-P transferase", is increased
plastidic.
[0889] The sequence of Ybr262c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
ybr262c-protein.
[0890] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "ybr262c-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [0891] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ybr262c or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ybr262c; or [0892] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ybr262c or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ybr262c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[0893] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "ybr262c-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0894] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "ybr262c-protein", is
increased cytoplasmic.
[0895] The sequence of Ycr019w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
protein necessary for structural stability of L-A double-stranded
RNA-containing particles.
[0896] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "protein necessary for structural
stability of L-A double-stranded RNA-containing particles" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [0897] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ycr019w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ycr019w; or [0898] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ycr019w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ycr019w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[0899] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "protein necessary for
structural stability of L-A double-stranded RNA-containing
particles", preferably it is the molecule of section (a) or (b) of
this paragraph.
[0900] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "protein necessary for
structural stability of L-A double-stranded RNA-containing
particles", is increased cytoplasmic.
[0901] The sequence of Ydr070c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
YDR070C-protein.
[0902] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "YDR070C-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [0903] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ydr070c or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ydr070c; or [0904] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ydr070c or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ydr070c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[0905] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "YDR070C-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0906] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "YDR070C-protein", is
increased cytoplasmic.
[0907] The sequence of Ydr079w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
chaperone.
[0908] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "chaperone" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [0909] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ydr079w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ydr079w; or [0910] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ydr079w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ydr079w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[0911] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "chaperone", preferably
it is the molecule of section (a) or (b) of this paragraph.
[0912] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "chaperone", is
increased cytoplasmic.
[0913] The sequence of Ydr123c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements.
[0914] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "helix-loop-helix transcription
activator that binds inositol/choline-responsive elements" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [0915] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ydr123c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ydr123c; or [0916] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ydr123c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ydr123c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[0917] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "helix-loop-helix
transcription activator that binds inositol/choline-responsive
elements", preferably it is the molecule of section (a) or (b) of
this paragraph.
[0918] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "helix-loop-helix
transcription activator that binds inositol/choline-responsive
elements", is increased cytoplasmic.
[0919] The sequence of Ydr137w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as golgi
membrane exchange factor subunit.
[0920] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "golgi membrane exchange factor
subunit" from Saccharomyces cerevisiae or its functional equivalent
or its homolog, e.g. the increase of [0921] (a) a gene product of a
gene comprising the nucleic acid molecule as shown in column 5 of
table I, application no. 1, and being depicted in the same
respective line as said Ydr137w or a functional equivalent or a
homologue thereof as shown in column 7 of table I, application no.
1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Ydr137w; or [0922] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ydr137w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ydr137w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[0923] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "golgi membrane exchange
factor subunit", preferably it is the molecule of section (a) or
(b) of this paragraph.
[0924] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "golgi membrane exchange
factor subunit", is increased cytoplasmic.
[0925] The sequence of Ydr294c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
dihydrosphingosine phosphate lyase.
[0926] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "dihydrosphingosine phosphate lyase"
from Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [0927] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ydr294c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ydr294c; or [0928] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ydr294c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ydr294c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[0929] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "dihydrosphingosine
phosphate lyase", preferably it is the molecule of section (a) or
(b) of this paragraph.
[0930] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "dihydrosphingosine
phosphate lyase", is increased cytoplasmic.
[0931] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "dihydrosphingosine
phosphate lyase", is increased plastidic.
[0932] The sequence of Ydr330w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
ubiquitin regulatory protein.
[0933] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "ubiquitin regulatory protein" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [0934] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ydr330w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ydr330w; or [0935] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ydr330w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ydr330w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[0936] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "ubiquitin regulatory
protein", preferably it is the molecule of section (a) or (b) of
this paragraph.
[0937] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "ubiquitin regulatory
protein", is increased cytoplasmic.
[0938] The sequence of Ydr355c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
ydr355c-protein.
[0939] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "ydr355c-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [0940] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ydr355c or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ydr355c; or [0941] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ydr355c or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ydr355c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[0942] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "ydr355c-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0943] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "ydr355c-protein", is
increased cytoplasmic.
[0944] The sequence of YDR430C from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
lysine-specific metalloprotease.
[0945] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "lysine-specific metalloprotease"
from Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [0946] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said YDR430C or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said YDR430C; or [0947] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said YDR430C or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said YDR430C, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[0948] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "lysine-specific
metalloprotease", preferably it is the molecule of section (a) or
(b) of this paragraph.
[0949] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "lysine-specific
metalloprotease", is increased plastidic.
[0950] The sequence of Ydr472w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
subunit of the transport protein particle (TRAPP) complex of the
cis-Golgi.
[0951] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "subunit of the transport protein
particle (TRAPP) complex of the cis-Golgi" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [0952] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ydr472w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ydr472w; or [0953] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ydr472w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ydr472w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[0954] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0955] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi", is
increased cytoplasmic.
[0956] The sequence of YDR497C from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
myo-inositol transporter.
[0957] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "myo-inositol transporter" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [0958] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said YDR497C or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said YDR497C; or [0959] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said YDR497C or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said YDR497C, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[0960] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "myo-inositol
transporter", preferably it is the molecule of section (a) or (b)
of this paragraph.
[0961] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "myo-inositol
transporter", is increased plastidic.
[0962] The sequence of Yer029c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as SM
complex B protein for mRNA splicing.
[0963] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "SM complex B protein for mRNA
splicing" from Saccharomyces cerevisiae or its functional
equivalent or its homolog, e.g. the increase of [0964] (a) a gene
product of a gene comprising the nucleic acid molecule as shown in
column 5 of table I, application no. 1, and being depicted in the
same respective line as said Yer029c or a functional equivalent or
a homologue thereof as shown in column 7 of table I, application
no. 1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Yer029c; or [0965] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yer029c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yer029c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[0966] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "SM complex B protein
for mRNA splicing", preferably it is the molecule of section (a) or
(b) of this paragraph.
[0967] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "SM complex B protein
for mRNA splicing", is increased cytoplasmic.
[0968] The sequence of YFR007W from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
YFR007W-protein.
[0969] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "YFR007W-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [0970] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
YFR007W or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said YFR007W; or [0971] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said YFR007W or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said YFR007W, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[0972] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "YFR007W-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0973] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "YFR007W-protein", is
increased cytoplasmic.
[0974] The sequence of YGL039W from Saccharomyces cerevisiae, e.g.
as shown in column of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
oxidoreductase.
[0975] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "oxidoreductase" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [0976] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
YGL039W or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said YGL039W; or [0977] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said YGL039W or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said YGL039W, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[0978] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "oxidoreductase",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0979] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "oxidoreductase", is
increased cytoplasmic.
[0980] The sequence of Ygl043w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
transcription elongation factor.
[0981] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "transcription elongation factor"
from Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [0982] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ygl043w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ygl043w; or [0983] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ygl043w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ygl043w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[0984] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "transcription
elongation factor", preferably it is the molecule of section (a) or
(b) of this paragraph.
[0985] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "transcription
elongation factor", is increased cytoplasmic.
[0986] The sequence of Ygr088w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
cytosolic catalase.
[0987] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "cytosolic catalase" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [0988] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ygr088w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ygr088w; or [0989] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ygr088w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ygr088w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[0990] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "cytosolic catalase",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0991] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "cytosolic catalase", is
increased cytoplasmic.
[0992] The sequence of Ygr122c-a from Saccharomyces cerevisiae,
e.g. as shown in column 5 of table I, application no. 1, is
published (e.g. sequences from Saccharomyces cerevisiae have been
published in Goffeau et al., Science 274 (5287), 546 (1996),
sequences from Escherichia coli have been published in Blattner et
al., Science 277 (5331), 1453 (1997)), and/or its activity is
described as ygr122c-a-protein.
[0993] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "ygr122c-a-protein" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [0994] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ygr122c-a or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ygr122c-a; or [0995] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ygr122c-a or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ygr122c-a, as mentioned herein,
for an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[0996] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "ygr122c-a-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[0997] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "ygr122c-a-protein", is
increased cytoplasmic.
[0998] The sequence of Ygr142w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
v-SNARE binding protein.
[0999] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "v-SNARE binding protein" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1000] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ygr142w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ygr142w; or [1001] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ygr142w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ygr142w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1002] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "v-SNARE binding
protein", preferably it is the molecule of section (a) or (b) of
this paragraph.
[1003] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "v-SNARE binding
protein", is increased cytoplasmic.
[1004] The sequence of Ygr143w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
protein involved in sphingolipid biosynthesis.
[1005] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "protein involved in sphingolipid
biosynthesis" from Saccharomyces cerevisiae or its functional
equivalent or its homolog, e.g. the increase of [1006] (a) a gene
product of a gene comprising the nucleic acid molecule as shown in
column 5 of table I, application no. 1, and being depicted in the
same respective line as said Ygr143w or a functional equivalent or
a homologue thereof as shown in column 7 of table I, application
no. 1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Ygr143w; or [1007] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ygr143w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ygr143w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1008] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "protein involved in
sphingolipid biosynthesis", preferably it is the molecule of
section (a) or (b) of this paragraph.
[1009] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "protein involved in
sphingolipid biosynthesis", is increased cytoplasmic.
[1010] The sequence of Ygr165w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
mitochondrial ribosomal protein of the small subunit.
[1011] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "mitochondrial ribosomal protein of
the small subunit" from Saccharomyces cerevisiae or its functional
equivalent or its homolog, e.g. the increase of [1012] (a) a gene
product of a gene comprising the nucleic acid molecule as shown in
column 5 of table I, application no. 1, and being depicted in the
same respective line as said Ygr165w or a functional equivalent or
a homologue thereof as shown in column 7 of table I, application
no. 1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Ygr165w; or [1013] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ygr165w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ygr165w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1014] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "mitochondrial ribosomal
protein of the small subunit", preferably it is the molecule of
section (a) or (b) of this paragraph.
[1015] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "mitochondrial ribosomal
protein of the small subunit", is increased cytoplasmic.
[1016] The sequence of Ygr170w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
phosphatidylserine decarboxylase.
[1017] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "phosphatidylserine decarboxylase"
from Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1018] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ygr170w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ygr170w; or [1019] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ygr170w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ygr170w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1020] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "phosphatidylserine
decarboxylase", preferably it is the molecule of section (a) or (b)
of this paragraph.
[1021] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "phosphatidylserine
decarboxylase", is increased cytoplasmic.
[1022] The sequence of Ygr202c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
cholinephosphate cytidylyltransferase.
[1023] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "cholinephosphate
cytidylyltransferase" from Saccharomyces cerevisiae or its
functional equivalent or its homolog, e.g. the increase of [1024]
(a) a gene product of a gene comprising the nucleic acid molecule
as shown in column 5 of table I, application no. 1, and being
depicted in the same respective line as said Ygr202c or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said Ygr202c; or
[1025] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said Ygr202c or a
functional equivalent or a homologue thereof as depicted in column
7 of table II, application no. 1, preferably a homologue or
functional equivalent as depicted in column 7 of table II B,
application no. 1, and being depicted in the same respective line
as said Ygr202c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1026] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "cholinephosphate
cytidylyltransferase", preferably it is the molecule of section (a)
or (b) of this paragraph.
[1027] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "cholinephosphate
cytidylyltransferase", is increased cytoplasmic.
[1028] The sequence of Ygr266w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
ygr266w-protein.
[1029] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "ygr266w-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1030] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ygr266w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ygr266w; or [1031] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ygr266w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ygr266w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1032] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "ygr266w-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1033] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "ygr266w-protein", is
increased cytoplasmic.
[1034] The sequence of Ygr282c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as cell
wall endo-beta-1,3-glucanase.
[1035] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "cell wall endo-beta-1,3-glucanase"
from Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1036] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ygr282c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ygr282c; or [1037] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ygr282c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ygr282c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1038] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "cell wall
endo-beta-1,3-glucanase", preferably it is the molecule of section
(a) or (b) of this paragraph.
[1039] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "cell wall
endo-beta-1,3-glucanase", is increased cytoplasmic.
[1040] The sequence of Ygr290w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
ygr290w-protein.
[1041] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "ygr290w-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1042] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ygr290w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ygr290w; or [1043] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ygr290w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ygr290w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1044] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "ygr290w-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1045] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "ygr290w-protein", is
increased cytoplasmic.
[1046] The sequence of Yhl021c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
yhl021c-protein.
[1047] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "yhl021c-protein"from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1048] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Yhl021c or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Yhl021c; or [1049] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Yhl021c or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Yhl021c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1050] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "yhl021c-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1051] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "yhl021c-protein", is
increased cytoplasmic.
[1052] The sequence of Yhl031c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
v-SNARE protein involved in Golgi transport.
[1053] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "v-SNARE protein involved in Golgi
transport" from Saccharomyces cerevisiae or its functional
equivalent or its homolog, e.g. the increase of [1054] (a) a gene
product of a gene comprising the nucleic acid molecule as shown in
column 5 of table I, application no. 1, and being depicted in the
same respective line as said Yhl031c or a functional equivalent or
a homologue thereof as shown in column 7 of table I, application
no. 1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Yhl031c; or [1055] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yhl031c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yhl031c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1056] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "v-SNARE protein
involved in Golgi transport", preferably it is the molecule of
section (a) or (b) of this paragraph.
[1057] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "v-SNARE protein
involved in Golgi transport", is increased cytoplasmic.
[1058] The sequence of Yhr011w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
mitochondrial seryl-tRNA synthetase.
[1059] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "mitochondrial seryl-tRNA
synthetase" from Saccharomyces cerevisiae or its functional
equivalent or its homolog, e.g. the increase of [1060] (a) a gene
product of a gene comprising the nucleic acid molecule as shown in
column 5 of table I, application no. 1, and being depicted in the
same respective line as said Yhr011w or a functional equivalent or
a homologue thereof as shown in column 7 of table I, application
no. 1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Yhr011w; or [1061] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yhr011w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yhr011w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1062] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "mitochondrial
seryl-tRNA synthetase", preferably it is the molecule of section
(a) or (b) of this paragraph.
[1063] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "mitochondrial
seryl-tRNA synthetase", is increased cytoplasmic.
[1064] The sequence of Yhr127w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
yhr127w-protein.
[1065] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "yhr127w-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1066] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Yhr127w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Yhr127w; or [1067] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Yhr127w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Yhr127w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1068] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "yhr127w-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1069] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "yhr127w-protein", is
increased cytoplasmic.
[1070] The sequence of Yhr137w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
aromatic amino acid aminotransferase II.
[1071] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "aromatic amino acid
aminotransferase II" from Saccharomyces cerevisiae or its
functional equivalent or its homolog, e.g. the increase of [1072]
(a) a gene product of a gene comprising the nucleic acid molecule
as shown in column 5 of table I, application no. 1, and being
depicted in the same respective line as said Yhr137w or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said Yhr137w; or
[1073] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said Yhr137w or a
functional equivalent or a homologue thereof as depicted in column
7 of table II, application no. 1, preferably a homologue or
functional equivalent as depicted in column 7 of table II B,
application no. 1, and being depicted in the same respective line
as said Yhr137w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1074] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "aromatic amino acid
aminotransferase II", preferably it is the molecule of section (a)
or (b) of this paragraph.
[1075] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "aromatic amino acid
aminotransferase II", is increased cytoplasmic.
[1076] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "aromatic amino acid
aminotransferase II", is increased plastidic.
[1077] The sequence of Yil099w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
glucoamylase.
[1078] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "glucoamylase" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1079] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Yil099w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Yil099w; or [1080] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Yil099w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Yil099w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1081] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "glucoamylase",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1082] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "glucoamylase", is
increased cytoplasmic.
[1083] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "glucoamylase", is
increased plastidic.
[1084] The sequence of Yil147c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
histidine kinase osmosensor that regulates an osmosensing MAP
kinase cascade.
[1085] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "histidine kinase osmosensor that
regulates an osmosensing MAP kinase cascade" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1086] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Yil147c or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Yil147c; or [1087] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Yil147c or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Yil147c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1088] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "histidine kinase
osmosensor that regulates an osmosensing MAP kinase cascade",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1089] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "histidine kinase
osmosensor that regulates an osmosensing MAP kinase cascade", is
increased cytoplasmic.
[1090] The sequence of Yir034c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
saccharopine dehydrogenase.
[1091] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "saccharopine dehydrogenase" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1092] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Yir034c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Yir034c; or [1093] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yir034c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yir034c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1094] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "saccharopine
dehydrogenase", preferably it is the molecule of section (a) or (b)
of this paragraph.
[1095] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "saccharopine
dehydrogenase", is increased cytoplasmic.
[1096] The sequence of Yjl013c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
spindle checkpoint complex subunit.
[1097] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "spindle checkpoint complex subunit"
from Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1098] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Yjl013c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Yjl013c; or [1099] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yjl013c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yjl013c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1100] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "spindle checkpoint
complex subunit", preferably it is the molecule of section (a) or
(b) of this paragraph.
[1101] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "spindle checkpoint
complex subunit", is increased cytoplasmic.
[1102] The sequence of Yjl041w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
nuclear pore complex subunit.
[1103] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "nuclear pore complex subunit" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1104] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Yjl041w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Yjl041w; or [1105] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yjl041w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yjl041w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1106] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "nuclear pore complex
subunit", preferably it is the molecule of section (a) or (b) of
this paragraph.
[1107] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "nuclear pore complex
subunit", is increased cytoplasmic.
[1108] The sequence of Yjl064w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
yjl064w-protein.
[1109] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "yjl064w-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1110] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Yjl064w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Yjl064w; or [1111] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Yjl064w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Yjl064w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1112] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "yjl064w-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1113] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "yjl064w-protein", is
increased cytoplasmic.
[1114] The sequence of Yjl067w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
yjl067w-protein.
[1115] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "yjl067w-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1116] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Yjl067w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Yjl067w; or [1117] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Yjl067w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Yjl067w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1118] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "yjl067w-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1119] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "yjl067w-protein", is
increased cytoplasmic.
[1120] The sequence of Yjl094c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
potassium:hydrogen antiporter.
[1121] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "potassium:hydrogen antiporter" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1122] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Yjl094c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Yjl094c; or [1123] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yjl094c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yjl094c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1124] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "potassium:hydrogen
antiporter", preferably it is the molecule of section (a) or (b) of
this paragraph.
[1125] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "potassium:hydrogen
antiporter", is increased cytoplasmic.
[1126] The sequence of Yjl171c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
GPI-anchored cell wall protein.
[1127] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "GPI-anchored cell wall protein"
from Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1128] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Yjl171c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Yjl171c; or [1129] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yjl171c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yjl171c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1130] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "GPI-anchored cell wall
protein", preferably it is the molecule of section (a) or (b) of
this paragraph.
[1131] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "GPI-anchored cell wall
protein", is increased cytoplasmic.
[1132] The sequence of Yjl213w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
yjl213w-protein.
[1133] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "yjl213w-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1134] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Yjl213w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Yjl213w; or [1135] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Yjl213w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Yjl213w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1136] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "yjl213w-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1137] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "yjl213w-protein", is
increased cytoplasmic.
[1138] The sequence of Yjr017c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
peptidyl-prolyl cis-trans isomerase.
[1139] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "peptidyl-prolyl cis-trans
isomerase" from Saccharomyces cerevisiae or its functional
equivalent or its homolog, e.g. the increase of [1140] (a) a gene
product of a gene comprising the nucleic acid molecule as shown in
column 5 of table I, application no. 1, and being depicted in the
same respective line as said Yjr017c or a functional equivalent or
a homologue thereof as shown in column 7 of table I, application
no. 1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Yjr017c; or [1141] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yjr017c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yjr017c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1142] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "peptidyl-prolyl
cis-trans isomerase", preferably it is the molecule of section (a)
or (b) of this paragraph.
[1143] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "peptidyl-prolyl
cis-trans isomerase", is increased cytoplasmic.
[1144] The sequence of Yjr058c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
clathrin associated protein complex small subunit.
[1145] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "clathrin associated protein complex
small subunit" from Saccharomyces cerevisiae or its functional
equivalent or its homolog, e.g. the increase of [1146] (a) a gene
product of a gene comprising the nucleic acid molecule as shown in
column 5 of table I, application no. 1, and being depicted in the
same respective line as said Yjr058c or a functional equivalent or
a homologue thereof as shown in column 7 of table I, application
no. 1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Yjr058c; or [1147] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yjr058c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yjr058c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1148] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "clathrin associated
protein complex small subunit", preferably it is the molecule of
section (a) or (b) of this paragraph.
[1149] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "clathrin associated
protein complex small subunit", is increased cytoplasmic.
[1150] The sequence of Yjr117w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as zinc
metalloprotease.
[1151] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "zinc metalloprotease" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1152] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Yjr117w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Yjr117w; or [1153] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yjr117w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yjr117w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1154] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "zinc metalloprotease",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1155] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "zinc metalloprotease",
is increased cytoplasmic.
[1156] The sequence of Yjr121w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as F1F0
ATP synthase beta subunit.
[1157] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "F1F0 ATP synthase beta subunit"
from Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1158] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Yjr121w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Yjr121w; or [1159] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yjr121w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yjr121w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1160] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "F1F0 ATP synthase beta
subunit", preferably it is the molecule of section (a) or (b) of
this paragraph.
[1161] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "F1F0 ATP synthase beta
subunit", is increased cytoplasmic.
[1162] The sequence of Yjr131w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
alpha-mannosidase.
[1163] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "alpha-mannosidase" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1164] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Yjr131w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Yjr131w; or [1165] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yjr131w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yjr131w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1166] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "alpha-mannosidase",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1167] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "alpha-mannosidase", is
increased cytoplasmic.
[1168] The sequence of Yjr145c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
ribosomal protein of the small subunit.
[1169] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "ribosomal protein of the small
subunit" from Saccharomyces cerevisiae or its functional equivalent
or its homolog, e.g. the increase of [1170] (a) a gene product of a
gene comprising the nucleic acid molecule as shown in column 5 of
table I, application no. 1, and being depicted in the same
respective line as said Yjr145c or a functional equivalent or a
homologue thereof as shown in column 7 of table I, application no.
1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Yjr145c; or [1171] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yjr145c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yjr145c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1172] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "ribosomal protein of
the small subunit", preferably it is the molecule of section (a) or
(b) of this paragraph.
[1173] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "ribosomal protein of
the small subunit", is increased cytoplasmic.
[1174] The sequence of Ykl084w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
mitochondrial intermembrane space protein.
[1175] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "mitochondrial intermembrane space
protein" from Saccharomyces cerevisiae or its functional equivalent
or its homolog, e.g. the increase of [1176] (a) a gene product of a
gene comprising the nucleic acid molecule as shown in column 5 of
table I, application no. 1, and being depicted in the same
respective line as said Ykl084w or a functional equivalent or a
homologue thereof as shown in column 7 of table I, application no.
1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Ykl084w; or [1177] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ykl084w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ykl084w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1178] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "mitochondrial
intermembrane space protein", preferably it is the molecule of
section (a) or (b) of this paragraph.
[1179] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "mitochondrial
intermembrane space protein", is increased cytoplasmic.
[1180] The sequence of Ykl088w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
phosphopantothenoylcysteine decarboxylase.
[1181] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "phosphopantothenoylcysteine
decarboxylase" from Saccharomyces cerevisiae or its functional
equivalent or its homolog, e.g. the increase of [1182] (a) a gene
product of a gene comprising the nucleic acid molecule as shown in
column 5 of table I, application no. 1, and being depicted in the
same respective line as said Ykl088w or a functional equivalent or
a homologue thereof as shown in column 7 of table I, application
no. 1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Ykl088w; or [1183] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ykl088w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ykl088w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1184] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a
"phosphopantothenoylcysteine decarboxylase", preferably it is the
molecule of section (a) or (b) of this paragraph.
[1185] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a
"phosphopantothenoylcysteine decarboxylase", is increased
cytoplasmic.
[1186] The sequence of Ykl100c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
ykl100c-protein.
[1187] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "ykl100c-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1188] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ykl100c or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ykl100c; or [1189] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ykl100c or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ykl100c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1190] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "ykl100c-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1191] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "ykl100c-protein", is
increased cytoplasmic.
[1192] The sequence of Ykl131w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
ykl131w-protein.
[1193] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "ykl131w-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1194] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ykl131w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ykl131w; or [1195] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ykl131w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ykl131w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1196] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "ykl131w-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1197] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "ykl131w-protein", is
increased cytoplasmic.
[1198] The sequence of Ykl138c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
mitochondrial ribosomal protein of the large subunit.
[1199] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "mitochondrial ribosomal protein of
the large subunit" from Saccharomyces cerevisiae or its functional
equivalent or its homolog, e.g. the increase of [1200] (a) a gene
product of a gene comprising the nucleic acid molecule as shown in
column 5 of table I, application no. 1, and being depicted in the
same respective line as said Ykl138c or a functional equivalent or
a homologue thereof as shown in column 7 of table I, application
no. 1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Ykl138c; or [1201] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ykl138c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ykl138c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1202] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "mitochondrial ribosomal
protein of the large subunit", preferably it is the molecule of
section (a) or (b) of this paragraph.
[1203] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "mitochondrial ribosomal
protein of the large subunit", is increased cytoplasmic.
[1204] The sequence of Ykl178c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as G
protein coupled pheromone receptor receptor.
[1205] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "G protein coupled pheromone
receptor receptor" from Saccharomyces cerevisiae or its functional
equivalent or its homolog, e.g. the increase of [1206] (a) a gene
product of a gene comprising the nucleic acid molecule as shown in
column 5 of table I, application no. 1, and being depicted in the
same respective line as said Ykl178c or a functional equivalent or
a homologue thereof as shown in column 7 of table I, application
no. 1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Ykl178c; or [1207] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ykl178c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ykl178c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1208] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "G protein coupled
pheromone receptor receptor", preferably it is the molecule of
section (a) or (b) of this paragraph.
[1209] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "G protein coupled
pheromone receptor receptor", is increased cytoplasmic.
[1210] The sequence of Ykl179c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as golgi
membrane protein.
[1211] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "golgi membrane protein" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1212] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ykl179c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ykl179c; or [1213] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ykl179c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ykl179c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1214] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "golgi membrane
protein", preferably it is the molecule of section (a) or (b) of
this paragraph.
[1215] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "golgi membrane
protein", is increased cytoplasmic.
[1216] The sequence of Ykl193c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
regulatory subunit of Glc7p type 1 protein serine-threonine
phosphatase.
[1217] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "regulatory subunit of Glc7p type 1
protein serine-threonine phosphatase" from Saccharomyces cerevisiae
or its functional equivalent or its homolog, e.g. the increase of
[1218] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said Ykl193c or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said Ykl193c; or
[1219] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said Ykl193c or a
functional equivalent or a homologue thereof as depicted in column
7 of table II, application no. 1, preferably a homologue or
functional equivalent as depicted in column 7 of table II B,
application no. 1, and being depicted in the same respective line
as said Ykl193c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1220] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "regulatory subunit of
Glc7p type 1 protein serine-threonine phosphatase", preferably it
is the molecule of section (a) or (b) of this paragraph.
[1221] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "regulatory subunit of
Glc7p type 1 protein serine-threonine phosphatase", is increased
cytoplasmic.
[1222] The sequence of Ykl216w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
dihydroorotate dehydrogenase.
[1223] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "dihydroorotate dehydrogenase" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1224] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ykl216w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ykl216w; or [1225] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ykl216w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ykl216w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1226] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "dihydroorotate
dehydrogenase", preferably it is the molecule of section (a) or (b)
of this paragraph.
[1227] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "dihydroorotate
dehydrogenase", is increased cytoplasmic.
[1228] The sequence of Ykr016w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
ykr016w-protein.
[1229] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "ykr016w-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1230] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ykr016w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ykr016w; or [1231] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ykr016w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ykr016w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1232] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "ykr016w-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1233] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "ykr016w-protein", is
increased cytoplasmic.
[1234] The sequence of Ykr021w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
ykr021w-protein.
[1235] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "ykr021w-protein"from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1236] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ykr021w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ykr021w; or [1237] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ykr021w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ykr021w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1238] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "ykr021w-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1239] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "ykr021w-protein", is
increased cytoplasmic.
[1240] The sequence of Ykr055w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
non-essential small GTPase of the Rho/Rac subfamily of Ras-like
proteins.
[1241] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "non-essential small GTPase of the
Rho/Rac subfamily of Ras-like proteins" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1242] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ykr055w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ykr055w; or [1243] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ykr055w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ykr055w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1244] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "non-essential small
GTPase of the Rho/Rac subfamily of Ras-like proteins", preferably
it is the molecule of section (a) or (b) of this paragraph.
[1245] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "non-essential small
GTPase of the Rho/Rac subfamily of Ras-like proteins", is increased
cytoplasmic.
[1246] The sequence of Ykr088c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
integral membrane protein localized to late Golgi vesicles.
[1247] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "integral membrane protein localized
to late Golgi vesicles" from Saccharomyces cerevisiae or its
functional equivalent or its homolog, e.g. the increase of [1248]
(a) a gene product of a gene comprising the nucleic acid molecule
as shown in column 5 of table I, application no. 1, and being
depicted in the same respective line as said Ykr088c or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said Ykr088c; or
[1249] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said Ykr088c or a
functional equivalent or a homologue thereof as depicted in column
7 of table II, application no. 1, preferably a homologue or
functional equivalent as depicted in column 7 of table II B,
application no. 1, and being depicted in the same respective line
as said Ykr088c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1250] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "integral membrane
protein localized to late Golgi vesicles", preferably it is the
molecule of section (a) or (b) of this paragraph.
[1251] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "integral membrane
protein localized to late Golgi vesicles", is increased
plastidic.
[1252] The sequence of Ykr093w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
peptide transporter.
[1253] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "peptide transporter" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1254] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ykr093w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ykr093w; or [1255] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ykr093w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ykr093w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1256] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "peptide transporter",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1257] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "peptide transporter",
is increased cytoplasmic.
[1258] The sequence of Ykr099w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
transcription factor.
[1259] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "transcription factor" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1260] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ykr099w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ykr099w; or [1261] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ykr099w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ykr099w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1262] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "transcription factor",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1263] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "transcription factor",
is increased cytoplasmic.
[1264] The sequence of Ykr100c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
transmembrane protein with a role in cell wall polymer
composition.
[1265] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "transmembrane protein with a role
in cell wall polymer composition" from Saccharomyces cerevisiae or
its functional equivalent or its homolog, e.g. the increase of
[1266] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said Ykr100c or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said Ykr100c; or
[1267] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said Ykr100c or a
functional equivalent or a homologue thereof as depicted in column
7 of table II, application no. 1, preferably a homologue or
functional equivalent as depicted in column 7 of table II B,
application no. 1, and being depicted in the same respective line
as said Ykr100c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1268] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "transmembrane protein
with a role in cell wall polymer composition", preferably it is the
molecule of section (a) or (b) of this paragraph.
[1269] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "transmembrane protein
with a role in cell wall polymer composition", is increased
cytoplasmic.
[1270] The sequence of Yll014w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
yll014w-protein.
[1271] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "yll014w-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1272] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Yll014w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Yll014w; or [1273] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Yll014w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Yll014w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1274] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "yll014w-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1275] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "yll014w-protein", is
increased cytoplasmic.
[1276] The sequence of Yll016w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
non-essential Ras guanine nucleotide exchange factor.
[1277] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "non-essential Ras guanine
nucleotide exchange factor" from Saccharomyces cerevisiae or its
functional equivalent or its homolog, e.g. the increase of [1278]
(a) a gene product of a gene comprising the nucleic acid molecule
as shown in column 5 of table I, application no. 1, and being
depicted in the same respective line as said Yll016w or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said Yll016w; or
[1279] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said Yll016w or a
functional equivalent or a homologue thereof as depicted in column
7 of table II, application no. 1, preferably a homologue or
functional equivalent as depicted in column 7 of table II B,
application no. 1, and being depicted in the same respective line
as said Yll016w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1280] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "non-essential Ras
guanine nucleotide exchange factor", preferably it is the molecule
of section (a) or (b) of this paragraph.
[1281] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "non-essential Ras
guanine nucleotide exchange factor", is increased cytoplasmic.
[1282] The sequence of Yll023c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
yll023c-protein.
[1283] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "yll023c-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1284] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Yll023c or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Yll023c; or [1285] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Yll023c or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Yll023c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1286] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "yll023c-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1287] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "yll023c-protein", is
increased cytoplasmic.
[1288] The sequence of Yll037w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
yll037w-protein.
[1289] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "yll037w-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1290] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Yll037w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Yll037w; or [1291] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Yll037w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Yll037w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1292] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "yll037w-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1293] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "yll037w-protein", is
increased cytoplasmic.
[1294] The sequence of Yll049w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
yll049w-protein.
[1295] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "yll049w-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1296] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Yll049w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Yll049w; or [1297] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Yll049w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Yll049w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1298] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "yll049w-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1299] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "yll049w-protein", is
increased cytoplasmic.
[1300] The sequence of Yll055w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
cysteine transporter.
[1301] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "cysteine transporter" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1302] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Yll055w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Yll055w; or [1303] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yll055w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yll055w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1304] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "cysteine transporter",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1305] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "cysteine transporter",
is increased cytoplasmic.
[1306] The sequence of Ylr034c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as metal
ion transporter.
[1307] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "metal ion transporter" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1308] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ylr034c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ylr034c; or [1309] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ylr034c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ylr034c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1310] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "metal ion transporter",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1311] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "metal ion transporter",
is increased cytoplasmic.
[1312] The sequence of Ylr042c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
ylr042c-protein.
[1313] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "ylr042c-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1314] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ylr042c or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ylr042c; or [1315] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ylr042c or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ylr042c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1316] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "ylr042c-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1317] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "ylr042c-protein", is
increased cytoplasmic.
[1318] The sequence of Ylr053c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
YLR053c-protein.
[1319] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "YLR053c-- protein" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1320] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ylr053c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ylr053c; or [1321] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ylr053c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ylr053c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1322] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "YLR053c-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1323] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "YLR053c-protein", is
increased cytoplasmic.
[1324] The sequence of Ylr058c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
cytosolic serine hydroxymethyltransferase.
[1325] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "cytosolic serine
hydroxymethyltransferase" from Saccharomyces cerevisiae or its
functional equivalent or its homolog, e.g. the increase of [1326]
(a) a gene product of a gene comprising the nucleic acid molecule
as shown in column 5 of table I, application no. 1, and being
depicted in the same respective line as said Ylr058c or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said Ylr058c; or
[1327] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said Ylr058c or a
functional equivalent or a homologue thereof as depicted in column
7 of table II, application no. 1, preferably a homologue or
functional equivalent as depicted in column 7 of table II B,
application no. 1, and being depicted in the same respective line
as said Ylr058c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1328] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "cytosolic serine
hydroxymethyltransferase", preferably it is the molecule of section
(a) or (b) of this paragraph.
[1329] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "cytosolic serine
hydroxymethyltransferase", is increased cytoplasmic.
[1330] The sequence of Ylr060w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
subunit of cytoplasmic phenylalanyl-tRNA synthetase.
[1331] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "subunit of cytoplasmic
phenylalanyl-tRNA synthetase" from Saccharomyces cerevisiae or its
functional equivalent or its homolog, e.g. the increase of [1332]
(a) a gene product of a gene comprising the nucleic acid molecule
as shown in column 5 of table I, application no. 1, and being
depicted in the same respective line as said Ylr060w or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said Ylr060w; or
[1333] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said Ylr060w or a
functional equivalent or a homologue thereof as depicted in column
7 of table II, application no. 1, preferably a homologue or
functional equivalent as depicted in column 7 of table II B,
application no. 1, and being depicted in the same respective line
as said Ylr060w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1334] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "subunit of cytoplasmic
phenylalanyl-tRNA synthetase", preferably it is the molecule of
section (a) or (b) of this paragraph.
[1335] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "subunit of cytoplasmic
phenylalanyl-tRNA synthetase", is increased cytoplasmic.
[1336] The sequence of Ylr065c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
ylr065c-protein.
[1337] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "ylr065c-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1338] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ylr065c or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ylr065c; or [1339] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ylr065c or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ylr065c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1340] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "ylr065c-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1341] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "ylr065c-protein", is
increased cytoplasmic.
[1342] The sequence of Ylr070c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
xylitol dehydrogenase.
[1343] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "xylitol dehydrogenase"from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1344] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ylr070c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ylr070c; or [1345] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ylr070c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ylr070c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1346] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "xylitol dehydrogenase",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1347] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "xylitol dehydrogenase",
is increased cytoplasmic.
[1348] The sequence of Ylr100w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
3-keto sterol reductase.
[1349] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "3-keto sterol reductase" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1350] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ylr100w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ylr100w; or [1351] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ylr100w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ylr100w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1352] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "3-keto sterol
reductase", preferably it is the molecule of section (a) or (b) of
this paragraph.
[1353] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "3-keto sterol
reductase", is increased cytoplasmic.
[1354] The sequence of Ylr109w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as alkyl
hydroperoxide reductase.
[1355] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "alkyl hydroperoxide reductase" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1356] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ylr109w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ylr109w; or [1357] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ylr109w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ylr109w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1358] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "alkyl hydroperoxide
reductase", preferably it is the molecule of section (a) or (b) of
this paragraph.
[1359] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "alkyl hydroperoxide
reductase", is increased cytoplasmic.
[1360] The sequence of Ylr125w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
ylr125w-protein.
[1361] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "ylr125w-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1362] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ylr125w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ylr125w; or [1363] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ylr125w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ylr125w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1364] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "ylr125w-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1365] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "ylr125w-protein", is
increased cytoplasmic.
[1366] The sequence of Ylr127c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
anaphase promoting complex (APC) subunit.
[1367] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "anaphase promoting complex (APC)
subunit" from Saccharomyces cerevisiae or its functional equivalent
or its homolog, e.g. the increase of [1368] (a) a gene product of a
gene comprising the nucleic acid molecule as shown in column 5 of
table I, application no. 1, and being depicted in the same
respective line as said Ylr127c or a functional equivalent or a
homologue thereof as shown in column 7 of table I, application no.
1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Ylr127c; or [1369] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ylr127c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ylr127c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1370] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "anaphase promoting
complex (APC) subunit", preferably it is the molecule of section
(a) or (b) of this paragraph.
[1371] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "anaphase promoting
complex (APC) subunit", is increased cytoplasmic.
[1372] The sequence of Ylr185w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
protein component of the large ribosomal subunit.
[1373] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "protein component of the large
ribosomal subunit" from Saccharomyces cerevisiae or its functional
equivalent or its homolog, e.g. the increase of [1374] (a) a gene
product of a gene comprising the nucleic acid molecule as shown in
column 5 of table I, application no. 1, and being depicted in the
same respective line as said Ylr185w or a functional equivalent or
a homologue thereof as shown in column 7 of table I, application
no. 1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Ylr185w; or [1375] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ylr185w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ylr185w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1376] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "protein component of
the large ribosomal subunit", preferably it is the molecule of
section (a) or (b) of this paragraph.
[1377] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "protein component of
the large ribosomal subunit", is increased cytoplasmic.
[1378] The sequence of Ylr204w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
mitochondrial protein.
[1379] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "mitochondrial protein" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1380] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ylr204w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ylr204w; or [1381] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ylr204w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ylr204w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1382] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "mitochondrial protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1383] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "mitochondrial protein",
is increased cytoplasmic.
[1384] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "mitochondrial protein",
is increased plastidic.
[1385] The sequence of Ylr242c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as ARV1
protein.
[1386] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "ARV1 protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1387] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ylr242c or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ylr242c; or [1388] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ylr242c or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ylr242c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1389] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "ARV1 protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1390] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "ARV1 protein", is
increased cytoplasmic.
[1391] The sequence of Ylr293c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
GTP-binding protein.
[1392] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "GTP-binding protein" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1393] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ylr293c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ylr293c; or [1394] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ylr293c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ylr293c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1395] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "GTP-binding protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1396] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "GTP-binding protein",
is increased cytoplasmic.
[1397] The sequence of Ylr313c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
protein involved in shmoo formation and bipolar bud site
selection.
[1398] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "protein involved in shmoo formation
and bipolar bud site selection" from Saccharomyces cerevisiae or
its functional equivalent or its homolog, e.g. the increase of
[1399] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said Ylr313c or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said Ylr313c; or
[1400] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said Ylr313c or a
functional equivalent or a homologue thereof as depicted in column
7 of table II, application no. 1, preferably a homologue or
functional equivalent as depicted in column 7 of table II B,
application no. 1, and being depicted in the same respective line
as said Ylr313c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1401] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "protein involved in
shmoo formation and bipolar bud site selection", preferably it is
the molecule of section (a) or (b) of this paragraph.
[1402] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "protein involved in
shmoo formation and bipolar bud site selection", is increased
cytoplasmic.
[1403] The sequence of Ylr315w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
non-essential kinetochore protein.
[1404] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "non-essential kinetochore protein"
from Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1405] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ylr315w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ylr315w; or [1406] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ylr315w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ylr315w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1407] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "non-essential
kinetochore protein", preferably it is the molecule of section (a)
or (b) of this paragraph.
[1408] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "non-essential
kinetochore protein", is increased cytoplasmic.
[1409] The sequence of Ylr329w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
Meiotic recombination protein.
[1410] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "Meiotic recombination protein" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1411] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ylr329w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ylr329w; or [1412] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ylr329w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ylr329w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1413] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "Meiotic recombination
protein", preferably it is the molecule of section (a) or (b) of
this paragraph.
[1414] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "Meiotic recombination
protein", is increased cytoplasmic.
[1415] The sequence of Ylr362w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
signal transducing MEK kinase.
[1416] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "signal transducing MEK kinase" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1417] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ylr362w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ylr362w; or [1418] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ylr362w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ylr362w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1419] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "signal transducing MEK
kinase", preferably it is the molecule of section (a) or (b) of
this paragraph.
[1420] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "signal transducing MEK
kinase", is increased cytoplasmic.
[1421] The sequence of Ylr395c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
cytochrome c oxidase subunit VIII.
[1422] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "cytochrome c oxidase subunit VIII"
from Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1423] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ylr395c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ylr395c; or [1424] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ylr395c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ylr395c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1425] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "cytochrome c oxidase
subunit VIII", preferably it is the molecule of section (a) or (b)
of this paragraph.
[1426] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "cytochrome c oxidase
subunit VIII", is increased cytoplasmic.
[1427] The sequence of Ylr404w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
ylr404w-protein.
[1428] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "ylr404w-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1429] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ylr404w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ylr404w; or [1430] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ylr404w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ylr404w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1431] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "ylr404w-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1432] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "ylr404w-protein", is
increased cytoplasmic.
[1433] The sequence of Ylr463c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
ylr463c-protein.
[1434] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "ylr463c-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1435] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ylr463c or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ylr463c; or [1436] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ylr463c or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ylr463c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1437] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "ylr463c-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1438] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "ylr463c-protein", is
increased cytoplasmic.
[1439] The sequence of Yml022w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
adenine phosphoribosyltransferase.
[1440] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "adenine phosphoribosyltransferase"
from Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1441] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Yml022w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Yml022w; or [1442] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yml022w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yml022w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1443] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "adenine
phosphoribosyltransferase", preferably it is the molecule of
section (a) or (b) of this paragraph.
[1444] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "adenine
phosphoribosyltransferase", is increased cytoplasmic.
[1445] The sequence of Yml027w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as Mcm1p
binding transcriptional repressor.
[1446] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "Mcm1p binding transcriptional
repressor" from Saccharomyces cerevisiae or its functional
equivalent or its homolog, e.g. the increase of [1447] (a) a gene
product of a gene comprising the nucleic acid molecule as shown in
column 5 of table I, application no. 1, and being depicted in the
same respective line as said Yml027w or a functional equivalent or
a homologue thereof as shown in column 7 of table I, application
no. 1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Yml027w; or [1448] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yml027w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yml027w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1449] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "Mcm1p binding
transcriptional repressor", preferably it is the molecule of
section (a) or (b) of this paragraph.
[1450] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "Mcm1p binding
transcriptional repressor", is increased cytoplasmic.
[1451] The sequence of Yml065w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
origin recognition complex subunit.
[1452] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "origin recognition complex subunit"
from Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1453] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Yml065w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Yml065w; or [1454] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yml065w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yml065w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1455] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "origin recognition
complex subunit", preferably it is the molecule of section (a) or
(b) of this paragraph.
[1456] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "origin recognition
complex subunit", is increased cytoplasmic.
[1457] The sequence of Yml089c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
yml089c-protein.
[1458] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "yml089c-protein"from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1459] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Yml089c or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Yml089c; or [1460] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Yml089c or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Yml089c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1461] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "yml089c-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1462] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "yml089c-protein", is
increased cytoplasmic.
[1463] The sequence of Yml128c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
yml128c-protein.
[1464] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "yml128c-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1465] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Yml128c or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Yml128c; or [1466] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Yml128c or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Yml128c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1467] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "yml128c-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1468] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "yml128c-protein", is
increased cytoplasmic.
[1469] The sequence of Ymr011w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
hexose transporter.
[1470] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "hexose transporter" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1471] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ymr011w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ymr011w; or [1472] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ymr011w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ymr011w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1473] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "hexose transporter",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1474] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "hexose transporter", is
increased cytoplasmic.
[1475] The sequence of Ymr037c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as Zinc
finger protein.
[1476] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "Zinc finger protein" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1477] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ymr037c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ymr037c; or [1478] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ymr037c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ymr037c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1479] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "Zinc finger protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1480] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "Zinc finger protein",
is increased cytoplasmic.
[1481] The sequence of Ymr049c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
protein required for maturation of ribosomal RNAs.
[1482] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "protein required for maturation of
ribosomal RNAs" from Saccharomyces cerevisiae or its functional
equivalent or its homolog, e.g. the increase of [1483] (a) a gene
product of a gene comprising the nucleic acid molecule as shown in
column 5 of table I, application no. 1, and being depicted in the
same respective line as said Ymr049c or a functional equivalent or
a homologue thereof as shown in column 7 of table I, application
no. 1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Ymr049c; or [1484] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ymr049c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ymr049c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1485] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "protein required for
maturation of ribosomal RNAs", preferably it is the molecule of
section (a) or (b) of this paragraph.
[1486] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "protein required for
maturation of ribosomal RNAs", is increased cytoplasmic.
[1487] The sequence of Ymr052w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
Factor arrest protein.
[1488] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "Factor arrest protein" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1489] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ymr052w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ymr052w; or [1490] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ymr052w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ymr052w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1491] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "Factor arrest protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1492] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "Factor arrest protein",
is increased cytoplasmic.
[1493] The sequence of Ymr082c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
YMR082C-protein.
[1494] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "YMR082c-- protein" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1495] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ymr082c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ymr082c; or [1496] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ymr082c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ymr082c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1497] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "YMR082C-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1498] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "YMR082C-protein", is
increased cytoplasmic.
[1499] The sequence of YMR125W from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
Nuclear cap-binding protein complex subunit.
[1500] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "Nuclear cap-binding protein complex
subunit" from Saccharomyces cerevisiae or its functional equivalent
or its homolog, e.g. the increase of [1501] (a) a gene product of a
gene comprising the nucleic acid molecule as shown in column 5 of
table I, application no. 1, and being depicted in the same
respective line as said YMR125W or a functional equivalent or a
homologue thereof as shown in column 7 of table I, application no.
1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said YMR125W; or [1502] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said YMR125W or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said YMR125W, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1503] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "Nuclear cap-binding
protein complex subunit", preferably it is the molecule of section
(a) or (b) of this paragraph.
[1504] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "Nuclear cap-binding
protein complex subunit", is increased cytoplasmic.
[1505] The sequence of Ymr126c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
YMR126c membrane protein.
[1506] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "YMR126c membrane protein" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1507] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ymr126c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ymr126c; or [1508] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ymr126c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ymr126c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1509] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "YMR126c membrane
protein", preferably it is the molecule of section (a) or (b) of
this paragraph.
[1510] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "YMR126c membrane
protein", is increased cytoplasmic.
[1511] The sequence of Ymr144w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
YMR144W-protein.
[1512] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "YMR144W-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1513] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ymr144w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ymr144w; or [1514] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ymr144w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ymr144w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1515] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "YMR144W-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1516] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "YMR144W-protein", is
increased cytoplasmic.
[1517] The sequence of Ymr160w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
YMR160W-protein.
[1518] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "YMR160W-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1519] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ymr160w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ymr160w; or [1520] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, and being depicted in the same respective line as said Ymr160w
or a functional equivalent or a homologue thereof as depicted in
column 7 of table II, application no. 1, preferably a homologue or
functional equivalent as depicted in column 7 of table II B,
application no. 1, and being depicted in the same respective line
as said Ymr160w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1521] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "YMR160W-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1522] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "YMR160W-protein", is
increased cytoplasmic.
[1523] The sequence of Ymr191w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
Stationary phase protein.
[1524] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "Stationary phase protein" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1525] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ymr191w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ymr191w; or [1526] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ymr191w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ymr191w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1527] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "Stationary phase
protein", preferably it is the molecule of section (a) or (b) of
this paragraph.
[1528] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "Stationary phase
protein", is increased cytoplasmic.
[1529] The sequence of Ymr209c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
YMR209C-protein.
[1530] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "YMR209C-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1531] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ymr209c or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ymr209c; or [1532] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ymr209c or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ymr209c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1533] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "YMR209C-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1534] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "YMR209C-protein", is
increased cytoplasmic.
[1535] The sequence of Ymr233w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
YMR233W-protein.
[1536] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "YMR233W-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1537] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ymr233w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ymr233w; or [1538] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ymr233w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ymr233w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1539] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "YMR233W-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1540] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "YMR233W-protein", is
increased cytoplasmic.
[1541] The sequence of Ymr278w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
phosphoglucomutase/phosphomannomutase.
[1542] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a
"phosphoglucomutase/phosphomannomutase" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1543] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ymr278w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ymr278w; or [1544] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ymr278w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ymr278w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1545] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a
"phosphoglucomutase/phosphomannomutase", preferably it is the
molecule of section (a) or (b) of this paragraph.
[1546] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a
"phosphoglucomutase/phosphomannomutase", is increased
cytoplasmic.
[1547] The sequence of Ymr280c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
Regulatory CAT8 protein.
[1548] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "Regulatory CAT8 protein" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1549] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ymr280c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ymr280c; or [1550] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ymr280c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ymr280c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1551] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "Regulatory CAT8
protein", preferably it is the molecule of section (a) or (b) of
this paragraph.
[1552] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "Regulatory CAT8
protein", is increased cytoplasmic.
[1553] The sequence of Ynl014w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
translational elongation factor EF-3 (HEF3).
[1554] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "translational elongation factor
EF-3 (HEF3)" from Saccharomyces cerevisiae or its functional
equivalent or its homolog, e.g. the increase of [1555] (a) a gene
product of a gene comprising the nucleic acid molecule as shown in
column 5 of table I, application no. 1, and being depicted in the
same respective line as said Ynl014w or a functional equivalent or
a homologue thereof as shown in column 7 of table I, application
no. 1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Ynl014w; or [1556] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ynl014w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ynl014w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1557] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "translational
elongation factor EF-3 (HEF3)", preferably it is the molecule of
section (a) or (b) of this paragraph.
[1558] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "translational
elongation factor EF-3 (HEF3)", is increased cytoplasmic.
[1559] The sequence of Ynl320w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
YNL320W-protein.
[1560] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "YNL320W-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1561] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ynl320w or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ynl320w; or [1562] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ynl320w or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ynl320w, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1563] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "YNL320W-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1564] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "YNL320W-protein", is
increased cytoplasmic.
[1565] The sequence of Yol007c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
Chitin synthase 3 complex protein.
[1566] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "Chitin synthase 3 complex protein"
from Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1567] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Yol007c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Yol007c; or [1568] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yol007c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yol007c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1569] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "Chitin synthase 3
complex protein", preferably it is the molecule of section (a) or
(b) of this paragraph.
[1570] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "Chitin synthase 3
complex protein", is increased cytoplasmic.
[1571] The sequence of Yol164w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
Alkyl/aryl-sulfatase.
[1572] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "Alkyl/aryl-sulfatase" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1573] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Yol164w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Yol164w; or [1574] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yol164w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yol164w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1575] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "Alkyl/aryl-sulfatase",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1576] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "Alkyl/aryl-sulfatase",
is increased cytoplasmic.
[1577] The sequence of Yor076c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
antiviral adaptor protein.
[1578] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "antiviral adaptor protein" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1579] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Yor076c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Yor076c; or [1580] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yor076c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yor076c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1581] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "antiviral adaptor
protein", preferably it is the molecule of section (a) or (b) of
this paragraph.
[1582] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "antiviral adaptor
protein", is increased cytoplasmic.
[1583] The sequence of Yor083w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
repressor of G1 transcription.
[1584] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "repressor of G1 transcription" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1585] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Yor083w or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Yor083w; or [1586] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yor083w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yor083w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1587] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "repressor of G1
transcription", preferably it is the molecule of section (a) or (b)
of this paragraph.
[1588] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "repressor of G1
transcription", is increased cytoplasmic.
[1589] The sequence of Yor097c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
YOR097c-protein.
[1590] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "YOR097c-- protein" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1591] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Yor097c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Yor097c; or [1592] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yor097c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yor097c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1593] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "YOR097c-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1594] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "YOR097c-protein", is
increased cytoplasmic.
[1595] The sequence of Yor128c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
Phosphoribosylaminoimidazole carboxylase.
[1596] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "Phosphoribosylaminoimidazole
carboxylase" from Saccharomyces cerevisiae or its functional
equivalent or its homolog, e.g. the increase of [1597] (a) a gene
product of a gene comprising the nucleic acid molecule as shown in
column 5 of table I, application no. 1, and being depicted in the
same respective line as said Yor128c or a functional equivalent or
a homologue thereof as shown in column 7 of table I, application
no. 1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Yor128c; or [1598] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yor128c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yor128c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1599] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a
"Phosphoribosylaminoimidazole carboxylase", preferably it is the
molecule of section (a) or (b) of this paragraph.
[1600] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a
"Phosphoribosylaminoimidazole carboxylase", is increased
cytoplasmic.
[1601] The sequence of Yor353c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
component of the RAM signaling network.
[1602] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "component of the RAM signaling
network" from Saccharomyces cerevisiae or its functional equivalent
or its homolog, e.g. the increase of [1603] (a) a gene product of a
gene comprising the nucleic acid molecule as shown in column 5 of
table I, application no. 1, and being depicted in the same
respective line as said Yor353c or a functional equivalent or a
homologue thereof as shown in column 7 of table I, application no.
1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Yor353c; or [1604] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Yor353c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yor353c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1605] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "component of the RAM
signaling network", preferably it is the molecule of section (a) or
(b) of this paragraph.
[1606] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "component of the RAM
signaling network", is increased cytoplasmic.
[1607] The sequence of Ypl141c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
protein kinase.
[1608] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "protein kinase" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1609] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ypl141c or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ypl141c; or [1610] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ypl141c or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said Ypl141c, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1611] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "protein kinase",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1612] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "protein kinase", is
increased cytoplasmic.
[1613] The sequence of Ypr088c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
signal recognition particle subunit (SRP54).
[1614] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "signal recognition particle subunit
(SRP54)" from Saccharomyces cerevisiae or its functional equivalent
or its homolog, e.g. the increase of [1615] (a) a gene product of a
gene comprising the nucleic acid molecule as shown in column 5 of
table I, application no. 1, and being depicted in the same
respective line as said Ypr088c or a functional equivalent or a
homologue thereof as shown in column 7 of table I, application no.
1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Ypr088c; or [1616] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, and being depicted in the same respective line
as said Ypr088c or a functional equivalent or a homologue thereof
as depicted in column 7 of table II, application no. 1, preferably
a homologue or functional equivalent as depicted in column 7 of
table II B, application no. 1, and being depicted in the same
respective line as said Ypr088c, as mentioned herein, for an
increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1617] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "signal recognition
particle subunit (SRP54)", preferably it is the molecule of section
(a) or (b) of this paragraph.
[1618] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "signal recognition
particle subunit (SRP54)", is increased cytoplasmic.
[1619] The sequence of Ypr108w from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
regulatory subunit of the 26S proteasome.
[1620] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "regulatory subunit of the 26S
proteasome" from Saccharomyces cerevisiae or its functional
equivalent or its homolog, e.g. the increase of [1621] (a) a gene
product of a gene comprising the nucleic acid molecule as shown in
column 5 of table I, application no. 1, and being depicted in the
same respective line as said Ypr108w or a functional equivalent or
a homologue thereof as shown in column 7 of table I, application
no. 1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Ypr108w; or [1622] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ypr108w or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ypr108w, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1623] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "regulatory subunit of
the 26S proteasome", preferably it is the molecule of section (a)
or (b) of this paragraph.
[1624] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "regulatory subunit of
the 26S proteasome", is increased cytoplasmic.
[1625] The sequence of Ypr110c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as RNA
polymerase III subunit.
[1626] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "RNA polymerase III subunit" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1627] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ypr110c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said Ypr110c; or [1628] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ypr110c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ypr110c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1629] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "RNA polymerase III
subunit", preferably it is the molecule of section (a) or (b) of
this paragraph.
[1630] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "RNA polymerase III
subunit", is increased cytoplasmic.
[1631] The sequence of B3825.sub.--2 from Escherichia coli, e.g. as
shown in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
lysophospholipase.
[1632] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "lysophospholipase" from Escherichia
coli or its functional equivalent or its homolog, e.g. the increase
of [1633] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said B3825.sub.--2 or
a functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said
B3825.sub.--2; or [1634] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said B3825.sub.--2 or a functional equivalent or a homologue
thereof as depicted in column 7 of table II, application no. 1,
preferably a homologue or functional equivalent as depicted in
column 7 of table II B, application no. 1, and being depicted in
the same respective line as said B3825.sub.--2, as mentioned
herein, for an increased yield, especially an enhanced NUE and/or
increased biomass production, as compared to a corresponding
non-transformed wild type plant cell, plant or part thereof in
plant cell, plant or part thereof, as mentioned, especially for an
enhanced NUE, or increased biomass production, or an enhanced NUE
and increased biomass production.
[1635] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "lysophospholipase",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1636] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "lysophospholipase", is
increased plastidic.
[1637] The sequence of Yir034c.sub.--2 from Saccharomyces
cerevisiae, e.g. as shown in column 5 of table I, application no.
1, is published (e.g. sequences from Saccharomyces cerevisiae have
been published in Goffeau et al., Science 274 (5287), 546 (1996),
sequences from Escherichia coli have been published in Blattner et
al., Science 277 (5331), 1453 (1997)), and/or its activity is
described as saccharopine dehydrogenase.
[1638] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "saccharopine dehydrogenase" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1639] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Yir034c.sub.--2 or a functional equivalent or a
homologue thereof as shown in column 7 of table I, application no.
1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Yir034c.sub.--2; or [1640] (b) a
polypeptide comprising a polypeptide, a consensus sequence or a
polypeptide motif as shown in column 5 of table II or in column 7
of table IV, application no. 1, respectively, and being depicted in
the same respective line as said Yir034c.sub.--2 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said
Yir034c.sub.--2, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1641] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "saccharopine
dehydrogenase", preferably it is the molecule of section (a) or (b)
of this paragraph.
[1642] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "saccharopine
dehydrogenase", is increased cytoplasmic.
[1643] The sequence of Yjr131w.sub.--2 from Saccharomyces
cerevisiae, e.g. as shown in column 5 of table I, application no.
1, is published (e.g. sequences from Saccharomyces cerevisiae have
been published in Goffeau et al., Science 274 (5287), 546 (1996),
sequences from Escherichia coli have been published in Blattner et
al., Science 277 (5331), 1453 (1997)), and/or its activity is
described as alpha-mannosidase.
[1644] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "alpha-mannosidase" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1645] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Yjr131w.sub.--2 or a functional equivalent or a
homologue thereof as shown in column 7 of table I, application no.
1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Yjr131w.sub.--2; or [1646] (b) a
polypeptide comprising a polypeptide, a consensus sequence or a
polypeptide motif as shown in column 5 of table II or in column 7
of table IV, application no. 1, respectively, and being depicted in
the same respective line as said Yjr131w.sub.--2 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said
Yjr131w.sub.--2, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1647] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "alpha-mannosidase",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1648] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "alpha-mannosidase", is
increased cytoplasmic.
[1649] The sequence of Ykl100c.sub.--2 from Saccharomyces
cerevisiae, e.g. as shown in column of table I, application no. 1,
is published (e.g. sequences from Saccharomyces cerevisiae have
been published in Goffeau et al., Science 274 (5287), 546 (1996),
sequences from Escherichia coli have been published in Blattner et
al., Science 277 (5331), 1453 (1997)), and/or its activity is
described as ykl100c-protein.
[1650] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "ykl100c-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1651] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
Ykl100c.sub.--2 or a functional equivalent or a homologue thereof
as shown in column 7 of table I, application no. 1, preferably a
homologue or functional equivalent as shown in column 7 of table I
B, application no. 1, and being depicted in the same respective
line as said Ykl100c.sub.--2; or [1652] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said Ykl100c.sub.--2 or a functional equivalent
or a homologue thereof as depicted in column 7 of table II,
application no. 1, preferably a homologue or functional equivalent
as depicted in column 7 of table II B, application no. 1, and being
depicted in the same respective line as said Ykl100c.sub.--2, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[1653] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "ykl100c-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1654] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "ykl100c-protein", is
increased cytoplasmic.
[1655] The sequence of Ykl193c.sub.--2 from Saccharomyces
cerevisiae, e.g. as shown in column 5 of table I, application no.
1, is published (e.g. sequences from Saccharomyces cerevisiae have
been published in Goffeau et al., Science 274 (5287), 546 (1996),
sequences from Escherichia coli have been published in Blattner et
al., Science 277 (5331), 1453 (1997)), and/or its activity is
described as regulatory subunit of Glc7p type 1 protein
serine-threonine phosphatase.
[1656] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "regulatory subunit of Glc7p type 1
protein serine-threonine phosphatase" from Saccharomyces cerevisiae
or its functional equivalent or its homolog, e.g. the increase of
[1657] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said Ykl193c.sub.--2
or a functional equivalent or a homologue thereof as shown in
column 7 of table I, application no. 1, preferably a homologue or
functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said Ykl193c.sub.--2; or [1658] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ykl193c.sub.--2 or a functional equivalent or a homologue
thereof as depicted in column 7 of table II, application no. 1,
preferably a homologue or functional equivalent as depicted in
column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ykl193c.sub.--2, as mentioned
herein, for an increased yield, especially an enhanced NUE and/or
increased biomass production, as compared to a corresponding
non-transformed wild type plant cell, plant or part thereof in
plant cell, plant or part thereof, as mentioned, especially for an
enhanced NUE, or increased biomass production, or an enhanced NUE
and increased biomass production.
[1659] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "regulatory subunit of
Glc7p type 1 protein serine-threonine phosphatase", preferably it
is the molecule of section (a) or (b) of this paragraph.
[1660] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "regulatory subunit of
Glc7p type 1 protein serine-threonine phosphatase", is increased
cytoplasmic.
[1661] The sequence of Yll016w.sub.--2 from Saccharomyces
cerevisiae, e.g. as shown in column 5 of table I, application no.
1, is published (e.g. sequences from Saccharomyces cerevisiae have
been published in Goffeau et al., Science 274 (5287), 546 (1996),
sequences from Escherichia coli have been published in Blattner et
al., Science 277 (5331), 1453 (1997)), and/or its activity is
described as non-essential Ras guanine nucleotide exchange
factor.
[1662] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "non-essential Ras guanine
nucleotide exchange factor" from Saccharomyces cerevisiae or its
functional equivalent or its homolog, e.g. the increase of [1663]
(a) a gene product of a gene comprising the nucleic acid molecule
as shown in column 5 of table I, application no. 1, and being
depicted in the same respective line as said Yll016w.sub.--2 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said
Yll016w.sub.--2; or [1664] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Yll016w.sub.--2 or a functional equivalent or a homologue
thereof as depicted in column 7 of table II, application no. 1,
preferably a homologue or functional equivalent as depicted in
column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Yll016w.sub.--2, as mentioned
herein, for an increased yield, especially an enhanced NUE and/or
increased biomass production, as compared to a corresponding
non-transformed wild type plant cell, plant or part thereof in
plant cell, plant or part thereof, as mentioned, especially for an
enhanced NUE, or increased biomass production, or an enhanced NUE
and increased biomass production.
[1665] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "non-essential Ras
guanine nucleotide exchange factor", preferably it is the molecule
of section (a) or (b) of this paragraph.
[1666] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "non-essential Ras
guanine nucleotide exchange factor", is increased cytoplasmic.
[1667] The sequence of Ylr034c.sub.--2 from Saccharomyces
cerevisiae, e.g. as shown in column 5 of table I, application no.
1, is published (e.g. sequences from Saccharomyces cerevisiae have
been published in Goffeau et al., Science 274 (5287), 546 (1996),
sequences from Escherichia coli have been published in Blattner et
al., Science 277 (5331), 1453 (1997)), and/or its activity is
described as metal ion transporter.
[1668] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "metal ion transporter" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1669] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ylr034c.sub.--2 or a functional equivalent or a
homologue thereof as shown in column 7 of table I, application no.
1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Ylr034c.sub.--2; or [1670] (b) a
polypeptide comprising a polypeptide, a consensus sequence or a
polypeptide motif as shown in column 5 of table II or in column 7
of table IV, application no. 1, respectively, and being depicted in
the same respective line as said Ylr034c.sub.--2 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said
Ylr034c.sub.--2, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1671] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "metal ion transporter",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1672] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "metal ion transporter",
is increased cytoplasmic.
[1673] The sequence of Ylr060w.sub.--2 from Saccharomyces
cerevisiae, e.g. as shown in column 5 of table I, application no.
1, is published (e.g. sequences from Saccharomyces cerevisiae have
been published in Goffeau et al., Science 274 (5287), 546 (1996),
sequences from Escherichia coli have been published in Blattner et
al., Science 277 (5331), 1453 (1997)), and/or its activity is
described as subunit of cytoplasmic phenylalanyl-tRNA
synthetase.
[1674] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "subunit of cytoplasmic
phenylalanyl-tRNA synthetase" from Saccharomyces cerevisiae or its
functional equivalent or its homolog, e.g. the increase of [1675]
(a) a gene product of a gene comprising the nucleic acid molecule
as shown in column 5 of table I, application no. 1, and being
depicted in the same respective line as said Ylr060w.sub.--2 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said
Ylr060w.sub.--2; or [1676] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said Ylr060w.sub.--2 or a functional equivalent or a homologue
thereof as depicted in column 7 of table II, application no. 1,
preferably a homologue or functional equivalent as depicted in
column 7 of table II B, application no. 1, and being depicted in
the same respective line as said Ylr060w.sub.--2, as mentioned
herein, for an increased yield, especially an enhanced NUE and/or
increased biomass production, as compared to a corresponding
non-transformed wild type plant cell, plant or part thereof in
plant cell, plant or part thereof, as mentioned, especially for an
enhanced NUE, or increased biomass production, or an enhanced NUE
and increased biomass production.
[1677] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "subunit of cytoplasmic
phenylalanyl-tRNA synthetase", preferably it is the molecule of
section (a) or (b) of this paragraph.
[1678] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "subunit of cytoplasmic
phenylalanyl-tRNA synthetase", is increased cytoplasmic.
[1679] The sequence of YMR082C.sub.--2 from Saccharomyces
cerevisiae, e.g. as shown in column 5 of table I, application no.
1, is published (e.g. sequences from Saccharomyces cerevisiae have
been published in Goffeau et al., Science 274 (5287), 546 (1996),
sequences from Escherichia coli have been published in Blattner et
al., Science 277 (5331), 1453 (1997)), and/or its activity is
described as YMR082C-protein.
[1680] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "YMR082c-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1681] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
YMR082C.sub.--2 or a functional equivalent or a homologue thereof
as shown in column 7 of table I, application no. 1, preferably a
homologue or functional equivalent as shown in column 7 of table I
B, application no. 1, and being depicted in the same respective
line as said YMR082C.sub.--2; or [1682] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said YMR082C.sub.--2 or a functional equivalent
or a homologue thereof as depicted in column 7 of table II,
application no. 1, preferably a homologue or functional equivalent
as depicted in column 7 of table II B, application no. 1, and being
depicted in the same respective line as said YMR082C.sub.--2, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[1683] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "YMR082C-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1684] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "YMR082C-protein", is
increased cytoplasmic.
[1685] The sequence of B1258 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
B1258-protein.
[1686] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "B1258-protein" from Escherichia
coli or its functional equivalent or its homolog, e.g. the increase
of [1687] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said B1258 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said B1258; or
[1688] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said B1258 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said B1258, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[1689] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "B1258-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1690] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "B1258-protein", is
increased cytoplasmic.
[1691] The sequence of YML101C from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
YML101C-protein.
[1692] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "YML101C-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1693] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
YML101C or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said YML101C; or [1694] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said YML101C or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said YML101C, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1695] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "YML101C-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1696] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "YML101C-protein", is
increased cytoplasmic.
[1697] The sequence of YMR065W from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
nuclear fusion protein precursor.
[1698] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "nuclear fusion protein precursor"
from Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1699] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said YMR065W or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said YMR065W; or [1700] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said YMR065W or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said YMR065W, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1701] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "nuclear fusion protein
precursor", preferably it is the molecule of section (a) or (b) of
this paragraph.
[1702] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "nuclear fusion protein
precursor", is increased cytoplasmic.
[1703] The sequence of YMR163c from Saccharomyces cerevisiae, e.g.
as shown in column of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
inheritance of peroxisomes protein.
[1704] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "inheritance of peroxisomes protein"
from Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1705] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said YMR163c or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said YMR163c; or [1706] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said YMR163c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said YMR163c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1707] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "inheritance of
peroxisomes protein", preferably it is the molecule of section (a)
or (b) of this paragraph.
[1708] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "inheritance of
peroxisomes protein", is increased cytoplasmic.
[1709] The sequence of YOL042W from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
exoribonuclease.
[1710] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "exoribonuclease" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1711] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
YOL042W or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said YOL042W; or [1712] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said YOL042W or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said YOL042W, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1713] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "exoribonuclease",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1714] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "exoribonuclease", is
increased cytoplasmic.
[1715] The sequence of YOR226c from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as iron
sulfur cluster assembly protein.
[1716] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "iron sulfur cluster assembly
protein" from Saccharomyces cerevisiae or its functional equivalent
or its homolog, e.g. the increase of [1717] (a) a gene product of a
gene comprising the nucleic acid molecule as shown in column 5 of
table I, application no. 1, and being depicted in the same
respective line as said YOR226c or a functional equivalent or a
homologue thereof as shown in column 7 of table I, application no.
1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said YOR226c; or [1718] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said YOR226c or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said YOR226c, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1719] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "iron sulfur cluster
assembly protein", preferably it is the molecule of section (a) or
(b) of this paragraph.
[1720] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "iron sulfur cluster
assembly protein", is increased cytoplasmic.
[1721] The sequence of YPL068C from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
YPL068C-protein.
[1722] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "YPL068C-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1723] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
YPL068C or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said YPL068C; or [1724] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said YPL068C or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said YPL068C, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1725] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "YPL068C-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1726] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "YPL068C-protein", is
increased cytoplasmic.
[1727] The sequence of B0165 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
B0165-protein.
[1728] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "B0165-protein" from Escherichia
coli or its functional equivalent or its homolog, e.g. the increase
of [1729] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said B0165 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said B0165; or
[1730] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said B0165 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said B0165, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[1731] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "B0165-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1732] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "60165-protein", is
increased plastidic.
[1733] The sequence of YOR203W from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
YOR203W-protein.
[1734] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "YOR203W-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1735] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
YOR203W or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said YOR203W; or [1736] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said YOR203W or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said YOR203W, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1737] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "YOR203W-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1738] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "YOR203W-protein", is
increased cytoplasmic.
[1739] The sequence of YNL147W from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
ribonucleoprotein.
[1740] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "ribonucleoprotein" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1741] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said YNL147W or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said YNL147W; or [1742] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said YNL147W or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said YNL147W, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1743] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "ribonucleoprotein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1744] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "ribonucleoprotein", is
increased cytoplasmic.
[1745] The sequence of YBR083W from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
transcription factor.
[1746] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "transcription factor" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1747] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said YBR083W or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said YBR083W; or [1748] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said YBR083W or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said YBR083W, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1749] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "transcription factor",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1750] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "transcription factor",
is increased cytoplasmic.
[1751] The sequence of YKL111C from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
YKL111C-protein.
[1752] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "YKL111C-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1753] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
YKL111C or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said YKL111C; or [1754] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said YKL111C or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said YKL111C, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1755] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "YKL111C-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1756] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "YKL111C-protein", is
increased cytoplasmic.
[1757] The sequence of YPR067W from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as iron
sulfur cluster assembly protein.
[1758] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "iron sulfur cluster assembly
protein" from Saccharomyces cerevisiae or its functional equivalent
or its homolog, e.g. the increase of [1759] (a) a gene product of a
gene comprising the nucleic acid molecule as shown in column 5 of
table I, application no. 1, and being depicted in the same
respective line as said YPR067W or a functional equivalent or a
homologue thereof as shown in column 7 of table I, application no.
1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said YPR067W; or [1760] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said YPR067W or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said YPR067W, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1761] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "iron sulfur cluster
assembly protein", preferably it is the molecule of section (a) or
(b) of this paragraph.
[1762] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "iron sulfur cluster
assembly protein", is increased cytoplasmic.
[1763] The sequence of B1985 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
transport protein.
[1764] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "transport protein" from Escherichia
coli or its functional equivalent or its homolog, e.g. the increase
of [1765] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said B1985 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said B1985; or
[1766] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said B1985 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said B1985, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[1767] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "transport protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1768] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "transport protein", is
increased cytoplasmic.
[1769] The sequence of B3838 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
protein translocase protein.
[1770] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "protein translocase protein" from
Escherichia coli or its functional equivalent or its homolog, e.g.
the increase of [1771] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said B3838
or a functional equivalent or a homologue thereof as shown in
column 7 of table I, application no. 1, preferably a homologue or
functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said B3838; or [1772] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said B3838 or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said B3838, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1773] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "protein translocase
protein", preferably it is the molecule of section (a) or (b) of
this paragraph.
[1774] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "protein translocase
protein", is increased cytoplasmic.
[1775] The sequence of YJL010C from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
YJL010C-protein.
[1776] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "YJL010C-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1777] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
YJL010C or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said YJL010C; or [1778] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said YJL010C or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said YJL010C, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1779] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "YJL010C-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1780] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "YJL010C-protein", is
increased cytoplasmic.
[1781] The sequence of B1267 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
B1267-protein.
[1782] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "B1267-protein" from Escherichia
coli or its functional equivalent or its homolog, e.g. the increase
of [1783] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said B1267 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said B1267; or
[1784] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said B1267 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said B1267, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[1785] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "B1267-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1786] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "B1267-protein", is
increased cytoplasmic.
[1787] The sequence of B1322 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
membrane protein.
[1788] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "membrane protein" from Escherichia
coli or its functional equivalent or its homolog, e.g. the increase
of [1789] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said B1322 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said B1322; or
[1790] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said B1322 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said B1322, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[1791] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "membrane protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1792] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "membrane protein", is
increased cytoplasmic.
[1793] The sequence of B1381 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
B1381-protein.
[1794] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "61381-protein" from Escherichia
coli or its functional equivalent or its homolog, e.g. the increase
of [1795] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said B1381 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said B1381; or
[1796] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said B1381 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said B1381, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[1797] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "B1381-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1798] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "B1381-protein", is
increased cytoplasmic.
[1799] The sequence of B2646 from Escherichia coli, e.g. as shown
in column 5 of table I, application no. 1, is published (e.g.
sequences from Saccharomyces cerevisiae have been published in
Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
B2646-protein.
[1800] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "B2646-protein" from Escherichia
coli or its functional equivalent or its homolog, e.g. the increase
of [1801] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said B2646 or a
functional equivalent or a homologue thereof as shown in column 7
of table I, application no. 1, preferably a homologue or functional
equivalent as shown in column 7 of table I B, application no. 1,
and being depicted in the same respective line as said B2646; or
[1802] (b) a polypeptide comprising a polypeptide, a consensus
sequence or a polypeptide motif as shown in column 5 of table II or
in column 7 of table IV, application no. 1, respectively, and being
depicted in the same respective line as said B2646 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said B2646, as
mentioned herein, for an increased yield, especially an enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in plant cell, plant or part thereof, as mentioned,
especially for an enhanced NUE, or increased biomass production, or
an enhanced NUE and increased biomass production.
[1803] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "B2646-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1804] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "B2646-protein", is
increased cytoplasmic.
[1805] The sequence of YBR191W from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as 60S
ribosomal protein.
[1806] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "60S ribosomal protein" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1807] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said YBR191W or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said YBR191W; or [1808] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said YBR191W or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said YBR191W, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1809] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "60S ribosomal protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1810] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "60S ribosomal protein",
is increased cytoplasmic.
[1811] The sequence of YDL135C from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as Rho
GDP-dissociation inhibitor.
[1812] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "Rho GDP-dissociation inhibitor"
from Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1813] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said YDL135C or a functional equivalent or a homologue
thereof as shown in column 7 of table I, application no. 1,
preferably a homologue or functional equivalent as shown in column
7 of table I B, application no. 1, and being depicted in the same
respective line as said YDL135C; or [1814] (b) a polypeptide
comprising a polypeptide, a consensus sequence or a polypeptide
motif as shown in column 5 of table II or in column 7 of table IV,
application no. 1, respectively, and being depicted in the same
respective line as said YDL135C or a functional equivalent or a
homologue thereof as depicted in column 7 of table II, application
no. 1, preferably a homologue or functional equivalent as depicted
in column 7 of table II B, application no. 1, and being depicted in
the same respective line as said YDL135C, as mentioned herein, for
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof in plant cell, plant or
part thereof, as mentioned, especially for an enhanced NUE, or
increased biomass production, or an enhanced NUE and increased
biomass production.
[1815] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "Rho GDP-dissociation
inhibitor", preferably it is the molecule of section (a) or (b) of
this paragraph.
[1816] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "Rho GDP-dissociation
inhibitor", is increased cytoplasmic.
[1817] The sequence of YHL005C from Saccharomyces cerevisiae, e.g.
as shown in column 5 of table I, application no. 1, is published
(e.g. sequences from Saccharomyces cerevisiae have been published
in Goffeau et al., Science 274 (5287), 546 (1996), sequences from
Escherichia coli have been published in Blattner et al., Science
277 (5331), 1453 (1997)), and/or its activity is described as
YHL005C-protein.
[1818] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "YHL005C-protein" from Saccharomyces
cerevisiae or its functional equivalent or its homolog, e.g. the
increase of [1819] (a) a gene product of a gene comprising the
nucleic acid molecule as shown in column 5 of table I, application
no. 1, and being depicted in the same respective line as said
YHL005C or a functional equivalent or a homologue thereof as shown
in column 7 of table I, application no. 1, preferably a homologue
or functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said YHL005C; or [1820] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said YHL005C or a functional equivalent or a homologue thereof as
depicted in column 7 of table II, application no. 1, preferably a
homologue or functional equivalent as depicted in column 7 of table
II B, application no. 1, and being depicted in the same respective
line as said YHL005C, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1821] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "YHL005C-protein",
preferably it is the molecule of section (a) or (b) of this
paragraph.
[1822] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "YHL005C-protein", is
increased cytoplasmic.
[1823] The sequence of YKR100C.sub.--2 from Saccharomyces
cerevisiae, e.g. as shown in column 5 of table I, application no.
1, is published (e.g. sequences from Saccharomyces cerevisiae have
been published in Goffeau et al., Science 274 (5287), 546 (1996),
sequences from Escherichia coli have been published in Blattner et
al., Science 277 (5331), 1453 (1997)), and/or its activity is
described as transmembrane protein with a role in cell wall polymer
composition.
[1824] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "transmembrane protein with a role
in cell wall polymer composition" from Saccharomyces cerevisiae or
its functional equivalent or its homolog, e.g. the increase of
[1825] (a) a gene product of a gene comprising the nucleic acid
molecule as shown in column 5 of table I, application no. 1, and
being depicted in the same respective line as said YKR100C.sub.--2
or a functional equivalent or a homologue thereof as shown in
column 7 of table I, application no. 1, preferably a homologue or
functional equivalent as shown in column 7 of table I B,
application no. 1, and being depicted in the same respective line
as said YKR100C.sub.--2; or [1826] (b) a polypeptide comprising a
polypeptide, a consensus sequence or a polypeptide motif as shown
in column 5 of table II or in column 7 of table IV, application no.
1, respectively, and being depicted in the same respective line as
said YKR100C.sub.--2 or a functional equivalent or a homologue
thereof as depicted in column 7 of table II, application no. 1,
preferably a homologue or functional equivalent as depicted in
column 7 of table II B, application no. 1, and being depicted in
the same respective line as said YKR100C.sub.--2, as mentioned
herein, for an increased yield, especially an enhanced NUE and/or
increased biomass production, as compared to a corresponding
non-transformed wild type plant cell, plant or part thereof in
plant cell, plant or part thereof, as mentioned, especially for an
enhanced NUE, or increased biomass production, or an enhanced NUE
and increased biomass production.
[1827] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "transmembrane protein
with a role in cell wall polymer composition", preferably it is the
molecule of section (a) or (b) of this paragraph.
[1828] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "transmembrane protein
with a role in cell wall polymer composition", is increased
cytoplasmic.
[1829] The sequence of Ymr191w.sub.--2 from Saccharomyces
cerevisiae, e.g. as shown in column 5 of table I, application no.
1, is published (e.g. sequences from Saccharomyces cerevisiae have
been published in Goffeau et al., Science 274 (5287), 546 (1996),
sequences from Escherichia coli have been published in Blattner et
al., Science 277 (5331), 1453 (1997)), and/or its activity is
described as Stationary phase protein.
[1830] Accordingly, in one embodiment, the process of the present
invention comprises increasing or generating the activity of a gene
product with the activity of a "Stationary phase protein" from
Saccharomyces cerevisiae or its functional equivalent or its
homolog, e.g. the increase of [1831] (a) a gene product of a gene
comprising the nucleic acid molecule as shown in column 5 of table
I, application no. 1, and being depicted in the same respective
line as said Ymr191w.sub.--2 or a functional equivalent or a
homologue thereof as shown in column 7 of table I, application no.
1, preferably a homologue or functional equivalent as shown in
column 7 of table I B, application no. 1, and being depicted in the
same respective line as said Ymr191w.sub.--2; or [1832] (b) a
polypeptide comprising a polypeptide, a consensus sequence or a
polypeptide motif as shown in column 5 of table II or in column 7
of table IV, application no. 1, respectively, and being depicted in
the same respective line as said Ymr191w.sub.--2 or a functional
equivalent or a homologue thereof as depicted in column 7 of table
II, application no. 1, preferably a homologue or functional
equivalent as depicted in column 7 of table II B, application no.
1, and being depicted in the same respective line as said
Ymr191w.sub.--2, as mentioned herein, for an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof in plant cell, plant or part thereof, as
mentioned, especially for an enhanced NUE, or increased biomass
production, or an enhanced NUE and increased biomass
production.
[1833] Accordingly, in one embodiment, the molecule which activity
is to be increased in the process of the invention is the gene
product with an activity of described as a "Stationary phase
protein", preferably it is the molecule of section (a) or (b) of
this paragraph.
[1834] In one embodiment, said molecule, which activity is to be
increased in the process of the invention and which is the gene
product with an activity as described as a "Stationary phase
protein", is increased cytoplasmic.
[1835] Surprisingly, it was observed that an increasing or
generating of at least one gene conferring an activity selected
from the group consisting of 2-dehydro-3-deoxy-phosphoheptonate
aldolase, 3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease or of a gene
comprising a nucleic acid sequence described in column 5 of table
I, application no. 1, in a plant conferred an increased yield,
especially an enhanced NUE and/or increased biomass production, in
the transformed plants as compared to a corresponding
non-transformed wild type plant, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and increased
biomass production.
[1836] Surprisingly, it was observed that an increasing or
generating of at least one gene conferring an activity selected
from the group consisting of 2-dehydro-3-deoxy-phosphoheptonate
aldolase, 3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease or of a gene
comprising a nucleic acid sequence described in column 5 of table
I, application no. 1, in Arabidopsis thaliana conferred an
increased yield, especially an enhanced NUE and/or increased
biomass production in the transformed plants as compared to a
corresponding non-transformed wild type plant, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and increased biomass production.
[1837] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"b0017-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 38 or a nucleic acid which differs from the
nucleic acid SEQ ID NO. 38 by exchanging the stop codon taa by tga
in Arabidopsis thaliana conferred an increased yield, especially an
increased NUE than the wild type control.
[1838] It was further observed that increasing or generating the
activity of a gene product with the activity of a "b0017-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
38 or a nucleic acid which differs from the nucleic acid SEQ ID NO.
38 by exchanging the stop codon taa by tga in Arabidopsis thaliana
conferred an increased biomass production compared with the wild
type control.
[1839] It was further observed that increasing or generating the
activity of a gene product with the activity of a "b0017-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
38 or a nucleic acid which differs from the nucleic acid SEQ ID NO.
38 by exchanging the stop codon taa by tga in Arabidopsis thaliana
conferred an increased NUE and an increased biomass production
compared with the wild type control.
[1840] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "transport
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 42 in Arabidopsis thaliana conferred an increased yield,
especially an increased NUE compared with the wild type
control.
[1841] It was further observed that increasing or generating the
activity of a gene product with the activity of a "transport
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO.: 42 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[1842] It was further observed that increasing or generating the
activity of a gene product with the activity of a "transport
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 42 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[1843] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"hydroxymyristol acyl carrier protein dehydratase" encoded by a
gene comprising the nucleic acid sequence SEQ ID NO. 123 or a
nucleic acid which differs from the nucleic acid SEQ ID NO. 123 by
exchanging the stop codon taa by tga in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[1844] It was further observed that increasing or generating the
activity of a gene product with the activity of a "hydroxymyristol
acyl carrier protein dehydratase" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO.: 123 or a nucleic acid which
differs from the nucleic acid SEQ ID NO. 123 by exchanging the stop
codon taa by tga in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[1845] It was further observed that increasing or generating the
activity of a gene product with the activity of a "hydroxymyristol
acyl carrier protein dehydratase" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 123 or a nucleic acid which
differs from the nucleic acid SEQ ID NO. 123 by exchanging the stop
codon taa by tga in Arabidopsis thaliana conferred an increased NUE
and an increased biomass production compared with the wild type
control.
[1846] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"gamma-glutamyl kinase" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 380 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1847] It was further observed that increasing or generating the
activity of a gene product with the activity of a "gamma-glutamyl
kinase" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO.: 380 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[1848] It was further observed that increasing or generating the
activity of a gene product with the activity of a "gamma-glutamyl
kinase" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 380 in Arabidopsis thaliana conferred an increased NUE and
an increased biomass production compared with the wild type
control.
[1849] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"alpha-glucosidase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 679 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1850] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"alpha-glucosidase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 679 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[1851] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"alpha-glucosidase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 679 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[1852] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "adenylate
kinase" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 812 in Arabidopsis thaliana conferred an increased yield,
especially an increased NUE compared with the wild type
control.
[1853] It was further observed that increasing or generating the
activity of a gene product with the activity of a "adenylate
kinase" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO.: 812 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[1854] It was further observed that increasing or generating the
activity of a gene product with the activity of a "adenylate
kinase" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 812 in Arabidopsis thaliana conferred an increased NUE and
an increased biomass production compared with the wild type
control.
[1855] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"2-dehydro-3-deoxy-phosphoheptonate aldolase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 1055 in Arabidopsis
thaliana conferred an increased yield, especially an increased NUE
compared with the wild type control.
[1856] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"2-dehydro-3-deoxy-phosphoheptonate aldolase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO.: 1055 in
Arabidopsis thaliana conferred an increased biomass production
compared with the wild type control.
[1857] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"2-dehydro-3-deoxy-phosphoheptonate aldolase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 1055 in Arabidopsis
thaliana conferred an increased NUE and an increased biomass
production compared with the wild type control.
[1858] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"molybdopterin biosynthesis protein" encoded by a gene comprising
the nucleic acid sequence SEQ ID NO. 1563 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[1859] It was further observed that increasing or generating the
activity of a gene product with the activity of a "molybdopterin
biosynthesis protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 1563 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[1860] It was further observed that increasing or generating the
activity of a gene product with the activity of a "molybdopterin
biosynthesis protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 1563 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[1861] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"hydroxylamine reductase" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 1705 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1862] It was further observed that increasing or generating the
activity of a gene product with the activity of a "hydroxylamine
reductase" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO.: 1705 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[1863] It was further observed that increasing or generating the
activity of a gene product with the activity of a "hydroxylamine
reductase" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 1705 in Arabidopsis thaliana conferred an increased NUE
and an increased biomass production compared with the wild type
control.
[1864] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "proline
dehydrogenase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 1844 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1865] It was further observed that increasing or generating the
activity of a gene product with the activity of a "proline
dehydrogenase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 1844 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[1866] It was further observed that increasing or generating the
activity of a gene product with the activity of a "proline
dehydrogenase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 1844 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[1867] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "PhoH-like
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 1950 in Arabidopsis thaliana conferred an increased yield,
especially an increased NUE compared with the wild type
control.
[1868] It was further observed that increasing or generating the
activity of a gene product with the activity of a "PhoH-like
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO.: 1950 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[1869] It was further observed that increasing or generating the
activity of a gene product with the activity of a "PhoH-like
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 1950 in Arabidopsis thaliana conferred an increased NUE and
an increased biomass production compared with the wild type
control.
[1870] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "isomerase"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
1975 in Arabidopsis thaliana conferred an increased yield,
especially an increased NUE compared with the wild type
control.
[1871] It was further observed that increasing or generating the
activity of a gene product with the activity of a "isomerase"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
1975 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[1872] It was further observed that increasing or generating the
activity of a gene product with the activity of a "isomerase"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
1975 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[1873] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"b1933-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 2127 or a nucleic acid which differs from the
nucleic acid SEQ
[1874] ID NO. 2127 by exchanging the stop codon taa by tga in
Arabidopsis thaliana conferred an increased yield, especially an
increased NUE compared with the wild type control.
[1875] It was further observed that increasing or generating the
activity of a gene product with the activity of a "b1933-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
2127 or a nucleic acid which differs from the nucleic acid SEQ ID
NO. 2127 by exchanging the stop codon taa by tga in Arabidopsis
thaliana conferred an increased biomass production compared with
the wild type control.
[1876] It was further observed that increasing or generating the
activity of a gene product with the activity of a "b1933-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
2127 or a nucleic acid which differs from the nucleic acid SEQ ID
NO. 2127 by exchanging the stop codon taa by tga in Arabidopsis
thaliana conferred an increased NUE and an increased biomass
production compared with the wild type control.
[1877] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"glycosyltransferase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 2135 or a nucleic acid which differs from the
nucleic acid SEQ ID NO. 2135 by exchanging the stop codon taa by
tga in Arabidopsis thaliana conferred an increased yield,
especially an increased NUE compared with the wild type
control.
[1878] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"glycosyltransferase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 2135 or a nucleic acid which differs from the
nucleic acid SEQ ID NO. 2135 by exchanging the stop codon taa by
tga in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[1879] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"glycosyltransferase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 2135 or a nucleic acid which differs from the
nucleic acid SEQ ID NO. 2135 by exchanging the stop codon taa by
tga in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[1880] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"b2165-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 2171 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1881] It was further observed that increasing or generating the
activity of a gene product with the activity of a "b2165-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
2171 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[1882] It was further observed that increasing or generating the
activity of a gene product with the activity of a "b2165-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
2171 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[1883] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "short chain
fatty acid transporter" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 2297 or a nucleic acid which differs from
the nucleic acid SEQ ID NO. 2297 by exchanging the stop codon taa
by tga in Arabidopsis thaliana conferred an increased yield,
especially an increased NUE compared with the wild type
control.
[1884] It was further observed that increasing or generating the
activity of a gene product with the activity of a "short chain
fatty acid transporter" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO.: 2297 or a nucleic acid which differs from
the nucleic acid SEQ ID NO. 2297 by exchanging the stop codon taa
by tga in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[1885] It was further observed that increasing or generating the
activity of a gene product with the activity of a "short chain
fatty acid transporter" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 2297 or a nucleic acid which differs from
the nucleic acid SEQ ID NO. 2297 by exchanging the stop codon taa
by tga in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[1886] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"b2238-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 2426 or a nucleic acid which differs from the
nucleic acid SEQ ID NO. 2426 by exchanging the stop codon taa by
tga in Arabidopsis thaliana conferred an increased yield,
especially an increased NUE compared with the wild type
control.
[1887] It was further observed that increasing or generating the
activity of a gene product with the activity of a "b2238-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
2426 or a nucleic acid which differs from the nucleic acid SEQ ID
NO. 2426 by exchanging the stop codon taa by tga in Arabidopsis
thaliana conferred an increased biomass production compared with
the wild type control.
[1888] It was further observed that increasing or generating the
activity of a gene product with the activity of a "b2238-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
2426 or a nucleic acid which differs from the nucleic acid SEQ ID
NO. 2426 by exchanging the stop codon taa by tga in Arabidopsis
thaliana conferred an increased NUE and an increased biomass
production compared with the wild type control.
[1889] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"lysine/arginine/ornithine transporter subunit" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 2452 or a nucleic
acid which differs from the nucleic acid SEQ ID NO. 2452 by
exchanging the stop codon taa by tga in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[1890] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"lysine/arginine/ornithine transporter subunit" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO.: 2452 or a nucleic
acid which differs from the nucleic acid SEQ ID NO. 2452 by
exchanging the stop codon taa by tga in Arabidopsis thaliana
conferred an increased biomass production compared with the wild
type control.
[1891] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"lysine/arginine/ornithine transporter subunit" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 2452 or a nucleic
acid which differs from the nucleic acid SEQ ID NO. 2452 by
exchanging the stop codon taa by tga in Arabidopsis thaliana
conferred an increased NUE and an increased biomass production
compared with the wild type control.
[1892] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"b2431-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 2551 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1893] It was further observed that increasing or generating the
activity of a gene product with the activity of a "b2431-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
2551 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[1894] It was further observed that increasing or generating the
activity of a gene product with the activity of a "b2431-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
2551 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[1895] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "chorismate
mutase T/prephenate dehydrogenase (bifunctional)" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 2600 in Arabidopsis
thaliana conferred an increased yield, especially an increased NUE
compared with the wild type control.
[1896] It was further observed that increasing or generating the
activity of a gene product with the activity of a "chorismate
mutase T/prephenate dehydrogenase (bifunctional)" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO.: 2600 in
Arabidopsis thaliana conferred an increased biomass production
compared with the wild type control.
[1897] It was further observed that increasing or generating the
activity of a gene product with the activity of a "chorismate
mutase T/prephenate dehydrogenase (bifunctional)" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 2600 in Arabidopsis
thaliana conferred an increased NUE and an increased biomass
production compared with the wild type control.
[1898] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"b2766-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 2668 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1899] It was further observed that increasing or generating the
activity of a gene product with the activity of a "b2766-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
2668 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[1900] It was further observed that increasing or generating the
activity of a gene product with the activity of a "b2766-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
2668 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[1901] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "glycine
decarboxylase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 2772 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1902] It was further observed that increasing or generating the
activity of a gene product with the activity of a "glycine
decarboxylase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 2772 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[1903] It was further observed that increasing or generating the
activity of a gene product with the activity of a "glycine
decarboxylase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 2772 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[1904] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "threonine
ammonia-lyase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 3117 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1905] It was further observed that increasing or generating the
activity of a gene product with the activity of a "threonine
ammonia-lyase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 3117 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[1906] It was further observed that increasing or generating the
activity of a gene product with the activity of a "threonine
ammonia-lyase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 3117 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[1907] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"b3120-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 3390 or a nucleic acid which differs from the
nucleic acid SEQ ID NO. 3390 by exchanging the stop codon taa by
tga in Arabidopsis thaliana conferred an increased yield,
especially an increased NUE compared with the wild type
control.
[1908] It was further observed that increasing or generating the
activity of a gene product with the activity of a "b3120-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
3390 or a nucleic acid which differs from the nucleic acid SEQ ID
NO. 3390 by exchanging the stop codon taa by tga in Arabidopsis
thaliana conferred an increased biomass production compared with
the wild type control.
[1909] It was further observed that increasing or generating the
activity of a gene product with the activity of a "b3120-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
3390 or a nucleic acid which differs from the nucleic acid SEQ ID
NO. 3390 by exchanging the stop codon taa by tga in Arabidopsis
thaliana conferred an increased NUE and an increased biomass
production compared with the wild type control.
[1910] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "outer
membrane usher protein" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 3396 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1911] It was further observed that increasing or generating the
activity of a gene product with the activity of a "outer membrane
usher protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 3396 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[1912] It was further observed that increasing or generating the
activity of a gene product with the activity of a "outer membrane
usher protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 3396 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[1913] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"glycerol-3-phosphate transporter subunit" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 3470 in Arabidopsis
thaliana conferred an increased yield, especially an increased NUE
compared with the wild type control.
[1914] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"glycerol-3-phosphate transporter subunit" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO.: 3470 in
Arabidopsis thaliana conferred an increased biomass production
compared with the wild type control.
[1915] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"glycerol-3-phosphate transporter subunit" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 3470 in Arabidopsis
thaliana conferred an increased NUE and an increased biomass
production compared with the wild type control.
[1916] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "hydro-lyase"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
3563 or a nucleic acid which differs from the nucleic acid SEQ ID
NO. 3563 by exchanging the stop codon taa by tga in Arabidopsis
thaliana conferred an increased yield, especially an increased NUE
compared with the wild type control.
[1917] It was further observed that increasing or generating the
activity of a gene product with the activity of a "hydro-lyase"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
3563 or a nucleic acid which differs from the nucleic acid SEQ ID
NO. 3563 by exchanging the stop codon taa by tga in Arabidopsis
thaliana conferred an increased biomass production compared with
the wild type control.
[1918] It was further observed that increasing or generating the
activity of a gene product with the activity of a "hydro-lyase"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
3563 or a nucleic acid which differs from the nucleic acid SEQ ID
NO. 3563 by exchanging the stop codon taa by tga in Arabidopsis
thaliana conferred an increased NUE and an increased biomass
production compared with the wild type control.
[1919] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"lysophospholipase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 3770 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1920] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"lysophospholipase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 3770 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[1921] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"lysophospholipase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 3770 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[1922] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"yal019w-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 3868 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1923] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yal019w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
3868 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[1924] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yal019w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
3868 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[1925] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "carnitine
acetyltransferase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 3895 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1926] It was further observed that increasing or generating the
activity of a gene product with the activity of a "carnitine
acetyltransferase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 3895 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[1927] It was further observed that increasing or generating the
activity of a gene product with the activity of a "carnitine
acetyltransferase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 3895 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[1928] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"Transcriptional activator" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 3953 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[1929] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Transcriptional
activator" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO.: 3953 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[1930] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Transcriptional
activator" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 3953 in Arabidopsis thaliana conferred an increased NUE
and an increased biomass production compared with the wild type
control.
[1931] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "splicing
factor" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 4111 in Arabidopsis thaliana conferred an increased yield,
especially an increased NUE compared with the wild type
control.
[1932] It was further observed that increasing or generating the
activity of a gene product with the activity of a "splicing factor"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
4111 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[1933] It was further observed that increasing or generating the
activity of a gene product with the activity of a "splicing factor"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
4111 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[1934] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"autophagy-specific phosphatidylinositol 3-kinase complex protein
subunit" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 4149 in Arabidopsis thaliana conferred an increased yield,
especially an increased NUE compared with the wild type
control.
[1935] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"autophagy-specific phosphatidylinositol 3-kinase complex protein
subunit" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO.: 4149 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[1936] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"autophagy-specific phosphatidylinositol 3-kinase complex protein
subunit" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 4149 in Arabidopsis thaliana conferred an increased NUE and
an increased biomass production compared with the wild type
control.
[1937] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "microsomal
beta-keto-reductase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 4162 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1938] It was further observed that increasing or generating the
activity of a gene product with the activity of a "microsomal
beta-keto-reductase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 4162 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[1939] It was further observed that increasing or generating the
activity of a gene product with the activity of a "microsomal
beta-keto-reductase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 4162 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[1940] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"UDP-N-acetyl-glucosamine-1-P transferase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 4235 in Arabidopsis
thaliana conferred an increased yield, especially an increased NUE
compared with the wild type control.
[1941] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"UDP-N-acetyl-glucosamine-1-P transferase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO.: 4235 in
Arabidopsis thaliana conferred an increased biomass production
compared with the wild type control.
[1942] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"UDP-N-acetyl-glucosamine-1-P transferase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 4235 in Arabidopsis
thaliana conferred an increased NUE and an increased biomass
production compared with the wild type control.
[1943] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"ybr262c-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 4280 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1944] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ybr262c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
4280 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[1945] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ybr262c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
4280 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[1946] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "protein
necessary for structural stability of L-A double-stranded
RNA-containing particles" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 4288 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1947] It was further observed that increasing or generating the
activity of a gene product with the activity of a "protein
necessary for structural stability of L-A double-stranded
RNA-containing particles" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO.: 4288 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[1948] It was further observed that increasing or generating the
activity of a gene product with the activity of a "protein
necessary for structural stability of L-A double-stranded
RNA-containing particles" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 4288 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[1949] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"YDR070C-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 4315 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1950] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YDR070C-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
4315 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[1951] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YDR070C-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
4315 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[1952] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "chaperone"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
4325 in Arabidopsis thaliana conferred an increased yield,
especially an increased NUE compared with the wild type
control.
[1953] It was further observed that increasing or generating the
activity of a gene product with the activity of a "chaperone"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
4325 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[1954] It was further observed that increasing or generating the
activity of a gene product with the activity of a "chaperone"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
4325 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[1955] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"helix-loop-helix transcription activator that binds
inositol/choline-responsive elements" encoded by a gene comprising
the nucleic acid sequence SEQ ID NO. 4335 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[1956] It was further observed that increasing or generating the
activity of a gene product with the activity of a "helix-loop-helix
transcription activator that binds inositol/choline-responsive
elements" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO.: 4335 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[1957] It was further observed that increasing or generating the
activity of a gene product with the activity of a "helix-loop-helix
transcription activator that binds inositol/choline-responsive
elements" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 4335 in Arabidopsis thaliana conferred an increased NUE
and an increased biomass production compared with the wild type
control.
[1958] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "golgi
membrane exchange factor subunit" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 4346 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[1959] It was further observed that increasing or generating the
activity of a gene product with the activity of a "golgi membrane
exchange factor subunit" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO.: 4346 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[1960] It was further observed that increasing or generating the
activity of a gene product with the activity of a "golgi membrane
exchange factor subunit" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 4346 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[1961] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"dihydrosphingosine phosphate lyase" encoded by a gene comprising
the nucleic acid sequence SEQ ID NO. 4361 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[1962] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"dihydrosphingosine phosphate lyase" encoded by a gene comprising
the nucleic acid sequence SEQ ID NO.: 4361 in Arabidopsis thaliana
conferred an increased biomass production compared with the wild
type control.
[1963] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"dihydrosphingosine phosphate lyase" encoded by a gene comprising
the nucleic acid sequence SEQ ID NO. 4361 in Arabidopsis thaliana
conferred an increased NUE and an increased biomass production
compared with the wild type control.
[1964] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "ubiquitin
regulatory protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 4402 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1965] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ubiquitin
regulatory protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 4402 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[1966] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ubiquitin
regulatory protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 4402 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[1967] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"ydr355c-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 4431 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1968] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ydr355c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
4431 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[1969] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ydr355c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
4431 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[1970] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"lysine-specific metalloprotease" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 4435 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[1971] It was further observed that increasing or generating the
activity of a gene product with the activity of a "lysine-specific
metalloprotease" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 4435 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[1972] It was further observed that increasing or generating the
activity of a gene product with the activity of a "lysine-specific
metalloprotease" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 4435 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[1973] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "subunit of
the transport protein particle (TRAPP) complex of the cis-Golgi"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
4485 in Arabidopsis thaliana conferred an increased yield,
especially an increased NUE compared with the wild type
control.
[1974] It was further observed that increasing or generating the
activity of a gene product with the activity of a "subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
4485 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[1975] It was further observed that increasing or generating the
activity of a gene product with the activity of a "subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
4485 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[1976] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "myo-inositol
transporter" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 4506 in Arabidopsis thaliana conferred an increased
yield, especially an increased NUE compared with the wild type
control.
[1977] It was further observed that increasing or generating the
activity of a gene product with the activity of a "myo-inositol
transporter" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO.: 4506 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[1978] It was further observed that increasing or generating the
activity of a gene product with the activity of a "myo-inositol
transporter" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 4506 in Arabidopsis thaliana conferred an increased NUE
and an increased biomass production compared with the wild type
control.
[1979] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "SM complex B
protein for mRNA splicing" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 4790 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1980] It was further observed that increasing or generating the
activity of a gene product with the activity of a "SM complex B
protein for mRNA splicing" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO.: 4790 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[1981] It was further observed that increasing or generating the
activity of a gene product with the activity of a "SM complex B
protein for mRNA splicing" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 4790 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[1982] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"YFR007W-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 4806 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1983] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YFR007W-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
4806 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[1984] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YFR007W-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
4806 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[1985] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"oxidoreductase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 4836 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1986] It was further observed that increasing or generating the
activity of a gene product with the activity of a "oxidoreductase"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
4836 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[1987] It was further observed that increasing or generating the
activity of a gene product with the activity of a "oxidoreductase"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
4836 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[1988] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"transcription elongation factor" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 5311 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[1989] It was further observed that increasing or generating the
activity of a gene product with the activity of a "transcription
elongation factor" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 5311 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[1990] It was further observed that increasing or generating the
activity of a gene product with the activity of a "transcription
elongation factor" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 5311 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[1991] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "cytosolic
catalase" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 5346 in Arabidopsis thaliana conferred an increased
yield, especially an increased NUE compared with the wild type
control.
[1992] It was further observed that increasing or generating the
activity of a gene product with the activity of a "cytosolic
catalase" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO.: 5346 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[1993] It was further observed that increasing or generating the
activity of a gene product with the activity of a "cytosolic
catalase" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 5346 in Arabidopsis thaliana conferred an increased NUE
and an increased biomass production compared with the wild type
control.
[1994] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"ygr122c-a-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 5533 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1995] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"ygr122c-a-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 5533 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[1996] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"ygr122c-a-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 5533 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[1997] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "v-SNARE
binding protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 5551 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[1998] It was further observed that increasing or generating the
activity of a gene product with the activity of a "v-SNARE binding
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO.: 5551 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[1999] It was further observed that increasing or generating the
activity of a gene product with the activity of a "v-SNARE binding
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 5551 in Arabidopsis thaliana conferred an increased NUE and
an increased biomass production compared with the wild type
control.
[2000] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "protein
involved in sphingolipid biosynthesis" encoded by a gene comprising
the nucleic acid sequence SEQ ID NO. 5559 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[2001] It was further observed that increasing or generating the
activity of a gene product with the activity of a "protein involved
in sphingolipid biosynthesis" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO.: 5559 in Arabidopsis thaliana
conferred an increased biomass production compared with the wild
type control.
[2002] It was further observed that increasing or generating the
activity of a gene product with the activity of a "protein involved
in sphingolipid biosynthesis" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 5559 in Arabidopsis thaliana
conferred an increased NUE and an increased biomass production
compared with the wild type control.
[2003] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"mitochondrial ribosomal protein of the small subunit" encoded by a
gene comprising the nucleic acid sequence SEQ ID NO. 5602 in
Arabidopsis thaliana conferred an increased yield, especially an
increased NUE compared with the wild type control.
[2004] It was further observed that increasing or generating the
activity of a gene product with the activity of a "mitochondrial
ribosomal protein of the small subunit" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO.: 5602 in
Arabidopsis thaliana conferred an increased biomass production
compared with the wild type control.
[2005] It was further observed that increasing or generating the
activity of a gene product with the activity of a "mitochondrial
ribosomal protein of the small subunit" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 5602 in Arabidopsis
thaliana conferred an increased NUE and an increased biomass
production compared with the wild type control.
[2006] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"phosphatidylserine decarboxylase" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 5608 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[2007] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"phosphatidylserine decarboxylase" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO.: 5608 in Arabidopsis thaliana
conferred an increased biomass production compared with the wild
type control.
[2008] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"phosphatidylserine decarboxylase" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 5608 in Arabidopsis thaliana
conferred an increased NUE and an increased biomass production
compared with the wild type control.
[2009] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"cholinephosphate cytidylyltransferase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 5614 in Arabidopsis
thaliana conferred an increased yield, especially an increased NUE
compared with the wild type control.
[2010] It was further observed that increasing or generating the
activity of a gene product with the activity of a "cholinephosphate
cytidylyltransferase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 5614 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2011] It was further observed that increasing or generating the
activity of a gene product with the activity of a "cholinephosphate
cytidylyltransferase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 5614 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2012] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"ygr266w-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 5666 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2013] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ygr266w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
5666 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2014] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ygr266w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
5666 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2015] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "cell wall
endo-beta-1,3-glucanase" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 5701 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2016] It was further observed that increasing or generating the
activity of a gene product with the activity of a "cell wall
endo-beta-1,3-glucanase" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO.: 5701 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2017] It was further observed that increasing or generating the
activity of a gene product with the activity of a "cell wall
endo-beta-1,3-glucanase" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 5701 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2018] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"ygr290w-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 5750 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2019] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ygr290w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
5750 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2020] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ygr290w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
5750 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2021] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"yhl021c-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 5754 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2022] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yhl021c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
5754 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2023] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yhl021c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
5754 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2024] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "v-SNARE
protein involved in Golgi transport" encoded by a gene comprising
the nucleic acid sequence SEQ ID NO. 5778 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[2025] It was further observed that increasing or generating the
activity of a gene product with the activity of a "v-SNARE protein
involved in Golgi transport" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO.: 5778 in Arabidopsis thaliana
conferred an increased biomass production compared with the wild
type control.
[2026] It was further observed that increasing or generating the
activity of a gene product with the activity of a "v-SNARE protein
involved in Golgi transport" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 5778 in Arabidopsis thaliana
conferred an increased NUE and an increased biomass production
compared with the wild type control.
[2027] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"mitochondrial seryl-tRNA synthetase" encoded by a gene comprising
the nucleic acid sequence SEQ ID NO. 5812 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[2028] It was further observed that increasing or generating the
activity of a gene product with the activity of a "mitochondrial
seryl-tRNA synthetase" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO.: 5812 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2029] It was further observed that increasing or generating the
activity of a gene product with the activity of a "mitochondrial
seryl-tRNA synthetase" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 5812 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2030] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"yhr127w-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 5967 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2031] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yhr127w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
5967 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2032] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yhr127w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
5967 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2033] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "aromatic
amino acid aminotransferase II" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 5973 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[2034] It was further observed that increasing or generating the
activity of a gene product with the activity of a "aromatic amino
acid aminotransferase II" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO.: 5973 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2035] It was further observed that increasing or generating the
activity of a gene product with the activity of a "aromatic amino
acid aminotransferase II" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 5973 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2036] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"glucoamylase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 6027 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2037] It was further observed that increasing or generating the
activity of a gene product with the activity of a "glucoamylase"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
6027 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2038] It was further observed that increasing or generating the
activity of a gene product with the activity of a "glucoamylase"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
6027 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2039] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
6107 in Arabidopsis thaliana conferred an increased yield,
especially an increased NUE compared with the wild type
control.
[2040] It was further observed that increasing or generating the
activity of a gene product with the activity of a "histidine kinase
osmosensor that regulates an osmosensing MAP kinase cascade"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
6107 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2041] It was further observed that increasing or generating the
activity of a gene product with the activity of a "histidine kinase
osmosensor that regulates an osmosensing MAP kinase cascade"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
6107 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2042] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "saccharopine
dehydrogenase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 6150 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2043] It was further observed that increasing or generating the
activity of a gene product with the activity of a "saccharopine
dehydrogenase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 6150 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2044] It was further observed that increasing or generating the
activity of a gene product with the activity of a "saccharopine
dehydrogenase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 6150 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2045] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "spindle
checkpoint complex subunit" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 6198 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[2046] It was further observed that increasing or generating the
activity of a gene product with the activity of a "spindle
checkpoint complex subunit" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO.: 6198 in Arabidopsis thaliana
conferred an increased biomass production compared with the wild
type control.
[2047] It was further observed that increasing or generating the
activity of a gene product with the activity of a "spindle
checkpoint complex subunit" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 6198 in Arabidopsis thaliana
conferred an increased NUE and an increased biomass production
compared with the wild type control.
[2048] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "nuclear pore
complex subunit" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 6208 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2049] It was further observed that increasing or generating the
activity of a gene product with the activity of a "nuclear pore
complex subunit" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 6208 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2050] It was further observed that increasing or generating the
activity of a gene product with the activity of a "nuclear pore
complex subunit" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 6208 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2051] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"yjl064w-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 6242 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2052] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yjl064w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
6242 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2053] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yjl064w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
6242 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2054] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"yjl067w-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 6246 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2055] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yjl067w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
6246 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2056] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yjl067w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
6246 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2057] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"potassium:hydrogen antiporter" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 6250 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[2058] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"potassium:hydrogen antiporter" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO.: 6250 in Arabidopsis thaliana
conferred an increased biomass production compared with the wild
type control.
[2059] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"potassium:hydrogen antiporter" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 6250 in Arabidopsis thaliana
conferred an increased NUE and an increased biomass production
compared with the wild type control.
[2060] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "GPI-anchored
cell wall protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 6297 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2061] It was further observed that increasing or generating the
activity of a gene product with the activity of a "GPI-anchored
cell wall protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 6297 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2062] It was further observed that increasing or generating the
activity of a gene product with the activity of a "GPI-anchored
cell wall protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 6297 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2063] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"yjl213w-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 6326 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2064] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yjl213w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
6326 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2065] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yjl213w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
6326 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2066] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"peptidyl-prolyl cis-trans isomerase" encoded by a gene comprising
the nucleic acid sequence SEQ ID NO. 6488 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[2067] It was further observed that increasing or generating the
activity of a gene product with the activity of a "peptidyl-prolyl
cis-trans isomerase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 6488 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2068] It was further observed that increasing or generating the
activity of a gene product with the activity of a "peptidyl-prolyl
cis-trans isomerase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 6488 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2069] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "clathrin
associated protein complex small subunit" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 6550 in Arabidopsis
thaliana conferred an increased yield, especially an increased NUE
compared with the wild type control.
[2070] It was further observed that increasing or generating the
activity of a gene product with the activity of a "clathrin
associated protein complex small subunit" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO.: 6550 in
Arabidopsis thaliana conferred an increased biomass production
compared with the wild type control.
[2071] It was further observed that increasing or generating the
activity of a gene product with the activity of a "clathrin
associated protein complex small subunit" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 6550 in Arabidopsis
thaliana conferred an increased NUE and an increased biomass
production compared with the wild type control.
[2072] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "zinc
metalloprotease" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 6700 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2073] It was further observed that increasing or generating the
activity of a gene product with the activity of a "zinc
metalloprotease" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 6700 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2074] It was further observed that increasing or generating the
activity of a gene product with the activity of a "zinc
metalloprotease" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 6700 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2075] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "F1F0 ATP
synthase beta subunit" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 6816 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2076] It was further observed that increasing or generating the
activity of a gene product with the activity of a "F1F0 ATP
synthase beta subunit" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO.: 6816 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2077] It was further observed that increasing or generating the
activity of a gene product with the activity of a "F1F0 ATP
synthase beta subunit" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 6816 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2078] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"alpha-mannosidase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 7366 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2079] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"alpha-mannosidase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 7366 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2080] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"alpha-mannosidase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 7366 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2081] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "ribosomal
protein of the small subunit" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 7475 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[2082] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ribosomal
protein of the small subunit" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO.: 7475 in Arabidopsis thaliana
conferred an increased biomass production compared with the wild
type control.
[2083] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ribosomal
protein of the small subunit" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 7475 in Arabidopsis thaliana
conferred an increased NUE and an increased biomass production
compared with the wild type control.
[2084] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"mitochondrial intermembrane space protein" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 7602 in Arabidopsis
thaliana conferred an increased yield, especially an increased NUE
compared with the wild type control.
[2085] It was further observed that increasing or generating the
activity of a gene product with the activity of a "mitochondrial
intermembrane space protein" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO.: 7602 in Arabidopsis thaliana
conferred an increased biomass production compared with the wild
type control.
[2086] It was further observed that increasing or generating the
activity of a gene product with the activity of a "mitochondrial
intermembrane space protein" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 7602 in Arabidopsis thaliana
conferred an increased NUE and an increased biomass production
compared with the wild type control.
[2087] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"phosphopantothenoylcysteine decarboxylase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 7651 in Arabidopsis
thaliana conferred an increased yield, especially an increased NUE
compared with the wild type control.
[2088] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"phosphopantothenoylcysteine decarboxylase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO.: 7651 in
Arabidopsis thaliana conferred an increased biomass production
compared with the wild type control.
[2089] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"phosphopantothenoylcysteine decarboxylase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 7651 in Arabidopsis
thaliana conferred an increased NUE and an increased biomass
production compared with the wild type control.
[2090] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"ykl100c-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 7661 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2091] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ykl100c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
7661 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2092] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ykl100c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
7661 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2093] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"ykl131w-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 7675 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2094] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ykl131w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
7675 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2095] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ykl131w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
7675 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2096] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"mitochondrial ribosomal protein of the large subunit" encoded by a
gene comprising the nucleic acid sequence SEQ ID NO. 7679 in
Arabidopsis thaliana conferred an increased yield, especially an
increased NUE compared with the wild type control.
[2097] It was further observed that increasing or generating the
activity of a gene product with the activity of a "mitochondrial
ribosomal protein of the large subunit" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO.: 7679 in
Arabidopsis thaliana conferred an increased biomass production
compared with the wild type control.
[2098] It was further observed that increasing or generating the
activity of a gene product with the activity of a "mitochondrial
ribosomal protein of the large subunit" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 7679 in Arabidopsis
thaliana conferred an increased NUE and an increased biomass
production compared with the wild type control.
[2099] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "G protein
coupled pheromone receptor receptor" encoded by a gene comprising
the nucleic acid sequence SEQ ID NO. 7710 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[2100] It was further observed that increasing or generating the
activity of a gene product with the activity of a "G protein
coupled pheromone receptor receptor" encoded by a gene comprising
the nucleic acid sequence SEQ ID NO.: 7710 in Arabidopsis thaliana
conferred an increased biomass production compared with the wild
type control.
[2101] It was further observed that increasing or generating the
activity of a gene product with the activity of a "G protein
coupled pheromone receptor receptor" encoded by a gene comprising
the nucleic acid sequence SEQ ID NO. 7710 in Arabidopsis thaliana
conferred an increased NUE and an increased biomass production
compared with the wild type control.
[2102] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "golgi
membrane protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 7735 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2103] It was further observed that increasing or generating the
activity of a gene product with the activity of a "golgi membrane
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO.: 7735 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2104] It was further observed that increasing or generating the
activity of a gene product with the activity of a "golgi membrane
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 7735 in Arabidopsis thaliana conferred an increased NUE and
an increased biomass production compared with the wild type
control.
[2105] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
7778 in Arabidopsis thaliana conferred an increased yield,
especially an increased NUE compared with the wild type
control.
[2106] It was further observed that increasing or generating the
activity of a gene product with the activity of a "regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
7778 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2107] It was further observed that increasing or generating the
activity of a gene product with the activity of a "regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
7778 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2108] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"dihydroorotate dehydrogenase" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 7829 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[2109] It was further observed that increasing or generating the
activity of a gene product with the activity of a "dihydroorotate
dehydrogenase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 7829 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2110] It was further observed that increasing or generating the
activity of a gene product with the activity of a "dihydroorotate
dehydrogenase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 7829 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2111] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"ykr016w-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 8017 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2112] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ykr016w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
8017 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2113] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ykr016w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
8017 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2114] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"ykr021w-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 8045 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2115] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ykr021w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
8045 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2116] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ykr021w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
8045 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2117] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"non-essential small GTPase of the Rho/Rac subfamily of Ras-like
proteins" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 8073 in Arabidopsis thaliana conferred an increased
yield, especially an increased NUE compared with the wild type
control.
[2118] It was further observed that increasing or generating the
activity of a gene product with the activity of a "non-essential
small GTPase of the Rho/Rac subfamily of Ras-like proteins" encoded
by a gene comprising the nucleic acid sequence SEQ ID NO.: 8073 in
Arabidopsis thaliana conferred an increased biomass production
compared with the wild type control.
[2119] It was further observed that increasing or generating the
activity of a gene product with the activity of a "non-essential
small GTPase of the Rho/Rac subfamily of Ras-like proteins" encoded
by a gene comprising the nucleic acid sequence SEQ ID NO. 8073 in
Arabidopsis thaliana conferred an increased NUE and an increased
biomass production compared with the wild type control.
[2120] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "integral
membrane protein localized to late Golgi vesicles" encoded by a
gene comprising the nucleic acid sequence SEQ ID NO. 8263 in
Arabidopsis thaliana conferred an increased yield, especially an
increased NUE compared with the wild type control.
[2121] It was further observed that increasing or generating the
activity of a gene product with the activity of a "integral
membrane protein localized to late Golgi vesicles" encoded by a
gene comprising the nucleic acid sequence SEQ ID NO.: 8263 in
Arabidopsis thaliana conferred an increased biomass production
compared with the wild type control.
[2122] It was further observed that increasing or generating the
activity of a gene product with the activity of a "integral
membrane protein localized to late Golgi vesicles" encoded by a
gene comprising the nucleic acid sequence SEQ ID NO. 8263 in
Arabidopsis thaliana conferred an increased NUE and an increased
biomass production compared with the wild type control.
[2123] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "peptide
transporter" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 8287 in Arabidopsis thaliana conferred an increased
yield, especially an increased NUE compared with the wild type
control.
[2124] It was further observed that increasing or generating the
activity of a gene product with the activity of a "peptide
transporter" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO.: 8287 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[2125] It was further observed that increasing or generating the
activity of a gene product with the activity of a "peptide
transporter" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 8287 in Arabidopsis thaliana conferred an increased NUE
and an increased biomass production compared with the wild type
control.
[2126] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"transcription factor" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 8468 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2127] It was further observed that increasing or generating the
activity of a gene product with the activity of a "transcription
factor" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO.: 8468 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2128] It was further observed that increasing or generating the
activity of a gene product with the activity of a "transcription
factor" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 8468 in Arabidopsis thaliana conferred an increased NUE and
an increased biomass production compared with the wild type
control.
[2129] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"transmembrane protein with a role in cell wall polymer
composition" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 8484 in Arabidopsis thaliana conferred an increased
yield, especially an increased NUE compared with the wild type
control.
[2130] It was further observed that increasing or generating the
activity of a gene product with the activity of a "transmembrane
protein with a role in cell wall polymer composition" encoded by a
gene comprising the nucleic acid sequence SEQ ID NO.: 8484 in
Arabidopsis thaliana conferred an increased biomass production
compared with the wild type control.
[2131] It was further observed that increasing or generating the
activity of a gene product with the activity of a "transmembrane
protein with a role in cell wall polymer composition" encoded by a
gene comprising the nucleic acid sequence SEQ ID NO. 8484 in
Arabidopsis thaliana conferred an increased NUE and an increased
biomass production compared with the wild type control.
[2132] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"yll014w-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 8492 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2133] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yll014w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
8492 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2134] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yll014w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
8492 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2135] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"non-essential Ras guanine nucleotide exchange factor" encoded by a
gene comprising the nucleic acid sequence SEQ ID NO. 8514 in
Arabidopsis thaliana conferred an increased yield, especially an
increased NUE compared with the wild type control.
[2136] It was further observed that increasing or generating the
activity of a gene product with the activity of a "non-essential
Ras guanine nucleotide exchange factor" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO.: 8514 in
Arabidopsis thaliana conferred an increased biomass production
compared with the wild type control.
[2137] It was further observed that increasing or generating the
activity of a gene product with the activity of a "non-essential
Ras guanine nucleotide exchange factor" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 8514 in Arabidopsis
thaliana conferred an increased NUE and an increased biomass
production compared with the wild type control.
[2138] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"yll023c-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 8539 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2139] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yll023c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
8539 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2140] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yll023c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
8539 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2141] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"yll037w-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 8571 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2142] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yll037w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
8571 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2143] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yll037w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
8571 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2144] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"yll049w-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 8575 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2145] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yll049w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
8575 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2146] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yll049w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
8575 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2147] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "cysteine
transporter" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 8579 in Arabidopsis thaliana conferred an increased
yield, especially an increased NUE compared with the wild type
control.
[2148] It was further observed that increasing or generating the
activity of a gene product with the activity of a "cysteine
transporter" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO.: 8579 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[2149] It was further observed that increasing or generating the
activity of a gene product with the activity of a "cysteine
transporter" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 8579 in Arabidopsis thaliana conferred an increased NUE
and an increased biomass production compared with the wild type
control.
[2150] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "metal ion
transporter" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 8661 in Arabidopsis thaliana conferred an increased
yield, especially an increased NUE compared with the wild type
control.
[2151] It was further observed that increasing or generating the
activity of a gene product with the activity of a "metal ion
transporter" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO.: 8661 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[2152] It was further observed that increasing or generating the
activity of a gene product with the activity of a "metal ion
transporter" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 8661 in Arabidopsis thaliana conferred an increased NUE
and an increased biomass production compared with the wild type
control.
[2153] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"ylr042c-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 8991 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2154] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ylr042c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
8991 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2155] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ylr042c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
8991 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2156] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"YLR053c-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 8995 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2157] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YLR053c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
8995 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2158] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YLR053c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
8995 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2159] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "cytosolic
serine hydroxymethyltransferase" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 8999 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[2160] It was further observed that increasing or generating the
activity of a gene product with the activity of a "cytosolic serine
hydroxymethyltransferase" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO.: 8999 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2161] It was further observed that increasing or generating the
activity of a gene product with the activity of a "cytosolic serine
hydroxymethyltransferase" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 8999 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2162] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "subunit of
cytoplasmic phenylalanyl-tRNA synthetase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 9551 in Arabidopsis
thaliana conferred an increased yield, especially an increased NUE
compared with the wild type control.
[2163] It was further observed that increasing or generating the
activity of a gene product with the activity of a "subunit of
cytoplasmic phenylalanyl-tRNA synthetase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO.: 9551 in
Arabidopsis thaliana conferred an increased biomass production
compared with the wild type control.
[2164] It was further observed that increasing or generating the
activity of a gene product with the activity of a "subunit of
cytoplasmic phenylalanyl-tRNA synthetase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 9551 in Arabidopsis
thaliana conferred an increased NUE and an increased biomass
production compared with the wild type control.
[2165] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"ylr065c-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 9637 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2166] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ylr065c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
9637 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2167] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ylr065c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
9637 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2168] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "xylitol
dehydrogenase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 9672 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2169] It was further observed that increasing or generating the
activity of a gene product with the activity of a "xylitol
dehydrogenase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 9672 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2170] It was further observed that increasing or generating the
activity of a gene product with the activity of a "xylitol
dehydrogenase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 9672 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2171] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "3-keto
sterol reductase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 10182 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2172] It was further observed that increasing or generating the
activity of a gene product with the activity of a "3-keto sterol
reductase" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO.: 10182 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[2173] It was further observed that increasing or generating the
activity of a gene product with the activity of a "3-keto sterol
reductase" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 10182 in Arabidopsis thaliana conferred an increased NUE
and an increased biomass production compared with the wild type
control.
[2174] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "alkyl
hydroperoxide reductase" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 10214 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2175] It was further observed that increasing or generating the
activity of a gene product with the activity of a "alkyl
hydroperoxide reductase" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO.: 10214 in Arabidopsis thaliana conferred
an increased biomass production compared with the wild type
control.
[2176] It was further observed that increasing or generating the
activity of a gene product with the activity of a "alkyl
hydroperoxide reductase" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 10214 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2177] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"ylr125w-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 10447 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2178] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ylr125w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
10447 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2179] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ylr125w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
10447 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2180] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "anaphase
promoting complex (APC) subunit" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 10451 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[2181] It was further observed that increasing or generating the
activity of a gene product with the activity of a "anaphase
promoting complex (APC) subunit" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO.: 10451 in Arabidopsis thaliana
conferred an increased biomass production compared with the wild
type control.
[2182] It was further observed that increasing or generating the
activity of a gene product with the activity of a "anaphase
promoting complex (APC) subunit" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 10451 in Arabidopsis thaliana
conferred an increased NUE and an increased biomass production
compared with the wild type control.
[2183] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "protein
component of the large ribosomal subunit" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 10463 in
Arabidopsis thaliana conferred an increased yield, especially an
increased NUE compared with the wild type control.
[2184] It was further observed that increasing or generating the
activity of a gene product with the activity of a "protein
component of the large ribosomal subunit" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO.: 10463 in
Arabidopsis thaliana conferred an increased biomass production
compared with the wild type control.
[2185] It was further observed that increasing or generating the
activity of a gene product with the activity of a "protein
component of the large ribosomal subunit" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 10463 in
Arabidopsis thaliana conferred an increased NUE and an increased
biomass production compared with the wild type control.
[2186] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"mitochondrial protein" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 10533 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2187] It was further observed that increasing or generating the
activity of a gene product with the activity of a "mitochondrial
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO.: 10533 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[2188] It was further observed that increasing or generating the
activity of a gene product with the activity of a "mitochondrial
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 10533 in Arabidopsis thaliana conferred an increased NUE and
an increased biomass production compared with the wild type
control.
[2189] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "ARV1
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 10541 in Arabidopsis thaliana conferred an increased yield,
especially an increased NUE compared with the wild type
control.
[2190] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ARV1 protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
10541 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2191] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ARV1 protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
10541 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2192] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "GTP-binding
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 10562 in Arabidopsis thaliana conferred an increased yield,
especially an increased NUE compared with the wild type
control.
[2193] It was further observed that increasing or generating the
activity of a gene product with the activity of a "GTP-binding
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO.: 10562 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[2194] It was further observed that increasing or generating the
activity of a gene product with the activity of a "GTP-binding
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 10562 in Arabidopsis thaliana conferred an increased NUE and
an increased biomass production compared with the wild type
control.
[2195] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "protein
involved in shmoo formation and bipolar bud site selection" encoded
by a gene comprising the nucleic acid sequence SEQ ID NO. 10990 in
Arabidopsis thaliana conferred an increased yield, especially an
increased NUE compared with the wild type control.
[2196] It was further observed that increasing or generating the
activity of a gene product with the activity of a "protein involved
in shmoo formation and bipolar bud site selection" encoded by a
gene comprising the nucleic acid sequence SEQ ID NO.: 10990 in
Arabidopsis thaliana conferred an increased biomass production
compared with the wild type control.
[2197] It was further observed that increasing or generating the
activity of a gene product with the activity of a "protein involved
in shmoo formation and bipolar bud site selection" encoded by a
gene comprising the nucleic acid sequence SEQ ID NO. 10990 in
Arabidopsis thaliana conferred an increased NUE and an increased
biomass production compared with the wild type control.
[2198] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"non-essential kinetochore protein" encoded by a gene comprising
the nucleic acid sequence SEQ ID NO. 10998 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[2199] It was further observed that increasing or generating the
activity of a gene product with the activity of a "non-essential
kinetochore protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 10998 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2200] It was further observed that increasing or generating the
activity of a gene product with the activity of a "non-essential
kinetochore protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 10998 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2201] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "Meiotic
recombination protein" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 11004 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2202] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Meiotic
recombination protein" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO.: 11004 in Arabidopsis thaliana conferred
an increased biomass production compared with the wild type
control.
[2203] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Meiotic
recombination protein" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 11004 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2204] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "signal
transducing MEK kinase" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 11012 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2205] It was further observed that increasing or generating the
activity of a gene product with the activity of a "signal
transducing MEK kinase" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO.: 11012 in Arabidopsis thaliana conferred
an increased biomass production compared with the wild type
control.
[2206] It was further observed that increasing or generating the
activity of a gene product with the activity of a "signal
transducing MEK kinase" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 11012 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2207] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "cytochrome c
oxidase subunit VIII" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 11054 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2208] It was further observed that increasing or generating the
activity of a gene product with the activity of a "cytochrome c
oxidase subunit VIII" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 11054 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2209] It was further observed that increasing or generating the
activity of a gene product with the activity of a "cytochrome c
oxidase subunit VIII" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 11054 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2210] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"ylr404w-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 11066 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2211] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ylr404w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
11066 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2212] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ylr404w-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
11066 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2213] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"ylr463c-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 11074 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2214] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ylr463c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
11074 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2215] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ylr463c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
11074 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2216] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "adenine
phosphoribosyltransferase" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 11080 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2217] It was further observed that increasing or generating the
activity of a gene product with the activity of a "adenine
phosphoribosyltransferase" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO.: 11080 in Arabidopsis thaliana conferred
an increased biomass production compared with the wild type
control.
[2218] It was further observed that increasing or generating the
activity of a gene product with the activity of a "adenine
phosphoribosyltransferase" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 11080 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2219] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "Mcm1p
binding transcriptional repressor" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 11552 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[2220] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Mcm1p binding
transcriptional repressor" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO.: 11552 in Arabidopsis thaliana conferred
an increased biomass production compared with the wild type
control.
[2221] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Mcm1p binding
transcriptional repressor" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 11552 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2222] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "origin
recognition complex subunit" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 11569 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[2223] It was further observed that increasing or generating the
activity of a gene product with the activity of a "origin
recognition complex subunit" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO.: 11569 in Arabidopsis thaliana
conferred an increased biomass production compared with the wild
type control.
[2224] It was further observed that increasing or generating the
activity of a gene product with the activity of a "origin
recognition complex subunit" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 11569 in Arabidopsis thaliana
conferred an increased NUE and an increased biomass production
compared with the wild type control.
[2225] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"yml089c-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 11596 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2226] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yml089c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
11596 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2227] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yml089c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
11596 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2228] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"yml128c-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 11600 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2229] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yml128c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
11600 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2230] It was further observed that increasing or generating the
activity of a gene product with the activity of a "yml128c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
11600 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2231] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "hexose
transporter" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 11612 in Arabidopsis thaliana conferred an increased
yield, especially an increased NUE compared with the wild type
control.
[2232] It was further observed that increasing or generating the
activity of a gene product with the activity of a "hexose
transporter" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO.: 11612 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[2233] It was further observed that increasing or generating the
activity of a gene product with the activity of a "hexose
transporter" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 11612 in Arabidopsis thaliana conferred an increased NUE
and an increased biomass production compared with the wild type
control.
[2234] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "Zinc finger
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 12246 in Arabidopsis thaliana conferred an increased yield,
especially an increased NUE compared with the wild type
control.
[2235] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Zinc finger
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO.: 12246 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[2236] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Zinc finger
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 12246 in Arabidopsis thaliana conferred an increased NUE and
an increased biomass production compared with the wild type
control.
[2237] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "protein
required for maturation of ribosomal RNAs" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 12263 in
Arabidopsis thaliana conferred an increased yield, especially an
increased NUE compared with the wild type control.
[2238] It was further observed that increasing or generating the
activity of a gene product with the activity of a "protein required
for maturation of ribosomal RNAs" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO.: 12263 in Arabidopsis thaliana
conferred an increased biomass production compared with the wild
type control.
[2239] It was further observed that increasing or generating the
activity of a gene product with the activity of a "protein required
for maturation of ribosomal RNAs" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 12263 in Arabidopsis thaliana
conferred an increased NUE and an increased biomass production
compared with the wild type control.
[2240] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "Factor
arrest protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 12316 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2241] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Factor arrest
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO.: 12316 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[2242] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Factor arrest
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 12316 in Arabidopsis thaliana conferred an increased NUE and
an increased biomass production compared with the wild type
control.
[2243] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"YMR082C-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 12327 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2244] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YMR082C-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
12327 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2245] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YMR082C-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
12327 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2246] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "Nuclear
cap-binding protein complex subunit" encoded by a gene comprising
the nucleic acid sequence SEQ ID NO. 12331 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[2247] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Nuclear
cap-binding protein complex subunit" encoded by a gene comprising
the nucleic acid sequence SEQ ID NO.: 12331 in Arabidopsis thaliana
conferred an increased biomass production compared with the wild
type control.
[2248] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Nuclear
cap-binding protein complex subunit" encoded by a gene comprising
the nucleic acid sequence SEQ ID NO. 12331 in Arabidopsis thaliana
conferred an increased NUE and an increased biomass production
compared with the wild type control.
[2249] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "YMR126c
membrane protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 12378 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2250] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YMR126c membrane
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO.: 12378 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[2251] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YMR126c membrane
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 12378 in Arabidopsis thaliana conferred an increased NUE and
an increased biomass production compared with the wild type
control.
[2252] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"YMR144W-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 12394 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2253] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YMR144W-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
12394 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2254] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YMR144W-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
12394 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2255] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"YMR160W-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 12406 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2256] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YMR160W-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
12406 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2257] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YMR160W-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
12406 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2258] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "Stationary
phase protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 12414 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2259] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Stationary phase
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO.: 12414 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[2260] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Stationary phase
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 12414 in Arabidopsis thaliana conferred an increased NUE and
an increased biomass production compared with the wild type
control.
[2261] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"YMR209C-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 12420 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2262] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YMR209C-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
12420 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2263] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YMR209C-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
12420 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2264] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"YMR233W-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 12440 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2265] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YMR233W-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
12440 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2266] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YMR233W-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
12440 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2267] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"phosphoglucomutase/phosphomannomutase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 12470 in
Arabidopsis thaliana conferred an increased yield, especially an
increased NUE compared with the wild type control.
[2268] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"phosphoglucomutase/phosphomannomutase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO.: 12470 in
Arabidopsis thaliana conferred an increased biomass production
compared with the wild type control.
[2269] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"phosphoglucomutase/phosphomannomutase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 12470 in
Arabidopsis thaliana conferred an increased NUE and an increased
biomass production compared with the wild type control.
[2270] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "Regulatory
CAT8 protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 12749 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2271] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Regulatory CAT8
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO.: 12749 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[2272] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Regulatory CAT8
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 12749 in Arabidopsis thaliana conferred an increased NUE and
an increased biomass production compared with the wild type
control.
[2273] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"translational elongation factor EF-3 (HEF3)" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 12773 in
Arabidopsis thaliana conferred an increased yield, especially an
increased NUE compared with the wild type control.
[2274] It was further observed that increasing or generating the
activity of a gene product with the activity of a "translational
elongation factor EF-3 (HEF3)" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO.: 12773 in Arabidopsis thaliana
conferred an increased biomass production compared with the wild
type control.
[2275] It was further observed that increasing or generating the
activity of a gene product with the activity of a "translational
elongation factor EF-3 (HEF3)" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 12773 in Arabidopsis thaliana
conferred an increased NUE and an increased biomass production
compared with the wild type control.
[2276] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"YNL320W-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 12829 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2277] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YNL320W-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
12829 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2278] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YNL320W-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
12829 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2279] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "Chitin
synthase 3 complex protein" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 12883 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[2280] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Chitin synthase
3 complex protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 12883 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2281] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Chitin synthase
3 complex protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 12883 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2282] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"Alkyl/aryl-sulfatase" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 12889 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2283] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"Alkyl/aryl-sulfatase" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO.: 12889 in Arabidopsis thaliana conferred
an increased biomass production compared with the wild type
control.
[2284] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"Alkyl/aryl-sulfatase" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 12889 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2285] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "antiviral
adaptor protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 13014 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2286] It was further observed that increasing or generating the
activity of a gene product with the activity of a "antiviral
adaptor protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 13014 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2287] It was further observed that increasing or generating the
activity of a gene product with the activity of a "antiviral
adaptor protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 13014 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2288] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "repressor of
G1 transcription" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 13018 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2289] It was further observed that increasing or generating the
activity of a gene product with the activity of a "repressor of G1
transcription" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 13018 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2290] It was further observed that increasing or generating the
activity of a gene product with the activity of a "repressor of G1
transcription" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 13018 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2291] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"YOR097c-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 13024 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2292] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YOR097c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
13024 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2293] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YOR097c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
13024 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2294] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"Phosphoribosylaminoimidazole carboxylase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 13030 in
Arabidopsis thaliana conferred an increased yield, especially an
increased NUE compared with the wild type control.
[2295] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"Phosphoribosylaminoimidazole carboxylase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO.: 13030 in
Arabidopsis thaliana conferred an increased biomass production
compared with the wild type control.
[2296] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"Phosphoribosylaminoimidazole carboxylase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 13030 in
Arabidopsis thaliana conferred an increased NUE and an increased
biomass production compared with the wild type control.
[2297] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "component of
the RAM signaling network" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 14085 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2298] It was further observed that increasing or generating the
activity of a gene product with the activity of a "component of the
RAM signaling network" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO.: 14085 in Arabidopsis thaliana conferred
an increased biomass production compared with the wild type
control.
[2299] It was further observed that increasing or generating the
activity of a gene product with the activity of a "component of the
RAM signaling network" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 14085 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2300] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "protein
kinase" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 14093 in Arabidopsis thaliana conferred an increased yield,
especially an increased NUE compared with the wild type
control.
[2301] It was further observed that increasing or generating the
activity of a gene product with the activity of a "protein kinase"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
14093 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2302] It was further observed that increasing or generating the
activity of a gene product with the activity of a "protein kinase"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
14093 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2303] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "signal
recognition particle subunit (SRP54)" encoded by a gene comprising
the nucleic acid sequence SEQ ID NO. 14113 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[2304] It was further observed that increasing or generating the
activity of a gene product with the activity of a "signal
recognition particle subunit (SRP54)" encoded by a gene comprising
the nucleic acid sequence SEQ ID NO.: 14113 in Arabidopsis thaliana
conferred an increased biomass production compared with the wild
type control.
[2305] It was further observed that increasing or generating the
activity of a gene product with the activity of a "signal
recognition particle subunit (SRP54)" encoded by a gene comprising
the nucleic acid sequence SEQ ID NO. 14113 in Arabidopsis thaliana
conferred an increased NUE and an increased biomass production
compared with the wild type control.
[2306] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "regulatory
subunit of the 26S proteasome" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 14246 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[2307] It was further observed that increasing or generating the
activity of a gene product with the activity of a "regulatory
subunit of the 26S proteasome" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO.: 14246 in Arabidopsis thaliana
conferred an increased biomass production compared with the wild
type control.
[2308] It was further observed that increasing or generating the
activity of a gene product with the activity of a "regulatory
subunit of the 26S proteasome" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 14246 in Arabidopsis thaliana
conferred an increased NUE and an increased biomass production
compared with the wild type control.
[2309] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "RNA
polymerase III subunit" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 14311 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2310] It was further observed that increasing or generating the
activity of a gene product with the activity of a "RNA polymerase
III subunit" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO.: 14311 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[2311] It was further observed that increasing or generating the
activity of a gene product with the activity of a "RNA polymerase
III subunit" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 14311 in Arabidopsis thaliana conferred an increased NUE
and an increased biomass production compared with the wild type
control.
[2312] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"lysophospholipase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 14914 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2313] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"lysophospholipase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 14914 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2314] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"lysophospholipase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 14914 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2315] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "saccharopine
dehydrogenase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 15382 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2316] It was further observed that increasing or generating the
activity of a gene product with the activity of a "saccharopine
dehydrogenase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 15382 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2317] It was further observed that increasing or generating the
activity of a gene product with the activity of a "saccharopine
dehydrogenase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 15382 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2318] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"alpha-mannosidase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 15460 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2319] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"alpha-mannosidase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 15460 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2320] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"alpha-mannosidase" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 15460 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2321] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"ykl100c-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 15571 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2322] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ykl100c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
15571 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2323] It was further observed that increasing or generating the
activity of a gene product with the activity of a "ykl100c-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
15571 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2324] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
15593 in Arabidopsis thaliana conferred an increased yield,
especially an increased NUE compared with the wild type
control.
[2325] It was further observed that increasing or generating the
activity of a gene product with the activity of a "regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
15593 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2326] It was further observed that increasing or generating the
activity of a gene product with the activity of a "regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
15593 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2327] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"non-essential Ras guanine nucleotide exchange factor" encoded by a
gene comprising the nucleic acid sequence SEQ ID NO. 15646 in
Arabidopsis thaliana conferred an increased yield, especially an
increased NUE compared with the wild type control.
[2328] It was further observed that increasing or generating the
activity of a gene product with the activity of a "non-essential
Ras guanine nucleotide exchange factor" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO.: 15646 in
Arabidopsis thaliana conferred an increased biomass production
compared with the wild type control.
[2329] It was further observed that increasing or generating the
activity of a gene product with the activity of a "non-essential
Ras guanine nucleotide exchange factor" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 15646 in
Arabidopsis thaliana conferred an increased NUE and an increased
biomass production compared with the wild type control.
[2330] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "metal ion
transporter" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 15673 in Arabidopsis thaliana conferred an increased
yield, especially an increased NUE compared with the wild type
control.
[2331] It was further observed that increasing or generating the
activity of a gene product with the activity of a "metal ion
transporter" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO.: 15673 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[2332] It was further observed that increasing or generating the
activity of a gene product with the activity of a "metal ion
transporter" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 15673 in Arabidopsis thaliana conferred an increased NUE
and an increased biomass production compared with the wild type
control.
[2333] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "subunit of
cytoplasmic phenylalanyl-tRNA synthetase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 16005 in
Arabidopsis thaliana conferred an increased yield, especially an
increased NUE compared with the wild type control.
[2334] It was further observed that increasing or generating the
activity of a gene product with the activity of a "subunit of
cytoplasmic phenylalanyl-tRNA synthetase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO.: 16005 in
Arabidopsis thaliana conferred an increased biomass production
compared with the wild type control.
[2335] It was further observed that increasing or generating the
activity of a gene product with the activity of a "subunit of
cytoplasmic phenylalanyl-tRNA synthetase" encoded by a gene
comprising the nucleic acid sequence SEQ ID NO. 16005 in
Arabidopsis thaliana conferred an increased NUE and an increased
biomass production compared with the wild type control.
[2336] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"YMR082C-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 16114 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2337] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YMR082C-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
16114 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2338] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YMR082C-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
16114 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2339] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"B1258-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 14402 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2340] It was further observed that increasing or generating the
activity of a gene product with the activity of a "B1258-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
14402 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2341] It was further observed that increasing or generating the
activity of a gene product with the activity of a "B1258-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
14402 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2342] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"YML101C-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 16093 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2343] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YML101C-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
16093 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2344] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YML101C-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
16093 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2345] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "nuclear
fusion protein precursor" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 16106 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2346] It was further observed that increasing or generating the
activity of a gene product with the activity of a "nuclear fusion
protein precursor" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 16106 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2347] It was further observed that increasing or generating the
activity of a gene product with the activity of a "nuclear fusion
protein precursor" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 16106 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2348] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "inheritance
of peroxisomes protein" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 16120 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2349] It was further observed that increasing or generating the
activity of a gene product with the activity of a "inheritance of
peroxisomes protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 16120 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2350] It was further observed that increasing or generating the
activity of a gene product with the activity of a "inheritance of
peroxisomes protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 16120 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2351] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"exoribonuclease" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 16275 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2352] It was further observed that increasing or generating the
activity of a gene product with the activity of a "exoribonuclease"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
16275 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2353] It was further observed that increasing or generating the
activity of a gene product with the activity of a "exoribonuclease"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
16275 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2354] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "iron sulfur
cluster assembly protein" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 16305 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2355] It was further observed that increasing or generating the
activity of a gene product with the activity of a "iron sulfur
cluster assembly protein" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO.: 16305 in Arabidopsis thaliana conferred
an increased biomass production compared with the wild type
control.
[2356] It was further observed that increasing or generating the
activity of a gene product with the activity of a "iron sulfur
cluster assembly protein" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 16305 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2357] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"YPL068C-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 16573 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2358] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YPL068C-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
16573 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2359] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YPL068C-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
16573 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2360] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"B0165-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 14396 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2361] It was further observed that increasing or generating the
activity of a gene product with the activity of a "B0165-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
14396 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2362] It was further observed that increasing or generating the
activity of a gene product with the activity of a "B0165-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
14396 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2363] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"YOR203W-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 16299 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2364] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YOR203W-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
16299 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2365] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YOR203W-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
16299 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2366] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"ribonucleoprotein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 16133 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2367] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"ribonucleoprotein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 16133 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2368] It was further observed that increasing or generating the
activity of a gene product with the activity of a
"ribonucleoprotein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 16133 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2369] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"transcription factor" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 15056 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2370] It was further observed that increasing or generating the
activity of a gene product with the activity of a "transcription
factor" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO.: 15056 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[2371] It was further observed that increasing or generating the
activity of a gene product with the activity of a "transcription
factor" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 15056 in Arabidopsis thaliana conferred an increased NUE and
an increased biomass production compared with the wild type
control.
[2372] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"YKL111C-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 15587 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2373] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YKL111C-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
15587 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2374] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YKL111C-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
15587 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2375] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "iron sulfur
cluster assembly protein" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 16582 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2376] It was further observed that increasing or generating the
activity of a gene product with the activity of a "iron sulfur
cluster assembly protein" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO.: 16582 in Arabidopsis thaliana conferred
an increased biomass production compared with the wild type
control.
[2377] It was further observed that increasing or generating the
activity of a gene product with the activity of a "iron sulfur
cluster assembly protein" encoded by a gene comprising the nucleic
acid sequence SEQ ID NO. 16582 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2378] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "transport
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 14839 in Arabidopsis thaliana conferred an increased yield,
especially an increased NUE compared with the wild type
control.
[2379] It was further observed that increasing or generating the
activity of a gene product with the activity of a "transport
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO.: 14839 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[2380] It was further observed that increasing or generating the
activity of a gene product with the activity of a "transport
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 14839 in Arabidopsis thaliana conferred an increased NUE and
an increased biomass production compared with the wild type
control.
[2381] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "protein
translocase protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 15014 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2382] It was further observed that increasing or generating the
activity of a gene product with the activity of a "protein
translocase protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO.: 15014 in Arabidopsis thaliana conferred an
increased biomass production compared with the wild type
control.
[2383] It was further observed that increasing or generating the
activity of a gene product with the activity of a "protein
translocase protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 15014 in Arabidopsis thaliana conferred an
increased NUE and an increased biomass production compared with the
wild type control.
[2384] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"YJL010C-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 15432 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2385] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YJL010C-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
15432 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2386] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YJL010C-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
15432 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2387] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"B1267-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 14497 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2388] It was further observed that increasing or generating the
activity of a gene product with the activity of a "B1267-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
14497 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2389] It was further observed that increasing or generating the
activity of a gene product with the activity of a "B1267-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
14497 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2390] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "membrane
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 14718 in Arabidopsis thaliana conferred an increased yield,
especially an increased NUE compared with the wild type
control.
[2391] It was further observed that increasing or generating the
activity of a gene product with the activity of a "membrane
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO.: 14718 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[2392] It was further observed that increasing or generating the
activity of a gene product with the activity of a "membrane
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 14718 in Arabidopsis thaliana conferred an increased NUE and
an increased biomass production compared with the wild type
control.
[2393] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"B1381-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 14791 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2394] It was further observed that increasing or generating the
activity of a gene product with the activity of a "B1381-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
14791 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2395] It was further observed that increasing or generating the
activity of a gene product with the activity of a "B1381-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
14791 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2396] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"B2646-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 14879 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2397] It was further observed that increasing or generating the
activity of a gene product with the activity of a "B2646-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
14879 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2398] It was further observed that increasing or generating the
activity of a gene product with the activity of a "B2646-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
14879 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2399] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "60S
ribosomal protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 15064 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2400] It was further observed that increasing or generating the
activity of a gene product with the activity of a "60S ribosomal
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO.: 15064 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[2401] It was further observed that increasing or generating the
activity of a gene product with the activity of a "60S ribosomal
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 15064 in Arabidopsis thaliana conferred an increased NUE and
an increased biomass production compared with the wild type
control.
[2402] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "Rho
GDP-dissociation inhibitor" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 15257 in Arabidopsis thaliana
conferred an increased yield, especially an increased NUE compared
with the wild type control.
[2403] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Rho
GDP-dissociation inhibitor" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO.: 15257 in Arabidopsis thaliana
conferred an increased biomass production compared with the wild
type control.
[2404] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Rho
GDP-dissociation inhibitor" encoded by a gene comprising the
nucleic acid sequence SEQ ID NO. 15257 in Arabidopsis thaliana
conferred an increased NUE and an increased biomass production
compared with the wild type control.
[2405] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"YHL005C-protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 15378 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2406] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YHL005C-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.:
15378 in Arabidopsis thaliana conferred an increased biomass
production compared with the wild type control.
[2407] It was further observed that increasing or generating the
activity of a gene product with the activity of a "YHL005C-protein"
encoded by a gene comprising the nucleic acid sequence SEQ ID NO.
15378 in Arabidopsis thaliana conferred an increased NUE and an
increased biomass production compared with the wild type
control.
[2408] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a
"transmembrane protein with a role in cell wall polymer
composition" encoded by a gene comprising the nucleic acid sequence
SEQ ID NO. 16629 in Arabidopsis thaliana conferred an increased
yield, especially an increased NUE compared with the wild type
control.
[2409] It was further observed that increasing or generating the
activity of a gene product with the activity of a "transmembrane
protein with a role in cell wall polymer composition" encoded by a
gene comprising the nucleic acid sequence SEQ ID NO.: 16629 in
Arabidopsis thaliana conferred an increased biomass production
compared with the wild type control.
[2410] It was further observed that increasing or generating the
activity of a gene product with the activity of a "transmembrane
protein with a role in cell wall polymer composition" encoded by a
gene comprising the nucleic acid sequence SEQ ID NO. 16629 in
Arabidopsis thaliana conferred an increased NUE and an increased
biomass production compared with the wild type control.
[2411] In particular, it was observed that increasing or generating
the activity of a gene product with the activity of a "Stationary
phase protein" encoded by a gene comprising the nucleic acid
sequence SEQ ID NO. 16647 in Arabidopsis thaliana conferred an
increased yield, especially an increased NUE compared with the wild
type control.
[2412] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Stationary phase
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO.: 16647 in Arabidopsis thaliana conferred an increased
biomass production compared with the wild type control.
[2413] It was further observed that increasing or generating the
activity of a gene product with the activity of a "Stationary phase
protein" encoded by a gene comprising the nucleic acid sequence SEQ
ID NO. 16647 in Arabidopsis thaliana conferred an increased NUE and
an increased biomass production compared with the wild type
control.
[2414] Thus, according to the method of the invention an enhanced
NUE and/or increased biomass production in a plant cell, plant or a
part thereof compared to a control or wild type can be
achieved.
[2415] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 39, or encoded
by a nucleic acid molecule comprising the nucleic acid SEQ ID NO.
38 or a nucleic acid which differs from the nucleic acid SEQ ID NO.
38 by exchanging the stop codon taa by tga or a homolog of said
nucleic acid molecule or polypeptide, e.g. if the activity of a
nucleic acid molecule or a polypeptide comprising the nucleic acid
or polypeptide or the consensus sequence or the polypeptide motif,
as depicted in Table I, II or IV, application no. 1, column 7 in
the respective same line as the nucleic acid molecule SEQ ID NO. 38
or polypeptide SEQ ID NO. 39, respectively is increased or
generated or if the activity "b0017-protein" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2416] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 43, or encoded
by a nucleic acid molecule comprising the nucleic acid SEQ ID NO.
42 or a homolog of said nucleic acid molecule or polypeptide, e.g.
if the activity of a nucleic acid molecule or a polypeptide
comprising the nucleic acid or polypeptide or the consensus
sequence or the polypeptide motif, as depicted in Table I, II or
IV, application no. 1, column 7 in the respective same line as the
nucleic acid molecule SEQ ID NO. 42 or polypeptide SEQ ID NO. 43,
respectively is increased or generated or if the activity
"transport protein" is increased or generated in an organism, an
increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2417] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 124, or encoded
by a nucleic acid molecule comprising the nucleic acid SEQ ID NO.
123 or a nucleic acid which differs from the nucleic acid SEQ ID
NO. 123 by exchanging the stop codon taa by tga or a homolog of
said nucleic acid molecule or polypeptide, e.g. if the activity of
a nucleic acid molecule or a polypeptide comprising the nucleic
acid or polypeptide or the consensus sequence or the polypeptide
motif, as depicted in Table I, II or IV, application no. 1, column
7 in the respective same line as the nucleic acid molecule SEQ ID
NO. 123 or polypeptide SEQ ID NO. 124, respectively is increased or
generated or if the activity "hydroxymyristol acyl carrier protein
dehydratase" is increased or generated in an organism, an increased
yield, preferably an enhanced NUE and/or an increased biomass
production compared with the wild type control is conferred in said
organism, especially an enhanced NUE, or an increased biomass
production, or an enhanced NUE and an increased biomass
production.
[2418] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 381, or encoded
by a nucleic acid molecule comprising the nucleic acid SEQ ID NO.
380 or a homolog of said nucleic acid molecule or polypeptide, e.g.
if the activity of a nucleic acid molecule or a polypeptide
comprising the nucleic acid or polypeptide or the consensus
sequence or the polypeptide motif, as depicted in Table I, II or
IV, application no. 1, column 7 in the respective same line as the
nucleic acid molecule SEQ ID NO. 380 or polypeptide SEQ ID NO. 381,
respectively is increased or generated or if the activity
"gamma-glutamyl kinase" is increased or generated in an organism,
an increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2419] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 680, or encoded
by a nucleic acid molecule comprising the nucleic acid SEQ ID NO.
679 or a homolog of said nucleic acid molecule or polypeptide, e.g.
if the activity of a nucleic acid molecule or a polypeptide
comprising the nucleic acid or polypeptide or the consensus
sequence or the polypeptide motif, as depicted in Table I, II or
IV, application no. 1, column 7 in the respective same line as the
nucleic acid molecule SEQ ID NO. 679 or polypeptide SEQ ID NO. 680,
respectively is increased or generated or if the activity
"alpha-glucosidase" is increased or generated in an organism, an
increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2420] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 813, or encoded
by a nucleic acid molecule comprising the nucleic acid SEQ ID NO.
812 or a homolog of said nucleic acid molecule or polypeptide, e.g.
if the activity of a nucleic acid molecule or a polypeptide
comprising the nucleic acid or polypeptide or the consensus
sequence or the polypeptide motif, as depicted in Table I, II or
IV, application no. 1, column 7 in the respective same line as the
nucleic acid molecule SEQ ID NO. 812 or polypeptide SEQ ID NO. 813,
respectively is increased or generated or if the activity
"adenylate kinase" is increased or generated in an organism, an
increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2421] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 1056, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 1055 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 1055 or polypeptide
SEQ ID NO. 1056, respectively is increased or generated or if the
activity "2-dehydro-3-deoxy-phosphoheptonate aldolase" is increased
or generated in an organism, an increased yield, preferably an
enhanced
[2422] NUE and/or an increased biomass production compared with the
wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2423] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 1564, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 1563 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 1563 or polypeptide
SEQ ID NO. 1564, respectively is increased or generated or if the
activity "molybdopterin biosynthesis protein" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2424] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 1706, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 1705 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 1705 or polypeptide
SEQ ID NO. 1706, respectively is increased or generated or if the
activity "hydroxylamine reductase" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2425] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 1845, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 1844 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 1844 or polypeptide
SEQ ID NO. 1845, respectively is increased or generated or if the
activity "proline dehydrogenase" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2426] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 1951, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 1950 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 1950 or polypeptide
SEQ ID NO. 1951, respectively is increased or generated or if the
activity "PhoH-like protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2427] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 1976, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 1975 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 1975 or polypeptide
SEQ ID NO. 1976, respectively is increased or generated or if the
activity "isomerase" is increased or generated in an organism, an
increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2428] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 2128, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 2127 or a nucleic acid which differs from the nucleic acid
SEQ ID NO. 2127 by exchanging the stop codon taa by tga or a
homolog of said nucleic acid molecule or polypeptide, e.g. if the
activity of a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in Table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 2127 or polypeptide SEQ ID NO. 2128,
respectively is increased or generated or if the activity
"b1933-protein" is increased or generated in an organism, an
increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2429] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 2136, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 2135 or a nucleic acid which differs from the nucleic acid
SEQ ID NO. 2135 by exchanging the stop codon taa by tga or a
homolog of said nucleic acid molecule or polypeptide, e.g. if the
activity of a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in Table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 2135 or polypeptide SEQ ID NO. 2136,
respectively is increased or generated or if the activity
"glycosyltransferase" is increased or generated in an organism, an
increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2430] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 2172, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 2171 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 2171 or polypeptide
SEQ ID NO. 2172, respectively is increased or generated or if the
activity "b2165-protein" is increased or generated in an organism,
an increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2431] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 2298, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 2297 or a nucleic acid which differs from the nucleic acid
SEQ
[2432] ID NO. 2297 by exchanging the stop codon taa by tga or a
homolog of said nucleic acid molecule or polypeptide, e.g. if the
activity of a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in Table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 2297 or polypeptide SEQ ID NO. 2298,
respectively is increased or generated or if the activity "short
chain fatty acid transporter" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2433] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 2427, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 2426 or a nucleic acid which differs from the nucleic acid
SEQ ID NO. 2426 by exchanging the stop codon taa by tga or a
homolog of said nucleic acid molecule or polypeptide, e.g. if the
activity of a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in Table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 2426 or polypeptide SEQ ID NO. 2427,
respectively is increased or generated or if the activity
"b2238-protein" is increased or generated in an organism, an
increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2434] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 2453, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 2452 or a nucleic acid which differs from the nucleic acid
SEQ ID NO. 2452 by exchanging the stop codon taa by tga or a
homolog of said nucleic acid molecule or polypeptide, e.g. if the
activity of a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in Table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 2452 or polypeptide SEQ ID NO. 2453,
respectively is increased or generated or if the activity
"lysine/arginine/ornithine transporter subunit" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2435] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 2552, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 2551 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 2551 or polypeptide
SEQ ID NO. 2552, respectively is increased or generated or if the
activity "b2431-protein" is increased or generated in an organism,
an increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2436] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 2601, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 2600 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 2600 or polypeptide
SEQ ID NO. 2601, respectively is increased or generated or if the
activity "chorismate mutase T/prephenate dehydrogenase
(bifunctional)" is increased or generated in an organism, an
increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2437] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 2669, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 2668 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 2668 or polypeptide
SEQ ID NO. 2669, respectively is increased or generated or if the
activity "b2766-protein" is increased or generated in an organism,
an increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2438] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 2773, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 2772 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 2772 or polypeptide
SEQ ID NO. 2773, respectively is increased or generated or if the
activity "glycine decarboxylase" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2439] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 3118, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 3117 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 3117 or polypeptide
SEQ ID NO. 3118, respectively is increased or generated or if the
activity "threonine ammonia-lyase" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2440] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 3391, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 3390 or a nucleic acid which differs from the nucleic acid
SEQ ID NO. 3390 by exchanging the stop codon taa by tga or a
homolog of said nucleic acid molecule or polypeptide, e.g. if the
activity of a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in Table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 3390 or polypeptide SEQ ID NO. 3391,
respectively is increased or generated or if the activity
"b3120-protein" is increased or generated in an organism, an
increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2441] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 3397, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 3396 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 3396 or polypeptide
SEQ ID NO. 3397, respectively is increased or generated or if the
activity "outer membrane usher protein" is increased or generated
in an organism, an increased yield, preferably an enhanced NUE
and/or an increased biomass production compared with the wild type
control is conferred in said organism, especially an enhanced NUE,
or an increased biomass production, or an enhanced NUE and an
increased biomass production.
[2442] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 3471, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 3470 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 3470 or polypeptide
SEQ ID NO. 3471, respectively is increased or generated or if the
activity "glycerol-3-phosphate transporter subunit" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2443] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 3564, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 3563 or a nucleic acid which differs from the nucleic acid
SEQ ID NO. 3563 by exchanging the stop codon taa by tga or a
homolog of said nucleic acid molecule or polypeptide, e.g. if the
activity of a nucleic acid molecule or a polypeptide comprising the
nucleic acid or polypeptide or the consensus sequence or the
polypeptide motif, as depicted in Table I, II or IV, application
no. 1, column 7 in the respective same line as the nucleic acid
molecule SEQ ID NO. 3563 or polypeptide SEQ ID NO. 3564,
respectively is increased or generated or if the activity
"hydro-lyase" is increased or generated in an organism, an
increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2444] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 3771, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 3770 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 3770 or polypeptide
SEQ ID NO. 3771, respectively is increased or generated or if the
activity "lysophospholipase" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2445] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 3869, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 3868 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 3868 or polypeptide
SEQ ID NO. 3869, respectively is increased or generated or if the
activity "yal019w-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2446] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 3896, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 3895 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 3895 or polypeptide
SEQ ID NO. 3896, respectively is increased or generated or if the
activity "carnitine acetyltransferase" is increased or generated in
an organism, an increased yield, preferably an enhanced NUE and/or
an increased biomass production compared with the wild type control
is conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2447] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 3954, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 3953 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 3953 or polypeptide
SEQ ID NO. 3954, respectively is increased or generated or if the
activity "Transcriptional activator" is increased or generated in
an organism, an increased yield, preferably an enhanced NUE and/or
an increased biomass production compared with the wild type control
is conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2448] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 4112, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 4111 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 4111 or polypeptide
SEQ ID NO. 4112, respectively is increased or generated or if the
activity "splicing factor" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2449] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 4150, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 4149 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 4149 or polypeptide
SEQ ID NO. 4150, respectively is increased or generated or if the
activity "autophagy-specific phosphatidylinositol 3-kinase complex
protein subunit" is increased or generated in an organism, an
increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2450] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 4163, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 4162 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 4162 or polypeptide
SEQ ID NO. 4163, respectively is increased or generated or if the
activity "microsomal beta-keto-reductase" is increased or generated
in an organism, an increased yield, preferably an enhanced NUE
and/or an increased biomass production compared with the wild type
control is conferred in said organism, especially an enhanced NUE,
or an increased biomass production, or an enhanced NUE and an
increased biomass production.
[2451] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 4236, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 4235 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 4235 or polypeptide
SEQ ID NO. 4236, respectively is increased or generated or if the
activity "UDP-N-acetyl-glucosamine-1-P transferase" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2452] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 4281, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 4280 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 4280 or polypeptide
SEQ ID NO. 4281, respectively is increased or generated or if the
activity "ybr262c-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2453] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 4289, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 4288 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 4288 or polypeptide
SEQ ID NO. 4289, respectively is increased or generated or if the
activity "protein necessary for structural stability of L-A
double-stranded RNA-containing particles" is increased or generated
in an organism, an increased yield, preferably an enhanced NUE
and/or an increased biomass production compared with the wild type
control is conferred in said organism, especially an enhanced NUE,
or an increased biomass production, or an enhanced NUE and an
increased biomass production.
[2454] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 4316, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 4315 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 4315 or polypeptide
SEQ ID NO. 4316, respectively is increased or generated or if the
activity "YDR070C-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2455] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 4326, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 4325 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 4325 or polypeptide
SEQ ID NO. 4326, respectively is increased or generated or if the
activity "chaperone" is increased or generated in an organism, an
increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2456] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 4336, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 4335 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 4335 or polypeptide
SEQ ID NO. 4336, respectively is increased or generated or if the
activity "helix-loop-helix transcription activator that binds
inositol/choline-responsive elements" is increased or generated in
an organism, an increased yield, preferably an enhanced NUE and/or
an increased biomass production compared with the wild type control
is conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2457] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 4347, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 4346 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 4346 or polypeptide
SEQ ID NO. 4347, respectively is increased or generated or if the
activity "golgi membrane exchange factor subunit" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2458] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 4362, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 4361 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 4361 or polypeptide
SEQ ID NO. 4362, respectively is increased or generated or if the
activity "dihydrosphingosine phosphate lyase" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2459] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 4403, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 4402 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 4402 or polypeptide
SEQ ID NO. 4403, respectively is increased or generated or if the
activity "ubiquitin regulatory protein" is increased or generated
in an organism, an increased yield, preferably an enhanced NUE
and/or an increased biomass production compared with the wild type
control is conferred in said organism, especially an enhanced NUE,
or an increased biomass production, or an enhanced NUE and an
increased biomass production.
[2460] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 4432, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 4431 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 4431 or polypeptide
SEQ ID NO. 4432, respectively is increased or generated or if the
activity "ydr355c-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2461] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 4436, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 4435 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 4435 or polypeptide
SEQ ID NO. 4436, respectively is increased or generated or if the
activity "lysine-specific metalloprotease" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2462] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 4486, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 4485 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 4485 or polypeptide
SEQ ID NO. 4486, respectively is increased or generated or if the
activity "subunit of the transport protein particle (TRAPP) complex
of the cis-Golgi" is increased or generated in an organism, an
increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2463] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 4507, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 4506 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 4506 or polypeptide
SEQ ID NO. 4507, respectively is increased or generated or if the
activity "myo-inositol transporter" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2464] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 4791, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 4790 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 4790 or polypeptide
SEQ ID NO. 4791, respectively is increased or generated or if the
activity "SM complex B protein for mRNA splicing" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2465] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 4807, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 4806 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 4806 or polypeptide
SEQ ID NO. 4807, respectively is increased or generated or if the
activity "YFR007W-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2466] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 4837, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 4836 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 4836 or polypeptide
SEQ ID NO. 4837, respectively is increased or generated or if the
activity "oxidoreductase" is increased or generated in an organism,
an increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2467] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 5312, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 5311 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 5311 or polypeptide
SEQ ID NO. 5312, respectively is increased or generated or if the
activity "transcription elongation factor" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2468] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 5347, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 5346 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 5346 or polypeptide
SEQ ID NO. 5347, respectively is increased or generated or if the
activity "cytosolic catalase" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2469] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 5534, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 5533 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 5533 or polypeptide
SEQ ID NO. 5534, respectively is increased or generated or if the
activity "ygr122c-a-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2470] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 5552, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 5551 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 5551 or polypeptide
SEQ ID NO. 5552, respectively is increased or generated or if the
activity "v-SNARE binding protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2471] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 5560, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 5559 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 5559 or polypeptide
SEQ ID NO. 5560, respectively is increased or generated or if the
activity "protein involved in sphingolipid biosynthesis" is
increased or generated in an organism, an increased yield,
preferably an enhanced NUE and/or an increased biomass production
compared with the wild type control is conferred in said organism,
especially an enhanced NUE, or an increased biomass production, or
an enhanced NUE and an increased biomass production.
[2472] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 5603, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 5602 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 5602 or polypeptide
SEQ ID NO. 5603, respectively is increased or generated or if the
activity "mitochondrial ribosomal protein of the small subunit" is
increased or generated in an organism, an increased yield,
preferably an enhanced NUE and/or an increased biomass production
compared with the wild type control is conferred in said organism,
especially an enhanced NUE, or an increased biomass production, or
an enhanced NUE and an increased biomass production.
[2473] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 5609, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 5608 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 5608 or polypeptide
SEQ ID NO. 5609, respectively is increased or generated or if the
activity "phosphatidylserine decarboxylase" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2474] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 5615, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 5614 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 5614 or polypeptide
SEQ ID NO. 5615, respectively is increased or generated or if the
activity "cholinephosphate cytidylyltransferase" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2475] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 5667, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 5666 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 5666 or polypeptide
SEQ ID NO. 5667, respectively is increased or generated or if the
activity "ygr266w-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2476] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 5702, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 5701 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 5701 or polypeptide
SEQ ID NO. 5702, respectively is increased or generated or if the
activity "cell wall endo-beta-1,3-glucanase" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2477] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 5751, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 5750 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 5750 or polypeptide
SEQ ID NO. 5751, respectively is increased or generated or if the
activity "ygr290w-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2478] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 5755, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 5754 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 5754 or polypeptide
SEQ ID NO. 5755, respectively is increased or generated or if the
activity "yhl021c-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2479] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 5779, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 5778 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 5778 or polypeptide
SEQ ID NO. 5779, respectively is increased or generated or if the
activity "v-SNARE protein involved in Golgi transport" is increased
or generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2480] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 5813, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 5812 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 5812 or polypeptide
SEQ ID NO. 5813, respectively is increased or generated or if the
activity "mitochondrial seryl-tRNA synthetase" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2481] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 5968, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 5967 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 5967 or polypeptide
SEQ ID NO. 5968, respectively is increased or generated or if the
activity "yhr127w-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2482] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 5974, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 5973 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 5973 or polypeptide
SEQ ID NO. 5974, respectively is increased or generated or if the
activity "aromatic amino acid aminotransferase II" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2483] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 6028, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 6027 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 6027 or polypeptide
SEQ ID NO. 6028, respectively is increased or generated or if the
activity "glucoamylase" is increased or generated in an organism,
an increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2484] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 6108, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 6107 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 6107 or polypeptide
SEQ ID NO. 6108, respectively is increased or generated or if the
activity "histidine kinase osmosensor that regulates an osmosensing
MAP kinase cascade" is increased or generated in an organism, an
increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2485] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 6151, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 6150 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 6150 or polypeptide
SEQ ID NO. 6151, respectively is increased or generated or if the
activity "saccharopine dehydrogenase" is increased or generated in
an organism, an increased yield, preferably an enhanced NUE and/or
an increased biomass production compared with the wild type control
is conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2486] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 6199, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 6198 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 6198 or polypeptide
SEQ ID NO. 6199, respectively is increased or generated or if the
activity "spindle checkpoint complex subunit" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2487] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 6209, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 6208 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 6208 or polypeptide
SEQ ID NO. 6209, respectively is increased or generated or if the
activity "nuclear pore complex subunit" is increased or generated
in an organism, an increased yield, preferably an enhanced NUE
and/or an increased biomass production compared with the wild type
control is conferred in said organism, especially an enhanced NUE,
or an increased biomass production, or an enhanced NUE and an
increased biomass production.
[2488] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 6243, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 6242 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 6242 or polypeptide
SEQ ID NO. 6243, respectively is increased or generated or if the
activity "yjl064w-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2489] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 6247, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 6246 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 6246 or polypeptide
SEQ ID NO. 6247, respectively is increased or generated or if the
activity "yjl067w-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2490] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 6251, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 6250 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 6250 or polypeptide
SEQ ID NO. 6251, respectively is increased or generated or if the
activity "potassium:hydrogen antiporter" is increased or generated
in an organism, an increased yield, preferably an enhanced NUE
and/or an increased biomass production compared with the wild type
control is conferred in said organism, especially an enhanced NUE,
or an increased biomass production, or an enhanced NUE and an
increased biomass production.
[2491] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 6298, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 6297 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 6297 or polypeptide
SEQ ID NO. 6298, respectively is increased or generated or if the
activity "GPI-anchored cell wall protein" is increased or generated
in an organism, an increased yield, preferably an enhanced NUE
and/or an increased biomass production compared with the wild type
control is conferred in said organism, especially an enhanced NUE,
or an increased biomass production, or an enhanced NUE and an
increased biomass production.
[2492] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 6327, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 6326 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 6326 or polypeptide
SEQ ID NO. 6327, respectively is increased or generated or if the
activity "yjl213w-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2493] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 6489, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 6488 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 6488 or polypeptide
SEQ ID NO. 6489, respectively is increased or generated or if the
activity "peptidyl-prolyl cis-trans isomerase" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2494] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 6551, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 6550 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 6550 or polypeptide
SEQ ID NO. 6551, respectively is increased or generated or if the
activity "clathrin associated protein complex small subunit" is
increased or generated in an organism, an increased yield,
preferably an enhanced NUE and/or an increased biomass production
compared with the wild type control is conferred in said organism,
especially an enhanced NUE, or an increased biomass production, or
an enhanced NUE and an increased biomass production.
[2495] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 6701, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 6700 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 6700 or polypeptide
SEQ ID NO. 6701, respectively is increased or generated or if the
activity "zinc metalloprotease" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2496] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 6817, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 6816 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 6816 or polypeptide
SEQ ID NO. 6817, respectively is increased or generated or if the
activity "F1F0 ATP synthase beta subunit" is increased or generated
in an organism, an increased yield, preferably an enhanced NUE
and/or an increased biomass production compared with the wild type
control is conferred in said organism, especially an enhanced NUE,
or an increased biomass production, or an enhanced NUE and an
increased biomass production.
[2497] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 7367, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 7366 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 7366 or polypeptide
SEQ ID NO. 7367, respectively is increased or generated or if the
activity "alpha-mannosidase" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2498] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 7476, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 7475 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 7475 or polypeptide
SEQ ID NO. 7476, respectively is increased or generated or if the
activity "ribosomal protein of the small subunit" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2499] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 7603, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 7602 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 7602 or polypeptide
SEQ ID NO. 7603, respectively is increased or generated or if the
activity "mitochondrial intermembrane space protein" is increased
or generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2500] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 7652, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 7651 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 7651 or polypeptide
SEQ ID NO. 7652, respectively is increased or generated or if the
activity "phosphopantothenoylcysteine decarboxylase" is increased
or generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2501] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 7662, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 7661 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 7661 or polypeptide
SEQ ID NO. 7662, respectively is increased or generated or if the
activity "ykl100c-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2502] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 7676, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 7675 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 7675 or polypeptide
SEQ ID NO. 7676, respectively is increased or generated or if the
activity "ykl131w-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2503] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 7680, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 7679 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 7679 or polypeptide
SEQ ID NO. 7680, respectively is increased or generated or if the
activity "mitochondrial ribosomal protein of the large subunit" is
increased or generated in an organism, an increased yield,
preferably an enhanced NUE and/or an increased biomass production
compared with the wild type control is conferred in said organism,
especially an enhanced NUE, or an increased biomass production, or
an enhanced NUE and an increased biomass production.
[2504] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 7711, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 7710 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 7710 or polypeptide
SEQ ID NO. 7711, respectively is increased or generated or if the
activity "G protein coupled pheromone receptor receptor" is
increased or generated in an organism, an increased yield,
preferably an enhanced NUE and/or an increased biomass production
compared with the wild type control is conferred in said organism,
especially an enhanced NUE, or an increased biomass production, or
an enhanced NUE and an increased biomass production.
[2505] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 7736, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 7735 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 7735 or polypeptide
SEQ ID NO. 7736, respectively is increased or generated or if the
activity "golgi membrane protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2506] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 7779, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 7778 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 7778 or polypeptide
SEQ ID NO. 7779, respectively is increased or generated or if the
activity "regulatory subunit of Glc7p type 1 protein
serine-threonine phosphatase" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2507] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 7830, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 7829 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 7829 or polypeptide
SEQ ID NO. 7830, respectively is increased or generated or if the
activity "dihydroorotate dehydrogenase" is increased or generated
in an organism, an increased yield, preferably an enhanced NUE
and/or an increased biomass production compared with the wild type
control is conferred in said organism, especially an enhanced NUE,
or an increased biomass production, or an enhanced NUE and an
increased biomass production.
[2508] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 8018, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 8017 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 8017 or polypeptide
SEQ ID NO. 8018, respectively is increased or generated or if the
activity "ykr016w-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2509] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 8046, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 8045 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 8045 or polypeptide
SEQ ID NO. 8046, respectively is increased or generated or if the
activity "ykr021w-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2510] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 8074, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 8073 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 8073 or polypeptide
SEQ ID NO. 8074, respectively is increased or generated or if the
activity "non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins" is increased or generated in an organism, an
increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2511] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 8264, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 8263 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 8263 or polypeptide
SEQ ID NO. 8264, respectively is increased or generated or if the
activity "integral membrane protein localized to late Golgi
vesicles" is increased or generated in an organism, an increased
yield, preferably an enhanced NUE and/or an increased biomass
production compared with the wild type control is conferred in said
organism, especially an enhanced NUE, or an increased biomass
production, or an enhanced NUE and an increased biomass
production.
[2512] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 8288, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 8287 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 8287 or polypeptide
SEQ ID NO. 8288, respectively is increased or generated or if the
activity "peptide transporter" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2513] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 8469, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 8468 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 8468 or polypeptide
SEQ ID NO. 8469, respectively is increased or generated or if the
activity "transcription factor" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2514] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 8485, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 8484 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 8484 or polypeptide
SEQ ID NO. 8485, respectively is increased or generated or if the
activity "transmembrane protein with a role in cell wall polymer
composition" is increased or generated in an organism, an increased
yield, preferably an enhanced NUE and/or an increased biomass
production compared with the wild type control is conferred in said
organism, especially an enhanced NUE, or an increased biomass
production, or an enhanced NUE and an increased biomass
production.
[2515] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 8493, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 8492 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 8492 or polypeptide
SEQ ID NO. 8493, respectively is increased or generated or if the
activity "yll014w-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2516] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 8515, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 8514 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 8514 or polypeptide
SEQ ID NO. 8515, respectively is increased or generated or if the
activity "non-essential Ras guanine nucleotide exchange factor" is
increased or generated in an organism, an increased yield,
preferably an enhanced NUE and/or an increased biomass production
compared with the wild type control is conferred in said organism,
especially an enhanced NUE, or an increased biomass production, or
an enhanced NUE and an increased biomass production.
[2517] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 8540, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 8539 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 8539 or polypeptide
SEQ ID NO. 8540, respectively is increased or generated or if the
activity "yll023c-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2518] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 8572, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 8571 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 8571 or polypeptide
SEQ ID NO. 8572, respectively is increased or generated or if the
activity "yll037w-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2519] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 8576, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 8575 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 8575 or polypeptide
SEQ ID NO. 8576, respectively is increased or generated or if the
activity "yll049w-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2520] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 8580, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 8579 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 8579 or polypeptide
SEQ ID NO. 8580, respectively is increased or generated or if the
activity "cysteine transporter" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2521] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 8662, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 8661 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 8661 or polypeptide
SEQ ID NO. 8662, respectively is increased or generated or if the
activity "metal ion transporter" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2522] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 8992, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 8991 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 8991 or polypeptide
SEQ ID NO. 8992, respectively is increased or generated or if the
activity "ylr042c-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2523] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 8996, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 8995 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 8995 or polypeptide
SEQ ID NO. 8996, respectively is increased or generated or if the
activity "YLR053c-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2524] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 9000, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 8999 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 8999 or polypeptide
SEQ ID NO. 9000, respectively is increased or generated or if the
activity "cytosolic serine hydroxymethyltransferase" is increased
or generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2525] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 9552, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 9551 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 9551 or polypeptide
SEQ ID NO. 9552, respectively is increased or generated or if the
activity "subunit of cytoplasmic phenylalanyl-tRNA synthetase" is
increased or generated in an organism, an increased yield,
preferably an enhanced NUE and/or an increased biomass production
compared with the wild type control is conferred in said organism,
especially an enhanced NUE, or an increased biomass production, or
an enhanced NUE and an increased biomass production.
[2526] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 9638, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 9637 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 9637 or polypeptide
SEQ ID NO. 9638, respectively is increased or generated or if the
activity "ylr065c-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2527] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 9673, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 9672 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 9672 or polypeptide
SEQ ID NO. 9673, respectively is increased or generated or if the
activity "xylitol dehydrogenase" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2528] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 10183, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 10182 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 10182 or polypeptide
SEQ ID NO. 10183, respectively is increased or generated or if the
activity "3-keto sterol reductase" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2529] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 10215, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 10214 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 10214 or polypeptide
SEQ ID NO. 10215, respectively is increased or generated or if the
activity "alkyl hydroperoxide reductase" is increased or generated
in an organism, an increased yield, preferably an enhanced NUE
and/or an increased biomass production compared with the wild type
control is conferred in said organism, especially an enhanced NUE,
or an increased biomass production, or an enhanced NUE and an
increased biomass production.
[2530] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 10448, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 10447 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 10447 or polypeptide
SEQ ID NO. 10448, respectively is increased or generated or if the
activity "ylr125w-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2531] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 10452, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 10451 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 10451 or polypeptide
SEQ ID NO. 10452, respectively is increased or generated or if the
activity "anaphase promoting complex (APC) subunit" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2532] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 10464, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 10463 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 10463 or polypeptide
SEQ ID NO. 10464, respectively is increased or generated or if the
activity "protein component of the large ribosomal subunit"is
increased or generated in an organism, an increased yield,
preferably an enhanced NUE and/or an increased biomass production
compared with the wild type control is conferred in said organism,
especially an enhanced NUE, or an increased biomass production, or
an enhanced NUE and an increased biomass production.
[2533] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 10534, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 10533 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 10533 or polypeptide
SEQ ID NO. 10534, respectively is increased or generated or if the
activity "mitochondrial protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2534] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 10542, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 10541 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 10541 or polypeptide
SEQ ID NO. 10542, respectively is increased or generated or if the
activity "ARV1 protein" is increased or generated in an organism,
an increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2535] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 10563, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 10562 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 10562 or polypeptide
SEQ ID NO. 10563, respectively is increased or generated or if the
activity "GTP-binding protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2536] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 10991, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 10990 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 10990 or polypeptide
SEQ ID NO. 10991, respectively is increased or generated or if the
activity "protein involved in shmoo formation and bipolar bud site
selection" is increased or generated in an organism, an increased
yield, preferably an enhanced NUE and/or an increased biomass
production compared with the wild type control is conferred in said
organism, especially an enhanced NUE, or an increased biomass
production, or an enhanced NUE and an increased biomass
production.
[2537] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 10999, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 10998 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 10998 or polypeptide
SEQ ID NO. 10999, respectively is increased or generated or if the
activity "non-essential kinetochore protein" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2538] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 11005, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 11004 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 11004 or polypeptide
SEQ ID NO. 11005, respectively is increased or generated or if the
activity "Meiotic recombination protein" is increased or generated
in an organism, an increased yield, preferably an enhanced NUE
and/or an increased biomass production compared with the wild type
control is conferred in said organism, especially an enhanced NUE,
or an increased biomass production, or an enhanced NUE and an
increased biomass production.
[2539] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 11013, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 11012 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 11012 or polypeptide
SEQ ID NO. 11013, respectively is increased or generated or if the
activity "signal transducing MEK kinase" is increased or generated
in an organism, an increased yield, preferably an enhanced NUE
and/or an increased biomass production compared with the wild type
control is conferred in said organism, especially an enhanced NUE,
or an increased biomass production, or an enhanced NUE and an
increased biomass production.
[2540] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 11055, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 11054 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 11054 or polypeptide
SEQ ID NO. 11055, respectively is increased or generated or if the
activity "cytochrome c oxidase subunit VIII" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2541] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 11067, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 11066 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 11066 or polypeptide
SEQ ID NO. 11067, respectively is increased or generated or if the
activity "ylr404w-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2542] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 11075, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 11074 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 11074 or polypeptide
SEQ ID NO. 11075, respectively is increased or generated or if the
activity "ylr463c-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2543] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 11081, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 11080 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 11080 or polypeptide
SEQ ID NO. 11081, respectively is increased or generated or if the
activity "adenine phosphoribosyltransferase" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2544] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 11553, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 11552 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 11552 or polypeptide
SEQ ID NO. 11553, respectively is increased or generated or if the
activity "Mcm1p binding transcriptional repressor" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2545] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 11570, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 11569 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 11569 or polypeptide
SEQ ID NO. 11570, respectively is increased or generated or if the
activity "origin recognition complex subunit" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2546] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 11597, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 11596 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 11596 or polypeptide
SEQ ID NO. 11597, respectively is increased or generated or if the
activity "yml089c-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2547] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 11601, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 11600 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 11600 or polypeptide
SEQ ID NO. 11601, respectively is increased or generated or if the
activity "yml128c-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2548] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 11613, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 11612 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 11612 or polypeptide
SEQ ID NO. 11613, respectively is increased or generated or if the
activity "hexose transporter" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2549] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 12247, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 12246 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 12246 or polypeptide
SEQ ID NO. 12247, respectively is increased or generated or if the
activity "Zinc finger protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2550] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 12264, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 12263 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 12263 or polypeptide
SEQ ID NO. 12264, respectively is increased or generated or if the
activity "protein required for maturation of ribosomal RNAs" is
increased or generated in an organism, an increased yield,
preferably an enhanced NUE and/or an increased biomass production
compared with the wild type control is conferred in said organism,
especially an enhanced NUE, or an increased biomass production, or
an enhanced NUE and an increased biomass production.
[2551] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 12317, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 12316 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 12316 or polypeptide
SEQ ID NO. 12317, respectively is increased or generated or if the
activity "Factor arrest protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2552] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 12328, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 12327 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 12327 or polypeptide
SEQ ID NO. 12328, respectively is increased or generated or if the
activity "YMR082C-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2553] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 12332, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 12331 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 12331 or polypeptide
SEQ ID NO. 12332, respectively is increased or generated or if the
activity "Nuclear cap-binding protein complex subunit" is increased
or generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2554] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 12379, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 12378 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 12378 or polypeptide
SEQ ID NO. 12379, respectively is increased or generated or if the
activity "YMR126c membrane protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2555] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 12395, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 12394 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 12394 or polypeptide
SEQ ID NO. 12395, respectively is increased or generated or if the
activity "YMR144W-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2556] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 12407, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 12406 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 12406 or polypeptide
SEQ ID NO. 12407, respectively is increased or generated or if the
activity "YMR160W-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2557] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 12415, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 12414 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 12414 or polypeptide
SEQ ID NO. 12415, respectively is increased or generated or if the
activity "Stationary phase protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2558] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 12421, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 12420 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 12420 or polypeptide
SEQ ID NO. 12421, respectively is increased or generated or if the
activity "YMR209C-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2559] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 12441, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 12440 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 12440 or polypeptide
SEQ ID NO. 12441, respectively is increased or generated or if the
activity "YMR233W-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2560] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 12471, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 12470 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 12470 or polypeptide
SEQ ID NO. 12471, respectively is increased or generated or if the
activity "phosphoglucomutase/phosphomannomutase" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2561] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 12750, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 12749 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 12749 or polypeptide
SEQ ID NO. 12750, respectively is increased or generated or if the
activity "Regulatory CAT8 protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2562] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 12774, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 12773 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 12773 or polypeptide
SEQ ID NO. 12774, respectively is increased or generated or if the
activity "translational elongation factor EF-3 (HEF3)" is increased
or generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2563] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 12830, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 12829 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 12829 or polypeptide
SEQ ID NO. 12830, respectively is increased or generated or if the
activity "YNL320W-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2564] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 12884, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 12883 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 12883 or polypeptide
SEQ ID NO. 12884, respectively is increased or generated or if the
activity "Chitin synthase 3 complex protein" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2565] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 12890, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 12889 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 12889 or polypeptide
SEQ ID NO. 12890, respectively is increased or generated or if the
activity "Alkyl/aryl-sulfatase" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2566] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 13015, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 13014 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 13014 or polypeptide
SEQ ID NO. 13015, respectively is increased or generated or if the
activity "antiviral adaptor protein" is increased or generated in
an organism, an increased yield, preferably an enhanced NUE and/or
an increased biomass production compared with the wild type control
is conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2567] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 13019, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 13018 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 13018 or polypeptide
SEQ ID NO. 13019, respectively is increased or generated or if the
activity "repressor of G1 transcription" is increased or generated
in an organism, an increased yield, preferably an enhanced NUE
and/or an increased biomass production compared with the wild type
control is conferred in said organism, especially an enhanced NUE,
or an increased biomass production, or an enhanced NUE and an
increased biomass production.
[2568] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 13025, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 13024 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 13024 or polypeptide
SEQ ID NO. 13025, respectively is increased or generated or if the
activity "YOR097c-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2569] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 13031, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 13030 or a homolog of said nucleic acid molecule of an
eukaryote or polypeptide, e.g. if the activity of a nucleic acid
molecule or a polypeptide comprising the nucleic acid or
polypeptide or the consensus sequence or the polypeptide motif, as
depicted in Table I, II or IV, application no. 1, column 7 in the
respective same line as the nucleic acid molecule SEQ ID NO. 13030
or polypeptide SEQ ID NO. 13031, respectively is increased or
generated or if the activity "Phosphoribosylaminoimidazole
carboxylase" is increased or generated in an organism, an increased
yield, preferably an enhanced NUE and/or an increased biomass
production compared with the wild type control is conferred in said
organism, especially an enhanced NUE, or an increased biomass
production, or an enhanced NUE and an increased biomass
production.
[2570] In eukaryote the polypeptide is bifunctional and encoded by
one nucleic acid molecule. Usually in prokaryote these two
functions are encoded by two distinct nucleic acid molecules. The
homologs of the respective nucleic acid molecules are listed in
tables IA NHOM, IA CHOM, IIA NHOM and IIA CHOM (NHOM for the
nucleic acid molecule encoding for the polypeptide covering the
N-terminus and the polypeptide covering the N-terminus,
respectively; CHOM for the nucleic acid molecule encoding for the
polypeptide covering the C-terminus and the polypeptide covering
the C-terminus, respectively). The co-expression and/or expression
of a gene fusion of these homologs, which may be performed by
methods known to a skilled person, give the same results as the
expression of the eukaryotic homologs.
[2571] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 14086, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 14085 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 14085 or polypeptide
SEQ ID NO. 14086, respectively is increased or generated or if the
activity "component of the RAM signaling network" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2572] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 14094, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 14093 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 14093 or polypeptide
SEQ ID NO. 14094, respectively is increased or generated or if the
activity "protein kinase" is increased or generated in an organism,
an increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2573] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 14114, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 14113 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 14113 or polypeptide
SEQ ID NO. 14114, respectively is increased or generated or if the
activity "signal recognition particle subunit (SRP54)" is increased
or generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2574] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 14247, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 14246 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 14246 or polypeptide
SEQ ID NO. 14247, respectively is increased or generated or if the
activity "regulatory subunit of the 26S proteasome" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2575] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 14312, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 14311 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 14311 or polypeptide
SEQ ID NO. 14312, respectively is increased or generated or if the
activity "RNA polymerase III subunit" is increased or generated in
an organism, an increased yield, preferably an enhanced NUE and/or
an increased biomass production compared with the wild type control
is conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2576] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 14915, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 14914 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 14914 or polypeptide
SEQ ID NO. 14915, respectively is increased or generated or if the
activity "lysophospholipase" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2577] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 15383, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 15382 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 15382 or polypeptide
SEQ ID NO. 15383, respectively is increased or generated or if the
activity "saccharopine dehydrogenase" is increased or generated in
an organism, an increased yield, preferably an enhanced NUE and/or
an increased biomass production compared with the wild type control
is conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2578] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 15461, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 15460 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 15460 or polypeptide
SEQ ID NO. 15461, respectively is increased or generated or if the
activity "alpha-mannosidase" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2579] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 15572, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 15571 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 15571 or polypeptide
SEQ ID NO. 15572, respectively is increased or generated or if the
activity "ykl100c-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2580] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 15594, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 15593 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 15593 or polypeptide
SEQ ID NO. 15594, respectively is increased or generated or if the
activity "regulatory subunit of Glc7p type 1 protein
serine-threonine phosphatase" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2581] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 15647, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 15646 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 15646 or polypeptide
SEQ ID NO. 15647, respectively is increased or generated or if the
activity "non-essential Ras guanine nucleotide exchange factor" is
increased or generated in an organism, an increased yield,
preferably an enhanced NUE and/or an increased biomass production
compared with the wild type control is conferred in said organism,
especially an enhanced NUE, or an increased biomass production, or
an enhanced NUE and an increased biomass production.
[2582] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 15674, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 15673 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 15673 or polypeptide
SEQ ID NO. 15674, respectively is increased or generated or if the
activity "metal ion transporter" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2583] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 16006, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 16005 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 16005 or polypeptide
SEQ ID NO. 16006, respectively is increased or generated or if the
activity "subunit of cytoplasmic phenylalanyl-tRNA synthetase" is
increased or generated in an organism, an increased yield,
preferably an enhanced NUE and/or an increased biomass production
compared with the wild type control is conferred in said organism,
especially an enhanced NUE, or an increased biomass production, or
an enhanced NUE and an increased biomass production.
[2584] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 16115, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 16114 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 16114 or polypeptide
SEQ ID NO. 16115, respectively is increased or generated or if the
activity "YMR082C-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2585] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 14403, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 14402 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 14402 or polypeptide
SEQ ID NO. 14403, respectively is increased or generated or if the
activity "B1258-protein" is increased or generated in an organism,
an increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2586] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 16094, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 16093 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 16093 or polypeptide
SEQ ID NO. 16094, respectively is increased or generated or if the
activity "YML101C-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2587] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 16107, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 16106 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 16106 or polypeptide
SEQ ID NO. 16107, respectively is increased or generated or if the
activity "nuclear fusion protein precursor" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2588] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 16121, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 16120 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 16120 or polypeptide
SEQ ID NO. 16121, respectively is increased or generated or if the
activity "inheritance of peroxisomes protein" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2589] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 16276, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 16275 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 16275 or polypeptide
SEQ ID NO. 16276, respectively is increased or generated or if the
activity "exoribonuclease" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2590] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 16306, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 16305 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 16305 or polypeptide
SEQ ID NO. 16306, respectively is increased or generated or if the
activity "iron sulfur cluster assembly protein" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2591] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 16574, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 16573 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 16573 or polypeptide
SEQ ID NO. 16574, respectively is increased or generated or if the
activity "YPL068C-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2592] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 14397, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 14396 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 14396 or polypeptide
SEQ ID NO. 14397, respectively is increased or generated or if the
activity "B0165-protein" is increased or generated in an organism,
an increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2593] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 16300, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 16299 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 16299 or polypeptide
SEQ ID NO. 16300, respectively is increased or generated or if the
activity "YOR203W-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2594] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 16134, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 16133 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 16133 or polypeptide
SEQ ID NO. 16134, respectively is increased or generated or if the
activity "ribonucleoprotein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2595] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 15057, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 15056 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 15056 or polypeptide
SEQ ID NO. 15057, respectively is increased or generated or if the
activity "transcription factor" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2596] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 15588, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 15587 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 15587 or polypeptide
SEQ ID NO. 15588, respectively is increased or generated or if the
activity "YKL111C-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2597] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 16583, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 16582 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 16582 or polypeptide
SEQ ID NO. 16583, respectively is increased or generated or if the
activity "iron sulfur cluster assembly protein" is increased or
generated in an organism, an increased yield, preferably an
enhanced NUE and/or an increased biomass production compared with
the wild type control is conferred in said organism, especially an
enhanced NUE, or an increased biomass production, or an enhanced
NUE and an increased biomass production.
[2598] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 14840, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 14839 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 14839 or polypeptide
SEQ ID NO. 14840, respectively is increased or generated or if the
activity "transport protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2599] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 15015, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 15014 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 15014 or polypeptide
SEQ ID NO. 15015, respectively is increased or generated or if the
activity "protein translocase protein" is increased or generated in
an organism, an increased yield, preferably an enhanced NUE and/or
an increased biomass production compared with the wild type control
is conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2600] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 15433, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 15432 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 15432 or polypeptide
SEQ ID NO. 15433, respectively is increased or generated or if the
activity "YJL010C-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2601] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 14498, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 14497 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 14497 or polypeptide
SEQ ID NO. 14498, respectively is increased or generated or if the
activity "B1267-protein" is increased or generated in an organism,
an increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2602] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 14719, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 14718 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 14718 or polypeptide
SEQ ID NO. 14719, respectively is increased or generated or if the
activity "membrane protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2603] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 14792, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 14791 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 14791 or polypeptide
SEQ ID NO. 14792, respectively is increased or generated or if the
activity "B1381-protein" is increased or generated in an organism,
an increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2604] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 14880, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 14879 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 14879 or polypeptide
SEQ ID NO. 14880, respectively is increased or generated or if the
activity "B2646-protein" is increased or generated in an organism,
an increased yield, preferably an enhanced NUE and/or an increased
biomass production compared with the wild type control is conferred
in said organism, especially an enhanced NUE, or an increased
biomass production, or an enhanced NUE and an increased biomass
production.
[2605] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 15065, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 15064 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 15064 or polypeptide
SEQ ID NO. 15065, respectively is increased or generated or if the
activity "60S ribosomal protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2606] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 15258, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 15257 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 15257 or polypeptide
SEQ ID NO. 15258, respectively is increased or generated or if the
activity "Rho GDP-dissociation inhibitor" is increased or generated
in an organism, an increased yield, preferably an enhanced NUE
and/or an increased biomass production compared with the wild type
control is conferred in said organism, especially an enhanced NUE,
or an increased biomass production, or an enhanced NUE and an
increased biomass production.
[2607] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 15379, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 15378 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 15378 or polypeptide
SEQ ID NO. 15379, respectively is increased or generated or if the
activity "YHL005C-protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2608] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 16630, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 16629 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 16629 or polypeptide
SEQ ID NO. 16630, respectively is increased or generated or if the
activity "transmembrane protein with a role in cell wall polymer
composition" is increased or generated in an organism, an increased
yield, preferably an enhanced NUE and/or an increased biomass
production compared with the wild type control is conferred in said
organism, especially an enhanced NUE, or an increased biomass
production, or an enhanced NUE and an increased biomass
production.
[2609] Accordingly, in one embodiment, in case the activity of a
polypeptide according to the polypeptide SEQ ID NO. 16648, or
encoded by a nucleic acid molecule comprising the nucleic acid SEQ
ID NO. 16647 or a homolog of said nucleic acid molecule or
polypeptide, e.g. if the activity of a nucleic acid molecule or a
polypeptide comprising the nucleic acid or polypeptide or the
consensus sequence or the polypeptide motif, as depicted in Table
I, II or IV, application no. 1, column 7 in the respective same
line as the nucleic acid molecule SEQ ID NO. 16647 or polypeptide
SEQ ID NO. 16648, respectively is increased or generated or if the
activity "Stationary phase protein" is increased or generated in an
organism, an increased yield, preferably an enhanced NUE and/or an
increased biomass production compared with the wild type control is
conferred in said organism, especially an enhanced NUE, or an
increased biomass production, or an enhanced NUE and an increased
biomass production.
[2610] It was further observed that increasing or generating the
activity of a nucleic acid molecule derived from the nucleic acid
molecule shown in table VII-A in a plant, for example A. thaliana,
conferred increased nutrient use efficiency, e.g. an increased the
nitrogen use efficiency, compared with the wild type control. Thus,
in one embodiment, a nucleic acid molecule indicated in table VII-A
or its homolog as indicated in table I or the expression product is
used in the method of the present invention to increase nutrient
use efficiency, e.g. to increase the nitrogen use efficiency, of a
plant compared with the wild type control.
[2611] It was further observed that increasing or generating the
activity of a nucleic acid molecule derived from the nucleic acid
molecule shown in table VII-B in a plant, for example A. thaliana,
conferred increased stress tolerance, e.g. increased low
temperature tolerance, compared with the wild type control. Thus,
in one embodiment, a nucleic acid molecule indicated in table VII-B
or its homolog as indicated in table I or the expression product is
used in the method of the present invention to increase stress
tolerance, e.g. increase low temperature tolerance, of a plant
compared with the wild type control.
[2612] It was further observed that increasing or generating the
activity of a nucleic acid molecule derived from the nucleic acid
molecule shown in table VII-C in a plant, for example A. thaliana,
conferred increased stress tolerance, e.g. increased cycling
drought tolerance, compared with the wild type control. Thus, in
one embodiment, a nucleic acid molecule indicated in table VII-C or
its homolog as indicated in table I or the expression product is
used in the method of the present invention to increase stress
tolerance, e.g. increase cycling drought tolerance, of a plant
compared with the wild type control.
[2613] It was further observed that increasing or generating the
activity of a nucleic acid molecule derived from the nucleic acid
molecule shown in Table VII-D in a plant, for example A. thaliana,
conferred increase in intrinsic yield, e.g. increased biomass under
standard conditions, e.g. increased biomass in the absence of
stress conditions as well as in the absence of nutrient deficiency,
compared with the wild type control. Thus, in one embodiment, a
nucleic acid molecule indicated in table VII-D or its homolog as
indicated in table I or the expression product is used in the
method of the present invention to increase intrinsic yield, e.g.
to increase yield, in the absence of stress conditions as well as
in the absence of nutrient deficiency, of a plant compared with the
wild type control.
[2614] The term "expression" refers to the transcription and/or
translation of a codogenic gene segment or gene. As a rule, the
resulting product is an mRNA or a protein. However, expression
products can also include functional RNAs such as, for example,
antisense, nucleic acids, tRNAs, snRNAs, rRNAs, RNAi, siRNA,
ribozymes etc. Expression may be systemic, local or temporal, for
example limited to certain cell types, tissues organs or organelles
or time periods.
[2615] In one embodiment, the process of the present invention
comprises one or more of the following steps [2616] (a) stabilizing
a protein conferring the increased expression of a protein encoded
by the nucleic acid molecule of the invention or of the polypeptide
of the invention having the herein-mentioned activity selected from
the group consisting of 2-dehydro-3-deoxy-phosphoheptonate
aldolase, 3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein,
[2617] YMR126c membrane protein, YMR144W-protein, YMR160W-protein,
YMR209C-protein, YMR233W-protein, YNL320W-protein, YOR097c-protein,
YOR203W-protein, YPL068C-protein, Zinc finger protein, and zinc
metalloprotease and conferring an increased yield, especially an
enhanced NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof; [2618] (b) stabilizing a mRNA conferring the increased
expression of a protein encoded by the nucleic acid molecule of the
invention or its homologs or of a mRNA encoding the polypeptide of
the present invention having the herein-mentioned activity selected
from the group consisting of 2-dehydro-3-deoxy-phosphoheptonate
aldolase, 3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease and conferring an
increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof; [2619] (c) increasing
the specific activity of a protein conferring the increased
expression of a protein encoded by the nucleic acid molecule of the
invention or of the polypeptide of the present invention or
decreasing the inhibitory regulation of the polypeptide of the
invention; [2620] (d) generating or increasing the expression of an
endogenous or artificial transcription factor mediating the
expression of a protein conferring the increased expression of a
protein encoded by the nucleic acid molecule of the invention or of
the polypeptide of the invention having the herein-mentioned
activity selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease and conferring an
increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof; [2621] (e) stimulating
activity of a protein conferring the increased expression of a
protein encoded by the nucleic acid molecule of the present
invention or a polypeptide of the present invention having the
herein-mentioned activity selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein,
YJL010C-protein, yjl064w-protein, yjl067w-protein, yjl213w-protein,
ykl100c-protein, YKL111C-protein, ykl131w-protein, ykr016w-protein,
ykr021w-protein, yll014w-protein, yll023c-protein, yll037w-protein,
yll049w-protein, ylr042c-protein, YLR053c-protein, ylr065c-protein,
ylr125w-protein, ylr404w-protein, ylr463c-protein, yml089c-protein,
YML101C-protein, yml128c-protein, YMR082C-protein, YMR126c membrane
protein, YMR144W-protein, YMR160W-protein, YMR209C-protein,
YMR233W-protein, YNL320W-protein, YOR097c-protein, YOR203W-protein,
YPL068C-protein, Zinc finger protein, and zinc metalloprotease and
conferring an increased yield, especially an enhanced NUE and/or
increased biomass production, as compared to a corresponding
non-transformed wild type plant cell, plant or part thereof by
adding one or more exogenous inducing factors to the organisms or
parts thereof;
[2622] (f) expressing a transgenic gene encoding a protein
conferring the increased expression of a polypeptide encoded by the
nucleic acid molecule of the present invention or a polypeptide of
the present invention, having the herein-mentioned activity
selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase,
[2623] Alkyl/aryl-sulfatase, alpha-glucosidase, alpha-mannosidase,
anaphase promoting complex (APC) subunit, antiviral adaptor
protein, aromatic amino acid aminotransferase II, ARV1 protein,
autophagy-specific phosphatidylinositol 3-kinase complex protein
subunit, b0017-protein, B0165-protein, B1258-protein,
61267-protein, B1381-protein, b1933-protein, b2165-protein,
b2238-protein, b2431-protein, B2646-protein, b2766-protein,
b3120-protein, carnitine acetyltransferase, cell wall
endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease and conferring an
increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof; and/or [2624] (g)
increasing the copy number of a gene conferring the increased
expression of a nucleic acid molecule encoding a polypeptide
encoded by the nucleic acid molecule of the invention or the
polypeptide of the invention having the herein-mentioned activity
selected from the group consisting of
2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto sterol
reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease and conferring an
increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof; [2625] (h) increasing
the expression of the endogenous gene encoding the polypeptide of
the invention or its homologs by adding positive expression or
removing negative expression elements, e.g. homologous
recombination can be used to either introduce positive regulatory
elements like for plants the 35S enhancer into the promoter or to
remove repressor elements form regulatory regions. Further gene
conversion methods can be used to disrupt repressor elements or to
enhance to activity of positive elements-positive elements can be
randomly introduced in plants by T-DNA or transposon mutagenesis
and lines can be identified in which the positive elements have
been integrated near to a gene of the invention, the expression of
which is thereby enhanced; and/or [2626] (i) modulating growth
conditions of the plant in such a manner, that the expression or
activity of the gene encoding the protein of the invention or the
protein itself is enhanced; [2627] (j) selecting of organisms with
especially high activity of the proteins of the invention from
natural or from mutagenized resources and breeding them into the
target organisms, e.g. the elite crops.
[2628] Preferably, said mRNA is the nucleic acid molecule of the
present invention and/or the protein conferring the increased
expression of a protein encoded by the nucleic acid molecule of the
present invention alone or linked to a transit nucleic acid
sequence or transit peptide encoding nucleic acid sequence or the
polypeptide having the herein mentioned activity, e.g. conferring
an increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof after increasing the
expression or activity of the encoded polypeptide or having the
activity of a polypeptide having an activity as the protein as
shown in table II column 3 or its homologs.
[2629] In general, the amount of mRNA or polypeptide in a cell or a
compartment of an organism correlates with the amount of encoded
protein and thus with the overall activity of the encoded protein
in said volume. Said correlation is not always linear, the activity
in the volume is dependent on the stability of the molecules or the
presence of activating or inhibiting co-factors. Further, product
and educt inhibitions of enzymes are well known and described in
textbooks, e.g. Stryer, Biochemistry.
[2630] In general, the amount of mRNA, polynucleotide or nucleic
acid molecule in a cell or a compartment of an organism correlates
with the amount of encoded protein and thus with the overall
activity of the encoded protein in said volume. Said correlation is
not always linear, the activity in the volume is dependent on the
stability of the molecules, the degradation of the molecules or the
presence of activating or inhibiting co-factors. Further, product
and educt inhibitions of enzymes are well known, e.g. Zinser et al.
"Enzyminhibitoren"/Enzyme inhibitors".
[2631] The activity of the abovementioned proteins and/or
polypeptides encoded by the nucleic acid molecule of the present
invention can be increased in various ways. For example, the
activity in an organism or in a part thereof, like a cell, is
increased via increasing the gene product number, e.g. by
increasing the expression rate, like introducing a stronger
promoter, or by increasing the stability of the mRNA expressed,
thus increasing the translation rate, and/or increasing the
stability of the gene product, thus reducing the proteins decayed.
Further, the activity or turnover of enzymes can be influenced in
such a way that a reduction or increase of the reaction rate or a
modification (reduction or increase) of the affinity to the
substrate results, is reached. A mutation in the catalytic center
of an polypeptide of the invention, e.g. as enzyme, can modulate
the turn over rate of the enzyme, e.g. a knock out of an essential
amino acid can lead to a reduced or completely knock out activity
of the enzyme, or the deletion or mutation of regulator binding
sites can reduce a negative regulation like a feedback inhibition
(or a substrate inhibition, if the substrate level is also
increased). The specific activity of an enzyme of the present
invention can be increased such that the turn over rate is
increased or the binding of a co-factor is improved. Improving the
stability of the encoding mRNA or the protein can also increase the
activity of a gene product. The stimulation of the activity is also
under the scope of the term "increased activity".
[2632] Moreover, the regulation of the abovementioned nucleic acid
sequences may be modified so that gene expression is increased.
This can be achieved advantageously by means of heterologous
regulatory sequences or by modifying, for example mutating, the
natural regulatory sequences which are present. The advantageous
methods may also be combined with each other.
[2633] In general, an activity of a gene product in an organism or
part thereof, in particular in a plant cell or organelle of a plant
cell, a plant, or a plant tissue or a part thereof or in a
microorganism can be increased by increasing the amount of the
specific encoding mRNA or the corresponding protein in said
organism or part thereof.
[2634] "Amount of protein or mRNA" is understood as meaning the
molecule number of polypeptides or mRNA molecules in an organism,
especially a plant, a tissue, a cell or a cell compartment.
"Increase" in the amount of a protein means the quantitative
increase of the molecule number of said protein in an organism,
especially a plant, a tissue, a cell or a cell compartment such as
an organelle like a plastid or mitochondria or part thereof--for
example by one of the methods described herein below--in comparison
to a wild type, control or reference.
[2635] The increase in molecule number amounts preferably to at
least 1%, preferably to more than 10%, more preferably to 30% or
more, especially preferably to 50%, 70% or more, very especially
preferably to 100%, most preferably to 500% or more. However, a de
novo expression is also regarded as subject of the present
invention.
[2636] A modification, i.e. an increase, can be caused by
endogenous or exogenous factors. For example, an increase in
activity in an organism or a part thereof can be caused by adding a
gene product or a precursor or an activator or an agonist to the
media or nutrition or can be caused by introducing said subjects
into an organism, transient or stable. Furthermore such an increase
can be reached by the introduction of the inventive nucleic acid
sequence or the encoded protein in the correct cell compartment for
example into the nucleus or cytoplasm respectively or into plastids
either by transformation and/or targeting.
[2637] In one embodiment the increased yield level, especially the
enhancement of the NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell in
the plant or a part thereof, e.g. in a cell, a tissue, a organ, an
organelle, the cytosol etc., is achieved by increasing the
endogenous level of the polypeptide of the invention. Accordingly,
in an embodiment of the present invention, the present invention
relates to a process wherein the gene copy number of a gene
encoding the polynucleotide or nucleic acid molecule of the
invention is increased. Further, the endogenous level of the
polypeptide of the invention can for example be increased by
modifying the transcriptional or translational regulation of the
polypeptide.
[2638] In one embodiment an increased yield, especially the
enhanced NUE and/or increased biomass production, of the plant or
part thereof can be altered by targeted or random mutagenesis of
the endogenous genes of the invention. For example homologous
recombination can be used to either introduce positive regulatory
elements like for plants the .sup.35S enhancer into the promoter or
to remove repressor elements form regulatory regions. In addition
gene conversion like methods described by Kochevenko and Willmitzer
(Plant Physiol. 132 (1), 174 (2003)) and citations therein can be
used to disrupt repressor elements or to enhance to activity of
positive regulatory elements.
[2639] Furthermore positive elements can be randomly introduced in
(plant) genomes by T-DNA or transposon mutagenesis and lines can be
screened for, in which the positive elements have been integrated
near to a gene of the invention, the expression of which is thereby
enhanced. The activation of plant genes by random integrations of
enhancer elements has been described by Hayashi et al. (Science
258,1350 (1992)) or Weigel et al. (Plant Physiol. 122, 1003 (2000))
and others citied therein.
[2640] Reverse genetic strategies to identify insertions (which
eventually carrying the activation elements) near in genes of
interest have been described for various cases e.g. Krysan et al.
(Plant Cell 11, 2283 (1999)); Sessions et al. (Plant Cell 14, 2985
(2002)); Young et al. (Plant Physiol. 125, 513 (2001)); Koprek et
al. (Plant J. 24, 253 (2000)); Jeon et al. (Plant J. 22, 561
(2000)); Tissier et al. (Plant Cell 11, 1841 (1999)); Speulmann et
al. (Plant Cell 11, 1853 (1999)). Briefly material from all plants
of a large T-DNA or transposon mutagenized plant population is
harvested and genomic DNA prepared. Then the genomic DNA is pooled
following specific architectures as described for example in Krysan
et al. (Plant Cell 11, 2283 (1999)). Pools of genomics DNAs are
then screened by specific multiplex PCR reactions detecting the
combination of the insertional mutagen (e.g. T-DNA or Transposon)
and the gene of interest. Therefore PCR reactions are run on the
DNA pools with specific combinations of T-DNA or transposon border
primers and gene specific primers. General rules for primer design
can again be taken from Krysan et al. (Plant Cell 11, 2283 (1999)).
Rescreening of lower levels DNA pools lead to the identification of
individual plants in which the gene of interest is activated by the
insertional mutagen.
[2641] The enhancement of positive regulatory elements or the
disruption or weakening of negative regulatory elements can also be
achieved through common mutagenesis techniques: The production of
chemically or radiation mutated populations is a common technique
and known to the skilled worker. Methods for plants are described
by Koorneef et al. (Mutat Res. March 93 (1) (1982)) and the
citations therein and by Lightner and Caspar in "Methods in
Molecular Biology" Vol. 82. These techniques usually induce point
mutations that can be identified in any known gene using methods
such as TILLING (Colbert et al., Plant Physiol, 126, (2001)).
[2642] Accordingly, the expression level can be increased if the
endogenous genes encoding a polypeptide conferring an increased
expression of the polypeptide of the present invention, in
particular genes comprising the nucleic acid molecule of the
present invention, are modified via homologous recombination,
Tilling approaches or gene conversion. It also possible to add as
mentioned herein targeting sequences to the inventive nucleic acid
sequences.
[2643] Regulatory sequences, if desired, in addition to a target
sequence or part thereof can be operatively linked to the coding
region of an endogenous protein and control its transcription and
translation or the stability or decay of the encoding mRNA or the
expressed protein. In order to modify and control the expression,
promoter, UTRs, splicing sites, processing signals, polyadenylation
sites, terminators, enhancers, repressors, post transcriptional or
posttranslational modification sites can be changed, added or
amended. For example, the activation of plant genes by random
integrations of enhancer elements has been described by Hayashi et
al. (Science 258, 1350 (1992)) or Weigel et al. (Plant Physiol.
122, 1003 (2000)) and others citied therein. For example, the
expression level of the endogenous protein can be modulated by
replacing the endogenous promoter with a stronger transgenic
promoter or by replacing the endogenous 3'UTR with a 3'UTR, which
provides more stability without amending the coding region.
Further, the transcriptional regulation can be modulated by
introduction of an artificial transcription factor as described in
the examples. Alternative promoters, terminators and UTR are
described below.
[2644] The activation of an endogenous polypeptide having
above-mentioned activity, e.g. having the activity of a protein as
shown in table II, application no. 1, column 3 or of the
polypeptide of the invention, e.g. conferring the increased yield
effect, especially the enhancement of NUE and/or increased biomass
production, as compared to a corresponding non-transformed wild
type plant cell, plant or part thereof after increase of expression
or activity in the cytosol and/or in an organelle like a plastid,
can also be increased by introducing a synthetic transcription
factor, which binds close to the coding region of the gene encoding
the protein as shown in table II, application no. 1, column 3 and
activates its transcription. A chimeric zinc finger protein can be
constructed, which comprises a specific DNA-binding domain and an
activation domain as e.g. the VP16 domain of Herpes Simplex virus.
The specific binding domain can bind to the regulatory region of
the gene encoding the protein as shown in table II, application no.
1, column 3. The expression of the chimeric transcription factor in
a organism, in particular in a plant, leads to a specific
expression of the protein as shown in table II, application no. 1,
column 3. The methods thereto a known to a skilled person and/or
disclosed e.g. in WO01/52620, Oriz, Proc. Natl. Acad. Sci. USA, 99,
13290 (2002) or Guan, Proc. Natl. Acad. Sci. USA 99, 13296
(2002).
[2645] In one further embodiment of the process according to the
invention, organisms are used in which one of the abovementioned
genes, or one of the above-mentioned nucleic acids, is mutated in a
way that the activity of the encoded gene products is less
influenced by cellular factors, or not at all, in comparison with
the unmutated proteins. For example, well known regulation
mechanism of enzymatic activity are substrate inhibition or feed
back regulation mechanisms. Ways and techniques for the
introduction of substitution, deletions and additions of one or
more bases, nucleotides or amino acids of a corresponding sequence
are described herein below in the corresponding paragraphs and the
references listed there, e.g. in Sambrook et al., Molecular
Cloning, Cold Spring Habour, N.Y., 1989. The person skilled in the
art will be able to identify regulation domains and binding sites
of regulators by comparing the sequence of the nucleic acid
molecule of the present invention or the expression product thereof
with the state of the art by computer software means which comprise
algorithms for the identifying of binding sites and regulation
domains or by introducing into a nucleic acid molecule or in a
protein systematically mutations and assaying for those mutations
which will lead to an increased specific activity or an increased
activity per volume, in particular per cell.
[2646] It can therefore be advantageous to express in an organism a
nucleic acid molecule of the invention or a polypeptide of the
invention derived from a evolutionary distantly related organism,
as e.g. using a prokaryotic gene in a eukaryotic host, as in these
cases the regulation mechanism of the host cell may not weaken the
activity (cellular or specific) of the gene or its expression
product.
[2647] The mutation is introduced in such a way that the enhanced
yield, particularly due to one or more improved yield related
traits as defined above, especially the enhanced NUE and/or biomass
increase, are not adversely affected.
[2648] Less influence on the regulation of a gene or its gene
product is understood as meaning a reduced regulation of the
enzymatic activity leading to an increased specific or cellular
activity of the gene or its product. An increase of the enzymatic
activity is understood as meaning an enzymatic activity, which is
increased by at least 10%, advantageously at least 20, 30 or 40%,
especially advantageously by at least 50, 60 or 70% in comparison
with the starting organism. This leads to an enhanced NUE and/or
increased biomass production as compared to a corresponding
non-transformed wild type plant cell, plant or part thereof.
[2649] The invention provides that the above methods can be
performed such that the tolerance to abiotic environmental stress
is increased, wherein particularly the tolerance to low temperature
and/or water use efficiency is increased. In another preferred
embodiment the invention provides that the above methods can be
performed such that the nutrient use efficiency, particularly the
NUE is increased. In a further preferred embodiment the invention
provides that the above methods can be performed such that the
tolerance to abiotic stress, particularly the tolerance to low
temperature and/or water use efficiency, and at the same time, the
nutrient use efficiency, particularly the nitrogen use efficiency
is increased. In another preferred embodiment the invention
provides that the above methods can be performed such that the
yield is increased in the absence of nutrient deficiencies as well
as the absence of stress conditions. In a further preferred
embodiment the invention provides that the above methods can be
performed such that the nutrient use efficiency, particularly the
nitrogen use efficiency, and the yield, in the absence of nutrient
deficiencies as well as the absence of stress conditions, is
increased. In a further preferred embodiment the invention provides
that the above methods can be performed such that the tolerance to
abiotic stress, particularly the tolerance to low temperature
and/or water use efficiency, and at the same time, the nutrient use
efficiency, particularly the nitrogen use efficiency, and the yield
in the absence of nutrient deficiencies as well as the absence of
stress conditions, is increased.
[2650] The invention is not limited to specific nucleic acids,
specific polypeptides, specific cell types, specific host cells,
specific conditions or specific methods etc. as such, but may vary
and numerous modifications and variations therein will be apparent
to those skilled in the art. It is also to be understood that the
terminology used herein is for the purpose of describing specific
embodiments only and is not intended to be limiting.
[2651] The present invention also relates to isolated nucleic acids
comprising a nucleic acid molecule selected from the group
consisting of: [2652] (a) a nucleic acid molecule encoding the
polypeptide shown in column 7 of table II B, application no. 1;
[2653] (b) a nucleic acid molecule shown in column 7 of table I B,
application no. 1; [2654] (c) a nucleic acid molecule, which, as a
result of the degeneracy of the genetic code, can be derived from a
polypeptide sequence depicted in column 5 or 7 of table II,
application no. 1, and confers an increased yield, especially an
enhanced NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof; [2655] (d) a nucleic acid molecule having at least
30% identity, preferably at least 40%, 50%, 60%, 70%, 75%, 80%,
85%, 90%, 95%, 96%, 97%, 98%, 99%, 99.5%, with the nucleic acid
molecule sequence of a polynucleotide comprising the nucleic acid
molecule shown in column 5 or 7 of table I, application no. 1, and
confers an increased yield, especially an enhanced NUE and/or
increased biomass production, as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof;
[2656] (e) a nucleic acid molecule encoding a polypeptide having at
least 30% identity, preferably at least 40%, 50%, 60%, 70%, 75%,
80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 99.5%, with the amino acid
sequence of the polypeptide encoded by the nucleic acid molecule of
(a), (b), (c) or (d) and having the activity represented by a
nucleic acid molecule comprising a polynucleotide as depicted in
column 5 of table I, application no. 1, and confers an increased
yield, especially an enhanced NUE and/or increased biomass
production, as compared to a corresponding non-transformed wild
type plant cell, a plant or a part thereof; [2657] (f) nucleic acid
molecule which hybridizes with a nucleic acid molecule of (a), (b),
(c), (d) or (e) under stringent hybridization conditions and
confers an increased yield, especially an enhanced NUE and/or
increased biomass production, as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof;
[2658] (g) a nucleic acid molecule encoding a polypeptide which can
be isolated with the aid of monoclonal or polyclonal antibodies
made against a polypeptide encoded by one of the nucleic acid
molecules of (a), (b), (c), (d), (e) or (f) and having the activity
represented by the nucleic acid molecule comprising a
polynucleotide as depicted in column 5 of table I, application no.
1; [2659] (h) a nucleic acid molecule encoding a polypeptide
comprising the consensus sequence or one or more polypeptide motifs
as shown in column 7 of table IV, application no. 1, and preferably
having the activity represented by a protein molecule comprising a
polypeptide as depicted in column 5 of table II or IV, application
no. 1, [2660] (i) a nucleic acid molecule encoding a polypeptide
having the activity represented by a protein as depicted in column
5 of table II, application no. 1, and confers an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof; [2661] (i) nucleic acid molecule which
comprises a polynucleotide, which is obtained by amplifying a cDNA
library or a genomic library using the primers in column 7 of table
III, application no. 1, (which in a special embodiment do not start
at their 5'-end with the nucleotides ATA and) preferably having the
activity represented by a protein molecule comprising a polypeptide
as depicted in column 5 of table II or IV, application no. 1; and
[2662] (k) a nucleic acid molecule which is obtainable by screening
a suitable nucleic acid library, especially a cDNA library and/or a
genomic library, under stringent hybridization conditions with a
probe comprising a complementary sequence of a nucleic acid
molecule of (a) or (b) or with a fragment thereof, having at least
15 nt, preferably 20 nt, 30 nt, 50 nt, 100 nt, 200 nt, 500 nt, 750
nt or 1000 nt of a nucleic acid molecule complementary to a nucleic
acid molecule sequence characterized in (a) to (e) and encoding a
polypeptide having the activity represented by a protein comprising
a polypeptide as depicted in column 5 of table II, application no.
1; whereby the nucleic acid molecule according to (a), (b), (c),
(d), (e), (f), (g), (h), (i), (j) and (k) is at least in one or
more nucleotides different from the sequence depicted in column 5
or 7 of table I A, application no. 1, and preferably which encodes
a protein which differs at least in one or more amino acids from
the protein sequences depicted in column 5 or 7 of table II A,
application no. 1.
[2663] In one embodiment the invention relates to homologs of the
afore-mentioned sequences, which can be isolated advantageously
from yeast, fungi, viruses, algae, bacteria, such as Acetobacter
(subgen. Acetobacter) aceti; Acidithiobacillus ferrooxidans;
Acinetobacter sp.; Actinobacillus sp; Aeromonas salmonicida;
Agrobacterium tumefaciens; Aquifex aeolicus; Arcanobacterium
pyogenes; Aster yellows phytoplasma; Bacillus sp.; Bifidobacterium
sp.; Borrelia burgdorferi; Brevibacterium linens; Brucella
melitensis; Buchnera sp.; Butyrivibrio fibrisolvens; Campylobacter
jejuni; Caulobacter crescentus; Chlamydia sp.; Chlamydophila sp.;
Chlorobium limicola; Citrobacter rodentium; Clostridium sp.;
Comamonas testosteroni; Corynebacterium sp.; Coxiella burnetii;
Deinococcus radiodurans; Dichelobacter nodosus; Edwardsiella
ictaluri; Enterobacter sp.; Erysipelothrix rhusiopathiae;
Escherichia coli; Flavobacterium sp.; Francisella tularensis;
Frankia sp. Cpl1; Fusobacterium nucleatum; Geobacillus
stearothermophilus; Gluconobacter oxydans; Haemophilus sp.;
Helicobacter pylori; Klebsiella pneumoniae; Lactobacillus sp.;
Lactococcus lactis; Listeria sp.; Mannheimia haemolytica;
Mesorhizobium loti; Methylophaga thalassica; Microcystis
aeruginosa; Microscilla sp. PRE1; Moraxella sp. TA144;
Mycobacterium sp.; Mycoplasma sp.; Neisseria sp.; Nitrosomonas sp.;
Nostoc sp. PCC 7120; Novosphingobium aromaticivorans; Oenococcus
oeni; Pantoea citrea; Pasteurella multocida; Pediococcus
pentosaceus; Phormidium foveolarum; Phytoplasma sp.; Plectonema
boryanum; Prevotella ruminicola; Propionibacterium sp.; Proteus
vulgaris; Pseudomonas sp.; Ralstonia sp.; Rhizobium sp.;
Rhodococcus equi; Rhodothermus marinus; Rickettsia sp.; Riemerella
anatipestifer; Ruminococcus flavefaciens; Salmonella sp.;
Selenomonas ruminantium; Serratia entomophila; Shigella sp.;
Sinorhizobium meliloti; Staphylococcus sp.; Streptococcus sp.;
Streptomyces sp.; Synechococcus sp.; Synechocystis sp. PCC 6803;
Thermotoga maritima; Treponema sp.; Ureaplasma urealyticum; Vibrio
cholerae; Vibrio parahaemolyticus; Xylella fastidiosa; Yersinia
sp.; Zymomonas mobilis, preferably Salmonella sp. or Escherichia
coli or plants, preferably from yeasts such as from the genera
Saccharomyces, Pichia, Candida, Hansenula, Torulopsis or
Schizosaccharomyces or plants such as Arabidopsis thaliana, maize,
wheat, rye, oat, triticale, rice, barley, soybean, peanut, cotton,
borage, sunflower, linseed, primrose, rapeseed, canola and turnip
rape, manihot, pepper, sunflower, tagetes, solanaceous plant such
as potato, tobacco, eggplant and tomato, Vicia species, pea,
alfalfa, bushy plants such as coffee, cacao, tea, Salix species,
trees such as oil palm, coconut, perennial grass, such as ryegrass
and fescue, and forage crops, such as alfalfa and clover and from
spruce, pine or fir for example. More preferably homologs of
aforementioned sequences can be isolated from Saccharomyces
cerevisiae, E. coli or Synechocystis sp. or plants, preferably
Brassica napus, Glycine max, Zea mays, cotton or Oryza sativa.
[2664] The (NUE related) proteins (NUERPs) of the present invention
are preferably produced by recombinant DNA techniques. For example,
a nucleic acid molecule encoding the protein is cloned into an
expression vector, for example in to a binary vector, the
expression vector is introduced into a host cell, for example the
Arabidopsis thaliana wild type NASC N906 or any other plant cell as
described in the examples see below, and the NUE related protein is
expressed in said host cell. Examples for binary vectors are
pBIN19, pBI101, pBinAR, pGPTV, pCAMBIA, pBIB-HYG, pBecks, pGreen or
pPZP (Hajukiewicz, P. et al., Plant Mol. Biol. 25, 989 (1994), and
Hellens et al, Trends in Plant Science 5, 446 (2000)).
[2665] In one embodiment the (NUE related) protein (NUERP) of the
present invention is preferably produced in a compartment of the
cell, more preferably in the plastids. Ways of introducing nucleic
acids into plastids and producing proteins in this compartment are
known to the person skilled in the art have been also described in
this application.
[2666] In another embodiment of the (NUE related) protein (NUERP)
of the present invention is preferably produced in the cytosol of
the cell. Ways of producing proteins in the cytosol are known to
the person skilled in the art.
[2667] In another embodiment the protein of the present invention
is preferably produced cytoplasmic, meaning without artificial
targeting as defined in 0066.1.1.1. Ways of producing proteins
without artificial targeting are known to the person skilled in the
art.
[2668] Advantageously, the nucleic acid sequences according to the
invention or the gene construct together with at least one reporter
gene are cloned into an expression cassette, which is introduced
into the organism via a vector or directly into the genome. This
reporter gene should allow easy detection via a growth,
fluorescence, chemical, bioluminescence or resistance assay or via
a photometric measurement. Examples of reporter genes which may be
mentioned are antibiotic- or herbicide-resistance genes, hydrolase
genes, fluorescence protein genes, bioluminescence genes, sugar or
nucleotide metabolic genes or biosynthesis genes such as the Ura3
gene, the IIv2 gene, the luciferase gene, the .beta.-galactosidase
gene, the gfp gene, the 2-desoxyglucose-6-phosphate phosphatase
gene, the .beta.-glucuronidase gene, .beta.-lactamase gene, the
neomycin phosphotransferase gene, the hygromycin phosphotransferase
gene, a mutated acetohydroxyacid synthase (AHAS) gene (also known
as acetolactate synthase (ALS) gene), a gene for a D-amino acid
metabolizing enzmye or the BASTA (=gluphosinate-resistance) gene.
These genes permit easy measurement and quantification of the
transcription activity and hence of the expression of the genes. In
this way genome positions may be identified which exhibit differing
productivity.
[2669] In a preferred embodiment a nucleic acid construct, for
example an expression cassette, comprises upstream, i.e. at the 5'
end of the encoding sequence, a promoter and downstream, i.e. at
the 3' end, a polyadenylation signal and optionally other
regulatory elements which are operably linked to the intervening
encoding sequence with one of the nucleic acids of SEQ ID NO as
depicted in table I, application no. 1, column 5 and 7. By an
operable linkage is meant the sequential arrangement of promoter,
encoding sequence, terminator and optionally other regulatory
elements in such a way that each of the regulatory elements can
fulfill its function in the expression of the encoding sequence in
due manner. In one embodiment the sequences preferred for operable
linkage are targeting sequences for ensuring subcellular
localization in plastids. However, targeting sequences for ensuring
subcellular localization in the mitochondrium, in the endoplasmic
reticulum (=ER), in the nucleus, in oil corpuscles or other
compartments may also be employed as well as translation promoters
such as the 5' lead sequence in tobacco mosaic virus (Gallie et
al., Nucl. Acids Res. 15 8693 (1987)).
[2670] A nucleic acid construct, for example an expression cassette
may, for example, contain a constitutive promoter or a
tissue-specific promoter (preferably the USP or napin promoter) the
gene to be expressed and the ER retention signal. For the ER
retention signal the KDEL amino acid sequence (lysine, aspartic
acid, glutamic acid, leucine) or the KKX amino acid sequence
(lysine-lysine-X-stop, wherein X means every other known amino
acid) is preferably employed.
[2671] For expression in a host organism, for example a plant, the
expression cassette is advantageously inserted into a vector such
as by way of example a plasmid, a phage or other DNA which allows
optimal expression of the genes in the host organism. Examples of
suitable plasmids are: in E. coli pLG338, pACYC184, pBR series such
as e.g. pBR322, pUC series such as pUC18 or pUC19, M113mp series,
pKC30, pRep4, pHS1, pHS2, pPLc236, pMBL24, pLG200, pUR290,
pIN-III.sup.113-B1, .lamda.gt11 or pBdCI; in Streptomyces pIJ101,
pIJ364, pIJ702 or pIJ361; in Bacillus pUB110, pC194 or pBD214; in
Corynebacterium pSA77 or pAJ667; in fungi pALS1, pIL2 or pBB116;
other advantageous fungal vectors are described by Romanos M. A. et
al., Yeast 8, 423 (1992) and by van den Hondel, C.A.M.J. J. et al.
[(1991) "Heterologous gene expression in filamentous fungi"] as
well as in "More Gene Manipulations" in "Fungi" in Bennet J.W.
& Lasure L. L., eds., pp. 396-428, Academic Press, San Diego,
and in "Gene transfer systems and vector development for
filamentous fungi" [van den Hondel, C.A.M.J.J. & Punt, P.J.
(1991) in: Applied Molecular Genetics of Fungi, Peberdy, J. F. et
al., eds., pp. 1-28, Cambridge University Press: Cambridge].
Examples of advantageous yeast promoters are 2 .mu.M, pAG-1, YEp6,
YEp13 or pEMBLYe23. Examples of algal or plant promoters are
pLGV23, pGHlac.sup.+, pBIN19, pAK2004, pVKH or pDH51 (see Schmidt,
R. and Willmitzer, L., Plant Cell Rep. 7, 583 (1988))). The vectors
identified above or derivatives of the vectors identified above are
a small selection of the possible plasmids. Further plasmids are
well known to those skilled in the art and may be found, for
example, in "Cloning Vectors" (Eds. Pouwels P. H. et al. Elsevier,
Amsterdam-New York-Oxford, 1985, ISBN 0 444 904018). Suitable plant
vectors are described inter alia in "Methods in Plant Molecular
Biology and Biotechnology" (CRC Press, Ch. 6/7, pp. 71-119).
Advantageous vectors are known as shuttle vectors or binary vectors
which replicate in E. coli and Agrobacterium.
[2672] By vectors is meant with the exception of plasmids all other
vectors known to those skilled in the art such as by way of example
phages, viruses such as SV40, CMV, baculovirus, adenovirus,
transposons, IS elements, phasmids, phagemids, cosmids, linear or
circular DNA. These vectors can be replicated autonomously in the
host organism or be chromosomally replicated, chromosomal
replication being preferred.
[2673] In a further embodiment of the vector the expression
cassette according to the invention may also advantageously be
introduced into the organisms in the form of a linear DNA and be
integrated into the genome of the host organism by way of
heterologous or homologous recombination. This linear DNA may be
composed of a linearized plasmid or only of the expression cassette
as vector or the nucleic acid sequences according to the
invention.
[2674] In a further advantageous embodiment the nucleic acid
sequence according to the invention can also be introduced into an
organism on its own.
[2675] If in addition to the nucleic acid sequence according to the
invention further genes are to be introduced into the organism, all
together with a reporter gene in a single vector or each single
gene with a reporter gene in a vector in each case can be
introduced into the organism, whereby the different vectors can be
introduced simultaneously or successively.
[2676] The vector advantageously contains at least one copy of the
nucleic acid sequences according to the invention and/or the
expression cassette (=gene construct) according to the
invention.
[2677] The invention further provides an isolated recombinant
expression vector comprising a nucleic acid encoding a polypeptide
as depicted in table II, application no. 1, column 5 or 7, wherein
expression of the vector in a host cell results in increased yield,
especially in enhanced NUE and/or biomass production, as compared
to a wild type variety of the host cell.
[2678] As used herein, the term "vector" refers to a nucleic acid
molecule capable of transporting another nucleic acid to which it
has been linked. One type of vector is a "plasmid", which refers to
a circular double stranded DNA loop into which additional DNA
segments can be ligated. Another type of vector is a viral vector,
wherein additional DNA segments can be ligated into the viral
genome. Certain vectors are capable of autonomous replication in a
host cell into which they are introduced (e.g. bacterial vectors
having a bacterial origin of replication and episomal mammalian
vectors). Other vectors (e.g. non-episomal mammalian vectors) are
integrated into the genome of a host cell or an organelle upon
introduction into the host cell, and thereby are replicated along
with the host or organelle genome. Moreover, certain vectors are
capable of directing the expression of genes to which they are
operatively linked. Such vectors are referred to herein as
"expression vectors." In general, expression vectors of utility in
recombinant DNA techniques are often in the form of plasmids. In
the present specification, "plasmid" and "vector" can be used
interchangeably as the plasmid is the most commonly used form of
vector. However, the invention is intended to include such other
forms of expression vectors, such as viral vectors (e.g.,
replication defective retroviruses, adenoviruses, and
adeno-associated viruses), which serve equivalent functions.
[2679] The recombinant expression vectors of the invention comprise
a nucleic acid of the invention in a form suitable for expression
of the nucleic acid in a host cell, which means that the
recombinant expression vectors include one or more regulatory
sequences, selected on the basis of the host cells to be used for
expression, which is operatively linked to the nucleic acid
sequence to be expressed. As used herein with respect to a
recombinant expression vector, "operatively linked" is intended to
mean that the nucleotide sequence of interest is linked to the
regulatory sequence(s) in a manner which allows for expression of
the nucleotide sequence (e.g. in an in vitro
transcription/translation system or in a host cell when the vector
is introduced into the host cell). The term "regulatory sequence"
is intended to include promoters, enhancers, and other expression
control elements (e.g. polyadenylation signals). Such regulatory
sequences are described, for example, in Goeddel, Gene Expression
Technology: Methods in Enzymology 185, Academic Press, San Diego,
Calif. (1990), and Gruber and Crosby, in: Methods in Plant
Molecular Biology and Biotechnology, eds. Glick and Thompson,
Chapter 7, 89-108, CRC Press; Boca Raton, Fla., including the
references therein. Regulatory sequences include those that direct
constitutive expression of a nucleotide sequence in many types of
host cells and those that direct expression of the nucleotide
sequence only in certain host cells or under certain conditions. It
will be appreciated by those skilled in the art that the design of
the expression vector can depend on such factors as the choice of
the host cell to be transformed, the level of expression of
polypeptide desired, etc. The expression vectors of the invention
can be introduced into host cells to thereby produce polypeptides
or peptides, including fusion polypeptides or peptides, encoded by
nucleic acids as described herein (e.g., NUERPs, mutant forms of
NUERPs, fusion polypeptides, etc.).
[2680] The recombinant expression vectors of the invention can be
designed for expression of the polypeptide of the invention in
plant cells. For example, NUERP genes can be expressed in plant
cells (see Schmidt R., and Willmitzer L., Plant Cell Rep. 7 (1988);
Plant Molecular Biology and Biotechnology, C Press, Boca Raton,
Fla., Chapter 6/7, p. 71-119 (1993); White F.F., Jenes B. et al.,
Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1,
Engineering and Utilization, eds. Kung and Wu R., 128-43, Academic
Press: 1993; Potrykus, Annu. Rev. Plant Physiol. Plant Molec. Biol.
42, 205 (1991) and references cited therein). Suitable host cells
are discussed further in Goeddel, Gene Expression Technology:
Methods in Enzymology 185, Academic Press: San Diego, Calif.
(1990). Alternatively, the recombinant expression vector can be
transcribed and translated in vitro, for example using T7 promoter
regulatory sequences and T7 polymerase.
[2681] Expression of polypeptides in prokaryotes is most often
carried out with vectors containing constitutive or inducible
promoters directing the expression of either fusion or non-fusion
polypeptides. Fusion vectors add a number of amino acids to a
polypeptide encoded therein, usually to the amino terminus of the
recombinant polypeptide but also to the C-terminus or fused within
suitable regions in the polypeptides. Such fusion vectors typically
serve three purposes: 1) to increase expression of a recombinant
polypeptide; 2) to increase the solubility of a recombinant
polypeptide; and 3) to aid in the purification of a recombinant
polypeptide by acting as a ligand in affinity purification. Often,
in fusion expression vectors, a proteolytic cleavage site is
introduced at the junction of the fusion moiety and the recombinant
polypeptide to enable separation of the recombinant polypeptide
from the fusion moiety subsequent to purification of the fusion
polypeptide. Such enzymes, and their cognate recognition sequences,
include Factor Xa, thrombin, and enterokinase.
[2682] By way of example the plant expression cassette can be
installed in the pRT transformation vector ((a) Toepfer et al.,
Methods Enzymol. 217, 66 (1993), (b) Toepfer et al., Nucl. Acids.
Res. 15, 5890 (1987)).
[2683] Alternatively, a recombinant vector (=expression vector) can
also be transcribed and translated in vitro, e.g. by using the T7
promoter and the T7 RNA polymerase.
[2684] Expression vectors employed in prokaryotes frequently make
use of inducible systems with and without fusion proteins or fusion
oligopeptides, wherein these fusions can ensue in both N-terminal
and C-terminal manner or in other useful domains of a protein. Such
fusion vectors usually have the following purposes: 1) to increase
the RNA expression rate; 2) to increase the achievable protein
synthesis rate; 3) to increase the solubility of the protein; 4) or
to simplify purification by means of a binding sequence usable for
affinity chromatography. Proteolytic cleavage points are also
frequently introduced via fusion proteins, which allow cleavage of
a portion of the fusion protein and purification. Such recognition
sequences for proteases are recognized, e.g. factor Xa, thrombin
and enterokinase.
[2685] Typical advantageous fusion and expression vectors are pGEX
(Pharmacia Biotech Inc; Smith D.B. and Johnson K.S., Gene 67, 31
(1988)), pMAL (New England Biolabs, Beverly, Mass.) and pRIT5
(Pharmacia, Piscataway, N.J.) which contains glutathione
S-transferase (GST), maltose binding protein or protein A.
[2686] In one embodiment, the coding sequence of the polypeptide of
the invention is cloned into a pGEX expression vector to create a
vector encoding a fusion polypeptide comprising, from the
N-terminus to the C-terminus, GST-thrombin cleavage site-X
polypeptide. The fusion polypeptide can be purified by affinity
chromatography using glutathione-agarose resin. Recombinant PKNUERP
unfused to GST can be recovered by cleavage of the fusion
polypeptide with thrombin.
[2687] Other examples of E. coli expression vectors are pTrc (Amann
et al., Gene 69, 301 (1988)) and pET vectors (Studier et al., Gene
Expression Technology: Methods in Enzymology 185, Academic Press,
San Diego, Calif. (1990) 60-89; Stratagene, Amsterdam, The
Netherlands).
[2688] Target gene expression from the pTrc vector relies on host
RNA polymerase transcription from a hybrid trp-lac fusion promoter.
Target gene expression from the pET 11d vector relies on
transcription from a T7 gn10-lac fusion promoter mediated by a
co-expressed viral RNA polymerase (T7 gn1). This viral polymerase
is supplied by host strains BL21(DE3) or HMS174(DE3) from a
resident I prophage harboring a T7 gn1 gene under the
transcriptional control of the lacUV 5 promoter.
[2689] In a preferred embodiment of the present invention, the
NUERPs are expressed in plants and plants cells such as unicellular
plant cells (e.g. algae) (see Falciatore et al., Marine
Biotechnology 1 (3), 239 (1999) and references therein) and plant
cells from higher plants (e.g., the spermatophytes, such as crop
plants). A nucleic acid molecule coding for NUERP as depicted in
table II, application no. 1, column 5 or 7 may be "introduced" into
a plant cell by any means, including transfection, transformation
or transduction, electroporation, particle bombardment,
agroinfection, and the like. One transformation method known to
those of skill in the art is the dipping of a flowering plant into
an Agrobacteria solution, wherein the Agrobacteria contains the
nucleic acid of the invention, followed by breeding of the
transformed gametes.
[2690] Other suitable methods for transforming or transfecting host
cells including plant cells can be found in Sambrook et al.,
Molecular Cloning: A Laboratory Manual. 2.sup.nd, ed., Cold Spring
Harbor Laboratory, Cold Spring Harbor Laboratory Press, Cold Spring
Harbor, N.Y., 1989, and other laboratory manuals such as Methods in
Molecular Biology, 1995, Vol. 44, Agrobacterium protocols, ed:
Gartland and Davey, Humana Press, Totowa, N.J. As increased NUE
and/or biomass production is a general trait wished to be inherited
into a wide variety of plants like maize, wheat, rye, oat,
triticale, rice, barley, soybean, peanut, cotton, rapeseed and
canola, manihot, pepper, sunflower and tagetes, solanaceous plants
like potato, tobacco, eggplant, and tomato, Vicia species, pea,
alfalfa, bushy plants (coffee, cacao, tea), Salix species, trees
(oil palm, coconut), perennial grasses, and forage crops, these
crop plants are also preferred target plants for a genetic
engineering as one further embodiment of the present invention.
Forage crops include, but are not limited to Wheatgrass,
Canarygrass, Bromegrass, Wildrye Grass, Bluegrass, Orchardgrass,
Alfalfa, Salfoin, Birdsfoot Trefoil, Alsike Clover, Red Clover and
Sweet Clover.
[2691] In one embodiment of the present invention, transfection of
a nucleic acid molecule coding for NUERP as depicted in table II,
application no. 1, column 5 or 7 into a plant is achieved by
Agrobacterium mediated gene transfer. Agrobacterium mediated plant
transformation can be performed using for example the GV3101(pMP90)
(Koncz and Schell, Mol. Gen. Genet. 204, 383 (1986)) or LBA4404
(Clontech) Agrobacterium tumefaciens strain. Transformation can be
performed by standard transformation and regeneration techniques
(Deblaere et al., Nucl. Acids Res. 13, 4777 (1994), Gelvin, Stanton
B. and Schilperoort Robert A, Plant Molecular Biology Manual,
2.sup.nd Ed.--Dordrecht: Kluwer Academic Publ., 1995.--in Sect.,
Ringbuc Zentrale Signatur: BT11-P ISBN 0-7923-2731-4; Glick Bernard
R., Thompson John E., Methods in Plant Molecular Biology and
Biotechnology, Boca Raton: CRC Press, 1993 360 S., ISBN
0-8493-5164-2). For example, rapeseed can be transformed via
cotyledon or hypocotyl transformation (Moloney et al., Plant Cell
Report 8, 238 (1989); De Block et al., Plant Physiol. 91, 694
(1989)). Use of antibiotics for Agrobacterium and plant selection
depends on the binary vector and the Agrobacterium strain used for
transformation. Rapeseed selection is normally performed using
kanamycin as selectable plant marker. Agrobacterium mediated gene
transfer to flax can be performed using, for example, a technique
described by Mlynarova et al., Plant Cell Report 13, 282 (1994).
Additionally, transformation of soybean can be performed using for
example a technique described in European Patent No. 424 047, U.S.
Pat. No. 5,322,783, European Patent No. 397 687, U.S. Pat. No.
5,376,543 or U.S. Pat. No. 5,169,770. Transformation of maize can
be achieved by particle bombardment, polyethylene glycol mediated
DNA uptake or via the silicon carbide fiber technique. (See, for
example, Freeling and Walbot "The maize handbook" Springer Verlag:
New York (1993) ISBN 3-540-97826-7). A specific example of maize
transformation is found in U.S. Pat. No. 5,990,387, and a specific
example of wheat transformation can be found in PCT Application No.
WO 93/07256.
[2692] According to the present invention, the introduced nucleic
acid molecule coding for NUERP as depicted in table II, application
no. 1, column 5 or 7 may be maintained in the plant cell stably if
it is incorporated into a non-chromosomal autonomous replicon or
integrated into the plant chromosomes or organelle genome.
Alternatively, the introduced NUERP may be present on an
extra-chromosomal non-replicating vector and be transiently
expressed or transiently active.
[2693] In one embodiment, a homologous recombinant microorganism
can be created wherein the NUERP is integrated into a chromosome, a
vector is prepared which contains at least a portion of a nucleic
acid molecule coding for NUERP as depicted in table II, application
no. 1, column 5 or 7 into which a deletion, addition, or
substitution has been introduced to thereby alter, e.g.,
functionally disrupt, the NUERP gene. Preferably, the NUERP gene is
a yeast, E. coli gene, but it can be a homolog from a related plant
or even from a mammalian or insect source. The vector can be
designed such that, upon homologous recombination, the endogenous
nucleic acid molecule coding for NUERP as depicted in table II,
application no. 1, column 5 or 7 is mutated or otherwise altered
but still encodes a functional polypeptide (e.g., the upstream
regulatory region can be altered to thereby alter the expression of
the endogenous NUERP). In a preferred embodiment the biological
activity of the protein of the invention is increased upon
homologous recombination. To create a point mutation via homologous
recombination, DNA-RNA hybrids can be used in a technique known as
chimeraplasty (Cole-Strauss et al., Nucleic Acids Research 27
(5),1323 (1999) and Kmiec, Gene Therapy American Scientist. 87 (3),
240 (1999)). Homologous recombination procedures in Physcomitrella
patens are also well known in the art and are contemplated for use
herein.
[2694] Whereas in the homologous recombination vector, the altered
portion of the nucleic acid molecule coding for NUERP as depicted
in table II, application no. 1, column 5 or 7 is flanked at its 5'
and 3' ends by an additional nucleic acid molecule of the NUERP
gene to allow for homologous recombination to occur between the
exogenous NUERP gene carried by the vector and an endogenous NUERP
gene, in a microorganism or plant. The additional flanking NUERP
nucleic acid molecule is of sufficient length for successful
homologous recombination with the endogenous gene. Typically,
several hundreds of base pairs up to kilobases of flanking DNA
(both at the 5' and 3' ends) are included in the vector. See, e.g.,
Thomas K.R., and Capecchi M.R., Cell 51, 503 (1987) for a
description of homologous recombination vectors or Strepp et al.,
PNAS, 95 (8), 4368 (1998) for cDNA based recombination in
Physcomitrella patens. The vector is introduced into a
microorganism or plant cell (e.g. via polyethylene glycol mediated
DNA), and cells in which the introduced NUERP gene has homologously
recombined with the endogenous NUERP gene are selected using
art-known techniques.
[2695] Whether present in an extra-chromosomal non-replicating
vector or a vector that is integrated into a chromosome, the
nucleic acid molecule coding for NUERP as depicted in table II,
application no. 1, column 5 or 7 preferably resides in a plant
expression cassette. A plant expression cassette preferably
contains regulatory sequences capable of driving gene expression in
plant cells that are operatively linked so that each sequence can
fulfill its function, for example, termination of transcription by
polyadenylation signals. Preferred polyadenylation signals are
those originating from Agrobacterium tumefaciens t-DNA such as the
gene 3 known as octopine synthase of the Ti-plasmid pTiACH5 (Gielen
et al., EMBO J. 3, 835 (1984)) or functional equivalents thereof
but also all other terminators functionally active in plants are
suitable. As plant gene expression is very often not limited on
transcriptional levels, a plant expression cassette preferably
contains other operatively linked sequences like translational
enhancers such as the overdrive-sequence containing the
5''-untranslated leader sequence from tobacco mosaic virus
enhancing the polypeptide per RNA ratio (Gallie et al., Nucl. Acids
Research 15, 8693 (1987)). Examples of plant expression vectors
include those detailed in: Becker D. et al., Plant Mol. Biol. 20,
1195 (1992); and Bevan M.W., Nucl. Acid. Res. 12, 8711 (1984); and
"Vectors for Gene Transfer in Higher Plants" in: Transgenic Plants,
Vol. 1, Engineering and Utilization, eds. Kung and Wu R., Academic
Press, 1993, S. 15-38.
[2696] "Transformation" is defined herein as a process for
introducing heterologous DNA into a plant cell, plant tissue, or
plant. It may occur under natural or artificial conditions using
various methods well known in the art. Transformation may rely on
any known method for the insertion of foreign nucleic acid
sequences into aprokaryotic or eukaryotic host cell. The method is
selected based on the host cell being transformed and may include,
but is not limited to, viral infection, electroporation,
lipofection, and particle bombardment. Such "transformed" cells
include stably transformed cells in which the inserted DNA is
capable of replication either as an autonomously replicating
plasmid or as part of the host chromosome. They also include cells
which transiently express the inserted DNA or RNA for limited
periods of time. Transformed plant cells, plant tissue, or plants
are understood to encompass not only the end product of a
transformation process, but also transgenic progeny thereof.
[2697] The terms "transformed," "transgenic," and "recombinant"
refer to a host organism such as a bacterium or a plant into which
a heterologous nucleic acid molecule has been introduced. The
nucleic acid molecule can be stably integrated into the genome of
the host or the nucleic acid molecule can also be present as an
extrachromosomal molecule. Such an extrachromosomal molecule can be
auto-replicating. Transformed cells, tissues, or plants are
understood to encompass not only the end product of a
transformation process, but also transgenic progeny thereof. A
"non-transformed", "non-transgenic" or "non-recombinant" host
refers to a wild-type organism, e.g. a bacterium or plant, which
does not contain the heterologous nucleic acid molecule.
[2698] A "transgenic plant", as used herein, refers to a plant
which contains a foreign nucleotide sequence inserted into either
its nuclear genome or organellar genome. It encompasses further the
offspring generations i.e. the T1-, T2- and consecutively
generations or BC1-, BC2- and consecutively generation as well as
crossbreeds thereof with non-transgenic or other transgenic
plants.
[2699] The host organism (=transgenic organism) advantageously
contains at least one copy of the nucleic acid according to the
invention and/or of the nucleic acid construct according to the
invention.
[2700] In principle all plants can be used as host organism.
Preferred transgenic plants are, for example, selected from the
families Aceraceae, Anacardiaceae, Apiaceae, Asteraceae,
Brassicaceae, Cactaceae, Cucurbitaceae, Euphorbiaceae, Fabaceae,
Malvaceae, Nymphaeaceae, Papaveraceae, Rosaceae, Salicaceae,
Solanaceae, Arecaceae, Bromeliaceae, Cyperaceae, Iridaceae,
Liliaceae, Orchidaceae, Gentianaceae, Labiaceae, Magnoliaceae,
Ranunculaceae, Carifolaceae, Rubiaceae, Scrophulariaceae,
Caryophyllaceae, Ericaceae, Polygonaceae, Violaceae, Juncaceae or
Poaceae and preferably from a plant selected from the group of the
families Apiaceae, Asteraceae, Brassicaceae, Cucurbitaceae,
Fabaceae, Papaveraceae, Rosaceae, Solanaceae, Liliaceae or Poaceae.
Preferred are crop plants such as plants advantageously selected
from the group of the genus peanut, oilseed rape, canola,
sunflower, safflower, olive, sesame, hazelnut, almond, avocado,
bay, pumpkin/squash, linseed, soya, pistachio, borage, maize,
wheat, rye, oats, sorghum and millet, triticale, rice, barley,
cassava, potato, sugarbeet, egg plant, alfalfa, and perennial
grasses and forage plants, oil palm, vegetables (brassicas, root
vegetables, tuber vegetables, pod vegetables, fruiting vegetables,
onion vegetables, leafy vegetables and stem vegetables), buckwheat,
Jerusalem artichoke, broad bean, vetches, lentil, dwarf bean,
lupin, clover and Lucerne for mentioning only some of them.
[2701] In one embodiment of the invention transgenic plants are
selected from the group comprising cereals, soybean, rapeseed
(including oil seed rape, especially canola and winter oil seed
rape), cotton sugarcane and potato, especially corn, soy, rapeseed
(including oil seed rape, especially canola and winter oil seed
rape), cotton, wheat and rice.
[2702] In another embodiment of the invention the transgenic plant
is a gymnosperm plant, especially a spruce, pine or fir.
[2703] In one preferred embodiment, the host plant is selected from
the families Aceraceae, Anacardiaceae, Apiaceae, Asteraceae,
Brassicaceae, Cactaceae, Cucurbitaceae, Euphorbiaceae, Fabaceae,
Malvaceae, Nymphaeaceae, Papaveraceae, Rosaceae, Salicaceae,
Solanaceae, Arecaceae, Bromeliaceae, Cyperaceae, Iridaceae,
Liliaceae, Orchidaceae, Gentianaceae, Labiaceae, Magnoliaceae,
Ranunculaceae, Carifolaceae, Rubiaceae, Scrophulariaceae,
Caryophyllaceae, Ericaceae, Polygonaceae, Violaceae, Juncaceae or
Poaceae and preferably from a plant selected from the group of the
families Apiaceae, Asteraceae, Brassicaceae, Cucurbitaceae,
Fabaceae, Papaveraceae, Rosaceae, Solanaceae, Liliaceae or Poaceae.
Preferred are crop plants and in particular plants mentioned herein
above as host plants such as the families and genera mentioned
above for example preferred the species Anacardium occidentale,
Calendula officinalis, Carthamus tinctorius, Cichorium intybus,
Cynara scolymus, Helianthus annus, Tagetes lucida, Tagetes erecta,
Tagetes tenuifolia; Daucus carota; Corylus avellana, Corylus
colurna, Borago officinalis; Brassica napus, Brassica rapa ssp.,
Sinapis arvensis Brassica juncea, Brassica juncea var. juncea,
Brassica juncea var. crispifolia, Brassica juncea var. foliosa,
Brassica nigra, Brassica sinapioides, Melanosinapis communis,
Brassica oleracea, Arabidopsis thaliana, Anana comosus, Ananas
ananas, Bromelia comosa, Carica papaya, Cannabis sative, Ipomoea
batatus, Ipomoea pandurata, Convolvulus batatas, Convolvulus
tilliaceus, Ipomoea fastigiata, Ipomoea tiliacea, Ipomoea triloba,
Convolvulus panduratus, Beta vulgaris, Beta vulgaris var.
altissima, Beta vulgaris var. vulgaris, Beta maritima, Beta
vulgaris var. perennis, Beta vulgaris var. conditiva, Beta vulgaris
var. esculenta, Cucurbita maxima, Cucurbita mixta, Cucurbita pepo,
Cucurbita moschata, Olea europaea, Manihot utillssima, Janipha
manihot, Jatropha manihot, Manihot aipil, Manihot dulcis, Manihot
manihot, Manihot melanobasis, Manihot esculenta, Ricinus communis,
Pisum sativum, Pisum arvense, Pisum humile, Medicago sativa,
Medicago falcata, Medicago varia, Glycine max Dolichos soja,
Glycine gracilis, Glycine hispida, Phaseolus max, Soja hispida,
Soja max, Cocos nucifera, Pelargonium grossularioides, Oleum
cocoas, Laurus nobilis, Persea ameficana, Arachis hypogaea, Linum
usitatissimum, Linum humile, Linum austriacum, Linum bienne, Linum
augustifolium, Linum catharticum, Linum flavum, Linum grandiflorum,
Adenolinum grandiflorum, Linum lewisii, Linum narbonense, Linum
perenne, Linum perenne var. lewisii, Linum pratense, Linum
trigynum, Punica granatum, Gossypium hirsutum, Gossypium arboreum,
Gossypium barbadense, Gossypium herbaceum, Gossypium thurberi, Musa
nana, Musa acuminata, Musa paradisiaca, Musa spp., Elaeis
guineensis, Papaver orientate, Papaver rhoeas, Papaver dubium,
Sesamum indicum, Piper aduncum, Piper amalago, Piper angustifolium,
Piper auritum, Piper betel, Piper cubeba, Piper longum, Piper
nigrum, Piper retrofractum, Artanthe adunca, Artanthe elongata,
Peperomia elongata, Piper elongatum, Steffensia elongata, Hordeum
vulgare, Hordeum jubatum, Hordeum murinum, Hordeum secalinum,
Hordeum distichon Hordeum aegiceras, Hordeum hexastichon., Hordeum
hexastichum, Hordeum irregulare, Hordeum sativum, Hordeum
secalinum, Avena sativa, Avena fatua, Avena byzantina, Avena fatua
var. sativa, Avena hybrida, Sorghum bicolor, Sorghum halepense,
Sorghum saccharatum, Sorghum vulgare, Andropogon drummondii, Holcus
bicolor, Holcus sorghum, Sorghum aethiopicum, Sorghum arundinaceum,
Sorghum caffrorum, Sorghum cernuum, Sorghum dochna, Sorghum
drummondii, Sorghum durra, Sorghum guineense, Sorghum lanceolatum,
Sorghum nervosum, Sorghum saccharatum, Sorghum subglabrescens,
Sorghum verticilliflorum, Sorghum vulgare, Holcus halepensis,
Sorghum mlliaceum millet, Panicum militaceum, Zea mays, Triticum
aestivum, Triticum durum, Triticum turgidum, Triticum hybernum,
Triticum macha, Triticum sativum or Triticum vulgare, Cofea spp.,
Coffea arabica, Coffea canephora, Coffea liberica, Capsicum annuum,
Capsicum annuum var. glabriusculum, Capsicum frutescens, Capsicum
annuum, Nicotiana tabacum, Solanum tuberosum, Solanum metongena,
Lycopersicon esculentum, Lycopersicon lycopersicum, Lycopersicon
pyriforme, Solanum integrifolium, Solanum lycopersicum Theobroma
cacao or Camellia sinensis.
[2704] Anacardiaceae such as the genera Pistacia, Mangifera,
Anacardium e.g. the species Pistacia vera [pistachios, Pistazie],
Mangifer indica [Mango] or Anacardium occidentale [Cashew];
Asteraceae such as the genera Calendula, Carthamus, Centaurea,
Cichorium, Cynara, Helianthus, Lactuca, Locusta, Tagetes, Valeriana
e.g. the species Calendula officinags [Marigold], Carthamus
tinctorius [safflower], Centaurea cyanus [cornflower], Cichorium
intybus [blue daisy], Cynara scolymus [Artichoke], Helianthus annus
[sunflower], Lactuca sativa, Lactuca crispa, Lactuca esculenta,
Lactuca scariola L. ssp. sativa, Lactuca scariola L. var.
integrata, Lactuca scariola L. var. integrifolia, Lactuca sativa
subsp. roman, Locusta communis, Vaterian locusta [lettuce], Tagetes
lucida, Tagetes erecta or Tagetes tenuifolia [Marigold]; Apiaceae
such as the genera Daucus e.g. the species Daucus carota [carrot];
Betulaceae such as the genera Corylus e.g. the species Corylus
aveilana or Corylus colurna [hazelnut]; Boraginaceae such as the
genera Borago e.g. the species Borago officinalis [borage];
Brassicaceae such as the genera Brassica, Melanosinapis, Sinapis,
Arabadopsis e.g. the species Brassica napus, Brassica raga ssp.
[canola, oilseed rape, turnip rape], Sinapis arvensis Brassica
juncea, Brassica juncea var. juncea, Brassica juncea var.
crispifolia, Brassica juncea var. foliosa, Brassica nigra, Brassica
sinapioides, Melanosinapis communis [mustard], Brassica oteracea
[fodder beet] or Arabidopsis thaliana; Bromeliaceae such as the
genera Anana, Bromelia e.g. the species Anana comosus, Ananas
ananas or Bromelia comosa [pineapple]; Caricaceae such as the
genera Carica e.g. the species Carica papaya [papaya]; Cannabaceae
such as the genera Cannabis e.g. the species Cannbis sative [hemp],
Convolvulaceae such as the genera Ipomea, Convolvulus e.g. the
species Ipomoea batatus, Ipomoea pandurata, Convolvulus batatas,
Convolvulus tikaceus, Ipomoea fastigiata, Ipomoea tiliacea, Ipomoea
triloba or Convolvulus panduratus [sweet potato, Man of the Earth,
wild potato], Chenopodiaceae such as the genera Beta, i.e. the
species Beta vulgaris, Beta vulgaris var. altissima, Beta vulgaris
var. Vulgaris, Beta maritima, Beta vulgaris var. perennis, Beta
vulgaris var conditiva or Beta vulgaris var. esculenta [sugar
beet]; Cucurbitaceae such as the genera Cucubita e.g. the species
Cucurbita maxima, Cucurbita mixta, Cucurbita pepo or Cucurbita
moschata [pumpkin, squash]; Elaeagnaceae such as the genera
Elaeagnus e.g. the species Olea europaea [olive]; Ericaceae such as
the genera Kalmia e.g. the species Kalmia latifoka, Kalmia
angustifolia, Kalmia microphylla, Kalmia polifoka, Kalmia
occidentalis, Cistus chamaerhodendros or Kalmia lucida [American
laurel, broad-leafed laurel, calico bush, spoon wood, sheep laurel,
alpine laurel, bog laurel, western bog-laurel, swamp-laurel];
Euphorbiaceae such as the genera Manihot, Janipha, Jatropha,
Ricinus e.g. the species Manihot ultissima, Janipha manihot,
Jatropha manihot, Manihot aipil, Manihot dulcis, Manihot manihot,
Manihot melanobasis, Manihot esculenta [manihot, arrowroot,
tapioca, cassava] or Ricinus communis [castor bean, Castor Oil
Bush, Castor Oil Plant, Palma Christi, Wonder Tree]; Fabaceae such
as the genera Pisum, Albizia, Cathormion, Feuillea, Inga,
Pithecolobium, Acacia, Mimosa, Medicajo, Glycine, Dolichos,
Phaseolus, Soja e.g. the species Pisum sativum, Pisum arvense,
Pisum humile [pea], Albizia bertenana, Albizia julibrissin, Albizia
lebbeck, Acacia bertenana, Acacia littoralis, Albizia bertenana,
Albizzia bertenana, Cathormion bertenana, Feuillea bertenana, Inga
fragrans, Pithecellobium bertenanum, Pithecellobium fragrans,
Pithecolobium bertenanum, Pseudalbizzia bertenana, Acacia
jukbrissin, Acacia nemu, Albizia nemu, Feuilleea julibrissin,
Mimosa julibrissin, Mimosa speciosa, Sericanrda julibrissin, Acacia
lebbeck, Acacia macrophylla, Albizia lebbek, Feuilleea lebbeck,
Mimosa lebbeck, Mimosa speciosa [bastard logwood, silk tree, East
Indian Walnut], Medicago sativa, Medicago falcata, Medicago varia
[alfalfa] Glycine max Dolichos soja, Glycine gracilis, Glycine
hispida, Phaseolus max, Soja hispida or Soja max [soybean];
Geraniaceae such as the genera Pelargonium, Cocos, Oleum e.g. the
species Cocos nucifera, Pelargonium grossulariodes or Oleum cocois
[coconut]; Gramineae such as the genera Saccharum e.g. the species
Saccharum officinarum, Juglandaceae such as the genera Juglans,
Wallia e.g. the species Juglans regia, Juglans ailanthifoka,
Juglans sieboldiana, Juglans cinerea, Walka cinerea, Juglans
bixbyi, Juglans californica, Juglans hindsii, Juglans intermedia,
Juglans jamaicensis, Juglans major, Juglans microcarpa, Juglans
nigra or Wallia nigra [walnut, black walnut, common walnut, persian
walnut, white walnut, butternut, black walnut]; Lauraceae such as
the genera Persea, Laurus e.g. the species laurel Laurus nobilis
[bay, laurel, bay laurel, sweet bay], Persea americana Persea
americana, Persea gratissima or Persea persea [avocado];
Leguminosae such as the genera Arachis e.g. the species Arachis
hypogaea [peanut]; Linaceae such as the genera Linum, Adenolinum
e.g. the species Linum usitatissimum, Linum humile, Linum
austriacum, Linum bienne, Linum angustifolium, Linum catharticum,
Linum flavum, Linum grandiflorum, Adenoknum grandiflorum, Linum
lewisii, Linum narbonense, Linum perenne, Linum perenne var.
lewisii, Linum pratense or Linum trigynum [flax, linseed];
Lythrarieae such as the genera Punica e.g. the species Punica
granatum [pomegranate]; Malvaceae such as the genera Gossypium e.g.
the species Gossypium hirsutum, Gossypium arboreum, Gossypium
barbadense, Gossypium herbaceum or Gossypium thurberi [cotton];
Musaceae such as the genera Musa e.g. the species Musa nana, Musa
acuminata, Musa paradisiaca, Musa spp. [banana]; Onagraceae such as
the genera Camissonia, Oenothera e.g. the species Oenothera biennis
or Camissonia brevipes [primrose, evening primrose]; Palmae such as
the genera Elacis e.g. the species Elaeiis guineensis [oil plam];
Papaveraceae such as the genera Papaver e.g. the species Papaver
orientate, Papaver rhoeas, Papaver dubium [poppy, oriental poppy,
corn poppy, field poppy, shirley poppies, field poppy, long-headed
poppy, long-pod poppy]; Pedaliaceae such as the genera Sesamum e.g.
the species Sesamum indicum [sesame]; Piperaceae such as the genera
Piper, Artanthe, Peperomia, Steffensia e.g. the species Piper
aduncum, Piper amalago, Piper angustifolium, Piper auritum, Piper
betel Piper cubeba, Piper longum, Piper nigrum, Piper retrofractum,
Artanthe adunca, Artanthe elongata, Peperomia elongata, Piper
elongatum, Steffensia elongata. [Cayenne pepper, wild pepper];
Poaceae such as the genera Hordeum, Secale, Avena, Sorghum,
Andropogon, Holcus, Panicum, Oryza, Zea, Triticum e.g. the species
Hordeum vulgare, Hordeum jubatum, Hordeum munnum, Hordeum
secalinum, Hordeum distichon Hordeum aegiceras, Hordeum
hexastichon., Hordeum hexastichum, Hordeum irregulare, Hordeum
sativum, Hordeum secalinum [barley, pearl barley, foxtail barley,
wall barley, meadow barley], Secale cereale [rye], Avena sativa,
Avena fatua, Avena byzantina, Avena fatua var. sativa, Avena
hybrida [oat], Sorghum bicolor, Sorghum halepense, Sorghum
saccharatum, Sorghum vulgare, Andropogon drummondii, Holcus
bicolor, Holcus sorghum, Sorghum aethiopicum, Sorghum arundinaceum,
Sorghum caffrorum, Sorghum cernuum, Sorghum dochna, Sorghum
drummondii, Sorghum durra, Sorghum guineense, Sorghum lanceolatum,
Sorghum nervosum, Sorghum saccharatum, Sorghum subglabrescens,
Sorghum verticilliflorum, Sorghum vulgare, Holcus halepensis,
Sorghum miliaceum millet, Panicum militaceum [Sorghum, millet],
Oryza sativa, Oryza latifolia [rice], Zea mays [corn, maize]
Triticum aestivum, Triticum durum, Triticum turgidum, Triticum
hybernum, Triticum macha, Triticum sativum or Triticum vulgare
[wheat, bread wheat, common wheat], Proteaceae such as the genera
Macadamia e.g. the species Macadamia intergrifolia [macadamia];
Rubiaceae such as the genera Coffea e.g. the species Cofea spp.,
Coffea arabica, Coffea canephora or Coffea liberica [coffee];
Scrophulariaceae such as the genera Verbascum e.g. the species
Verbascum blattana, Verbascum chaixii, Verbascum densiflorum,
Verbascum lagurus, Verbascum longifolium, Verbascum lychnitis,
Verbascum nigrum, Verbascum olympibum, Verbascum phlomoides,
Verbascum phoenicum, Verbascum pulverulentum or Verbascum thapsus
[mullein, white moth mullein, nettle-leaved mullein, dense-flowered
mullein, silver mullein, long-leaved mullein, white mullein, dark
mullein, greek mullein, orange mullein, purple mullein, hoary
mullein, great mullein]; Solanaceae such as the genera Capsicum,
Nicotiana, Solanum, Lycopersicon e.g. the species Capsicum annuum,
Capsicum annuum var. glabriusculum, Capsicum frutescens [pepper],
Capsicum annuum [paprika], Nicotiana tabacum, Nicotiana alata,
Nicotiana attenuata, Nicotiana glauca, Nicotiana langsdorffii,
Nicotiana obtusifolia, Nicotiana quadrivalvis, Nicotiana repanda,
Nicotiana rustica, Nicotiana sylvestris [tobacco], Solanum
tuberosum [potato], Solanum melongena [egg-plant] (Lycopersicon
esculentum, Lycopersicon lycopersicum., Lycopersicon pyriforme,
Solanum integrifolium or Solanum lycopersicum [tomato];
Sterculiaceae such as the genera Theobroma e.g. the species
Theobroma cacao [cacao]; Theaceae such as the genera Camellia e.g.
the species Camellia sinensis) [tea].
[2705] The introduction of the nucleic acids according to the
invention, the expression cassette or the vector into organisms,
plants for example, can in principle be done by all of the methods
known to those skilled in the art. The introduction of the nucleic
acid sequences gives rise to recombinant or transgenic
organisms.
[2706] Unless otherwise specified, the terms "polynucleotides",
"nucleic acid" and "nucleic acid molecule" as used herein are
interchangeably. Unless otherwise specified, the terms "peptide",
"polypeptide" and "protein" are interchangeably in the present
context. The term "sequence" may relate to polynucleotides, nucleic
acids, nucleic acid molecules, peptides, polypeptides and proteins,
depending on the context in which the term "sequence" is used. The
terms "gene(s)", "polynucleotide", "nucleic acid sequence",
"nucleotide sequence", or "nucleic acid molecule(s)" as used herein
refers to a polymeric form of nucleotides of any length, either
ribonucleotides or deoxyribonucleotides. The terms refer only to
the primary structure of the molecule.
[2707] Thus, the terms "gene(s)", "polynucleotide", "nucleic acid
sequence", "nucleotide sequence", or "nucleic acid molecule(s)" as
used herein include double- and single-stranded DNA and RNA. They
also include known types of modifications, for example,
methylation, "caps", substitutions of one or more of the naturally
occurring nucleotides with an analog. Preferably, the DNA or RNA
sequence of the invention comprises a coding sequence encoding the
herein defined polypeptide.
[2708] The genes of the invention, coding for an activity selected
from the group consisting of 2-dehydro-3-deoxy-phosphoheptonate
aldolase, 3-keto sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase
T/prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-keto-reductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease are also called
"NUERP gene".
[2709] A "coding sequence" is a nucleotide sequence, which is
transcribed into mRNA and/or translated into a polypeptide when
placed under the control of appropriate regulatory sequences. The
boundaries of the coding sequence are determined by a translation
start codon at the 5'-terminus and a translation stop codon at the
3'-terminus. The triplets taa, tga and tag represent the (usual)
stop codons which are interchangeable. A coding sequence can
include, but is not limited to mRNA, cDNA, recombinant nucleotide
sequences or genomic DNA, while introns may be present as well
under certain circumstances.
[2710] The transfer of foreign genes into the genome of a plant is
called transformation. In doing this the methods described for the
transformation and regeneration of plants from plant tissues or
plant cells are utilized for transient or stable transformation.
Suitable methods are protoplast transformation by poly(ethylene
glycol)-induced DNA uptake, the "biolistic" method using the gene
cannon--referred to as the particle bombardment method,
electroporation, the incubation of dry embryos in DNA solution,
microinjection and gene transfer mediated by Agrobacterium. Said
methods are described by way of example in Jenes B. et al.,
Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1,
Engineering and Utilization, eds. Kung S. D and Wu R., Academic
Press (1993) 128-143 and in Potrykus, Annu. Rev. Plant Physiol.
Plant Molec. Biol. 42, 205 (1991). The nucleic acids or the
construct to be expressed is preferably cloned into a vector which
is suitable for transforming Agrobacterium tumefaciens, for example
pBin19 (Bevan et al., Nucl. Acids Res. 12, 8711 (1984)).
Agrobacteria transformed by such a vector can then be used in known
manner for the transformation of plants, in particular of crop
plants such as by way of example tobacco plants, for example by
bathing bruised leaves or chopped leaves in an agrobacterial
solution and then culturing them in suitable media. The
transformation of plants by means of Agrobacterium tumefaciens is
described, for example, by Hofgen and Willmitzer in Nucl. Acid Res.
16, 9877 (1988) or is known inter alia from White F.F., Vectors for
Gene Transfer in Higher Plants; in Transgenic Plants, Vol. 1,
Engineering and Utilization, eds. Kung S.D. and Wu R., Academic
Press, 1993, pp. 15-38.
[2711] Agrobacteria transformed by an expression vector according
to the invention may likewise be used in known manner for the
transformation of plants such as test plants like Arabidopsis or
crop plants such as cereal crops, corn, oats, rye, barley, wheat,
soybean, rice, cotton, sugar beet, canola, sunflower, flax, hemp,
potatoes, tobacco, tomatoes, carrots, paprika, oilseed rape,
tapioca, cassava, arrowroot, tagetes, alfalfa, lettuce and the
various tree, nut and vine species, in particular oil-containing
crop plants such as soybean, peanut, castor oil plant, sunflower,
corn, cotton, flax, oilseed rape, coconut, oil palm, safflower
(Carthamus tinctorius) or cocoa bean, or in particular corn, wheat,
soybean, rice, cotton and canola, e.g. by bathing bruised leaves or
chopped leaves in an agrobacterial solution and then culturing them
in suitable media.
[2712] The genetically modified plant cells may be regenerated by
all of the methods known to those skilled in the art. Appropriate
methods can be found in the publications referred to above by Kung
S.D. and Wu R., Potrykus or Hofgen and Willmitzer.
[2713] Accordingly, a further aspect of the invention relates to
transgenic organisms transformed by at least one nucleic acid
sequence, expression cassette or vector according to the invention
as well as cells, cell cultures, tissue, parts--such as, for
example, leaves, roots, etc. in the case of plant organisms--or
reproductive material derived from such organisms. The terms "host
organism", "host cell", "recombinant (host) organism" and
"transgenic (host) cell" are used here interchangeably. Of course
these terms relate not only to the particular host organism or the
particular target cell but also to the descendants or potential
descendants of these organisms or cells. Since, due to mutation or
environmental effects certain modifications may arise in successive
generations, these descendants need not necessarily be identical
with the parental cell but nevertheless are still encompassed by
the term as used here.
[2714] For the purposes of the invention "transgenic" or
"recombinant" means with regard for example to a nucleic acid
sequence, an expression cassette (=gene construct, nucleic acid
construct) or a vector containing the nucleic acid sequence
according to the invention or an organism transformed by the
nucleic acid sequences, expression cassette or vector according to
the invention all those constructions produced by genetic
engineering methods in which either [2715] (a) the nucleic acid
sequence depicted in table I, application no. 1, column 5 or 7 or
its derivatives or parts thereof; or [2716] (b) a genetic control
sequence functionally linked to the nucleic acid sequence described
under (a), for example a 3'- and/or 5'-genetic control sequence
such as a promoter or terminator, or [2717] (c) (a) and (b); are
not found in their natural, genetic environment or have been
modified by genetic engineering methods, wherein the modification
may by way of example be a substitution, addition, deletion,
inversion or insertion of one or more nucleotide residues. Natural
genetic environment means the natural genomic or chromosomal locus
in the organism of origin or inside the host organism or presence
in a genomic library. In the case of a genomic library the natural
genetic environment of the nucleic acid sequence is preferably
retained at least in part. The environment borders the nucleic acid
sequence at least on one side and has a sequence length of at least
50 bp, preferably at least 500 bp, particularly preferably at least
1,000 bp, most particularly preferably at least 5,000 bp. A
naturally occurring expression cassette--for example the naturally
occurring combination of the natural promoter of the nucleic acid
sequence according to the invention with the corresponding
gene--turns into a transgenic expression cassette when the latter
is modified by unnatural, synthetic ("artificial") methods such as
by way of example a mutagenation. Appropriate methods are described
by way of example in U.S. Pat. No. 5,565,350 or WO 00/15815.
[2718] Suitable organisms or host organisms for the nucleic acid,
expression cassette or vector according to the invention are
advantageously in principle all organisms, which are suitable for
the expression of recombinant genes as described above. Further
examples which may be mentioned are plants such as Arabidopsis,
Asteraceae such as Calendula or crop plants such as soybean,
peanut, castor oil plant, sunflower, flax, corn, cotton, flax,
oilseed rape, coconut, oil palm, safflower (Carthamus tinctorius)
or cocoa bean.
[2719] In one embodiment of the invention host plants for the
nucleic acid, expression cassette or vector according to the
invention are selected from the group comprising corn, soy, oil
seed rape (including canola and winter oil seed rape), cotton,
wheat and rice.
[2720] A further object of the invention relates to the use of a
nucleic acid construct, e.g. an expression cassette, containing DNA
sequences encoding polypeptides shown in table II or DNA sequences
hybridizing therewith for the transformation of plant cells,
tissues or parts of plants.
[2721] In doing so, depending on the choice of promoter, the
sequences shown in table I can be expressed specifically in the
leaves, in the seeds, the nodules, in roots, in the stem or other
parts of the plant. Those transgenic plants overproducing sequences
as depicted in table I, the reproductive material thereof, together
with the plant cells, tissues or parts thereof are a further object
of the present invention.
[2722] The expression cassette or the nucleic acid sequences or
construct according to the invention containing sequences according
to table I can, moreover, also be employed for the transformation
of the organisms identified by way of example above such as
bacteria, yeasts, filamentous fungi and plants.
[2723] Within the framework of the present invention, increased
yield, especially enhanced NUE and/or biomass production, means,
for example, the artificially acquired trait of increased yield,
especially of enhanced NUE and/or biomass production, due to
functional over expression of polypeptide sequences of table II
encoded by the corresponding nucleic acid molecules as depicted in
table I, column 5 or 7 and/or homologs in the organisms according
to the invention, advantageously in the transgenic plants according
to the invention, by comparison with the nongenetically modified
initial plants at least for the duration of at least one plant
generation.
[2724] A constitutive expression of the polypeptide sequences of
table II, application no. 1, encoded by the corresponding nucleic
acid molecule as depicted in table I, application no. 1, column 5
or 7 and/or homologs is, moreover, advantageous. On the other hand,
however, an inducible expression may also appear desirable.
Expression of the polypeptide sequences of the invention can be
either direct to the cytoplasm or the organelles, preferably the
plastids of the host cells, preferably the plant cells.
[2725] The efficiency of the expression of the sequences of the of
table II, application no. 1, encoded by the corresponding nucleic
acid molecule as depicted in table I, application no. 1, column 5
or 7 and/or homologs can be determined, for example, in vitro by
shoot meristem propagation. In addition, an expression of the
sequences of table II, application no. 1, encoded by the
corresponding nucleic acid molecule as depicted in table I,
application no. 1, column 5 or 7 and/or homologs modified in nature
and level and its effect effect on yield, particularly tolerance to
abiotic environmental stress and/or nutrient use efficiency, but
also on the metabolic pathways performance can be tested on test
plants in greenhouse trials.
[2726] An additional object of the invention comprises transgenic
organisms such as transgenic plants transformed by an expression
cassette containing sequences of as depicted in table I,
application no. 1, column 5 or 7 according to the invention or DNA
sequences hybridizing therewith, as well as transgenic cells,
tissue, parts and reproduction material of such plants. Particular
preference is given in this case to transgenic crop plants such as
by way of example barley, wheat, rye, oats, corn, soybean, rice,
cotton, sugar beet, oilseed rape and canola, sunflower, flax, hemp,
thistle, potatoes, tobacco, tomatoes, tapioca, cassava, arrowroot,
alfalfa, lettuce and the various tree, nut and vine species.
[2727] In one embodiment of the invention transgenic plants
transformed by an expression cassette containing sequences of as
depicted in table I, application no. 1, column 5 or 7 according to
the invention or DNA sequences hybridizing therewith are selected
from the group comprising corn, soy, oil seed rape (including
canola and winter oil seed rape), cotton, wheat and rice.
[2728] For the purposes of the invention plants are mono- and
dicotyledonous plants, mosses or algae, especially plants,
preferably monocotyledonous plants, or preferably dicotyledonous
plants.
[2729] A further refinement according to the invention are
transgenic plants as described above which contain a nucleic acid
sequence or construct according to the invention or a expression
cassette according to the invention.
[2730] However, transgenic also means that the nucleic acids
according to the invention are located at their natural position in
the genome of an organism, but that the sequence has been modified
in comparison with the natural sequence and/or that the regulatory
sequences of the natural sequences have been modified. Preferably,
transgenic/recombinant is to be understood as meaning the
transcription of the nucleic acids of the invention and shown in
table I, occurs at a non-natural position in the genome, that is to
say the expression of the nucleic acids is homologous or,
preferably, heterologous. This expression can be transiently or of
a sequence integrated stably into the genome.
[2731] The term "transgenic plants" used in accordance with the
invention also refers to the progeny of a transgenic plant, for
example the T1, T2, T3 and subsequent plant generations or the BC1,
BC2, BC3 and subsequent plant generations. Thus, the transgenic
plants according to the invention can be raised and selfed or
crossed with other individuals in order to obtain further
transgenic plants according to the invention. Transgenic plants may
also be obtained by propagating transgenic plant cells
vegetatively. The present invention also relates to transgenic
plant material, which can be derived from a transgenic plant
population according to the invention. Such material includes plant
cells and certain tissues, organs and parts of plants in all their
manifestations, such as seeds, leaves, anthers, fibers, tubers,
roots, root hairs, stems, embryo, calli, cotelydons, petioles,
harvested material, plant tissue, reproductive tissue and cell
cultures, which are derived from the actual transgenic plant and/or
can be used for bringing about the transgenic plant.
[2732] Any transformed plant obtained according to the invention
can be used in a conventional breeding scheme or in vitro plant
propagation to produce more transformed plants with the same
characteristics and/or can be used to introduce the same
characteristic in other varieties of the same or related species.
Such plants are also part of the invention. Seeds obtained from the
transformed plants genetically also contain the same characteristic
and are part of the invention. As mentioned before, the present
invention is in principle applicable to any plant and crop that can
be transformed with any of the transformation method known to those
skilled in the art.
[2733] Advantageous inducible plant promoters are by way of example
the PRP1 promoter (Ward et al., Plant. Mol. Biol. 22361 (1993)), a
promoter inducible by benzenesulfonamide (EP 388 186), a promoter
inducible by tetracycline (Gatz et al., Plant J. 2, 397 (1992)), a
promoter inducible by salicylic acid (WO 95/19443), a promoter
inducible by abscisic acid (EP 335 528) and a promoter inducible by
ethanol or cyclohexanone (WO 93/21334). Other examples of plant
promoters which can advantageously be used are the promoter of
cytosolic FBPase from potato, the ST-LSI promoter from potato
(Stockhaus et al., EMBO J. 8, 2445 (1989)), the promoter of
phosphoribosyl pyrophosphate amidotransferase from Glycine max (see
also gene bank accession number U87999) or a nodiene-specific
promoter as described in EP 249 676. Particular advantageous are
those promoters which ensure expression upon conditions of limited
nutrient availability, e.g. the onset of limited nitrogen sources
in case the nitrogen of the soil or nutrient is exhausted, and/or
expression upon at the onset of chilling and/or freezing
temperatures and/or water deficiency, as defined hereinabove. Such
promotors are known to the person skilled in the art or can be
isolated from genes which are induced under the conditions
mentioned above.
[2734] In one embodiment seed-specific promoters may be used for
monocotyledonous or dicotyledonous plants.
[2735] In principle all natural promoters with their regulation
sequences can be used like those named above for the expression
cassette according to the invention and the method according to the
invention. Over and above this, synthetic promoters may also
advantageously be used.
[2736] In the preparation of an expression cassette various DNA
fragments can be manipulated in order to obtain a nucleotide
sequence, which usefully reads in the correct direction and is
equipped with a correct reading frame. To connect the DNA fragments
(=nucleic acids according to the invention) to one another adaptors
or linkers may be attached to the fragments.
[2737] The promoter and the terminator regions can usefully be
provided in the transcription direction with a linker or polylinker
containing one or more restriction points for the insertion of this
sequence. Generally, the linker has 1 to 10, mostly 1 to 8,
preferably 2 to 6, restriction points. In general the size of the
linker inside the regulatory region is less than 100 bp, frequently
less than 60 bp, but at least 5 bp. The promoter may be both native
or homologous as well as foreign or heterologous to the host
organism, for example to the host plant. In the 5'-3' transcription
direction the expression cassette contains the promoter, a DNA
sequence which shown in table I and a region for transcription
termination. Different termination regions can be exchanged for one
another in any desired fashion.
[2738] As also used herein, the terms "nucleic acid" and "nucleic
acid molecule" are intended to include DNA molecules (e.g. cDNA or
genomic DNA) and RNA molecules (e.g. mRNA) and analogs of the DNA
or RNA generated using nucleotide analogs. This term also
encompasses untranslated sequence located at both the 3' and 5'
ends of the coding region of the gene--at least about 1000
nucleotides of sequence upstream from the 5' end of the coding
region and at least about 200 nucleotides of sequence downstream
from the 3' end of the coding region of the gene. The nucleic acid
molecule can be single-stranded or double-stranded, but preferably
is double-stranded DNA.
[2739] An "isolated" nucleic acid molecule is one that is
substantially separated from other nucleic acid molecules, which
are present in the natural source of the nucleic acid. That means
other nucleic acid molecules are present in an amount less than 5%
based on weight of the amount of the desired nucleic acid,
preferably less than 2% by weight, more preferably less than 1% by
weight, most preferably less than 0.5% by weight. Preferably, an
"isolated" nucleic acid is free of some of the sequences that
naturally flank the nucleic acid (i.e., sequences located at the 5'
and 3' ends of the nucleic acid) in the genomic DNA of the organism
from which the nucleic acid is derived. For example, in various
embodiments, the isolated NUE related protein (NUERP) encoding
nucleic acid molecule can contain less than about 5 kb, 4 kb, 3 kb,
2 kb, 1 kb, 0.5 kb or 0.1 kb of nucleotide sequences which
naturally flank the nucleic acid molecule in genomic DNA of the
cell from which the nucleic acid is derived. Moreover, an
"isolated" nucleic acid molecule, such as a cDNA molecule, can be
free from some of the other cellular material with which it is
naturally associated, or culture medium when produced by
recombinant techniques, or chemical precursors or other chemicals
when chemically synthesized.
[2740] A nucleic acid molecule of the present invention, e.g., a
nucleic acid molecule encoding an NUERP or a portion thereof which
confers enhanced tolerance to abiotic environmental stress and/or
enhanced nutrient use efficiency and/or increased yield, especially
enhanced NUE and/or increased biomass production, in plants, can be
isolated using standard molecular biological techniques and the
sequence information provided herein. For example, an Arabidopsis
thaliana NUERP encoding cDNA can be isolated from a A. thaliana
c-DNA library or a Synechocystis sp., Brassica napus, Glycine max,
Zea mays or Oryza sativa NUERP encoding cDNA can be isolated from a
Synechocystis sp., Brassica napus, Glycine max, Zea mays or Oryza
sativa c-DNA library respectively using all or portion of one of
the sequences shown in table I. Moreover, a nucleic acid molecule
encompassing all or a portion of one of the sequences of table I
can be isolated by the polymerase chain reaction using
oligonucleotide primers designed based upon this sequence. For
example, mRNA can be isolated from plant cells (e.g., by the
guanidinium-thiocyanate extraction procedure of Chirgwin et al.,
Biochemistry 18, 5294 (1979)) and cDNA can be prepared using
reverse transcriptase (e.g., Moloney MLV reverse transcriptase,
available from Gibco/BRL, Bethesda, Md.; or AMV reverse
transcriptase, available from Seikagaku America, Inc., St.
Petersburg, Fla.). Synthetic oligonucleotide primers for polymerase
chain reaction amplification can be designed based upon one of the
nucleotide sequences shown in table I. A nucleic acid molecule of
the invention can be amplified using cDNA or, alternatively,
genomic DNA, as a template and appropriate oligonucleotide primers
according to standard PCR amplification techniques. The nucleic
acid molecule so amplified can be cloned into an appropriate vector
and characterized by DNA sequence analysis. Furthermore,
oligonucleotides corresponding to a NUERP encoding nucleotide
sequence can be prepared by standard synthetic techniques, e.g.,
using an automated DNA synthesizer.
[2741] In a preferred embodiment, an isolated nucleic acid molecule
of the invention comprises one of the nucleotide sequences shown in
table I encoding the NUERP (i.e., the "coding region"), as well as
5' untranslated sequences and 3' untranslated sequences.
[2742] Moreover, the nucleic acid molecule of the invention can
comprise only a portion of the coding region of one of the
sequences of the nucleic acid of table I, for example, a fragment
which can be used as a probe or primer or a fragment encoding a
biologically active portion of a NUERP.
[2743] Portions of proteins encoded by the NUERP encoding nucleic
acid molecules of the invention are preferably biologically active
portions described herein. As used herein, the term "biologically
active portion of" a NUERP is intended to include a portion, e.g. a
domain/motif, of NUE related protein (NUERP), which is sufficient
to confer enhanced yield, particularly due to one or more improved
yield related traits as defined above, especially which
participates in an enhanced NUE efficiency and/or increased biomass
production, in a plant. To determine whether a NUERP, or a
biologically active portion thereof, results in an enhanced yield,
particularly due to one or more improved yield related traits as
defined above, especially an enhanced NUE efficiency and/or
increased biomass production, in a plant, an analysis of a plant
comprising the NUERP may be performed. Such analysis methods are
well known to those skilled in the art, as detailed in the
Examples. More specifically, nucleic acid fragments encoding
biologically active portions of a NUERP can be prepared by
isolating a portion of one of the sequences of the nucleic acid of
table I expressing the encoded portion of the NUERP or peptide
(e.g., by recombinant expression in vitro) and assessing the
activity of the encoded portion of the NUERP or peptide.
[2744] Biologically active portions of a NUERP are encompassed by
the present invention and include peptides comprising amino acid
sequences derived from the amino acid sequence of a NUERP encoding
gene, or the amino acid sequence of a protein homologous to a
NUERP, which include fewer amino acids than a full length NUERP or
the full length protein which is homologous to a NUERP, and
exhibits at least some enzymatic or biological activity of a NUERP.
Typically, biologically active portions (e.g., peptides which are,
for example, 5, 10, 15, 20, 30, 35, 36, 37, 38, 39, 40, 50, 100 or
more amino acids in length) comprise a domain or motif with at
least one activity of a NUERP. Moreover, other biologically active
portions in which other regions of the protein are deleted, can be
prepared by recombinant techniques and evaluated for one or more of
the activities described herein. Preferably, the biologically
active portions of a NUERP include one or more selected
domains/motifs or portions thereof having biological activity.
[2745] The term "biological active portion" or "biological
activity" means a polypeptide as depicted in table II, column 3 or
a portion of said polypeptide which still has at least 10% or 20%,
preferably 30%, 40%, 50% or 60%, especially preferably 70%, 75%,
80%, 90% or 95% of the enzymatic or biological activity of the
natural or starting enzyme or protein.
[2746] In the process according to the invention nucleic acid
sequences can be used, which, if appropriate, contain synthetic,
non-natural or modified nucleotide bases, which can be incorporated
into DNA or RNA. Said synthetic, non-natural or modified bases can
for example increase the stability of the nucleic acid molecule
outside or inside a cell. The nucleic acid molecules of the
invention can contain the same modifications as aforementioned.
[2747] As used in the present context the term "nucleic acid
molecule" may also encompass the untranslated sequence located at
the 3' and at the 5' end of the coding gene region, for example at
least 500, preferably 200, especially preferably 100, nucleotides
of the sequence upstream of the 5' end of the coding region and at
least 100, preferably 50, especially preferably 20, nucleotides of
the sequence downstream of the 3' end of the coding gene region. It
is often advantageous only to choose the coding region for cloning
and expression purposes.
[2748] Preferably, the nucleic acid molecule used in the process
according to the invention or the nucleic acid molecule of the
invention is an isolated nucleic acid molecule.
[2749] An "isolated" polynucleotide or nucleic acid molecule is
separated from other polynucleotides or nucleic acid molecules,
which are present in the natural source of the nucleic acid
molecule. An isolated nucleic acid molecule may be a chromosomal
fragment of several kb, or preferably, a molecule only comprising
the coding region of the gene. Accordingly, an isolated nucleic
acid molecule of the invention may comprise chromosomal regions,
which are adjacent 5' and 3' or further adjacent chromosomal
regions, but preferably comprises no such sequences which naturally
flank the nucleic acid molecule sequence in the genomic or
chromosomal context in the organism from which the nucleic acid
molecule originates (for example sequences which are adjacent to
the regions encoding the 5'- and 3'-UTRs of the nucleic acid
molecule).
[2750] In various embodiments, the isolated nucleic acid molecule
used in the process according to the invention may, for example
comprise less than approximately 5 kb, 4 kb, 3 kb, 2 kb, 1 kb, 0.5
kb or 0.1 kb nucleotide sequences which naturally flank the nucleic
acid molecule in the genomic DNA of the cell from which the nucleic
acid molecule originates.
[2751] The nucleic acid molecules used in the process, for example
the polynucleotide of the invention or of a part thereof can be
isolated using molecularbiological standard techniques and the
sequence information provided herein. Also, for example a
homologous sequence or homologous, conserved sequence regions at
the DNA or amino acid level can be identified with the aid of
comparison algorithms. The former can be used as hybridization
probes under standard hybridization techniques (for example those
described in Sambrook et al., Molecular Cloning: A Laboratory
Manual. 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor
Laboratory Press, Cold Spring Harbor, N.Y., 1989) for isolating
further nucleic acid sequences useful in this process.
[2752] A nucleic acid molecule encompassing a complete sequence of
the nucleic acid molecules used in the process, for example the
polynucleotide of the invention, or a part thereof may additionally
be isolated by polymerase chain reaction, oligonucleotide primers
based on this sequence or on parts thereof being used. For example,
a nucleic acid molecule comprising the complete sequence or part
thereof can be isolated by polymerase chain reaction using
oligonucleotide primers which have been generated on the basis of
this very sequence. For example, mRNA can be isolated from cells
(for example by means of the guanidinium thiocyanate extraction
method of Chirgwin et al., Biochemistry 18, 5294 (1979)) and cDNA
can be generated by means of reverse transcriptase (for example
Moloney MLV reverse transcriptase, available from Gibco/BRL,
Bethesda, Md., or AMV reverse transcriptase, obtainable from
Seikagaku America, Inc., St. Petersburg, Fla.).
[2753] Synthetic oligonucleotide primers for the amplification,
e.g. as shown in table III, column 7, by means of polymerase chain
reaction can be generated on the basis of a sequence shown herein,
for example the sequence shown in table I, application no. 1,
columns 5 and 7 or the sequences derived from table II, application
no. 1, columns 5 and 7.
[2754] Moreover, it is possible to identify conserved protein by
carrying out protein sequence alignments with the polypeptide
encoded by the nucleic acid molecules of the present invention, in
particular with the sequences encoded by the nucleic acid molecule
shown in column 5 or 7 of table I, application no. 1, from which
conserved regions, and in turn, degenerate primers can be
derived.
[2755] Conserved regions are those, which show a very little
variation in the amino acid in one particular position of several
homologs from different origin. The consenus sequence and
polypeptide motifs shown in column 7 of table IV, application no.
1, are derived from said alignments. Moreover, it is possible to
identify conserved regions from various organisms by carrying out
protein sequence alignments with the polypeptide encoded by the
nucleic acid of the present invention, in particular with the
sequences encoded by the polypeptide molecule shown in column 5 or
7 of table II, from which conserved regions, and in turn,
degenerate primers can be derived.
[2756] In one advantageous embodiment, in the method of the present
invention the activity of a polypeptide is increased comprising or
consisting of a consensus sequence or a polypeptide motif shown in
table IV, application no. 1, column 7 and in one another
embodiment, the present invention relates to a polypeptide
comprising or consisting of a consensus sequence or a polypeptide
motif shown in table IV, application no. 1, column 7 whereby less
than 20, preferably less than 15 or 10, preferably less than 9, 8,
7, or 6, more preferred less than 5 or 4, even more preferred less
then 3, even more preferred less then 2, even more preferred 0 of
the amino acids positions indicated can be replaced by any amino
acid. In one embodiment not more than 15%, preferably 10%, even
more preferred 5%, 4%, 3%, or 2%, most preferred 1% or 0% of the
amino acid position indicated by a letter are/is replaced another
amino acid. In one embodiment less than 20, preferably less than 15
or 10, preferably less than 9, 8, 7, or 6, more preferred less than
5 or 4, even more preferred less than 3, even more preferred less
than 2, even more preferred 0 amino acids are inserted into a
consensus sequence or protein motif.
[2757] The consensus sequence was derived from a multiple alignment
of the sequences as listed in table II. The letters represent the
one letter amino acid code and indicate that the amino acids are
conserved in at least 80% of the aligned proteins. The letter X
stands for amino acids, which are not conserved in at least 80%
sequences. The consensus sequence starts with the first conserved
amino acid in the alignment, and ends with the last conserved amino
acid in the alignment of the investigated sequences. The number of
given X indicates the distances between conserved amino acid
residues, e.g. Y-x(21,23)-F means that conserved tyrosine and
phenylalanine residues are separated from each other by minimum 21
and maximum 23 amino acid residues in all investigated
sequences.
[2758] Conserved domains were identified from all sequences and are
described using a subset of the standard Prosite notation, e.g. the
pattern Y-x(21,23)-[FW] means that a conserved tyrosine is
separated by minimum 21 and maximum 23 amino acid residues from
either a phenylalanine or tryptophane. Patterns had to match at
least 80% of the investigated proteins.
[2759] Conserved patterns were identified with the software tool
MEME version 3.5.1 or manually. MEME was developed by Timothy L.
Bailey and Charles Elkan, Dept. of Computer Science and
Engeneering, University of California, San Diego, USA and is
described by Timothy L. Bailey and Charles Elkan (Fitting a mixture
model by expectation maximization to discover motifs in
biopolymers, Proceedings of the Second International Conference on
Intelligent Systems for Molecular Biology, pp. 28-36, AAAI Press,
Menlo Park, Calif., 1994). The source code for the stand-alone
program is public available from the San Diego Supercomputer center
(http://meme.sdsc.edu).
[2760] For identifying common motifs in all sequences with the
software tool MEME, the following settings were used: -maxsize
500000, -nmotifs 15, -evt 0.001, -maxw 60, -distance 1e-3,
-minsites number of sequences used for the analysis. Input
sequences for MEME were non-aligned sequences in Fasta format.
Other parameters were used in the default settings in this software
version.
[2761] Prosite patterns for conserved domains were generated with
the software tool Pratt version 2.1 or manually. Pratt was
developed by Inge Jonassen, Dept. of Informatics, University of
Bergen, Norway and is described by Jonassen et al. (I. Jonassen,
J.F.Collins and D.G.Higgins, Finding flexible patterns in unaligned
protein sequences, Protein Science 4 (1995), pp. 1587-1595;
I.Jonassen, Efficient discovery of conserved patterns using a
pattern graph, Submitted to CABIOS Febr. 1997]. The source code
(ANSI C) for the stand-alone program is public available, e.g. at
established Bioinformatic centers like EBI (European Bioinformatics
Institute).
[2762] For generating patterns with the software tool Pratt,
following settings were used: PL (max Pattern Length): 100, PN (max
Nr of Pattern Symbols): 100, PX (max Nr of consecutive x's): 30, FN
(max Nr of flexible spacers): 5, FL (max Flexibility): 30, FP (max
Flex.Product): 10, ON (max number patterns): 50. Input sequences
for Pratt were distinct regions of the protein sequences exhibiting
high similarity as identified from software tool MEME. The minimum
number of sequences, which have to match the generated patterns
(CM, min Nr of Seqs to Match) was set to at least 80% of the
provided sequences. Parameters not mentioned here were used in
their default settings.
[2763] The Prosite patterns of the conserved domains can be used to
search for protein sequences matching this pattern. Various
established Bioinformatic centers provide public Internet portals
for using those patterns in database searches (e.g. PIR (Protein
Information Resource, located at Georgetown University Medical
Center) or ExPASy (Expert Protein Analysis System)). Alternatively,
stand-alone software is available, like the program Fuzzpro, which
is part of the EMBOSS software package. For example, the program
Fuzzpro not only allows searching for an exact pattern-protein
match but also allows setting various ambiguities in the performed
search.
[2764] The alignment was performed with the software ClustalW
(version 1.83) and is described by Thompson et al. (Nucleic Acids
Research 22, 4673 (1994)). The source code for the stand-alone
program is public available from the European Molecular Biology
Laboratory; Heidelberg, Germany. The analysis was performed using
the default parameters of ClustalW v1.83 (gap open penalty: 10.0;
gap extension penalty: 0.2; protein matrix: Gonnet; protein/DNA
endgap: -1; protein/DNA gapdist: 4).
[2765] Degenerated primers can then be utilized by PCR for the
amplification of fragments of novel proteins having above-mentioned
activity, e.g. conferring conferring the increase in yield,
particularly enhanced tolerance to abiotic environmental stress
and/or enhanced nutrient use efficiency, especially the enhanced
NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof after increasing the expression or activity or having the
activity of a protein as shown in table II, application no. 1,
column 3 or further functional homologs of the polypeptide of the
invention from other organisms.
[2766] These fragments can then be utilized as hybridization probe
for isolating the complete gene sequence. As an alternative, the
missing 5' and 3' sequences can be isolated by means of RACE-PCR. A
nucleic acid molecule according to the invention can be amplified
using cDNA or, as an alternative, genomic DNA as template and
suitable oligonucleotide primers, following standard PCR
amplification techniques. The nucleic acid molecule amplified thus
can be cloned into a suitable vector and characterized by means of
DNA sequence analysis. Oligonucleotides, which correspond to one of
the nucleic acid molecules used in the process, can be generated by
standard synthesis methods, for example using an automatic DNA
synthesizer.
[2767] Nucleic acid molecules which are advantageously for the
process according to the invention can be isolated based on their
homology to the nucleic acid molecules disclosed herein using the
sequences or part thereof as hybridization probe and following
standard hybridization techniques under stringent hybridization
conditions. In this context, it is possible to use, for example,
isolated nucleic acid molecules of at least 15, 20, 25, 30, 35, 40,
50, 60 or more nucleotides, preferably of at least 15, or 25
nucleotides in length which hybridize under stringent conditions
with the above-described nucleic acid molecules, in particular with
those which encompass a nucleotide sequence of the nucleic acid
molecule used in the process of the invention or encoding a protein
used in the invention or of the nucleic acid molecule of the
invention. Nucleic acid molecules with 30, 50, 100, 250 or more
nucleotides may also be used.
[2768] The term "homology" means that the respective nucleic acid
molecules or encoded proteins are functionally and/or structurally
equivalent. The nucleic acid molecules that are homologous to the
nucleic acid molecules described above and that are derivatives of
said nucleic acid molecules are, for example, variations of said
nucleic acid molecules which represent modifications having the
same biological function, in particular encoding proteins with the
same or substantially the same biological function. They may be
naturally occurring variations, such as sequences from other plant
varieties or species, or mutations. These mutations may occur
naturally or may be obtained by mutagenesis techniques. The allelic
variations may be naturally occurring allelic variants as well as
synthetically produced or genetically engineered variants.
Structurally equivalents can, for example, be identified by testing
the binding of said polypeptide to antibodies or computer based
predictions. Structurally equivalents have the similar
immunological characteristic, e.g. comprise similar epitopes.
[2769] By "hybridizing" it is meant that such nucleic acid
molecules hybridize under conventional hybridization conditions,
preferably under stringent conditions such as described by, e.g.,
Sambrook (Molecular Cloning; A Laboratory Manual, 2.sup.nd Edition,
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
(1989)) or in Current Protocols in Molecular Biology, John Wiley
& Sons, N.Y. (1989), 6.3.1-6.3.6.
[2770] According to the invention, DNA as well as RNA molecules of
the nucleic acid of the invention can be used as probes. Further,
as template for the identification of functional homologues
Northern blot assays as well as Southern blot assays can be
performed. The Northern blot assay advantageously provides further
information about the expressed gene product: e.g. expression
pattern, occurrence of processing steps, like splicing and capping,
etc. The Southern blot assay provides additional information about
the chromosomal localization and organization of the gene encoding
the nucleic acid molecule of the invention.
[2771] A preferred, nonlimiting example of stringent hybridization
conditions are hybridizations in 6.times. sodium chloride/sodium
citrate (.dbd.SSC) at approximately 45.degree. C., followed by one
or more wash steps in 0.2.times.SSC, 0.1% SDS at 50 to 65.degree.
C., for example at 50.degree. C., 55.degree. C. or 60.degree. C.
The skilled worker knows that these hybridization conditions differ
as a function of the type of the nucleic acid and, for example when
organic solvents are present, with regard to the temperature and
concentration of the buffer. The temperature under "standard
hybridization conditions" differs for example as a function of the
type of the nucleic acid between 42.degree. C. and 58.degree. C.,
preferably between 45.degree. C. and 50.degree. C. in an aqueous
buffer with a concentration of 0.1.times., 0.5.times., 1.times.,
2.times., 3.times., 4.times. or 5.times.SSC (pH 7.2). If organic
solvent(s) is/are present in the abovementioned buffer, for example
50% formamide, the temperature under standard conditions is
approximately 40.degree. C., 42.degree. C. or 45.degree. C. The
hybridization conditions for DNA:DNA hybrids are preferably for
example 0.1.times.SSC and 20.degree. C., 25.degree. C., 30.degree.
C., 35.degree. C., 40.degree. C. or 45.degree. C., preferably
between 30.degree. C. and 45.degree. C. The hybridization
conditions for DNA:RNA hybrids are preferably for example
0.1.times.SSC and 30.degree. C., 35.degree. C., 40.degree. C.,
45.degree. C., 50.degree. C. or 55.degree. C., preferably between
45.degree. C. and 55.degree. C. The abovementioned hybridization
temperatures are determined for example for a nucleic acid
approximately 100 by (=base pairs) in length and a G+C content of
50% in the absence of formamide. The skilled worker knows to
determine the hybridization conditions required with the aid of
textbooks, for example the ones mentioned above, or from the
following textbooks: Sambrook et al., "Molecular Cloning", Cold
Spring Harbor Laboratory, 1989; Hames and Higgins (Ed.) 1985,
"Nucleic Acids Hybridization: A Practical Approach", IRL Press at
Oxford University Press, Oxford; Brown (Ed.) 1991, "Essential
Molecular Biology: A Practical Approach", IRL Press at Oxford
University Press, Oxford.
[2772] A further example of one such stringent hybridization
condition is hybridization at 4.times.SSC at 65.degree. C.,
followed by a washing in 0.1.times.SSC at 65.degree. C. for one
hour. Alternatively, an exemplary stringent hybridization condition
is in 50% form amide, 4.times.SSC at 42.degree. C. Further, the
conditions during the wash step can be selected from the range of
conditions delimited by low-stringency conditions (approximately
2.times.SSC at 50.degree. C.) and high-stringency conditions
(approximately 0.2.times.SSC at 50.degree. C., preferably at
65.degree. C.) (20.times.SSC: 0.3 M sodium citrate, 3 M NaCl, pH
7.0). In addition, the temperature during the wash step can be
raised from low-stringency conditions at room temperature,
approximately 22.degree. C., to higher-stringency conditions at
approximately 65.degree. C. Both of the parameters salt
concentration and temperature can be varied simultaneously, or else
one of the two parameters can be kept constant while only the other
is varied. Denaturants, for example formamide or SDS, may also be
employed during the hybridization. In the presence of 50%
formamide, hybridization is preferably effected at 42.degree. C.
Relevant factors like 1) length of treatment, 2) salt conditions,
3) detergent conditions, 4) competitor DNAs, 5) temperature and 6)
probe selection can be combined case by case so that not all
possibilities can be mentioned herein.
[2773] Thus, in a preferred embodiment, Northern blots are
prehybridized with Rothi-Hybri-Quick buffer (Roth, Karlsruhe) at
68.degree. C. for 2 h. Hybridization with radioactive labelled
probe is done overnight at 68.degree. C. Subsequent washing steps
are performed at 68.degree. C. with 1.times.SSC.
[2774] For Southern blot assays the membrane is prehybridized with
Rothi-Hybri-Quick buffer (Roth, Karlsruhe) at 68.degree. C. for 2
h. The hybridization with radioactive labelled probe is conducted
over night at 68.degree. C. Subsequently the hybridization buffer
is discarded and the filter shortly washed using 2.times.SSC; 0,1%
SDS. After discarding the washing buffer new 2.times.SSC; 0,1% SDS
buffer is added and incubated at 68.degree. C. for 15 minutes. This
washing step is performed twice followed by an additional washing
step using 1.times.SSC; 0,1% SDS at 68.degree. C. for 10 min.
[2775] Some examples of conditions for DNA hybridization (Southern
blot assays) and wash step are shown herein below:
(1) Hybridization conditions can be selected, for example, from the
following conditions: [2776] (a) 4.times.SSC at 65.degree. C.,
[2777] (b) 6.times.SSC at 45.degree. C., [2778] (c) 6.times.SSC,
100 mg/ml denatured fragmented fish sperm DNA at 68.degree. C.,
[2779] (d) 6.times.SSC, 0.5% SDS, 100 mg/ml denatured salmon sperm
DNA at 68.degree. C., [2780] (e) 6.times.SSC, 0.5% SDS, 100 mg/ml
denatured fragmented salmon sperm DNA, 50% formamide at 42.degree.
C., [2781] (f) 50% formamide, 4.times.SSC at 42.degree. C., [2782]
(g) 50% (v/v) formamide, 0.1% bovine serum albumin, 0.1% Ficoll,
0.1% polyvinylpyrrolidone, 50 mM sodium phosphate buffer pH 6.5,
750 mM NaCl, 75 mM sodium citrate at 42.degree. C., [2783] (h)
2.times. or 4.times.SSC at 50.degree. C. (low-stringency
condition), or [2784] (i) 30 to 40% formamide, 2.times. or
4.times.SSC at 42.degree. C. (low-stringency condition). (2) Wash
steps can be selected, for example, from the following conditions:
[2785] (a) 0.015 M NaCl/0.0015 M sodium citrate/0.1% SDS at
50.degree. C. [2786] (b) 0.1.times.SSC at 65.degree. C. [2787] (c)
0.1.times.SSC, 0.5% SDS at 68.degree. C. [2788] (d) 0.1.times.SSC,
0.5% SDS, 50% formamide at 42.degree. C. [2789] (e) 0.2.times.SSC,
0.1% SDS at 42.degree. C. [2790] (f) 2.times.SSC at 65.degree. C.
(low-stringency condition).
[2791] Polypeptides having above-mentioned activity, i.e.
conferring increase in yield, especially enhanced NUE and/or
increased biomass production, as compared to a corresponding
non-transformed wild type plant cell, plant or part thereof,
derived from other organisms, can be encoded by other DNA sequences
which hybridize to the sequences shown in table I, application no.
1, columns 5 and 7 under relaxed hybridization conditions and which
code on expression for peptides conferring increase in yield,
especially the enhanced NUE efficiency and/or increased biomass
production, as compared to a corresponding non-transformed wild
type plant cell, plant or part thereof.
[2792] Further, some applications have to be performed at low
stringency hybridization conditions, without any consequences for
the specificity of the hybridization. For example, a Southern blot
analysis of total DNA could be probed with a nucleic acid molecule
of the present invention and washed at low stringency (55.degree.
C. in 2.times.SSPE, 0,1% SDS). The hybridization analysis could
reveal a simple pattern of only genes encoding polypeptides of the
present invention or used in the process of the invention, e.g.
having the herein-mentioned activity of enhancing the NUE and/or
increasing the biomass production as compared to a corresponding
non-transformed wild type plant cell, plant or part thereof. A
further example of such low-stringent hybridization conditions is
4.times.SSC at 50.degree. C. or hybridization with 30 to 40%
formamide at 42.degree. C. Such molecules comprise those which are
fragments, analogues or derivatives of the polypeptide of the
invention or used in the process of the invention and differ, for
example, by way of amino acid and/or nucleotide deletion(s),
insertion(s), substitution (s), addition(s) and/or recombination
(s) or any other modification(s) known in the art either alone or
in combination from the above-described amino acid sequences or
their underlying nucleotide sequence(s). However, it is preferred
to use high stringency hybridization conditions.
[2793] Hybridization should advantageously be carried out with
fragments of at least 5, 10, 15, 20, 25, 30, 35 or 40 bp,
advantageously at least 50, 60, 70 or 80 bp, preferably at least
90, 100 or 110 bp. Most preferably are fragments of at least 15,
20, 25 or 30 bp. Preferably are also hybridizations with at least
100 by or 200, very especially preferably at least 400 by in
length. In an especially preferred embodiment, the hybridization
should be carried out with the entire nucleic acid sequence with
conditions described above.
[2794] The terms "fragment", "fragment of a sequence" or "part of a
sequence" mean a truncated sequence of the original sequence
referred to. The truncated sequence (nucleic acid or protein
sequence) can vary widely in length; the minimum size being a
sequence of sufficient size to provide a sequence with at least a
comparable function and/or activity of the original sequence
referred to or hybridizing with the nucleic acid molecule of the
invention or used in the process of the invention under stringend
conditions, while the maximum size is not critical. In some
applications, the maximum size usually is not substantially greater
than that required to provide the desired activity and/or
function(s) of the original sequence.
[2795] Typically, the truncated amino acid sequence will range from
about 5 to about 310 amino acids in length. More typically,
however, the sequence will be a maximum of about 250 amino acids in
length, preferably a maximum of about 200 or 100 amino acids. It is
usually desirable to select sequences of at least about 10, 12 or
15 amino acids, up to a maximum of about 20 or 25 amino acids.
[2796] The term "epitope" relates to specific immunoreactive sites
within an antigen, also known as antigenic determinates. These
epitopes can be a linear array of monomers in a polymeric
composition--such as amino acids in a protein--or consist of or
comprise a more complex secondary or tertiary structure. Those of
skill will recognize that immunogens (i.e., substances capable of
eliciting an immune response) are antigens; however, some antigen,
such as haptens, are not immunogens but may be made immunogenic by
coupling to a carrier molecule. The term "antigen" includes
references to a substance to which an antibody can be generated
and/or to which the antibody is specifically immunoreactive.
[2797] In one embodiment the present invention relates to a epitope
of the polypeptide of the present invention or used in the process
of the present invention and confers an increased yield, especially
an enhanced NUE and/or an increased biomass production, as compared
to a corresponding non-transformed wild type plant cell, plant or
part thereof.
[2798] The term "one or several amino acids" relates to at least
one amino acid but not more than that number of amino acids, which
would result in a homology of below 50% identity. Preferably, the
identity is more than 70% or 80%, more preferred are 85%, 90%, 91%,
92%, 93%, 94% or 95%, even more preferred are 96%, 97%, 98%, or 99%
identity.
[2799] Further, the nucleic acid molecule of the invention
comprises a nucleic acid molecule, which is a complement of one of
the nucleotide sequences of above mentioned nucleic acid molecules
or a portion thereof. A nucleic acid molecule which is
complementary to one of the nucleotide sequences shown in table I,
application no. 1, columns 5 and 7 is one which is sufficiently
complementary to one of the nucleotide sequences shown in table I,
columns 5 and 7 such that it can hybridize to one of the nucleotide
sequences shown in table I, application no. 1, columns 5 and 7,
thereby forming a stable duplex. Preferably, the hybridization is
performed under stringent hybridization conditions. However, a
complement of one of the herein disclosed sequences is preferably a
sequence complement thereto according to the base pairing of
nucleic acid molecules well known to the skilled person. For
example, the bases A and G undergo base pairing with the bases T
and U or C, resp. and visa versa. Modifications of the bases can
influence the base-pairing partner.
[2800] The nucleic acid molecule of the invention comprises a
nucleotide sequence which is at least about 30%, 35%, 40% or 45%,
preferably at least about 50%, 55%, 60% or 65%, more preferably at
least about 70%, 80%, or 90%, and even more preferably at least
about 95%, 97%, 98%, 99% or more homologous to a nucleotide
sequence shown in table I, application no. 1, columns 5 and 7, or a
portion thereof and preferably has above mentioned activity, in
particular an increase in yield, especially having a NUE enhancing
activity and/or biomass production increasing activity, after
increasing the activity or an activity of a gene product as shown
in table II, application no. 1, column 3 by for example expression
either in the cytsol or in an organelle such as a plastid or
mitochondria or both, preferably in plastids.
[2801] The nucleic acid molecule of the invention comprises a
nucleotide sequence which hybridizes, preferably hybridizes under
stringent conditions as defined herein, to one of the nucleotide
sequences shown in table I, application no. 1, columns 5 and 7, or
a portion thereof and encodes a protein having above-mentioned
activity, e.g. conferring an increased yield, especially an
enhanced NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof by for example expression either in the cytsol or in an
organelle such as a plastid or mitochondria or both, preferably in
plastids, and optionally, the activity selected from the group
consisting of 2-dehydro-3-deoxy-phosphoheptonate aldolase, 3-keto
sterol reductase, 60S ribosomal protein, adenine
phosphoribosyltransferase, adenylate kinase, alkyl hydroperoxide
reductase, Alkyl/aryl-sulfatase, alpha-glucosidase,
alpha-mannosidase, anaphase promoting complex (APC) subunit,
antiviral adaptor protein, aromatic amino acid aminotransferase II,
ARV1 protein, autophagy-specific phosphatidylinositol 3-kinase
complex protein subunit, b0017-protein, B0165-protein,
B1258-protein, B1267-protein, B1381-protein, b1933-protein,
b2165-protein, b2238-protein, b2431-protein, B2646-protein,
b2766-protein, b3120-protein, carnitine acetyltransferase, cell
wall endo-beta-1,3-glucanase, chaperone, Chitin synthase 3 complex
protein, cholinephosphate cytidylyltransferase, chorismate mutase T
prephenate dehydrogenase (bifunctional), clathrin associated
protein complex small subunit, component of the RAM signaling
network, cysteine transporter, cytochrome c oxidase subunit VIII,
cytosolic catalase, cytosolic serine hydroxymethyltransferase,
dihydroorotate dehydrogenase, dihydrosphingosine phosphate lyase,
exoribonuclease, F1F0 ATP synthase beta subunit, Factor arrest
protein, G protein coupled pheromone receptor receptor,
gamma-glutamyl kinase, glucoamylase, glycerol-3-phosphate
transporter subunit, glycine decarboxylase, glycosyltransferase,
golgi membrane exchange factor subunit, golgi membrane protein,
GPI-anchored cell wall protein, GTP-binding protein,
helix-loop-helix transcription activator that binds
inositol/choline-responsive elements, hexose transporter, histidine
kinase osmosensor that regulates an osmosensing MAP kinase cascade,
hydro-lyase, hydroxylamine reductase, hydroxymyristol acyl carrier
protein dehydratase, inheritance of peroxisomes protein, integral
membrane protein localized to late Golgi vesicles, iron sulfur
cluster assembly protein, isomerase, lysine/arginine/ornithine
transporter subunit, lysine-specific metalloprotease,
lysophospholipase, Mcm1p binding transcriptional repressor, Meiotic
recombination protein, membrane protein, metal ion transporter,
microsomal beta-ketoreductase, mitochondrial intermembrane space
protein, mitochondrial protein, mitochondrial ribosomal protein of
the large subunit, mitochondrial ribosomal protein of the small
subunit, mitochondrial seryl-tRNA synthetase, molybdopterin
biosynthesis protein, myo-inositol transporter, non-essential
kinetochore protein, non-essential Ras guanine nucleotide exchange
factor, non-essential small GTPase of the Rho/Rac subfamily of
Ras-like proteins, Nuclear cap-binding protein complex subunit,
nuclear fusion protein precursor, nuclear pore complex subunit,
origin recognition complex subunit, outer membrane usher protein,
oxidoreductase, peptide transporter, peptidyl-prolyl cis-trans
isomerase, PhoH-like protein, phosphatidylserine decarboxylase,
phosphoglucomutase/phosphomannomutase, phosphopantothenoylcysteine
decarboxylase, Phosphoribosylaminoimidazole carboxylase,
potassium:hydrogen antiporter, proline dehydrogenase, protein
component of the large ribosomal subunit, protein involved in shmoo
formation and bipolar bud site selection, protein involved in
sphingolipid biosynthesis, protein kinase, protein necessary for
structural stability of L-A double-stranded RNA-containing
particles, protein required for maturation of ribosomal RNAs,
protein translocase protein, Regulatory CAT8 protein, regulatory
subunit of Glc7p type 1 protein serine-threonine phosphatase,
regulatory subunit of the 26S proteasome, repressor of G1
transcription, Rho GDP-dissociation inhibitor, ribonucleoprotein,
ribosomal protein of the small subunit, RNA polymerase III subunit,
saccharopine dehydrogenase, short chain fatty acid transporter,
signal recognition particle subunit (SRP54), signal transducing MEK
kinase, SM complex B protein for mRNA splicing, spindle checkpoint
complex subunit, splicing factor, Stationary phase protein, subunit
of cytoplasmic phenylalanyl-tRNA synthetase, subunit of the
transport protein particle (TRAPP) complex of the cis-Golgi,
threonine ammonia-lyase, transcription elongation factor,
transcription factor, Transcriptional activator, translational
elongation factor EF-3 (HEF3), transmembrane protein with a role in
cell wall polymer composition, transport protein, ubiquitin
regulatory protein, UDP-N-acetyl-glucosamine-1-P transferase,
v-SNARE binding protein, v-SNARE protein involved in Golgi
transport, xylitol dehydrogenase, yal019w-protein, ybr262c-protein,
YDR070C-protein, ydr355c-protein, YFR007W-protein,
ygr122c-a-protein, ygr266w-protein, ygr290w-protein,
YHL005C-protein, yhl021c-protein, yhr127w-protein, YJL010C-protein,
yjl064w-protein, yjl067w-protein, yjl213w-protein, ykl100c-protein,
YKL111C-protein, ykl131w-protein, ykr016w-protein, ykr021w-protein,
yll014w-protein, yll023c-protein, yll037w-protein, yll049w-protein,
ylr042c-protein, YLR053c-protein, ylr065c-protein, ylr125w-protein,
ylr404w-protein, ylr463c-protein, yml089c-protein, YML101C-protein,
yml128c-protein, YMR082C-protein, YMR126c membrane protein,
YMR144W-protein, YMR160W-protein, YMR209C-protein, YMR233W-protein,
YNL320W-protein, YOR097c-protein, YOR203W-protein, YPL068C-protein,
Zinc finger protein, and zinc metalloprotease.
[2802] Moreover, the nucleic acid molecule of the invention can
comprise only a portion of the coding region of one of the
sequences shown in table I, application no. 1, columns 5 and 7, for
example a fragment which can be used as a probe or primer or a
fragment encoding a biologically active portion of the polypeptide
of the present invention or of a polypeptide used in the process of
the present invention, i.e. having above-mentioned activity, e.g.
conferring an increased yield, especially an enhanced NUE and/or
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof f its activity is
increased by for example expression either in the cytsol or in an
organelle such as a plastid or mitochondria or both, preferably in
plastids. The nucleotide sequences determined from the cloning of
the present protein-according-to-the-invention-encoding gene allows
for the generation of probes and primers designed for use in
identifying and/or cloning its homologues in other cell types and
organisms. The probe/primer typically comprises substantially
purified oligonucleotide. The oligonucleotide typically comprises a
region of nucleotide sequence that hybridizes under stringent
conditions to at least about 12, 15 preferably about 20 or 25, more
preferably about 40, 50 or 75 consecutive nucleotides of a sense
strand of one of the sequences set forth, e.g., in table I,
application no. 1, columns 5 and 7, an anti-sense sequence of one
of the sequences, e.g., set forth in table I, application no. 1,
columns 5 and 7, or naturally occurring mutants thereof. Primers
based on a nucleotide of invention can be used in PCR reactions to
clone homologues of the polypeptide of the invention or of the
polypeptide used in the process of the invention, e.g. as the
primers described in the examples of the present invention, e.g. as
shown in the examples. A PCR with the primers shown in table III,
application no. 1, column 7 will result in a fragment of the gene
product as shown in table II, application no. 1, column 3.
[2803] Primer sets are interchangeable. The person skilled in the
art knows to combine said primers to result in the desired product,
e.g. in a full length clone or a partial sequence. Probes based on
the sequences of the nucleic acid molecule of the invention or used
in the process of the present invention can be used to detect
transcripts or genomic sequences encoding the same or homologous
proteins. The probe can further comprise a label group attached
thereto, e.g. the label group can be a radioisotope, a fluorescent
compound, an enzyme, or an enzyme co-factor. Such probes can be
used as a part of a genomic marker test kit for identifying cells
which express an polypepetide of the invention or used in the
process of the present invention, such as by measuring a level of
an encoding nucleic acid molecule in a sample of cells, e.g.,
detecting mRNA levels or determining, whether a genomic gene
comprising the sequence of the polynucleotide of the invention or
used in the process of the present invention has been mutated or
deleted.
[2804] The nucleic acid molecule of the invention encodes a
polypeptide or portion thereof which includes an amino acid
sequence which is sufficiently homologous to the amino acid
sequence shown in table II, application no. 1, columns 5 and 7 such
that the protein or portion thereof maintains the ability to
participate in increasing yield, especially in the enhancement of
NUE and/or increase of biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof, in particular increasing the activity as mentioned above
or as described in the examples in plants is comprised.
[2805] As used herein, the language "sufficiently homologous"
refers to proteins or portions thereof which have amino acid
sequences which include a minimum number of identical or equivalent
amino acid residues (e.g., an amino acid residue which has a
similar side chain as an amino acid residue in one of the sequences
of the polypeptide of the present invention) to an amino acid
sequence shown in table II, application no. 1, columns 5 and 7 such
that the protein or portion thereof is able to participate in an
increased yield, especially in the enhanced NUE and/or increase of
biomass production as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof. For examples having
the activity of a protein as shown in table II, application no. 1,
column 3 and as described herein.
[2806] In one embodiment, the nucleic acid molecule of the present
invention comprises a nucleic acid that encodes a portion of the
protein of the present invention. The protein is at least about
30%, 35%, 40%, 45% or 50%, preferably at least about 55%, 60%, 65%
or 70%, and more preferably at least about 75%, 80%, 85%, 90%, 91%,
92%, 93% or 94% and most preferably at least about 95%, 97%, 98%,
99% or more homologous to an entire amino acid sequence of table
II, application no. 1, columns 5 and 7 and having above-mentioned
activity, e.g. conferring an increased yield, especially an
enhanced NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof by for example expression either in the cytosol or in an
organelle such as a plastid or mitochondria or both, preferably in
plastids.
[2807] Portions of proteins encoded by the nucleic acid molecule of
the invention are preferably biologically active, preferably having
above-mentioned annotated activity, e.g. conferring an increased
yield, especially an enhanced NUE and/or increase in biomass
production, as compared to a corresponding non-transformed wild
type plant cell, plant or part thereof after increase of
activity.
[2808] As mentioned herein, the term "biologically active portion"
is intended to include a portion, e.g., a domain/motif, that
confers an increased yield, especially an enhanced NUE and/or
increase in biomass production, as compared to a corresponding
non-transformed wild type plant cell, plant or part thereof or has
an immunological activity such that it is binds to an antibody
binding specifically to the polypeptide of the present invention or
a polypeptide used in the process of the present invention for an
increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, plant or part thereof.
[2809] The invention further relates to nucleic acid molecules that
differ from one of the nucleotide sequences shown in table I A,
application no. 1, columns 5 and 7 (and portions thereof) due to
degeneracy of the genetic code and thus encode a polypeptide of the
present invention, in particular a polypeptide having above
mentioned activity, e.g. as that polypeptides depicted by the
sequence shown in table II, application no. 1, columns 5 and 7 or
the functional homologues. Advantageously, the nucleic acid
molecule of the invention comprises, or in an other embodiment has,
a nucleotide sequence encoding a protein comprising, or in an other
embodiment having, an amino acid sequence shown in table II,
application no. 1, columns 5 and 7 or the functional homologues. In
a still further embodiment, the nucleic acid molecule of the
invention encodes a full length protein which is substantially
homologous to an amino acid sequence shown in table II, application
no. 1, columns 5 and 7 or the functional homologues. However, in a
preferred embodiment, the nucleic acid molecule of the present
invention does not consist of the sequence shown in table I,
application no. 1, preferably table IA, columns 5 and 7.
[2810] In addition, it will be appreciated by those skilled in the
art that DNA sequence polymorphisms that lead to changes in the
amino acid sequences may exist within a population. Such genetic
polymorphism in the gene encoding the polypeptide of the invention
or comprising the nucleic acid molecule of the invention may exist
among individuals within a population due to natural variation.
[2811] As used herein, the terms "gene" and "recombinant gene"
refer to nucleic acid molecules comprising an open reading frame
encoding the polypeptide of the invention or comprising the nucleic
acid molecule of the invention or encoding the polypeptide used in
the process of the present invention, preferably from a crop plant
or from a microorganism useful for the method of the invention.
Such natural variations can typically result in 1 to 5% variance in
the nucleotide sequence of the gene. Any and all such nucleotide
variations and resulting amino acid polymorphisms in genes encoding
a polypeptide of the invention or comprising a the nucleic acid
molecule of the invention that are the result of natural variation
and that do not alter the functional activity as described are
intended to be within the scope of the invention.
[2812] Nucleic acid molecules corresponding to natural variants
homologues of a nucleic acid molecule of the invention, which can
also be a cDNA, can be isolated based on their homology to the
nucleic acid molecules disclosed herein using the nucleic acid
molecule of the invention, or a portion thereof, as a hybridization
probe according to standard hybridization techniques under
stringent hybridization conditions.
[2813] Accordingly, in another embodiment, a nucleic acid molecule
of the invention is at least 15, 20, 25 or 30 nucleotides in
length. Preferably, it hybridizes under stringent conditions to a
nucleic acid molecule comprising a nucleotide sequence of the
nucleic acid molecule of the present invention or used in the
process of the present invention, e.g. comprising the sequence
shown in table I, application no. 1, columns 5 and 7. The nucleic
acid molecule is preferably at least 20, 30, 50, 100, 250 or more
nucleotides in length.
[2814] The term "hybridizes under stringent conditions" is defined
above. In one embodiment, the term "hybridizes under stringent
conditions" is intended to describe conditions for hybridization
and washing under which nucleotide sequences at least 30%, 40%, 50%
or 65% identical to each other typically remain hybridized to each
other. Preferably, the conditions are such that sequences at least
about 70%, more preferably at least about 75% or 80%, and even more
preferably at least about 85%, 90% or 95% or more identical to each
other typically remain hybridized to each other.
[2815] Preferably, nucleic acid molecule of the invention that
hybridizes under stringent conditions to a sequence shown in table
I, application no. 1, columns 5 and 7 corresponds to a
naturally-occurring nucleic acid molecule of the invention. As used
herein, a "naturally-occurring" nucleic acid molecule refers to an
RNA or DNA molecule having a nucleotide sequence that occurs in
nature (e.g., encodes a natural protein). Preferably, the nucleic
acid molecule encodes a natural protein having above-mentioned
activity, e.g. conferring increased yield, especially an enhanced
NUE and/or increased biomass production, after increasing the
expression or activity thereof or the activity of a protein of the
invention or used in the process of the invention by for example
expression the nucleic acid sequence of the gene product in the
cytosol and/or in an organelle such as a plastid or mitochondria,
preferably in plastids.
[2816] In addition to naturally-occurring variants of the sequences
of the polypeptide or nucleic acid molecule of the invention as
well as of the polypeptide or nucleic acid molecule used in the
process of the invention that may exist in the population, the
skilled artisan will further appreciate that changes can be
introduced by mutation into a nucleotide sequence of the nucleic
acid molecule encoding the polypeptide of the invention or used in
the process of the present invention, thereby leading to changes in
the amino acid sequence of the encoded said polypeptide, without
altering the functional ability of the polypeptide, preferably not
decreasing said activity.
[2817] For example, nucleotide substitutions leading to amino acid
substitutions at "non-essential" amino acid residues can be made in
a sequence of the nucleic acid molecule of the invention or used in
the process of the invention, e.g. shown in table I, application
no. 1, columns 5 and 7.
[2818] A "non-essential" amino acid residue is a residue that can
be altered from the wild-type sequence of one without altering the
activity of said polypeptide, whereas an "essential" amino acid
residue is required for an activity as mentioned above, e.g.
leading to an increased yield, especially an enhancement of NUE
and/or increase of biomass production, as compared to a
corresponding non-transformed wild type plant cell, plant or part
thereof in an organism after an increase of activity of the
polypeptide. Other amino acid residues, however, (e.g., those that
are not conserved or only semi-conserved in the domain having said
activity) may not be essential for activity and thus are likely to
be amenable to alteration without altering said activity.
[2819] Further, a person skilled in the art knows that the codon
usage between organisms can differ. Therefore, he may adapt the
codon usage in the nucleic acid molecule of the present invention
to the usage of the organism or the cell compartment for example of
the plastid or mitochondria in which the polynucleotide or
polypeptide is expressed.
[2820] Accordingly, the invention relates to nucleic acid molecules
encoding a polypeptide having above-mentioned activity, in an
organism or a part thereof by for example expression either in the
cytosol or in an organelle such as a plastid or mitochondria or
both, preferably in plastids that contain changes in amino acid
residues that are not essential for said activity. Such
polypeptides differ in amino acid sequence from a sequence
contained in the sequences shown in table II, application no. 1,
columns 5 and 7 yet retain said activity described herein. The
nucleic acid molecule can comprise a nucleotide sequence encoding a
polypeptide, wherein the polypeptide comprises an amino acid
sequence at least about 50% identical to an amino acid sequence
shown in table II, application no. 1, columns 5 and 7 and is
capable of participation in increasing yield, especially in the
enhancement of NUE and/or increase of biomass production, as
compared to a corresponding non-transformed wild type plant cell,
plant or part thereof after increasing its activity, e.g. its
expression by for example expression either in the cytosol or in an
organelle such as a plastid or mitochondria or both, preferably in
plastids. Preferably, the protein encoded by the nucleic acid
molecule is at least about 60% identical to the sequence shown in
table II, application no. 1, columns 5 and 7, more preferably at
least about 70% identical to one of the sequences shown in table
II, application no. 1, columns 5 and 7, even more preferably at
least about 80%, 90%, 95% homologous to the sequence shown in table
II, application no. 1, columns 5 and 7, and most preferably at
least about 96%, 97%, 98%, or 99% identical to the sequence shown
in table II, application no. 1, columns 5 and 7.
[2821] To determine the percentage homology (=identity, herein used
interchangeably) of two amino acid sequences or of two nucleic acid
molecules, the sequences are written one underneath the other for
an optimal comparison (for example gaps may be inserted into the
sequence of a protein or of a nucleic acid in order to generate an
optimal alignment with the other protein or the other nucleic
acid).
[2822] The amino acid residues or nucleic acid molecules at the
corresponding amino acid positions or nucleotide positions are then
compared. If a position in one sequence is occupied by the same
amino acid residue or the same nucleic acid molecule as the
corresponding position in the other sequence, the molecules are
homologous at this position (i.e. amino acid or nucleic acid
"homology" as used in the present context corresponds to amino acid
or nucleic acid "identity". The percentage homology between the two
sequences is a function of the number of identical positions shared
by the sequences (i.e. % homology=number of identical
positions/total number of positions.times.100). The terms
"homology" and "identity" are thus to be considered as
synonyms.
[2823] For the determination of the percentage homology (=identity)
of two or more amino acids or of two or more nucleotide sequences
several computer software programs have been developed. The
homology of two or more sequences can be calculated with for
example the software fasta, which presently has been used in the
version fasta 3 (W. R. Pearson and D. J. Lipman, PNAS 85, 2444
(1988); W. R. Pearson, Methods in Enzymology 183, 63 (1990); W. R.
Pearson and D. J. Lipman, PNAS 85, 2444 (1988); W. R. Pearson,
Enzymology 183, 63 (1990)). Another useful program for the
calculation of homologies of different sequences is the standard
blast program, which is included in the Biomax pedant software
(Biomax, Munich, Federal Republic of Germany). This leads
unfortunately sometimes to suboptimal results since blast does not
always include complete sequences of the subject and the query.
Nevertheless as this program is very efficient it can be used for
the comparison of a huge number of sequences. The following
settings are typically used for such a comparisons of
sequences:
[2824] -p Program Name [String]; -d Database [String]; default=nr;
-i Query File [File In]; default=stdin; -e Expectation value (E)
[Real]; default=10.0; -m alignment view options: 0=pairwise;
1=query-anchored showing identities; 2=query-anchored no
identities; 3=flat query-anchored, show identities; 4=flat
query-anchored, no identities; 5=query-anchored no identities and
blunt ends; 6=flat query-anchored, no identities and blunt ends;
7=XML Blast output; 8=tabular; 9 tabular with comment lines
[Integer]; default=0; -o BLAST report Output File [File Out]
Optional; default=stdout; -F Filter query sequence (DUST with
blastn, SEG with others) [String]; default=T; -G Cost to open a gap
(zero invokes default behavior) [Integer]; default=0; -E Cost to
extend a gap (zero invokes default behavior) [Integer]; default=0;
-X X dropoff value for gapped alignment (in bits) (zero invokes
default behavior); blastn 30, megablast 20, tblastx 0, all others
15 [Integer]; default=0; -I Show GI's in deflines [T/F]; default=F;
-q Penalty for a nucleotide mismatch (blastn only) [Integer];
default=-3; -r Reward for a nucleotide match (blastn only)
[Integer]; default=1; -v Number of database sequences to show
one-line descriptions for (V) [Integer]; default=500; -b Number of
database sequence to show alignments for (B) [Integer];
default=250; -f Threshold for extending hits, default if zero;
blastp 11, blastn 0, blastx 12, tblastn 13; tblastx 13, megablast 0
[Integer]; default=0; -g Perfom gapped alignment (not available
with tblastx) [T/F]; default=T; -Q Query Genetic code to use
[Integer]; default=1; -D DB Genetic code (for tblast[nx] only)
[Integer]; default=1; -a Number of processors to use [Integer];
default=1; -O SeqAlign file [File Out] Optional; -J Believe the
query defline [T/F]; default=F; -M Matrix [String];
default=BLOSUM62; -W Word size, default if zero (blastn 11,
megablast 28, all others 3) [Integer]; default=0; -z Effective
length of the database (use zero for the real size) [Real];
default=0; -K Number of best hits from a region to keep (off by
default, if used a value of 100 is recommended) [Integer];
default=0; -P 0 for multiple hit, 1 for single hit [Integer];
default=0; -Y Effective length of the search space (use zero for
the real size) [Real]; default=0; -S Query strands to search
against database (for blast[nx], and tblastx); 3 is both, 1 is top,
2 is bottom [Integer]; default=3; -T Produce HTML output [T/F];
default=F; -I Restrict search of database to list of GI's [String]
Optional; -U Use lower case filtering of FASTA sequence [T/F]
Optional; default=F; -y X dropoff value for ungapped extensions in
bits (0.0 invokes default behavior); blastn 20, megablast 10, all
others 7 [Real]; default=0.0; -Z X dropoff value for final gapped
alignment in bits (0.0 invokes default behavior); blastn/megablast
50, tblastx 0, all others 25 [Integer]; default=0; -R PSITBLASTN
checkpoint file [File In] Optional; -n MegaBlast search [T/F];
default=F; -L Location on query sequence [String] Optional; -A
Multiple Hits window size, default if zero (blastn/megablast 0, all
others 40 [Integer]; default=0; -w Frame shift penalty (OOF
algorithm for blastx) [Integer]; default=0; -t Length of the
largest intron allowed in tblastn for linking HSPs (0 disables
linking) [Integer]; default=0.
[2825] Results of high quality are reached by using the algorithm
of Needleman and Wunsch or Smith and Waterman. Therefore programs
based on said algorithms are preferred. Advantageously the
comparisons of sequences can be done with the program PileUp (J.
Mol. Evolution., 25, 351 (1987), Higgins et al., CABIOS 5, 151
(1989)) or preferably with the programs "Gap" and "Needle", which
are both based on the algorithms of Needleman and Wunsch (J. Mol.
Biol. 48; 443 (1970)), and "BestFit", which is based on the
algorithm of Smith and Waterman (Adv. Appl. Math. 2; 482 (1981)).
"Gap" and "BestFit" are part of the GCG software-package (Genetics
Computer Group, 575 Science Drive, Madison, Wis., USA 53711 (1991);
Altschul et al., (Nucleic Acids Res. 25, 3389 (1997)), "Needle" is
part of the The European Molecular Biology Open Software Suite
(EMBOSS) (Trends in Genetics 16 (6), 276 (2000)). Therefore
preferably the calculations to determine the percentages of
sequence homology are done with the programs "Gap" or "Needle" over
the whole range of the sequences. The following standard
adjustments for the comparison of nucleic acid sequences were used
for "Needle": matrix: EDNAFULL, Gap_penalty: 10.0, Extend_penalty:
0.5. The following standard adjustments for the comparison of
nucleic acid sequences were used for "Gap": gap weight: 50, length
weight: 3, average match: 10.000, average mismatch: 0.000.
[2826] For example a sequence, which has 80% homology with sequence
SEQ ID NO: 38 at the nucleic acid level is understood as meaning a
sequence which, upon comparison with the sequence SEQ ID NO: 38 by
the above program "Needle" with the above parameter set, has a 80%
homology.
[2827] Homology between two polypeptides is understood as meaning
the identity of the amino acid sequence over in each case the
entire sequence length which is calculated by comparison with the
aid of the above program "Needle" using Matrix: EBLOSUM62,
Gap_penalty: 8.0, Extend_penalty: 2.0.
[2828] For example a sequence which has a 80% homology with
sequence SEQ ID NO 39 at the protein level is understood as meaning
a sequence which, upon comparison with the sequence SEQ ID NO 39 by
the above program "Needle" with the above parameter set, has a 80%
homology.
[2829] Functional equivalents derived from the nucleic acid
sequence as shown in table I, application no. 1, columns 5 and 7
according to the invention by substitution, insertion or deletion
have at least 30%, 35%, 40%, 45% or 50%, preferably at least 55%,
60%, 65% or 70% by preference at least 80%, especially preferably
at least 85% or 90%, 91%, 92%, 93% or 94%, very especially
preferably at least 95%, 97%, 98% or 99% homology with one of the
polypeptides as shown in table II, application no. 1, columns 5 and
7 according to the invention and encode polypeptides having
essentially the same properties as the polypeptide as shown in
table II, application no. 1, columns 5 and 7.
[2830] Functional equivalents derived from one of the polypeptides
as shown in table II, application no. 1, columns 5 and 7 according
to the invention by substitution, insertion or deletion have at
least 30%, 35%, 40%, 45% or 50%, preferably at least 55%, 60%, 65%
or 70% by preference at least 80%, especially preferably at least
85% or 90%, 91%, 92%, 93% or 94%, very especially preferably at
least 95%, 97%, 98% or 99% homology with one of the polypeptides as
shown in table II, application no. 1, columns 5 and 7 according to
the invention and having essentially the same properties as the
polypeptide as shown in table II, application no. 1, columns 5 and
7.
[2831] "Essentially the same properties" of a functional equivalent
is above all understood as meaning that the functional equivalent
has above mentioned activity, by for example expression either in
the cytosol or in an organelle such as a plastid or mitochondria or
both, preferably in plastids while increasing the amount of
protein, activity or function of said functional equivalent in an
organism, e.g. a microorganism, a plant or plant tissue or animal
tissue, plant or animal cells or a part of the same.
[2832] A nucleic acid molecule encoding an homologous to a protein
sequence of table II, application no. 1, columns 5 and 7 can be
created by introducing one or more nucleotide substitutions,
additions or deletions into a nucleotide sequence of the nucleic
acid molecule of the present invention, in particular of table I,
application no. 1, columns 5 and 7 such that one or more amino acid
substitutions, additions or deletions are introduced into the
encoded protein. Mutations can be introduced into the encoding
sequences of table I, application no. 1, columns 5 and 7 by
standard techniques, such as site-directed mutagenesis and
PCR-mediated mutagenesis.
[2833] Preferably, conservative amino acid substitutions are made
at one or more predicted non-essential amino acid residues. A
"conservative amino acid substitution" is one in which the amino
acid residue is replaced with an amino acid residue having a
similar side chain. Families of amino acid residues having similar
side chains have been defined in the art. These families include
amino acids with basic side chains (e.g., lysine, arginine,
histidine), acidic side chains (e.g., aspartic acid, glutamic
acid), uncharged polar side chains (e.g., glycine, asparagine,
glutamine, serine, threonine, tyrosine, cysteine), nonpolar side
chains (e.g., alanine, valine, leucine, isoleucine, proline,
phenylalanine, methionine, tryptophane), beta-branched side chains
(e.g., threonine, valine, isoleucine) and aromatic side chains
(e.g., tyrosine, phenylalanine, tryptophane, histidine).
[2834] Thus, a predicted nonessential amino acid residue in a
polypeptide of the invention or a polypeptide used in the process
of the invention is preferably replaced with another amino acid
residue from the same family. Alternatively, in another embodiment,
mutations can be introduced randomly along all or part of a coding
sequence of a nucleic acid molecule of the invention or used in the
process of the invention, such as by saturation mutagenesis, and
the resultant mutants can be screened for activity described herein
to identify mutants that retain or even have increased above
mentioned activity, e.g. conferring an enhanced NUE and/or
increased biomass production as compared to a corresponding
non-transformed wild type plant cell, plant or part thereof.
[2835] Following mutagenesis of one of the sequences as shown
herein, the encoded protein can be expressed recombinant and the
activity of the protein can be determined using, for example,
assays described herein (see Examples).
[2836] The highest homology of the nucleic acid molecule used in
the process according to the invention was found for the following
database entries by Gap search.
[2837] Homologues of the nucleic acid sequences used, with the
sequence shown in table I, application no. 1, columns 5 and 7,
comprise also allelic variants with at least approximately 30%,
35%, 40% or 45% homology, by preference at least approximately 50%,
60% or 70%, more preferably at least approximately 90%, 91%, 92%,
93%, 94% or 95% and even more preferably at least approximately
96%, 97%, 98%, 99% or more homology with one of the nucleotide
sequences shown or the abovementioned derived nucleic acid
sequences or their homologues, derivatives or analogues or parts of
these. Allelic variants encompass in particular functional variants
which can be obtained by deletion, insertion or substitution of
nucleotides from the sequences shown, preferably from table I,
application no. 1, columns 5 and 7, or from the derived nucleic
acid sequences, the intention being, however, that the enzyme
activity or the biological activity of the resulting proteins
synthesized is advantageously retained or increased.
[2838] In one embodiment of the present invention, the nucleic acid
molecule of the invention or used in the process of the invention
comprises the sequences shown in any of the table I, application
no. 1, columns 5 and 7. It is preferred that the nucleic acid
molecule comprises as little as possible other nucleotides not
shown in any one of table I, application no. 1, columns 5 and 7. In
one embodiment, the nucleic acid molecule comprises less than 500,
400, 300, 200, 100, 90, 80, 70, 60, 50 or 40 further nucleotides.
In a further embodiment, the nucleic acid molecule comprises less
than 30, 20 or 10 further nucleotides. In one embodiment, the
nucleic acid molecule use in the process of the invention is
identical to the sequences shown in table I, application no. 1,
columns 5 and 7.
[2839] Also preferred is that the nucleic acid molecule used in the
process of the invention encodes a polypeptide comprising the
sequence shown in table II, application no. 1, columns 5 and 7. In
one embodiment, the nucleic acid molecule encodes less than 150,
130, 100, 80, 60, 50, 40 or 30 further amino acids. In a further
embodiment, the encoded polypeptide comprises less than 20, 15, 10,
9, 8, 7, 6 or 5 further amino acids. In one embodiment used in the
inventive process, the encoded polypeptide is identical to the
sequences shown in table II, application no. 1, columns 5 and
7.
[2840] In one embodiment, the nucleic acid molecule of the
invention or used in the process encodes a polypeptide comprising
the sequence shown in table II, application no. 1, columns 5 and 7
comprises less than 100 further nucleotides. In a further
embodiment, said nucleic acid molecule comprises less than 30
further nucleotides. In one embodiment, the nucleic acid molecule
used in the process is identical to a coding sequence of the
sequences shown in table I, application no. 1, columns 5 and 7.
[2841] Polypeptides (=proteins), which still have the essential
biological or enzymatic activity of the polypeptide of the present
invention conferring an increased yield, especially an enhanced NUE
and/or increased biomass production, as compared to a corresponding
non-transformed wild type plant cell, plant or part thereof i.e.
whose activity is essentially not reduced, are polypeptides with at
least 10% or 20%, by preference 30% or 40%, especially preferably
50% or 60%, very especially preferably 80% or 90 or more of the
wild type biological activity or enzyme activity, advantageously,
the activity is essentially not reduced in comparison with the
activity of a polypeptide shown in table II, application no. 1,
columns 5 and 7 expressed under identical conditions.
[2842] Homologues of table I, application no. 1, columns 5 and 7 or
of the derived sequences of table II, columns 5 and 7 also mean
truncated sequences, cDNA, single-stranded DNA or RNA of the coding
and noncoding DNA sequence. Homologues of said sequences are also
understood as meaning derivatives, which comprise noncoding regions
such as, for example, UTRs, terminators, enhancers or promoter
variants. The promoters upstream of the nucleotide sequences stated
can be modified by one or more nucleotide substitution(s),
insertion(s) and/or deletion(s) without, however, interfering with
the functionality or activity either of the promoters, the open
reading frame (=ORF) or with the 3'-regulatory region such as
terminators or other 3'-regulatory regions, which are far away from
the ORF. It is furthermore possible that the activity of the
promoters is increased by modification of their sequence, or that
they are replaced completely by more active promoters, even
promoters from heterologous organisms. Appropriate promoters are
known to the person skilled in the art and are mentioned herein
below.
[2843] In addition to the nucleic acid molecules encoding the
NUERPs described above, another aspect of the invention pertains to
negative regulators of the activity of a nucleic acid molecules
selected from the group according to table I, application no. 1,
column 5 and/or 7, preferably column 7. Antisense polynucleotides
thereto are thought to inhibit the downregulating activity of those
negative regulators by specifically binding the target
polynucleotide and interfering with transcription, splicing,
transport, translation, and/or stability of the target
polynucleotide. Methods are described in the prior art for
targeting the antisense polynucleotide to the chromosomal DNA, to a
primary RNA transcript, or to a processed mRNA. Preferably, the
target regions include splice sites, translation initiation codons,
translation termination codons, and other sequences within the open
reading frame.
[2844] The term "antisense," for the purposes of the invention,
refers to a nucleic acid comprising a polynucleotide that is
sufficiently complementary to all or a portion of a gene, primary
transcript, or processed mRNA, so as to interfere with expression
of the endogenous gene. "Complementary" polynucleotides are those
that are capable of base pairing according to the standard
Watson-Crick complementarity rules. Specifically, purines will base
pair with pyrimidines to form a combination of guanine paired with
cytosine (G:C) and adenine paired with either thymine (A:T) in the
case of DNA, or adenine paired with uracil (A:U) in the case of
RNA. It is understood that two polynucleotides may hybridize to
each other even if they are not completely complementary to each
other, provided that each has at least one region that is
substantially complementary to the other. The term "antisense
nucleic acid" includes single stranded RNA as well as
double-stranded DNA expression cassettes that can be transcribed to
produce an antisense RNA. "Active" antisense nucleic acids are
antisense RNA molecules that are capable of selectively hybridizing
with a negative regulator of the activity of a nucleic acid
molecules encoding a polypeptide having at least 80% sequence
identity with the polypeptide selected from the group according to
table II, application no. 1, column 5 and/or 7, preferably column
7.
[2845] The antisense nucleic acid can be complementary to an entire
negative regulator strand, or to only a portion thereof. In an
embodiment, the antisense nucleic acid molecule is antisense to a
"noncoding region" of the coding strand of a nucleotide sequence
encoding a NUERP. The term "noncoding region" refers to 5' and 3'
sequences that flank the coding region that are not translated into
amino acids (i.e., also referred to as 5' and 3' untranslated
regions). The antisense nucleic acid molecule can be complementary
to only a portion of the noncoding region of NUERP mRNA. For
example, the antisense oligonucleotide can be complementary to the
region surrounding the translation start site of NUERP mRNA. An
antisense oligonucleotide can be, for example, about 5, 10, 15, 20,
25, 30, 35, 40, 45 or 50 nucleotides in length. Typically, the
anti-sense molecules of the present invention comprise an RNA
having 60-100% sequence identity with at least 14 consecutive
nucleotides of a noncoding region of one of the nucleic acid of
table I. Preferably, the sequence identity will be at least 70%,
more preferably at least 75%, 80%, 85%, 90%, 95%, 98% and most
preferably 99%.
[2846] An antisense nucleic acid of the invention can be
constructed using chemical synthesis and enzymatic ligation
reactions using procedures known in the art. For example, an
antisense nucleic acid (e.g., an antisense oligonucleotide) can be
chemically synthesized using naturally occurring nucleotides or
variously modified nucleotides designed to increase the biological
stability of the molecules or to increase the physical stability of
the duplex formed between the antisense and sense nucleic acids,
e.g., phosphorothioate derivatives and acridine substituted
nucleotides can be used. Examples of modified nucleotides which can
be used to generate the antisense nucleic acid include
5-fluorouracil, 5-bromouracil, 5-chlorouracil, 5-iodouracil,
hypoxanthine, xanthine, 4-acetylcytosine,
5-(carboxyhydroxylmethyl)-uracil,
5-carboxymethylaminomethyl-2-thiouridine,
5-carboxymethylaminomethyluracil, dihydrouracil,
beta-D-galactosylqueosine, inosine, N6-isopentenyladenine,
1-methylguanine, 1-methylinosine, 2,2-dimethylguanine,
2-methyladenine, 2-methylguanine, 3-methylcytosine,
5-methylcytosine, N6-adenine, 7-methylguanine,
5-methylaminomethyluracil, 5-methoxyaminomethyl-2-thiouracil,
beta-D-mannosylqueosine, 5'-methoxycarboxymethyluracil,
5-methoxyuracil, 2-methylthio-N6-isopentenyladenine,
uracil-5-oxyacetic acid (v), wybutoxosine, pseudouracil, queosine,
2-thiocytosine, 5-methyl-2-thiouracil, 2-thiouracil, 4-thiouracil,
5-methyluracil, uracil-5-oxyacetic acid methylester,
5-methyl-2-thiouracil, 3-(3-amino-3-N-2-carboxypropyl)-uracil, acp3
and 2,6-diaminopurine. Alternatively, the antisense nucleic acid
can be produced biologically using an expression vector into which
a nucleic acid has been subcloned in an antisense orientation
(i.e., RNA transcribed from the inserted nucleic acid will be of an
antisense orientation to a target nucleic acid of interest,
described further in the following subsection).
[2847] In yet another embodiment, the antisense nucleic acid
molecule of the invention is an alpha-anomeric nucleic acid
molecule. An alpha-anomeric nucleic acid molecule forms specific
double-stranded hybrids with complementary RNA in which, contrary
to the usual b-units, the strands run parallel to each other
(Gaultier et al., Nucleic Acids. Res. 15, 6625 (1987)). The
antisense nucleic acid molecule can also comprise a
2'-o-methylribonucleotide (Inoue et al., Nucleic Acids Res. 15,
6131 (1987)) or a chimeric RNA-DNA analogue (Inoue et al., FEBS
Lett. 215, 327 (1987)).
[2848] The antisense nucleic acid molecules of the invention are
typically administered to a cell or generated in situ such that
they hybridize with or bind to cellular mRNA and/or genomic DNA.
The hybridization can be by conventional nucleotide complementarity
to form a stable duplex, or, for example, in the case of an
antisense nucleic acid molecule which binds to DNA duplexes,
through specific interactions in the major groove of the double
helix. The antisense molecule can be modified such that it
specifically binds to a receptor or an antigen expressed on a
selected cell surface, e.g., by linking the antisense nucleic acid
molecule to a peptide or an antibody which binds to a cell surface
receptor or antigen. The antisense nucleic acid molecule can also
be delivered to cells using the vectors described herein. To
achieve sufficient intracellular concentrations of the antisense
molecules, vector constructs in which the antisense nucleic acid
molecule is placed under the control of a strong prokaryotic,
viral, or eukaryotic (including plant) promoter are preferred.
[2849] As an alternative to antisense polynucleotides, ribozymes,
sense polynucleotides, or double stranded RNA (dsRNA) can be used
to reduce expression of a NUERP polypeptide. By "ribozyme" is meant
a catalytic RNA-based enzyme with ribonuclease activity which is
capable of cleaving a single-stranded nucleic acid, such as an
mRNA, to which it has a complementary region. Ribozymes (e.g.,
hammerhead ribozymes described in Haselhoff and Gerlach, Nature
334, 585 (1988)) can be used to catalytically cleave NUERP mRNA
transcripts to thereby inhibit translation of NUERP mRNA. A
ribozyme having specificity for a NUERP-encoding nucleic acid can
be designed based upon the nucleotide sequence of a NUERP cDNA, as
disclosed herein or on the basis of a heterologous sequence to be
isolated according to methods taught in this invention. For
example, a derivative of a Tetrahymena L-19 IVS RNA can be
constructed in which the nucleotide sequence of the active site is
complementary to the nucleotide sequence to be cleaved in a
NUERP-encoding mRNA. See, e.g. U.S. Pat. Nos. 4,987,071 and
5,116,742 to Cech et al. Alternatively, NUERP mRNA can be used to
select a catalytic RNA having a specific ribonuclease activity from
a pool of RNA molecules. See, e.g. Bartel D., and Szostak J.W.,
Science 261, 1411 (1993). In preferred embodiments, the ribozyme
will contain a portion having at least 7, 8, 9, 10, 12, 14, 16, 18
or 20 nucleotides, and more preferably 7 or 8 nucleotides, that
have 100% complementarity to a portion of the target RNA. Methods
for making ribozymes are known to those skilled in the art. See,
e.g. U.S. Pat. Nos. 6,025,167, 5,773,260 and 5,496,698.
[2850] The term "dsRNA," as used herein, refers to RNA hybrids
comprising two strands of RNA. The dsRNAs can be linear or circular
in structure. In a preferred embodiment, dsRNA is specific for a
polynucleotide encoding either the polypeptide according to table
II or a polypeptide having at least 70% sequence identity with a
polypeptide according to table II. The hybridizing RNAs may be
substantially or completely complementary. By "substantially
complementary," is meant that when the two hybridizing RNAs are
optimally aligned using the BLAST program as described above, the
hybridizing portions are at least 95% complementary. Preferably,
the dsRNA will be at least 100 base pairs in length. Typically, the
hybridizing RNAs will be of identical length with no over hanging
5' or 3' ends and no gaps. However, dsRNAs having 5' or 3'
overhangs of up to 100 nucleotides may be used in the methods of
the invention.
[2851] The dsRNA may comprise ribonucleotides or ribonucleotide
analogs, such as 2'-O-methyl ribosyl residues, or combinations
thereof. See, e.g. U.S. Pat. Nos. 4,130,641 and 4,024,222. A dsRNA
polyriboinosinic acid:polyribocytidylic acid is described in U.S.
Pat. No. 4,283,393. Methods for making and using dsRNA are known in
the art. One method comprises the simultaneous transcription of two
complementary DNA strands, either in vivo, or in a single in vitro
reaction mixture. See, e.g. U.S. Pat. No. 5,795,715. In one
embodiment, dsRNA can be introduced into a plant or plant cell
directly by standard transformation procedures. Alternatively,
dsRNA can be expressed in a plant cell by transcribing two
complementary RNAs.
[2852] Other methods for the inhibition of endogenous gene
expression, such as triple helix formation (Moser et al., Science
238, 645 (1987), and Cooney et al., Science 241, 456 (1988)) and
cosuppression (Napoli et al., The Plant Cell 2,279, 1990,) are
known in the art. Partial and full-length cDNAs have been used for
the cosuppression of endogenous plant genes. See, e.g. U.S. Pat.
Nos. 4,801,340, 5,034,323, 5,231,020, and 5,283,184; Van der Kroll
et al., The Plant Cell 2, 291, (1990); Smith et al., Mol. Gen.
Genetics 224, 477 (1990), and Napoli et al., The Plant Cell 2, 279
(1990).
[2853] For sense suppression, it is believed that introduction of a
sense polynucleotide blocks transcription of the corresponding
target gene. The sense polynucleotide will have at least 65%
sequence identity with the target plant gene or RNA. Preferably,
the percent identity is at least 80%, 90%, 95% or more. The
introduced sense polynucleotide need not be full length relative to
the target gene or transcript. Preferably, the sense polynucleotide
will have at least 65% sequence identity with at least 100
consecutive nucleotides of one of the nucleic acids as depicted in
table I, application no. 1. The regions of identity can comprise
introns and/or exons and untranslated regions. The introduced sense
polynucleotide may be present in the plant cell transiently, or may
be stably integrated into a plant chromosome or extrachromosomal
replicon.
[2854] Further, object of the invention is an expression vector
comprising a nucleic acid molecule comprising a nucleic acid
molecule selected from the group consisting of: [2855] (a) a
nucleic acid molecule encoding the polypeptide shown in column 5 or
7 of table II, application no. 1; [2856] (b) a nucleic acid
molecule shown in column 5 or 7 of table I, application no. 1;
[2857] (c) a nucleic acid molecule, which, as a result of the
degeneracy of the genetic code, can be derived from a polypeptide
sequence depicted in column 5 or 7 of table II, application no. 1,
and confers an increased yield, especially an enhanced NUE and/or
increased biomass production, as compared to a corresponding
non-transformed wild type plant cell, a plant or a part thereof;
[2858] (d) a nucleic acid molecule having at least 30% identity,
preferably at least 40%, 50%, 60%, 70%, 75%, 80%, 85%, 90%, 95%,
96%, 97%, 98%, 99%, 99.5% with the nucleic acid molecule sequence
of a polynucleotide comprising the nucleic acid molecule shown in
column 5 or 7 of table I, application no. 1, and confers an
increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, a plant or a part thereof; [2859] (e) a
nucleic acid molecule encoding a polypeptide having at least 30%
identity, preferably at least 40%, 50%, 60%, 70%, 75%, 80%, 85%,
90%, 95%, 96%, 97%, 98%, 99%, 99.5%, with the amino acid sequence
of the polypeptide encoded by the nucleic acid molecule of (a),
(b), (c) or (d) and having the activity represented by a nucleic
acid molecule comprising a polynucleotide as depicted in column 5
of table I, application no. 1, and confers an increased yield,
especially an enhanced NUE and/or increased biomass production, as
compared to a corresponding non-transformed wild type plant cell, a
plant or a part thereof; [2860] (f) nucleic acid molecule which
hybridizes with a nucleic acid molecule of (a), (b), (c), (d) or
(e) under stringent hybridization conditions and confers an
increased yield, especially an enhanced NUE and/or increased
biomass production, as compared to a corresponding non-transformed
wild type plant cell, a plant or a part thereof; [2861] (g) a
nucleic acid molecule encoding a polypeptide which can be isolated
with the aid of monoclonal or polyclonal antibodies made against a
polypeptide encoded by one of the nucleic acid molecules of (a),
(b), (c), (d), (e) or (f) and having the activity represented by
the nucleic acid molecule comprising a polynucleotide as depicted
in column 5 of table I, application no. 1; [2862] (h) a nucleic
acid molecule encoding a polypeptide comprising the consensus
sequence or one or more polypeptide motifs as shown in column 7 of
table IV, application no. 1, and preferably having the activity
represented by a protein molecule comprising a polypeptide as
depicted in column 5 of table II or IV, application no. 1, [2863]
(i) a nucleic acid molecule encoding a polypeptide having the
activity represented by a protein as depicted in column 5 of table
II, application no. 1, and confers an increased yield, especially
an enhanced NUE and/or increased biomass production, as compared to
a corresponding non-transformed wild type plant cell, a plant or a
part thereof; [2864] (j) nucleic acid molecule which comprises a
polynucleotide, which is obtained by amplifying a cDNA library or a
genomic library using the primers in column 7 of table III,
application no. 1, (which ion a special embodiment do not start at
their 5'-end with the nucleotides ATA and) preferably having the
activity represented by a protein molecule comprising a polypeptide
as depicted in column 5 of table II or IV, application no. 1; and
[2865] (k) a nucleic acid molecule which is obtainable by screening
a suitable nucleic acid library, especially a cDNA library and/or a
genomic library, under stringent hybridization conditions with a
probe comprising a complementary sequence of a nucleic acid
molecule of (a) or (b) or with a fragment thereof, having at least
15 nt, preferably 20 nt, 30 nt, 50 nt, 100 nt, 200 nt, 500 nt, 750
or 1000 nt of a nucleic acid molecule complementary to a nucleic
acid molecule sequence characterized in (a) to (e) and encoding a
polypeptide having the activity represented by a protein comprising
a polypeptide as depicted in column 5 of table II, application
no.
[2866] The invention further provides an isolated recombinant
expression vector comprising a NUERP encoding nucleic acid as
described above, wherein expression of the vector or NUERP encoding
nucleic acid, respectively in a host cell results in enhanced NUE
as compared to the corresponding non-transformed wild type of the
host cell. As used herein, the term "vector" refers to a nucleic
acid molecule capable of transporting another nucleic acid to which
it has been linked. One type of vector is a "plasmid", which refers
to a circular double stranded DNA loop into which additional DNA
segments can be ligated. Another type of vector is a viral vector,
wherein additional DNA segments can be ligated into the viral
genome. Further types of vectors can be linearized nucleic acid
sequences, such as transposons, which are pieces of DNA which can
copy and insert themselves. There have been 2 types of transposons
found: simple transposons, known as Insertion Sequences and
composite transposons, which can have several genes as well as the
genes that are required for transposition.
[2867] Certain vectors are capable of autonomous replication in a
host cell into which they are introduced (e.g., bacterial vectors
having a bacterial origin of replication and episomal mammalian
vectors). Other vectors (e.g., non-episomal mammalian vectors) are
integrated into the genome of a host cell upon introduction into
the host cell, and thereby are replicated along with the host
genome. Moreover, certain vectors are capable of directing the
expression of genes to which they are operatively linked. Such
vectors are referred to herein as "expression vectors". In general,
expression vectors of utility in recombinant DNA techniques are
often in the form of plasmids. In the present specification,
"plasmid" and "vector" can be used interchangeably as the plasmid
is the most commonly used form of vector. However, the invention is
intended to include such other forms of expression vectors, such as
viral vectors (e.g., replication defective retroviruses,
adenoviruses and adeno-associated viruses), which serve equivalent
functions.
[2868] A plant expression cassette preferably contains regulatory
sequences capable of driving gene expression in plant cells and
operably linked so that each sequence can fulfill its function, for
example, termination of transcription by polyadenylation signals.
Preferred polyadenylation signals are those originating from
Agrobacterium tumefaciens T-DNA such as the gene 3 known as
octopine synthase of the Ti-plasmid pTiACH5 (Gielen et al., EMBO J.
3, 835 1(984)) or functional equivalents thereof but also all other
terminators functionally active in plants are suitable.
[2869] As plant gene expression is very often not limited on
transcriptional levels, a plant expression cassette preferably
contains other operably linked sequences like translational
enhancers such as the overdrive-sequence containing the
5''-untranslated leader sequence from tobacco mosaic virus
enhancing the protein per RNA ratio (Gallie et al., Nucl. Acids
Research 15, 8693 (1987)).
[2870] Plant gene expression has to be operably linked to an
appropriate promoter conferring gene expression in a timely, cell
or tissue specific manner. Preferred are promoters driving
constitutive expression (Benfey et al., EMBO J. 8, 2195 (1989))
like those derived from plant viruses like the 35S CaMV (Franck et
al., Cell 21, 285 (1980)), the 19S CaMV (see also U.S. Pat. No.
5,352,605 and PCT Application No. WO 84/02913) or plant promoters
like those from Rubisco small subunit described in U.S. Pat. No.
4,962,028.
[2871] Additional advantageous regulatory sequences are, for
example, included in the plant promoters such as CaMV/35S (Franck
et al., Cell 21 285 (1980)), PRP1 (Ward et al., Plant. Mol. Biol.
22, 361 (1993)), SSU, OCS, lib4, usp, STLS1, B33, LEB4, nos,
ubiquitin, napin or phaseolin promoter. Also advantageous in this
connection are inducible promoters such as the promoters described
in EP 388 186 (benzyl sulfonamide inducible), Gatz et al., Plant J.
2, 397 (1992) (tetracyclin inducible), EP-A-0 335 528 (abscisic
acid inducible) or WO 93/21334 (ethanol or cyclohexenol inducible).
Additional useful plant promoters are the cytosolic FBPase promotor
or ST-LSI promoter of potato (Stockhaus et al., EMBO J. 8, 2445
(1989)), the phosphorybosyl phyrophoshate amido transferase
promoter of Glycine max (gene bank accession No. U87999) or the
noden specific promoter described in EP-A-0 249 676. Additional
particularly advantageous promoters are seed specific promoters
which can be used for monocotyledones or dicotyledones and are
described in U.S. Pat. No. 5,608,152 (napin promoter from
rapeseed), WO 98/45461 (phaseolin promoter from Arabidopsis), U.S.
Pat. No. 5,504,200 (phaseolin promoter from Phaseolus vulgaris), WO
91/13980 (Bce4 promoter from Brassica) and Baeumlein et al., Plant
J., 2 (2), 233 (1992) (LEB4 promoter from leguminosa). Said
promoters are useful in dicotyledones. The following promoters are
useful for example in monokcotyledones Ipt-2- or Ipt-1-promoter
from barley (WO 95/15389 and WO 95/23230) or hordein promoter from
barley. Other useful promoters are described in WO 99/16890.
[2872] It is possible in principle to use all natural promoters
with their regulatory sequences like those mentioned above for the
novel process. It is also possible and advantageous in addition to
use synthetic promoters.
[2873] The gene construct may also comprise further genes which are
to be inserted into the organisms and which are for example
involved in stress resistance and biomass production increase. It
is possible and advantageous to insert and express in host
organisms regulatory genes such as genes for inducers, repressors
or enzymes which intervene by their enzymatic activity in the
regulation, or one or more or all genes of a biosynthetic pathway.
These genes can be heterologous or homologous in origin. The
inserted genes may have their own promotor or else be under the
control of same promoter as the sequences of the nucleic acid of
table I or their homologs. The gene construct advantageously
comprises, for expression of the other genes present, additionally
3' and/or 5' terminal regulatory sequences to enhance expression,
which are selected for optimal expression depending on the selected
host organism and gene or genes.
[2874] These regulatory sequences are intended to make specific
expression of the genes and protein expression possible as
mentioned above. This may mean, depending on the host organism, for
example that the gene is expressed or overexpressed only after
induction, or that it is immediately expressed and/or
overexpressed.
[2875] The regulatory sequences or factors may moreover preferably
have a beneficial effect on expression of the introduced genes, and
thus increase it. It is possible in this way for the regulatory
elements to be enhanced advantageously at the transcription level
by using strong transcription signals such as promoters and/or
enhancers. However, in addition, it is also possible to enhance
translation by, for example, improving the stability of the
mRNA.
[2876] Other preferred sequences for use in plant gene expression
cassettes are targeting-sequences necessary to direct the gene
product in its appropriate cell compartment (for review see
Kermode, Crit. Rev. Plant Sci. 15 (4), 285 (1996) and references
cited therein) such as the vacuole, the nucleus, all types of
plastids like amyloplasts, chloroplasts, chromoplasts, the
extracellular space, mitochondria, the endoplasmic reticulum, oil
bodies, peroxisomes and other compartments of plant cells. Plant
gene expression can also be facilitated via an inducible promoter
(for review see Gatz, Annu. Rev. Plant Physiol. Plant Mol. Biol.
48, 89 (1997)). Chemically inducible promoters are especially
suitable if gene expression is wanted to occur in a time specific
manner.
[2877] Table VI lists several examples of promoters that may be
used to regulate transcription of the NUE related protein nucleic
acid coding sequences.
TABLE-US-00003 TABLE VI Examples of tissue-specific and inducible
promoters in plants Expression Reference Cor78 - Cold, drought,
salt, Ishitani, et al., Plant Cell 9, 1935 (1997), ABA,
wounding-inducible Yamaguchi-Shinozaki and Shinozaki, Plant Cell 6,
251 (1994) Rci2A - Cold, dehydration- Capel et al., Plant Physiol
115, 569 (1997) inducible Rd22 - Drought, salt Yamaguchi-Shinozaki
and Shinozaki, Mol. Gen. Genet 238, 17 (1993) Cor15A - Cold,
dehydration, Baker et al., Plant Mol. Biol. 24, ABA 701 (1994) GH3-
Auxin inducible Liu et al., Plant Cell 6, 645 (1994) ARSK1-Root,
salt inducible Hwang and Goodman, Plant J. 8, 37 (1995) PtxA -
Root, salt inducible GenBank accession X67427 SbHRGP3 - Root
specific Ahn et al., Plant Cell 8, 1477 (1998). KST1 - Guard cell
specific Plesch et al., Plant Journal. 28(4): 455- (2001) KAT1 -
Guard cell specific Plesch et al., Gene 249, 83 (2000), Nakamura et
al., Plant Physiol. 109, 371 (1995) salicylic acid inducible PCT
Application No. WO 95/19443 tetracycline inducible Gatz et al.
Plant J. 2, 397 (1992) Ethanol inducible PCT Application No. WO
93/21334 Pathogen inducible PRP1 Ward et al., Plant. Mol. Biol. 22,
361 -(1993) Heat inducible hsp80 U.S. Pat. No. 5,187,267 Cold
inducible alpha-amylase PCT Application No. WO 96/12814
Wound-inducible pinII European Patent No. 375 091 RD29A -
salt-inducible Yamaguchi-Shinozalei et al. Mol. Gen. Genet. 236,
331 (1993) Plastid-specific viral RNA- PCT Application No. WO
95/16783, PCT polymerase Application WO 97/06250
[2878] Other promotors, e.g. superpromotor (Ni et al., Plant
Journal 7, 661 (1995)), Ubiquitin promotor (Callis et al., J. Biol.
Chem., 265, 12486 (1990); U.S. Pat. No. 5,510,474; U.S. Pat. No.
6,020,190; Kawalleck et al., Plant. Molecular Biology, 21, 673
(1993)) or 34S promotor (GenBank Accession numbers M59930 and
X16673) were similar useful for the present invention and are known
to a person skilled in the art.
[2879] Developmental stage-preferred promoters are preferentially
expressed at certain stages of development. Tissue and organ
preferred promoters include those that are preferentially expressed
in certain tissues or organs, such as leaves, roots, seeds, or
xylem. Examples of tissue preferred and organ preferred promoters
include, but are not limited to fruit-preferred, ovule-preferred,
male tissue-preferred, seed-preferred, integument-preferred,
tuber-preferred, stalk-preferred, pericarp-preferred, and
leaf-preferred, stigma-preferred, pollen-preferred,
anther-preferred, a petal-preferred, sepal-preferred,
pedicel-preferred, silique-preferred, stem-preferred,
root-preferred promoters, and the like. Seed preferred promoters
are preferentially expressed during seed development and/or
germination. For example, seed preferred promoters can be
embryo-preferred, endosperm preferred, and seed coat-preferred. See
Thompson et al., BioEssays 10, 108 (1989). Examples of seed
preferred promoters include, but are not limited to, cellulose
synthase (celA), Cim1, gamma-zein, globulin-1, maize 19 kD zein
(cZ19B1), and the like.
[2880] Other promoters useful in the expression cassettes of the
invention include, but are not limited to, the major chlorophyll
a/b binding protein promoter, histone promoters, the Ap3 promoter,
the .beta.-conglycin promoter, the napin promoter, the soybean
lectin promoter, the maize 15 kD zein promoter, the 22 kD zein
promoter, the 27 kD zein promoter, the g-zein promoter, the waxy,
shrunken 1, shrunken 2 and bronze promoters, the Zm13 promoter
(U.S. Pat. No. 5,086,169), the maize polygalacturonase promoters
(PG) (U.S. Pat. Nos. 5,412,085 and 5,545,546), and the SGB6
promoter (U.S. Pat. No. 5,470,359), as well as synthetic or other
natural promoters.
[2881] Additional flexibility in controlling heterologous gene
expression in plants may be obtained by using DNA binding domains
and response elements from heterologous sources (i.e., DNA binding
domains from non-plant sources). An example of such a heterologous
DNA binding domain is the LexA DNA binding domain (Brent and
Ptashne, Cell 43, 729 (1985)).
[2882] The invention further provides a recombinant expression
vector comprising a NUERP DNA molecule of the invention cloned into
the expression vector in an antisense orientation. That is, the DNA
molecule is operatively linked to a regulatory sequence in a manner
that allows for expression (by transcription of the DNA molecule)
of an RNA molecule that is antisense to a NUERP mRNA. Regulatory
sequences operatively linked to a nucleic acid molecule cloned in
the antisense orientation can be chosen which direct the continuous
expression of the antisense RNA molecule in a variety of cell
types. For instance, viral promoters and/or enhancers, or
regulatory sequences can be chosen which direct constitutive,
tissue specific, or cell type specific expression of antisense RNA.
The antisense expression vector can be in the form of a recombinant
plasmid, phagemid, or attenuated virus wherein antisense nucleic
acids are produced under the control of a high efficiency
regulatory region. The activity of the regulatory region can be
determined by the cell type into which the vector is introduced.
For a discussion of the regulation of gene expression using
antisense genes, see Weintraub H. et al., Reviews--Trends in
Genetics, Vol. 1(1), 23 (1986) and Mol et al., FEBS Letters 268,
427 (1990).
[2883] Another aspect of the invention pertains to isolated NUERPs,
and biologically active portions thereof. An "isolated" or
"purified" polypeptide or biologically active portion thereof is
free of some of the cellular material when produced by recombinant
DNA techniques, or chemical precursors or other chemicals when
chemically synthesized. The language "substantially free of
cellular material" includes preparations of NUERP in which the
polypeptide is separated from some of the cellular components of
the cells in which it is naturally or recombinantly produced. In
one embodiment, the language "substantially free of cellular
material" includes preparations of a NUERP having less than about
30% (by dry weight) of non-NUERP material (also referred to herein
as a "contaminating polypeptide"), more preferably less than about
20% of non-NUERP material, still more preferably less than about
10% of non-NUERP material, and most preferably less than about 5%
non-NUERP material.
[2884] When the NUERP or biologically active portion thereof is
recombinantly produced, it is also preferably substantially free of
culture medium, i.e., culture medium represents less than about
20%, more preferably less than about 10%, and most preferably less
than about 5% of the volume of the polypeptide preparation. The
language "substantially free of chemical precursors or other
chemicals" includes preparations of NUERP in which the polypeptide
is separated from chemical precursors or other chemicals that are
involved in the synthesis of the polypeptide. In one embodiment,
the language "substantially free of chemical precursors or other
chemicals" includes preparations of a NUERP having less than about
30% (by dry weight) of chemical precursors or non-NUERP chemicals,
more preferably less than about 20% chemical precursors or
non-NUERP chemicals, still more preferably less than about 10%
chemical precursors or non-NUERP chemicals, and most preferably
less than about 5% chemical precursors or non-NUERP chemicals. In
preferred embodiments, isolated polypeptides, or biologically
active portions thereof, lack contaminating polypeptides from the
same organism from which the NUERP is derived. Typically, such
polypeptides are produced by recombinant expression of, for
example, a Saccharomyces cerevisiae, E. coli or Brassica napus,
Glycine max, Zea mays or Oryza sativa NUERP, in an microorganism
like Saccharomyces cerevisiae, E. coli, C. glutamicum, ciliates,
algae, fungi or plants, provided that the polypeptide is
recombinant expressed in an organism being different to the
original organism.
[2885] The nucleic acid molecules, polypeptides, polypeptide
homologs, fusion polypeptides, primers, vectors, and host cells
described herein can be used in one or more of the following
methods: identification of Saccharomyces cerevisiae, E. coli or
Brassica napus, Glycine max, Zea mays or Oryza sativa and related
organisms; mapping of genomes of organisms related to Saccharomyces
cerevisiae, E. coli, identification and localization of
Saccharomyces cerevisiae, E. coli or Brassica napus, Glycine max,
Zea mays or Oryza sativa sequences of interest; evolutionary
studies; determination of NUERP regions required for function;
modulation of a NUERP activity; modulation of the metabolism of one
or more cell functions; modulation of the transmembrane transport
of one or more compounds; modulation of the enhancement of yield,
especially of the NUE and/or biomass production; and modulation of
expression of NUERP nucleic acids.
[2886] The NUERP nucleic acid molecules of the invention are also
useful for evolutionary and polypeptide structural studies. The
metabolic and transport processes in which the molecules of the
invention participate are utilized by a wide variety of prokaryotic
and eukaryotic cells; by comparing the sequences of the nucleic
acid molecules of the present invention to those encoding similar
enzymes from other organisms, the evolutionary relatedness of the
organisms can be assessed. Similarly, such a comparison permits an
assessment of which regions of the sequence are conserved and which
are not, which may aid in determining those regions of the
polypeptide that are essential for the functioning of the enzyme.
This type of determination is of value for polypeptide engineering
studies and may give an indication of what the polypeptide can
tolerate in terms of mutagenesis without losing function.
[2887] Manipulation of the NUERP nucleic acid molecules of the
invention may result in the production of NUERPs having functional
differences from the wild-type NUERPs. These polypeptides may be
improved in efficiency or activity, may be present in greater
numbers in the cell than is usual, or may be decreased in
efficiency or activity. There are a number of mechanisms by which
the alteration of a NUERP of the invention may directly affect the
yield, especially the NUE and/or biomass production. In the case of
plants expressing NUERPs, increased transport can lead to increased
yield, especially an increased NUE and/or biomass production. By
either increasing the number or the activity of transporter
molecules which transport and distribute nitrogen compounds or
transport forms thereof, it may be possible to affect the nitrogen
use efficiency.
[2888] The effect of the genetic modification in plants regarding
the enhanced yield, particularly due to one or more improved yield
related traits as defined above, especially the NUE, can be
assessed by growing the modified plant under less than suitable
conditions and then analyzing the growth characteristics and/or
metabolism of the plant. Such analysis techniques are well known to
one skilled in the art, and include dry weight, fresh weight,
polypeptide synthesis, carbohydrate synthesis, lipid synthesis,
evapotranspiration rates, general plant and/or crop yield,
flowering, reproduction, seed setting, root growth, respiration
rates, photosynthesis rates, etc. (Applications of HPLC in
Biochemistry in: Laboratory Techniques in Biochemistry and
Molecular Biology, Vol. 17; Rehm et al., 1993 Biotechnology, Vol.
3, Chapter III: Product recovery and purification, page 469-714,
VCH: Weinheim; Belter P. A. et al., 1988, Bioseparations:
downstream processing for biotechnology, John Wiley and Sons;
Kennedy J.F., and Cabral J.M.S., 1992, Recovery processes for
biological materials, John Wiley and Sons; Shaeiwitz J.A. and Henry
J.D., 1988, Biochemical separations, in Ulmann's Encyclopedia of
Industrial Chemistry, Vol. B3, Chapter 11, page 1-27, VCH:
Weinheim; and Dechow F.J., 1989, Separation and purification
techniques in biotechnology, Noyes Publications).
[2889] For example, yeast expression vectors comprising the nucleic
acids disclosed herein, or fragments thereof, can be constructed
and transformed into Saccharomyces cerevisiae using standard
protocols. The resulting transgenic cells can then be assayed for
generation or alteration of their yield, particularly NUE and/or
biomass production. Similarly, plant expression vectors comprising
the nucleic acids disclosed herein, or fragments thereof, can be
constructed and transformed into an appropriate plant cell such as
Arabidopsis, soy, rape, maize, cotton, rice, wheat, Medicago
truncatula, etc., using standard protocols. The resulting
transgenic cells and/or plants derived therefrom can then be
assayed for yield increase, especially for generation or alteration
of their NUE and/or biomass production.
[2890] The engineering of one or more genes according to table I
and coding for the NUERP of table II of the invention may also
result in NUERPs having altered activities which indirectly and/or
directly impact yield, especially the NUE of algae, plants,
ciliates, fungi, or other microorganisms like C. glutamicum.
[2891] Additionally, the sequences disclosed herein, or fragments
thereof, can be used to generate knockout mutations in the genomes
of various organisms, such as bacteria, mammalian cells, yeast
cells, and plant cells (Girke, T., The Plant Journal 15, 39
(1998)). The resultant knockout cells can then be evaluated for
their ability or capacity to tolerate N-limited conditions for
their growth, their response to various N-limited growth
conditions, and the effect on the phenotype and/or genotype of the
mutation. For other methods of gene inactivation, see U.S. Pat. No.
6,004,804 and Puttaraju et al., Nature Biotechnology 17, 246
(1999).
[2892] The aforementioned mutagenesis strategies for NUERPs
resulting in increased yield, especially in enhanced NUE and/or
increased biomass production, are not meant to be limiting;
variations on these strategies will be readily apparent to one
skilled in the art. Using such strategies, and incorporating the
mechanisms disclosed herein, the nucleic acid and polypeptide
molecules of the invention may be utilized to generate algae,
ciliates, plants, fungi, or other microorganisms like C. glutamicum
expressing mutated NUERP nucleic acid and polypeptide molecules
such that the yield, especially the NUE and/or biomass production,
is improved.
[2893] The present invention also provides antibodies that
specifically bind to a NUERP, or a portion thereof, as encoded by a
nucleic acid described herein. Antibodies can be made by many
well-known methods (see, e.g. Harlow and Lane, "Antibodies; A
Laboratory Manual", Cold Spring Harbor Laboratory, Cold Spring
Harbor, N.Y., (1988)). Briefly, purified antigen can be injected
into an animal in an amount and in intervals sufficient to elicit
an immune response. Antibodies can either be purified directly, or
spleen cells can be obtained from the animal. The cells can then
fused with an immortal cell line and screened for antibody
secretion. The antibodies can be used to screen nucleic acid clone
libraries for cells secreting the antigen. Those positive clones
can then be sequenced. See, for example, Kelly et al.,
Bio/Technology 10, 163 (1992); Bebbington et al., Bio/Technology
10, 169 (1992).
[2894] The phrases "selectively binds" and "specifically binds"
with the polypeptide refer to a binding reaction that is
determinative of the presence of the polypeptide in a heterogeneous
population of polypeptides and other biologics. Thus, under
designated immunoassay conditions, the specified antibodies bound
to a particular polypeptide do not bind in a significant amount to
other polypeptides present in the sample. Selective binding of an
antibody under such conditions may require an antibody that is
selected for its specificity for a particular polypeptide. A
variety of immunoassay formats may be used to select antibodies
that selectively bind with a particular polypeptide. For example,
solid-phase ELISA immunoassays are routinely used to select
antibodies selectively immunoreactive with a polypeptide. See
Harlow and Lane, "Antibodies, A Laboratory Manual," Cold Spring
Harbor Publications, New York, (1988), for a description of
immunoassay formats and conditions that could be used to determine
selective binding. In some instances, it is desirable to prepare
monoclonal antibodies from various hosts. A description of
techniques for preparing such monoclonal antibodies may be found in
Stites et al., eds., "Basic and Clinical Immunology," (Lange
Medical Publications, Los Altos, Calif., Fourth Edition) and
references cited therein, and in Harlow and Lane, "Antibodies, A
Laboratory Manual," Cold Spring Harbor Publications, New York,
(1988).
[2895] Gene expression in plants is regulated by the interaction of
protein transcription factors with specific nucleotide sequences
within the regulatory region of a gene. One example of
transcription factors are polypeptides that contain zinc finger
(ZF) motifs. Each ZF module is approximately 30 amino acids long
folded around a zinc ion. The DNA recognition domain of a ZF
protein is a .alpha.-helical structure that inserts into the major
grove of the DNA double helix. The module contains three amino
acids that bind to the DNA with each amino acid contacting a single
base pair in the target DNA sequence. ZF motifs are arranged in a
modular repeating fashion to form a set of fingers that recognize a
contiguous DNA sequence. For example, a three-fingered ZF motif
will recognize 9 by of DNA. Hundreds of proteins have been shown to
contain ZF motifs with between 2 and 37 ZF modules in each protein
(Isalan M. et al., Biochemistry 37 (35),12026 (1998); Moore M. et
al., Proc. Natl. Acad. Sci. USA 98 (4), 1432 (2001) and Moore M. et
al., Proc. Natl. Acad. Sci. USA 98 (4), 1437 (2001); U.S. Pat. Nos.
6,007,988 and 6,013,453).
[2896] The regulatory region of a plant gene contains many short
DNA sequences (cis-acting elements) that serve as recognition
domains for transcription factors, including ZF proteins. Similar
recognition domains in different genes allow the coordinate
expression of several genes encoding enzymes in a metabolic pathway
by common transcription factors. Variation in the recognition
domains among members of a gene family facilitates differences in
gene expression within the same gene family, for example, among
tissues and stages of development and in response to environmental
conditions. Typical ZF proteins contain not only a DNA recognition
domain but also a functional domain that enables the ZF protein to
activate or repress transcription of a specific gene.
Experimentally, an activation domain has been used to activate
transcription of the target gene (U.S. Pat. No. 5,789,538 and
patent application WO 95/19431), but it is also possible to link a
transcription repressor domain to the ZF and thereby inhibit
transcription (patent applications WO 00/47754 and WO 01/002019).
It has been reported that an enzymatic function such as nucleic
acid cleavage can be linked to the ZF (patent application WO
00/20622).
[2897] The invention provides a method that allows one skilled in
the art to isolate the regulatory region of one or more NUERP
encoding genes from the genome of a plant cell and to design zinc
finger transcription factors linked to a functional domain that
will interact with the regulatory region of the gene. The
interaction of the zinc finger protein with the plant gene can be
designed in such a manner as to alter expression of the gene and
preferably thereby to confer increased yield, especially enhanced
NUE and/or increased biomass production.
[2898] In particular, the invention provides a method of producing
a transgenic plant with a NUERP coding nucleic acid, wherein
expression of the nucleic acid(s) in the plant results in increased
yield, especially in enhanced NUE and/or increased biomass
production, as compared to a wild type plant comprising: (a)
transforming a plant cell with an expression vector comprising a
NUERP encoding nucleic acid, and (b) generating from the plant cell
a transgenic plant with enhanced NUE and/or increased biomass
production as compared to a wild type plant. For such plant
transformation, binary vectors such as pBinAR can be used (Hofgen
and Willmitzer, Plant Science 66, 221 (1990)). Moreover suitable
binary vectors are for example pBIN19, pBI101, pGPTV or pPZP
(Hajukiewicz P. et al., Plant Mol. Biol., 25, 989 (1994)).
[2899] Construction of the binary vectors can be performed by
ligation of the cDNA into the T-DNA. 5' to the cDNA a plant
promoter activates transcription of the cDNA. A polyadenylation
sequence is located 3' to the cDNA. Tissue-specific expression can
be achieved by using a tissue specific promoter as listed above.
Also, any other promoter element can be used. For constitutive
expression within the whole plant, the CaMV 35S promoter can be
used. The expressed protein can be targeted to a cellular
compartment using a signal peptide, for example for plastids,
mitochondria or endoplasmic reticulum (Kermode, Crit. Rev. Plant
Sci. 4 (15), 285 (1996)). The nucleic acid encoding the signal
peptide is cloned 5' in frame to the cDNA to archive subcellular
localization of the fusion protein. One skilled in the art will
recognize that the promoter used should be operatively linked to
the nucleic acid such that the promoter causes transcription of the
nucleic acid which results in the synthesis of a mRNA which encodes
a polypeptide.
[2900] Alternate methods of transfection include the direct
transfer of DNA into developing flowers via electroporation or
Agrobacterium mediated gene transfer. Agrobacterium mediated plant
transformation can be performed using for example the GV3101(pMP90)
(Koncz and Schell, Mol. Gen. Genet. 204, 383 (1986)) or LBA4404
(Ooms et al., Plasmid, 7, 15 (1982); Hoekema et al., Nature, 303,
179 (1983)) Agrobacterium tumefaciens strain. Transformation can be
performed by standard transformation and regeneration techniques
(Deblaere et al., Nucl. Acids. Res. 13, 4777 (1994); Gelvin and
Schilperoort, Plant Molecular Biology Manual, 2.sup.nd
Ed.--Dordrecht: Kluwer Academic Publ., 1995.--in Sect., Ringbuc
Zentrale Signatur: BT11-P ISBN 0-7923-2731-4; Glick B.R. and
Thompson J.E., Methods in Plant Molecular Biology and
Biotechnology, Boca Raton: CRC Press, 1993.-360 S., ISBN
0-8493-5164-2). For example, rapeseed can be transformed via
cotyledon or hypocotyl transformation (Moloney et al., Plant Cell
Reports 8, 238 (1989); De Block et al., Plant Physiol. 91, 694
(1989)). Use of antibiotics for Agrobacterium and plant selection
depends on the binary vector and the Agrobacterium strain used for
transformation. Rapeseed selection is normally performed using
kanamycin as selectable plant marker. Agrobacterium mediated gene
transfer to flax can be performed using, for example, a technique
described by Mlynarova et al., Plant Cell Report 13, 282 (1994)).
Additionally, transformation of soybean can be performed using for
example a technique described in European Patent No. 424 047, U.S.
Pat. No. 5,322,783, European Patent No. 397 687, U.S. Pat. No.
5,376,543 or U.S. Pat. No. 5,169,770. Transformation of maize can
be achieved by particle bombardment, polyethylene glycol mediated
DNA uptake or via the silicon carbide fiber technique (see, for
example, Freeling and Walbot "The maize handbook" Springer Verlag:
New York (1993) ISBN 3-540-97826-7). A specific example of maize
transformation is found in U.S. Pat. No. 5,990,387 and a specific
example of wheat transformation can be found in PCT Application No.
WO 93/07256.
[2901] Growing the modified plants under defined N-conditions, in
an especial embodiment under N-limited conditions, and then
screening and analyzing the growth characteristics and/or metabolic
activity assess the effect of the genetic modification in plants on
enhanced NUE and/or increased biomass production. The same applies
for the other traits of the present invention, too. Such analysis
techniques are well known to one skilled in the art. They include
beneath to screening (Rompp Lexikon Biotechnologie, Stuttgart/New
York: Georg Thieme Verlag 1992, "screening" p. 701) dry weight,
fresh weight, protein synthesis, carbohydrate synthesis, lipid
synthesis, evapotranspiration rates, general plant and/or crop
yield, flowering, reproduction, seed setting, root growth,
respiration rates, photosynthesis rates, etc. (Applications of HPLC
in Biochemistry in: Laboratory Techniques in Biochemistry and
Molecular Biology, Vol. 17; Rehm et al., 1993 Biotechnology, Vol.
3, Chapter III: Product recovery and purification, page 469-714,
VCH: Weinheim; Belter, P. A. et al., 1988 Bioseparations:
downstream processing for biotechnology, John Wiley and Sons;
Kennedy J.F. and Cabral J.M.S., 1992 Recovery processes for
biological materials, John Wiley and Sons; Shaeiwitz J.A. and Henry
J.D., 1988 Biochemical separations, in: Ullmann's Encyclopedia of
Industrial Chemistry, Vol. B3, Chapter 11, page 1-27, VCH:
Weinheim; and Dechow F.J. (1989) Separation and purification
techniques in biotechnology, Noyes Publications).
[2902] In one embodiment, the present invention relates to a method
for the identification of a gene product conferring increased
nutrient use efficiency and optionally enhanced tolerance to
abiotic stress and/or increased yield, in the absence of stress as
well as in the absence of nutrient deficiency, especially an
enhanced NUE and/or increased biomass production, as compared to a
corresponding non-transformed wild type cell in a cell of an
organism for example plant, comprising the following steps: [2903]
(a) contacting, e.g. hybridizing, some or all nucleic acid
molecules of a sample, e.g. cells, tissues, plants or
microorganisms or a nucleic acid library, which can contain a
candidate gene encoding a gene product conferring increased
nutrient use efficiency and optionally enhanced tolerance to
abiotic stress and/or increased yield, in the absence of stress as
well as in the absence of nutrient deficiency, especially an
enhanced NUE efficiency and/or increased biomass, with a nucleic
acid molecule as shown in column 5 or 7 of table I A or B,
application no. 1, or a functional homologue thereof; [2904] (b)
identifying the nucleic acid molecules, which hybridize under
relaxed stringent conditions with said nucleic acid molecule, in
particular to the nucleic acid molecule sequence shown in column 5
or 7 of table I, application no. 1, and, optionally, isolating the
full length cDNA clone or complete genomic clone; [2905] (c)
identifying the candidate nucleic acid molecules or a fragment
thereof in host cells, preferably in a plant cell; [2906] (d)
increasing the expressing of the identified nucleic acid molecules
in the host cells for which increased nutrient use efficiency and
optionally enhanced tolerance to abiotic stress and/or and/or
increased yield, in the absence of stress as well as in the absence
of nutrient deficiency, especially an enhanced NUE and/or increased
biomass production, are desired; [2907] (e) assaying the level of
enhanced NUE and/or increased biomass production of the host cells;
and [2908] (f) identifying the nucleic acid molecule and its gene
product which increased expression confers increased nutrient use
efficiency and optionally enhanced tolerance to abiotic stress
and/or and/or increased yield, in the absence of stress as well as
in the absence of nutrient deficiency, especially an enhanced NUE
and/or increased biomass production, in the host cell compared to
the wild type. Relaxed hybridization conditions are: After standard
hybridization procedures washing steps can be performed at low to
medium stringency conditions usually with washing conditions of
40.degree.-55.degree. C. and salt conditions between 2.times.SSC
and 0,2.times.SSC with 0,1% SDS in comparison to stringent washing
conditions as e.g. 60.degree. to 68.degree. C. with 0,1% SDS.
Further examples can be found in the references listed above for
the stringend hybridization conditions. Usually washing steps are
repeated with increasing stringency and length until a useful
signal to noise ratio is detected and depend on many factors as the
target, e.g. its purity, GC-content, size etc, the probe, e.g. its
length, is it a RNA or a DNA probe, salt conditions, washing or
hybridization temperature, washing or hybridization time etc.
[2909] In another embodiment, the present invention relates to a
method for the identification of a gene product the expression of
which confers an increased nutrient use efficiency and optionally
enhanced tolerance to abiotic stress and/or and/or increased yield,
in the absence of stress as well as in the absence of nutrient
deficiency, especially an enhanced NUE and/or increased biomass
production, in a cell, comprising the following steps: [2910] (a)
identifiying a nucleic acid molecule in an organism, which is at
least 20%, preferably 25%, more preferably 30%, even more preferred
are 35%. 40% or 50%, even more preferred are 60%, 70% or 80%, most
preferred are 90% or 95% or more homolog to the nucleic acid
molecule encoding a protein comprising the polypeptide molecule as
shown in column 5 or 7 of table II, application no. 1, or
comprising a consensus sequence or a polypeptide motif as shown in
column 7 of table IV, application no. 1, or being encoded by a
nucleic acid molecule comprising a polynucleotide as shown in
column 5 or 7 of table I application no. 1, or a homologue thereof
as described herein, for example via homology search in a data
bank; [2911] (b) enhancing the expression of the identified nucleic
acid molecules in the host cells; [2912] (c) assaying the level of
increase of nutrient use efficiency and optionally enhancement of
tolerance to abiotic stress and/or and/or increase of yield, in the
absence of stress as well as in the absence of nutrient deficiency,
especially an enhancement of NUE and/or increased biomass
production, in the host cells; and [2913] (d) identifying the host
cell, in which the enhanced expression confers increased nutrient
use efficiency and optionally enhanced tolerance to abiotic stress
and/or and/or increased yield, in the absence of stress as well as
in the absence of nutrient deficiency, especially an enhanced NUE
and/or increased biomass production, in the host cell compared to a
wild type.
[2914] Further, the nucleic acid molecule disclosed herein, in
particular the nucleic acid molecule shown column 5 or 7 of table I
A or B, application no. 1, may be sufficiently homologous to the
sequences of related species such that these nucleic acid molecules
may serve as markers for the construction of a genomic map in
related organism or for association mapping. Furthermore natural
variation in the genomic regions corresponding to nucleic acids
disclosed herein, in particular the nucleic acid molecule shown
column 5 or 7 of table I A or B, application no. 1, or homologous
thereof may lead to variation in the activity of the proteins
disclosed herein, in particular the proteins comprising
polypeptides as shown in column 5 or 7 of table II A or B,
application no. 1, or comprising the consensus sequence or the
polypeptide motif as shown in column 7 of table IV, application no.
1, and their homolgous and in consequence in a natural variation of
increased nutrient use efficiency and optionally enhanced tolerance
to abiotic stress and/or and/or increased yield, in the absence of
stress as well as in the absence of nutrient deficiency, especially
of NUE and/or biomass production.
[2915] In consequence natural variation eventually also exists in
form of more active allelic variants leading already to a relative
increase in the tolerance to abiotic environmental stress and/or
nutrient use efficiency, especially enhancement of NUE and/or
biomass production, and/or yield. Different variants of the nucleic
acids molecule disclosed herein, in particular the nucleic acid
comprising the nucleic acid molecule as shown column 5 or 7 of
table I A or B, application no. 1, which corresponds to different
enhancement of yield levels, particularly due to one or more
improved yield related traits as defined above, especially NUE
and/or biomass production levels, can be indentified and used for
marker assisted breeding for enhanced yield, especially NUE and/or
increased biomass production.
[2916] Accordingly, the present invention relates to a method for
breeding plants with enhanced yield, especially enhanced nutrient
use efficiency, in particular NUE and/or increased biomass
production, and optionally enhanced abiotic stress tolerance and/or
increased yield, in the absence of stress as well as nutrient
deficiencies, comprising [2917] (a) selecting a first plant variety
with enhanced yield, especially enhanced nutrient use efficiency,
in particular NUE and/or increased biomass production, and
optionally enhanced abiotic stress tolerance and/or increased
yield, in the absence of stress as well as nutrient deficiencies,
based on increased expression of a nucleic acid of the invention as
disclosed herein, in particular of a nucleic acid molecule
comprising a nucleic acid molecule as shown in column 5 or 7 of
table I A or B, application no. 1, or a polypeptide comprising a
polypeptide as shown in column 5 or 7 of table II A or B,
application no. 1, or comprising a consensus sequence or a
polypeptide motif as shown in column 7 of table IV, application no.
1, or a homologue thereof as described herein; [2918] (b)
associating the level of enhancement of yield, especially of the
nutrient use efficiency, in particular the NUE and/or biomass
production, and optionally enhanced abiotic stress tolerance and/or
increased yield, in the absence of stress as well as nutrient
deficiencies, with the expression level or the genomic structure of
a gene encoding said polypeptide or said nucleic acid molecule;
[2919] (c) crossing the first plant variety with a second plant
variety, which significantly differs in its level of enhancement of
yield, especially enhanced nutrient use efficiency, in particular
NUE and/or biomass production; and [2920] (d) identifying, which of
the offspring varieties has got increased levels of enhanced NUE
and/or biomass production by the expression level of said
polypeptide or nucleic acid molecule or the genomic structure of
the genes encoding said polypeptide or nucleic acid molecule of the
invention. In one embodiment, the expression level of the gene
according to step (b) is increased.
[2921] Yet another embodiment of the invention relates to a process
for the identification of a compound conferring enhanced yield,
especially enhanced nutrient use efficiency, in particular enhanced
NUE and/or increased biomass production, and optionally enhanced
abiotic stress tolerance and/or increased yield, in the absence of
stress as well as nutrient deficiencies, as compared to a
corresponding non-transformed wild type plant cell, a plant or a
part thereof in a plant cell, a plant or a part thereof, a plant or
a part thereof, comprising the steps: [2922] (a) culturing a plant
cell; a plant or a part thereof maintaining a plant expressing the
polypeptide as shown in column 5 or 7 of table II, application no.
1, or being encoded by a nucleic acid molecule comprising a
polynucleotide as shown in column 5 or 7 of table I, application
no. 1, or a homologue thereof as described herein or a
polynucleotide encoding said polypeptide and conferring enhanced
yield, especially enhanced nutrient use efficiency, in particular
an enhanced NUE and/or increased biomass production, and optionally
enhanced abiotic stress tolerance and/or increased yield, in the
absence of stress as well as nutrient deficiencies, as compared to
a corresponding non-transformed wild type plant cell, a plant or a
part thereof; a non-transformed wild type plant or a part thereof
and providing a readout system capable of interacting with the
polypeptide under suitable conditions which permit the interaction
of the polypeptide with this readout system in the presence of a
chemical compound or a sample comprising a plurality of chemical
compounds and capable of providing a detectable signal in response
to the binding of a chemical compound to said polypeptide under
conditions which permit the expression of said readout system and
of the protein as shown in column 5 or 7 of table II, application
no. 1, or being encoded by a nucleic acid molecule comprising a
polynucleotide as shown in column 5 or 7 of table I application no.
1, or a homolog thereof as described herein; and [2923] (b)
identifying if the chemical compound is an effective agonist by
detecting the presence or absence or decrease or increase of a
signal produced by said readout system.
[2924] Said compound may be chemically synthesized or
microbiologically produced and/or comprised in, for example,
samples, e.g., cell extracts from, e.g., plants, animals or
microorganisms, e.g. pathogens. Furthermore, said compound(s) may
be known in the art but hitherto not known to be capable of
suppressing the polypeptide of the present invention. The reaction
mixture may be a cell free extract or may comprise a cell or tissue
culture. Suitable set ups for the process for identification of a
compound of the invention are known to the person skilled in the
art and are, for example, generally described in Alberts et al.,
Molecular Biology of the Cell, third edition (1994), in particular
Chapter 17. The compounds may be, e.g., added to the reaction
mixture, culture medium, injected into the cell or sprayed onto the
plant.
[2925] If a sample containing a compound is identified in the
process, then it is either possible to isolate the compound from
the original sample identified as containing the compound capable
of activating or enhancing enhanced yield, especially enhanced
nutrient use efficiency, in particular the NUE and/or increased
biomass production, and optionally enhanced abiotic stress
tolerance and/or increased yield, in the absence of stress as well
as nutrient deficiencies, as compared to a corresponding
non-transformed wild type, or one can further subdivide the
original sample, for example, if it consists of a plurality of
different compounds, so as to reduce the number of different
substances per sample and repeat the method with the subdivisions
of the original sample. Depending on the complexity of the samples,
the steps described above can be performed several times,
preferably until the sample identified according to the said
process only comprises a limited number of or only one
substance(s). Preferably said sample comprises substances of
similar chemical and/or physical properties, and most preferably
said substances are identical. Preferably, the compound identified
according to the described method above or its derivative is
further formulated in a form suitable for the application in plant
breeding or plant cell and tissue culture.
[2926] The compounds which can be tested and identified according
to said process may be expression libraries, e.g., cDNA expression
libraries, peptides, proteins, nucleic acids, antibodies, small
organic compounds, hormones, peptidomimetics, PNAs or the like
(Milner, Nature Medicine 1, 879 (1995); Hupp, Cell 83, 237 (1995);
Gibbs, Cell 79, 193 (1994), and references cited supra). Said
compounds can also be functional derivatives or analogues of known
inhibitors or activators. Methods for the preparation of chemical
derivatives and analogues are well known to those skilled in the
art and are described in, for example, Beilstein, Handbook of
Organic Chemistry, Springer, New York Inc., 175 Fifth Avenue, New
York, N.Y. 10010 U.S.A. and Organic Synthesis, Wiley, New York,
USA. Furthermore, said derivatives and analogues can be tested for
their effects according to methods known in the art. Furthermore,
peptidomimetics and/or computer aided design of appropriate
derivatives and analogues can be used, for example, according to
the methods described above. The cell or tissue that may be
employed in the process preferably is a host cell, plant cell or
plant tissue of the invention described in the embodiments
hereinbefore.
[2927] Thus, in a further embodiment the invention relates to a
compound obtained or identified according to the method for
identifying an agonist of the invention said compound being an
antagonist of the polypeptide of the present invention.
[2928] Accordingly, in one embodiment, the present invention
further relates to a compound identified by the method for
identifying a compound of the present invention.
[2929] In one embodiment, the invention relates to an antibody
specifically recognizing the compound or agonist of the present
invention.
[2930] The invention also relates to a diagnostic composition
comprising at least one of the aforementioned nucleic acid
molecules, antisense nucleic acid molecule, RNAi, snRNA, dsRNA,
siRNA, miRNA, ta-siRNA, cosuppression molecule, ribozyme, vectors,
proteins, antibodies or compounds of the invention and optionally
suitable means for detection.
[2931] The diagnostic composition of the present invention is
suitable for the isolation of mRNA from a cell and contacting the
mRNA so obtained with a probe comprising a nucleic acid probe as
described above under hybridizing conditions, detecting the
presence of mRNA hybridized to the probe, and thereby detecting the
expression of the protein in the cell. Further methods of detecting
the presence of a protein according to the present invention
comprise immunotechniques well known in the art, for example enzyme
linked immunoadsorbent assay. Furthermore, it is possible to use
the nucleic acid molecules according to the invention as molecular
markers or primers in plant breeding. Suitable means for detection
are well known to a person skilled in the art, e.g. buffers and
solutions for hydridization assays, e.g. the afore-mentioned
solutions and buffers, further and means for Southern-, Western-,
Northern- etc. --blots, as e.g. described in Sambrook et al. are
known. In one embodiment diagnostic composition contain PCR primers
designed to specifically detect the presence or the expression
level of the nucleic acid molecule to be reduced in the process of
the invention, e.g. of the nucleic acid molecule of the invention,
or to discriminate between different variants or alleles of the
nucleic acid molecule of the invention or which activity is to be
reduced in the process of the invention.
[2932] In another embodiment, the present invention relates to a
kit comprising the nucleic acid molecule, the vector, the host
cell, the polypeptide, or the antisense, RNAi, snRNA, dsRNA, siRNA,
miRNA, ta-siRNA, cosuppression molecule, or ribozyme molecule, or
the viral nucleic acid molecule, the antibody, plant cell, the
plant or plant tissue, the harvestable part, the propagation
material and/or the compound and/or agonist identified according to
the method of the invention.
[2933] The compounds of the kit of the present invention may be
packaged in containers such as vials, optionally with/in buffers
and/or solution. If appropriate, one or more of said components
might be packaged in one and the same container. Additionally or
alternatively, one or more of said components might be adsorbed to
a solid support as, e.g. a nitrocellulose filter, a glas plate, a
chip, or a nylon membrane or to the well of a micro titerplate. The
kit can be used for any of the herein described methods and
embodiments, e.g. for the production of the host cells, transgenic
plants, pharmaceutical compositions, detection of homologous
sequences, identification of antagonists or agonists, as food or
feed or as a supplement thereof or as supplement for the treating
of plants, etc.
[2934] Further, the kit can comprise instructions for the use of
the kit for any of said embodiments.
[2935] In one embodiment said kit comprises further a nucleic acid
molecule encoding one or more of the aforementioned protein, and/or
an antibody, a vector, a host cell, an anti-sense nucleic acid, a
plant cell or plant tissue or a plant. In another embodiment said
kit comprises PCR primers to detect and discriminate the nucleic
acid molecule to be reduced in the process of the invention, e.g.
of the nucleic acid molecule of the invention.
[2936] In a further embodiment, the present invention relates to a
method for the production of an agricultural composition providing
the nucleic acid molecule for the use according to the process of
the invention, the nucleic acid molecule of the invention, the
vector of the invention, the antisense, RNAi, snRNA, dsRNA, siRNA,
miRNA, ta-siRNA, cosuppression molecule, ribozyme, or antibody of
the invention, the viral nucleic acid molecule of the invention, or
the polypeptide of the invention or comprising the steps of the
method according to the invention for the identification of said
compound or agonist; and formulating the nucleic acid molecule, the
vector or the polypeptide of the invention or the agonist, or
compound identified according to the methods or processes of the
present invention or with use of the subject matters of the present
invention in a form applicable as plant agricultural
composition.
[2937] In another embodiment, the present invention relates to a
method for the production of the plant culture composition
comprising the steps of the method of the present invention; and
formulating the compound identified in a form acceptable as
agricultural composition.
[2938] Under "acceptable as agricultural composition" is
understood, that such a composition is in agreement with the laws
regulating the content of fungicides, plant nutrients, herbicides,
etc. Preferably such a composition is without any harm for the
protected plants and the animals (humans included) fed
therewith.
[2939] Throughout this application, various publications are
referenced. The disclosures of all of these publications and those
references cited within those publications in their entireties are
hereby incorporated by reference into this application in order to
more fully describe the state of the art to which this invention
pertains.
[2940] It should also be understood that the foregoing relates to
preferred embodiments of the present invention and that numerous
changes and variations may be made therein without departing from
the scope of the invention. The invention is further illustrated by
the following examples, which are not to be construed in any way as
limiting. On the contrary, it is to be clearly understood that
various other embodiments, modifications and equivalents thereof,
which, after reading the description herein, may suggest themselves
to those skilled in the art without departing from the spirit of
the present invention and/or the scope of the claims.
EXAMPLE 1
[2941] Engineering Arabidopsis plants expressing genes of the
present invention, especially with enhanced NUE and/or increased
biomass production by over-expressing NUE related protein
genes.
[2942] Cloning of the inventive sequences as shown in table I,
column 5 and 7, application no. 1, for the expression in plants.
Unless otherwise specified, standard methods as described in
Sambrook et al., Molecular Cloning: A laboratory manual, Cold
Spring Harbor 1989, Cold Spring Harbor Laboratory Press are
used.
[2943] The inventive sequences as shown in table I, column 5 and 7,
application no. 1, were amplified by PCR as described in the
protocol of the Pfu Turbo or Herculase DNA polymerase
(Stratagene).
[2944] Sequences as shown in table I, column 5, marked with
asterisk * reflect the respective sequence derived from public data
base information.
[2945] The composition for the protocol of the Pfu Turbo or
Herculase DNA polymerase was as follows: 1.times.PCR buffer
(Stratagene), 0.2 mM of each dNTP, 100 ng genomic DNA of
Saccharomyces cerevisiae (strain S288C; Research Genetics, Inc.,
now Invitrogen), Escherichia coli (strain MG1655; E. coli Genetic
Stock Center), 50 .mu.mol forward primer, 50 .mu.mol reverse
primer, 2.5 u Pfu Turbo or Herculase DNA polymerase.
[2946] The amplification cycles were as follows:
[2947] 1 cycle of 3 minutes at 94-95.degree. C., followed by 25-36
cycles of in each case 1 minute at 95.degree. C. or 30 seconds at
94.degree. C., 45 seconds at 50.degree. C., 30 seconds at
50.degree. C. or 30 seconds at 55.degree. C. and 210-480 seconds at
72.degree. C., followed by 1 cycle of 8 minutes at 72.degree. C.,
then 4.degree. C. --preferably for Saccharomyces cerevisiae; or
[2948] 1 cycle of 2-3 minutes at 94.degree. C., followed by 25-30
cycles of in each case 30 seconds at 94.degree. C., 30 seconds at
55-60.degree. C. and 5-10 minutes at 72.degree. C., followed by 1
cycle of 10 minutes at 72.degree. C., then 4.degree. C.
--preferably for Escherichia coli.
[2949] RNA were generated with the RNeasy Plant Kit according to
the standard protocol (Qiagen) and Supersript II Reverse
Transkriptase was used to produce double stranded cDNA according to
the standard protocol (Invitrogen).
[2950] The following adapter sequences were added to Saccharomyces
cerevisiae ORF specific primers (see table III) for cloning
purposes:
TABLE-US-00004 SEQ ID NO 7 i) foward primer:
5'-GGAATTCCAGCTGACCACC-3' SEQ ID NO 8 ii) reverse primer:
5'-GATCCCCGGGAATTGCCATG-3'
[2951] The following adapter sequences were added to Escherichia
coli or Synechocystis sp. ORF specific primers for cloning
purposes:
TABLE-US-00005 SEQ ID NO 9 iii) forward primer: 5'-TTGCTCTTCC- 3'
SEQ ID NO 10 iv) reverse primer: 5'-TTGCTCTTCG-3'
[2952] Therefore for amplification and cloning of Saccharomyces
cerevisiae SEQ ID NO: 3868, a primer consisting of the adaptor
sequence i) and the ORF specific sequence SEQ ID NO: 3878 and a
second primer consisting of the adaptor sequence ii) and the ORF
specific sequence SEQ ID NO: 3879 were used.
[2953] For amplification and cloning of Echerischia coli SEQ ID NO:
38, a primer consisting of the adaptor sequence iii) and the ORF
specific sequence SEQ ID NO: 40 and a second primer consisting of
the adaptor sequence iiii) and the ORF specific sequence SEQ ID NO:
41 were used.
[2954] Following these examples every sequence disclosed in table
I, preferably column 5, can be cloned by fusing the adaptor
sequences to the respective specific primers sequences as disclosed
in table III, column 7.
[2955] Construction of binary vectors for non-targeted and plastid
targeted expression of proteins.
[2956] For non-targeted expression the binary vectors used for
cloning were VC-MME220-1 SEQ ID NO 1 (FIG. 1a) and VC-MME220-1qcz
SEQ ID NO 14389 (FIG. 1b) VC-MME221-1 SEQ ID NO 2 (FIG. 2a) and
VC-MME221-1qcz SEQ ID NO 14390 (FIG. 2b), and VC-MME489-1p SEQ ID
NO 15 (FIG. 5a) and VC-MME489-1QCZ SEQ ID NO: 14395 (FIG. 5b),
respectively. The binary vectors used for cloning the targeting
sequence were VC-MME489-1p SEQ ID NO 15 (FIG. 5a) and VC-MME489-1
QCZ SEQ ID NO: 14395 (FIG. 5b), and pMTX0270p SEQ ID NO 16 (FIG.
6), respectively. Other useful binary vectors are known to the
skilled worker; an overview of binary vectors and their use can be
found in Hellens R., Mullineaux P. and Klee H., (Trends in Plant
Science, 5 (10), 446 (2000)). Such vectors have to be equally
equipped with appropriate promoters and targeting sequences.
[2957] Amplification of the Targeting Sequence of the Gene FNR from
Spinacia oleracea
[2958] In order to amplify the targeting sequence of the FNR gene
from S. oleracea, genomic DNA was extracted from leaves of 4 weeks
old S. oleracea plants (DNeasy Plant Mini Kit, Qiagen, Hilden). The
gDNA was used as the template for a PCR.
[2959] To enable cloning of the transit sequence into the vector
VC-MME0489-1p an EcoRI restriction enzyme recognition sequence was
added to both the forward and reverse primers, whereas for cloning
in the vectors pMTX0270p a PmeI restriction enzyme recognition
sequence was added to the forward primer and a NcoI site was added
to the reverse primer.
TABLE-US-00006 FNR5EcoResgen SEQ ID NO 11 ATA GAA TTC GCA TAA ACT
TAT CTT CAT AGT TGC C FNR3EcoResgen SEQ ID NO 12 ATA GAA TTC AGA
GGC GAT CTG GGC CCT FNR5PmeColic SEQ ID NO 13 ATA GTT TAA ACG CAT
AAA CTT ATC TTC ATA GTT GCC FNR3NcoColic SEQ ID NO 14 ATA CCA TGG
AAG AGC AAG AGG CGA TCT GGG CCC T
[2960] The resulting sequence SEQ ID NO: 36 amplified from genomic
spinach DNA, comprised a 5''UTR (bp 1-165), and the coding region
(bp 166-273 and 351-419). The coding sequence is interrupted by an
intronic sequence from by 274 to by 350:
TABLE-US-00007 (SEQ ID NO 36)
gcataaacttatcttcatagttgccactccaatttgctccttgaatctcctccacccaatacataatccactcc-
tccatcaccc
acttcactactaaatcaaacttaactctgtttttctctctcctcctttcatttcttattcttccaatcatcgta-
ctccgccatgaccac
cgctgtcaccgccgctgtttctttcccctctaccaaaaccacctctctctccgcccgaagctcctccgtcattt-
cccctgaca
aaatcagctacaaaaaggtgattcccaatttcactgtgttttttattaataatttgttattttgatgatgagat-
gattaatttgggt
gctgcaggttcctttgtactacaggaatgtatctgcaactgggaaaatgggacccatcagggcccagatcgcct-
ct
[2961] The PCR fragment derived with the primers FNR5EcoResgen and
FNR3EcoResgen was digested with EcoRI and ligated in the vector
VC-MME0489-1p that had also been digested with EcoRI. The correct
orientation of the FNR targeting sequence was tested by sequencing.
The vectors generated in this ligation step were VC-MME354-1 SEQ ID
NO 3 and VC-MME354-1QCZ SEQ ID NO 14391.
[2962] The PCR fragment derived with the primers FNR5PmeColi and
FNR3NcoColi was digested with SmaI and NcoI and ligated in the
vector pMTX0270p SEQ ID NO 16 (FIG. 6) that had also been digested
with PmeI and NcoI. The vectors generated in this ligation step
were VC-MME432-1 SEQ ID NO 5 (FIG. 4a) and VC-MME432-1qcz SEQ ID NO
14393 (FIG. 4b), respectively.
[2963] For cloning the ORF from S. cerevisiae, like the ORF of SEQ
ID NO: 3868, the vector DNA was treated with the restriction enzyme
NcoI. For cloning of ORFs from E. coli the vector DNA was treated
with the restriction enzymes PacI and NcoI following the standard
protocol (MBI Fermentas). The reaction was stopped by inactivation
at 70.degree. C. for 20 minutes and purified over QIAquick columns
following the standard protocol (Qiagen).
[2964] Then the PCR-product representing the amplified ORF and the
vector DNA were treated with T4 DNA polymerase according to the
standard protocol (MBI Fermentas) to produce single stranded
overhangs with the parameters 1 unit T4 DNA polymerase at
37.degree. C. for 2-10 minutes for the vector and 1 u T4 DNA
polymerase at 15.degree. C. for 10-60 minutes for the PCR product
representing, like that of SEQ ID NO: 3868.
[2965] The reaction was stopped by addition of high-salt buffer and
purified over QIAquick columns following the standard protocol
(Qiagen).
[2966] According to this example the skilled person is able to
clone all sequences disclosed in table I, preferably column 5.
[2967] Approximately 30 ng of prepared vector and a defined amount
of prepared amplificate were mixed and hybridized at 65.degree. C.
for 15 minutes followed by 37.degree. C. 0,1.degree. C./1 seconds,
followed by 37.degree. C. 10 minutes, followed by 0,1.degree. C./1
seconds, then 4.degree. C.
[2968] The ligated constructs were transformed in the same reaction
vessel by addition of competent E. coli cells (strain DHSalpha) and
incubation for 20 minutes at 1.degree. C. followed by a heat shock
for 90 seconds at 42.degree. C. and cooling to 4.degree. C. Then,
complete medium (SOC) was added and the mixture was incubated for
45 minutes at 37.degree. C. The entire mixture was subsequently
plated onto an agar plate with 0.05 mg/ml kanamycine and incubated
overnight at 37.degree. C.
[2969] The outcome of the cloning step was verified by
amplification with the aid of primers which bind upstream and
downstream of the integration site, thus allowing the amplification
of the insertion. The amplifications were carried as described in
the protocol of Taq DNA polymerase (Gibco-BRL).
[2970] The amplification cycles were as follows:
[2971] 1 cycle of 5 minutes at 94.degree. C., followed by 35 cycles
of in each case 15 seconds at 94.degree. C., 15 seconds at
50-66.degree. C. and 5 minutes at 72.degree. C., followed by 1
cycle of 10 minutes at 72.degree. C., then 4.degree. C.
[2972] Several colonies were checked, but only one colony for which
a PCR product of the expected size was detected was used in the
following steps.
[2973] A portion of this positive colony was transferred into a
reaction vessel filled with complete medium (LB) supplemented with
kanamycin and incubated overnight at 37.degree. C.
[2974] The plasmid preparation was carried out as specified in the
Qiaprep standard protocol (Qiagen).
[2975] Generation of transgenic plants which express SEQ ID NO:
3868 or any other sequence disclosed in table I, preferably column
5
[2976] 1-5 ng of the plasmid DNA isolated was transformed by
electroporation into competent cells of Agrobacterium tumefaciens,
of strain GV 3101 pMP90 (Koncz and Schell, Mol. Gen. Gent. 204, 383
(1986)). Thereafter, complete medium (YEP) was added and the
mixture was transferred into a fresh reaction vessel for 3 hours at
28.degree. C. Thereafter, all of the reaction mixture was plated
onto YEP agar plates supplemented with the respective antibiotics,
e.g. rifampicine (0.1 mg/ml), gentamycine (0.025 mg/ml and
kanamycine (0.05 mg/ml) and incubated for 48 hours at 28.degree.
C.
[2977] The agrobacteria that contains the plasmid construct were
then used for the transformation of plants.
[2978] A colony was picked from the agar plate with the aid of a
pipette tip and taken up in 3 ml of liquid TB medium, which also
contained suitable antibiotics as described above. The preculture
was grown for 48 hours at 28.degree. C. and 120 rpm. 400 ml of LB
medium containing the same antibiotics as above were used for the
main culture. The preculture was transferred into the main culture.
It was grown for 18 hours at 28.degree. C. and 120 rpm. After
centrifugation at 4 000 rpm, the pellet was resuspended in
infiltration medium (MS medium, 10% sucrose).
[2979] In order to grow the plants for the transformation, dishes
(Piki Saat 80, green, provided with a screen bottom,
30.times.20.times.4.5 cm, from Wiesauplast, Kunststofftechnik,
Germany) were half-filled with a GS 90 substrate (standard soil,
Werkverband E.V., Germany). The dishes were watered overnight with
0.05% Proplant solution (Chimac-Apriphar, Belgium). Arabidopsis
thaliana C24 seeds (Nottingham Arabidopsis Stock Centre, UK; NASC
Stock N906) were scattered over the dish, approximately 1 000 seeds
per dish. The dishes were covered with a hood and placed in the
stratification facility (8 h, 110 .mu.mol/m.sup.2s, 22.degree. C.;
16 h, dark, 6.degree. C.). After 5 days, the dishes were placed
into the short-day controlled environment chamber (8 h, 130
.mu.mol/m.sup.2s, 22.degree. C.; 16 h, dark, 20.degree. C.), where
they remained for approximately 10 days until the first true leaves
had formed.
[2980] The seedlings were transferred into pots containing the same
substrate (Teku pots, 7 cm, LC series, manufactured by Poppelmann
GmbH & Co, Germany). Five plants were pricked out into each
pot. The pots were then returned into the short-day controlled
environment chamber for the plant to continue growing.
[2981] After 10 days, the plants were transferred into the
greenhouse cabinet (supplementary illumination, 16 h, 340
.mu.E/m.sup.2s, 22.degree. C.; 8 h, dark, 20.degree. C.), where
they were allowed to grow for further 17 days.
[2982] For the transformation, 6-week-old Arabidopsis plants, which
had just started flowering were immersed for 10 seconds into the
above-described agrobacterial suspension which had previously been
treated with 10 .mu.l Silwett L77 (Crompton S.A., Osi Specialties,
Switzerland). The method in question is described by Clough J.C.
and Bent A.F. (Plant J. 16, 735 (1998)).
[2983] The plants were subsequently placed for 18 hours into a
humid chamber. Thereafter, the pots were returned to the greenhouse
for the plants to continue growing. The plants remained in the
greenhouse for another 10 weeks until the seeds were ready for
harvesting.
[2984] Depending on the resistance marker used for the selection of
the transformed plants the harvested seeds were planted in the
greenhouse and subjected to a spray selection or else first
sterilized and then grown on agar plates supplemented with the
respective selection agent. Since the vector contained the bar gene
as the resistance marker, plantlets were sprayed four times at an
interval of 2 to 3 days with 0.02% BASTA.RTM. and transformed
plants were allowed to set seeds.
[2985] The seeds of the transgenic A. thaliana plants were stored
in the freezer (at -20.degree. C.).
[2986] Plant Screening (Arabidopsis) for growth under low
temperature conditions or growth under limited nitrogen supply or
growth under conditions in the absence of stress as well as
nutrient deficiencies
[2987] Plant screening (Arabidopsis) for growth under limited
nitrogen supply
[2988] For screening of transgenic plants a specific culture
facility was used. For high-throughput purposes plants were
screened for biomass production on agar plates with limited supply
of nitrogen (adapted from Estelle and Somerville, 1987). This
screening pipeline consists of two levels. Transgenic lines are
subjected to subsequent level if biomass production was
significantly improved in comparison to wild type plants. With each
level number of replicates and statistical stringency was
increased.
[2989] For the sowing, the seeds, which had been stored in the
refrigerator (at -20.degree. C.), were removed from the Eppendorf
tubes with the aid of a toothpick and transferred onto the
above-mentioned agar plates, with limited supply of nitrogen (0.05
mM KNO.sub.3). In total, approximately 15-30 seeds were distributed
horizontally on each plate (12.times.12 cm).
[2990] After the seeds had been sown, plates are subjected to
stratification for 2-4 days in the dark at 4.degree. C. After the
stratification, the test plants were grown for 22 to 25 days at a
16-h-light, 8-h-dark rhythm at 20.degree. C., an atmospheric
humidity of 60% and a CO.sub.2 concentration of approximately 400
ppm. The light sources used generate a light resembling the solar
color spectrum with a light intensity of approximately 100
.mu.E/m.sup.2s. After 10 to 11 days the plants are individualized.
Improved growth under nitrogen limited conditions was assessed by
biomass production of shoots and roots of transgenic plants in
comparison to wild type control plants after 20-25 days growth.
[2991] Transgenic lines showing a significant improved biomass
production in comparison to wild type plants are subjected to
following experiment of the subsequent level:
[2992] Arabidopsis thaliana seeds are sown in pots containing a 1:1
(v:v) mixture of nutrient depleted soil ("Einheitserde Typ 0", 30%
clay, Tantau, Wansdorf Germany) and sand. Germination is induced by
a four day period at 4.degree. C., in the dark. Subsequently the
plants are grown under standard growth conditions (photoperiod of
16 h light and 8 h dark, 20.degree. C., 60% relative humidity, and
a photon flux density of 200 .mu.E/m.sup.2s). The plants are grown
and cultured, inter alia they are watered every second day with a
N-depleted nutrient solution. The N-depleted nutrient solution e.g.
contains beneath water
TABLE-US-00008 mineral nutrient final concentration KCl 3.00 mM
MgSO.sub.4 .times. 7 H.sub.2O 0.5 mM CaCl.sub.2 .times. 6 H.sub.2O
1.5 mM K.sub.2SO.sub.4 1.5 mM NaH.sub.2PO.sub.4 1.5 mM Fe-EDTA 40
.mu.M H.sub.3BO.sub.3 25 .mu.M MnSO.sub.4 .times. H.sub.2O 1 .mu.M
ZnSO.sub.4 .times. 7 H.sub.2O 0.5 .mu.M Cu.sub.2SO.sub.4 .times. 5
H.sub.2O 0.3 .mu.M Na.sub.2MoO.sub.4 .times. 2 H.sub.2O 0.05
.mu.M
[2993] After 9 to 10 days the plants are individualized. After a
total time of 29 to 31 days the plants are harvested and rated by
the fresh weight of the aerial parts of the plants. The results
thereof are summarized in table VII-A. The biomass increase has
been measured as ratio of the fresh weight of the aerial parts of
the respective transgene plant and the non-transgenic wild type
plant.
TABLE-US-00009 TABLE VII-A SeqID Target Locus Biomass Increase 38
Cytoplasmic B0017 1.19 42 Cytoplasmic B0045 1.15 123 Plastidic
B0180 1.41 380 Plastidic B0242 1.16 679 Plastidic B0403 1.10 812
Cytoplasmic B0474 1.24 1055 Plastidic B0754 1.15 1563 Cytoplasmic
B0784 1.20 1705 Plastidic B0873 1.17 1844 Cytoplasmic B1014 1.19
1950 Plastidic B1020 1.10 1975 Cytoplasmic B1180 1.23 2127
Plastidic B1933 1.55 2135 Plastidic B2032 1.24 2171 Plastidic B2165
1.24 2297 Plastidic B2223 1.36 2426 Plastidic B2238 1.26 2452
Plastidic B2310 1.18 2551 Plastidic B2431 1.47 2600 Plastidic B2600
1.12 2668 Plastidic B2766 1.10 2772 Cytoplasmic B2903 1.65 3117
Plastidic B3117 1.42 3390 Plastidic B3120 1.28 3396 Plastidic B3216
1.19 3470 Plastidic B3451 1.21 3563 Cytoplasmic B3791 1.25 3770*
Plastidic B3825 1.42 3868 Cytoplasmic Yal019w 1.42 3895 Cytoplasmic
Yar035w 1.38 3953 Cytoplasmic Ybl021c 1.15 4111 Cytoplasmic Ybr055c
1.10 4149 Cytoplasmic YBR128C 1.19 4162 Cytoplasmic Ybr159w 1.23
4235 Cytoplasmic Ybr243c 1.16 4280 Cytoplasmic Ybr262c 1.31 4288
Cytoplasmic Ycr019w 1.31 4315 Cytoplasmic Ydr070c 1.20 4325
Cytoplasmic Ydr079w 1.29 4335 Cytoplasmic Ydr123c 1.19 4346
Cytoplasmic Ydr137w 1.22 4361 Cytoplasmic Ydr294c 1.13 4402
Cytoplasmic Ydr330w 1.38 4431 Cytoplasmic Ydr355c 1.34 4435
Plastidic YDR430C 1.16 4485 Cytoplasmic Ydr472w 1.20 4506 Plastidic
YDR497C 1.16 4790 Cytoplasmic Yer029c 1.23 4806 Cytoplasmic YFR007W
1.36 4836 Cytoplasmic YGL039W 1.22 5311 Cytoplasmic Ygl043w 1.26
5346 Cytoplasmic Ygr088w 1.13 5533 Cytoplasmic Ygr122c-a 1.30 5551
Cytoplasmic Ygr142w 1.21 5559 Cytoplasmic Ygr143w 1.19 5602
Cytoplasmic Ygr165w 1.23 5608 Cytoplasmic Ygr170w 1.12 5614
Cytoplasmic Ygr202c 1.55 5666 Cytoplasmic Ygr266w 1.34 5701
Cytoplasmic Ygr282c 1.21 5750 Cytoplasmic Ygr290w 1.19 5754
Cytoplasmic Yhl021c 1.19 5778 Cytoplasmic Yhl031c 1.21 5812
Cytoplasmic Yhr011w 1.21 5967 Cytoplasmic Yhr127w 1.36 5973
Cytoplasmic Yhr137w 1.39 6027 Cytoplasmic Yil099w 3.09 6107
Cytoplasmic Yil147c 1.21 6150* Cytoplasmic Yir034c 2.42 6198
Cytoplasmic Yjl013c 1.42 6208 Cytoplasmic Yjl041w 1.41 6242
Cytoplasmic Yjl064w 1.30 6246 Cytoplasmic Yjl067w 1.29 6250
Cytoplasmic Yjl094c 1.23 6297 Cytoplasmic Yjl171c 1.19 6326
Cytoplasmic Yjl213w 1.62 6488 Cytoplasmic Yjr017c 1.50 6550
Cytoplasmic Yjr058c 1.28 6700 Cytoplasmic Yjr117w 1.81 6816
Cytoplasmic Yjr121w 1.52 7366* Cytoplasmic Yjr131w 1.52 7475
Cytoplasmic Yjr145c 1.41 7602 Cytoplasmic Ykl084w 1.20 7651
Cytoplasmic Ykl088w 1.23 7661* Cytoplasmic Ykl100c 1.25 7675
Cytoplasmic Ykl131w 1.22 7679 Cytoplasmic Ykl138c 1.24 7710
Cytoplasmic Ykl178c 2.69 7735 Cytoplasmic Ykl179c 1.58 7778*
Cytoplasmic Ykl193c 1.77 7829 Cytoplasmic Ykl216w 2.09 8017
Cytoplasmic Ykr016w 2.00 8045 Cytoplasmic Ykr021w 2.14 8073
Cytoplasmic Ykr055w 1.57 8263 Plastidic Ykr088c 1.29 8287
Cytoplasmic Ykr093w 3.98 8468 Cytoplasmic Ykr099w 1.15 8484*
Cytoplasmic Ykr100c 4.43 8492 Cytoplasmic Yll014w 1.61 8514*
Cytoplasmic Yll016w 1.24 8539 Cytoplasmic Yll023c 1.17 8571
Cytoplasmic Yll037w 1.32 8575 Cytoplasmic Yll049w 1.75 8579
Cytoplasmic Yll055w 5.25 8661* Cytoplasmic Ylr034c 4.38 8991
Cytoplasmic Ylr042c 1.40 8995 Cytoplasmic Ylr053c 1.55 8999
Cytoplasmic Ylr058c 1.19 9551* Cytoplasmic Ylr060w 3.72 9637
Cytoplasmic Ylr065c 1.88 9672 Cytoplasmic Ylr070c 2.66 10182
Cytoplasmic Ylr00w 1.57 10214 Cytoplasmic Ylr109w 1.55 10447
Cytoplasmic Ylr125w 1.28 10451 Cytoplasmic Ylr127c 1.22 10463
Cytoplasmic Ylr185w 1.14 10533 Cytoplasmic Ylr204w 1.38 10541
Cytoplasmic Ylr242c 1.61 10562 Cytoplasmic Ylr293c 2.75 10990
Cytoplasmic Ylr313c 1.25 10998 Cytoplasmic Ylr315w 1.54 11004
Cytoplasmic Ylr329w 1.27 11012 Cytoplasmic Ylr362w 3.40 11054
Cytoplasmic Ylr395c 1.56 11066 Cytoplasmic Ylr404w 1.33 11074
Cytoplasmic Ylr463c 1.33 11080 Cytoplasmic Yml022w 1.27 11552
Cytoplasmic Yml027w 1.42 11569 Cytoplasmic Yml065w 1.14 11596
Cytoplasmic Yml089c 1.17 11600 Cytoplasmic Yml128c 1.12 11612
Cytoplasmic Ymr011w 1.52 12246 Cytoplasmic Ymr037c 1.41 12263
Cytoplasmic Ymr049c 3.71 12316 Cytoplasmic Ymr052w 1.28 12327*
Cytoplasmic Ymr082c 1.26 12331 Cytoplasmic YMR125W 1.24 12378
Cytoplasmic Ymr126c 1.19 12394 Cytoplasmic Ymr144w 1.36 12406
Cytoplasmic Ymr160w 1.29 12414* Cytoplasmic Ymr191w 1.51 12420
Cytoplasmic Ymr209c 1.18 12440 Cytoplasmic Ymr233w 1.61 12470
Cytoplasmic Ymr278w 1.20 12749 Cytoplasmic Ymr280c 1.31 12773
Cytoplasmic Ynl014w 1.21 12829 Cytoplasmic Ynl320w 1.46 12883
Cytoplasmic Yol007c 1.15 12889 Cytoplasmic Yol164w 1.21 13014
Cytoplasmic Yor076c 1.10 13018 Cytoplasmic Yor083w 1.48 13024
Cytoplasmic Yor097c 1.19 13030 Cytoplasmic Yor128c 1.46 14085
Cytoplasmic Yor353c 1.26 14093 Cytoplasmic Ypl141c 1.33 14113
Cytoplasmic Ypr088c 1.61 14246 Cytoplasmic Ypr108w 1.25 14311
Cytoplasmic Ypr110c 1.22 14914 Plastidic B3825_2 1.42 15382
Cytoplasmic Yir034c_2 2.42 15460 Cytoplasmic Yjr131w_2 1.52 15571
Cytoplasmic Ykl100c_2 1.25 15593 Cytoplasmic Ykl193c_2 1.77 15646
Cytoplasmic Yll016w_2 1.24 15673 Cytoplasmic Ylr034c_2 4.38 16005
Cytoplasmic Ylr060w_2 3.72 16114 Cytoplasmic YMR082C_2 1.26 14402
Cytoplasmic B1258 1.36 16093 Cytoplasmic YML101C 1.35 16106
Cytoplasmic YMR065W 1.28 16120 Cytoplasmic YMR163C 1.21 16275
Cytoplasmic YOL042W 1.16 16305 Cytoplasmic YOR226C 1.24 16573
Cytoplasmic YPL068C 1.11 14396 Plastidic B0165 1.14 16299
Cytoplasmic YOR203W 1.21 16133 Cytoplasmic YNL147W 1.15 15056
Cytoplasmic YBR083W 1.11 15587 Cytoplasmic YKL111C 1.11 16582
Cytoplasmic YPR067W 1.13 14839 Cytoplasmic B1985 1.16 15014
Cytoplasmic B3838 1.42 15432 Cytoplasmic YJL010C 1.11 14497
Cytoplasmic B1267 1.23 14718 Cytoplasmic B1322 1.33 14791
Cytoplasmic B1381 1.11 14879 Cytoplasmic B2646 1.31 15064
Cytoplasmic YBR191W 1.12 15257 Cytoplasmic YDL135C 1.33 15378
Cytoplasmic YHL005C 1.25 16629 Cytoplasmic YKR100C_2 4.43 16647
Cytoplasmic Ymr191w_2 1.51 Sequences marked with asterisk * reflect
the respective sequence derived from public data bases
information.
[2994] Plant Screening (Arabidopsis) for Growth Under Low
Temperature Conditions
[2995] In a standard experiment soil was prepared as 3.5:1 (v:v)
mixture of nutrient rich soil (GS90, Tantau, Wansdorf, Germany) and
sand. Pots were filled with soil mixture and placed into trays.
Water was added to the trays to let the soil mixture take up
appropriate amount of water for the sowing procedure. The seeds for
transgenic Arabidopsis thaliana plants (created as described above)
were sown in pots (6 cm diameter). Pots were collected until they
filled a tray for the growth chamber. Then the filled tray was
covered with a transparent lid and transferred into the shelf
system of the precooled (4.degree. C.-5.degree. C.) growth chamber.
Stratification was established for a period of 2-3 days in the dark
at 4.degree. C.-5.degree. C. Germination of seeds and growth was
initiated at a growth condition of 20.degree. C., 60% relative
humidity, 16 h photoperiod and illumination with fluorescent light
at 200 .mu.mol/m.sup.2s. Covers were removed 7 days after sowing.
BASTA selection was done at day 9 after sowing by spraying pots
with plantlets from the top. Therefore, a 0.07% (v:v) solution of
BASTA concentrate (183 g/L glufosinate-ammonium) in tap water was
sprayed. Transgenic events and wildtype control plants were
distributed randomly over the chamber. The location of the trays
inside the chambers was changed on working days from day 7 after
sowing. Watering was carried out every two days after covers were
removed from the trays. Plants were individualized 12-13 days after
sowing by removing the surplus of seedlings leaving one seedling in
a pot. Cold (chilling to 11.degree. C.-12.degree. C.) was applied
14 days after sowing until the end of the experiment. For measuring
biomass performance, plant fresh weight was determined at harvest
time (29-31 days after sowing) by cutting shoots and weighing them.
Besides weighing, phenotypic information was added in case of
plants that differ from the wild type control. Plants were in the
stage prior to flowering and prior to growth of inflorescence when
harvested.
[2996] Three successive experiments were conducted. In the first
experiment, one individual of each transformed line was tested.
[2997] In the second experiment, the event that had been determined
as chilling tolerant or resistant in the first experiment, i.e.
showed increased yield, in this case increased biomass production,
in comparison to wild type, were put through a confirmation screen
according to the same experimental procedures. In this experiment,
max. 10 plants of each tolerant or resistant event were grown,
treated and measured as before.
[2998] In the first two experiments, chilling tolerance or
tolerance and biomass production was compared to wild type
plants.
[2999] In the third experiment, up to 20 replicates of each
confirmed tolerant event, i.e. those that had been scored as
tolerant or resistant in the second experiment, were grown, treated
and scored as before. The results thereof are summarized in table
VII-B.
TABLE-US-00010 TABLE VII-B SeqID Target Locus Biomass Increase 1055
Plastidic B0754 1.09 1950 Plastidic B1020 1.17 2127 Plastidic B1933
1.12 2426 Plastidic B2238 1.19 2452 Plastidic B2310 1.25 2551
Plastidic B2431 1.34 2668 Plastidic B2766 1.26 3117 Plastidic B3117
1.16 3390 Plastidic B3120 1.15 3470 Plastidic B3451 1.10 4162
Cytoplasmic Ybr159w 1.07 4235 Plastidic Ybr243c 1.26 4288
Cytoplasmic Ycr019w 1.24 4325 Cytoplasmic Ydr079w 1.09 4346
Cytoplasmic Ydr137w 1.14 4402 Cytoplasmic Ydr330w 1.24 4435
Plastidic YDR430C 1.10 4506 Plastidic YDR497C 1.23/1.24 (promoter
1/2) 4790 Cytoplasmic Yer029c 1.13 4836 Cytoplasmic YGL039W 1.32
5754 Cytoplasmic Yhl021c 1.12 5973 Plastidic Yhr137w 1.13 6027
Plastidic Yil099w 1.20 6326 Cytoplasmic Yjl213w 1.12 7602
Cytoplasmic Ykl084w 1.10 7735 Cytoplasmic Ykl179c 1.22 8073
Cytoplasmic Ykr055w 1.09 8263 Plastidic Ykr088c 1.20 8484
Cytoplasmic Ykr100c 1.12 10533 Plastidic Ylr204w 1.22 12773
Cytoplasmic Ynl014w 1.11 14113 Cytoplasmic Ypr088c 1.26 14396
Plastidic B0165 1.08 14718 Cytoplasmic B1322 1.06 14879 Cytoplasmic
B2646 1.11 16629 Cytoplasmic YKR100C_2 1.12
[3000] Plant Screening (Arabidopsis) for Growth Under Cycling
Drought Conditions
[3001] In the cycling drought assay repetitive stress is applied to
plants without leading to desiccation. In a standard experiment
soil is prepared as 1:1 (v:v) mixture of nutrient rich soil (GS90,
Tantau, Wansdorf, Germany) and quarz sand. Pots (6 cm diameter)
were filled with this mixture and placed into trays. Water was
added to the trays to let the soil mixture take up appropriate
amount of water for the sowing procedure (day 1) and subsequently
seeds of transgenic A. thaliana plants and their wild-type controls
were sown in pots. Then the filled tray was covered with a
transparent lid and transferred into a precooled (4.degree.
C.-5.degree. C.) and darkened growth chamber. Stratification was
established for a period of 3 days in the dark at 4.degree.
C.-5.degree. C. or, alternatively, for 4 days in the dark at
4.degree. C. Germination of seeds and growth was initiated at a
growth condition of 20.degree. C., 60% relative humidity, 16 h
photoperiod and illumination with fluorescent light at
approximately 200 .mu.mol/m.sup.2s. Covers were removed 7-8 days
after sowing. BASTA selection was done at day 10 or day 11 (9 or 10
days after sowing) by spraying pots with plantlets from the top. In
the standard experiment, a 0.07% (v/v) solution of BASTA
concentrate (183 g/L glufosinate-ammonium) in tap water was sprayed
once or, alternatively, a 0.02% (v:v) solution of BASTA was sprayed
three times. The wild-type control plants were sprayed with tap
water only (instead of spraying with BASTA dissolved in tap water)
but were otherwise treated identically. Plants were individualized
13-14 days after sowing by removing the surplus of seedlings and
leaving one seedling in soil. Transgenic events and wild-type
control plants were evenly distributed over the chamber.
[3002] The water supply throughout the experiment was limited and
plants were subjected to cycles of drought and re-watering.
Watering was carried out at day 1 (before sowing), day 14 or day
15, day 21 or day 22, and, finally, day 27 or day 28. For measuring
biomass production, plant fresh weight was determined one day after
the final watering (day 28 or day 29) by cutting shoots and
weighing them. Besides weighing, phenotypic information was added
in case of plants that differ from the wild type control. Plants
were in the stage prior to flowering and prior to growth of
inflorescence when harvested.
[3003] Up to five lines (events) per transgenic construct were
tested in successive experimental levels (up to 4). Only constructs
that displayed positive performance were subjected to the next
experimental level. Usually in the first level five plants per
construct were tested and in the subsequent levels 30-60 plants
were tested. Biomass performance was evaluated as described above.
Data are shown for constructs that displayed increased biomass
performance in at least two successive experimental levels in Table
VII-C.
[3004] Biomass production was measured by weighing plant rosettes.
Biomass increase was calculated as ratio of average weight for
transgenic plants compared to average weight of wild type control
plants from the same experiment. The mean biomass increase of
transgenic constructs is given.
TABLE-US-00011 TABLE VII-C SeqID Target Locus Biomass Increase 2426
Cytoplasmic B2238 1.11 4361 Plastidic Ydr294c 1.35 4506 Plastidic
YDR497C 1.10 9637 Cytoplasmic Ylr065c 1.24
[3005] Plant Screening (Arabidopsis) for Yield Increase Under
Standardized Conditions
[3006] In this experiment, a plant screening for yield increase (in
this case: biomass yield increase) under standardized growth
conditions in the absence of substantial abiotic stress and biotic
stress has been performed. In a standard experiment soil is
prepared as 3.5:1 (v:v) mixture of nutrient rich soil (GS90,
Tantau, Wansdorf, Germany) and quartz sand. Alternatively, plants
were sown on nutrient rich soil (GS90, Tantau, Germany). Pots were
filled with soil mixture and placed into trays. Water was added to
the trays to let the soil mixture take up appropriate amount of
water for the sowing procedure. The seeds for transgenic A.
thaliana plants and their non-transgenic wild-type controls were
sown in pots (6 cm diameter). Then the filled tray was covered with
a transparent lid and transferred into a precooled (4.degree.
C.-5.degree. C.) and darkened growth chamber. Stratification was
established for a period of 3-4 days in the dark at 4.degree.
C.-5.degree. C. Germination of seeds and growth was initiated at a
growth condition of 20.degree. C., 60% relative humidity, 16 h
photoperiod and illumination with fluorescent light at
approximately 200 .mu.mol/m.sup.2s. Covers were removed 7-8 days
after sowing. BASTA selection was done at day 10 or day 11 (9 or 10
days after sowing) by spraying pots with plantlets from the top. In
the standard experiment, a 0.07% (v:v) solution of BASTA
concentrate (183 g/L glufosinate-ammonium) in tap water was sprayed
once or, alternatively, a 0.02% (v:v) solution of BASTA was sprayed
three times. The wild-type control plants were sprayed with tap
water only (instead of spraying with BASTA dissolved in tap water)
but were otherwise treated identically. Plants were individualized
13-14 days after sowing by removing the surplus of seedlings and
leaving one seedling in soil. Transgenic events and wild-type
control plants were evenly distributed over the chamber. Watering
was carried out as needed, every two days after removing the covers
in a standard experiment or, alternatively, every day. For
measuring biomass performance, plant fresh weight was determined at
harvest time (24-29 days after sowing) by cutting shoots and
weighing them. Plants were in the stage prior to flowering and
prior to growth of inflorescence when harvested. Transgenic plants
were compared to the non-transgenic wild-type control plants.
[3007] Per transgenic construct up to five events, with up to 60
plants per event, were tested in up to four experimental levels.
Biomass performance was evaluated as described below; the
respective data are summarized in table VII-D.
[3008] Biomass production was measured by harvesting and weighing
plant rosettes. Biomass increase was calculated as ratio of average
weight of transgenic plants compared to average weight of wild-type
control plants from the same experiment. The mean biomass increase
of transgenic constructs is given.
TABLE-US-00012 TABLE VII-D SeqID Target Locus Biomass Increase 123
Plastidic B0180 1.33 812 Cytoplasmic B0474 1.09 1055 Plastidic
B0754 1.23 1975 Cytoplasmic B1180 1.18 2135 Plastidic B2032 1.14
2171 Plastidic B2165 1.24 2426 Plastidic B2238 1.18 2452 Plastidic
B2310 1.20 2551 Plastidic B2431 1.17 2600 Plastidic B2600 1.16 2668
Plastidic B2766 1.20 3390 Plastidic B3120 1.39 3470 Plastidic B3451
1.23 3868 Cytoplasmic Yal019w 1.14 3895 Cytoplasmic Yar035w 1.43
4235 Plastidic Ybr243c 1.29 4315 Cytoplasmic Ydr070c 1.47 4402
Cytoplasmic Ydr330w 1.14 4435 Plastidic YDR430C 1.61 4506 Plastidic
YDR497C 1.14 4790 Cytoplasmic Yer029c 1.10 6550 Cytoplasmic Yjr058c
1.36 6700 Cytoplasmic Yjr117w 1.22 6816 Cytoplasmic Yjr121w 1.37
7710 Cytoplasmic Ykl178c 1.57 8468 Cytoplasmic Ykr099w 1.50 8484
Cytoplasmic Ykr100c 1.30 8995 Cytoplasmic Ylr053c 1.17 14396
Plastidic B0165 1.79 15432 Cytoplasmic YJL010C 1.47 14718
Cytoplasmic B1322 1.20 14879 Cytoplasmic B2646 1.23 16629
Cytoplasmic YKR100C_2 1.30
EXAMPLE 2
[3009] Engineering Arabidopsis plants with increased yield,
especially enhanced stress tolerance, preferably tolerance to low
temperature and/or tolerance to drought conditions, and/or enhanced
nutrient use efficiency, in particular enhanced NUE and/or
increased biomass production, and/or increased biomass production
by over-expressing NUE (NUERP) related protein encoding genes from
Saccharomyces cereviesae or E. coli using tissue-specific promoters
and/or stress inducible promoters.
[3010] Transgenic Arabidopsis plants are created as in example 1 to
express the NUE related protein (NUERP) encoding transgenes under
the control of a tissue-specific promoter and/or stress inducible
promoters.
[3011] T2 generation plants are produced and are grown under the
respective conditions (low temperature, drought conditions,
N-limited conditions, conditions in the absence of stress as well
as nutrient deficiencies. Biomass production is determined after a
total time of 29 to 31 days starting with the sowing. The
transgenic Arabidopsis produces more biomass than non-transgenic
control plants.
EXAMPLE 3
[3012] Engineering alfalfa plants with increased yield, especially
enhanced stress tolerance, preferably tolerance to low temperature
and/or tolerance to drought conditions, and/or enhanced nutrient
use efficiency, in particular enhanced NUE and/or increased biomass
production, by over-expressing NUE related protein (NUERP) encoding
genes from Saccharomyces cerevisiae or E. coli by over-expressing
NUE related protein (NUERP) encoding genes for example from
Brassica napus, Glycine max, Zea mays or Oryza sativa for
example
[3013] A regenerating clone of alfalfa (Medicago sativa) is
transformed using the method of (McKersie et al., Plant Physiol
119, 839 (1999)). Regeneration and transformation of alfalfa is
genotype dependent and therefore a regenerating plant is required.
Methods to obtain regenerating plants have been described. For
example, these can be selected from the cultivar Rangelander
(Agriculture Canada) or any other commercial alfalfa variety as
described by Brown D.C.W. and Atanassov A. (Plant Cell Tissue Organ
Culture 4, 111 (1985)). Alternatively, the RA3 variety (University
of Wisconsin) is selected for use in tissue culture (Walker et al.,
Am. J. Bot. 65, 654 (1978)).
[3014] Petiole explants are cocultivated with an overnight culture
of Agrobacterium tumefaciens C58C1 pMP90 (McKersie et al., Plant
Physiol 119, 839 (1999)) or LBA4404 containing a binary vector.
Many different binary vector systems have been described for plant
transformation (e.g. An G., in Agrobacterium Protocols, Methods in
Molecular Biology, Vol 44, pp 47-62, Gartland K.M.A. and Davey M.R.
eds. Humana Press, Totowa, N.J.). Many are based on the vector
pBIN19 described by Bevan (Nucleic Acid Research. 12, 8711 (1984))
that includes a plant gene expression cassette flanked by the left
and right border sequences from the Ti plasmid of Agrobacterium
tumefaciens. A plant gene expression cassette consists of at least
two genes--a selection marker gene and a plant promoter regulating
the transcription of the cDNA or genomic DNA of the trait gene.
Various selection marker genes can be used including the
Arabidopsis gene encoding a mutated acetohydroxy acid synthase
(AHAS) enzyme (U.S. Pat. Nos. 5,7673,666 and 6,225,105). Similarly,
various promoters can be used to regulate the trait gene that
provides constitutive, developmental, tissue or environmental
regulation of gene transcription. In this example, the 34S promoter
(GenBank Accession numbers M59930 and X16673) is used to provide
constitutive expression of the trait gene.
[3015] The explants are cocultivated for 3 days in the dark on SH
induction medium containing 288 mg/L Pro, 53 mg/L thioproline, 4.35
g/L K.sub.2SO.sub.4, and 100 .mu.m acetosyringinone. The explants
are washed in half-strength Murashige-Skoog medium (Murashige and
Skoog, 1962) and plated on the same SH induction medium without
acetosyringinone but with a suitable selection agent and suitable
antibiotic to inhibit Agrobacterium growth. After several weeks,
somatic embryos are transferred to BOi2Y development medium
containing no growth regulators, no antibiotics, and 50 g/L
sucrose. Somatic embryos are subsequently germinated on
half-strength Murashige-Skoog medium. Rooted seedlings are
transplanted into pots and grown in a greenhouse.
[3016] The T0 transgenic plants are propagated by node cuttings and
rooted in Turface growth medium. T1 or T2 generation plants are
produced and are grown under the respective conditions (low
temperature, drought conditions, N-limited conditions, conditions
in the absence of stress as well as nutrient deficiencies,
especially subjected to experiments with limited nitrogen supply:
Plants receive limited nitrogen supply by use of a nutrient
depleted soil. Nutrients apart from nitrogen are supplied by a
nutrient solution. For NUE assessment biomass production and/or dry
matter production and/or seed yield is compared to non-transgenic
wild type plants. For the other traits the procedure is adapted
accordingly.
EXAMPLE 4
[3017] Engineering ryegrass plants with increased yield, especially
enhanced stress tolerance, preferably tolerance to low temperature
and/or tolerance to drought conditions, and/or enhanced nutrient
use efficiency, in particular enhanced NUE, by over-expressing NUE
related protein (NUERP) encoding genes from Saccharomyces
cerevisiae or E. coli or by over-expressing NUE related protein
(NUERP) encoding genes from for example Brassica napus, Glycine
max, Zea mays or Oryza sativa.
[3018] Seeds of several different ryegrass varieties may be used as
explant sources for transformation, including the commercial
variety Gunne available from Svalof Weibull seed company or the
variety Affinity. Seeds are surface-sterilized sequentially with 1%
Tween-20 for 1 minute, 100% bleach for 60 minutes, 3 rinses with 5
minutes each with deionized and distilled H.sub.2O, and then
germinated for 3-4 days on moist, sterile filter paper in the dark.
Seedlings are further sterilized for 1 minute with 1% Tween-20, 5
minutes with 75% bleach, and rinsed 3 times with double distilled
H.sub.2O, 5 min each.
[3019] Surface-sterilized seeds are placed on the callus induction
medium containing Murashige and Skoog basal salts and vitamins, 20
g/L sucrose, 150 mg/L asparagine, 500 mg/L casein hydrolysate, 3
g/L Phytagel, 10 mg/L BAP, and 5 mg/L dicamba. Plates are incubated
in the dark at 25.degree. C. for 4 weeks for seed germination and
embryogenic callus induction.
[3020] After 4 weeks on the callus induction medium, the shoots and
roots of the seedlings are trimmed away, the callus is transferred
to fresh media, maintained in culture for another 4 weeks, and then
transferred to MSO medium in light for 2 weeks. Several pieces of
callus (11-17 weeks old) are either strained through a 10 mesh
sieve and put onto callus induction medium, or cultured in 100 ml
of liquid ryegrass callus induction media (same medium as for
callus induction with agar) in a 250 ml flask. The flask is wrapped
in foil and shaken at 175 rpm in the dark at 23.degree. C. for 1
week. Sieving the liquid culture with a 40-mesh sieve collected the
cells. The fraction collected on the sieve is plated and cultured
on solid ryegrass callus induction medium for 1 week in the dark at
25.degree. C. The callus is then transferred to and cultured on MS
medium containing 1% sucrose for 2 weeks.
[3021] Transformation can be accomplished with either Agrobacterium
of with particle bombardment methods. An expression vector is
created containing a constitutive plant promoter and the cDNA of
the gene in a pUC vector. The plasmid DNA is prepared from E. coli
cells using with Qiagen kit according to manufacturer's
instruction. Approximately 2 g of embryogenic callus is spread in
the center of a sterile filter paper in a Petri dish. An aliquot of
liquid MSO with 10 g/L sucrose is added to the filter paper. Gold
particles (1.0 .mu.m in size) are coated with plasmid DNA according
to method of Sanford et al., 1993 and delivered to the embryogenic
callus with the following parameters: 500 .mu.g particles and 2
.mu.g DNA per shot, 1300 psi and a target distance of 8.5 cm from
stopping plate to plate of callus and 1 shot per plate of
callus.
[3022] After the bombardment, calli are transferred back to the
fresh callus development medium and maintained in the dark at room
temperature for a 1-week period. The callus is then transferred to
growth conditions in the light at 25.degree. C. to initiate embryo
differentiation with the appropriate selection agent, e.g. 250 nM
Arsenal, 5 mg/L PPT or 50 mg/L kanamycin. Shoots resistant to the
selection agent are appearing and once rotted are transferred to
soil.
[3023] Samples of the primary transgenic plants (T0) are analyzed
by PCR to confirm the presence of T-DNA. These results are
confirmed by Southern hybridization in which DNA is electrophoresed
on a 1% agarose gel and transferred to a positively charged nylon
membrane (Roche Diagnostics). The PCR DIG Probe Synthesis Kit
(Roche Diagnostics) is used to prepare a digoxigenin-labelled probe
by PCR, and used as recommended by the manufacturer.
[3024] Transgenic T0 ryegrass plants are propagated vegetatively by
excising tillers. The transplanted tillers are maintained in the
greenhouse for 2 months until well established. The shoots are
defoliated and allowed to grow for 2 weeks.
[3025] T1 or T2 generation plants are produced and are grown under
the respective conditions (low temperature, drought conditions,
N-limited conditions, conditions in the absence of stress as well
as nutrient deficiencies), and for example subjected to experiments
with limited nitrogen supply: Plants receive limited nitrogen
supply by use of a nutrient depleted soil. Nutrients apart from
nitrogen are supplied by a nutrient solution. For NUE assessment
biomass production and/or dry matter production and/or seed yield
is compared to non-transgenic wild type plants. For the other
traits the procedure is adapted accordingly.
EXAMPLE 5
[3026] Engineering soybean plants with increased yield, especially
enhanced stress tolerance, preferably tolerance to low temperature
and/or tolerance to drought conditions, and/or enhanced nutrient
use efficiency, in particular enhanced NUE and/or increased biomass
production by over-expressing NUE related protein (NUERP) encoding
genes from Saccharomyces cerevisiae or E. coli or by
over-expressing NUE related protein (NUERP) encoding genes from for
example Brassica napus, Glycine max, Zea mays or Oryza sativa
[3027] Soybean is transformed according to the following
modification of the method described in the Texas A&M patent
U.S. Pat. No. 5,164,310. Several commercial soybean varieties are
amenable to transformation by this method. The cultivar Jack
(available from the Illinois Seed Foundation) is a commonly used
for transformation. Seeds are sterilized by immersion in 70% (v:v)
ethanol for 6 min and in 25% commercial bleach (NaOCl) supplemented
with 0.1% (v:v) Tween for 20 min, followed by rinsing 4 times with
sterile double distilled water. Seven-day seedlings are propagated
by removing the radicle, hypocotyl and one cotyledon from each
seedling. Then, the epicotyl with one cotyledon is transferred to
fresh germination media in petri dishes and incubated at 25.degree.
C. under a 16-h photoperiod (approx. 100 .mu.E/m.sup.2s) for three
weeks. Axillary nodes (approx. 4 mm in length) were cut from 3-4
week-old plants. Axillary nodes are excised and incubated in
Agrobacterium LBA4404 culture.
[3028] Many different binary vector systems have been described for
plant transformation (e.g. An G., in Agrobacterium Protocols.
Methods in Molecular Biology Vol. 44, p. 47-62, Gartland K.M.A. and
Davey M.R. eds. Humana Press, Totowa, N.J.). Many are based on the
vector pBIN19 described by Bevan (Nucleic Acid Research. 12, 8711
(1984)) that includes a plant gene expression cassette flanked by
the left and right border sequences from the Ti plasmid of
Agrobacterium tumefaciens. A plant gene expression cassette
consists of at least two genes--a selection marker gene and a plant
promoter regulating the transcription of the cDNA or genomic DNA of
the trait gene. Various selection marker genes can be used
including the Arabidopsis gene encoding a mutated acetohydroxy acid
synthase (AHAS) enzyme (U.S. Pat. Nos. 5,7673,666 and 6,225,105).
Similarly, various promoters can be used to regulate the trait gene
to provide constitutive, developmental, tissue or environmental
regulation of gene transcription. In this example, the 34S promoter
(GenBank Accession numbers M59930 and X16673) can be used to
provide constitutive expression of the trait gene.
[3029] After the co-cultivation treatment, the explants are washed
and transferred to selection media supplemented with 500 mg/L
timentin. Shoots are excised and placed on a shoot elongation
medium. Shoots longer than 1 cm are placed on rooting medium for
two to four weeks prior to transplanting to soil.
[3030] The primary transgenic plants (T0) are analyzed by PCR to
confirm the presence of T-DNA. These results are confirmed by
Southern hybridization in which DNA is electrophoresed on a 1
agarose gel and transferred to a positively charged nylon membrane
(Roche Diagnostics). The PCR DIG Probe Synthesis Kit (Roche
Diagnostics) is used to prepare a digoxigenin-labelled probe by
PCR, and used as recommended by the manufacturer.
[3031] Soybean Plants Over-Expressing NUE-Related Genes from
Brassica napus, Glycine Max, Zea Mays or Oryza sativa for Example
have Higher Seed Yields
[3032] T1 or T2 generation plants are produced and are grown under
the respective conditions (low temperature, drought conditions,
N-limited conditions, conditions in the absence of stress as well
as nutrient deficiencies), and for example subjected to experiments
with limited nitrogen supply: Plants receive limited nitrogen
supply by use of a nutrient depleted soil. Nutrients apart from
nitrogen are supplied by a nutrient solution. For NUE assessment
biomass production and/or dry matter production and/or seed yield
is compared to non-transgenic wild type plants. For the other
traits the procedure is adapted accordingly.
EXAMPLE 6
[3033] Engineering Rapeseed/Canola plants with increased yield,
especially enhanced stress tolerance, preferably tolerance to low
temperature and/or tolerance to drought conditions, and/or enhanced
nutrient use efficiency, in particular enhanced NUE and/or
increased biomass production, by over-expressing NUE related
protein (NUERP) encoding genes from Saccharomyces cerevisiae or E.
coli or by over-expressing NUE related protein (NUERP) encoding
genes from for example Brassica napus, Glycine max, Zea mays or
Oryza sativa
[3034] Cotyledonary petioles and hypocotyls of 5-6 day-old young
seedlings are used as explants for tissue culture and transformed
according to Babic et al. (Plant Cell Rep 17, 183 (1998)). The
commercial cultivar Westar (Agriculture Canada) is the standard
variety used for transformation, but other varieties can be
used.
[3035] Agrobacterium tumefaciens LBA4404 containing a binary vector
can be used for canola transformation. Many different binary vector
systems have been described for plant transformation (e.g. An G.,
in Agrobacterium Protocols. Methods in Molecular Biology Vol. 44,
p. 47-62, Gartland K.M.A. and Davey M.R. eds. Humana Press, Totowa,
N.J.). Many are based on the vector pBIN19 described by Bevan
(Nucleic Acid Research. 12, 8711 (1984)) that includes a plant gene
expression cassette flanked by the left and right border sequences
from the Ti plasmid of Agrobacterium tumefaciens. A plant gene
expression cassette consists of at least two genes--a selection
marker gene and a plant promoter regulating the transcription of
the cDNA or genomic DNA of the trait gene. Various selection marker
genes can be used including the Arabidopsis gene encoding a mutated
acetohydroxy acid synthase (AHAS) enzyme (U.S. Pat. Nos. 5,7673,666
and 6,225,105). Similarly, various promoters can be used to
regulate the trait gene to provide constitutive, developmental,
tissue or environmental regulation of gene transcription. In this
example, the 34S promoter (GenBank Accession numbers M59930 and
X16673) can be used to provide constitutive expression of the trait
gene.
[3036] Canola seeds are surface-sterilized in 70% ethanol for 2
min., and then in 30% Clorox with a drop of Tween-20 for 10 min,
followed by three rinses with sterilized distilled water. Seeds are
then germinated in vitro 5 days on half strength MS medium without
hormones, 1% sucrose, 0.7% Phytagar at 23.degree. C., 16 h light.
The cotyledon petiole explants with the cotyledon attached are
excised from the in vitro seedlings, and inoculated with
Agrobacterium by dipping the cut end of the petiole explant into
the bacterial suspension. The explants are then cultured for 2 days
on MSBAP-3 medium containing 3 mg/L BAP, 3% sucrose, 0.7% Phytagar
at 23.degree. C., 16 h light. After two days of co-cultivation with
Agrobacterium, the petiole explants are transferred to MSBAP-3
medium containing 3 mg/L BAP, cefotaxime, carbenicillin, or
timentin (300 mg/L) for 7 days, and then cultured on MSBAP-3 medium
with cefotaxime, carbenicillin, or timentin and selection agent
until shoot regeneration. When the shoots were 5-10 mm in length,
they are cut and transferred to shoot elongation medium (MSBAP-0.5,
containing 0.5 mg/L BAP). Shoots of about 2 cm in length are
transferred to the rooting medium (MSO) for root induction.
[3037] Samples of the primary transgenic plants (T0) are analyzed
by PCR to confirm the presence of T-DNA. These results are
confirmed by Southern hybridization in which DNA is electrophoresed
on a 1 agarose gel and transferred to a positively charged nylon
membrane (Roche Diagnostics). The PCR DIG Probe Synthesis Kit
(Roche Diagnostics) is used to prepare a digoxigenin-labelled probe
by PCR, and used as recommended by the manufacturer.
[3038] The transgenic plants are then evaluated for their enhanced
increased yield, especially enhanced stress tolerance, preferably
tolerance to low temperature and/or tolerance to drought
conditions, and/or enhanced nutrient use efficiency, in particular
NUE and/or increased biomass production, according to the method
described in Example 3. It is found that transgenic rapeseed/canola
over-expressing NUE related protein (NUERP) encoding genes from
Brassica napus, Glycine max, Zea mays or Oryza sativa for example
show an increase in yield, especially enhanced stress tolerance,
preferably tolerance to low temperature and/or tolerance to drought
conditions, and/or enhanced nutrient use efficiency, in particular
enhanced NUE and/or increased biomass production, compared to
non-transgenic control plants.
[3039] T1 or T2 generation plants are produced and are grown under
the respective conditions (low temperature, drought conditions,
N-limited conditions, conditions in the absence of stress as well
as nutrient deficiencies), and for example subjected to experiments
with limited nitrogen supply: Plants receive limited nitrogen
supply by use of a nutrient depleted soil. Nutrients apart from
nitrogen are supplied by a nutrient solution. For NUE assessment
biomass production and/or dry matter production and/or seed yield
is compared to non-transgenic wild type plants. For the other
traits the procedure is adapted accordingly.
EXAMPLE 7
[3040] Engineering corn plants with increased yield, especially
enhanced stress tolerance, preferably tolerance to low temperature
and/or tolerance to drought conditions, and/or enhanced nutrient
use efficiency, in particular enhanced NUE and/or increased biomass
production, by over-expressing NUE related protein (NUERP) encoding
genes from Saccharomyces cerevisiae or E. coli or by
over-expressing NUE related protein (NUERP) encoding genes from for
example Brassica napus, Glycine max, Zea mays or Oryza sativa
[3041] Transformation of maize (Zea Mays L.) is performed with a
modification of the method described by Ishida et al. (Nature
Biotech 14745 (1996)). Transformation is genotype-dependent in corn
and only specific genotypes are amenable to transformation and
regeneration. The inbred line A188 (University of Minnesota) or
hybrids with A188 as a parent are good sources of donor material
for transformation (Fromm et al. Biotech 8, 833 (1990)), but other
genotypes can be used successfully as well. Ears are harvested from
corn plants at approximately 11 days after pollination (DAP) when
the length of immature embryos is about 1 to 1.2 mm. Immature
embryos are co-cultivated with Agrobacterium tumefaciens that carry
"super binary" vectors and transgenic plants are recovered through
organogenesis. The super binary vector system of Japan Tobacco is
described in WO patents WO 94/00977 and WO 95/06722. Vectors were
constructed as described. Various selection marker genes can be
used including the maize gene encoding a mutated acetohydroxy acid
synthase (AHAS) enzyme (U.S. Pat. No. 6,025,541). Similarly,
various promoters can be used to regulate the trait gene to provide
constitutive, developmental, tissue or environmental regulation of
gene transcription. In this example, the 34S promoter (GenBank
Accession numbers M59930 and X16673) was used to provide
constitutive expression of the trait gene.
[3042] Excised embryos are grown on callus induction medium, then
maize regeneration medium, containing an imidazolinone herbicide as
a selection agent. The Petri plates are incubated in the light at
25.degree. C. for 2-3 weeks, or until shoots develop. The green
shoots are transferred from each embryo to maize rooting medium and
incubated at 25.degree. C. for 2-3 weeks, until roots develop. The
rooted shoots are transplanted to soil in the greenhouse. T1 seeds
are produced from plants that exhibit tolerance to the
imidazolinone herbicides and which are PCR positive for the
transgenes.
[3043] The T1 transgenic plants are then evaluated for their
increased yield, especially enhanced stress tolerance, preferably
tolerance to low temperature and/or tolerance to drought
conditions, and/or enhanced nutrient use efficiency, in particular
enhanced NUE and/or increased biomass production, according to the
methods described in Example 3. The T1 generation of single locus
insertions of the T-DNA will segregate for the transgene in a 3:1
ratio (more precisely in a 1:2:1 ratio). Those progeny containing
one or two copies of the transgene are tolerant regarding the
imidazolinone herbicide, and exhibit an increase in yield,
especially enhanced stress tolerance, preferably tolerance to low
temperature and/or tolerance to drought conditions, and/or enhanced
nutrient use efficiency, in particular enhancement of NUE and/or
increased biomass production, than those progeny lacking the
transgenes.
[3044] T1 or T2 generation plants are produced and are grown under
the respective conditions (low temperature, drought conditions,
N-limited conditions, conditions in the absence of stress as well
as nutrient deficiencies), and for example subjected to experiments
with limited nitrogen supply: Plants receive limited nitrogen
supply by use of a nutrient depleted soil. Nutrients apart from
nitrogen are supplied by a nutrient solution. For NUE assessment
biomass production and/or dry matter production and/or seed yield
is compared to non-transgenic wild type plants. For the other
traits the procedure is adapted accordingly. Homozygous T2 plants
exhibited similar phenotypes. Hybrid plants (F1 progeny) of
homozygous transgenic plants and non-transgenic plants also
exhibited an increase in yield, especially enhanced stress
tolerance, preferably tolerance to low temperature and/or tolerance
to drought conditions, and/or enhanced nutrient use efficiency, in
particular enhanced NUE efficiency.
EXAMPLE 8
[3045] Engineering wheat plants with increased yield, especially
enhanced stress tolerance, preferably tolerance to low temperature
and/or tolerance to drought conditions, and/or enhanced nutrient
use efficiency, in particular enhanced NUE and/or increased biomass
production, by over-expressing NUE related protein (NUERP) encoding
genes from Saccharomyces cerevisiae or E. coli or by
over-expressing NUE related protein (NUERP) encoding genes from for
example Brassica napus, Glycine max, Zea mays or Oryza sativa for
example
[3046] Transformation of wheat is performed with the method
described by Ishida et al. (Nature Biotech. 14745 (1996)). The
cultivar Bobwhite (available from CYMMIT, Mexico) is commonly used
in transformation. Immature embryos are co-cultivated with
Agrobacterium tumefaciens that carry "super binary" vectors, and
transgenic plants are recovered through organogenesis. The super
binary vector system of Japan Tobacco is described in WO patents WO
94/00977 and WO 95/06722. Vectors were constructed as described.
Various selection marker genes can be used including the maize gene
encoding a mutated acetohydroxy acid synthase (AHAS) enzyme (U.S.
Pat. No. 6,025,541). Similarly, various promoters can be used to
regulate the trait gene to provide constitutive, developmental,
tissue or environmental regulation of gene transcription. In this
example, the 34S promoter (GenBank Accession numbers M59930 and
X16673) was used to provide constitutive expression of the trait
gene.
[3047] After incubation with Agrobacterium, the embryos are grown
on callus induction medium, then regeneration medium, containing an
imidazolinone herbicide as a selection agent. The Petri plates are
incubated in the light at 25.degree. C. for 2-3 weeks, or until
shoots develop. The green shoots are transferred from each embryo
to rooting medium and incubated at 25.degree. C. for 2-3 weeks,
until roots develop. The rooted shoots are transplanted to soil in
the greenhouse. T1 seeds are produced from plants that exhibit
tolerance to the imidazolinone herbicides and which are PCR
positive for the transgenes.
[3048] The T1 transgenic plants are then evaluated for their
increased yield, especially enhanced stress tolerance, preferably
tolerance to low temperature and/or tolerance to drought
conditions, and/or enhanced nutrient use efficiency, in particular
enhanced NUE and/or increased biomass production, according to the
method described in the previous example 2. The T1 generation of
single locus insertions of the T-DNA will segregate for the
transgene in a 3:1 ratio (more precisely in a 1:2:1 ratio). Those
progeny containing one or two copies of the transgene are tolerant
regarding the imidazolinone herbicide, and exhibit an increase in
yield, especially enhanced stress tolerance, preferably tolerance
to low temperature and/or tolerance to drought conditions, and/or
enhanced nutrient use efficiency, in particular an enhanced NUE
and/or increased biomass production, than those progeny lacking the
transgenes. Homozygous T2 plants exhibited similar phenotypes.
Plants with an increase in yield, especially enhanced stress
tolerance, preferably tolerance to low temperature and/or tolerance
to drought conditions, and/or enhanced nutrient use efficiency, in
particular NUE, have increased biomass production and/or dry matter
production and/or seed yield under the respective conditions, like
low temperature, drought conditions, limited nitrogen supply when
compared to non-transgenic wild type plants. Also plants with
higher yield, in the absence of stress conditions as well as in the
absence of nutrient deficiencies, have increased biomass production
and/or dry matter production and/or seed yield under the respective
conditions.
EXAMPLE 9
Identification of Identical and Heterologous Genes
[3049] Gene sequences can be used to identify identical or
heterologous genes from cDNA or genomic libraries. Identical genes
(e.g. full-length cDNA clones) can be isolated via nucleic acid
hybridization using for example cDNA libraries. Depending on the
abundance of the gene of interest, 100,000 up to 1,000,000
recombinant bacteriophages are plated and transferred to nylon
membranes. After denaturation with alkali, DNA is immobilized on
the membrane by e.g. UV cross linking. Hybridization is carried out
at high stringency conditions. In aqueous solution, hybridization
and washing is performed at an ionic strength of 1 M NaCl and a
temperature of 68.degree. C. Hybridization probes are generated by
e.g. radioactive (.sup.32P) nick transcription labeling (High
Prime, Roche, Mannheim, Germany). Signals are detected by
autoradiography.
[3050] Partially identical or heterologous genes that are related
but not identical can be identified in a manner analogous to the
above-described procedure using low stringency hybridization and
washing conditions. For aqueous hybridization, the ionic strength
is normally kept at 1 M NaCl while the temperature is progressively
lowered from 68 to 42.degree. C.
[3051] Isolation of gene sequences with homology (or sequence
identity/similarity) only in a distinct domain of (for example
10-20 amino acids) can be carried out by using synthetic radio
labeled oligonucleotide probes. Radiolabeled oligonucleotides are
prepared by phosphorylation of the 5-prime end of two complementary
oligonucleotides with T4 polynucleotide kinase. The complementary
oligonucleotides are annealed and ligated to form concatemers. The
double stranded concatemers are than radiolabeled by, for example,
nick transcription. Hybridization is normally performed at low
stringency conditions using high oligonucleotide
concentrations.
[3052] Oligonucleotide Hybridization Solution:
[3053] 6.times.SSC
[3054] 0.01 M sodium phosphate
[3055] 1 mM EDTA (pH 8)
[3056] 0.5% SDS
[3057] 100 .mu.g/mL denatured salmon sperm DNA
[3058] 0.1% nonfat dried milk
[3059] During hybridization, temperature is lowered stepwise to
5-10.degree. C. below the estimated oligonucleotide T.sub.m or down
to room temperature followed by washing steps and autoradiography.
Washing is performed with low stringency such as 3 washing steps
using 4.times.SSC. Further details are described by Sambrook J. et
al., 1989, "Molecular Cloning: A Laboratory Manual," Cold Spring
Harbor Laboratory Press or Ausubel F. M. et al., 1994, "Current
Protocols in Molecular Biology," John Wiley & Sons.
EXAMPLE 10
Identification of Identical Genes by Screening Expression Libraries
with Antibodies
[3060] c-DNA clones can be used to produce recombinant polypeptide
for example in E. coli (e.g. Qiagen QIAexpress pQE system).
Recombinant polypeptides are then normally affinity purified via
Ni-NTA affinity chromatography (Qiagen). Recombinant polypeptides
are then used to produce specific antibodies for example by using
standard techniques for rabbit immunization. Antibodies are
affinity purified using a Ni-NTA column saturated with the
recombinant antigen as described by Gu et al., BioTechniques 17,
257 (1994). The antibody can than be used to screen expression cDNA
libraries to identify identical or heterologous genes via an
immunological screening (Sambrook, J. et al., 1989, "Molecular
Cloning: A Laboratory Manual," Cold Spring Harbor Laboratory Press
or Ausubel, F. M. et al., 1994, "Current Protocols in Molecular
Biology", John Wiley & Sons).
EXAMPLE 11
In Vivo Mutagenesis
[3061] In vivo mutagenesis of microorganisms can be performed by
passage of plasmid (or other vector) DNA through E. coli or other
microorganisms (e.g. Bacillus spp. or yeasts such as Saccharomyces
cerevisiae) which are impaired in their capabilities to maintain
the integrity of their genetic information. Typical mutator strains
have mutations in the genes for the DNA repair system (e.g.,
mutHLS, mutD, mutT, etc.; for reference, see Rupp W.D., DNA repair
mechanisms, in: Escherichia coif and Salmonella, p. 2277-2294, ASM,
1996, Washington.) Such strains are well known to those skilled in
the art. The use of such strains is illustrated, for example, in
Greener A. and Callahan M., Strategies 7, 32 (1994). Transfer of
mutated DNA molecules into plants is preferably done after
selection and testing in microorganisms. Transgenic plants are
generated according to various examples within the exemplification
of this document.
EXAMPLE 12
[3062] Engineering Arabidopsis plants with increased yield,
especially enhanced stress tolerance, preferably tolerance to low
temperature and/or tolerance to drought conditions, and/or enhanced
nutrient use efficiency, in particular enhanced NUE and/or
increased biomass production, by over-expressing NUERP encoding
genes for example from Brassica Napus, Glycine Max, Zea Mays or
Oryza sativa using tissue-specific promoters.
[3063] Transgenic Arabidopsis plants over-expressing NUE related
protein (NUERP) encoding genes from Brassica napus, Glycine max,
Zea mays and Oryza sativa for example are created as described in
example 1 to express the NUE related protein (NUERP) encoding
transgenes under the control of a tissue-specific promoter. T2
generation plants are produced and grown under N-limited
conditions. Plants with an increase in yield, especially enhanced
stress tolerance, preferably tolerance to low temperature and/or
tolerance to drought conditions, and/or enhanced nutrient use
efficiency, in particular NUE, have increased biomass production
and/or dry matter production and/or seed yield under the respective
conditions, like low temperature, drought conditions, limited
nitrogen supply when compared to non-transgenic wild type plants.
Also plants with higher yield, in the absence of stress conditions
as well as in the absence of nutrient deficiencies, have increased
biomass production and/or dry matter production and/or seed yield
under the respective conditions.
EXAMPLE 13
[3064] Engineering rice plants with increased yield, especially
enhanced stress tolerance, preferably tolerance to low temperature
and/or tolerance to drought conditions, and/or enhanced nutrient
use efficiency, in particular enhanced NUE and/or increased biomass
production, by over-expressing NUE related protein (NUERP) encoding
genes from Saccharomyces cerevisiae or E. coli or by
over-expressing NUE related protein (NUERP) encoding genes from for
example Brassica napus, Glycine max, Zea mays or Oryza sativa
[3065] The Agrobacterium containing the expression vector of the
invention is used to transform Oryza sativa plants. Mature dry
seeds of the rice japonica cultivar Nipponbare are dehusked.
Sterilization is carried out by incubating for one minute in 70%
ethanol, followed by 30 minutes in 0.2% HgCl.sub.2, followed by a 6
times 15 minutes wash with sterile distilled water. The sterile
seeds are then germinated on a medium containing 2,4-D (callus
induction medium). After incubation in the dark for four weeks,
embryogenic, scutellum-derived calli are excised and propagated on
the same medium. After two weeks, the calli are multiplied or
propagated by subculture on the same medium for another 2 weeks.
Embryogenic callus pieces are sub-cultured on fresh medium 3 days
before co-cultivation (to boost cell division activity).
[3066] Agrobacterium strain LBA4404 containing the expression
vector of the invention is used for co-cultivation. Agrobacterium
is inoculated on AB medium with the appropriate antibiotics and
cultured for 3 days at 28.degree. C. The bacteria are then
collected and suspended in liquid co-cultivation medium to a
density (OD600) of about 1. The suspension is then transferred to a
Petri dish and the calli immersed in the suspension for 15 minutes.
The callus tissues are then blotted dry on a filter paper and
transferred to solidified, co-cultivation medium and incubated for
3 days in the dark at 25.degree. C. Co-cultivated calli are grown
on 2,4-D-containing medium for 4 weeks in the dark at 28.degree. C.
in the presence of a selection agent. During this period, rapidly
growing resistant callus islands developed. After transfer of this
material to a regeneration medium and incubation in the light, the
embryogenic potential is released and shoots developed in the next
four to five weeks. Shoots are excised from the calli and incubated
for 2 to 3 weeks on an auxin-containing medium from which they are
transferred to soil. Hardened shoots are grown under high humidity
and short days in a greenhouse.
[3067] Approximately 35 independent T0 rice transformants are
generated for one construct. The primary transformants are
transferred from a tissue culture chamber to a greenhouse. After a
quantitative PCR analysis to verify copy number of the T-DNA
insert, only single copy transgenic plants that exhibit tolerance
to the selection agent are kept for harvest of T1 seed. Seeds are
then harvested three to five months after transplanting. The method
yielded single locus transformants at a rate of over 50% (Aldemita
and Hodges 1996, Chan et al. 1993, Hiei et al. 1994).
[3068] For the cycling drought assay repetitive stress is applied
to plants without leading to desiccation. The water supply
throughout the experiment is limited and plants are subjected to
cycles of drought and re-watering. For measuring biomass
production, plant fresh weight is determined one day after the
final watering by cutting shoots and weighing them. At an
equivalent degree of drought stress, tolerant plants are able to
resume normal growth whereas susceptible plants have died or suffer
significant injury resulting in shorter leaves and less dry
matter.
[3069] For testing the other traits according to the present
invention the procedure is adapted accordingly.
FIGURES
[3070] FIG. 1a Vector VC-MME220-1 SEQ ID NO 1 used for cloning gene
of interest for non-targeted expression.
[3071] FIG. 1b Vector VC-MME220-1 qcz SEQ ID NO 14389 used for
cloning gene of interest for non-targeted expression.
[3072] FIG. 2a Vector VC-MME221-1 SEQ ID NO: 2 used for cloning
gene of interest for non-targeted expression.
[3073] FIG. 2b Vector VC-MME221-1qcz SEQ ID NO 14390 used for
cloning gene of interest for non-targeted expression.
[3074] FIG. 3a Vector VC-MME354-1 SEQ ID NO: 3 used for cloning
gene of interest for targeted expression.
[3075] FIG. 3b Vector VC-MME354-1 QCZ SEQ ID NO 14391 used for
cloning gene of interest for targeted expression.
[3076] FIG. 4a Vector VC-MME432-1 SEQ ID NO: 5 used for cloning
gene of interest for targeted expression.
[3077] FIG. 4b Vector VC-MME432-1qcz SEQ ID NO 14393 used for
cloning gene of interest for targeted expression.
[3078] FIG. 5a Vector VC-MME489-1p SEQ ID NO 15 used for cloning
gene of interest for non-targeted expression and cloning of a
targeting sequence.
[3079] FIG. 5b Vector VC-MME489-1QCZ SEQ ID NO 14395 used for
cloning gene of interest for non-targeted expression and cloning of
a targeting sequence.
[3080] FIG. 6 Vector pMTX0270p SEQ ID NO: 16 used for cloning of a
targeting sequence.
[3081] In the sequence listing the so-called numeric identifier
<223> refers some times to "transl_table=11". This is a
reference to rules of translation of the coding sequences mentioned
in "the Genetic Code" Item 11 "The Bacterial and Plant tissue Code
(transl_table=11)" by
ncbi.nlm.nih.gov/Taxonomy/Utils/wprintgc.cgi.
TABLE-US-00013 TABLE IA Nucleic acid sequence ID numbers Ap- 5.
pli- Lead ca- 1. 2. 3. 4. SEQ 6. 7. tion Hit Project Locus Organism
ID Target SEQ IDs of Nucleic Acid Homologs 1 1 NUE_OEX_1 B0017 E.
coli 38 Cytoplasmic -- 1 2 NUE_OEX_1 B0045 E. coli 42 Cytoplasmic
44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76,
78, 80, 82, 84, 86, 88, 90, 92, 94, 96 1 3 NUE_OEX_1 B0180 E. coli
123 Plastidic 125, 127, 129, 131, 133, 135, 137, 139, 141, 143,
145, 147, 149, 151, 153, 155, 157, 159, 161, 163, 165, 167, 169,
171, 173, 175, 177, 179, 181, 183, 185, 187, 189, 191, 193, 195,
197, 199, 201, 203, 205, 207, 209, 211, 213, 215, 217, 219, 221,
223, 225, 227, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247,
249, 251, 253, 255, 257, 259, 261, 263, 265, 267, 269, 271, 273,
275, 277, 279, 281, 283, 285, 287, 289, 291, 293, 295, 297, 299,
301, 303, 305, 307, 309, 311, 313, 315, 317, 319, 321, 323, 325,
327, 329, 331, 333, 335, 337, 339, 341, 343, 345, 347, 349, 351,
353, 355, 357, 359, 361, 363 1 4 NUE_OEX_1 B0242 E. coli 380
Plastidic 382, 384, 386, 388, 390, 392, 394, 396, 398, 400, 402,
404, 406, 408, 410, 412, 414, 416, 418, 420, 422, 424, 426, 428,
430, 432, 434, 436, 438, 440, 442, 444, 446, 448, 450, 452, 454,
456, 458, 460, 462, 464, 466, 468, 470, 472, 474, 476, 478, 480,
482, 484, 486, 488, 490, 492, 494, 496, 498, 500, 502, 504, 506,
508, 510, 512, 514, 516, 518, 520, 522, 524, 526, 528, 530, 532,
534, 536, 538, 540, 542, 544, 546, 548, 550, 552, 554, 556, 558,
560, 562, 564, 566, 568, 570, 572, 574, 576, 578, 580, 582, 584,
586, 588, 590, 592, 594, 596, 598, 600, 602, 604, 606, 608, 610,
612, 614, 616, 618, 620, 622, 624, 626, 628, 630, 632, 634, 636,
638, 640, 642, 644, 646, 648, 650, 652, 654, 656, 658, 660 1 5
NUE_OEX_1 B0403 E. coli 679 Plastidic 681, 683, 685, 687, 689, 691,
693, 695, 697, 699, 701, 703, 705, 707, 709, 711, 713, 715, 717,
719, 721, 723, 725, 727, 729, 731, 733, 735, 737, 739, 741, 743,
745, 747, 749, 751, 753, 755, 757, 759, 761, 763, 765, 767, 769,
771, 773, 775, 777, 779, 781, 783, 785, 787, 789, 791, 793, 795,
797, 799 1 6 NUE_OEX_1 B0474 E. coli 812 Cytoplasmic 814, 816, 818,
820, 822, 824, 826, 828, 830, 832, 834, 836, 838, 840, 842, 844,
846, 848, 850, 852, 854, 856, 858, 860, 862, 864, 866, 868, 870,
872, 874, 876, 878, 880, 882, 884, 886, 888, 890, 892, 894, 896,
898, 900, 902, 904, 906, 908, 910, 912, 914, 916, 918, 920, 922,
924, 926, 928, 930, 932, 934, 936, 938, 940, 942, 944, 946, 948,
950, 952, 954, 956 1 7 NUE_OEX_1 B0754 E. coli 1055 Plastidic 1057,
1059, 1061, 1063, 1065, 1067, 1069, 1071, 1073, 1075, 1077, 1079,
1081, 1083, 1085, 1087, 1089, 1091, 1093, 1095, 1097, 1099, 1101,
1103, 1105, 1107, 1109, 1111, 1113, 1115, 1117, 1119, 1121, 1123,
1125, 1127, 1129, 1131, 1133, 1135, 1137, 1139, 1141, 1143, 1145,
1147, 1149, 1151, 1153, 1155, 1157, 1159, 1161, 1163, 1165, 1167,
1169, 1171, 1173, 1175, 1177, 1179, 1181, 1183, 1185, 1187, 1189,
1191, 1193, 1195, 1197, 1199, 1201, 1203, 1205, 1207, 1209, 1211,
1213, 1215, 1217, 1219, 1221, 1223, 1225, 1227, 1229, 1231, 1233,
1235, 1237, 1239, 1241, 1243, 1245, 1247, 1249, 1251, 1253, 1255,
1257, 1259, 1261, 1263, 1265, 1267, 1269, 1271, 1273, 1275, 1277,
1279, 1281, 1283, 1285, 1287, 1289, 1291, 1293, 1295, 1297, 1299,
1301, 1303, 1305, 1307, 1309, 1311, 1313, 1315, 1317, 1319, 1321,
1323, 1325, 1327, 1329, 1331, 1333, 1335, 1337, 1339, 1341, 1343,
1345, 1347, 1349, 1351, 1353, 1355, 1357, 1359, 1361, 1363, 1365,
1367, 1369, 1371, 1373, 1375, 1377, 1379, 1381, 1383, 1385, 1387,
1389, 1391, 1393, 1395, 1397, 1399, 1401, 1403, 1405, 1407, 1409,
1411, 1413, 1415, 1417, 1419, 1421, 1423, 1425, 1427, 1429, 1431,
1433, 1435, 1437, 1439, 1441, 1443, 1445, 1447, 1449, 1451, 1453,
1455, 1457, 1459, 1461, 1463, 1465, 1467, 1469, 1471, 1473, 1475,
1477, 1479, 1481, 1483, 1485, 1487, 1489, 1491, 1493, 1495, 1497,
1499, 1501, 1503, 1505, 1507, 1509, 1511, 1513, 1515, 1517, 1519,
1521, 1523, 1525, 1527, 1529, 1531, 1533, 1535, 1537, 1539, 1541,
1543, 1545, 1547, 1549 1 8 NUE_OEX_1 B0784 E. coli 1563 Cytoplasmic
1565, 1567, 1569, 1571, 1573, 1575, 1577, 1579, 1581, 1583, 1585,
1587, 1589, 1591, 1593, 1595, 1597, 1599, 1601, 1603, 1605, 1607,
1609, 1611, 1613, 1615, 1617, 1619, 1621, 1623, 1625, 1627, 1629,
1631, 1633, 1635, 1637, 1639, 1641, 1643, 1645, 1647, 1649, 1651,
1653, 1655, 1657, 1659, 1661, 1663, 1665, 1667, 1669, 1671, 1673,
1675, 1677, 1679, 1681, 1683, 1685, 1687, 1689, 1691, 1693, 1695,
1697, 1699 1 9 NUE_OEX_1 B0873 E. coli 1705 Plastidic 1707, 1709,
1711, 1713, 1715, 1717, 1719, 1721, 1723, 1725, 1727, 1729, 1731,
1733, 1735, 1737, 1739, 1741, 1743, 1745, 1747, 1749, 1751, 1753,
1755, 1757, 1759, 1761, 1763, 1765, 1767, 1769, 1771, 1773, 1775,
1777, 1779, 1781, 1783, 1785, 1787, 1789, 1791, 1793, 1795, 1797,
1799, 1801, 1803, 1805, 1807, 1809, 1811, 1813, 1815, 1817, 1819,
1821, 1823, 1825, 1827, 1829 1 10 NUE_OEX_1 B1014 E. coli 1844
Cytoplasmic 1846, 1848, 1850, 1852, 1854, 1856, 1858, 1860, 1862,
1864, 1866, 1868, 1870, 1872, 1874, 1876, 1878, 1880, 1882, 1884,
1886, 1888, 1890, 1892, 1894, 1896, 1898, 1900, 1902, 1904, 1906,
1908, 1910, 1912, 1914, 1916, 1918, 1920, 1922, 1924, 1926, 1928,
1930 1 11 NUE_OEX_1 B1020 E. coli 1950 Plastidic 1952, 1954, 1956,
1958, 1960, 1962, 1964 1 12 NUE_OEX_1 B1180 E. coli 1975
Cytoplasmic 1977, 1979, 1981, 1983, 1985, 1987, 1989, 1991, 1993,
1995, 1997, 1999, 2001, 2003, 2005, 2007, 2009, 2011, 2013, 2015,
2017, 2019, 2021, 2023, 2025, 2027, 2029, 2031, 2033, 2035, 2037,
2039, 2041, 2043, 2045, 2047, 2049, 2051, 2053, 2055, 2057, 2059,
2061, 2063, 2065, 2067, 2069, 2071, 2073, 2075, 2077, 2079, 2081,
2083, 2085, 2087, 2089, 2091, 2093, 2095, 2097 1 13 NUE_OEX_1 B1933
E. coli 2127 Plastidic 2129, 2131 1 14 NUE_OEX_1 B2032 E. coli 2135
Plastidic 2137, 2139, 2141, 2143, 2145, 2147, 2149, 2151, 2153,
2155, 2157, 2159, 2161, 2163, 2165 1 15 NUE_OEX_1 B2165 E. coli
2171 Plastidic 2173, 2175, 2177, 2179, 2181, 2183, 2185, 2187,
2189, 2191, 2193, 2195, 2197, 2199, 2201, 2203, 2205, 2207, 2209,
2211, 2213, 2215, 2217, 2219, 2221, 2223, 2225, 2227, 2229, 2231,
2233, 2235, 2237, 2239, 2241, 2243, 2245, 2247, 2249, 2251, 2253,
2255, 2257, 2259, 2261, 2263, 2265, 2267, 2269, 2271, 2273, 2275,
2277, 2279, 2281, 2283 1 16 NUE_OEX_1 B2223 E. coli 2297 Plastidic
2299, 2301, 2303, 2305, 2307, 2309, 2311, 2313, 2315, 2317, 2319,
2321, 2323, 2325, 2327, 2329, 2331, 2333, 2335, 2337, 2339, 2341,
2343, 2345, 2347, 2349, 2351, 2353, 2355, 2357, 2359, 2361, 2363,
2365, 2367, 2369, 2371, 2373, 2375, 2377, 2379, 2381, 2383, 2385,
2387, 2389, 2391, 2393, 2395, 2397, 2399, 2401, 2403, 2405, 2407,
2409, 2411, 2413, 2415, 2417 1 17 NUE_OEX_1 B2238 E. coli 2426
Plastidic 2428, 2430, 2432, 2434, 2436, 2438, 2440, 2442 1 17
NUE_OEX_1 B2238 E. coli 2426 Cytoplasmic 2428, 2430, 2432, 2434,
2436, 2438, 2440, 2442 1 18 NUE_OEX_1 B2310 E. coli 2452 Plastidic
2454, 2456, 2458, 2460, 2462, 2464, 2466, 2468, 2470, 2472, 2474,
2476, 2478, 2480, 2482, 2484, 2486, 2488, 2490, 2492, 2494, 2496,
2498, 2500, 2502, 2504, 2506, 2508, 2510, 2512, 2514, 2516, 2518,
2520, 2522, 2524, 2526, 2528, 2530, 2532, 2534, 2536, 2538, 2540,
2542 1 19 NUE_OEX_1 B2431 E. coli 2551 Plastidic 2553, 2555, 2557,
2559, 2561, 2563, 2565, 2567, 2569, 2571, 2573, 2575, 2577, 2579,
2581, 2583, 2585, 2587, 2589 1 20 NUE_OEX_1 B2600 E. coli 2600
Plastidic 2602, 2604, 2606, 2608, 2610, 2612, 2614, 2616, 2618,
2620, 2622, 2624, 2626, 2628, 2630, 2632, 2634, 2636, 2638, 2640,
2642, 2644, 2646, 2648, 2650, 2652, 2654, 2656 1 21 NUE_OEX_1 B2766
E. coli 2668 Plastidic 2670, 2672, 2674, 2676, 2678, 2680, 2682,
2684, 2686, 2688, 2690, 2692, 2694, 2696, 2698, 2700, 2702, 2704,
2706, 2708, 2710, 2712, 2714, 2716, 2718, 2720, 2722, 2724, 2726,
2728, 2730, 2732, 2734, 2736, 2738, 2740, 2742, 2744, 2746, 2748,
2750, 2752, 2754, 2756, 2758, 2760, 2762, 2764 1 22 NUE_OEX_1 B2903
E. coli 2772 Cytoplasmic 2774, 2776, 2778, 2780, 2782, 2784, 2786,
2788, 2790, 2792, 2794, 2796, 2798, 2800, 2802, 2804, 2806, 2808,
2810, 2812, 2814, 2816, 2818, 2820, 2822, 2824, 2826, 2828, 2830,
2832, 2834, 2836, 2838, 2840, 2842, 2844, 2846, 2848, 2850, 2852,
2854, 2856, 2858, 2860, 2862, 2864, 2866, 2868, 2870, 2872, 2874,
2876, 2878, 2880, 2882, 2884, 2886, 2888, 2890, 2892, 2894, 2896,
2898, 2900, 2902, 2904, 2906, 2908, 2910, 2912, 2914, 2916, 2918,
2920, 2922, 2924, 2926, 2928, 2930, 2932, 2934, 2936, 2938, 2940,
2942, 2944, 2946, 2948, 2950, 2952, 2954, 2956, 2958, 2960, 2962,
2964, 2966, 2968, 2970, 2972, 2974, 2976, 2978, 2980, 2982, 2984,
2986, 2988, 2990, 2992, 2994, 2996, 2998, 3000, 3002, 3004, 3006,
3008, 3010, 3012, 3014, 3016, 3018, 3020, 3022, 3024, 3026, 3028,
3030, 3032, 3034, 3036, 3038, 3040, 3042, 3044, 3046, 3048, 3050,
3052, 3054, 3056, 3058, 3060, 3062, 3064, 3066, 3068, 3070, 3072,
3074, 3076, 3078, 3080, 3082, 3084, 3086, 3088, 3090, 3092, 3094 1
23 NUE_OEX_1 B3117 E. coli 3117 Plastidic 3119, 3121, 3123, 3125,
3127, 3129, 3131, 3133, 3135, 3137, 3139, 3141, 3143, 3145, 3147,
3149, 3151, 3153, 3155, 3157, 3159, 3161, 3163, 3165, 3167, 3169,
3171, 3173, 3175, 3177, 3179, 3181, 3183, 3185, 3187, 3189, 3191,
3193, 3195, 3197, 3199, 3201, 3203, 3205, 3207, 3209, 3211, 3213,
3215, 3217, 3219, 3221, 3223, 3225, 3227, 3229, 3231, 3233, 3235,
3237, 3239, 3241, 3243, 3245, 3247, 3249, 3251, 3253, 3255, 3257,
3259, 3261, 3263, 3265, 3267, 3269, 3271, 3273, 3275, 3277, 3279,
3281, 3283, 3285, 3287, 3289, 3291, 3293, 3295, 3297, 3299, 3301,
3303, 3305, 3307, 3309, 3311, 3313, 3315, 3317, 3319, 3321, 3323,
3325, 3327, 3329, 3331, 3333, 3335, 3337, 3339, 3341, 3343, 3345,
3347, 3349, 3351, 3353, 3355, 3357, 3359, 3361, 3363, 3365, 3367,
3369, 3371 1 24 NUE_OEX_1 B3120 E. coli 3390 Plastidic 3392 1 25
NUE_OEX_1 B3216 E. coli 3396 Plastidic 3398, 3400, 3402, 3404,
3406, 3408, 3410, 3412, 3414, 3416, 3418, 3420, 3422, 3424, 3426,
3428, 3430, 3432, 3434, 3436, 3438, 3440, 3442, 3444, 3446, 3448,
3450, 3452, 3454, 3456, 3458, 3460, 3462, 3464 1 26 NUE_OEX_1 B3451
E. coli 3470 Plastidic 3472, 3474, 3476, 3478, 3480, 3482, 3484,
3486, 3488, 3490, 3492, 3494, 3496, 3498, 3500, 3502, 3504, 3506,
3508, 3510, 3512, 3514, 3516, 3518, 3520, 3522, 3524, 3526, 3528,
3530, 3532, 3534, 3536, 3538, 3540, 3542, 3544, 3546, 3548, 3550,
3552, 3554 1 27 NUE_OEX_1 B3791 E. coli 3563 Cytoplasmic 3565,
3567, 3569, 3571, 3573, 3575, 3577, 3579, 3581, 3583, 3585, 3587,
3589, 3591, 3593, 3595, 3597, 3599, 3601, 3603, 3605, 3607, 3609,
3611, 3613, 3615, 3617, 3619, 3621, 3623, 3625, 3627, 3629, 3631,
3633, 3635, 3637, 3639, 3641, 3643, 3645, 3647, 3649, 3651, 3653,
3655, 3657, 3659, 3661, 3663, 3665, 3667, 3669, 3671, 3673, 3675,
3677, 3679, 3681, 3683, 3685, 3687, 3689, 3691, 3693, 3695, 3697,
3699, 3701, 3703, 3705, 3707, 3709, 3711, 3713, 3715, 3717, 3719,
3721, 3723, 3725, 3727, 3729, 3731, 3733, 3735, 3737, 3739, 3741,
3743, 3745, 3747, 3749, 3751, 3753, 3755, 3757, 3759, 3761, 3763 1
28 NUE_OEX_1 B3825 E. coli 3770* Plastidic 3772, 3774, 3776, 3778,
3780, 3782, 3784, 3786, 3788, 3790, 3792, 3794, 3796, 3798, 3800,
3802, 3804, 3806, 3808, 3810, 3812, 3814, 3816, 3818, 3820, 3822,
3824, 3826, 3828, 3830, 3832, 3834, 3836, 3838, 3840, 3842, 3844,
3846, 3848, 3850, 3852, 3854, 3856, 3858, 3860, 3862 1 29 NUE_OEX_1
YAL019W S. cerevisiae 3868 Cytoplasmic 3870, 3872, 3874, 3876 1 30
NUE_OEX_1 YAR035W S. cerevisiae 3895 Cytoplasmic 3897, 3899, 3901,
3903, 3905, 3907, 3909, 3911, 3913, 3915, 3917, 3919, 3921, 3923,
3925, 3927, 3929, 3931, 3933, 3935, 3937, 3939 1 31 NUE_OEX_1
YBL021C S. cerevisiae 3953 Cytoplasmic 3955, 3957, 3959, 3961,
3963, 3965, 3967, 3969, 3971, 3973, 3975, 3977, 3979, 3981, 3983,
3985, 3987, 3989, 3991, 3993, 3995, 3997, 3999, 4001, 4003, 4005,
4007, 4009, 4011, 4013, 4015, 4017, 4019, 4021, 4023, 4025, 4027,
4029 1 32 NUE_OEX_1 YBR055C S. cerevisiae 4111 Cytoplasmic 4113,
4115, 4117, 4119, 4121, 4123, 4125, 4127, 4129, 4131, 4133, 4135,
4137, 4139 1 33 NUE_OEX_1 YBR128C S. cerevisiae 4149 Cytoplasmic
4151, 4153, 4155 1 34 NUE_OEX_1 YBR159W S. cerevisiae 4162
Cytoplasmic 4164, 4166, 4168, 4170, 4172, 4174, 4176, 4178, 4180,
4182, 4184, 4186, 4188, 4190, 4192, 4194, 4196, 4198, 4200, 4202,
4204, 4206, 4208, 4210, 4212 1 35 NUE_OEX_1 YBR243C S. cerevisiae
4235 Cytoplasmic 4237, 4239, 4241, 4243, 4245, 4247, 4249, 4251,
4253, 4255, 4257, 4259, 4261, 4263, 4265 1 35 NUE_OEX_1 YBR243C S.
cerevisiae 4235 Plastidic 4237, 4239, 4241, 4243, 4245, 4247, 4249,
4251, 4253, 4255, 4257, 4259, 4261, 4263, 4265 1 36 NUE_OEX_1
YBR262C S. cerevisiae 4280 Cytoplasmic 4282, 4284 1 37 NUE_OEX_1
YCR019W S. cerevisiae 4288 Cytoplasmic 4290, 4292, 4294, 4296,
4298, 4300, 4302, 4304 1 38 NUE_OEX_1 YDR070C S. cerevisiae 4315
Cytoplasmic 4317, 4319 1 39 NUE_OEX_1 YDR079W S. cerevisiae 4325
Cytoplasmic 4327, 4329 1 40 NUE_OEX_1 YDR123C S. cerevisiae 4335
Cytoplasmic 4337, 4339 1 41 NUE_OEX_1 YDR137W S. cerevisiae 4346
Cytoplasmic 4348, 4350 1 42 NUE_OEX_1 YDR294C S. cerevisiae 4361
Cytoplasmic 4363, 4365, 4367, 4369, 4371, 4373, 4375, 4377, 4379,
4381, 4383, 4385, 4387, 4389 1 42 NUE_OEX_1 YDR294C S. cerevisiae
4361 Plastidic 4363, 4365, 4367, 4369, 4371, 4373, 4375, 4377,
4379, 4381, 4383, 4385, 4387, 4389 1 43 NUE_OEX_1 YDR330W S.
cerevisiae 4402 Cytoplasmic 4404, 4406, 4408, 4410, 4412, 4414,
4416, 4418, 4420, 4422
1 44 NUE_OEX_1 YDR355C S. cerevisiae 4431 Cytoplasmic -- 1 45
NUE_OEX_1 YDR430C S. cerevisiae 4435 Plastidic 4437, 4439, 4441,
4443, 4445, 4447, 4449, 4451, 4453, 4455, 4457, 4459, 4461, 4463,
4465, 4467 1 46 NUE_OEX_1 YDR472W S. cerevisiae 4485 Cytoplasmic
4487, 4489, 4491, 4493, 4495 1 47 NUE_OEX_1 YDR497C S. cerevisiae
4506 Plastidic 4508, 4510, 4512, 4514, 4516, 4518, 4520, 4522,
4524, 4526, 4528, 4530, 4532, 4534, 4536, 4538, 4540, 4542, 4544,
4546, 4548, 4550, 4552, 4554, 4556, 4558, 4560, 4562, 4564, 4566,
4568, 4570, 4572, 4574, 4576, 4578, 4580, 4582, 4584, 4586, 4588,
4590, 4592, 4594, 4596, 4598, 4600, 4602, 4604, 4606, 4608, 4610,
4612, 4614, 4616, 4618, 4620, 4622, 4624, 4626, 4628, 4630, 4632,
4634, 4636, 4638, 4640, 4642, 4644, 4646, 4648, 4650, 4652, 4654,
4656, 4658, 4660, 4662, 4664, 4666, 4668, 4670, 4672, 4674, 4676,
4678, 4680, 4682, 4684, 4686, 4688, 4690, 4692, 4694, 4696, 4698,
4700, 4702, 4704, 4706, 4708, 4710, 4712, 4714, 4716, 4718, 4720,
4722, 4724, 4726, 4728, 4730, 4732, 4734, 4736 1 48 NUE_OEX_1
YER029C S. cerevisiae 4790 Cytoplasmic 4792, 4794, 4796, 4798 1 49
NUE_OEX_1 YFR007W S. cerevisiae 4806 Cytoplasmic 4808, 4810, 4812,
4814, 4816, 4818, 4820, 4822, 4824, 4826, 4828 1 50 NUE_OEX_1
YGL039W S. cerevisiae 4836 Cytoplasmic 4838, 4840, 4842, 4844,
4846, 4848, 4850, 4852, 4854, 4856, 4858, 4860, 4862, 4864, 4866,
4868, 4870, 4872, 4874, 4876, 4878, 4880, 4882, 4884, 4886, 4888,
4890, 4892, 4894, 4896, 4898, 4900, 4902, 4904, 4906, 4908, 4910,
4912, 4914, 4916, 4918, 4920, 4922, 4924, 4926, 4928, 4930, 4932,
4934, 4936, 4938, 4940, 4942, 4944, 4946, 4948, 4950, 4952, 4954,
4956, 4958, 4960, 4962, 4964, 4966, 4968, 4970, 4972, 4974, 4976,
4978, 4980, 4982, 4984, 4986, 4988, 4990, 4992, 4994, 4996, 4998,
5000, 5002, 5004, 5006, 5008, 5010, 5012, 5014, 5016, 5018, 5020,
5022, 5024, 5026, 5028, 5030, 5032, 5034, 5036, 5038, 5040, 5042,
5044, 5046, 5048, 5050, 5052, 5054, 5056, 5058, 5060, 5062, 5064,
5066, 5068, 5070, 5072, 5074, 5076, 5078, 5080, 5082, 5084, 5086,
5088, 5090, 5092, 5094, 5096, 5098, 5100, 5102, 5104, 5106, 5108,
5110, 5112, 5114, 5116, 5118, 5120, 5122, 5124, 5126, 5128, 5130,
5132, 5134, 5136, 5138, 5140, 5142, 5144, 5146, 5148, 5150, 5152,
5154, 5156, 5158, 5160, 5162, 5164, 5166, 5168, 5170, 5172, 5174,
5176, 5178, 5180, 5182, 5184, 5186, 5188, 5190, 5192, 5194, 5196,
5198, 5200, 5202, 5204, 5206, 5208, 5210, 5212 1 51 NUE_OEX_1
YGL043W S. cerevisiae 5311 Cytoplasmic 5313, 5315, 5317, 5319,
5321, 5323, 5325, 5327, 5329, 5331, 5333 1 52 NUE_OEX_1 YGR088W S.
cerevisiae 5346 Cytoplasmic 5348, 5350, 5352, 5354, 5356, 5358,
5360, 5362, 5364, 5366, 5368, 5370, 5372, 5374, 5376, 5378, 5380,
5382, 5384, 5386, 5388, 5390, 5392, 5394, 5396, 5398, 5400, 5402,
5404, 5406, 5408, 5410, 5412, 5414, 5416, 5418, 5420, 5422, 5424,
5426, 5428, 5430, 5432, 5434, 5436, 5438, 5440, 5442, 5444, 5446,
5448, 5450, 5452, 5454, 5456, 5458, 5460, 5462, 5464, 5466, 5468,
5470, 5472, 5474, 5476, 5478, 5480, 5482, 5484, 5486, 5488, 5490,
5492, 5494, 5496, 5498, 5500, 5502, 5504, 5506, 5508, 5510, 5512,
5514, 5516, 5518, 5520, 5522 1 53 NUE_OEX_1 YGR122C-A S. cerevisiae
5533 Cytoplasmic 5535, 5537, 5539, 5541, 5543, 5545 1 54 NUE_OEX_1
YGR142W S. cerevisiae 5551 Cytoplasmic 5553, 5555 1 55 NUE_OEX_1
YGR143W S. cerevisiae 5559 Cytoplasmic 5561, 5563, 5565, 5567,
5569, 5571, 5573, 5575, 5577, 5579, 5581, 5583, 5585 1 56 NUE_OEX_1
YGR165W S. cerevisiae 5602 Cytoplasmic 5604 1 57 NUE_OEX_1 YGR170W
S. cerevisiae 5608 Cytoplasmic 5610 1 58 NUE_OEX_1 YGR202C S.
cerevisiae 5614 Cytoplasmic 5616, 5618, 5620, 5622, 5624, 5626,
5628, 5630, 5632, 5634, 5636, 5638, 5640, 5642, 5644, 5646, 5648,
5650, 5652, 5654, 5656, 5658 1 59 NUE_OEX_1 YGR266W S. cerevisiae
5666 Cytoplasmic 5668, 5670, 5672, 5674, 5676, 5678, 5680, 5682,
5684, 5686 1 60 NUE_OEX_1 YGR282C S. cerevisiae 5701 Cytoplasmic
5703, 5705, 5707, 5709, 5711, 5713, 5715, 5717, 5719, 5721, 5723,
5725, 5727, 5729, 5731, 5733, 5735, 5737, 5739 1 61 NUE_OEX_1
YGR290W S. cerevisiae 5750 Cytoplasmic -- 1 62 NUE_OEX_1 YHL021C S.
cerevisiae 5754 Cytoplasmic 5756, 5758, 5760, 5762, 5764, 5766,
5768 1 63 NUE_OEX_1 YHL031C S. cerevisiae 5778 Cytoplasmic 5780,
5782, 5784, 5786, 5788, 5790, 5792, 5794, 5796, 5798, 5800, 5802,
5804, 5806 1 64 NUE_OEX_1 YHR011W S. cerevisiae 5812 Cytoplasmic
5814, 5816, 5818, 5820, 5822, 5824, 5826, 5828, 5830, 5832, 5834,
5836, 5838, 5840, 5842, 5844, 5846, 5848, 5850, 5852, 5854, 5856,
5858, 5860, 5862, 5864, 5866, 5868, 5870, 5872, 5874, 5876, 5878,
5880, 5882, 5884, 5886, 5888, 5890, 5892, 5894, 5896, 5898, 5900,
5902, 5904, 5906, 5908, 5910, 5912, 5914, 5916, 5918, 5920, 5922,
5924, 5926, 5928, 5930, 5932, 5934, 5936, 5938, 5940, 5942, 5944,
5946, 5948, 5950, 5952 1 65 NUE_OEX_1 YHR127W S. cerevisiae 5967
Cytoplasmic 5969 1 66 NUE_OEX_1 YHR137W S. cerevisiae 5973
Cytoplasmic 5975, 5977, 5979, 5981, 5983, 5985, 5987, 5989, 5991,
5993, 5995, 5997, 5999, 6001, 6003, 6005, 6007, 6009, 6011, 6013,
6015, 6017, 6019 1 66 NUE_OEX_1 YHR137W S. cerevisiae 5973
Plastidic 5975, 5977, 5979, 5981, 5983, 5985, 5987, 5989, 5991,
5993, 5995, 5997, 5999, 6001, 6003, 6005, 6007, 6009, 6011, 6013,
6015, 6017, 6019 1 67 NUE_OEX_1 YIL099W S. cerevisiae 6027
Cytoplasmic 6029, 6031, 6033, 6035, 6037, 6039, 6041, 6043, 6045,
6047, 6049, 6051, 6053, 6055, 6057, 6059, 6061, 6063, 6065, 6067,
6069, 6071, 6073, 6075, 6077, 6079, 6081, 6083, 6085, 6087, 6089,
6091, 6093, 6095, 6097 1 67 NUE_OEX_1 YIL099W S. cerevisiae 6027
Plastidic 6029, 6031, 6033, 6035, 6037, 6039, 6041, 6043, 6045,
6047, 6049, 6051, 6053, 6055, 6057, 6059, 6061, 6063, 6065, 6067,
6069, 6071, 6073, 6075, 6077, 6079, 6081, 6083, 6085, 6087, 6089,
6091, 6093, 6095, 6097 1 68 NUE_OEX_1 YIL147C S. cerevisiae 6107
Cytoplasmic 6109, 6111, 6113, 6115, 6117, 6119, 6121, 6123, 6125,
6127, 6129, 6131 1 69 NUE_OEX_1 YIR034C S. cerevisiae 6150*
Cytoplasmic 6152, 6154, 6156, 6158, 6160, 6162, 6164, 6166, 6168,
6170, 6172, 6174, 6176, 6178, 6180, 6182, 6184 1 70 NUE_OEX_1
YJL013C S. cerevisiae 6198 Cytoplasmic 6200, 6202, 6204 1 71
NUE_OEX_1 YJL041W S. cerevisiae 6208 Cytoplasmic 6210, 6212, 6214,
6216, 6218, 6220, 6222, 6224, 6226, 6228, 6230, 6232, 6234 1 72
NUE_OEX_1 YJL064W S. cerevisiae 6242 Cytoplasmic -- 1 73 NUE_OEX_1
YJL067W S. cerevisiae 6246 Cytoplasmic -- 1 74 NUE_OEX_1 YJL094C S.
cerevisiae 6250 Cytoplasmic 6252, 6254, 6256, 6258, 6260, 6262,
6264, 6266, 6268, 6270, 6272, 6274, 6276, 6278, 6280, 6282, 6284 1
75 NUE_OEX_1 YJL171C S. cerevisiae 6297 Cytoplasmic 6299, 6301,
6303, 6305, 6307, 6309, 6311, 6313, 6315 1 76 NUE_OEX_1 YJL213W S.
cerevisiae 6326 Cytoplasmic 6328, 6330, 6332, 6334, 6336, 6338,
6340, 6342, 6344, 6346, 6348, 6350, 6352, 6354, 6356, 6358, 6360,
6362, 6364, 6366, 6368, 6370, 6372, 6374, 6376, 6378, 6380, 6382,
6384, 6386, 6388, 6390, 6392, 6394, 6396, 6398, 6400, 6402, 6404,
6406, 6408, 6410, 6412, 6414, 6416, 6418, 6420, 6422, 6424, 6426,
6428, 6430, 6432, 6434, 6436, 6438, 6440, 6442, 6444, 6446, 6448,
6450, 6452, 6454, 6456, 6458, 6460, 6462, 6464, 6466, 6468, 6470,
6472, 6474, 6476, 6478, 6480 1 77 NUE_OEX_1 YJR017C S. cerevisiae
6488 Cytoplasmic 6490, 6492, 6494, 6496, 6498, 6500, 6502, 6504,
6506, 6508, 6510, 6512, 6514, 6516, 6518, 6520, 6522, 6524, 6526,
6528, 6530, 6532, 6534, 6536, 6538, 6540 1 78 NUE_OEX_1 YJR058C S.
cerevisiae 6550 Cytoplasmic 6552, 6554, 6556, 6558, 6560, 6562,
6564, 6566, 6568, 6570, 6572, 6574, 6576, 6578, 6580, 6582, 6584,
6586, 6588, 6590, 6592, 6594, 6596, 6598, 6600, 6602, 6604, 6606,
6608, 6610, 6612, 6614, 6616, 6618, 6620, 6622, 6624, 6626, 6628,
6630, 6632, 6634, 6636, 6638, 6640, 6642, 6644, 6646, 6648, 6650,
6652, 6654, 6656, 6658, 6660 1 79 NUE_OEX_1 YJR117W S. cerevisiae
6700 Cytoplasmic 6702, 6704, 6706, 6708, 6710, 6712, 6714, 6716,
6718, 6720, 6722, 6724, 6726, 6728, 6730, 6732, 6734, 6736, 6738,
6740, 6742, 6744, 6746, 6748, 6750, 6752, 6754, 6756, 6758, 6760,
6762, 6764, 6766, 6768, 6770, 6772, 6774, 6776, 6778, 6780, 6782,
6784, 6786, 6788 1 80 NUE_OEX_1 YJR121W S. cerevisiae 6816
Cytoplasmic 6818, 6820, 6822, 6824, 6826, 6828, 6830, 6832, 6834,
6836, 6838, 6840, 6842, 6844, 6846, 6848, 6850, 6852, 6854, 6856,
6858, 6860, 6862, 6864, 6866, 6868, 6870, 6872, 6874, 6876, 6878,
6880, 6882, 6884, 6886, 6888, 6890, 6892, 6894, 6896, 6898, 6900,
6902, 6904, 6906, 6908, 6910, 6912, 6914, 6916, 6918, 6920, 6922,
6924, 6926, 6928, 6930, 6932, 6934, 6936, 6938, 6940, 6942, 6944,
6946, 6948, 6950, 6952, 6954, 6956, 6958, 6960, 6962, 6964, 6966,
6968, 6970, 6972, 6974, 6976, 6978, 6980, 6982, 6984, 6986, 6988,
6990, 6992, 6994, 6996, 6998, 7000, 7002, 7004, 7006, 7008, 7010,
7012, 7014, 7016, 7018, 7020, 7022, 7024, 7026, 7028, 7030, 7032,
7034, 7036, 7038, 7040, 7042, 7044, 7046, 7048, 7050, 7052, 7054,
7056, 7058, 7060, 7062, 7064, 7066, 7068, 7070, 7072, 7074, 7076,
7078, 7080, 7082, 7084, 7086, 7088, 7090, 7092, 7094, 7096, 7098,
7100, 7102, 7104, 7106, 7108, 7110, 7112, 7114, 7116, 7118, 7120,
7122, 7124, 7126, 7128, 7130, 7132, 7134, 7136, 7138, 7140, 7142,
7144, 7146, 7148, 7150, 7152, 7154, 7156, 7158, 7160, 7162, 7164,
7166, 7168, 7170, 7172, 7174, 7176, 7178, 7180, 7182, 7184, 7186,
7188, 7190, 7192, 7194, 7196, 7198, 7200, 7202, 7204, 7206, 7208,
7210, 7212, 7214, 7216, 7218, 7220, 7222, 7224, 7226, 7228, 7230,
7232, 7234, 7236, 7238, 7240, 7242, 7244, 7246, 7248, 7250, 7252,
7254, 7256, 7258, 7260, 7262, 7264, 7266, 7268, 7270, 7272, 7274,
7276, 7278, 7280, 7282, 7284, 7286, 7288, 7290, 7292, 7294, 7296,
7298, 7300, 7302, 7304, 7306, 7308, 7310, 7312, 7314, 7316, 7318,
7320, 7322, 7324, 7326, 7328, 7330, 7332, 7334 1 81 NUE_OEX_1
YJR131W S. cerevisiae 7366* Cytoplasmic 7368, 7370, 7372, 7374,
7376, 7378, 7380, 7382, 7384, 7386, 7388, 7390, 7392, 7394, 7396,
7398, 7400, 7402, 7404, 7406, 7408, 7410, 7412, 7414, 7416, 7418,
7420, 7422, 7424, 7426, 7428, 7430, 7432, 7434, 7436, 7438, 7440,
7442, 7444, 7446, 7448, 7450, 7452, 7454, 7456, 7458 1 82 NUE_OEX_1
YJR145C S. cerevisiae 7475 Cytoplasmic 7477, 7479, 7481, 7483,
7485, 7487, 7489, 7491, 7493, 7495, 7497, 7499, 7501, 7503, 7505,
7507, 7509, 7511, 7513, 7515, 7517, 7519, 7521, 7523, 7525, 7527,
7529, 7531, 7533, 7535, 7537, 7539, 7541, 7543, 7545, 7547, 7549,
7551, 7553, 7555, 7557 1 83 NUE_OEX_1 YKL084W S. cerevisiae 7602
Cytoplasmic 7604, 7606, 7608, 7610, 7612, 7614, 7616, 7618, 7620,
7622, 7624, 7626, 7628, 7630, 7632, 7634, 7636, 7638, 7640, 7642,
7644 1 84 NUE_OEX_1 YKL088W S. cerevisiae 7651 Cytoplasmic 7653 1
85 NUE_OEX_1 YKL100C S. cerevisiae 7661* Cytoplasmic 7663, 7665,
7667 1 86 NUE_OEX_1 YKL131W S. cerevisiae 7675 Cytoplasmic -- 1 87
NUE_OEX_1 YKL138C S. cerevisiae 7679 Cytoplasmic 7681, 7683, 7685,
7687, 7689, 7691, 7693, 7695, 7697, 7699, 7701, 7703 1 88 NUE_OEX_1
YKL178C S. cerevisiae 7710 Cytoplasmic 7712, 7714, 7716, 7718 1 89
NUE_OEX_1 YKL179C S. cerevisiae 7735 Cytoplasmic 7737, 7739, 7741,
7743, 7745, 7747, 7749, 7751, 7753, 7755, 7757, 7759, 7761, 7763,
7765, 7767 1 90 NUE_OEX_1 YKL193C S. cerevisiae 7778* Cytoplasmic
7780, 7782, 7784, 7786, 7788, 7790, 7792, 7794, 7796, 7798, 7800,
7802, 7804, 7806, 7808, 7810, 7812 1 91 NUE_OEX_1 YKL216W S.
cerevisiae 7829 Cytoplasmic 7831, 7833, 7835, 7837, 7839, 7841,
7843, 7845, 7847, 7849, 7851, 7853, 7855, 7857, 7859, 7861, 7863,
7865, 7867, 7869, 7871, 7873, 7875, 7877, 7879, 7881, 7883, 7885,
7887, 7889, 7891, 7893, 7895, 7897, 7899, 7901, 7903, 7905, 7907,
7909, 7911, 7913, 7915, 7917, 7919, 7921, 7923, 7925, 7927, 7929,
7931, 7933, 7935, 7937, 7939, 7941, 7943, 7945, 7947, 7949, 7951,
7953, 7955, 7957, 7959, 7961, 7963, 7965, 7967, 7969, 7971, 7973,
7975, 7977, 7979, 7981, 7983, 7985, 7987, 7989, 7991, 7993, 7995,
7997, 7999, 8001, 8003, 8005, 8007, 8009, 8011 1 92 NUE_OEX_1
YKR016W S. cerevisiae 8017 Cytoplasmic 8019, 8021, 8023, 8025,
8027, 8029, 8031, 8033, 8035, 8037 1 93 NUE_OEX_1 YKR021W S.
cerevisiae 8045 Cytoplasmic 8047, 8049, 8051, 8053, 8055, 8057,
8059 1 94 NUE_OEX_1 YKR055W S. cerevisiae 8073 Cytoplasmic 8075,
8077, 8079, 8081, 8083, 8085, 8087, 8089, 8091, 8093, 8095, 8097,
8099, 8101, 8103, 8105, 8107, 8109, 8111, 8113, 8115, 8117, 8119,
8121, 8123, 8125, 8127, 8129, 8131, 8133, 8135, 8137, 8139, 8141,
8143, 8145, 8147, 8149, 8151, 8153, 8155, 8157, 8159, 8161, 8163,
8165, 8167, 8169, 8171, 8173, 8175, 8177, 8179, 8181, 8183, 8185,
8187, 8189, 8191, 8193, 8195, 8197, 8199, 8201, 8203, 8205, 8207,
8209, 8211, 8213, 8215, 8217, 8219, 8221, 8223, 8225, 8227, 8229,
8231, 8233, 8235, 8237, 8239, 8241, 8243, 8245, 8247, 8249, 8251,
8253, 8255 1 95 NUE_OEX_1 YKR088C S. cerevisiae 8263 Plastidic
8265, 8267, 8269, 8271, 8273, 8275, 8277, 8279 1 96 NUE_OEX_1
YKR093W S. cerevisiae 8287 Cytoplasmic 8289, 8291, 8293, 8295,
8297, 8299, 8301, 8303, 8305, 8307, 8309, 8311, 8313, 8315, 8317,
8319, 8321, 8323, 8325, 8327, 8329, 8331, 8333, 8335, 8337, 8339,
8341, 8343, 8345, 8347, 8349, 8351, 8353, 8355, 8357, 8359, 8361,
8363, 8365, 8367, 8369, 8371, 8373, 8375, 8377, 8379, 8381, 8383,
8385, 8387, 8389, 8391, 8393, 8395, 8397, 8399, 8401, 8403, 8405,
8407, 8409, 8411, 8413, 8415, 8417, 8419, 8421, 8423, 8425, 8427,
8429, 8431, 8433, 8435, 8437, 8439, 8441 1 97 NUE_OEX_1 YKR099W S.
cerevisiae 8468 Cytoplasmic 8470, 8472 1 98 NUE_OEX_1 YKR100C S.
cerevisiae 8484 Cytoplasmic 8486, 8488 1 99 NUE_OEX_1 YLL014W S.
cerevisiae 8492 Cytoplasmic 8494, 8496, 8498, 8500, 8502, 8504,
8506, 8508 1 100 NUE_OEX_1 YLL016W S. cerevisiae 8514* Cytoplasmic
8516, 8518, 8520, 8522, 8524, 8526 1 101 NUE_OEX_1 YLL023C S.
cerevisiae 8539 Cytoplasmic 8541, 8543, 8545,
8547, 8549, 8551, 8553, 8555, 8557, 8559, 8561, 8563, 8565 1 102
NUE_OEX_1 YLL037W S. cerevisiae 8571 Cytoplasmic -- 1 103 NUE_OEX_1
YLL049W S. cerevisiae 8575 Cytoplasmic -- 1 104 NUE_OEX_1 YLL055W
S. cerevisiae 8579 Cytoplasmic 8581, 8583, 8585, 8587, 8589, 8591,
8593, 8595, 8597, 8599, 8601, 8603, 8605, 8607, 8609, 8611, 8613,
8615, 8617, 8619, 8621, 8623, 8625, 8627, 8629, 8631, 8633, 8635,
8637, 8639, 8641, 8643, 8645, 8647, 8649, 8651, 8653, 8655 1 105
NUE_OEX_1 YLR034C S. cerevisiae 8661* Cytoplasmic 8663, 8665, 8667,
8669, 8671, 8673, 8675, 8677, 8679, 8681, 8683, 8685, 8687, 8689,
8691, 8693, 8695, 8697, 8699, 8701, 8703, 8705, 8707, 8709, 8711,
8713, 8715, 8717, 8719, 8721, 8723, 8725, 8727, 8729, 8731, 8733,
8735, 8737, 8739, 8741, 8743, 8745, 8747, 8749, 8751, 8753, 8755,
8757, 8759, 8761, 8763, 8765, 8767, 8769, 8771, 8773, 8775, 8777,
8779, 8781, 8783, 8785, 8787, 8789, 8791, 8793, 8795, 8797, 8799,
8801, 8803, 8805, 8807, 8809, 8811, 8813, 8815, 8817, 8819, 8821,
8823, 8825, 8827, 8829, 8831, 8833, 8835, 8837, 8839, 8841, 8843,
8845, 8847, 8849, 8851, 8853, 8855, 8857, 8859, 8861, 8863, 8865,
8867, 8869, 8871, 8873, 8875, 8877, 8879, 8881, 8883, 8885, 8887,
8889, 8891, 8893, 8895, 8897, 8899, 8901, 8903, 8905, 8907, 8909,
8911, 8913, 8915, 8917, 8919, 8921, 8923, 8925, 8927, 8929, 8931,
8933, 8935, 8937, 8939, 8941, 8943, 8945, 8947, 8949, 8951, 8953,
8955, 8957, 8959, 8961 1 106 NUE_OEX_1 YLR042C S. cerevisiae 8991
Cytoplasmic -- 1 107 NUE_OEX_1 YLR053C S. cerevisiae 8995
Cytoplasmic -- 1 108 NUE_OEX_1 YLR058C S. cerevisiae 8999
Cytoplasmic 9001, 9003, 9005, 9007, 9009, 9011, 9013, 9015, 9017,
9019, 9021, 9023, 9025, 9027, 9029, 9031, 9033, 9035, 9037, 9039,
9041, 9043, 9045, 9047, 9049, 9051, 9053, 9055, 9057, 9059, 9061,
9063, 9065, 9067, 9069, 9071, 9073, 9075, 9077, 9079, 9081, 9083,
9085, 9087, 9089, 9091, 9093, 9095, 9097, 9099, 9101, 9103, 9105,
9107, 9109, 9111, 9113, 9115, 9117, 9119, 9121, 9123, 9125, 9127,
9129, 9131, 9133, 9135, 9137, 9139, 9141, 9143, 9145, 9147, 9149,
9151, 9153, 9155, 9157, 9159, 9161, 9163, 9165, 9167, 9169, 9171,
9173, 9175, 9177, 9179, 9181, 9183, 9185, 9187, 9189, 9191, 9193,
9195, 9197, 9199, 9201, 9203, 9205, 9207, 9209, 9211, 9213, 9215,
9217, 9219, 9221, 9223, 9225, 9227, 9229, 9231, 9233, 9235, 9237,
9239, 9241, 9243, 9245, 9247, 9249, 9251, 9253, 9255, 9257, 9259,
9261, 9263, 9265, 9267, 9269, 9271, 9273, 9275, 9277, 9279, 9281,
9283, 9285, 9287, 9289, 9291, 9293, 9295, 9297, 9299, 9301, 9303,
9305, 9307, 9309, 9311, 9313, 9315, 9317, 9319, 9321, 9323, 9325,
9327, 9329, 9331, 9333, 9335, 9337, 9339, 9341, 9343, 9345, 9347,
9349, 9351, 9353, 9355, 9357, 9359, 9361, 9363, 9365, 9367, 9369,
9371, 9373, 9375, 9377, 9379, 9381, 9383, 9385, 9387, 9389, 9391,
9393, 9395, 9397, 9399, 9401, 9403, 9405, 9407, 9409, 9411, 9413,
9415, 9417, 9419, 9421, 9423, 9425, 9427, 9429, 9431, 9433, 9435,
9437, 9439, 9441, 9443, 9445, 9447, 9449, 9451, 9453, 9455, 9457,
9459, 9461, 9463, 9465, 9467, 9469, 9471, 9473, 9475, 9477, 9479,
9481, 9483, 9485, 9487, 9489, 9491, 9493, 9495, 9497, 9499 1 109
NUE_OEX_1 YLR060W S. cerevisiae 9551* Cytoplasmic 9553, 9555, 9557,
9559, 9561, 9563, 9565, 9567, 9569, 9571, 9573, 9575, 9577, 9579,
9581, 9583, 9585, 9587, 9589, 9591, 9593, 9595, 9597, 9599, 9601,
9603, 9605, 9607, 9609, 9611, 9613, 9615, 9617, 9619, 9621, 9623,
9625, 9627 1 110 NUE_OEX_1 YLR065C S. cerevisiae 9637 Cytoplasmic
9639, 9641, 9643, 9645, 9647, 9649, 9651, 9653, 9655, 9657, 9659,
9661, 9663, 9665, 9667 1 111 NUE_OEX_1 YLR070C S. cerevisiae 9672
Cytoplasmic 9674, 9676, 9678, 9680, 9682, 9684, 9686, 9688, 9690,
9692, 9694, 9696, 9698, 9700, 9702, 9704, 9706, 9708, 9710, 9712,
9714, 9716, 9718, 9720, 9722, 9724, 9726, 9728, 9730, 9732, 9734,
9736, 9738, 9740, 9742, 9744, 9746, 9748, 9750, 9752, 9754, 9756,
9758, 9760, 9762, 9764, 9766, 9768, 9770, 9772, 9774, 9776, 9778,
9780, 9782, 9784, 9786, 9788, 9790, 9792, 9794, 9796, 9798, 9800,
9802, 9804, 9806, 9808, 9810, 9812, 9814, 9816, 9818, 9820, 9822,
9824, 9826, 9828, 9830, 9832, 9834, 9836, 9838, 9840, 9842, 9844,
9846, 9848, 9850, 9852, 9854, 9856, 9858, 9860, 9862, 9864, 9866,
9868, 9870, 9872, 9874, 9876, 9878, 9880, 9882, 9884, 9886, 9888,
9890, 9892, 9894, 9896, 9898, 9900, 9902, 9904, 9906, 9908, 9910,
9912, 9914, 9916, 9918, 9920, 9922, 9924, 9926, 9928, 9930, 9932,
9934, 9936, 9938, 9940, 9942, 9944, 9946, 9948, 9950, 9952, 9954,
9956, 9958, 9960, 9962, 9964, 9966, 9968, 9970, 9972, 9974, 9976,
9978, 9980, 9982, 9984, 9986, 9988, 9990, 9992, 9994, 9996, 9998,
10000, 10002, 10004, 10006, 10008, 10010, 10012, 10014, 10016,
10018, 10020, 10022, 10024, 10026, 10028, 10030, 10032, 10034,
10036, 10038, 10040, 10042, 10044, 10046, 10048, 10050, 10052,
10054, 10056, 10058, 10060, 10062, 10064, 10066, 10068, 10070,
10072, 10074, 10076, 10078, 10080, 10082, 10084, 10086, 10088,
10090, 10092, 10094, 10096, 10098, 10100, 10102, 10104, 10106,
10108, 10110, 10112, 10114, 10116 1 112 NUE_OEX_1 YLR100W S.
cerevisiae 10182 Cytoplasmic 10184, 10186, 10188, 10190, 10192,
10194, 10196, 10198, 10200, 10202 1 113 NUE_OEX_1 YLR109W S.
cerevisiae 10214 Cytoplasmic 10216, 10218, 10220, 10222, 10224,
10226, 10228, 10230, 10232, 10234, 10236, 10238, 10240, 10242,
10244, 10246, 10248, 10250, 10252, 10254, 10256, 10258, 10260,
10262, 10264, 10266, 10268, 10270, 10272, 10274, 10276, 10278,
10280, 10282, 10284, 10286, 10288, 10290, 10292, 10294, 10296,
10298, 10300, 10302, 10304, 10306, 10308, 10310, 10312, 10314,
10316, 10318, 10320, 10322, 10324, 10326, 10328, 10330, 10332,
10334, 10336, 10338, 10340, 10342, 10344, 10346, 10348, 10350,
10352, 10354, 10356, 10358, 10360, 10362, 10364, 10366, 10368,
10370, 10372, 10374, 10376, 10378, 10380, 10382, 10384, 10386,
10388, 10390, 10392, 10394, 10396, 10398, 10400, 10402, 10404,
10406, 10408, 10410, 10412, 10414, 10416 1 114 NUE_OEX_1 YLR125W S.
cerevisiae 10447 Cytoplasmic -- 1 115 NUE_OEX_1 YLR127C S.
cerevisiae 10451 Cytoplasmic 10453, 10455, 10457, 10459 1 116
NUE_OEX_1 YLR185W S. cerevisiae 10463 Cytoplasmic 10465, 10467,
10469, 10471, 10473, 10475, 10477, 10479, 10481, 10483, 10485,
10487, 10489, 10491, 10493, 10495, 10497, 10499, 10501, 10503,
10505, 10507, 10509, 10511 1 117 NUE_OEX_1 YLR204W S. cerevisiae
10533 Cytoplasmic 10535, 10537 1 117 NUE_OEX_1 YLR204W S.
cerevisiae 10533 Plastidic 10535, 10537 1 118 NUE_OEX_1 YLR242C S.
cerevisiae 10541 Cytoplasmic 10543, 10545, 10547, 10549, 10551,
10553 1 119 NUE_OEX_1 YLR293C S. cerevisiae 10562 Cytoplasmic
10564, 10566, 10568, 10570, 10572, 10574, 10576, 10578, 10580,
10582, 10584, 10586, 10588, 10590, 10592, 10594, 10596, 10598,
10600, 10602, 10604, 10606, 10608, 10610, 10612, 10614, 10616,
10618, 10620, 10622, 10624, 10626, 10628, 10630, 10632, 10634,
10636, 10638, 10640, 10642, 10644, 10646, 10648, 10650, 10652,
10654, 10656, 10658, 10660, 10662, 10664, 10666, 10668, 10670,
10672, 10674, 10676, 10678, 10680, 10682, 10684, 10686, 10688,
10690, 10692, 10694, 10696, 10698, 10700, 10702, 10704, 10706,
10708, 10710, 10712 1 120 NUE_OEX_1 YLR313C S. cerevisiae 10990
Cytoplasmic 10992, 10994 1 121 NUE_OEX_1 YLR315W S. cerevisiae
10998 Cytoplasmic 11000 1 122 NUE_OEX_1 YLR329W S. cerevisiae 11004
Cytoplasmic 11006, 11008 1 123 NUE_OEX_1 YLR362W S. cerevisiae
11012 Cytoplasmic 11014, 11016, 11018, 11020, 11022, 11024, 11026,
11028, 11030, 11032, 11034, 11036, 11038, 11040, 11042 1 124
NUE_OEX_1 YLR395C S. cerevisiae 11054 Cytoplasmic 11056, 11058,
11060 1 125 NUE_OEX_1 YLR404W S. cerevisiae 11066 Cytoplasmic
11068, 11070 1 126 NUE_OEX_1 YLR463C S. cerevisiae 11074
Cytoplasmic 11076 1 127 NUE_OEX_1 YML022W S. cerevisiae 11080
Cytoplasmic 11082, 11084, 11086, 11088, 11090, 11092, 11094, 11096,
11098, 11100, 11102, 11104, 11106, 11108, 11110, 11112, 11114,
11116, 11118, 11120, 11122, 11124, 11126, 11128, 11130, 11132,
11134, 11136, 11138, 11140, 11142, 11144, 11146, 11148, 11150,
11152, 11154, 11156, 11158, 11160, 11162, 11164, 11166, 11168,
11170, 11172, 11174, 11176, 11178, 11180, 11182, 11184, 11186,
11188, 11190, 11192, 11194, 11196, 11198, 11200, 11202, 11204,
11206, 11208, 11210, 11212, 11214, 11216, 11218, 11220, 11222,
11224, 11226, 11228, 11230, 11232, 11234, 11236, 11238, 11240,
11242, 11244, 11246, 11248, 11250, 11252, 11254, 11256, 11258,
11260, 11262, 11264, 11266, 11268, 11270, 11272, 11274, 11276,
11278, 11280, 11282, 11284, 11286, 11288, 11290, 11292, 11294,
11296, 11298, 11300, 11302, 11304, 11306, 11308, 11310, 11312,
11314, 11316, 11318, 11320, 11322, 11324, 11326, 11328, 11330,
11332, 11334, 11336, 11338, 11340, 11342, 11344, 11346, 11348,
11350, 11352, 11354, 11356, 11358, 11360, 11362, 11364, 11366,
11368, 11370, 11372, 11374, 11376, 11378, 11380, 11382, 11384,
11386, 11388, 11390, 11392, 11394, 11396, 11398, 11400, 11402,
11404, 11406, 11408, 11410, 11412, 11414, 11416, 11418, 11420,
11422, 11424, 11426, 11428, 11430, 11432, 11434, 11436, 11438,
11440, 11442, 11444, 11446, 11448, 11450, 11452, 11454, 11456,
11458, 11460, 11462, 11464, 11466, 11468, 11470, 11472, 11474,
11476, 11478, 11480, 11482, 11484, 11486, 11488, 11490, 11492,
11494, 11496, 11498, 11500, 11502, 11504, 11506, 11508, 11510,
11512, 11514, 11516, 11518, 11520, 11522, 11524 1 128 NUE_OEX_1
YML027W S. cerevisiae 11552 Cytoplasmic 11554, 11556, 11558, 11560,
11562 1 129 NUE_OEX_1 YML065W S. cerevisiae 11569 Cytoplasmic
11571, 11573, 11575, 11577, 11579, 11581, 11583, 11585 1 130
NUE_OEX_1 YML089C S. cerevisiae 11596 Cytoplasmic -- 1 131
NUE_OEX_1 YML128C S. cerevisiae 11600 Cytoplasmic 11602, 11604,
11606, 11608 1 132 NUE_OEX_1 YMR011W S. cerevisiae 11612
Cytoplasmic 11614, 11616, 11618, 11620, 11622, 11624, 11626, 11628,
11630, 11632, 11634, 11636, 11638, 11640, 11642, 11644, 11646,
11648, 11650, 11652, 11654, 11656, 11658, 11660, 11662, 11664,
11666, 11668, 11670, 11672, 11674, 11676, 11678, 11680, 11682,
11684, 11686, 11688, 11690, 11692, 11694, 11696, 11698, 11700,
11702, 11704, 11706, 11708, 11710, 11712, 11714, 11716, 11718,
11720, 11722, 11724, 11726, 11728, 11730, 11732, 11734, 11736,
11738, 11740, 11742, 11744, 11746, 11748, 11750, 11752, 11754,
11756, 11758, 11760, 11762, 11764, 11766, 11768, 11770, 11772,
11774, 11776, 11778, 11780, 11782, 11784, 11786, 11788, 11790,
11792, 11794, 11796, 11798, 11800, 11802, 11804, 11806, 11808,
11810, 11812, 11814, 11816, 11818, 11820, 11822, 11824, 11826,
11828, 11830, 11832, 11834, 11836, 11838, 11840, 11842, 11844,
11846, 11848, 11850, 11852, 11854, 11856, 11858, 11860, 11862,
11864, 11866, 11868, 11870, 11872, 11874, 11876, 11878, 11880,
11882, 11884, 11886, 11888, 11890, 11892, 11894, 11896, 11898,
11900, 11902, 11904, 11906, 11908, 11910, 11912, 11914, 11916,
11918, 11920, 11922, 11924, 11926, 11928, 11930, 11932, 11934,
11936, 11938, 11940, 11942, 11944, 11946, 11948, 11950, 11952,
11954, 11956, 11958, 11960, 11962, 11964, 11966, 11968, 11970,
11972, 11974, 11976, 11978, 11980, 11982, 11984, 11986, 11988,
11990, 11992, 11994, 11996, 11998, 12000, 12002, 12004, 12006,
12008, 12010, 12012, 12014, 12016, 12018, 12020, 12022, 12024,
12026, 12028, 12030, 12032, 12034, 12036, 12038, 12040, 12042,
12044, 12046, 12048, 12050, 12052, 12054, 12056, 12058, 12060,
12062, 12064, 12066, 12068, 12070, 12072, 12074, 12076, 12078,
12080, 12082, 12084, 12086, 12088, 12090, 12092, 12094, 12096,
12098, 12100, 12102, 12104, 12106, 12108, 12110, 12112, 12114,
12116, 12118, 12120, 12122 1 133 NUE_OEX_1 YMR037C S. cerevisiae
12246 Cytoplasmic 12248, 12250, 12252, 12254 1 134 NUE_OEX_1
YMR049C S. cerevisiae 12263 Cytoplasmic 12265, 12267, 12269, 12271,
12273, 12275, 12277, 12279, 12281, 12283, 12285, 12287, 12289,
12291, 12293, 12295, 12297 1 135 NUE_OEX_1 YMR052W S. cerevisiae
12316 Cytoplasmic 12318, 12320 1 136 NUE_OEX_1 YMR082C S.
cerevisiae 12327* Cytoplasmic -- 1 137 NUE_OEX_1 YMR125W S.
cerevisiae 12331 Cytoplasmic 12333, 12335, 12337, 12339, 12341,
12343, 12345, 12347, 12349, 12351, 12353, 12355, 12357, 12359,
12361, 12363, 12365 1 138 NUE_OEX_1 YMR126C S. cerevisiae 12378
Cytoplasmic 12380, 12382, 12384 1 139 NUE_OEX_1 YMR144W S.
cerevisiae 12394 Cytoplasmic 12396, 12398 1 140 NUE_OEX_1 YMR160W
S. cerevisiae 12406 Cytoplasmic 12408, 12410 1 141 NUE_OEX_1
YMR191W S. cerevisiae 12414 Cytoplasmic 12416 1 142 NUE_OEX_1
YMR209C S. cerevisiae 12420 Cytoplasmic 12422, 12424, 12426, 12428
1 143 NUE_OEX_1 YMR233W S. cerevisiae 12440 Cytoplasmic 12442,
12444, 12446, 12448, 12450, 12452, 12454, 12456, 12458, 12460,
12462, 12464 1 144 NUE_OEX_1 YMR278W S. cerevisiae 12470
Cytoplasmic 12472, 12474, 12476, 12478, 12480, 12482, 12484, 12486,
12488, 12490, 12492, 12494, 12496, 12498, 12500, 12502, 12504,
12506, 12508, 12510, 12512, 12514, 12516, 12518, 12520, 12522,
12524, 12526, 12528, 12530, 12532, 12534, 12536, 12538, 12540,
12542, 12544, 12546, 12548, 12550, 12552, 12554, 12556, 12558,
12560, 12562, 12564, 12566, 12568, 12570, 12572, 12574, 12576,
12578, 12580, 12582, 12584, 12586, 12588, 12590, 12592, 12594,
12596, 12598, 12600, 12602, 12604, 12606, 12608, 12610, 12612,
12614, 12616, 12618, 12620, 12622, 12624, 12626, 12628, 12630,
12632, 12634, 12636, 12638, 12640, 12642, 12644, 12646, 12648,
12650, 12652, 12654, 12656, 12658, 12660, 12662, 12664, 12666,
12668, 12670, 12672, 12674, 12676, 12678, 12680, 12682, 12684,
12686, 12688, 12690, 12692, 12694, 12696, 12698, 12700, 12702,
12704, 12706, 12708, 12710, 12712, 12714, 12716, 12718, 12720,
12722, 12724, 12726, 12728, 12730, 12732, 12734, 12736, 12738 1 145
NUE_OEX_1 YMR280C S. cerevisiae 12749 Cytoplasmic 12751, 12753,
12755 1 146 NUE_OEX_1 YNL014W S. cerevisiae 12773 Cytoplasmic
12775, 12777, 12779, 12781, 12783, 12785, 12787, 12789, 12791,
12793, 12795, 12797, 12799, 12801, 12803, 12805, 12807, 12809 1 147
NUE_OEX_1 YNL320W S. cerevisiae 12829 Cytoplasmic 12831, 12833,
12835, 12837, 12839, 12841, 12843, 12845, 12847, 12849, 12851,
12853, 12855, 12857, 12859, 12861, 12863, 12865 1 148 NUE_OEX_1
YOL007C S. cerevisiae 12883 Cytoplasmic 12885 1 149 NUE_OEX_1
YOL164W S. cerevisiae 12889 Cytoplasmic 12891, 12893, 12895, 12897,
12899, 12901, 12903, 12905, 12907, 12909, 12911, 12913, 12915,
12917, 12919, 12921, 12923, 12925, 12927, 12929, 12931, 12933,
12935, 12937, 12939, 12941, 12943, 12945, 12947, 12949, 12951,
12953, 12955, 12957, 12959, 12961, 12963, 12965, 12967, 12969,
12971, 12973, 12975, 12977, 12979, 12981, 12983, 12985, 12987,
12989, 12991, 12993, 12995, 12997, 12999 1 150 NUE_OEX_1 YOR076C S.
cerevisiae 13014 Cytoplasmic -- 1 151 NUE_OEX_1 YOR083W S.
cerevisiae 13018 Cytoplasmic 13020 1 152 NUE_OEX_1 YOR097C S.
cerevisiae 13024 Cytoplasmic 13026 1 153 NUE_OEX_1 YOR128C S.
cerevisiae 13030 Cytoplasmic 13032, 13034, 13036, 13038, 13040,
13042, 13044, 13046, 13048, 13050, 13052, 13054, 13056, 13058,
13060, 13062, 13064, 13066, 13068, 13070, 13072, 13074, 13076,
13078, 13080, 13082, 13084, 13086, 13088, 13090, 13092, 13094,
13096 1 154 NUE_OEX_1 YOR353C S. cerevisiae 14085 Cytoplasmic
14087, 14089 1 155 NUE_OEX_1 YPL141C S. cerevisiae 14093
Cytoplasmic 14095, 14097, 14099 1 156 NUE_OEX_1 YPR088C S.
cerevisiae 14113 Cytoplasmic 14115, 14117, 14119, 14121, 14123,
14125, 14127, 14129, 14131, 14133, 14135, 14137, 14139, 14141,
14143, 14145, 14147, 14149, 14151, 14153, 14155, 14157, 14159,
14161, 14163, 14165, 14167, 14169, 14171, 14173, 14175, 14177,
14179, 14181, 14183, 14185, 14187, 14189, 14191, 14193, 14195,
14197, 14199, 14201, 14203, 14205, 14207, 14209, 14211, 14213 1 157
NUE_OEX_1 YPR108W S. cerevisiae 14246 Cytoplasmic 14248, 14250,
14252, 14254, 14256, 14258, 14260, 14262, 14264, 14266, 14268,
14270, 14272, 14274, 14276, 14278, 14280, 14282, 14284, 14286,
14288 1 158 NUE_OEX_1 YPR110C S. cerevisiae 14311 Cytoplasmic
14313, 14315, 14317, 14319, 14321, 14323, 14325, 14327, 14329,
14331, 14333, 14335, 14337, 14339, 14341, 14343, 14345, 14347,
14349, 14351, 14353, 14355, 14357, 14359, 14361, 14363, 14365,
14367, 14369, 14371 1 159 NUE_OEX_1 B3825_2 E. coli 14914 Plastidic
14916, 14918, 14920, 14922, 14924, 14926, 14928, 14930, 14932,
14934, 14936, 14938, 14940, 14942, 14944, 14946, 14948, 14950,
14952, 14954, 14956, 14958, 14960, 14962, 14964, 14966, 14968,
14970, 14972, 14974, 14976, 14978, 14980, 14982, 14984, 14986,
14988, 14990, 14992, 14994, 14996, 14998, 15000, 15002, 15004,
15006, 15008 1 160 NUE_OEX_1 YIR034C_2 S. cerevisiae 15382
Cytoplasmic 15384, 15386, 15388, 15390, 15392, 15394, 15396, 15398,
15400, 15402, 15404, 15406, 15408, 15410, 15412, 15414, 15416,
15418 1 161 NUE_OEX_1 YJR131W_2 S. cerevisiae 15460 Cytoplasmic
15462, 15464, 15466, 15468, 15470, 15472, 15474, 15476, 15478,
15480, 15482, 15484, 15486, 15488, 15490, 15492, 15494, 15496,
15498, 15500, 15502, 15504, 15506, 15508, 15510, 15512, 15514,
15516, 15518, 15520, 15522, 15524, 15526, 15528, 15530, 15532,
15534, 15536, 15538, 15540, 15542, 15544, 15546, 15548, 15550,
15552, 15554 1 162 NUE_OEX_1 YKL100C_2 S. cerevisiae 15571
Cytoplasmic 15573, 15575, 15577, 15579 1 163 NUE_OEX_1 YKL193C_2 S.
cerevisiae 15593 Cytoplasmic 15595, 15597, 15599, 15601, 15603,
15605, 15607, 15609, 15611, 15613, 15615, 15617, 15619, 15621,
15623, 15625, 15627, 15629 1 164 NUE_OEX_1 YLL016W_2 S. cerevisiae
15646 Cytoplasmic 15648, 15650, 15652, 15654, 15656, 15658, 15660 1
165 NUE_OEX_1 YLR034C_2 S. cerevisiae 15673 Cytoplasmic 15675,
15677, 15679, 15681, 15683, 15685, 15687, 15689, 15691, 15693,
15695, 15697, 15699, 15701, 15703, 15705, 15707, 15709, 15711,
15713, 15715, 15717, 15719, 15721, 15723, 15725, 15727, 15729,
15731, 15733, 15735, 15737, 15739, 15741, 15743, 15745, 15747,
15749, 15751, 15753, 15755, 15757, 15759, 15761, 15763, 15765,
15767, 15769, 15771, 15773, 15775, 15777, 15779, 15781, 15783,
15785, 15787, 15789, 15791, 15793, 15795, 15797, 15799, 15801,
15803, 15805, 15807, 15809, 15811, 15813, 15815, 15817, 15819,
15821, 15823, 15825, 15827, 15829, 15831, 15833, 15835, 15837,
15839, 15841, 15843, 15845, 15847, 15849, 15851, 15853, 15855,
15857, 15859, 15861, 15863, 15865, 15867, 15869, 15871, 15873,
15875, 15877, 15879, 15881, 15883, 15885, 15887, 15889, 15891,
15893, 15895, 15897, 15899, 15901, 15903, 15905, 15907, 15909,
15911, 15913, 15915, 15917, 15919, 15921, 15923, 15925, 15927,
15929, 15931, 15933, 15935, 15937, 15939, 15941, 15943, 15945,
15947, 15949, 15951, 15953, 15955, 15957, 15959, 15961, 15963,
15965, 15967, 15969, 15971, 15973, 15975 1 166 NUE_OEX_1 YLR060W_2
S. cerevisiae 16005 Cytoplasmic 16007, 16009, 16011, 16013, 16015,
16017, 16019, 16021, 16023, 16025, 16027, 16029, 16031, 16033,
16035, 16037, 16039, 16041, 16043, 16045, 16047, 16049, 16051,
16053, 16055, 16057, 16059, 16061, 16063, 16065, 16067, 16069,
16071, 16073, 16075, 16077, 16079, 16081, 16083 1 167 NUE_OEX_1
YMR082C_2 S. cerevisiae 16114 Cytoplasmic 16116 1 168 NUE_OEX_1
B1258 E. coli 14402 Cytoplasmic 14404, 14406, 14408, 14410, 14412,
14414, 14416, 14418, 14420, 14422, 14424, 14426, 14428, 14430,
14432, 14434, 14436, 14438, 14440, 14442, 14444, 14446, 14448,
14450, 14452, 14454, 14456, 14458, 14460, 14462, 14464, 14466,
14468, 14470, 14472, 14474, 14476, 14478, 14480, 14482, 14484,
14486, 14488, 14490 1 169 NUE_OEX_1 YML101C S. cerevisiae 16093
Cytoplasmic 16095, 16097, 16099 1 170 NUE_OEX_1 YMR065W S.
cerevisiae 16106 Cytoplasmic 16108, 16110 1 171 NUE_OEX_1 YMR163C
S. cerevisiae 16120 Cytoplasmic 16122, 16124, 16126 1 172 NUE_OEX_1
YOL042W S. cerevisiae 16275 Cytoplasmic 16277, 16279, 16281, 16283,
16285, 16287 1 173 NUE_OEX_1 YOR226C S. cerevisiae 16305
Cytoplasmic 16307, 16309, 16311, 16313, 16315, 16317, 16319, 16321,
16323, 16325, 16327, 16329, 16331, 16333, 16335, 16337, 16339,
16341, 16343, 16345, 16347, 16349, 16351, 16353, 16355, 16357,
16359, 16361, 16363, 16365, 16367, 16369, 16371, 16373, 16375,
16377, 16379, 16381, 16383, 16385, 16387, 16389, 16391, 16393,
16395, 16397, 16399, 16401, 16403, 16405, 16407, 16409, 16411,
16413, 16415, 16417, 16419, 16421, 16423, 16425, 16427, 16429,
16431, 16433, 16435, 16437, 16439, 16441, 16443, 16445, 16447,
16449, 16451, 16453, 16455, 16457, 16459, 16461, 16463, 16465,
16467, 16469, 16471, 16473, 16475, 16477, 16479, 16481, 16483,
16485, 16487, 16489, 16491, 16493, 16495, 16497, 16499, 16501,
16503, 16505, 16507, 16509, 16511, 16513, 16515, 16517, 16519,
16521, 16523, 16525, 16527, 16529, 16531, 16533, 16535 1 174
NUE_OEX_1 YPL068C S. cerevisiae 16573 Cytoplasmic 16575, 16577 1
175 NUE_OEX_1 B0165 E. coli 14396 Plastidic 14398 1 176 NUE_OEX_1
YOR203W S. cerevisiae 16299 Cytoplasmic 16301 1 177 NUE_OEX_1
YNL147W S. cerevisiae 16133 Cytoplasmic 16135, 16137, 16139, 16141,
16143, 16145, 16147, 16149, 16151, 16153, 16155, 16157, 16159,
16161, 16163, 16165, 16167, 16169, 16171, 16173, 16175, 16177,
16179, 16181, 16183, 16185, 16187, 16189, 16191, 16193, 16195,
16197, 16199, 16201, 16203, 16205, 16207, 16209, 16211, 16213,
16215, 16217, 16219, 16221, 16223, 16225, 16227, 16229, 16231,
16233, 16235, 16237, 16239, 16241, 16243, 16245, 16247, 16249,
16251, 16253, 16255 1 178 NUE_OEX_1 YBR083W S. cerevisiae 15056
Cytoplasmic 15058, 15060 1 179 NUE_OEX_1 YKL111C S. cerevisiae
15587 Cytoplasmic 15589 1 180 NUE_OEX_1 YPR067W S. cerevisiae 16582
Cytoplasmic 16584, 16586, 16588, 16590, 16592, 16594, 16596, 16598,
16600, 16602, 16604, 16606, 16608, 16610, 16612, 16614, 16616,
16618, 16620, 16622 1 181 NUE_OEX_1 B1985 E. coli 14839 Cytoplasmic
14841, 14843, 14845, 14847, 14849, 14851, 14853, 14855, 14857,
14859, 14861, 14863, 14865 1 182 NUE_OEX_1 B3838 E. coli 15014
Cytoplasmic 15016, 15018, 15020, 15022, 15024, 15026, 15028, 15030,
15032, 15034, 15036, 15038, 15040, 15042, 15044, 15046, 15048 1 183
NUE_OEX_1 YJL010C S. cerevisiae 15432 Cytoplasmic 15434, 15436,
15438, 15440, 15442, 15444, 15446, 15448 1 184 NUE_OEX_1 B1267 E.
coli 14497 Cytoplasmic 14499, 14501, 14503, 14505, 14507, 14509,
14511, 14513, 14515, 14517, 14519, 14521, 14523, 14525, 14527,
14529, 14531, 14533, 14535, 14537, 14539, 14541, 14543, 14545,
14547, 14549, 14551, 14553, 14555, 14557, 14559, 14561, 14563,
14565, 14567, 14569, 14571, 14573, 14575, 14577, 14579, 14581,
14583, 14585, 14587, 14589, 14591, 14593, 14595, 14597, 14599,
14601, 14603, 14605, 14607, 14609, 14611, 14613, 14615, 14617,
14619, 14621, 14623, 14625, 14627, 14629, 14631, 14633, 14635,
14637, 14639, 14641, 14643, 14645, 14647, 14649, 14651, 14653,
14655, 14657, 14659, 14661, 14663, 14665, 14667, 14669, 14671,
14673, 14675, 14677, 14679, 14681, 14683, 14685, 14687, 14689,
14691, 14693, 14695, 14697, 14699, 14701, 14703, 14705, 14707 1 185
NUE_OEX_1 B1322 E. coli 14718 Cytoplasmic 14720, 14722, 14724,
14726, 14728, 14730, 14732, 14734, 14736, 14738, 14740, 14742,
14744, 14746, 14748, 14750, 14752, 14754, 14756, 14758, 14760,
14762, 14764, 14766, 14768, 14770, 14772, 14774, 14776, 14778,
14780, 14782, 14784 1 186 NUE_OEX_1 B1381 E. coli 14791 Cytoplasmic
14793, 14795, 14797, 14799, 14801, 14803, 14805, 14807, 14809,
14811, 14813, 14815, 14817, 14819 1 187 NUE_OEX_1 B2646 E. coli
14879 Cytoplasmic 14881, 14883, 14885, 14887, 14889, 14891, 14893,
14895, 14897, 14899, 14901, 14903, 14905, 14907 1 188 NUE_OEX_1
YBR191W S. cerevisiae 15064 Cytoplasmic 15066, 15068, 15070, 15072,
15074, 15076, 15078, 15080, 15082, 15084, 15086, 15088, 15090,
15092, 15094, 15096, 15098, 15100, 15102, 15104, 15106, 15108,
15110, 15112, 15114, 15116, 15118, 15120, 15122, 15124, 15126,
15128, 15130, 15132, 15134, 15136, 15138, 15140, 15142, 15144,
15146, 15148, 15150, 15152, 15154, 15156, 15158, 15160, 15162,
15164, 15166, 15168, 15170, 15172, 15174, 15176, 15178, 15180,
15182, 15184, 15186, 15188, 15190, 15192, 15194, 15196, 15198,
15200, 15202, 15204, 15206, 15208, 15210, 15212, 15214, 15216 1 189
NUE_OEX_1 YDL135C S. cerevisiae 15257 Cytoplasmic 15259, 15261,
15263, 15265, 15267, 15269, 15271, 15273, 15275, 15277, 15279,
15281, 15283, 15285, 15287, 15289, 15291, 15293, 15295, 15297,
15299, 15301, 15303, 15305, 15307, 15309, 15311, 15313, 15315,
15317, 15319, 15321, 15323, 15325, 15327, 15329, 15331, 15333,
15335, 15337, 15339, 15341, 15343, 15345, 15347, 15349, 15351,
15353, 15355 1 190 NUE_OEX_1 YHL005C S. cerevisiae 15378
Cytoplasmic -- 1 191 NUE_OEX_1 YKR100C_2 S. cerevisiae 16629
Cytoplasmic 16631, 16633, 16635, 16637 1 192 NUE_OEX_1 YMR191W_2 S.
cerevisiae 16647 Cytoplasmic 16649, 16651
TABLE-US-00014 TABLE IA _CHOM Nucleic acid sequence ID numbers 5.
Appli- 1. 2. 3. 4. Lead 6. 7. cation Hit Project Locus Organism SEQ
ID Target SEQ IDs of Nucleic Acid Homologs 1 1 NUE_OEX_1 yor128c S.
cerevisiae 13030 Cytoplasmic 13117, 13119, 13121, 13123, 13125,
13127, 13129, 13131, CHOM 13133, 13135, 13137, 13139, 13141, 13143,
13145, 13147, 13149, 13151, 13153, 13155, 13157, 13159, 13161,
13163, 13165, 13167, 13169, 13171, 13173, 13175, 13177, 13179,
13181, 13183, 13185, 13187, 13189, 13191, 13193, 13195, 13197,
13199, 13201, 13203, 13205, 13207, 13209, 13211, 13213, 13215,
13217, 13219, 13221, 13223, 13225, 13227, 13229, 13231, 13233,
13235, 13237, 13239, 13241, 13243, 13245, 13247, 13249, 13251,
13253, 13255, 13257, 13259, 13261, 13263, 13265, 13267, 13269,
13271, 13273, 13275, 13277, 13279, 13281, 13283, 13285, 13287,
13289, 13291, 13293, 13295, 13297, 13299, 13301, 13303, 13305,
13307, 13309, 13311, 13313, 13315, 13317, 13319, 13321, 13323,
13325, 13327, 13329, 13331, 13333, 13335, 13337, 13339, 13341,
13343, 13345, 13347, 13349, 13351, 13353, 13355, 13357, 13359,
13361, 13363, 13365, 13367, 13369, 13371, 13373, 13375, 13377,
13379, 13381, 13383, 13385, 13387, 13389, 13391, 13393, 13395,
13397, 13399, 13401, 13403, 13405, 13407, 13409, 13411, 13413,
13415, 13417, 13419, 13421, 13423, 13425, 13427, 13429, 13431,
13433, 13435, 13437, 13439, 13441, 13443, 13445, 13447, 13449,
13451, 13453, 13455, 13457, 13459, 13461, 13463, 13465, 13467,
13469, 13471, 13473, 13475, 13477, 13479, 13481, 13483, 13485,
13487, 13489, 13491, 13493, 13495, 13497, 13499, 13501, 13503,
13505, 13507, 13509, 13511, 13513, 13515, 13517, 13519, 13521,
13523, 13525, 13527, 13529, 13531, 13533, 13535, 13537, 13539,
13541, 13543, 13545, 13547, 13549, 13551, 13553, 13555, 13557,
13559, 13561, 13563, 13565, 13567, 13569, 13571, 13573, 13575,
13577, 13579, 13581, 13583, 13585, 13587, 13589, 13591, 13593,
13595, 13597, 13599, 13601, 13603, 13605, 13607, 13609, 13611,
13613, 13615
TABLE-US-00015 TABLE IA _NHOM Nucleic acid sequence ID numbers 5.
Appli- 1. 2. 3. 4. Lead 6. 7. cation Hit Project Locus Organism SEQ
ID Target SEQ IDs of Nucleic Acid Homologs 1 1 NUE_OEX_1 yor128c S.
cerevisiae 13030 Cytoplasmic 13624, 13626, 13628, 13630, 13632,
13634, 13636, 13638, NHOM 13640, 13642, 13644, 13646, 13648, 13650,
13652, 13654, 13656, 13658, 13660, 13662, 13664, 13666, 13668,
13670, 13672, 13674, 13676, 13678, 13680, 13682, 13684, 13686,
13688, 13690, 13692, 13694, 13696, 13698, 13700, 13702, 13704,
13706, 13708, 13710, 13712, 13714, 13716, 13718, 13720, 13722,
13724, 13726, 13728, 13730, 13732, 13734, 13736, 13738, 13740,
13742, 13744, 13746, 13748, 13750, 13752, 13754, 13756, 13758,
13760, 13762, 13764, 13766, 13768, 13770, 13772, 13774, 13776,
13778, 13780, 13782, 13784, 13786, 13788, 13790, 13792, 13794,
13796, 13798, 13800, 13802, 13804, 13806, 13808, 13810, 13812,
13814, 13816, 13818, 13820, 13822, 13824, 13826, 13828, 13830,
13832, 13834, 13836, 13838, 13840, 13842, 13844, 13846, 13848,
13850, 13852, 13854, 13856, 13858, 13860, 13862, 13864, 13866,
13868, 13870, 13872, 13874, 13876, 13878, 13880, 13882, 13884,
13886, 13888, 13890, 13892, 13894, 13896, 13898, 13900, 13902,
13904, 13906, 13908, 13910, 13912, 13914, 13916, 13918, 13920,
13922, 13924, 13926, 13928, 13930, 13932, 13934, 13936, 13938,
13940, 13942, 13944, 13946, 13948, 13950, 13952, 13954, 13956,
13958, 13960, 13962, 13964, 13966, 13968, 13970, 13972, 13974,
13976, 13978, 13980, 13982, 13984, 13986, 13988, 13990, 13992,
13994, 13996, 13998, 14000, 14002, 14004, 14006, 14008, 14010,
14012, 14014, 14016, 14018, 14020, 14022, 14024, 14026, 14028,
14030, 14032, 14034, 14036, 14038, 14040, 14042, 14044, 14046,
14048, 14050, 14052, 14054, 14056, 14058, 14060, 14062, 14064,
14066, 14068, 14070, 14072, 14074, 14076, 14078, 14080
TABLE-US-00016 TABLE IB Nucleic acid sequence ID numbers Ap- pli-
5. ca- 1. 2. 3. 4. Lead 6. 7. tion Hit Project Locus Organism SEQ
ID Target SEQ IDs of Nucleic Acid Homologs 1 1 NUE_OEX_1 B0017 E.
coli 38 Cytoplasmic -- 1 2 NUE_OEX_1 B0045 E. coli 42 Cytoplasmic
98, 100, 102, 104, 106, 108, 110, 112, 114, 116 1 3 NUE_OEX_1 B0180
E. coli 123 Plastidic 365, 367, 369, 371, 373 1 4 NUE_OEX_1 B0242
E. coli 380 Plastidic 662, 664, 666, 668 1 5 NUE_OEX_1 B0403 E.
coli 679 Plastidic -- 1 6 NUE_OEX_1 B0474 E. coli 812 Cytoplasmic
958, 960, 962, 964, 966, 968, 970, 972, 974, 976, 978, 980, 982,
984, 986, 988, 990, 992, 994, 996, 998, 1000, 1002, 1004, 1006,
1008, 1010, 1012, 1014, 1016, 1018, 1020, 1022, 1024, 1026, 1028,
1030, 1032, 1034, 1036, 1038, 1040, 1042, 1044, 1046, 1048, 16657 1
7 NUE_OEX_1 B0754 E. coli 1055 Plastidic -- 1 8 NUE_OEX_1 B0784 E.
coli 1563 Cytoplasmic -- 1 9 NUE_OEX_1 B0873 E. coli 1705 Plastidic
-- 1 10 NUE_OEX_1 B1014 E. coli 1844 Cytoplasmic -- 1 11 NUE_OEX_1
B1020 E. coli 1950 Plastidic -- 1 12 NUE_OEX_1 B1180 E. coli 1975
Cytoplasmic 2099, 2101, 2103, 2105, 2107, 2109, 2111, 2113, 2115,
2117, 2119, 16661 1 13 NUE_OEX_1 B1933 E. coli 2127 Plastidic -- 1
14 NUE_OEX_1 B2032 E. coli 2135 Plastidic -- 1 15 NUE_OEX_1 B2165
E. coli 2171 Plastidic 2285, 2287 1 16 NUE_OEX_1 B2223 E. coli 2297
Plastidic -- 1 17 NUE_OEX_1 B2238 E. coli 2426 Plastidic -- 1 17
NUE_OEX_1 B2238 E. coli 2426 Cytoplasmic -- 1 18 NUE_OEX_1 B2310 E.
coli 2452 Plastidic -- 1 19 NUE_OEX_1 B2431 E. coli 2551 Plastidic
-- 1 20 NUE_OEX_1 B2600 E. coli 2600 Plastidic -- 1 21 NUE_OEX_1
B2766 E. coli 2668 Plastidic -- 1 22 NUE_OEX_1 B2903 E. coli 2772
Cytoplasmic 3096, 3098 1 23 NUE_OEX_1 B3117 E. coli 3117 Plastidic
3373, 3375, 3377, 3379, 3381 1 24 NUE_OEX_1 B3120 E. coli 3390
Plastidic -- 1 25 NUE_OEX_1 B3216 E. coli 3396 Plastidic -- 1 26
NUE_OEX_1 B3451 E. coli 3470 Plastidic -- 1 27 NUE_OEX_1 B3791 E.
coli 3563 Cytoplasmic -- 1 28 NUE_OEX_1 B3825 E. coli 3770*
Plastidic -- 1 29 NUE_OEX_1 YAL019W S. cerevisiae 3868 Cytoplasmic
-- 1 30 NUE_OEX_1 YAR035W S. cerevisiae 3895 Cytoplasmic -- 1 31
NUE_OEX_1 YBL021C S. cerevisiae 3953 Cytoplasmic 4031, 4033, 4035,
4037, 4039, 4041, 4043, 4045, 4047, 4049, 4051, 4053, 4055, 4057,
4059, 4061, 4063, 4065, 4067, 4069, 4071, 4073, 4075, 4077, 4079,
4081, 4083, 4085, 4087, 4089, 4091, 4093, 4095, 4097, 4099, 4101,
4103, 4105 1 32 NUE_OEX_1 YBR055C S. cerevisiae 4111 Cytoplasmic --
1 33 NUE_OEX_1 YBR128C S. cerevisiae 4149 Cytoplasmic -- 1 34
NUE_OEX_1 YBR159W S. cerevisiae 4162 Cytoplasmic 4214, 4216, 4218,
4220, 4222, 4224, 4226 1 35 NUE_OEX_1 YBR243C S. cerevisiae 4235
Cytoplasmic 4267, 4269 1 35 NUE_OEX_1 YBR243C S. cerevisiae 4235
Plastidic 4267, 4269 1 36 NUE_OEX_1 YBR262C S. cerevisiae 4280
Cytoplasmic -- 1 37 NUE_OEX_1 YCR019W S. cerevisiae 4288
Cytoplasmic -- 1 38 NUE_OEX_1 YDR070C S. cerevisiae 4315
Cytoplasmic -- 1 39 NUE_OEX_1 YDR079W S. cerevisiae 4325
Cytoplasmic -- 1 40 NUE_OEX_1 YDR123C S. cerevisiae 4335
Cytoplasmic -- 1 41 NUE_OEX_1 YDR137W S. cerevisiae 4346
Cytoplasmic -- 1 42 NUE_OEX_1 YDR294C S. cerevisiae 4361
Cytoplasmic -- 1 42 NUE_OEX_1 YDR294C S. cerevisiae 4361 Plastidic
-- 1 43 NUE_OEX_1 YDR330W S. cerevisiae 4402 Cytoplasmic -- 1 44
NUE_OEX_1 YDR355C S. cerevisiae 4431 Cytoplasmic -- 1 45 NUE_OEX_1
YDR430C S. cerevisiae 4435 Plastidic -- 1 46 NUE_OEX_1 YDR472W S.
cerevisiae 4485 Cytoplasmic -- 1 47 NUE_OEX_1 YDR497C S. cerevisiae
4506 Plastidic 4738, 4740, 4742, 4744, 4746, 4748, 4750, 4752,
4754, 4756, 4758, 4760, 4762, 4764, 4766, 4768, 4770, 4772, 4774,
4776, 4778, 4780, 4782, 4784, 16665 1 48 NUE_OEX_1 YER029C S.
cerevisiae 4790 Cytoplasmic -- 1 49 NUE_OEX_1 YFR007W S. cerevisiae
4806 Cytoplasmic -- 1 50 NUE_OEX_1 YGL039W S. cerevisiae 4836
Cytoplasmic 5214, 5216, 5218, 5220, 5222, 5224, 5226, 5228, 5230,
5232, 5234, 5236, 5238, 5240, 5242, 5244, 5246, 5248, 5250, 5252,
5254, 5256, 5258, 5260, 5262, 5264, 5266, 5268, 5270, 5272, 5274,
5276, 5278, 5280, 5282, 5284, 5286, 5288, 5290, 5292, 5294, 5296,
5298, 5300, 5302, 5304 1 51 NUE_OEX_1 YGL043W S. cerevisiae 5311
Cytoplasmic 5335, 5337, 5339 1 52 NUE_OEX_1 YGR088W S. cerevisiae
5346 Cytoplasmic 5524 1 53 NUE_OEX_1 YGR122C-A S. cerevisiae 5533
Cytoplasmic -- 1 54 NUE_OEX_1 YGR142W S. cerevisiae 5551
Cytoplasmic -- 1 55 NUE_OEX_1 YGR143W S. cerevisiae 5559
Cytoplasmic -- 1 56 NUE_OEX_1 YGR165W S. cerevisiae 5602
Cytoplasmic -- 1 57 NUE_OEX_1 YGR170W S. cerevisiae 5608
Cytoplasmic -- 1 58 NUE_OEX_1 YGR202C S. cerevisiae 5614
Cytoplasmic -- 1 59 NUE_OEX_1 YGR266W S. cerevisiae 5666
Cytoplasmic -- 1 60 NUE_OEX_1 YGR282C S. cerevisiae 5701
Cytoplasmic -- 1 61 NUE_OEX_1 YGR290W S. cerevisiae 5750
Cytoplasmic -- 1 62 NUE_OEX_1 YHL021C S. cerevisiae 5754
Cytoplasmic -- 1 63 NUE_OEX_1 YHL031C S. cerevisiae 5778
Cytoplasmic -- 1 64 NUE_OEX_1 YHR011W S. cerevisiae 5812
Cytoplasmic 5954, 5956, 5958, 16669 1 65 NUE_OEX_1 YHR127W S.
cerevisiae 5967 Cytoplasmic -- 1 66 NUE_OEX_1 YHR137W S. cerevisiae
5973 Cytoplasmic -- 1 66 NUE_OEX_1 YHR137W S. cerevisiae 5973
Plastidic -- 1 67 NUE_OEX_1 YIL099W S. cerevisiae 6027 Cytoplasmic
-- 1 67 NUE_OEX_1 YIL099W S. cerevisiae 6027 Plastidic -- 1 68
NUE_OEX_1 YIL147C S. cerevisiae 6107 Cytoplasmic -- 1 69 NUE_OEX_1
YIR034C S. cerevisiae 6150* Cytoplasmic -- 1 70 NUE_OEX_1 YJL013C
S. cerevisiae 6198 Cytoplasmic -- 1 71 NUE_OEX_1 YJL041W S.
cerevisiae 6208 Cytoplasmic -- 1 72 NUE_OEX_1 YJL064W S. cerevisiae
6242 Cytoplasmic -- 1 73 NUE_OEX_1 YJL067W S. cerevisiae 6246
Cytoplasmic -- 1 74 NUE_OEX_1 YJL094C S. cerevisiae 6250
Cytoplasmic -- 1 75 NUE_OEX_1 YJL171C S. cerevisiae 6297
Cytoplasmic -- 1 76 NUE_OEX_1 YJL213W S. cerevisiae 6326
Cytoplasmic -- 1 77 NUE_OEX_1 YJR017C S. cerevisiae 6488
Cytoplasmic 6542 1 78 NUE_OEX_1 YJR058C S. cerevisiae 6550
Cytoplasmic 6662, 6664, 6666, 6668, 6670, 6672, 6674, 6676, 6678,
6680, 6682, 6684, 6686, 6688, 6690, 6692, 6694, 16673, 16675 1 79
NUE_OEX_1 YJR117W S. cerevisiae 6700 Cytoplasmic 6790, 6792, 6794,
6796, 6798, 6800, 6802, 6804, 6806 1 80 NUE_OEX_1 YJR121W S.
cerevisiae 6816 Cytoplasmic 7336, 7338, 7340, 7342, 7344, 7346,
7348 1 81 NUE_OEX_1 YJR131W S. cerevisiae 7366* Cytoplasmic 7460,
7462, 7464, 7466 1 82 NUE_OEX_1 YJR145C S. cerevisiae 7475
Cytoplasmic 7559, 7561, 7563, 7565, 7567, 7569, 7571, 7573, 7575,
7577, 7579, 7581, 7583, 7585, 7587, 7589, 7591, 7593, 7595, 16679 1
83 NUE_OEX_1 YKL084W S. cerevisiae 7602 Cytoplasmic -- 1 84
NUE_OEX_1 YKL088W S. cerevisiae 7651 Cytoplasmic -- 1 85 NUE_OEX_1
YKL100C S. cerevisiae 7661* Cytoplasmic -- 1 86 NUE_OEX_1 YKL131W
S. cerevisiae 7675 Cytoplasmic -- 1 87 NUE_OEX_1 YKL138C S.
cerevisiae 7679 Cytoplasmic -- 1 88 NUE_OEX_1 YKL178C S. cerevisiae
7710 Cytoplasmic -- 1 89 NUE_OEX_1 YKL179C S. cerevisiae 7735
Cytoplasmic -- 1 90 NUE_OEX_1 YKL193C S. cerevisiae 7778*
Cytoplasmic 7814, 7816, 7818, 7820 1 91 NUE_OEX_1 YKL216W S.
cerevisiae 7829 Cytoplasmic -- 1 92 NUE_OEX_1 YKR016W S. cerevisiae
8017 Cytoplasmic -- 1 93 NUE_OEX_1 YKR021W S. cerevisiae 8045
Cytoplasmic -- 1 94 NUE_OEX_1 YKR055W S. cerevisiae 8073
Cytoplasmic 8257 1 95 NUE_OEX_1 YKR088C S. cerevisiae 8263
Plastidic -- 1 96 NUE_OEX_1 YKR093W S. cerevisiae 8287 Cytoplasmic
8443, 8445, 8447, 8449, 8451, 8453, 8455, 8457, 8459, 8461 1 97
NUE_OEX_1 YKR099W S. cerevisiae 8468 Cytoplasmic -- 1 98 NUE_OEX_1
YKR100C S. cerevisiae 8484 Cytoplasmic -- 1 99 NUE_OEX_1 YLL014W S.
cerevisiae 8492 Cytoplasmic -- 1 100 NUE_OEX_1 YLL016W S.
cerevisiae 8514* Cytoplasmic -- 1 101 NUE_OEX_1 YLL023C S.
cerevisiae 8539 Cytoplasmic -- 1 102 NUE_OEX_1 YLL037W S.
cerevisiae 8571 Cytoplasmic -- 1 103 NUE_OEX_1 YLL049W S.
cerevisiae 8575 Cytoplasmic -- 1 104 NUE_OEX_1 YLL055W S.
cerevisiae 8579 Cytoplasmic -- 1 105 NUE_OEX_1 YLR034C S.
cerevisiae 8661* Cytoplasmic 8963, 8965, 8967, 8969, 8971, 8973,
8975, 8977, 8979, 8981 1 106 NUE_OEX_1 YLR042C S. cerevisiae 8991
Cytoplasmic -- 1 107 NUE_OEX_1 YLR053C S. cerevisiae 8995
Cytoplasmic -- 1 108 NUE_OEX_1 YLR058C S. cerevisiae 8999
Cytoplasmic 9501, 9503, 9505, 9507, 9509, 9511, 9513, 9515, 9517,
9519, 9521, 9523, 9525, 9527, 9529, 9531, 9533, 9535, 9537, 9539 1
109 NUE_OEX_1 YLR060W S. cerevisiae 9551* Cytoplasmic -- 1 110
NUE_OEX_1 YLR065C S. cerevisiae 9637 Cytoplasmic -- 1 111 NUE_OEX_1
YLR070C S. cerevisiae 9672 Cytoplasmic 10118, 10120, 10122, 10124,
10126, 10128, 10130, 10132, 10134, 10136, 10138, 10140, 10142,
10144, 10146, 10148, 10150, 10152, 10154, 10156, 10158, 10160,
10162, 10164, 10166, 10168, 10170, 10172, 10174, 10176 1 112
NUE_OEX_1 YLR100W S. cerevisiae 10182 Cytoplasmic -- 1 113
NUE_OEX_1 YLR109W S. cerevisiae 10214 Cytoplasmic 10418, 10420,
10422, 10424, 10426, 10428, 10430, 10432, 10434, 10436, 10438,
10440, 10442 1 114 NUE_OEX_1 YLR125W S. cerevisiae 10447
Cytoplasmic -- 1 115 NUE_OEX_1 YLR127C S. cerevisiae 10451
Cytoplasmic -- 1 116 NUE_OEX_1 YLR185W S. cerevisiae 10463
Cytoplasmic 10513, 10515, 10517, 10519, 10521, 10523, 10525 1 117
NUE_OEX_1 YLR204W S. cerevisiae 10533 Cytoplasmic -- 1 117
NUE_OEX_1 YLR204W S. cerevisiae 10533 Plastidic -- 1 118 NUE_OEX_1
YLR242C S. cerevisiae 10541 Cytoplasmic -- 1 119 NUE_OEX_1 YLR293C
S. cerevisiae 10562 Cytoplasmic 10714, 10716, 10718, 10720, 10722,
10724, 10726, 10728, 10730, 10732, 10734, 10736, 10738, 10740,
10742, 10744, 10746, 10748, 10750, 10752, 10754, 10756, 10758,
10760, 10762, 10764, 10766, 10768, 10770, 10772, 10774, 10776,
10778, 10780, 10782, 10784, 10786, 10788, 10790, 10792, 10794,
10796, 10798, 10800, 10802, 10804, 10806, 10808, 10810, 10812,
10814, 10816, 10818, 10820, 10822, 10824, 10826, 10828, 10830,
10832, 10834, 10836, 10838, 10840, 10842, 10844, 10846, 10848,
10850, 10852, 10854, 10856, 10858, 10860, 10862, 10864, 10866,
10868, 10870, 10872, 10874, 10876, 10878, 10880, 10882, 10884,
10886, 10888, 10890, 10892, 10894, 10896, 10898, 10900, 10902,
10904, 10906, 10908, 10910, 10912, 10914, 10916, 10918, 10920,
10922, 10924, 10926, 10928, 10930, 10932, 10934, 10936, 10938,
10940, 10942, 10944, 10946, 10948, 10950, 10952, 10954, 10956,
10958, 10960, 10962, 10964, 10966, 10968, 10970, 10972, 10974,
10976, 10978, 10980, 10982 1 120 NUE_OEX_1 YLR313C S. cerevisiae
10990 Cytoplasmic -- 1 121 NUE_OEX_1 YLR315W S. cerevisiae 10998
Cytoplasmic -- 1 122 NUE_OEX_1 YLR329W S. cerevisiae 11004
Cytoplasmic -- 1 123 NUE_OEX_1 YLR362W S. cerevisiae 11012
Cytoplasmic -- 1 124 NUE_OEX_1 YLR395C S. cerevisiae 11054
Cytoplasmic -- 1 125 NUE_OEX_1 YLR404W S. cerevisiae 11066
Cytoplasmic -- 1 126 NUE_OEX_1 YLR463C S. cerevisiae 11074
Cytoplasmic -- 1 127 NUE_OEX_1 YML022W S. cerevisiae 11080
Cytoplasmic 11526, 11528, 11530, 11532, 11534, 11536, 11538, 11540,
11542, 11544, 11546 1 128 NUE_OEX_1 YML027W S. cerevisiae 11552
Cytoplasmic -- 1 129 NUE_OEX_1 YML065W S. cerevisiae 11569
Cytoplasmic -- 1 130 NUE_OEX_1 YML089C S. cerevisiae 11596
Cytoplasmic -- 1 131 NUE_OEX_1 YML128C S. cerevisiae 11600
Cytoplasmic -- 1 132 NUE_OEX_1 YMR011W S. cerevisiae 11612
Cytoplasmic 12124, 12126, 12128, 12130, 12132, 12134, 12136, 12138,
12140, 12142, 12144, 12146, 12148, 12150, 12152, 12154, 12156,
12158, 12160, 12162, 12164, 12166, 12168, 12170, 12172, 12174,
12176, 12178, 12180, 12182, 12184, 12186, 12188, 12190, 12192,
12194, 12196, 12198, 12200, 12202, 12204, 12206, 12208, 12210,
12212, 12214, 12216, 12218, 12220, 12222, 12224, 12226, 12228,
12230, 12232, 12234, 12236, 12238, 12240 1 133 NUE_OEX_1 YMR037C S.
cerevisiae 12246 Cytoplasmic -- 1 134 NUE_OEX_1 YMR049C S.
cerevisiae 12263 Cytoplasmic -- 1 135 NUE_OEX_1 YMR052W S.
cerevisiae 12316 Cytoplasmic -- 1 136 NUE_OEX_1 YMR082C S.
cerevisiae 12327* Cytoplasmic -- 1 137 NUE_OEX_1 YMR125W S.
cerevisiae 12331 Cytoplasmic -- 1 138 NUE_OEX_1 YMR126C S.
cerevisiae 12378 Cytoplasmic -- 1 139 NUE_OEX_1 YMR144W S.
cerevisiae 12394 Cytoplasmic -- 1 140 NUE_OEX_1 YMR160W S.
cerevisiae 12406 Cytoplasmic -- 1 141 NUE_OEX_1 YMR191W S.
cerevisiae 12414 Cytoplasmic -- 1 142 NUE_OEX_1 YMR209C S.
cerevisiae 12420 Cytoplasmic -- 1 143 NUE_OEX_1 YMR233W S.
cerevisiae 12440 Cytoplasmic -- 1 144 NUE_OEX_1 YMR278W S.
cerevisiae 12470 Cytoplasmic -- 1 145 NUE_OEX_1 YMR280C S.
cerevisiae 12749 Cytoplasmic -- 1 146 NUE_OEX_1 YNL014W S.
cerevisiae 12773 Cytoplasmic -- 1 147 NUE_OEX_1 YNL320W S.
cerevisiae 12829 Cytoplasmic 12867, 12869, 12871, 12873 1 148
NUE_OEX_1 YOL007C S. cerevisiae 12883 Cytoplasmic -- 1 149
NUE_OEX_1 YOL164W S. cerevisiae 12889 Cytoplasmic -- 1 150
NUE_OEX_1 YOR076C S. cerevisiae 13014 Cytoplasmic -- 1 151
NUE_OEX_1 YOR083W S. cerevisiae 13018 Cytoplasmic -- 1 152
NUE_OEX_1 YOR097C S. cerevisiae 13024 Cytoplasmic -- 1 153
NUE_OEX_1 YOR128C S. cerevisiae 13030 Cytoplasmic 13098 1 154
NUE_OEX_1 YOR353C S. cerevisiae 14085 Cytoplasmic -- 1 155
NUE_OEX_1 YPL141C S. cerevisiae 14093 Cytoplasmic -- 1 156
NUE_OEX_1 YPR088C S. cerevisiae 14113 Cytoplasmic 14215, 14217,
14219, 14221, 14223, 14225, 14227, 14229, 14231, 14233 1 157
NUE_OEX_1 YPR108W S. cerevisiae 14246 Cytoplasmic 14290, 14292,
14294, 14296, 14298 1 158 NUE_OEX_1 YPR110C S. cerevisiae 14311
Cytoplasmic 14373, 14375, 14377, 14379, 14381 1 159 NUE_OEX_1
B3825_2 E. coli 14914 Plastidic -- 1 160 NUE_OEX_1 YIR034C_2 S.
cerevisiae 15382 Cytoplasmic -- 1 161 NUE_OEX_1 YJR131W_2 S.
cerevisiae 15460 Cytoplasmic 15556, 15558,
15560, 15562 1 162 NUE_OEX_1 YKL100C_2 S. cerevisiae 15571
Cytoplasmic -- 1 163 NUE_OEX_1 YKL193C_2 S. cerevisiae 15593
Cytoplasmic 15631, 15633, 15635, 15637 1 164 NUE_OEX_1 YLL016W_2 S.
cerevisiae 15646 Cytoplasmic -- 1 165 NUE_OEX_1 YLR034C_2 S.
cerevisiae 15673 Cytoplasmic 15977, 15979, 15981, 15983, 15985,
15987, 15989, 15991, 15993, 15995 1 166 NUE_OEX_1 YLR060W_2 S.
cerevisiae 16005 Cytoplasmic -- 1 167 NUE_OEX_1 YMR082C_2 S.
cerevisiae 16114 Cytoplasmic -- 1 168 NUE_OEX_1 B1258 E. coli 14402
Cytoplasmic -- 1 169 NUE_OEX_1 YML101C S. cerevisiae 16093
Cytoplasmic -- 1 170 NUE_OEX_1 YMR065W S. cerevisiae 16106
Cytoplasmic -- 1 171 NUE_OEX_1 YMR163C S. cerevisiae 16120
Cytoplasmic -- 1 172 NUE_OEX_1 YOL042W S. cerevisiae 16275
Cytoplasmic -- 1 173 NUE_OEX_1 YOR226C S. cerevisiae 16305
Cytoplasmic 16537, 16539, 16541, 16543, 16545, 16547, 16549, 16551,
16553, 16555, 16557, 16559, 16561, 16563, 16565 1 174 NUE_OEX_1
YPL068C S. cerevisiae 16573 Cytoplasmic -- 1 175 NUE_OEX_1 B0165 E.
coli 14396 Plastidic -- 1 176 NUE_OEX_1 YOR203W S. cerevisiae 16299
Cytoplasmic -- 1 177 NUE_OEX_1 YNL147W S. cerevisiae 16133
Cytoplasmic 16257, 16259, 16261, 16263, 16265, 16267, 16269 1 178
NUE_OEX_1 YBR083W S. cerevisiae 15056 Cytoplasmic -- 1 179
NUE_OEX_1 YKL111C S. cerevisiae 15587 Cytoplasmic -- 1 180
NUE_OEX_1 YPR067W S. cerevisiae 16582 Cytoplasmic -- 1 181
NUE_OEX_1 B1985 E. coli 14839 Cytoplasmic -- 1 182 NUE_OEX_1 B3838
E. coli 15014 Cytoplasmic -- 1 183 NUE_OEX_1 YJL010C S. cerevisiae
15432 Cytoplasmic -- 1 184 NUE_OEX_1 B1267 E. coli 14497
Cytoplasmic 14709, 14711 1 185 NUE_OEX_1 B1322 E. coli 14718
Cytoplasmic -- 1 186 NUE_OEX_1 B1381 E. coli 14791 Cytoplasmic -- 1
187 NUE_OEX_1 B2646 E. coli 14879 Cytoplasmic -- 1 188 NUE_OEX_1
YBR191W S. cerevisiae 15064 Cytoplasmic 15218, 15220, 15222, 15224,
15226, 15228, 15230, 15232, 15234, 15236, 15238, 15240, 15242,
15244, 15246, 15248 1 189 NUE_OEX_1 YDL135C S. cerevisiae 15257
Cytoplasmic 15357, 15359, 15361, 15363, 15365, 15367, 15369, 15371
1 190 NUE_OEX_1 YHL005C S. cerevisiae 15378 Cytoplasmic -- 1 191
NUE_OEX_1 YKR100C_2 S. cerevisiae 16629 Cytoplasmic -- 1 192
NUE_OEX_1 YMR191W_2 S. cerevisiae 16647 Cytoplasmic --
TABLE-US-00017 TABLE IIA Amino acid sequence ID numbers Ap- 5.
plica- 1. 2. 3. 4. Lead 6. 7. tion Hit Project Locus Organism SEQ
ID Target SEQ IDs of Polypeptide Homologs 1 1 NUE_OEX_1 B0017 E.
coli 39 Cytoplasmic -- 1 2 NUE_OEX_1 B0045 E. coli 43 Cytoplasmic
45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77,
79, 81, 83, 85, 87, 89, 91, 93, 95, 97 1 3 NUE_OEX_1 B0180 E. coli
124 Plastidic 126, 128, 130, 132, 134, 136, 138, 140, 142, 144,
146, 148, 150, 152, 154, 156, 158, 160, 162, 164, 166, 168, 170,
172, 174, 176, 178, 180, 182, 184, 186, 188, 190, 192, 194, 196,
198, 200, 202, 204, 206, 208, 210, 212, 214, 216, 218, 220, 222,
224, 226, 228, 230, 232, 234, 236, 238, 240, 242, 244, 246, 248,
250, 252, 254, 256, 258, 260, 262, 264, 266, 268, 270, 272, 274,
276, 278, 280, 282, 284, 286, 288, 290, 292, 294, 296, 298, 300,
302, 304, 306, 308, 310, 312, 314, 316, 318, 320, 322, 324, 326,
328, 330, 332, 334, 336, 338, 340, 342, 344, 346, 348, 350, 352,
354, 356, 358, 360, 362, 364 1 4 NUE_OEX_1 B0242 E. coli 381
Plastidic 383, 385, 387, 389, 391, 393, 395, 397, 399, 401, 403,
405, 407, 409, 411, 413, 415, 417, 419, 421, 423, 425, 427, 429,
431, 433, 435, 437, 439, 441, 443, 445, 447, 449, 451, 453, 455,
457, 459, 461, 463, 465, 467, 469, 471, 473, 475, 477, 479, 481,
483, 485, 487, 489, 491, 493, 495, 497, 499, 501, 503, 505, 507,
509, 511, 513, 515, 517, 519, 521, 523, 525, 527, 529, 531, 533,
535, 537, 539, 541, 543, 545, 547, 549, 551, 553, 555, 557, 559,
561, 563, 565, 567, 569, 571, 573, 575, 577, 579, 581, 583, 585,
587, 589, 591, 593, 595, 597, 599, 601, 603, 605, 607, 609, 611,
613, 615, 617, 619, 621, 623, 625, 627, 629, 631, 633, 635, 637,
639, 641, 643, 645, 647, 649, 651, 653, 655, 657, 659, 661 1 5
NUE_OEX_1 B0403 E. coli 680 Plastidic 682, 684, 686, 688, 690, 692,
694, 696, 698, 700, 702, 704, 706, 708, 710, 712, 714, 716, 718,
720, 722, 724, 726, 728, 730, 732, 734, 736, 738, 740, 742, 744,
746, 748, 750, 752, 754, 756, 758, 760, 762, 764, 766, 768, 770,
772, 774, 776, 778, 780, 782, 784, 786, 788, 790, 792, 794, 796,
798, 800 1 6 NUE_OEX_1 B0474 E. coli 813 Cytoplasmic 815, 817, 819,
821, 823, 825, 827, 829, 831, 833, 835, 837, 839, 841, 843, 845,
847, 849, 851, 853, 855, 857, 859, 861, 863, 865, 867, 869, 871,
873, 875, 877, 879, 881, 883, 885, 887, 889, 891, 893, 895, 897,
899, 901, 903, 905, 907, 909, 911, 913, 915, 917, 919, 921, 923,
925, 927, 929, 931, 933, 935, 937, 939, 941, 943, 945, 947, 949,
951, 953, 955, 957 1 7 NUE_OEX_1 B0754 E. coli 1056 Plastidic 1058,
1060, 1062, 1064, 1066, 1068, 1070, 1072, 1074, 1076, 1078, 1080,
1082, 1084, 1086, 1088, 1090, 1092, 1094, 1096, 1098, 1100, 1102,
1104, 1106, 1108, 1110, 1112, 1114, 1116, 1118, 1120, 1122, 1124,
1126, 1128, 1130, 1132, 1134, 1136, 1138, 1140, 1142, 1144, 1146,
1148, 1150, 1152, 1154, 1156, 1158, 1160, 1162, 1164, 1166, 1168,
1170, 1172, 1174, 1176, 1178, 1180, 1182, 1184, 1186, 1188, 1190,
1192, 1194, 1196, 1198, 1200, 1202, 1204, 1206, 1208, 1210, 1212,
1214, 1216, 1218, 1220, 1222, 1224, 1226, 1228, 1230, 1232, 1234,
1236, 1238, 1240, 1242, 1244, 1246, 1248, 1250, 1252, 1254, 1256,
1258, 1260, 1262, 1264, 1266, 1268, 1270, 1272, 1274, 1276, 1278,
1280, 1282, 1284, 1286, 1288, 1290, 1292, 1294, 1296, 1298, 1300,
1302, 1304, 1306, 1308, 1310, 1312, 1314, 1316, 1318, 1320, 1322,
1324, 1326, 1328, 1330, 1332, 1334, 1336, 1338, 1340, 1342, 1344,
1346, 1348, 1350, 1352, 1354, 1356, 1358, 1360, 1362, 1364, 1366,
1368, 1370, 1372, 1374, 1376, 1378, 1380, 1382, 1384, 1386, 1388,
1390, 1392, 1394, 1396, 1398, 1400, 1402, 1404, 1406, 1408, 1410,
1412, 1414, 1416, 1418, 1420, 1422, 1424, 1426, 1428, 1430, 1432,
1434, 1436, 1438, 1440, 1442, 1444, 1446, 1448, 1450, 1452, 1454,
1456, 1458, 1460, 1462, 1464, 1466, 1468, 1470, 1472, 1474, 1476,
1478, 1480, 1482, 1484, 1486, 1488, 1490, 1492, 1494, 1496, 1498,
1500, 1502, 1504, 1506, 1508, 1510, 1512, 1514, 1516, 1518, 1520,
1522, 1524, 1526, 1528, 1530, 1532, 1534, 1536, 1538, 1540, 1542,
1544, 1546, 1548, 1550 1 8 NUE_OEX_1 B0784 E. coli 1564 Cytoplasmic
1566, 1568, 1570, 1572, 1574, 1576, 1578, 1580, 1582, 1584, 1586,
1588, 1590, 1592, 1594, 1596, 1598, 1600, 1602, 1604, 1606, 1608,
1610, 1612, 1614, 1616, 1618, 1620, 1622, 1624, 1626, 1628, 1630,
1632, 1634, 1636, 1638, 1640, 1642, 1644, 1646, 1648, 1650, 1652,
1654, 1656, 1658, 1660, 1662, 1664, 1666, 1668, 1670, 1672, 1674,
1676, 1678, 1680, 1682, 1684, 1686, 1688, 1690, 1692, 1694, 1696,
1698, 1700 1 9 NUE_OEX_1 B0873 E. coli 1706 Plastidic 1708, 1710,
1712, 1714, 1716, 1718, 1720, 1722, 1724, 1726, 1728, 1730, 1732,
1734, 1736, 1738, 1740, 1742, 1744, 1746, 1748, 1750, 1752, 1754,
1756, 1758, 1760, 1762, 1764, 1766, 1768, 1770, 1772, 1774, 1776,
1778, 1780, 1782, 1784, 1786, 1788, 1790, 1792, 1794, 1796, 1798,
1800, 1802, 1804, 1806, 1808, 1810, 1812, 1814, 1816, 1818, 1820,
1822, 1824, 1826, 1828, 1830 1 10 NUE_OEX_1 B1014 E. coli 1845
Cytoplasmic 1847, 1849, 1851, 1853, 1855, 1857, 1859, 1861, 1863,
1865, 1867, 1869, 1871, 1873, 1875, 1877, 1879, 1881, 1883, 1885,
1887, 1889, 1891, 1893, 1895, 1897, 1899, 1901, 1903, 1905, 1907,
1909, 1911, 1913, 1915, 1917, 1919, 1921, 1923, 1925, 1927, 1929,
1931 1 11 NUE_OEX_1 B1020 E. coli 1951 Plastidic 1953, 1955, 1957,
1959, 1961, 1963, 1965 1 12 NUE_OEX_1 B1180 E. coli 1976
Cytoplasmic 1978, 1980, 1982, 1984, 1986, 1988, 1990, 1992, 1994,
1996, 1998, 2000, 2002, 2004, 2006, 2008, 2010, 2012, 2014, 2016,
2018, 2020, 2022, 2024, 2026, 2028, 2030, 2032, 2034, 2036, 2038,
2040, 2042, 2044, 2046, 2048, 2050, 2052, 2054, 2056, 2058, 2060,
2062, 2064, 2066, 2068, 2070, 2072, 2074, 2076, 2078, 2080, 2082,
2084, 2086, 2088, 2090, 2092, 2094, 2096, 2098 1 13 NUE_OEX_1 B1933
E. coli 2128 Plastidic 2130, 2132 1 14 NUE_OEX_1 B2032 E. coli 2136
Plastidic 2138, 2140, 2142, 2144, 2146, 2148, 2150, 2152, 2154,
2156, 2158, 2160, 2162, 2164, 2166 1 15 NUE_OEX_1 B2165 E. coli
2172 Plastidic 2174, 2176, 2178, 2180, 2182, 2184, 2186, 2188,
2190, 2192, 2194, 2196, 2198, 2200, 2202, 2204, 2206, 2208, 2210,
2212, 2214, 2216, 2218, 2220, 2222, 2224, 2226, 2228, 2230, 2232,
2234, 2236, 2238, 2240, 2242, 2244, 2246, 2248, 2250, 2252, 2254,
2256, 2258, 2260, 2262, 2264, 2266, 2268, 2270, 2272, 2274, 2276,
2278, 2280, 2282, 2284 1 16 NUE_OEX_1 B2223 E. coli 2298 Plastidic
2300, 2302, 2304, 2306, 2308, 2310, 2312, 2314, 2316, 2318, 2320,
2322, 2324, 2326, 2328, 2330, 2332, 2334, 2336, 2338, 2340, 2342,
2344, 2346, 2348, 2350, 2352, 2354, 2356, 2358, 2360, 2362, 2364,
2366, 2368, 2370, 2372, 2374, 2376, 2378, 2380, 2382, 2384, 2386,
2388, 2390, 2392, 2394, 2396, 2398, 2400, 2402, 2404, 2406, 2408,
2410, 2412, 2414, 2416, 2418 1 17 NUE_OEX_1 B2238 E. coli 2427
Plastidic 2429, 2431, 2433, 2435, 2437, 2439, 2441, 2443 1 17
NUE_OEX_1 B2238 E. coli 2427 Cytoplasmic 2429, 2431, 2433, 2435,
2437, 2439, 2441, 2443 1 18 NUE_OEX_1 B2310 E. coli 2453 Plastidic
2455, 2457, 2459, 2461, 2463, 2465, 2467, 2469, 2471, 2473, 2475,
2477, 2479, 2481, 2483, 2485, 2487, 2489, 2491, 2493, 2495, 2497,
2499, 2501, 2503, 2505, 2507, 2509, 2511, 2513, 2515, 2517, 2519,
2521, 2523, 2525, 2527, 2529, 2531, 2533, 2535, 2537, 2539, 2541,
2543 1 19 NUE_OEX_1 B2431 E. coli 2552 Plastidic 2554, 2556, 2558,
2560, 2562, 2564, 2566, 2568, 2570, 2572, 2574, 2576, 2578, 2580,
2582, 2584, 2586, 2588, 2590 1 20 NUE_OEX_1 B2600 E. coli 2601
Plastidic 2603, 2605, 2607, 2609, 2611, 2613, 2615, 2617, 2619,
2621, 2623, 2625, 2627, 2629, 2631, 2633, 2635, 2637, 2639, 2641,
2643, 2645, 2647, 2649, 2651, 2653, 2655, 2657 1 21 NUE_OEX_1 B2766
E. coli 2669 Plastidic 2671, 2673, 2675, 2677, 2679, 2681, 2683,
2685, 2687, 2689, 2691, 2693, 2695, 2697, 2699, 2701, 2703, 2705,
2707, 2709, 2711, 2713, 2715, 2717, 2719, 2721, 2723, 2725, 2727,
2729, 2731, 2733, 2735, 2737, 2739, 2741, 2743, 2745, 2747, 2749,
2751, 2753, 2755, 2757, 2759, 2761, 2763, 2765 1 22 NUE_OEX_1 B2903
E. coli 2773 Cytoplasmic 2775, 2777, 2779, 2781, 2783, 2785, 2787,
2789, 2791, 2793, 2795, 2797, 2799, 2801, 2803, 2805, 2807, 2809,
2811, 2813, 2815, 2817, 2819, 2821, 2823, 2825, 2827, 2829, 2831,
2833, 2835, 2837, 2839, 2841, 2843, 2845, 2847, 2849, 2851, 2853,
2855, 2857, 2859, 2861, 2863, 2865, 2867, 2869, 2871, 2873, 2875,
2877, 2879, 2881, 2883, 2885, 2887, 2889, 2891, 2893, 2895, 2897,
2899, 2901, 2903, 2905, 2907, 2909, 2911, 2913, 2915, 2917, 2919,
2921, 2923, 2925, 2927, 2929, 2931, 2933, 2935, 2937, 2939, 2941,
2943, 2945, 2947, 2949, 2951, 2953, 2955, 2957, 2959, 2961, 2963,
2965, 2967, 2969, 2971, 2973, 2975, 2977, 2979, 2981, 2983, 2985,
2987, 2989, 2991, 2993, 2995, 2997, 2999, 3001, 3003, 3005, 3007,
3009, 3011, 3013, 3015, 3017, 3019, 3021, 3023, 3025, 3027, 3029,
3031, 3033, 3035, 3037, 3039, 3041, 3043, 3045, 3047, 3049, 3051,
3053, 3055, 3057, 3059, 3061, 3063, 3065, 3067, 3069, 3071, 3073,
3075, 3077, 3079, 3081, 3083, 3085, 3087, 3089, 3091, 3093, 3095 1
23 NUE_OEX_1 B3117 E. coli 3118 Plastidic 3120, 3122, 3124, 3126,
3128, 3130, 3132, 3134, 3136, 3138, 3140, 3142, 3144, 3146, 3148,
3150, 3152, 3154, 3156, 3158, 3160, 3162, 3164, 3166, 3168, 3170,
3172, 3174, 3176, 3178, 3180, 3182, 3184, 3186, 3188, 3190, 3192,
3194, 3196, 3198, 3200, 3202, 3204, 3206, 3208, 3210, 3212, 3214,
3216, 3218, 3220, 3222, 3224, 3226, 3228, 3230, 3232, 3234, 3236,
3238, 3240, 3242, 3244, 3246, 3248, 3250, 3252, 3254, 3256, 3258,
3260, 3262, 3264, 3266, 3268, 3270, 3272, 3274, 3276, 3278, 3280,
3282, 3284, 3286, 3288, 3290, 3292, 3294, 3296, 3298, 3300, 3302,
3304, 3306, 3308, 3310, 3312, 3314, 3316, 3318, 3320, 3322, 3324,
3326, 3328, 3330, 3332, 3334, 3336, 3338, 3340, 3342, 3344, 3346,
3348, 3350, 3352, 3354, 3356, 3358, 3360, 3362, 3364, 3366, 3368,
3370, 3372 1 24 NUE_OEX_1 B3120 E. coli 3391 Plastidic 3393 1 25
NUE_OEX_1 B3216 E. coli 3397 Plastidic 3399, 3401, 3403, 3405,
3407, 3409, 3411, 3413, 3415, 3417, 3419, 3421, 3423, 3425, 3427,
3429, 3431, 3433, 3435, 3437, 3439, 3441, 3443, 3445, 3447, 3449,
3451, 3453, 3455, 3457, 3459, 3461, 3463, 3465 1 26 NUE_OEX_1 B3451
E. coli 3471 Plastidic 3473, 3475, 3477, 3479, 3481, 3483, 3485,
3487, 3489, 3491, 3493, 3495, 3497, 3499, 3501, 3503, 3505, 3507,
3509, 3511, 3513, 3515, 3517, 3519, 3521, 3523, 3525, 3527, 3529,
3531, 3533, 3535, 3537, 3539, 3541, 3543, 3545, 3547, 3549, 3551,
3553, 3555 1 27 NUE_OEX_1 B3791 E. coli 3564 Cytoplasmic 3566,
3568, 3570, 3572, 3574, 3576, 3578, 3580, 3582, 3584, 3586, 3588,
3590, 3592, 3594, 3596, 3598, 3600, 3602, 3604, 3606, 3608, 3610,
3612, 3614, 3616, 3618, 3620, 3622, 3624, 3626, 3628, 3630, 3632,
3634, 3636, 3638, 3640, 3642, 3644, 3646, 3648, 3650, 3652, 3654,
3656, 3658, 3660, 3662, 3664, 3666, 3668, 3670, 3672, 3674, 3676,
3678, 3680, 3682, 3684, 3686, 3688, 3690, 3692, 3694, 3696, 3698,
3700, 3702, 3704, 3706, 3708, 3710, 3712, 3714, 3716, 3718, 3720,
3722, 3724, 3726, 3728, 3730, 3732, 3734, 3736, 3738, 3740, 3742,
3744, 3746, 3748, 3750, 3752, 3754, 3756, 3758, 3760, 3762, 3764 1
28 NUE_OEX_1 B3825 E. coli 3771 Plastidic 3773, 3775, 3777, 3779,
3781, 3783, 3785, 3787, 3789, 3791, 3793, 3795, 3797, 3799, 3801,
3803, 3805, 3807, 3809, 3811, 3813, 3815, 3817, 3819, 3821, 3823,
3825, 3827, 3829, 3831, 3833, 3835, 3837, 3839, 3841, 3843, 3845,
3847, 3849, 3851, 3853, 3855, 3857, 3859, 3861, 3863 1 29 NUE_OEX_1
YAL019W S. cerevisiae 3869 Cytoplasmic 3871, 3873, 3875, 3877 1 30
NUE_OEX_1 YAR035W S. cerevisiae 3896 Cytoplasmic 3898, 3900, 3902,
3904, 3906, 3908, 3910, 3912, 3914, 3916, 3918, 3920, 3922, 3924,
3926, 3928, 3930, 3932, 3934, 3936, 3938, 3940 1 31 NUE_OEX_1
YBL021C S. cerevisiae 3954 Cytoplasmic 3956, 3958, 3960, 3962,
3964, 3966, 3968, 3970, 3972, 3974, 3976, 3978, 3980, 3982, 3984,
3986, 3988, 3990, 3992, 3994, 3996, 3998, 4000, 4002, 4004, 4006,
4008, 4010, 4012, 4014, 4016, 4018, 4020, 4022, 4024, 4026, 4028,
4030 1 32 NUE_OEX_1 YBR055C S. cerevisiae 4112 Cytoplasmic 4114,
4116, 4118, 4120, 4122, 4124, 4126, 4128, 4130, 4132, 4134, 4136,
4138, 4140 1 33 NUE_OEX_1 YBR128C S. cerevisiae 4150 Cytoplasmic
4152, 4154, 4156 1 34 NUE_OEX_1 YBR159W S. cerevisiae 4163
Cytoplasmic 4165, 4167, 4169, 4171, 4173, 4175, 4177, 4179, 4181,
4183, 4185, 4187, 4189, 4191, 4193, 4195, 4197, 4199, 4201, 4203,
4205, 4207, 4209, 4211, 4213 1 35 NUE_OEX_1 YBR243C S. cerevisiae
4236 Cytoplasmic 4238, 4240, 4242, 4244, 4246, 4248, 4250, 4252,
4254, 4256, 4258, 4260, 4262, 4264, 4266 1 35 NUE_OEX_1 YBR243C S.
cerevisiae 4236 Plastidic 4238, 4240, 4242, 4244, 4246, 4248, 4250,
4252, 4254, 4256, 4258, 4260, 4262, 4264, 4266 1 36 NUE_OEX_1
YBR262C S. cerevisiae 4281 Cytoplasmic 4283, 4285 1 37 NUE_OEX_1
YCR019W S. cerevisiae 4289 Cytoplasmic 4291, 4293, 4295, 4297,
4299, 4301, 4303, 4305 1 38 NUE_OEX_1 YDR070C S. cerevisiae 4316
Cytoplasmic 4318, 4320 1 39 NUE_OEX_1 YDR079W S. cerevisiae 4326
Cytoplasmic 4328, 4330 1 40 NUE_OEX_1 YDR123C S. cerevisiae 4336
Cytoplasmic 4338, 4340 1 41 NUE_OEX_1 YDR137W S. cerevisiae 4347
Cytoplasmic 4349, 4351 1 42 NUE_OEX_1 YDR294C S. cerevisiae 4362
Cytoplasmic 4364, 4366, 4368, 4370, 4372, 4374, 4376, 4378, 4380,
4382, 4384, 4386, 4388, 4390 1 42 NUE_OEX_1 YDR294C S. cerevisiae
4362 Plastidic 4364, 4366, 4368, 4370, 4372, 4374, 4376, 4378,
4380, 4382, 4384, 4386, 4388, 4390 1 43 NUE_OEX_1 YDR330W S.
cerevisiae 4403 Cytoplasmic 4405, 4407, 4409, 4411, 4413, 4415,
4417, 4419, 4421, 4423 1 44 NUE_OEX_1 YDR355C S. cerevisiae 4432
Cytoplasmic --
1 45 NUE_OEX_1 YDR430C S. cerevisiae 4436 Plastidic 4438, 4440,
4442, 4444, 4446, 4448, 4450, 4452, 4454, 4456, 4458, 4460, 4462,
4464, 4466, 4468 1 46 NUE_OEX_1 YDR472W S. cerevisiae 4486
Cytoplasmic 4488, 4490, 4492, 4494, 4496 1 47 NUE_OEX_1 YDR497C S.
cerevisiae 4507 Plastidic 4509, 4511, 4513, 4515, 4517, 4519, 4521,
4523, 4525, 4527, 4529, 4531, 4533, 4535, 4537, 4539, 4541, 4543,
4545, 4547, 4549, 4551, 4553, 4555, 4557, 4559, 4561, 4563, 4565,
4567, 4569, 4571, 4573, 4575, 4577, 4579, 4581, 4583, 4585, 4587,
4589, 4591, 4593, 4595, 4597, 4599, 4601, 4603, 4605, 4607, 4609,
4611, 4613, 4615, 4617, 4619, 4621, 4623, 4625, 4627, 4629, 4631,
4633, 4635, 4637, 4639, 4641, 4643, 4645, 4647, 4649, 4651, 4653,
4655, 4657, 4659, 4661, 4663, 4665, 4667, 4669, 4671, 4673, 4675,
4677, 4679, 4681, 4683, 4685, 4687, 4689, 4691, 4693, 4695, 4697,
4699, 4701, 4703, 4705, 4707, 4709, 4711, 4713, 4715, 4717, 4719,
4721, 4723, 4725, 4727, 4729, 4731, 4733, 4735, 4737 1 48 NUE_OEX_1
YER029C S. cerevisiae 4791 Cytoplasmic 4793, 4795, 4797, 4799 1 49
NUE_OEX_1 YFR007W S. cerevisiae 4807 Cytoplasmic 4809, 4811, 4813,
4815, 4817, 4819, 4821, 4823, 4825, 4827, 4829 1 50 NUE_OEX_1
YGL039W S. cerevisiae 4837 Cytoplasmic 4839, 4841, 4843, 4845,
4847, 4849, 4851, 4853, 4855, 4857, 4859, 4861, 4863, 4865, 4867,
4869, 4871, 4873, 4875, 4877, 4879, 4881, 4883, 4885, 4887, 4889,
4891, 4893, 4895, 4897, 4899, 4901, 4903, 4905, 4907, 4909, 4911,
4913, 4915, 4917, 4919, 4921, 4923, 4925, 4927, 4929, 4931, 4933,
4935, 4937, 4939, 4941, 4943, 4945, 4947, 4949, 4951, 4953, 4955,
4957, 4959, 4961, 4963, 4965, 4967, 4969, 4971, 4973, 4975, 4977,
4979, 4981, 4983, 4985, 4987, 4989, 4991, 4993, 4995, 4997, 4999,
5001, 5003, 5005, 5007, 5009, 5011, 5013, 5015, 5017, 5019, 5021,
5023, 5025, 5027, 5029, 5031, 5033, 5035, 5037, 5039, 5041, 5043,
5045, 5047, 5049, 5051, 5053, 5055, 5057, 5059, 5061, 5063, 5065,
5067, 5069, 5071, 5073, 5075, 5077, 5079, 5081, 5083, 5085, 5087,
5089, 5091, 5093, 5095, 5097, 5099, 5101, 5103, 5105, 5107, 5109,
5111, 5113, 5115, 5117, 5119, 5121, 5123, 5125, 5127, 5129, 5131,
5133, 5135, 5137, 5139, 5141, 5143, 5145, 5147, 5149, 5151, 5153,
5155, 5157, 5159, 5161, 5163, 5165, 5167, 5169, 5171, 5173, 5175,
5177, 5179, 5181, 5183, 5185, 5187, 5189, 5191, 5193, 5195, 5197,
5199, 5201, 5203, 5205, 5207, 5209, 5211, 5213 1 51 NUE_OEX_1
YGL043W S. cerevisiae 5312 Cytoplasmic 5314, 5316, 5318, 5320,
5322, 5324, 5326, 5328, 5330, 5332, 5334 1 52 NUE_OEX_1 YGR088W S.
cerevisiae 5347 Cytoplasmic 5349, 5351, 5353, 5355, 5357, 5359,
5361, 5363, 5365, 5367, 5369, 5371, 5373, 5375, 5377, 5379, 5381,
5383, 5385, 5387, 5389, 5391, 5393, 5395, 5397, 5399, 5401, 5403,
5405, 5407, 5409, 5411, 5413, 5415, 5417, 5419, 5421, 5423, 5425,
5427, 5429, 5431, 5433, 5435, 5437, 5439, 5441, 5443, 5445, 5447,
5449, 5451, 5453, 5455, 5457, 5459, 5461, 5463, 5465, 5467, 5469,
5471, 5473, 5475, 5477, 5479, 5481, 5483, 5485, 5487, 5489, 5491,
5493, 5495, 5497, 5499, 5501, 5503, 5505, 5507, 5509, 5511, 5513,
5515, 5517, 5519, 5521, 5523 1 53 NUE_OEX_1 YGR122C-A S. cerevisiae
5534 Cytoplasmic 5536, 5538, 5540, 5542, 5544, 5546 1 54 NUE_OEX_1
YGR142W S. cerevisiae 5552 Cytoplasmic 5554, 5556 1 55 NUE_OEX_1
YGR143W S. cerevisiae 5560 Cytoplasmic 5562, 5564, 5566, 5568,
5570, 5572, 5574, 5576, 5578, 5580, 5582, 5584, 5586 1 56 NUE_OEX_1
YGR165W S. cerevisiae 5603 Cytoplasmic 5605 1 57 NUE_OEX_1 YGR170W
S. cerevisiae 5609 Cytoplasmic 5611 1 58 NUE_OEX_1 YGR202C S.
cerevisiae 5615 Cytoplasmic 5617, 5619, 5621, 5623, 5625, 5627,
5629, 5631, 5633, 5635, 5637, 5639, 5641, 5643, 5645, 5647, 5649,
5651, 5653, 5655, 5657, 5659 1 59 NUE_OEX_1 YGR266W S. cerevisiae
5667 Cytoplasmic 5669, 5671, 5673, 5675, 5677, 5679, 5681, 5683,
5685, 5687 1 60 NUE_OEX_1 YGR282C S. cerevisiae 5702 Cytoplasmic
5704, 5706, 5708, 5710, 5712, 5714, 5716, 5718, 5720, 5722, 5724,
5726, 5728, 5730, 5732, 5734, 5736, 5738, 5740 1 61 NUE_OEX_1
YGR290W S. cerevisiae 5751 Cytoplasmic -- 1 62 NUE_OEX_1 YHL021C S.
cerevisiae 5755 Cytoplasmic 5757, 5759, 5761, 5763, 5765, 5767,
5769 1 63 NUE_OEX_1 YHL031C S. cerevisiae 5779 Cytoplasmic 5781,
5783, 5785, 5787, 5789, 5791, 5793, 5795, 5797, 5799, 5801, 5803,
5805, 5807 1 64 NUE_OEX_1 YHR011W S. cerevisiae 5813 Cytoplasmic
5815, 5817, 5819, 5821, 5823, 5825, 5827, 5829, 5831, 5833, 5835,
5837, 5839, 5841, 5843, 5845, 5847, 5849, 5851, 5853, 5855, 5857,
5859, 5861, 5863, 5865, 5867, 5869, 5871, 5873, 5875, 5877, 5879,
5881, 5883, 5885, 5887, 5889, 5891, 5893, 5895, 5897, 5899, 5901,
5903, 5905, 5907, 5909, 5911, 5913, 5915, 5917, 5919, 5921, 5923,
5925, 5927, 5929, 5931, 5933, 5935, 5937, 5939, 5941, 5943, 5945,
5947, 5949, 5951, 5953 1 65 NUE_OEX_1 YHR127W S. cerevisiae 5968
Cytoplasmic 5970 1 66 NUE_OEX_1 YHR137W S. cerevisiae 5974
Cytoplasmic 5976, 5978, 5980, 5982, 5984, 5986, 5988, 5990, 5992,
5994, 5996, 5998, 6000, 6002, 6004, 6006, 6008, 6010, 6012, 6014,
6016, 6018, 6020 1 66 NUE_OEX_1 YHR137W S. cerevisiae 5974
Plastidic 5976, 5978, 5980, 5982, 5984, 5986, 5988, 5990, 5992,
5994, 5996, 5998, 6000, 6002, 6004, 6006, 6008, 6010, 6012, 6014,
6016, 6018, 6020 1 67 NUE_OEX_1 YIL099W S. cerevisiae 6028
Cytoplasmic 6030, 6032, 6034, 6036, 6038, 6040, 6042, 6044, 6046,
6048, 6050, 6052, 6054, 6056, 6058, 6060, 6062, 6064, 6066, 6068,
6070, 6072, 6074, 6076, 6078, 6080, 6082, 6084, 6086, 6088, 6090,
6092, 6094, 6096, 6098 1 67 NUE_OEX_1 YIL099W S. cerevisiae 6028
Plastidic 6030, 6032, 6034, 6036, 6038, 6040, 6042, 6044, 6046,
6048, 6050, 6052, 6054, 6056, 6058, 6060, 6062, 6064, 6066, 6068,
6070, 6072, 6074, 6076, 6078, 6080, 6082, 6084, 6086, 6088, 6090,
6092, 6094, 6096, 6098 1 68 NUE_OEX_1 YIL147C S. cerevisiae 6108
Cytoplasmic 6110, 6112, 6114, 6116, 6118, 6120, 6122, 6124, 6126,
6128, 6130, 6132 1 69 NUE_OEX_1 YIR034C S. cerevisiae 6151
Cytoplasmic 6153, 6155, 6157, 6159, 6161, 6163, 6165, 6167, 6169,
6171, 6173, 6175, 6177, 6179, 6181, 6183, 6185 1 70 NUE_OEX_1
YJL013C S. cerevisiae 6199 Cytoplasmic 6201, 6203, 6205 1 71
NUE_OEX_1 YJL041W S. cerevisiae 6209 Cytoplasmic 6211, 6213, 6215,
6217, 6219, 6221, 6223, 6225, 6227, 6229, 6231, 6233, 6235 1 72
NUE_OEX_1 YJL064W S. cerevisiae 6243 Cytoplasmic -- 1 73 NUE_OEX_1
YJL067W S. cerevisiae 6247 Cytoplasmic -- 1 74 NUE_OEX_1 YJL094C S.
cerevisiae 6251 Cytoplasmic 6253, 6255, 6257, 6259, 6261, 6263,
6265, 6267, 6269, 6271, 6273, 6275, 6277, 6279, 6281, 6283, 6285 1
75 NUE_OEX_1 YJL171C S. cerevisiae 6298 Cytoplasmic 6300, 6302,
6304, 6306, 6308, 6310, 6312, 6314, 6316 1 76 NUE_OEX_1 YJL213W S.
cerevisiae 6327 Cytoplasmic 6329, 6331, 6333, 6335, 6337, 6339,
6341, 6343, 6345, 6347, 6349, 6351, 6353, 6355, 6357, 6359, 6361,
6363, 6365, 6367, 6369, 6371, 6373, 6375, 6377, 6379, 6381, 6383,
6385, 6387, 6389, 6391, 6393, 6395, 6397, 6399, 6401, 6403, 6405,
6407, 6409, 6411, 6413, 6415, 6417, 6419, 6421, 6423, 6425, 6427,
6429, 6431, 6433, 6435, 6437, 6439, 6441, 6443, 6445, 6447, 6449,
6451, 6453, 6455, 6457, 6459, 6461, 6463, 6465, 6467, 6469, 6471,
6473, 6475, 6477, 6479, 6481 1 77 NUE_OEX_1 YJR017C S. cerevisiae
6489 Cytoplasmic 6491, 6493, 6495, 6497, 6499, 6501, 6503, 6505,
6507, 6509, 6511, 6513, 6515, 6517, 6519, 6521, 6523, 6525, 6527,
6529, 6531, 6533, 6535, 6537, 6539, 6541 1 78 NUE_OEX_1 YJR058C S.
cerevisiae 6551 Cytoplasmic 6553, 6555, 6557, 6559, 6561, 6563,
6565, 6567, 6569, 6571, 6573, 6575, 6577, 6579, 6581, 6583, 6585,
6587, 6589, 6591, 6593, 6595, 6597, 6599, 6601, 6603, 6605, 6607,
6609, 6611, 6613, 6615, 6617, 6619, 6621, 6623, 6625, 6627, 6629,
6631, 6633, 6635, 6637, 6639, 6641, 6643, 6645, 6647, 6649, 6651,
6653, 6655, 6657, 6659, 6661 1 79 NUE_OEX_1 YJR117W S. cerevisiae
6701 Cytoplasmic 6703, 6705, 6707, 6709, 6711, 6713, 6715, 6717,
6719, 6721, 6723, 6725, 6727, 6729, 6731, 6733, 6735, 6737, 6739,
6741, 6743, 6745, 6747, 6749, 6751, 6753, 6755, 6757, 6759, 6761,
6763, 6765, 6767, 6769, 6771, 6773, 6775, 6777, 6779, 6781, 6783,
6785, 6787, 6789 1 80 NUE_OEX_1 YJR121W S. cerevisiae 6817
Cytoplasmic 6819, 6821, 6823, 6825, 6827, 6829, 6831, 6833, 6835,
6837, 6839, 6841, 6843, 6845, 6847, 6849, 6851, 6853, 6855, 6857,
6859, 6861, 6863, 6865, 6867, 6869, 6871, 6873, 6875, 6877, 6879,
6881, 6883, 6885, 6887, 6889, 6891, 6893, 6895, 6897, 6899, 6901,
6903, 6905, 6907, 6909, 6911, 6913, 6915, 6917, 6919, 6921, 6923,
6925, 6927, 6929, 6931, 6933, 6935, 6937, 6939, 6941, 6943, 6945,
6947, 6949, 6951, 6953, 6955, 6957, 6959, 6961, 6963, 6965, 6967,
6969, 6971, 6973, 6975, 6977, 6979, 6981, 6983, 6985, 6987, 6989,
6991, 6993, 6995, 6997, 6999, 7001, 7003, 7005, 7007, 7009, 7011,
7013, 7015, 7017, 7019, 7021, 7023, 7025, 7027, 7029, 7031, 7033,
7035, 7037, 7039, 7041, 7043, 7045, 7047, 7049, 7051, 7053, 7055,
7057, 7059, 7061, 7063, 7065, 7067, 7069, 7071, 7073, 7075, 7077,
7079, 7081, 7083, 7085, 7087, 7089, 7091, 7093, 7095, 7097, 7099,
7101, 7103, 7105, 7107, 7109, 7111, 7113, 7115, 7117, 7119, 7121,
7123, 7125, 7127, 7129, 7131, 7133, 7135, 7137, 7139, 7141, 7143,
7145, 7147, 7149, 7151, 7153, 7155, 7157, 7159, 7161, 7163, 7165,
7167, 7169, 7171, 7173, 7175, 7177, 7179, 7181, 7183, 7185, 7187,
7189, 7191, 7193, 7195, 7197, 7199, 7201, 7203, 7205, 7207, 7209,
7211, 7213, 7215, 7217, 7219, 7221, 7223, 7225, 7227, 7229, 7231,
7233, 7235, 7237, 7239, 7241, 7243, 7245, 7247, 7249, 7251, 7253,
7255, 7257, 7259, 7261, 7263, 7265, 7267, 7269, 7271, 7273, 7275,
7277, 7279, 7281, 7283, 7285, 7287, 7289, 7291, 7293, 7295, 7297,
7299, 7301, 7303, 7305, 7307, 7309, 7311, 7313, 7315, 7317, 7319,
7321, 7323, 7325, 7327, 7329, 7331, 7333, 7335 1 81 NUE_OEX_1
YJR131W S. cerevisiae 7367 Cytoplasmic 7369, 7371, 7373, 7375,
7377, 7379, 7381, 7383, 7385, 7387, 7389, 7391, 7393, 7395, 7397,
7399, 7401, 7403, 7405, 7407, 7409, 7411, 7413, 7415, 7417, 7419,
7421, 7423, 7425, 7427, 7429, 7431, 7433, 7435, 7437, 7439, 7441,
7443, 7445, 7447, 7449, 7451, 7453, 7455, 7457, 7459 1 82 NUE_OEX_1
YJR145C S. cerevisiae 7476 Cytoplasmic 7478, 7480, 7482, 7484,
7486, 7488, 7490, 7492, 7494, 7496, 7498, 7500, 7502, 7504, 7506,
7508, 7510, 7512, 7514, 7516, 7518, 7520, 7522, 7524, 7526, 7528,
7530, 7532, 7534, 7536, 7538, 7540, 7542, 7544, 7546, 7548, 7550,
7552, 7554, 7556, 7558 1 83 NUE_OEX_1 YKL084W S. cerevisiae 7603
Cytoplasmic 7605, 7607, 7609, 7611, 7613, 7615, 7617, 7619, 7621,
7623, 7625, 7627, 7629, 7631, 7633, 7635, 7637, 7639, 7641, 7643,
7645 1 84 NUE_OEX_1 YKL088W S. cerevisiae 7652 Cytoplasmic 7654 1
85 NUE_OEX_1 YKL100C S. cerevisiae 7662 Cytoplasmic 7664, 7666,
7668 1 86 NUE_OEX_1 YKL131W S. cerevisiae 7676 Cytoplasmic -- 1 87
NUE_OEX_1 YKL138C S. cerevisiae 7680 Cytoplasmic 7682, 7684, 7686,
7688, 7690, 7692, 7694, 7696, 7698, 7700, 7702, 7704 1 88 NUE_OEX_1
YKL178C S. cerevisiae 7711 Cytoplasmic 7713, 7715, 7717, 7719 1 89
NUE_OEX_1 YKL179C S. cerevisiae 7736 Cytoplasmic 7738, 7740, 7742,
7744, 7746, 7748, 7750, 7752, 7754, 7756, 7758, 7760, 7762, 7764,
7766, 7768 1 90 NUE_OEX_1 YKL193C S. cerevisiae 7779 Cytoplasmic
7781, 7783, 7785, 7787, 7789, 7791, 7793, 7795, 7797, 7799, 7801,
7803, 7805, 7807, 7809, 7811, 7813 1 91 NUE_OEX_1 YKL216W S.
cerevisiae 7830 Cytoplasmic 7832, 7834, 7836, 7838, 7840, 7842,
7844, 7846, 7848, 7850, 7852, 7854, 7856, 7858, 7860, 7862, 7864,
7866, 7868, 7870, 7872, 7874, 7876, 7878, 7880, 7882, 7884, 7886,
7888, 7890, 7892, 7894, 7896, 7898, 7900, 7902, 7904, 7906, 7908,
7910, 7912, 7914, 7916, 7918, 7920, 7922, 7924, 7926, 7928, 7930,
7932, 7934, 7936, 7938, 7940, 7942, 7944, 7946, 7948, 7950, 7952,
7954, 7956, 7958, 7960, 7962, 7964, 7966, 7968, 7970, 7972, 7974,
7976, 7978, 7980, 7982, 7984, 7986, 7988, 7990, 7992, 7994, 7996,
7998, 8000, 8002, 8004, 8006, 8008, 8010, 8012 1 92 NUE_OEX_1
YKR016W S. cerevisiae 8018 Cytoplasmic 8020, 8022, 8024, 8026,
8028, 8030, 8032, 8034, 8036, 8038 1 93 NUE_OEX_1 YKR021W S.
cerevisiae 8046 Cytoplasmic 8048, 8050, 8052, 8054, 8056, 8058,
8060 1 94 NUE_OEX_1 YKR055W S. cerevisiae 8074 Cytoplasmic 8076,
8078, 8080, 8082, 8084, 8086, 8088, 8090, 8092, 8094, 8096, 8098,
8100, 8102, 8104, 8106, 8108, 8110, 8112, 8114, 8116, 8118, 8120,
8122, 8124, 8126, 8128, 8130, 8132, 8134, 8136, 8138, 8140, 8142,
8144, 8146, 8148, 8150, 8152, 8154, 8156, 8158, 8160, 8162, 8164,
8166, 8168, 8170, 8172, 8174, 8176, 8178, 8180, 8182, 8184, 8186,
8188, 8190, 8192, 8194, 8196, 8198, 8200, 8202, 8204, 8206, 8208,
8210, 8212, 8214, 8216, 8218, 8220, 8222, 8224, 8226, 8228, 8230,
8232, 8234, 8236, 8238, 8240, 8242, 8244, 8246, 8248, 8250, 8252,
8254, 8256 1 95 NUE_OEX_1 YKR088C S. cerevisiae 8264 Plastidic
8266, 8268, 8270, 8272, 8274, 8276, 8278, 8280 1 96 NUE_OEX_1
YKR093W S. cerevisiae 8288 Cytoplasmic 8290, 8292, 8294, 8296,
8298, 8300, 8302, 8304, 8306, 8308, 8310, 8312, 8314, 8316, 8318,
8320, 8322, 8324, 8326, 8328, 8330, 8332, 8334, 8336, 8338, 8340,
8342, 8344, 8346, 8348, 8350, 8352, 8354, 8356, 8358, 8360, 8362,
8364, 8366, 8368, 8370, 8372, 8374, 8376, 8378, 8380, 8382, 8384,
8386, 8388, 8390, 8392, 8394, 8396, 8398, 8400, 8402, 8404, 8406,
8408, 8410, 8412, 8414, 8416, 8418, 8420, 8422, 8424, 8426, 8428,
8430, 8432, 8434, 8436, 8438, 8440, 8442 1 97 NUE_OEX_1 YKR099W S.
cerevisiae 8469 Cytoplasmic 8471, 8473 1 98 NUE_OEX_1 YKR100C S.
cerevisiae 8485 Cytoplasmic 8487, 8489 1 99 NUE_OEX_1 YLL014W S.
cerevisiae 8493 Cytoplasmic 8495, 8497, 8499, 8501, 8503, 8505,
8507, 8509 1 100 NUE_OEX_1 YLL016W S. cerevisiae 8515 Cytoplasmic
8517, 8519, 8521, 8523, 8525, 8527 1 101 NUE_OEX_1 YLL023C S.
cerevisiae 8540 Cytoplasmic 8542, 8544, 8546, 8548, 8550, 8552,
8554, 8556, 8558, 8560,
8562, 8564, 8566 1 102 NUE_OEX_1 YLL037W S. cerevisiae 8572
Cytoplasmic -- 1 103 NUE_OEX_1 YLL049W S. cerevisiae 8576
Cytoplasmic -- 1 104 NUE_OEX_1 YLL055W S. cerevisiae 8580
Cytoplasmic 8582, 8584, 8586, 8588, 8590, 8592, 8594, 8596, 8598,
8600, 8602, 8604, 8606, 8608, 8610, 8612, 8614, 8616, 8618, 8620,
8622, 8624, 8626, 8628, 8630, 8632, 8634, 8636, 8638, 8640, 8642,
8644, 8646, 8648, 8650, 8652, 8654, 8656 1 105 NUE_OEX_1 YLR034C S.
cerevisiae 8662 Cytoplasmic 8664, 8666, 8668, 8670, 8672, 8674,
8676, 8678, 8680, 8682, 8684, 8686, 8688, 8690, 8692, 8694, 8696,
8698, 8700, 8702, 8704, 8706, 8708, 8710, 8712, 8714, 8716, 8718,
8720, 8722, 8724, 8726, 8728, 8730, 8732, 8734, 8736, 8738, 8740,
8742, 8744, 8746, 8748, 8750, 8752, 8754, 8756, 8758, 8760, 8762,
8764, 8766, 8768, 8770, 8772, 8774, 8776, 8778, 8780, 8782, 8784,
8786, 8788, 8790, 8792, 8794, 8796, 8798, 8800, 8802, 8804, 8806,
8808, 8810, 8812, 8814, 8816, 8818, 8820, 8822, 8824, 8826, 8828,
8830, 8832, 8834, 8836, 8838, 8840, 8842, 8844, 8846, 8848, 8850,
8852, 8854, 8856, 8858, 8860, 8862, 8864, 8866, 8868, 8870, 8872,
8874, 8876, 8878, 8880, 8882, 8884, 8886, 8888, 8890, 8892, 8894,
8896, 8898, 8900, 8902, 8904, 8906, 8908, 8910, 8912, 8914, 8916,
8918, 8920, 8922, 8924, 8926, 8928, 8930, 8932, 8934, 8936, 8938,
8940, 8942, 8944, 8946, 8948, 8950, 8952, 8954, 8956, 8958, 8960,
8962 1 106 NUE_OEX_1 YLR042C S. cerevisiae 8992 Cytoplasmic -- 1
107 NUE_OEX_1 YLR053C S. cerevisiae 8996 Cytoplasmic -- 1 108
NUE_OEX_1 YLR058C S. cerevisiae 9000 Cytoplasmic 9002, 9004, 9006,
9008, 9010, 9012, 9014, 9016, 9018, 9020, 9022, 9024, 9026, 9028,
9030, 9032, 9034, 9036, 9038, 9040, 9042, 9044, 9046, 9048, 9050,
9052, 9054, 9056, 9058, 9060, 9062, 9064, 9066, 9068, 9070, 9072,
9074, 9076, 9078, 9080, 9082, 9084, 9086, 9088, 9090, 9092, 9094,
9096, 9098, 9100, 9102, 9104, 9106, 9108, 9110, 9112, 9114, 9116,
9118, 9120, 9122, 9124, 9126, 9128, 9130, 9132, 9134, 9136, 9138,
9140, 9142, 9144, 9146, 9148, 9150, 9152, 9154, 9156, 9158, 9160,
9162, 9164, 9166, 9168, 9170, 9172, 9174, 9176, 9178, 9180, 9182,
9184, 9186, 9188, 9190, 9192, 9194, 9196, 9198, 9200, 9202, 9204,
9206, 9208, 9210, 9212, 9214, 9216, 9218, 9220, 9222, 9224, 9226,
9228, 9230, 9232, 9234, 9236, 9238, 9240, 9242, 9244, 9246, 9248,
9250, 9252, 9254, 9256, 9258, 9260, 9262, 9264, 9266, 9268, 9270,
9272, 9274, 9276, 9278, 9280, 9282, 9284, 9286, 9288, 9290, 9292,
9294, 9296, 9298, 9300, 9302, 9304, 9306, 9308, 9310, 9312, 9314,
9316, 9318, 9320, 9322, 9324, 9326, 9328, 9330, 9332, 9334, 9336,
9338, 9340, 9342, 9344, 9346, 9348, 9350, 9352, 9354, 9356, 9358,
9360, 9362, 9364, 9366, 9368, 9370, 9372, 9374, 9376, 9378, 9380,
9382, 9384, 9386, 9388, 9390, 9392, 9394, 9396, 9398, 9400, 9402,
9404, 9406, 9408, 9410, 9412, 9414, 9416, 9418, 9420, 9422, 9424,
9426, 9428, 9430, 9432, 9434, 9436, 9438, 9440, 9442, 9444, 9446,
9448, 9450, 9452, 9454, 9456, 9458, 9460, 9462, 9464, 9466, 9468,
9470, 9472, 9474, 9476, 9478, 9480, 9482, 9484, 9486, 9488, 9490,
9492, 9494, 9496, 9498, 9500 1 109 NUE_OEX_1 YLR060W S. cerevisiae
9552 Cytoplasmic 9554, 9556, 9558, 9560, 9562, 9564, 9566, 9568,
9570, 9572, 9574, 9576, 9578, 9580, 9582, 9584, 9586, 9588, 9590,
9592, 9594, 9596, 9598, 9600, 9602, 9604, 9606, 9608, 9610, 9612,
9614, 9616, 9618, 9620, 9622, 9624, 9626, 9628 1 110 NUE_OEX_1
YLR065C S. cerevisiae 9638 Cytoplasmic 9640, 9642, 9644, 9646,
9648, 9650, 9652, 9654, 9656, 9658, 9660, 9662, 9664, 9666, 9668 1
111 NUE_OEX_1 YLR070C S. cerevisiae 9673 Cytoplasmic 9675, 9677,
9679, 9681, 9683, 9685, 9687, 9689, 9691, 9693, 9695, 9697, 9699,
9701, 9703, 9705, 9707, 9709, 9711, 9713, 9715, 9717, 9719, 9721,
9723, 9725, 9727, 9729, 9731, 9733, 9735, 9737, 9739, 9741, 9743,
9745, 9747, 9749, 9751, 9753, 9755, 9757, 9759, 9761, 9763, 9765,
9767, 9769, 9771, 9773, 9775, 9777, 9779, 9781, 9783, 9785, 9787,
9789, 9791, 9793, 9795, 9797, 9799, 9801, 9803, 9805, 9807, 9809,
9811, 9813, 9815, 9817, 9819, 9821, 9823, 9825, 9827, 9829, 9831,
9833, 9835, 9837, 9839, 9841, 9843, 9845, 9847, 9849, 9851, 9853,
9855, 9857, 9859, 9861, 9863, 9865, 9867, 9869, 9871, 9873, 9875,
9877, 9879, 9881, 9883, 9885, 9887, 9889, 9891, 9893, 9895, 9897,
9899, 9901, 9903, 9905, 9907, 9909, 9911, 9913, 9915, 9917, 9919,
9921, 9923, 9925, 9927, 9929, 9931, 9933, 9935, 9937, 9939, 9941,
9943, 9945, 9947, 9949, 9951, 9953, 9955, 9957, 9959, 9961, 9963,
9965, 9967, 9969, 9971, 9973, 9975, 9977, 9979, 9981, 9983, 9985,
9987, 9989, 9991, 9993, 9995, 9997, 9999, 10001, 10003, 10005,
10007, 10009, 10011, 10013, 10015, 10017, 10019, 10021, 10023,
10025, 10027, 10029, 10031, 10033, 10035, 10037, 10039, 10041,
10043, 10045, 10047, 10049, 10051, 10053, 10055, 10057, 10059,
10061, 10063, 10065, 10067, 10069, 10071, 10073, 10075, 10077,
10079, 10081, 10083, 10085, 10087, 10089, 10091, 10093, 10095,
10097, 10099, 10101, 10103, 10105, 10107, 10109, 10111, 10113,
10115, 10117 1 112 NUE_OEX_1 YLR100W S. cerevisiae 10183
Cytoplasmic 10185, 10187, 10189, 10191, 10193, 10195, 10197, 10199,
10201, 10203 1 113 NUE_OEX_1 YLR109W S. cerevisiae 10215
Cytoplasmic 10217, 10219, 10221, 10223, 10225, 10227, 10229, 10231,
10233, 10235, 10237, 10239, 10241, 10243, 10245, 10247, 10249,
10251, 10253, 10255, 10257, 10259, 10261, 10263, 10265, 10267,
10269, 10271, 10273, 10275, 10277, 10279, 10281, 10283, 10285,
10287, 10289, 10291, 10293, 10295, 10297, 10299, 10301, 10303,
10305, 10307, 10309, 10311, 10313, 10315, 10317, 10319, 10321,
10323, 10325, 10327, 10329, 10331, 10333, 10335, 10337, 10339,
10341, 10343, 10345, 10347, 10349, 10351, 10353, 10355, 10357,
10359, 10361, 10363, 10365, 10367, 10369, 10371, 10373, 10375,
10377, 10379, 10381, 10383, 10385, 10387, 10389, 10391, 10393,
10395, 10397, 10399, 10401, 10403, 10405, 10407, 10409, 10411,
10413, 10415, 10417 1 114 NUE_OEX_1 YLR125W S. cerevisiae 10448
Cytoplasmic -- 1 115 NUE_OEX_1 YLR127C S. cerevisiae 10452
Cytoplasmic 10454, 10456, 10458, 10460 1 116 NUE_OEX_1 YLR185W S.
cerevisiae 10464 Cytoplasmic 10466, 10468, 10470, 10472, 10474,
10476, 10478, 10480, 10482, 10484, 10486, 10488, 10490, 10492,
10494, 10496, 10498, 10500, 10502, 10504, 10506, 10508, 10510,
10512 1 117 NUE_OEX_1 YLR204W S. cerevisiae 10534 Cytoplasmic
10536, 10538 1 117 NUE_OEX_1 YLR204W S. cerevisiae 10534 Plastidic
10536, 10538 1 118 NUE_OEX_1 YLR242C S. cerevisiae 10542
Cytoplasmic 10544, 10546, 10548, 10550, 10552, 10554 1 119
NUE_OEX_1 YLR293C S. cerevisiae 10563 Cytoplasmic 10565, 10567,
10569, 10571, 10573, 10575, 10577, 10579, 10581, 10583, 10585,
10587, 10589, 10591, 10593, 10595, 10597, 10599, 10601, 10603,
10605, 10607, 10609, 10611, 10613, 10615, 10617, 10619, 10621,
10623, 10625, 10627, 10629, 10631, 10633, 10635, 10637, 10639,
10641, 10643, 10645, 10647, 10649, 10651, 10653, 10655, 10657,
10659, 10661, 10663, 10665, 10667, 10669, 10671, 10673, 10675,
10677, 10679, 10681, 10683, 10685, 10687, 10689, 10691, 10693,
10695, 10697, 10699, 10701, 10703, 10705, 10707, 10709, 10711,
10713 1 120 NUE_OEX_1 YLR313C S. cerevisiae 10991 Cytoplasmic
10993, 10995 1 121 NUE_OEX_1 YLR315W S. cerevisiae 10999
Cytoplasmic 11001 1 122 NUE_OEX_1 YLR329W S. cerevisiae 11005
Cytoplasmic 11007, 11009 1 123 NUE_OEX_1 YLR362W S. cerevisiae
11013 Cytoplasmic 11015, 11017, 11019, 11021, 11023, 11025, 11027,
11029, 11031, 11033, 11035, 11037, 11039, 11041, 11043 1 124
NUE_OEX_1 YLR395C S. cerevisiae 11055 Cytoplasmic 11057, 11059,
11061 1 125 NUE_OEX_1 YLR404W S. cerevisiae 11067 Cytoplasmic
11069, 11071 1 126 NUE_OEX_1 YLR463C S. cerevisiae 11075
Cytoplasmic 11077 1 127 NUE_OEX_1 YML022W S. cerevisiae 11081
Cytoplasmic 11083, 11085, 11087, 11089, 11091, 11093, 11095, 11097,
11099, 11101, 11103, 11105, 11107, 11109, 11111, 11113, 11115,
11117, 11119, 11121, 11123, 11125, 11127, 11129, 11131, 11133,
11135, 11137, 11139, 11141, 11143, 11145, 11147, 11149, 11151,
11153, 11155, 11157, 11159, 11161, 11163, 11165, 11167, 11169,
11171, 11173, 11175, 11177, 11179, 11181, 11183, 11185, 11187,
11189, 11191, 11193, 11195, 11197, 11199, 11201, 11203, 11205,
11207, 11209, 11211, 11213, 11215, 11217, 11219, 11221, 11223,
11225, 11227, 11229, 11231, 11233, 11235, 11237, 11239, 11241,
11243, 11245, 11247, 11249, 11251, 11253, 11255, 11257, 11259,
11261, 11263, 11265, 11267, 11269, 11271, 11273, 11275, 11277,
11279, 11281, 11283, 11285, 11287, 11289, 11291, 11293, 11295,
11297, 11299, 11301, 11303, 11305, 11307, 11309, 11311, 11313,
11315, 11317, 11319, 11321, 11323, 11325, 11327, 11329, 11331,
11333, 11335, 11337, 11339, 11341, 11343, 11345, 11347, 11349,
11351, 11353, 11355, 11357, 11359, 11361, 11363, 11365, 11367,
11369, 11371, 11373, 11375, 11377, 11379, 11381, 11383, 11385,
11387, 11389, 11391, 11393, 11395, 11397, 11399, 11401, 11403,
11405, 11407, 11409, 11411, 11413, 11415, 11417, 11419, 11421,
11423, 11425, 11427, 11429, 11431, 11433, 11435, 11437, 11439,
11441, 11443, 11445, 11447, 11449, 11451, 11453, 11455, 11457,
11459, 11461, 11463, 11465, 11467, 11469, 11471, 11473, 11475,
11477, 11479, 11481, 11483, 11485, 11487, 11489, 11491, 11493,
11495, 11497, 11499, 11501, 11503, 11505, 11507, 11509, 11511,
11513, 11515, 11517, 11519, 11521, 11523, 11525 1 128 NUE_OEX_1
YML027W S. cerevisiae 11553 Cytoplasmic 11555, 11557, 11559, 11561,
11563 1 129 NUE_OEX_1 YML065W S. cerevisiae 11570 Cytoplasmic
11572, 11574, 11576, 11578, 11580, 11582, 11584, 11586 1 130
NUE_OEX_1 YML089C S. cerevisiae 11597 Cytoplasmic -- 1 131
NUE_OEX_1 YML128C S. cerevisiae 11601 Cytoplasmic 11603, 11605,
11607, 11609 1 132 NUE_OEX_1 YMR011W S. cerevisiae 11613
Cytoplasmic 11615, 11617, 11619, 11621, 11623, 11625, 11627, 11629,
11631, 11633, 11635, 11637, 11639, 11641, 11643, 11645, 11647,
11649, 11651, 11653, 11655, 11657, 11659, 11661, 11663, 11665,
11667, 11669, 11671, 11673, 11675, 11677, 11679, 11681, 11683,
11685, 11687, 11689, 11691, 11693, 11695, 11697, 11699, 11701,
11703, 11705, 11707, 11709, 11711, 11713, 11715, 11717, 11719,
11721, 11723, 11725, 11727, 11729, 11731, 11733, 11735, 11737,
11739, 11741, 11743, 11745, 11747, 11749, 11751, 11753, 11755,
11757, 11759, 11761, 11763, 11765, 11767, 11769, 11771, 11773,
11775, 11777, 11779, 11781, 11783, 11785, 11787, 11789, 11791,
11793, 11795, 11797, 11799, 11801, 11803, 11805, 11807, 11809,
11811, 11813, 11815, 11817, 11819, 11821, 11823, 11825, 11827,
11829, 11831, 11833, 11835, 11837, 11839, 11841, 11843, 11845,
11847, 11849, 11851, 11853, 11855, 11857, 11859, 11861, 11863,
11865, 11867, 11869, 11871, 11873, 11875, 11877, 11879, 11881,
11883, 11885, 11887, 11889, 11891, 11893, 11895, 11897, 11899,
11901, 11903, 11905, 11907, 11909, 11911, 11913, 11915, 11917,
11919, 11921, 11923, 11925, 11927, 11929, 11931, 11933, 11935,
11937, 11939, 11941, 11943, 11945, 11947, 11949, 11951, 11953,
11955, 11957, 11959, 11961, 11963, 11965, 11967, 11969, 11971,
11973, 11975, 11977, 11979, 11981, 11983, 11985, 11987, 11989,
11991, 11993, 11995, 11997, 11999, 12001, 12003, 12005, 12007,
12009, 12011, 12013, 12015, 12017, 12019, 12021, 12023, 12025,
12027, 12029, 12031, 12033, 12035, 12037, 12039, 12041, 12043,
12045, 12047, 12049, 12051, 12053, 12055, 12057, 12059, 12061,
12063, 12065, 12067, 12069, 12071, 12073, 12075, 12077, 12079,
12081, 12083, 12085, 12087, 12089, 12091, 12093, 12095, 12097,
12099, 12101, 12103, 12105, 12107, 12109, 12111, 12113, 12115,
12117, 12119, 12121, 12123 1 133 NUE_OEX_1 YMR037C S. cerevisiae
12247 Cytoplasmic 12249, 12251, 12253, 12255 1 134 NUE_OEX_1
YMR049C S. cerevisiae 12264 Cytoplasmic 12266, 12268, 12270, 12272,
12274, 12276, 12278, 12280, 12282, 12284, 12286, 12288, 12290,
12292, 12294, 12296, 12298 1 135 NUE_OEX_1 YMR052W S. cerevisiae
12317 Cytoplasmic 12319, 12321 1 136 NUE_OEX_1 YMR082C S.
cerevisiae 12328 Cytoplasmic -- 1 137 NUE_OEX_1 YMR125W S.
cerevisiae 12332 Cytoplasmic 12334, 12336, 12338, 12340, 12342,
12344, 12346, 12348, 12350, 12352, 12354, 12356, 12358, 12360,
12362, 12364, 12366 1 138 NUE_OEX_1 YMR126C S. cerevisiae 12379
Cytoplasmic 12381, 12383, 12385 1 139 NUE_OEX_1 YMR144W S.
cerevisiae 12395 Cytoplasmic 12397, 12399 1 140 NUE_OEX_1 YMR160W
S. cerevisiae 12407 Cytoplasmic 12409, 12411 1 141 NUE_OEX_1
YMR191W S. cerevisiae 12415 Cytoplasmic 12417 1 142 NUE_OEX_1
YMR209C S. cerevisiae 12421 Cytoplasmic 12423, 12425, 12427, 12429
1 143 NUE_OEX_1 YMR233W S. cerevisiae 12441 Cytoplasmic 12443,
12445, 12447, 12449, 12451, 12453, 12455, 12457, 12459, 12461,
12463, 12465 1 144 NUE_OEX_1 YMR278W S. cerevisiae 12471
Cytoplasmic 12473, 12475, 12477, 12479, 12481, 12483, 12485, 12487,
12489, 12491, 12493, 12495, 12497, 12499, 12501, 12503, 12505,
12507, 12509, 12511, 12513, 12515, 12517, 12519, 12521, 12523,
12525, 12527, 12529, 12531, 12533, 12535, 12537, 12539, 12541,
12543, 12545, 12547, 12549, 12551, 12553, 12555, 12557, 12559,
12561, 12563, 12565, 12567, 12569, 12571, 12573, 12575, 12577,
12579, 12581, 12583, 12585, 12587, 12589, 12591, 12593, 12595,
12597, 12599, 12601, 12603, 12605, 12607, 12609, 12611, 12613,
12615, 12617, 12619, 12621, 12623, 12625, 12627, 12629, 12631,
12633, 12635, 12637, 12639, 12641, 12643, 12645, 12647, 12649,
12651, 12653, 12655, 12657, 12659, 12661, 12663, 12665, 12667,
12669, 12671, 12673, 12675, 12677, 12679, 12681, 12683, 12685,
12687, 12689, 12691, 12693, 12695, 12697, 12699, 12701, 12703,
12705, 12707, 12709, 12711, 12713, 12715, 12717, 12719, 12721,
12723, 12725, 12727, 12729, 12731, 12733, 12735, 12737, 12739 1 145
NUE_OEX_1 YMR280C S. cerevisiae 12750 Cytoplasmic 12752, 12754,
12756 1 146 NUE_OEX_1 YNL014W S. cerevisiae 12774 Cytoplasmic
12776, 12778, 12780, 12782, 12784, 12786, 12788, 12790, 12792,
12794, 12796, 12798, 12800, 12802, 12804, 12806, 12808, 12810 1 147
NUE_OEX_1 YNL320W S. cerevisiae 12830 Cytoplasmic 12832, 12834,
12836, 12838, 12840, 12842, 12844, 12846,
12848, 12850, 12852, 12854, 12856, 12858, 12860, 12862, 12864,
12866 1 148 NUE_OEX_1 YOL007C S. cerevisiae 12884 Cytoplasmic 12886
1 149 NUE_OEX_1 YOL164W S. cerevisiae 12890 Cytoplasmic 12892,
12894, 12896, 12898, 12900, 12902, 12904, 12906, 12908, 12910,
12912, 12914, 12916, 12918, 12920, 12922, 12924, 12926, 12928,
12930, 12932, 12934, 12936, 12938, 12940, 12942, 12944, 12946,
12948, 12950, 12952, 12954, 12956, 12958, 12960, 12962, 12964,
12966, 12968, 12970, 12972, 12974, 12976, 12978, 12980, 12982,
12984, 12986, 12988, 12990, 12992, 12994, 12996, 12998, 13000 1 150
NUE_OEX_1 YOR076C S. cerevisiae 13015 Cytoplasmic -- 1 151
NUE_OEX_1 YOR083W S. cerevisiae 13019 Cytoplasmic 13021 1 152
NUE_OEX_1 YOR097C S. cerevisiae 13025 Cytoplasmic 13027 1 153
NUE_OEX_1 YOR128C S. cerevisiae 13031 Cytoplasmic 13033, 13035,
13037, 13039, 13041, 13043, 13045, 13047, 13049, 13051, 13053,
13055, 13057, 13059, 13061, 13063, 13065, 13067, 13069, 13071,
13073, 13075, 13077, 13079, 13081, 13083, 13085, 13087, 13089,
13091, 13093, 13095, 13097 1 154 NUE_OEX_1 YOR353C S. cerevisiae
14086 Cytoplasmic 14088, 14090 1 155 NUE_OEX_1 YPL141C S.
cerevisiae 14094 Cytoplasmic 14096, 14098, 14100 1 156 NUE_OEX_1
YPR088C S. cerevisiae 14114 Cytoplasmic 14116, 14118, 14120, 14122,
14124, 14126, 14128, 14130, 14132, 14134, 14136, 14138, 14140,
14142, 14144, 14146, 14148, 14150, 14152, 14154, 14156, 14158,
14160, 14162, 14164, 14166, 14168, 14170, 14172, 14174, 14176,
14178, 14180, 14182, 14184, 14186, 14188, 14190, 14192, 14194,
14196, 14198, 14200, 14202, 14204, 14206, 14208, 14210, 14212,
14214 1 157 NUE_OEX_1 YPR108W S. cerevisiae 14247 Cytoplasmic
14249, 14251, 14253, 14255, 14257, 14259, 14261, 14263, 14265,
14267, 14269, 14271, 14273, 14275, 14277, 14279, 14281, 14283,
14285, 14287, 14289 1 158 NUE_OEX_1 YPR110C S. cerevisiae 14312
Cytoplasmic 14314, 14316, 14318, 14320, 14322, 14324, 14326, 14328,
14330, 14332, 14334, 14336, 14338, 14340, 14342, 14344, 14346,
14348, 14350, 14352, 14354, 14356, 14358, 14360, 14362, 14364,
14366, 14368, 14370, 14372 1 159 NUE_OEX_1 B3825_2 E. coli 14915
Plastidic 14917, 14919, 14921, 14923, 14925, 14927, 14929, 14931,
14933, 14935, 14937, 14939, 14941, 14943, 14945, 14947, 14949,
14951, 14953, 14955, 14957, 14959, 14961, 14963, 14965, 14967,
14969, 14971, 14973, 14975, 14977, 14979, 14981, 14983, 14985,
14987, 14989, 14991, 14993, 14995, 14997, 14999, 15001, 15003,
15005, 15007, 15009 1 160 NUE_OEX_1 YIR034C_2 S. cerevisiae 15383
Cytoplasmic 15385, 15387, 15389, 15391, 15393, 15395, 15397, 15399,
15401, 15403, 15405, 15407, 15409, 15411, 15413, 15415, 15417,
15419 1 161 NUE_OEX_1 YJR131W_2 S. cerevisiae 15461 Cytoplasmic
15463, 15465, 15467, 15469, 15471, 15473, 15475, 15477, 15479,
15481, 15483, 15485, 15487, 15489, 15491, 15493, 15495, 15497,
15499, 15501, 15503, 15505, 15507, 15509, 15511, 15513, 15515,
15517, 15519, 15521, 15523, 15525, 15527, 15529, 15531, 15533,
15535, 15537, 15539, 15541, 15543, 15545, 15547, 15549, 15551,
15553, 15555 1 162 NUE_OEX_1 YKL100C_2 S. cerevisiae 15572
Cytoplasmic 15574, 15576, 15578, 15580 1 163 NUE_OEX_1 YKL193C_2 S.
cerevisiae 15594 Cytoplasmic 15596, 15598, 15600, 15602, 15604,
15606, 15608, 15610, 15612, 15614, 15616, 15618, 15620, 15622,
15624, 15626, 15628, 15630 1 164 NUE_OEX_1 YLL016W_2 S. cerevisiae
15647 Cytoplasmic 15649, 15651, 15653, 15655, 15657, 15659, 15661 1
165 NUE_OEX_1 YLR034C_2 S. cerevisiae 15674 Cytoplasmic 15676,
15678, 15680, 15682, 15684, 15686, 15688, 15690, 15692, 15694,
15696, 15698, 15700, 15702, 15704, 15706, 15708, 15710, 15712,
15714, 15716, 15718, 15720, 15722, 15724, 15726, 15728, 15730,
15732, 15734, 15736, 15738, 15740, 15742, 15744, 15746, 15748,
15750, 15752, 15754, 15756, 15758, 15760, 15762, 15764, 15766,
15768, 15770, 15772, 15774, 15776, 15778, 15780, 15782, 15784,
15786, 15788, 15790, 15792, 15794, 15796, 15798, 15800, 15802,
15804, 15806, 15808, 15810, 15812, 15814, 15816, 15818, 15820,
15822, 15824, 15826, 15828, 15830, 15832, 15834, 15836, 15838,
15840, 15842, 15844, 15846, 15848, 15850, 15852, 15854, 15856,
15858, 15860, 15862, 15864, 15866, 15868, 15870, 15872, 15874,
15876, 15878, 15880, 15882, 15884, 15886, 15888, 15890, 15892,
15894, 15896, 15898, 15900, 15902, 15904, 15906, 15908, 15910,
15912, 15914, 15916, 15918, 15920, 15922, 15924, 15926, 15928,
15930, 15932, 15934, 15936, 15938, 15940, 15942, 15944, 15946,
15948, 15950, 15952, 15954, 15956, 15958, 15960, 15962, 15964,
15966, 15968, 15970, 15972, 15974, 15976 1 166 NUE_OEX_1 YLR060W_2
S. cerevisiae 16006 Cytoplasmic 16008, 16010, 16012, 16014, 16016,
16018, 16020, 16022, 16024, 16026, 16028, 16030, 16032, 16034,
16036, 16038, 16040, 16042, 16044, 16046, 16048, 16050, 16052,
16054, 16056, 16058, 16060, 16062, 16064, 16066, 16068, 16070,
16072, 16074, 16076, 16078, 16080, 16082, 16084 1 167 NUE_OEX_1
YMR082C_2 S. cerevisiae 16115 Cytoplasmic 16117 1 168 NUE_OEX_1
B1258 E. coli 14403 Cytoplasmic 14405, 14407, 14409, 14411, 14413,
14415, 14417, 14419, 14421, 14423, 14425, 14427, 14429, 14431,
14433, 14435, 14437, 14439, 14441, 14443, 14445, 14447, 14449,
14451, 14453, 14455, 14457, 14459, 14461, 14463, 14465, 14467,
14469, 14471, 14473, 14475, 14477, 14479, 14481, 14483, 14485,
14487, 14489, 14491 1 169 NUE_OEX_1 YML101C S. cerevisiae 16094
Cytoplasmic 16096, 16098, 16100 1 170 NUE_OEX_1 YMR065W S.
cerevisiae 16107 Cytoplasmic 16109, 16111 1 171 NUE_OEX_1 YMR163C
S. cerevisiae 16121 Cytoplasmic 16123, 16125, 16127 1 172 NUE_OEX_1
YOL042W S. cerevisiae 16276 Cytoplasmic 16278, 16280, 16282, 16284,
16286, 16288 1 173 NUE_OEX_1 YOR226C S. cerevisiae 16306
Cytoplasmic 16308, 16310, 16312, 16314, 16316, 16318, 16320, 16322,
16324, 16326, 16328, 16330, 16332, 16334, 16336, 16338, 16340,
16342, 16344, 16346, 16348, 16350, 16352, 16354, 16356, 16358,
16360, 16362, 16364, 16366, 16368, 16370, 16372, 16374, 16376,
16378, 16380, 16382, 16384, 16386, 16388, 16390, 16392, 16394,
16396, 16398, 16400, 16402, 16404, 16406, 16408, 16410, 16412,
16414, 16416, 16418, 16420, 16422, 16424, 16426, 16428, 16430,
16432, 16434, 16436, 16438, 16440, 16442, 16444, 16446, 16448,
16450, 16452, 16454, 16456, 16458, 16460, 16462, 16464, 16466,
16468, 16470, 16472, 16474, 16476, 16478, 16480, 16482, 16484,
16486, 16488, 16490, 16492, 16494, 16496, 16498, 16500, 16502,
16504, 16506, 16508, 16510, 16512, 16514, 16516, 16518, 16520,
16522, 16524, 16526, 16528, 16530, 16532, 16534, 16536 1 174
NUE_OEX_1 YPL068C S. cerevisiae 16574 Cytoplasmic 16576, 16578 1
175 NUE_OEX_1 B0165 E. coli 14397 Plastidic 14399 1 176 NUE_OEX_1
YOR203W S. cerevisiae 16300 Cytoplasmic 16302 1 177 NUE_OEX_1
YNL147W S. cerevisiae 16134 Cytoplasmic 16136, 16138, 16140, 16142,
16144, 16146, 16148, 16150, 16152, 16154, 16156, 16158, 16160,
16162, 16164, 16166, 16168, 16170, 16172, 16174, 16176, 16178,
16180, 16182, 16184, 16186, 16188, 16190, 16192, 16194, 16196,
16198, 16200, 16202, 16204, 16206, 16208, 16210, 16212, 16214,
16216, 16218, 16220, 16222, 16224, 16226, 16228, 16230, 16232,
16234, 16236, 16238, 16240, 16242, 16244, 16246, 16248, 16250,
16252, 16254, 16256 1 178 NUE_OEX_1 YBR083W S. cerevisiae 15057
Cytoplasmic 15059, 15061 1 179 NUE_OEX_1 YKL111C S. cerevisiae
15588 Cytoplasmic 15590 1 180 NUE_OEX_1 YPR067W S. cerevisiae 16583
Cytoplasmic 16585, 16587, 16589, 16591, 16593, 16595, 16597, 16599,
16601, 16603, 16605, 16607, 16609, 16611, 16613, 16615, 16617,
16619, 16621, 16623 1 181 NUE_OEX_1 B1985 E. coli 14840 Cytoplasmic
14842, 14844, 14846, 14848, 14850, 14852, 14854, 14856, 14858,
14860, 14862, 14864, 14866 1 182 NUE_OEX_1 B3838 E. coli 15015
Cytoplasmic 15017, 15019, 15021, 15023, 15025, 15027, 15029, 15031,
15033, 15035, 15037, 15039, 15041, 15043, 15045, 15047, 15049 1 183
NUE_OEX_1 YJL010C S. cerevisiae 15433 Cytoplasmic 15435, 15437,
15439, 15441, 15443, 15445, 15447, 15449 1 184 NUE_OEX_1 B1267 E.
coli 14498 Cytoplasmic 14500, 14502, 14504, 14506, 14508, 14510,
14512, 14514, 14516, 14518, 14520, 14522, 14524, 14526, 14528,
14530, 14532, 14534, 14536, 14538, 14540, 14542, 14544, 14546,
14548, 14550, 14552, 14554, 14556, 14558, 14560, 14562, 14564,
14566, 14568, 14570, 14572, 14574, 14576, 14578, 14580, 14582,
14584, 14586, 14588, 14590, 14592, 14594, 14596, 14598, 14600,
14602, 14604, 14606, 14608, 14610, 14612, 14614, 14616, 14618,
14620, 14622, 14624, 14626, 14628, 14630, 14632, 14634, 14636,
14638, 14640, 14642, 14644, 14646, 14648, 14650, 14652, 14654,
14656, 14658, 14660, 14662, 14664, 14666, 14668, 14670, 14672,
14674, 14676, 14678, 14680, 14682, 14684, 14686, 14688, 14690,
14692, 14694, 14696, 14698, 14700, 14702, 14704, 14706, 14708 1 185
NUE_OEX_1 B1322 E. coli 14719 Cytoplasmic 14721, 14723, 14725,
14727, 14729, 14731, 14733, 14735, 14737, 14739, 14741, 14743,
14745, 14747, 14749, 14751, 14753, 14755, 14757, 14759, 14761,
14763, 14765, 14767, 14769, 14771, 14773, 14775, 14777, 14779,
14781, 14783, 14785 1 186 NUE_OEX_1 B1381 E. coli 14792 Cytoplasmic
14794, 14796, 14798, 14800, 14802, 14804, 14806, 14808, 14810,
14812, 14814, 14816, 14818, 14820 1 187 NUE_OEX_1 B2646 E. coli
14880 Cytoplasmic 14882, 14884, 14886, 14888, 14890, 14892, 14894,
14896, 14898, 14900, 14902, 14904, 14906, 14908 1 188 NUE_OEX_1
YBR191W S. cerevisiae 15065 Cytoplasmic 15067, 15069, 15071, 15073,
15075, 15077, 15079, 15081, 15083, 15085, 15087, 15089, 15091,
15093, 15095, 15097, 15099, 15101, 15103, 15105, 15107, 15109,
15111, 15113, 15115, 15117, 15119, 15121, 15123, 15125, 15127,
15129, 15131, 15133, 15135, 15137, 15139, 15141, 15143, 15145,
15147, 15149, 15151, 15153, 15155, 15157, 15159, 15161, 15163,
15165, 15167, 15169, 15171, 15173, 15175, 15177, 15179, 15181,
15183, 15185, 15187, 15189, 15191, 15193, 15195, 15197, 15199,
15201, 15203, 15205, 15207, 15209, 15211, 15213, 15215, 15217 1 189
NUE_OEX_1 YDL135C S. cerevisiae 15258 Cytoplasmic 15260, 15262,
15264, 15266, 15268, 15270, 15272, 15274, 15276, 15278, 15280,
15282, 15284, 15286, 15288, 15290, 15292, 15294, 15296, 15298,
15300, 15302, 15304, 15306, 15308, 15310, 15312, 15314, 15316,
15318, 15320, 15322, 15324, 15326, 15328, 15330, 15332, 15334,
15336, 15338, 15340, 15342, 15344, 15346, 15348, 15350, 15352,
15354, 15356 1 190 NUE_OEX_1 YHL005C S. cerevisiae 15379
Cytoplasmic -- 1 191 NUE_OEX_1 YKR100C_2 S. cerevisiae 16630
Cytoplasmic 16632, 16634, 16636, 16638 1 192 NUE_OEX_1 YMR191W_2 S.
cerevisiae 16648 Cytoplasmic 16650, 16652
TABLE-US-00018 TABLE IIA_CHOM Amino acid sequence ID numbers 5. 1.
2. 3. 4. Lead 6. 7. Application Hit Project Locus Organism SEQ ID
Target SEQ IDs of Polypeptide Homologs 1 1 NUE_OE yor128c S. 13031
Cytoplasmic 13118, 13120, 13122, 13124, 13126, 13128, 13130, 13132,
X_1 CHOM cerevisiae 13134, 13136, 13138, 13140, 13142, 13144,
13146, 13148, 13150, 13152, 13154, 13156, 13158, 13160, 13162,
13164, 13166, 13168, 13170, 13172, 13174, 13176, 13178, 13180,
13182, 13184, 13186, 13188, 13190, 13192, 13194, 13196, 13198,
13200, 13202, 13204, 13206, 13208, 13210, 13212, 13214, 13216,
13218, 13220, 13222, 13224, 13226, 13228, 13230, 13232, 13234,
13236, 13238, 13240, 13242, 13244, 13246, 13248, 13250, 13252,
13254, 13256, 13258, 13260, 13262, 13264, 13266, 13268, 13270,
13272, 13274, 13276, 13278, 13280, 13282, 13284, 13286, 13288,
13290, 13292, 13294, 13296, 13298, 13300, 13302, 13304, 13306,
13308, 13310, 13312, 13314, 13316, 13318, 13320, 13322, 13324,
13326, 13328, 13330, 13332, 13334, 13336, 13338, 13340, 13342,
13344, 13346, 13348, 13350, 13352, 13354, 13356, 13358, 13360,
13362, 13364, 13366, 13368, 13370, 13372, 13374, 13376, 13378,
13380, 13382, 13384, 13386, 13388, 13390, 13392, 13394, 13396,
13398, 13400, 13402, 13404, 13406, 13408, 13410, 13412, 13414,
13416, 13418, 13420, 13422, 13424, 13426, 13428, 13430, 13432,
13434, 13436, 13438, 13440, 13442, 13444, 13446, 13448, 13450,
13452, 13454, 13456, 13458, 13460, 13462, 13464, 13466, 13468,
13470, 13472, 13474, 13476, 13478, 13480, 13482, 13484, 13486,
13488, 13490, 13492, 13494, 13496, 13498, 13500, 13502, 13504,
13506, 13508, 13510, 13512, 13514, 13516, 13518, 13520, 13522,
13524, 13526, 13528, 13530, 13532, 13534, 13536, 13538, 13540,
13542, 13544, 13546, 13548, 13550, 13552, 13554, 13556, 13558,
13560, 13562, 13564, 13566, 13568, 13570, 13572, 13574, 13576,
13578, 13580, 13582, 13584, 13586, 13588, 13590, 13592, 13594,
13596, 13598, 13600, 13602, 13604, 13606, 13608, 13610, 13612,
13614, 13616
TABLE-US-00019 TABLE IIA_NHOM Amino acid sequence ID numbers 5. 1.
2. 3. 4. Lead 6. 7. Application Hit Project Locus Organism SEQ ID
Target SEQ IDs of Polypeptide Homologs 1 1 NUE_OE yor128c S. 13031
Cytoplasmic 13625, 13627, 13629, 13631, 13633, 13635, 13637, 13639,
X_1 NHOM cerevisiae 13641, 13643, 13645, 13647, 13649, 13651,
13653, 13655, 13657, 13659, 13661, 13663, 13665, 13667, 13669,
13671, 13673, 13675, 13677, 13679, 13681, 13683, 13685, 13687,
13689, 13691, 13693, 13695, 13697, 13699, 13701, 13703, 13705,
13707, 13709, 13711, 13713, 13715, 13717, 13719, 13721, 13723,
13725, 13727, 13729, 13731, 13733, 13735, 13737, 13739, 13741,
13743, 13745, 13747, 13749, 13751, 13753, 13755, 13757, 13759,
13761, 13763, 13765, 13767, 13769, 13771, 13773, 13775, 13777,
13779, 13781, 13783, 13785, 13787, 13789, 13791, 13793, 13795,
13797, 13799, 13801, 13803, 13805, 13807, 13809, 13811, 13813,
13815, 13817, 13819, 13821, 13823, 13825, 13827, 13829, 13831,
13833, 13835, 13837, 13839, 13841, 13843, 13845, 13847, 13849,
13851, 13853, 13855, 13857, 13859, 13861, 13863, 13865, 13867,
13869, 13871, 13873, 13875, 13877, 13879, 13881, 13883, 13885,
13887, 13889, 13891, 13893, 13895, 13897, 13899, 13901, 13903,
13905, 13907, 13909, 13911, 13913, 13915, 13917, 13919, 13921,
13923, 13925, 13927, 13929, 13931, 13933, 13935, 13937, 13939,
13941, 13943, 13945, 13947, 13949, 13951, 13953, 13955, 13957,
13959, 13961, 13963, 13965, 13967, 13969, 13971, 13973, 13975,
13977, 13979, 13981, 13983, 13985, 13987, 13989, 13991, 13993,
13995, 13997, 13999, 14001, 14003, 14005, 14007, 14009, 14011,
14013, 14015, 14017, 14019, 14021, 14023, 14025, 14027, 14029,
14031, 14033, 14035, 14037, 14039, 14041, 14043, 14045, 14047,
14049, 14051, 14053, 14055, 14057, 14059, 14061, 14063, 14065,
14067, 14069, 14071, 14073, 14075, 14077, 14079, 14081
TABLE-US-00020 TABLE IIB Amino acid sequence ID numbers 5. 1. 2. 3.
4. Lead 6. 7. Application Hit Project Locus Organism SEQ ID Target
SEQ IDs of Polypeptide Homologs 1 1 NUE_OE B0017 E. coli 39
Cytoplasmic -- X_1 1 2 NUE_OE B0045 E. coli 43 Cytoplasmic 99, 101,
103, 105, 107, 109, 111, 113, 115, 117 X_1 1 3 NUE_OE B0180 E. coli
124 Plastidic 366, 368, 370, 372, 374 X_1 1 4 NUE_OE B0242 E. coli
381 Plastidic 663, 665, 667, 669 X_1 1 5 NUE_OE B0403 E. coli 680
Plastidic -- X_1 1 6 NUE_OE B0474 E. coli 813 Cytoplasmic 959, 961,
963, 965, 967, 969, 971, 973, 975, 977, X_1 979, 981, 983, 985,
987, 989, 991, 993, 995, 997, 999, 1001, 1003, 1005, 1007, 1009,
1011, 1013, 1015, 1017, 1019, 1021, 1023, 1025, 1027, 1029, 1031,
1033, 1035, 1037, 1039, 1041, 1043, 1045, 1047, 1049, 16658 1 7
NUE_OE B0754 E. coli 1056 Plastidic -- X_1 1 8 NUE_OE B0784 E. coli
1564 Cytoplasmic -- X_1 1 9 NUE_OE B0873 E. coli 1706 Plastidic --
X_1 1 10 NUE_OE B1014 E. coli 1845 Cytoplasmic -- X_1 1 11 NUE_OE
B1020 E. coli 1951 Plastidic -- X_1 1 12 NUE_OE B1180 E. coli 1976
Cytoplasmic 2100, 2102, 2104, 2106, 2108, 2110, 2112, 2114, X_1
2116, 2118, 2120, 16662 1 13 NUE_OE B1933 E. coli 2128 Plastidic --
X_1 1 14 NUE_OE B2032 E. coli 2136 Plastidic -- X_1 1 15 NUE_OE
B2165 E. coli 2172 Plastidic 2286, 2288 X_1 1 16 NUE_OE B2223 E.
coli 2298 Plastidic -- X_1 1 17 NUE_OE B2238 E. coli 2427 Plastidic
-- X_1 1 17 NUE_OE B2238 E. coli 2427 Cytoplasmic -- X_1 1 18
NUE_OE B2310 E. coli 2453 Plastidic -- X_1 1 19 NUE_OE B2431 E.
coli 2552 Plastidic -- X_1 1 20 NUE_OE B2600 E. coli 2601 Plastidic
-- X_1 1 21 NUE_OE B2766 E. coli 2669 Plastidic -- X_1 1 22 NUE_OE
B2903 E. coli 2773 Cytoplasmic 3097, 3099 X_1 1 23 NUE_OE B3117 E.
coli 3118 Plastidic 3374, 3376, 3378, 3380, 3382 X_1 1 24 NUE_OE
B3120 E. coli 3391 Plastidic -- X_1 1 25 NUE_OE B3216 E. coli 3397
Plastidic -- X_1 1 26 NUE_OE B3451 E. coli 3471 Plastidic -- X_1 1
27 NUE_OE B3791 E. coli 3564 Cytoplasmic -- X_1 1 28 NUE_OE B3825
E. coli 3771 Plastidic -- X_1 1 29 NUE_OE YAL019W S. 3869
Cytoplasmic -- X_1 cerevisiae 1 30 NUE_OE YAR035W S. 3896
Cytoplasmic -- X_1 cerevisiae 1 31 NUE_OE YBL021C S. 3954
Cytoplasmic 4032, 4034, 4036, 4038, 4040, 4042, 4044, 4046, X_1
cerevisiae 4048, 4050, 4052, 4054, 4056, 4058, 4060, 4062, 4064,
4066, 4068, 4070, 4072, 4074, 4076, 4078, 4080, 4082, 4084, 4086,
4088, 4090, 4092, 4094, 4096, 4098, 4100, 4102, 4104, 4106 1 32
NUE_OE YBR055C S. 4112 Cytoplasmic -- X_1 cerevisiae 1 33 NUE_OE
YBR128C S. 4150 Cytoplasmic -- X_1 cerevisiae 1 34 NUE_OE YBR159W
S. 4163 Cytoplasmic 4215, 4217, 4219, 4221, 4223, 4225, 4227 X_1
cerevisiae 1 35 NUE_OE YBR243C S. 4236 Cytoplasmic 4268, 4270 X_1
cerevisiae 1 35 NUE_OE YBR243C S. 4236 Plastidic 4268, 4270 X_1
cerevisiae 1 36 NUE_OE YBR262C S. 4281 Cytoplasmic -- X_1
cerevisiae 1 37 NUE_OE YCR019W S. 4289 Cytoplasmic -- X_1
cerevisiae 1 38 NUE_OE YDR070C S. 4316 Cytoplasmic -- X_1
cerevisiae 1 39 NUE_OE YDR079W S. 4326 Cytoplasmic -- X_1
cerevisiae 1 40 NUE_OE YDR123C S. 4336 Cytoplasmic -- X_1
cerevisiae 1 41 NUE_OE YDR137W S. 4347 Cytoplasmic -- X_1
cerevisiae 1 42 NUE_OE YDR294C S. 4362 Cytoplasmic -- X_1
cerevisiae 1 42 NUE_OE YDR294C S. 4362 Plastidic -- X_1 cerevisiae
1 43 NUE_OE YDR330W S. 4403 Cytoplasmic -- X_1 cerevisiae 1 44
NUE_OE YDR355C S. 4432 Cytoplasmic -- X_1 cerevisiae 1 45 NUE_OE
YDR430C S. 4436 Plastidic -- X_1 cerevisiae 1 46 NUE_OE YDR472W S.
4486 Cytoplasmic -- X_1 cerevisiae 1 47 NUE_OE YDR497C S. 4507
Plastidic 4739, 4741, 4743, 4745, 4747, 4749, 4751, 4753, X_1
cerevisiae 4755, 4757, 4759, 4761, 4763, 4765, 4767, 4769, 4771,
4773, 4775, 4777, 4779, 4781, 4783, 4785, 16666 1 48 NUE_OE YER029C
S. 4791 Cytoplasmic -- X_1 cerevisiae 1 49 NUE_OE YFR007W S. 4807
Cytoplasmic -- X_1 cerevisiae 1 50 NUE_OE YGL039W S. 4837
Cytoplasmic 5215, 5217, 5219, 5221, 5223, 5225, 5227, 5229, X_1
cerevisiae 5231, 5233, 5235, 5237, 5239, 5241, 5243, 5245, 5247,
5249, 5251, 5253, 5255, 5257, 5259, 5261, 5263, 5265, 5267, 5269,
5271, 5273, 5275, 5277, 5279, 5281, 5283, 5285, 5287, 5289, 5291,
5293, 5295, 5297, 5299, 5301, 5303, 5305 1 51 NUE_OE YGL043W S.
5312 Cytoplasmic 5336, 5338, 5340 X_1 cerevisiae 1 52 NUE_OE
YGR088W S. 5347 Cytoplasmic 5525 X_1 cerevisiae 1 53 NUE_OE
YGR122C-A S. 5534 Cytoplasmic -- X_1 cerevisiae 1 54 NUE_OE YGR142W
S. 5552 Cytoplasmic -- X_1 cerevisiae 1 55 NUE_OE YGR143W S. 5560
Cytoplasmic -- X_1 cerevisiae 1 56 NUE_OE YGR165W S. 5603
Cytoplasmic -- X_1 cerevisiae 1 57 NUE_OE YGR170W S. 5609
Cytoplasmic -- X_1 cerevisiae 1 58 NUE_OE YGR202C S. 5615
Cytoplasmic -- X_1 cerevisiae 1 59 NUE_OE YGR266W S. 5667
Cytoplasmic -- X_1 cerevisiae 1 60 NUE_OE YGR282C S. 5702
Cytoplasmic -- X_1 cerevisiae 1 61 NUE_OE YGR290W S. 5751
Cytoplasmic -- X_1 cerevisiae 1 62 NUE_OE YHL021C S. 5755
Cytoplasmic -- X_1 cerevisiae 1 63 NUE_OE YHL031C S. 5779
Cytoplasmic -- X_1 cerevisiae 1 64 NUE_OE YHR011W S. 5813
Cytoplasmic 5955, 5957, 5959, 16670 X_1 cerevisiae 1 65 NUE_OE
YHR127W S. 5968 Cytoplasmic -- X_1 cerevisiae 1 66 NUE_OE YHR137W
S. 5974 Cytoplasmic -- X_1 cerevisiae 1 66 NUE_OE YHR137W S. 5974
Plastidic -- X_1 cerevisiae 1 67 NUE_OE YIL099W S. 6028 Cytoplasmic
-- X_1 cerevisiae 1 67 NUE_OE YIL099W S. 6028 Plastidic -- X_1
cerevisiae 1 68 NUE_OE YIL147C S. 6108 Cytoplasmic -- X_1
cerevisiae 1 69 NUE_OE YIR034C S. 6151 Cytoplasmic -- X_1
cerevisiae 1 70 NUE_OE YJL013C S. 6199 Cytoplasmic -- X_1
cerevisiae 1 71 NUE_OE YJL041W S. 6209 Cytoplasmic -- X_1
cerevisiae 1 72 NUE_OE YJL064W S. 6243 Cytoplasmic -- X_1
cerevisiae 1 73 NUE_OE YJL067W S. 6247 Cytoplasmic -- X_1
cerevisiae 1 74 NUE_OE YJL094C S. 6251 Cytoplasmic -- X_1
cerevisiae 1 75 NUE_OE YJL171C S. 6298 Cytoplasmic -- X_1
cerevisiae 1 76 NUE_OE YJL213W S. 6327 Cytoplasmic -- X_1
cerevisiae 1 77 NUE_OE YJR017C S. 6489 Cytoplasmic 6543 X_1
cerevisiae 1 78 NUE_OE YJR058C S. 6551 Cytoplasmic 6663, 6665,
6667, 6669, 6671, 6673, 6675, 6677, X_1 cerevisiae 6679, 6681,
6683, 6685, 6687, 6689, 6691, 6693, 6695, 16674, 16676 1 79 NUE_OE
YJR117W S. 6701 Cytoplasmic 6791, 6793, 6795, 6797, 6799, 6801,
6803, 6805, X_1 cerevisiae 6807 1 80 NUE_OE YJR121W S. 6817
Cytoplasmic 7337, 7339, 7341, 7343, 7345, 7347, 7349 X_1 cerevisiae
1 81 NUE_OE YJR131W S. 7367 Cytoplasmic 7461, 7463, 7465, 7467 X_1
cerevisiae 1 82 NUE_OE YJR145C S. 7476 Cytoplasmic 7560, 7562,
7564, 7566, 7568, 7570, 7572, 7574, X_1 cerevisiae 7576, 7578,
7580, 7582, 7584, 7586, 7588, 7590, 7592, 7594, 7596, 16680 1 83
NUE_OE YKL084W S. 7603 Cytoplasmic -- X_1 cerevisiae 1 84 NUE_OE
YKL088W S. 7652 Cytoplasmic -- X_1 cerevisiae 1 85 NUE_OE YKL100C
S. 7662 Cytoplasmic -- X_1 cerevisiae 1 86 NUE_OE YKL131W S. 7676
Cytoplasmic -- X_1 cerevisiae 1 87 NUE_OE YKL138C S. 7680
Cytoplasmic -- X_1 cerevisiae 1 88 NUE_OE YKL178C S. 7711
Cytoplasmic -- X_1 cerevisiae 1 89 NUE_OE YKL179C S. 7736
Cytoplasmic -- X_1 cerevisiae 1 90 NUE_OE YKL193C S. 7779
Cytoplasmic 7815, 7817, 7819, 7821 X_1 cerevisiae 1 91 NUE_OE
YKL216W S. 7830 Cytoplasmic -- X_1 cerevisiae 1 92 NUE_OE YKR016W
S. 8018 Cytoplasmic -- X_1 cerevisiae 1 93 NUE_OE YKR021W S. 8046
Cytoplasmic -- X_1 cerevisiae 1 94 NUE_OE YKR055W S. 8074
Cytoplasmic 8258 X_1 cerevisiae 1 95 NUE_OE YKR088C S. 8264
Plastidic -- X_1 cerevisiae 1 96 NUE_OE YKR093W S. 8288 Cytoplasmic
8444, 8446, 8448, 8450, 8452, 8454, 8456, 8458, X_1 cerevisiae
8460, 8462 1 97 NUE_OE YKR099W S. 8469 Cytoplasmic -- X_1
cerevisiae 1 98 NUE_OE YKR100C S. 8485 Cytoplasmic -- X_1
cerevisiae 1 99 NUE_OE YLL014W S. 8493 Cytoplasmic -- X_1
cerevisiae 1 100 NUE_OE YLL016W S. 8515 Cytoplasmic -- X_1
cerevisiae 1 101 NUE_OE YLL023C S. 8540 Cytoplasmic -- X_1
cerevisiae 1 102 NUE_OE YLL037W S. 8572 Cytoplasmic -- X_1
cerevisiae 1 103 NUE_OE YLL049W S. 8576 Cytoplasmic --
X_1 cerevisiae 1 104 NUE_OE YLL055W S. 8580 Cytoplasmic -- X_1
cerevisiae 1 105 NUE_OE YLR034C S. 8662 Cytoplasmic 8964, 8966,
8968, 8970, 8972, 8974, 8976, 8978, X_1 cerevisiae 8980, 8982 1 106
NUE_OE YLR042C S. 8992 Cytoplasmic -- X_1 cerevisiae 1 107 NUE_OE
YLR053C S. 8996 Cytoplasmic -- X_1 cerevisiae 1 108 NUE_OE YLR058C
S. 9000 Cytoplasmic 9502, 9504, 9506, 9508, 9510, 9512, 9514, 9516,
X_1 cerevisiae 9518, 9520, 9522, 9524, 9526, 9528, 9530, 9532,
9534, 9536, 9538, 9540 1 109 NUE_OE YLR060W S. 9552 Cytoplasmic --
X_1 cerevisiae 1 110 NUE_OE YLR065C S. 9638 Cytoplasmic -- X_1
cerevisiae 1 111 NUE_OE YLR070C S. 9673 Cytoplasmic 10119, 10121,
10123, 10125, 10127, 10129, 10131, X_1 cerevisiae 10133, 10135,
10137, 10139, 10141, 10143, 10145, 10147, 10149, 10151, 10153,
10155, 10157, 10159, 10161, 10163, 10165, 10167, 10169, 10171,
10173, 10175, 10177 1 112 NUE_OE YLR100W S. 10183 Cytoplasmic --
X_1 cerevisiae 1 113 NUE_OE YLR109W S. 10215 Cytoplasmic 10419,
10421, 10423, 10425, 10427, 10429, 10431, X_1 cerevisiae 10433,
10435, 10437, 10439, 10441, 10443 1 114 NUE_OE YLR125W S. 10448
Cytoplasmic -- X_1 cerevisiae 1 115 NUE_OE YLR127C S. 10452
Cytoplasmic -- X_1 cerevisiae 1 116 NUE_OE YLR185W S. 10464
Cytoplasmic 10514, 10516, 10518, 10520, 10522, 10524, 10526 X_1
cerevisiae 1 117 NUE_OE YLR204W S. 10534 Cytoplasmic -- X_1
cerevisiae 1 117 NUE_OE YLR204W S. 10534 Plastidic -- X_1
cerevisiae 1 118 NUE_OE YLR242C S. 10542 Cytoplasmic -- X_1
cerevisiae 1 119 NUE_OE YLR293C S. 10563 Cytoplasmic 10715, 10717,
10719, 10721, 10723, 10725, 10727, X_1 cerevisiae 10729, 10731,
10733, 10735, 10737, 10739, 10741, 10743, 10745, 10747, 10749,
10751, 10753, 10755, 10757, 10759, 10761, 10763, 10765, 10767,
10769, 10771, 10773, 10775, 10777, 10779, 10781, 10783, 10785,
10787, 10789, 10791, 10793, 10795, 10797, 10799, 10801, 10803,
10805, 10807, 10809, 10811, 10813, 10815, 10817, 10819, 10821,
10823, 10825, 10827, 10829, 10831, 10833, 10835, 10837, 10839,
10841, 10843, 10845, 10847, 10849, 10851, 10853, 10855, 10857,
10859, 10861, 10863, 10865, 10867, 10869, 10871, 10873, 10875,
10877, 10879, 10881, 10883, 10885, 10887, 10889, 10891, 10893,
10895, 10899, 10901, 10903, 10897, 10905, 10907, 10909, 10911,
10913, 10915, 10917, 10919, 10921, 10923, 10925, 10927, 10929,
10931, 10933, 10935, 10937, 10939, 10941, 10943, 10945, 10947,
10949, 10951, 10953, 10955, 10957, 10959, 10961, 10963, 10965,
10967, 10969, 10971, 10973, 10975, 10977, 10979, 10981, 10983 1 120
NUE_OE YLR313C S. 10991 Cytoplasmic -- X_1 cerevisiae 1 121 NUE_OE
YLR315W S. 10999 Cytoplasmic -- X_1 cerevisiae 1 122 NUE_OE YLR329W
S. 11005 Cytoplasmic -- X_1 cerevisiae 1 123 NUE_OE YLR362W S.
11013 Cytoplasmic -- X_1 cerevisiae 1 124 NUE_OE YLR395C S. 11055
Cytoplasmic -- X_1 cerevisiae 1 125 NUE_OE YLR404W S. 11067
Cytoplasmic -- X_1 cerevisiae 1 126 NUE_OE YLR463C S. 11075
Cytoplasmic -- X_1 cerevisiae 1 127 NUE_OE YML022W S. 11081
Cytoplasmic 11527, 11529, 11531, 11533, 11535, 11537, 11539, X_1
cerevisiae 11541, 11543, 11545, 11547 1 128 NUE_OE YML027W S. 11553
Cytoplasmic -- X_1 cerevisiae 1 129 NUE_OE YML065W S. 11570
Cytoplasmic -- X_1 cerevisiae 1 130 NUE_OE YML089C S. 11597
Cytoplasmic -- X_1 cerevisiae 1 131 NUE_OE YML128C S. 11601
Cytoplasmic -- X_1 cerevisiae 1 132 NUE_OE YMR011W S. 11613
Cytoplasmic 12125, 12127, 12129, 12131, 12133, 12135, 12137, X_1
cerevisiae 12139, 12141, 12143, 12145, 12147, 12149, 12151, 12153,
12155, 12157, 12159, 12161, 12163, 12165, 12167, 12169, 12171,
12173, 12175, 12177, 12179, 12181, 12183, 12185, 12187, 12189,
12191, 12193, 12195, 12197, 12199, 12201, 12203, 12205, 12207,
12209, 12211, 12213, 12215, 12217, 12219, 12221, 12223, 12225,
12227, 12229, 12231, 12233, 12235, 12237, 12239, 12241 1 133 NUE_OE
YMR037C S. 12247 Cytoplasmic -- X_1 cerevisiae 1 134 NUE_OE YMR049C
S. 12264 Cytoplasmic -- X_1 cerevisiae 1 135 NUE_OE YMR052W S.
12317 Cytoplasmic -- X_1 cerevisiae 1 136 NUE_OE YMR082C S. 12328
Cytoplasmic -- X_1 cerevisiae 1 137 NUE_OE YMR125W S. 12332
Cytoplasmic -- X_1 cerevisiae 1 138 NUE_OE YMR126C S. 12379
Cytoplasmic -- X_1 cerevisiae 1 139 NUE_OE YMR144W S. 12395
Cytoplasmic -- X_1 cerevisiae 1 140 NUE_OE YMR160W S. 12407
Cytoplasmic -- X_1 cerevisiae 1 141 NUE_OE YMR191W S. 12415
Cytoplasmic -- X_1 cerevisiae 1 142 NUE_OE YMR209C S. 12421
Cytoplasmic -- X_1 cerevisiae 1 143 NUE_OE YMR233W S. 12441
Cytoplasmic -- X_1 cerevisiae 1 144 NUE_OE YMR278W S. 12471
Cytoplasmic -- X_1 cerevisiae 1 145 NUE_OE YMR280C S. 12750
Cytoplasmic -- X_1 cerevisiae 1 146 NUE_OE YNL014W S. 12774
Cytoplasmic -- X_1 cerevisiae 1 147 NUE_OE YNL320W S. 12830
Cytoplasmic 12868, 12870, 12872, 12874 X_1 cerevisiae 1 148 NUE_OE
YOL007C S. 12884 Cytoplasmic -- X_1 cerevisiae 1 149 NUE_OE YOL164W
S. 12890 Cytoplasmic -- X_1 cerevisiae 1 150 NUE_OE YOR076C S.
13015 Cytoplasmic -- X_1 cerevisiae 1 151 NUE_OE YOR083W S. 13019
Cytoplasmic -- X_1 cerevisiae 1 152 NUE_OE YOR097C S. 13025
Cytoplasmic -- X_1 cerevisiae 1 153 NUE_OE YOR128C S. 13031
Cytoplasmic 13099 X_1 cerevisiae 1 154 NUE_OE YOR353C S. 14086
Cytoplasmic -- X_1 cerevisiae 1 155 NUE_OE YPL141C S. 14094
Cytoplasmic -- X_1 cerevisiae 1 156 NUE_OE YPR088C S. 14114
Cytoplasmic 14216, 14218, 14220, 14222, 14224, 14226, 14228, X_1
cerevisiae 14230, 14232, 14234 1 157 NUE_OE YPR108W S. 14247
Cytoplasmic 14291, 14293, 14295, 14297, 14299 X_1 cerevisiae 1 158
NUE_OE YPR110C S. 14312 Cytoplasmic 14374, 14376, 14378, 14380,
14382 X_1 cerevisiae 1 159 NUE_OE B3825_2 E. coli 14915 Plastidic
-- X_1 1 160 NUE_OE YIR034C_2 S. 15383 Cytoplasmic -- X_1
cerevisiae 1 161 NUE_OE YJR131W_2 S. 15461 Cytoplasmic 15557,
15559, 15561, 15563 X_1 cerevisiae 1 162 NUE_OE YKL100C_2 S. 15572
Cytoplasmic -- X_1 cerevisiae 1 163 NUE_OE YKL193C_2 S. 15594
Cytoplasmic 15632, 15634, 15636, 15638 X_1 cerevisiae 1 164 NUE_OE
YLL016W_2 S. 15647 Cytoplasmic -- X_1 cerevisiae 1 165 NUE_OE
YLR034C_2 S. 15674 Cytoplasmic 15978, 15980, 15982, 15984, 15986,
15988, 15990, X_1 cerevisiae 15992, 15994, 15996 1 166 NUE_OE
YLR060W_2 S. 16006 Cytoplasmic -- X_1 cerevisiae 1 167 NUE_OE
YMR082C_2 S. 16115 Cytoplasmic -- X_1 cerevisiae 1 168 NUE_OE B1258
E. coli 14403 Cytoplasmic -- X_1 1 169 NUE_OE YML101C S. 16094
Cytoplasmic -- X_1 cerevisiae 1 170 NUE_OE YMR065W S. 16107
Cytoplasmic -- X_1 cerevisiae 1 171 NUE_OE YMR163C S. 16121
Cytoplasmic -- X_1 cerevisiae 1 172 NUE_OE YOL042W S. 16276
Cytoplasmic -- X_1 cerevisiae 1 173 NUE_OE YOR226C S. 16306
Cytoplasmic 16538, 16540, 16542, 16544, 16546, 16548, 16550, X_1
cerevisiae 16552, 16554, 16556, 16558, 16560, 16562, 16564, 16566 1
174 NUE_OE YPL068C S. 16574 Cytoplasmic -- X_1 cerevisiae 1 175
NUE_OE B0165 E. coli 14397 Plastidic -- X_1 1 176 NUE_OE YOR203W S.
16300 Cytoplasmic -- X_1 cerevisiae 1 177 NUE_OE YNL147W S. 16134
Cytoplasmic 16258, 16260, 16262, 16264, 16266, 16268, 16270 X_1
cerevisiae 1 178 NUE_OE YBR083W S. 15057 Cytoplasmic -- X_1
cerevisiae 1 179 NUE_OE YKL111C S. 15588 Cytoplasmic -- X_1
cerevisiae 1 180 NUE_OE YPR067W S. 16583 Cytoplasmic -- X_1
cerevisiae 1 181 NUE_OE B1985 E. coli 14840 Cytoplasmic -- X_1 1
182 NUE_OE B3838 E. coli 15015 Cytoplasmic -- X_1 1 183 NUE_OE
YJL010C S. 15433 Cytoplasmic -- X_1 cerevisiae 1 184 NUE_OE B1267
E. coli 14498 Cytoplasmic 14710, 14712 X_1 1 185 NUE_OE B1322 E.
coli 14719 Cytoplasmic -- X_1 1 186 NUE_OE B1381 E. coli 14792
Cytoplasmic -- X_1 1 187 NUE_OE B2646 E. coli 14880 Cytoplasmic --
X_1 1 188 NUE_OE YBR191W S. 15065 Cytoplasmic 15219, 15221, 15223,
15225, 15227, 15229, 15231, X_1 cerevisiae 15233, 15235, 15237,
15239, 15241, 15243, 15245, 15247, 15249 1 189 NUE_OE YDL135C S.
15258 Cytoplasmic 15358, 15360, 15362, 15364, 15366, 15368, 15370,
X_1 cerevisiae 15372 1 190 NUE_OE YHL005C S. 15379 Cytoplasmic --
X_1 cerevisiae 1 191 NUE_OE YKR100C_2 S. 16630 Cytoplasmic -- X_1
cerevisiae 1 192 NUE_OE YMR191W_2 S. 16648 Cytoplasmic -- X_1
cerevisiae
TABLE-US-00021 TABLE III Primer nucleic acid sequence ID numbers 5.
1. 2. 3. 4. Lead 6. 7. Application Hit Project Locus Organism SEQ
ID Target SEQ IDs of Primers 1 1 NUE_OE B0017 E. coli 38
Cytoplasmic 40, 41 X_1 1 2 NUE_OE B0045 E. coli 42 Cytoplasmic 118,
119 X_1 1 3 NUE_OE B0180 E. coli 123 Plastidic 375, 376 X_1 1 4
NUE_OE B0242 E. coli 380 Plastidic 670, 671 X_1 1 5 NUE_OE B0403 E.
coli 679 Plastidic 801, 802 X_1 1 6 NUE_OE B0474 E. coli 812
Cytoplasmic 1050, 1051 X_1 1 7 NUE_OE B0754 E. coli 1055 Plastidic
1551, 1552 X_1 1 8 NUE_OE B0784 E. coli 1563 Cytoplasmic 1701, 1702
X_1 1 9 NUE_OE B0873 E. coli 1705 Plastidic 1831, 1832 X_1 1 10
NUE_OE B1014 E. coli 1844 Cytoplasmic 1932, 1933 X_1 1 11 NUE_OE
B1020 E. coli 1950 Plastidic 1966, 1967 X_1 1 12 NUE_OE B1180 E.
coli 1975 Cytoplasmic 2121, 2122 X_1 1 13 NUE_OE B1933 E. coli 2127
Plastidic 2133, 2134 X_1 1 14 NUE_OE B2032 E. coli 2135 Plastidic
2167, 2168 X_1 1 15 NUE_OE B2165 E. coli 2171 Plastidic 2289, 2290
X_1 1 16 NUE_OE B2223 E. coli 2297 Plastidic 2419, 2420 X_1 1 17
NUE_OE B2238 E. coli 2426 Plastidic 2444, 2445 X_1 1 17 NUE_OE
B2238 E. coli 2426 Cytoplasmic 2444, 2445 X_1 1 18 NUE_OE B2310 E.
coli 2452 Plastidic 2544, 2545 X_1 1 19 NUE_OE B2431 E. coli 2551
Plastidic 2591, 2592 X_1 1 20 NUE_OE B2600 E. coli 2600 Plastidic
2658, 2659 X_1 1 21 NUE_OE B2766 E. coli 2668 Plastidic 2766, 2767
X_1 1 22 NUE_OE B2903 E. coli 2772 Cytoplasmic 3100, 3101 X_1 1 23
NUE_OE B3117 E. coli 3117 Plastidic 3383, 3384 X_1 1 24 NUE_OE
B3120 E. coli 3390 Plastidic 3394, 3395 X_1 1 25 NUE_OE B3216 E.
coli 3396 Plastidic 3466, 3467 X_1 1 26 NUE_OE B3451 E. coli 3470
Plastidic 3556, 3557 X_1 1 27 NUE_OE B3791 E. coli 3563 Cytoplasmic
3765, 3766 X_1 1 28 NUE_OE B3825 E. coli 3770 Plastidic 3864, 3865
X_1 1 29 NUE_OE YAL019W S. 3868 Cytoplasmic 3878, 3879 X_1
cerevisiae 1 30 NUE_OE YAR035W S. 3895 Cytoplasmic 3941, 3942 X_1
cerevisiae 1 31 NUE_OE YBL021C S. 3953 Cytoplasmic 4107, 4108 X_1
cerevisiae 1 32 NUE_OE YBR055C S. 4111 Cytoplasmic 4141, 4142 X_1
cerevisiae 1 33 NUE_OE YBR128C S. 4149 Cytoplasmic 4157, 4158 X_1
cerevisiae 1 34 NUE_OE YBR159W S. 4162 Cytoplasmic 4228, 4229 X_1
cerevisiae 1 35 NUE_OE YBR243C S. 4235 Cytoplasmic 4271, 4272 X_1
cerevisiae 1 35 NUE_OE YBR243C S. 4235 Plastidic 4271, 4272 X_1
cerevisiae 1 36 NUE_OE YBR262C S. 4280 Cytoplasmic 4286, 4287 X_1
cerevisiae 1 37 NUE_OE YCR019W S. 4288 Cytoplasmic 4306, 4307 X_1
cerevisiae 1 38 NUE_OE YDR070C S. 4315 Cytoplasmic 4321, 4322 X_1
cerevisiae 1 39 NUE_OE YDR079W S. 4325 Cytoplasmic 4331, 4332 X_1
cerevisiae 1 40 NUE_OE YDR123C S. 4335 Cytoplasmic 4341, 4342 X_1
cerevisiae 1 41 NUE_OE YDR137W S. 4346 Cytoplasmic 4352, 4353 X_1
cerevisiae 1 42 NUE_OE YDR294C S. 4361 Cytoplasmic 4391, 4392 X_1
cerevisiae 1 42 NUE_OE YDR294C S. 4361 Plastidic 4391, 4392 X_1
cerevisiae 1 43 NUE_OE YDR330W S. 4402 Cytoplasmic 4424, 4425 X_1
cerevisiae 1 44 NUE_OE YDR355C S. 4431 Cytoplasmic 4433, 4434 X_1
cerevisiae 1 45 NUE_OE YDR430C S. 4435 Plastidic 4469, 4470 X_1
cerevisiae 1 46 NUE_OE YDR472W S. 4485 Cytoplasmic 4497, 4498 X_1
cerevisiae 1 47 NUE_OE YDR497C S. 4506 Plastidic 4786, 4787 X_1
cerevisiae 1 48 NUE_OE YER029C S. 4790 Cytoplasmic 4800, 4801 X_1
cerevisiae 1 49 NUE_OE YFR007W S. 4806 Cytoplasmic 4830, 4831 X_1
cerevisiae 1 50 NUE_OE YGL039W S. 4836 Cytoplasmic 5306, 5307 X_1
cerevisiae 1 51 NUE_OE YGL043W S. 5311 Cytoplasmic 5341, 5342 X_1
cerevisiae 1 52 NUE_OE YGR088W S. 5346 Cytoplasmic 5526, 5527 X_1
cerevisiae 1 53 NUE_OE YGR122C-A S. 5533 Cytoplasmic 5547, 5548 X_1
cerevisiae 1 54 NUE_OE YGR142W S. 5551 Cytoplasmic 5557, 5558 X_1
cerevisiae 1 55 NUE_OE YGR143W S. 5559 Cytoplasmic 5587, 5588 X_1
cerevisiae 1 56 NUE_OE YGR165W S. 5602 Cytoplasmic 5606, 5607 X_1
cerevisiae 1 57 NUE_OE YGR170W S. 5608 Cytoplasmic 5612, 5613 X_1
cerevisiae 1 58 NUE_OE YGR202C S. 5614 Cytoplasmic 5660, 5661 X_1
cerevisiae 1 59 NUE_OE YGR266W S. 5666 Cytoplasmic 5688, 5689 X_1
cerevisiae 1 60 NUE_OE YGR282C S. 5701 Cytoplasmic 5741, 5742 X_1
cerevisiae 1 61 NUE_OE YGR290W S. 5750 Cytoplasmic 5752, 5753 X_1
cerevisiae 1 62 NUE_OE YHL021C S. 5754 Cytoplasmic 5770, 5771 X_1
cerevisiae 1 63 NUE_OE YHL031C S. 5778 Cytoplasmic 5808, 5809 X_1
cerevisiae 1 64 NUE_OE YHR011W S. 5812 Cytoplasmic 5960, 5961 X_1
cerevisiae 1 65 NUE_OE YHR127W S. 5967 Cytoplasmic 5971, 5972 X_1
cerevisiae 1 66 NUE_OE YHR137W S. 5973 Cytoplasmic 6021, 6022 X_1
cerevisiae 1 66 NUE_OE YHR137W S. 5973 Plastidic 6021, 6022 X_1
cerevisiae 1 67 NUE_OE YIL099W S. 6027 Cytoplasmic 6099, 6100 X_1
cerevisiae 1 67 NUE_OE YIL099W S. 6027 Plastidic 6099, 6100 X_1
cerevisiae 1 68 NUE_OE YIL147C S. 6107 Cytoplasmic 6133, 6134 X_1
cerevisiae 1 69 NUE_OE YIR034C S. 6150 Cytoplasmic 6186, 6187 X_1
cerevisiae 1 70 NUE_OE YJL013C S. 6198 Cytoplasmic 6206, 6207 X_1
cerevisiae 1 71 NUE_OE YJL041W S. 6208 Cytoplasmic 6236, 6237 X_1
cerevisiae 1 72 NUE_OE YJL064W S. 6242 Cytoplasmic 6244, 6245 X_1
cerevisiae 1 73 NUE_OE YJL067W S. 6246 Cytoplasmic 6248, 6249 X_1
cerevisiae 1 74 NUE_OE YJL094C S. 6250 Cytoplasmic 6286, 6287 X_1
cerevisiae 1 75 NUE_OE YJL171C S. 6297 Cytoplasmic 6317, 6318 X_1
cerevisiae 1 76 NUE_OE YJL213W S. 6326 Cytoplasmic 6482, 6483 X_1
cerevisiae 1 77 NUE_OE YJR017C S. 6488 Cytoplasmic 6544, 6545 X_1
cerevisiae 1 78 NUE_OE YJR058C S. 6550 Cytoplasmic 6696, 6697 X_1
cerevisiae 1 79 NUE_OE YJR117W S. 6700 Cytoplasmic 6808, 6809 X_1
cerevisiae 1 80 NUE_OE YJR121W S. 6816 Cytoplasmic 7350, 7351 X_1
cerevisiae 1 81 NUE_OE YJR131W S. 7366 Cytoplasmic 7468, 7469 X_1
cerevisiae 1 82 NUE_OE YJR145C S. 7475 Cytoplasmic 7597, 7598 X_1
cerevisiae 1 83 NUE_OE YKL084W S. 7602 Cytoplasmic 7646, 7647 X_1
cerevisiae 1 84 NUE_OE YKL088W S. 7651 Cytoplasmic 7655, 7656 X_1
cerevisiae 1 85 NUE_OE YKL100C S. 7661 Cytoplasmic 7669, 7670 X_1
cerevisiae 1 86 NUE_OE YKL131W S. 7675 Cytoplasmic 7677, 7678 X_1
cerevisiae 1 87 NUE_OE YKL138C S. 7679 Cytoplasmic 7705, 7706 X_1
cerevisiae 1 88 NUE_OE YKL178C S. 7710 Cytoplasmic 7720, 7721 X_1
cerevisiae 1 89 NUE_OE YKL179C S. 7735 Cytoplasmic 7769, 7770 X_1
cerevisiae 1 90 NUE_OE YKL193C S. 7778 Cytoplasmic 7822, 7823 X_1
cerevisiae 1 91 NUE_OE YKL216W S. 7829 Cytoplasmic 8013, 8014 X_1
cerevisiae 1 92 NUE_OE YKR016W S. 8017 Cytoplasmic 8039, 8040 X_1
cerevisiae 1 93 NUE_OE YKR021W S. 8045 Cytoplasmic 8061, 8062 X_1
cerevisiae 1 94 NUE_OE YKR055W S. 8073 Cytoplasmic 8259, 8260 X_1
cerevisiae 1 95 NUE_OE YKR088C S. 8263 Plastidic 8281, 8282 X_1
cerevisiae 1 96 NUE_OE YKR093W S. 8287 Cytoplasmic 8463, 8464 X_1
cerevisiae 1 97 NUE_OE YKR099W S. 8468 Cytoplasmic 8474, 8475 X_1
cerevisiae 1 98 NUE_OE YKR100C S. 8484 Cytoplasmic 8490, 8491 X_1
cerevisiae 1 99 NUE_OE YLL014W S. 8492 Cytoplasmic 8510, 8511 X_1
cerevisiae 1 100 NUE_OE YLL016W S. 8514 Cytoplasmic 8528, 8529 X_1
cerevisiae 1 101 NUE_OE YLL023C S. 8539 Cytoplasmic 8567, 8568 X_1
cerevisiae 1 102 NUE_OE YLL037W S. 8571 Cytoplasmic 8573, 8574 X_1
cerevisiae 1 103 NUE_OE YLL049W S. 8575 Cytoplasmic 8577, 8578 X_1
cerevisiae 1 104 NUE_OE YLL055W S. 8579 Cytoplasmic 8657, 8658 X_1
cerevisiae 1 105 NUE_OE YLR034C S. 8661 Cytoplasmic 8983, 8984 X_1
cerevisiae 1 106 NUE_OE YLR042C S. 8991 Cytoplasmic 8993, 8994 X_1
cerevisiae 1 107 NUE_OE YLR053C S. 8995 Cytoplasmic 8997, 8998 X_1
cerevisiae 1 108 NUE_OE YLR058C S. 8999 Cytoplasmic 9541, 9542 X_1
cerevisiae 1 109 NUE_OE YLR060W S. 9551 Cytoplasmic 9629, 9630 X_1
cerevisiae 1 110 NUE_OE YLR065C S. 9637 Cytoplasmic 9669, 9670 X_1
cerevisiae 1 111 NUE_OE YLR070C S. 9672 Cytoplasmic 10178, 10179
X_1 cerevisiae 1 112 NUE_OE YLR100W S. 10182 Cytoplasmic 10204,
10205 X_1 cerevisiae 1 113 NUE_OE YLR109W S. 10214 Cytoplasmic
10444, 10445 X_1 cerevisiae 1 114 NUE_OE YLR125W S. 10447
Cytoplasmic 10449, 10450 X_1 cerevisiae 1 115 NUE_OE YLR127C S.
10451 Cytoplasmic 10461, 10462 X_1 cerevisiae 1 116 NUE_OE YLR185W
S. 10463 Cytoplasmic 10527, 10528 X_1 cerevisiae 1 117 NUE_OE
YLR204W S. 10533 Cytoplasmic 10539, 10540
X_1 cerevisiae 1 117 NUE_OE YLR204W S. 10533 Plastidic 10539, 10540
X_1 cerevisiae 1 118 NUE_OE YLR242C S. 10541 Cytoplasmic 10555,
10556 X_1 cerevisiae 1 119 NUE_OE YLR293C S. 10562 Cytoplasmic
10984, 10985 X_1 cerevisiae 1 120 NUE_OE YLR313C S. 10990
Cytoplasmic 10996, 10997 X_1 cerevisiae 1 121 NUE_OE YLR315W S.
10998 Cytoplasmic 11002, 11003 X_1 cerevisiae 1 122 NUE_OE YLR329W
S. 11004 Cytoplasmic 11010, 11011 X_1 cerevisiae 1 123 NUE_OE
YLR362W S. 11012 Cytoplasmic 11044, 11045 X_1 cerevisiae 1 124
NUE_OE YLR395C S. 11054 Cytoplasmic 11062, 11063 X_1 cerevisiae 1
125 NUE_OE YLR404W S. 11066 Cytoplasmic 11072, 11073 X_1 cerevisiae
1 126 NUE_OE YLR463C S. 11074 Cytoplasmic 11078, 11079 X_1
cerevisiae 1 127 NUE_OE YML022W S. 11080 Cytoplasmic 11548, 11549
X_1 cerevisiae 1 128 NUE_OE YML027W S. 11552 Cytoplasmic 11564,
11565 X_1 cerevisiae 1 129 NUE_OE YML065W S. 11569 Cytoplasmic
11587, 11588 X_1 cerevisiae 1 130 NUE_OE YML089C S. 11596
Cytoplasmic 11598, 11599 X_1 cerevisiae 1 131 NUE_OE YML128C S.
11600 Cytoplasmic 11610, 11611 X_1 cerevisiae 1 132 NUE_OE YMR011W
S. 11612 Cytoplasmic 12242, 12243 X_1 cerevisiae 1 133 NUE_OE
YMR037C S. 12246 Cytoplasmic 12256, 12257 X_1 cerevisiae 1 134
NUE_OE YMR049C S. 12263 Cytoplasmic 12299, 12300 X_1 cerevisiae 1
135 NUE_OE YMR052W S. 12316 Cytoplasmic 12322, 12323 X_1 cerevisiae
1 136 NUE_OE YMR082C S. 12327 Cytoplasmic 12329, 12330 X_1
cerevisiae 1 137 NUE_OE YMR125W S. 12331 Cytoplasmic 12367, 12368
X_1 cerevisiae 1 138 NUE_OE YMR126C S. 12378 Cytoplasmic 12386,
12387 X_1 cerevisiae 1 139 NUE_OE YMR144W S. 12394 Cytoplasmic
12400, 12401 X_1 cerevisiae 1 140 NUE_OE YMR160W S. 12406
Cytoplasmic 12412, 12413 X_1 cerevisiae 1 141 NUE_OE YMR191W S.
12414 Cytoplasmic 12418, 12419 X_1 cerevisiae 1 142 NUE_OE YMR209C
S. 12420 Cytoplasmic 12430, 12431 X_1 cerevisiae 1 143 NUE_OE
YMR233W S. 12440 Cytoplasmic 12466, 12467 X_1 cerevisiae 1 144
NUE_OE YMR278W S. 12470 Cytoplasmic 12740, 12741 X_1 cerevisiae 1
145 NUE_OE YMR280C S. 12749 Cytoplasmic 12757, 12758 X_1 cerevisiae
1 146 NUE_OE YNL014W S. 12773 Cytoplasmic 12811, 12812 X_1
cerevisiae 1 147 NUE_OE YNL320W S. 12829 Cytoplasmic 12875, 12876
X_1 cerevisiae 1 148 NUE_OE YOL007C S. 12883 Cytoplasmic 12887,
12888 X_1 cerevisiae 1 149 NUE_OE YOL164W S. 12889 Cytoplasmic
13001, 13002 X_1 cerevisiae 1 150 NUE_OE YOR076C S. 13014
Cytoplasmic 13016, 13017 X_1 cerevisiae 1 151 NUE_OE YOR083W S.
13018 Cytoplasmic 13022, 13023 X_1 cerevisiae 1 152 NUE_OE YOR097C
S. 13024 Cytoplasmic 13028, 13029 X_1 cerevisiae 1 153 NUE_OE
YOR128C S. 13030 Cytoplasmic 13100, 13101 X_1 cerevisiae 1 154
NUE_OE YOR353C S. 14085 Cytoplasmic 14091, 14092 X_1 cerevisiae 1
155 NUE_OE YPL141C S. 14093 Cytoplasmic 14101, 14102 X_1 cerevisiae
1 156 NUE_OE YPR088C S. 14113 Cytoplasmic 14235, 14236 X_1
cerevisiae 1 157 NUE_OE YPR108W S. 14246 Cytoplasmic 14300, 14301
X_1 cerevisiae 1 158 NUE_OE YPR110C S. 14311 Cytoplasmic 14383,
14384 X_1 cerevisiae 1 159 NUE_OE B3825_2 E. coli 14914 Plastidic
15010, 15011 X_1 1 160 NUE_OE YIR034C_2 S. 15382 Cytoplasmic 15420,
15421 X_1 cerevisiae 1 161 NUE_OE YJR131W_2 S. 15460 Cytoplasmic
15564, 15565 X_1 cerevisiae 1 162 NUE_OE YKL100C_2 S. 15571
Cytoplasmic 15581, 15582 X_1 cerevisiae 1 163 NUE_OE YKL193C_2 S.
15593 Cytoplasmic 15639, 15640 X_1 cerevisiae 1 164 NUE_OE
YLL016W_2 S. 15646 Cytoplasmic 15662, 15663 X_1 cerevisiae 1 165
NUE_OE YLR034C_2 S. 15673 Cytoplasmic 15997, 15998 X_1 cerevisiae 1
166 NUE_OE YLR060W_2 S. 16005 Cytoplasmic 16085, 16086 X_1
cerevisiae 1 167 NUE_OE YMR082C_2 S. 16114 Cytoplasmic 16118, 16119
X_1 cerevisiae 1 168 NUE_OE B1258 E. coli 14402 Cytoplasmic 14492,
14493 X_1 1 169 NUE_OE YML101C S. 16093 Cytoplasmic 16101, 16102
X_1 cerevisiae 1 170 NUE_OE YMR065W S. 16106 Cytoplasmic 16112,
16113 X_1 cerevisiae 1 171 NUE_OE YMR163C S. 16120 Cytoplasmic
16128, 16129 X_1 cerevisiae 1 172 NUE_OE YOL042W S. 16275
Cytoplasmic 16289, 16290 X_1 cerevisiae 1 173 NUE_OE YOR226C S.
16305 Cytoplasmic 16567, 16568 X_1 cerevisiae 1 174 NUE_OE YPL068C
S. 16573 Cytoplasmic 16579, 16580 X_1 cerevisiae 1 175 NUE_OE B0165
E. coli 14396 Plastidic 14400, 14401 X_1 1 176 NUE_OE YOR203W S.
16299 Cytoplasmic 16303, 16304 X_1 cerevisiae 1 177 NUE_OE YNL147W
S. 16133 Cytoplasmic 16271, 16272 X_1 cerevisiae 1 178 NUE_OE
YBR083W S. 15056 Cytoplasmic 15062, 15063 X_1 cerevisiae 1 179
NUE_OE YKL111C S. 15587 Cytoplasmic 15591, 15592 X_1 cerevisiae 1
180 NUE_OE YPR067W S. 16582 Cytoplasmic 16624, 16625 X_1 cerevisiae
1 181 NUE_OE B1985 E. coli 14839 Cytoplasmic 14867, 14868 X_1 1 182
NUE_OE B3838 E. coli 15014 Cytoplasmic 15050, 15051 X_1 1 183
NUE_OE YJL010C S. 15432 Cytoplasmic 15450, 15451 X_1 cerevisiae 1
184 NUE_OE B1267 E. coli 14497 Cytoplasmic 14713, 14714 X_1 1 185
NUE_OE B1322 E. coli 14718 Cytoplasmic 14786, 14787 X_1 1 186
NUE_OE B1381 E. coli 14791 Cytoplasmic 14821, 14822 X_1 1 187
NUE_OE B2646 E. coli 14879 Cytoplasmic 14909, 14910 X_1 1 188
NUE_OE YBR191W S. 15064 Cytoplasmic 15250, 15251 X_1 cerevisiae 1
189 NUE_OE YDL135C S. 15257 Cytoplasmic 15373, 15374 X_1 cerevisiae
1 190 NUE_OE YHL005C S. 15378 Cytoplasmic 15380, 15381 X_1
cerevisiae 1 191 NUE_OE YKR100C_2 S. 16629 Cytoplasmic 16639, 16640
X_1 cerevisiae 1 192 NUE_OE YMR191W_2 S. 16647 Cytoplasmic 16653,
16654 X_1 cerevisiae
TABLE-US-00022 TABLE IV Consensus amino acid sequence ID numbers 5.
7. 1. 2. 3. 4. Lead 6. SEQ IDs of Consensus/ Application Hit
Project Locus Organism SEQ ID Target Pattern Sequences 1 1 NUE_OE
B0017 E. coli 39 Cytoplasmic -- X_1 1 2 NUE_OE B0045 E. coli 43
Cytoplasmic 120, 121, 122 X_1 1 3 NUE_OE B0180 E. coli 124
Plastidic 377, 378, 379 X_1 1 4 NUE_OE B0242 E. coli 381 Plastidic
672, 673, 674, 675, 676, 677, 678 X_1 1 5 NUE_OE B0403 E. coli 680
Plastidic 803, 804, 805, 806, 807, 808, 809, 810, 811 X_1 1 6
NUE_OE B0474 E. coli 813 Cytoplasmic 1052, 1053, 1054 X_1 1 7
NUE_OE B0754 E. coli 1056 Plastidic 1553, 1554, 1555, 1556, 1557,
1558, 1559, 1560, X_1 1561, 1562 1 8 NUE_OE B0784 E. coli 1564
Cytoplasmic 1703, 1704 X_1 1 9 NUE_OE B0873 E. coli 1706 Plastidic
1833, 1834, 1835, 1836, 1837, 1838, 1839, 1840, X_1 1841, 1842,
1843 1 10 NUE_OE B1014 E. coli 1845 Cytoplasmic 1934, 1935, 1936,
1937, 1938, 1939, 1940, 1941, X_1 1942, 1943, 1944, 1945, 1946,
1947, 1948, 1949 1 11 NUE_OE B1020 E. coli 1951 Plastidic 1968,
1969, 1970, 1971, 1972, 1973, 1974 X_1 1 12 NUE_OE B1180 E. coli
1976 Cytoplasmic 2123, 2124, 2125, 2126 X_1 1 13 NUE_OE B1933 E.
coli 2128 Plastidic -- X_1 1 14 NUE_OE B2032 E. coli 2136 Plastidic
2169, 2170 X_1 1 15 NUE_OE B2165 E. coli 2172 Plastidic 2291, 2292,
2293, 2294, 2295, 2296 X_1 1 16 NUE_OE B2223 E. coli 2298 Plastidic
2421, 2422, 2423, 2424, 2425 X_1 1 17 NUE_OE B2238 E. coli 2427
Plastidic 2446, 2447, 2448, 2449, 2450, 2451 X_1 1 17 NUE_OE B2238
E. coli 2427 Cytoplasmic 2446, 2447, 2448, 2449, 2450, 2451 X_1 1
18 NUE_OE B2310 E. coli 2453 Plastidic 2546, 2547, 2548, 2549, 2550
X_1 1 19 NUE_OE B2431 E. coli 2552 Plastidic 2593, 2594, 2595,
2596, 2597, 2598, 2599 X_1 1 20 NUE_OE B2600 E. coli 2601 Plastidic
2660, 2661, 2662, 2663, 2664, 2665, 2666, 2667 X_1 1 21 NUE_OE
B2766 E. coli 2669 Plastidic 2768, 2769, 2770, 2771 X_1 1 22 NUE_OE
B2903 E. coli 2773 Cytoplasmic 3102, 3103, 3104, 3105, 3106, 3107,
3108, 3109, X_1 3110, 3111, 3112, 3113, 3114, 3115, 3116 1 23
NUE_OE B3117 E. coli 3118 Plastidic 3385, 3386, 3387, 3388, 3389
X_1 1 24 NUE_OE B3120 E. coli 3391 Plastidic -- X_1 1 25 NUE_OE
B3216 E. coli 3397 Plastidic 3468, 3469 X_1 1 26 NUE_OE B3451 E.
coli 3471 Plastidic 3558, 3559, 3560, 3561, 3562 X_1 1 27 NUE_OE
B3791 E. coli 3564 Cytoplasmic 3767, 3768, 3769 X_1 1 28 NUE_OE
B3825 E. coli 3771 Plastidic 3866, 3867 X_1 1 29 NUE_OE YAL019W S.
3869 Cytoplasmic 3880, 3881, 3882, 3883, 3884, 3885, 3886, 3887,
X_1 cerevisiae 3888, 3889, 3890, 3891, 3892, 3893, 3894 1 30 NUE_OE
YAR035W S. 3896 Cytoplasmic 3943, 3944, 3945, 3946, 3947, 3948,
3949, 3950, X_1 cerevisiae 3951, 3952 1 31 NUE_OE YBL021C S. 3954
Cytoplasmic 4109, 4110 X_1 cerevisiae 1 32 NUE_OE YBR055C S. 4112
Cytoplasmic 4143, 4144, 4145, 4145, 4147, 4148 X_1 cerevisiae 1 33
NUE_OE YBR128C S. 4150 Cytoplasmic 4159, 4160, 4161 X_1 cerevisiae
1 34 NUE_OE YBR159W S. 4163 Cytoplasmic 4230, 4231, 4232, 4233,
4234 X_1 cerevisiae 1 35 NUE_OE YBR243C S. 4236 Cytoplasmic 4273,
4274, 4275, 4276, 4277, 4278, 4279 X_1 cerevisiae 1 35 NUE_OE
YBR243C S. 4236 Plastidic 4273, 4274, 4275, 4276, 4277, 4278, 4279
X_1 cerevisiae 1 36 NUE_OE YBR262C S. 4281 Cytoplasmic -- X_1
cerevisiae 1 37 NUE_OE YCR019W S. 4289 Cytoplasmic 4308, 4309,
4310, 4311, 4312, 4313, 4314 X_1 cerevisiae 1 38 NUE_OE YDR070C S.
4316 Cytoplasmic 4323, 4324 X_1 cerevisiae 1 39 NUE_OE YDR079W S.
4326 Cytoplasmic 4333, 4334 X_1 cerevisiae 1 40 NUE_OE YDR123C S.
4336 Cytoplasmic 4343, 4344, 4345 X_1 cerevisiae 1 41 NUE_OE
YDR137W S. 4347 Cytoplasmic 4354, 4355, 4356, 4357, 4358, 4359,
4360 X_1 cerevisiae 1 42 NUE_OE YDR294C S. 4362 Cytoplasmic 4393,
4394, 4395, 4396, 4397, 4398, 4399, 4400, X_1 cerevisiae 4401 1 42
NUE_OE YDR294C S. 4362 Plastidic 4393, 4394, 4395, 4396, 4397,
4398, 4399, 4400, X_1 cerevisiae 4401 1 43 NUE_OE YDR330W S. 4403
Cytoplasmic 4426, 4427, 4428, 4429, 4430 X_1 cerevisiae 1 44 NUE_OE
YDR355C S. 4432 Cytoplasmic -- X_1 cerevisiae 1 45 NUE_OE YDR430C
S. 4436 Plastidic 4471, 4472, 4473, 4474, 4475, 4476, 4477, 4478,
X_1 cerevisiae 4479, 4480, 4481, 4482, 4483, 4484 1 46 NUE_OE
YDR472W S. 4486 Cytoplasmic 4499, 4500, 4501, 4502, 4503, 4504,
4505 X_1 cerevisiae 1 47 NUE_OE YDR497C S. 4507 Plastidic 4788,
4789 X_1 cerevisiae 1 48 NUE_OE YER029C S. 4791 Cytoplasmic 4802,
4803, 4804, 4805 X_1 cerevisiae 1 49 NUE_OE YFR007W S. 4807
Cytoplasmic 4832, 4833, 4834, 4835 X_1 cerevisiae 1 50 NUE_OE
YGL039W S. 4837 Cytoplasmic 5308, 5309, 5310 X_1 cerevisiae 1 51
NUE_OE YGL043W S. 5312 Cytoplasmic 5343, 5344, 5345 X_1 cerevisiae
1 52 NUE_OE YGR088W S. 5347 Cytoplasmic 5528, 5529, 5530, 5531,
5532 X_1 cerevisiae 1 53 NUE_OE YGR122C-A S. 5534 Cytoplasmic 5549,
5550 X_1 cerevisiae 1 54 NUE_OE YGR142W S. 5552 Cytoplasmic -- X_1
cerevisiae 1 55 NUE_OE YGR143W S. 5560 Cytoplasmic 5589, 5590,
5591, 5592, 5593, 5594, 5595, 5596, X_1 cerevisiae 5597, 5598,
5599, 5600, 5601 1 56 NUE_OE YGR165W S. 5603 Cytoplasmic -- X_1
cerevisiae 1 57 NUE_OE YGR170W S. 5609 Cytoplasmic -- X_1
cerevisiae 1 58 NUE_OE YGR202C S. 5615 Cytoplasmic 5662, 5663,
5664, 5665 X_1 cerevisiae 1 59 NUE_OE YGR266W S. 5667 Cytoplasmic
5690, 5691, 5692, 5693, 5694, 5695, 5696, 5697, X_1 cerevisiae
5698, 5699, 5700 1 60 NUE_OE YGR282C S. 5702 Cytoplasmic 5743,
5744, 5745, 5746, 5747, 5748, 5749 X_1 cerevisiae 1 61 NUE_OE
YGR290W S. 5751 Cytoplasmic -- X_1 cerevisiae 1 62 NUE_OE YHL021C
S. 5755 Cytoplasmic 5772, 5773, 5774, 5775, 5776, 5777 X_1
cerevisiae 1 63 NUE_OE YHL031C S. 5779 Cytoplasmic 5810, 5811 X_1
cerevisiae 1 64 NUE_OE YHR011W S. 5813 Cytoplasmic 5962, 5963,
5964, 5965, 5966 X_1 cerevisiae 1 65 NUE_OE YHR127W S. 5968
Cytoplasmic -- X_1 cerevisiae 1 66 NUE_OE YHR137W S. 5974
Cytoplasmic 6023, 6024, 6025, 6026 X_1 cerevisiae 1 66 NUE_OE
YHR137W S. 5974 Plastidic 6023, 6024, 6025, 6026 X_1 cerevisiae 1
67 NUE_OE YIL099W S. 6028 Cytoplasmictidic 6101, 6102, 6103, 6104,
6105, 6106 X_1 cerevisiae 1 67 NUE_OE YIL099W S. 6028 Plastidic
6101, 6102, 6103, 6104, 6105, 6106 X_1 cerevisiae 1 68 NUE_OE
YIL147C S. 6108 Cytoplasmic 6135, 6136, 6137, 6138, 6139, 6140,
6141, 6142, X_1 cerevisiae 6143, 6144, 6145, 6146, 6147, 6148, 6149
1 69 NUE_OE YIR034C S. 6151 Cytoplasmic 6188, 6189, 6190, 6191,
6192, 6193, 6194, 6195, X_1 cerevisiae 6196, 6197 1 70 NUE_OE
YJL013C S. 6199 Cytoplasmic -- X_1 cerevisiae 1 71 NUE_OE YJL041W
S. 6209 Cytoplasmic 6238, 6239, 6240, 6241 X_1 cerevisiae 1 72
NUE_OE YJL064W S. 6243 Cytoplasmic -- X_1 cerevisiae 1 73 NUE_OE
YJL067W S. 6247 Cytoplasmic -- X_1 cerevisiae 1 74 NUE_OE YJL094C
S. 6251 Cytoplasmic 6288, 6289, 6290, 6291, 6292, 6293, 6294, 6295,
X_1 cerevisiae 6296 1 75 NUE_OE YJL171C S. 6298 Cytoplasmic 6319,
6320, 6321, 6322, 6323, 6324, 6325 X_1 cerevisiae 1 76 NUE_OE
YJL213W S. 6327 Cytoplasmic 6484, 6485, 6486, 6487 X_1 cerevisiae 1
77 NUE_OE YJR017C S. 6489 Cytoplasmic 6546, 6547, 6548, 6549 X_1
cerevisiae 1 78 NUE_OE YJR058C S. 6551 Cytoplasmic 6698, 6699 X_1
cerevisiae 1 79 NUE_OE YJR117W S. 6701 Cytoplasmic 6810, 6811,
6812, 6813, 6814, 6815 X_1 cerevisiae 1 80 NUE_OE YJR121W S. 6817
Cytoplasmic 7352, 7353, 7354, 7355, 7356, 7357, 7358, 7359, X_1
cerevisiae 7360, 7361, 7362, 7363, 7364, 7365 1 81 NUE_OE YJR131W
S. 7367 Cytoplasmic 7470, 7471, 7472, 7473, 7474 X_1 cerevisiae 1
82 NUE_OE YJR145C S. 7476 Cytoplasmic 7599, 7600, 7601 X_1
cerevisiae 1 83 NUE_OE YKL084W S. 7603 Cytoplasmic 7648, 7649, 7650
X_1 cerevisiae 1 84 NUE_OE YKL088W S. 7652 Cytoplasmic 7657, 7658,
7659, 7660 X_1 cerevisiae 1 85 NUE_OE YKL100C S. 7662 Cytoplasmic
7671, 7672, 7673, 7674 X_1 cerevisiae 1 86 NUE_OE YKL131W S. 7676
Cytoplasmic -- X_1 cerevisiae 1 87 NUE_OE YKL138C S. 7680
Cytoplasmic 7707, 7708, 7709 X_1 cerevisiae 1 88 NUE_OE YKL178C S.
7711 Cytoplasmic 7722, 7723, 7724, 7725, 7726, 7727, 7728, 7729,
X_1 cerevisiae 7730, 7731, 7732, 7733, 7734 1 89 NUE_OE YKL179C S.
7736 Cytoplasmic 7771, 7772, 7773, 7774, 7775, 7776, 7777 X_1
cerevisiae 1 90 NUE_OE YKL193C S. 7779 Cytoplasmic 7824, 7825,
7826, 7827, 7828 X_1 cerevisiae 1 91 NUE_OE YKL216W S. 7830
Cytoplasmic 8015, 8016 X_1 cerevisiae 1 92 NUE_OE YKR016W S. 8018
Cytoplasmic 8041, 8042, 8043, 8044 X_1 cerevisiae 1 93 NUE_OE
YKR021W S. 8046 Cytoplasmic 8063, 8064, 8065, 8066, 8067, 8068,
8069, 8070, X_1 cerevisiae 8071, 8072 1 94 NUE_OE YKR055W S. 8074
Cytoplasmic 8261, 8262 X_1 cerevisiae 1 95 NUE_OE YKR088C S. 8264
Plastidic 8283, 8284, 8285, 8286 X_1 cerevisiae 1 96 NUE_OE YKR093W
S. 8288 Cytoplasmic 8465, 8466, 8467 X_1 cerevisiae 1 97 NUE_OE
YKR099W S. 8469 Cytoplasmic 8476, 8477, 8478, 8479, 8480, 8481,
8482, 8483 X_1 cerevisiae 1 98 NUE_OE YKR100C S. 8485 Cytoplasmic
-- X_1 cerevisiae
1 99 NUE_OE YLL014W S. 8493 Cytoplasmic 8512, 8513 X_1 cerevisiae 1
100 NUE_OE YLL016W S. 8515 Cytoplasmic 8530, 8531, 8532, 8533,
8534, 8535, 8536, 8537, X_1 cerevisiae 8538 1 101 NUE_OE YLL023C S.
8540 Cytoplasmic 8569, 8570 X_1 cerevisiae 1 102 NUE_OE YLL037W S.
8572 Cytoplasmic -- X_1 cerevisiae 1 103 NUE_OE YLL049W S. 8576
Cytoplasmic -- X_1 cerevisiae 1 104 NUE_OE YLL055W S. 8580
Cytoplasmic 8659, 8660 X_1 cerevisiae 1 105 NUE_OE YLR034C S. 8662
Cytoplasmic 8985, 8986, 8987, 8988, 8989, 8990 X_1 cerevisiae 1 106
NUE_OE YLR042C S. 8992 Cytoplasmic -- X_1 cerevisiae 1 107 NUE_OE
YLR053C S. 8996 Cytoplasmic -- X_1 cerevisiae 1 108 NUE_OE YLR058C
S. 9000 Cytoplasmic 9543, 9544, 9545, 9546, 9547, 9548, 9549, 9550
X_1 cerevisiae 1 109 NUE_OE YLR060W S. 9552 Cytoplasmic 9631, 9632,
9633, 9634, 9635, 9636 X_1 cerevisiae 1 110 NUE_OE YLR065C S. 9638
Cytoplasmic 9671 X_1 cerevisiae 1 111 NUE_OE YLR070C S. 9673
Cytoplasmic 10180, 10181 X_1 cerevisiae 1 112 NUE_OE YLR100W S.
10183 Cytoplasmic 10206, 10207, 10208, 10209, 10210, 10211, 10212,
X_1 cerevisiae 10213 1 113 NUE_OE YLR109W S. 10215 Cytoplasmic
10446 X_1 cerevisiae 1 114 NUE_OE YLR125W S. 10448 Cytoplasmic --
X_1 cerevisiae 1 115 NUE_OE YLR127C S. 10452 Cytoplasmic -- X_1
cerevisiae 1 116 NUE_OE YLR185W S. 10464 Cytoplasmic 10529, 10530,
10531, 10532 X_1 cerevisiae 1 117 NUE_OE YLR204W S. 10534
Cytoplasmic -- X_1 cerevisiae 1 117 NUE_OE YLR204W S. 10534
Plastidic -- X_1 cerevisiae 1 118 NUE_OE YLR242C S. 10542
Cytoplasmic 10557, 10558, 10559, 10560, 10561 X_1 cerevisiae 1 119
NUE_OE YLR293C S. 10563 Cytoplasmic 10986, 10987, 10988, 10989 X_1
cerevisiae 1 120 NUE_OE YLR313C S. 10991 Cytoplasmic -- X_1
cerevisiae 1 121 NUE_OE YLR315W S. 10999 Cytoplasmic -- X_1
cerevisiae 1 122 NUE_OE YLR329W S. 11005 Cytoplasmic -- X_1
cerevisiae 1 123 NUE_OE YLR362W S. 11013 Cytoplasmic 11046, 11047,
11048, 11049, 11050, 11051, 11052, X_1 cerevisiae 11053 1 124
NUE_OE YLR395C S. 11055 Cytoplasmic 11064, 11065 X_1 cerevisiae 1
125 NUE_OE YLR404W S. 11067 Cytoplasmic -- X_1 cerevisiae 1 126
NUE_OE YLR463C S. 11075 Cytoplasmic -- X_1 cerevisiae 1 127 NUE_OE
YML022W S. 11081 Cytoplasmic 11550, 11551 X_1 cerevisiae 1 128
NUE_OE YML027W S. 11553 Cytoplasmic 11566, 11567, 11568 X_1
cerevisiae 1 129 NUE_OE YML065W S. 11570 Cytoplasmic 11589, 11590,
11591, 11592, 11593, 11594, 11595 X_1 cerevisiae 1 130 NUE_OE
YML089C S. 11597 Cytoplasmic -- X_1 cerevisiae 1 131 NUE_OE YML128C
S. 11601 Cytoplasmic -- X_1 cerevisiae 1 132 NUE_OE YMR011W S.
11613 Cytoplasmic 12244, 12245 X_1 cerevisiae 1 133 NUE_OE YMR037C
S. 12247 Cytoplasmic 12258, 12259, 12260, 12261, 12262 X_1
cerevisiae 1 134 NUE_OE YMR049C S. 12264 Cytoplasmic 12301, 12302,
12303, 12304, 12305, 12306, 12307, X_1 cerevisiae 12308, 12309,
12310, 12311, 12312, 12313, 12314, 12315 1 135 NUE_OE YMR052W S.
12317 Cytoplasmic 12324, 12325, 12326 X_1 cerevisiae 1 136 NUE_OE
YMR082C S. 12328 Cytoplasmic -- X_1 cerevisiae 1 137 NUE_OE YMR125W
S. 12332 Cytoplasmic 12369, 12370, 12371, 12372, 12373, 12374,
12375, X_1 cerevisiae 12376, 12377 1 138 NUE_OE YMR126C S. 12379
Cytoplasmic 12388, 12389, 12390, 12391, 12392, 12393 X_1 cerevisiae
1 139 NUE_OE YMR144W S. 12395 Cytoplasmic 12402, 12403, 12404,
12405 X_1 cerevisiae 1 140 NUE_OE YMR160W S. 12407 Cytoplasmic --
X_1 cerevisiae 1 141 NUE_OE YMR191W S. 12415 Cytoplasmic -- X_1
cerevisiae 1 142 NUE_OE YMR209C S. 12421 Cytoplasmic 12432, 12433,
12434, 12435, 12436, 12437, 12438, X_1 cerevisiae 12439 1 143
NUE_OE YMR233W S. 12441 Cytoplasmic 12468, 12469 X_1 cerevisiae 1
144 NUE_OE YMR278W S. 12471 Cytoplasmic 12742, 12743, 12744, 12745,
12746, 12747, 12748 X_1 cerevisiae 1 145 NUE_OE YMR280C S. 12750
Cytoplasmic 12759, 12760, 12761, 12762, 12763, 12764, 12765, X_1
cerevisiae 12766, 12767, 12768, 12769, 12770, 12771, 12772 1 146
NUE_OE YNL014W S. 12774 Cytoplasmic 12813, 12814, 12815, 12816,
12817, 12818, 12819, X_1 cerevisiae 12820, 12821, 12822, 12823,
12824, 12825, 12826, 12827, 12828 1 147 NUE_OE YNL320W S. 12830
Cytoplasmic 12877, 12878, 12879, 12880, 12881, 12882 X_1 cerevisiae
1 148 NUE_OE YOL007C S. 12884 Cytoplasmic -- X_1 cerevisiae 1 149
NUE_OE YOL164W S. 12890 Cytoplasmic 13003, 13004, 13005, 13006,
13007, 13008, 13009, X_1 cerevisiae 13010, 13011, 13012, 13013 1
150 NUE_OE YOR076C S. 13015 Cytoplasmic -- X_1 cerevisiae 1 151
NUE_OE YOR083W S. 13019 Cytoplasmic -- X_1 cerevisiae 1 152 NUE_OE
YOR097C S. 13025 Cytoplasmic -- X_1 cerevisiae 1 153 NUE_OE YOR128C
S. 13031 Cytoplasmic 13102, 13103, 13104, 13105, 13106, 13107,
13108, X_1 cerevisiae 13109, 13110, 13111, 13112, 13113, 13114 1
154 NUE_OE YOR353C S. 14086 Cytoplasmic -- X_1 cerevisiae 1 155
NUE_OE YPL141C S. 14094 Cytoplasmic 14103, 14104, 14105, 14106,
14107, 14108, 14109, X_1 cerevisiae 14110, 14111, 14112 1 156
NUE_OE YPR088C S. 14114 Cytoplasmic 14237, 14238, 14239, 14240,
14241, 14242, 14243, X_1 cerevisiae 14244, 14245 1 157 NUE_OE
YPR108W S. 14247 Cytoplasmic 14302, 14303, 14304, 14305, 14306,
14307, 14308, X_1 cerevisiae 14309, 14310 1 158 NUE_OE YPR110C S.
14312 Cytoplasmic 14385, 14386, 14387, 14388 X_1 cerevisiae 1 159
NUE_OE B3825_2 E. coli 14915 Plastidic 15012, 15013 X_1 1 160
NUE_OE YIR034C_2 S. 15383 Cytoplasmic 15422, 15423, 15424, 15425,
15426, 15427, 15428, X_1 cerevisiae 15429, 15430, 15431 1 161
NUE_OE YJR131W_2 S. 15461 Cytoplasmic 15566, 15567, 15568, 15569,
15570 X_1 cerevisiae 1 162 NUE_OE YKL100C_2 S. 15572 Cytoplasmic
15583, 15584, 15585, 15586 X_1 cerevisiae 1 163 NUE_OE YKL193C_2 S.
15594 Cytoplasmic 15641, 15642, 15643, 15644, 15645 X_1 cerevisiae
1 164 NUE_OE YLL016W_2 S. 15647 Cytoplasmic 15664, 15665, 15666,
15667, 15668, 15669, 15670, X_1 cerevisiae 15671, 15672 1 165
NUE_OE YLR034C_2 S. 15674 Cytoplasmic 15999, 16000, 16001, 16002,
16003, 16004 X_1 cerevisiae 1 166 NUE_OE YLR060W_2 S. 16006
Cytoplasmic 16087, 16088, 16089, 16090, 16091, 16092 X_1 cerevisiae
1 167 NUE_OE YMR082C_2 S. 16115 Cytoplasmic -- X_1 cerevisiae 1 168
NUE_OE B1258 E. coli 14403 Cytoplasmic 14494, 14495, 14496 X_1 1
169 NUE_OE YML101C S. 16094 Cytoplasmic 16103, 16104, 16105 X_1
cerevisiae 1 170 NUE_OE YMR065W S. 16107 Cytoplasmic -- X_1
cerevisiae 1 171 NUE_OE YMR163C S. 16121 Cytoplasmic 16130, 16131,
16132 X_1 cerevisiae 1 172 NUE_OE YOL042W S. 16276 Cytoplasmic
16291, 16292, 16293, 16294, 16295, 16296, 16297, X_1 cerevisiae
16298 1 173 NUE_OE YOR226C S. 16306 Cytoplasmic 16569, 16570,
16571, 16572 X_1 cerevisiae 1 174 NUE_OE YPL068C S. 16574
Cytoplasmic 16581 X_1 cerevisiae 1 175 NUE_OE B0165 E. coli 14397
Plastidic -- X_1 1 176 NUE_OE YOR203W S. 16300 Cytoplasmic -- X_1
cerevisiae 1 177 NUE_OE YNL147W S. 16134 Cytoplasmic 16273, 16274
X_1 cerevisiae 1 178 NUE_OE YBR083W S. 15057 Cytoplasmic -- X_1
cerevisiae 1 179 NUE_OE YKL111C S. 15588 Cytoplasmic -- X_1
cerevisiae 1 180 NUE_OE YPR067W S. 16583 Cytoplasmic 16626, 16627,
16628 X_1 cerevisiae 1 181 NUE_OE B1985 E. coli 14840 Cytoplasmic
14869, 14870, 14871, 14872, 14873, 14874, 14875, X_1 14876, 14877,
14878 1 182 NUE_OE B3838 E. coli 15015 Cytoplasmic 15052, 15053,
15054, 15055 X_1 1 183 NUE_OE YJL010C S. 15433 Cytoplasmic 15452,
15453, 15454, 15455, 15456, 15457, 15458, X_1 cerevisiae 15459 1
184 NUE_OE B1267 E. coli 14498 Cytoplasmic 14715, 14716, 14717 X_1
1 185 NUE_OE B1322 E. coli 14719 Cytoplasmic 14788, 14789, 14790
X_1 1 186 NUE_OE B1381 E. coli 14792 Cytoplasmic 14823, 14824,
14825, 14826, 14827, 14828, 14829, X_1 14830, 14831, 14832, 14833,
14834, 14835, 14836, 14837, 14838 1 187 NUE_OE B2646 E. coli 14880
Cytoplasmic 14911, 14912, 14913 X_1 1 188 NUE_OE YBR191W S. 15065
Cytoplasmic 15252, 15253, 15254, 15255, 15256 X_1 cerevisiae 1 189
NUE_OE YDL135C S. 15258 Cytoplasmic 15375, 15376, 15377 X_1
cerevisiae 1 190 NUE_OE YHL005C S. 15379 Cytoplasmic -- X_1
cerevisiae 1 191 NUE_OE YKR100C_2 S. 16630 Cytoplasmic 16641,
16642, 16643, 16644, 16645, 16646 X_1 cerevisiae 1 192 NUE_OE
YMR191W_2 S. 16648 Cytoplasmic -- X_1 cerevisiae
Sequence CWU 0 SQTB SEQUENCE LISTING The patent application
contains a lengthy "Sequence Listing" section. A copy of the
"Sequence Listing" is available in electronic form from the USPTO
web site
(http://seqdata.uspto.gov/?pageRequest=docDetail&DocID=US20140223605A1).
An electronic copy of the "Sequence Listing" will also be available
from the USPTO upon request and payment of the fee set forth in 37
CFR 1.19(b)(3).
0 SQTB SEQUENCE LISTING The patent application contains a lengthy
"Sequence Listing" section. A copy of the "Sequence Listing" is
available in electronic form from the USPTO web site
(http://seqdata.uspto.gov/?pageRequest=docDetail&DocID=US20140223605A1).
An electronic copy of the "Sequence Listing" will also be available
from the USPTO upon request and payment of the fee set forth in 37
CFR 1.19(b)(3).
* * * * *
References